project.project_id	cases.case_id	cases.consent_type	cases.days_to_consent	cases.disease_type	cases.index_date	cases.lost_to_followup	cases.primary_site	cases.submitter_id	demographic.age_at_index	demographic.age_is_obfuscated	demographic.country_of_residence_at_enrollment	demographic.days_to_birth	demographic.days_to_death	demographic.demographic_id	demographic.ethnicity	demographic.gender	demographic.race	demographic.submitter_id	demographic.vital_status	diagnoses.age_at_diagnosis	diagnoses.ajcc_pathologic_m	diagnoses.ajcc_pathologic_n	diagnoses.ajcc_pathologic_stage	diagnoses.ajcc_pathologic_t	diagnoses.ajcc_staging_system_edition	diagnoses.classification_of_tumor	diagnoses.days_to_diagnosis	diagnoses.days_to_last_follow_up	diagnoses.diagnosis_id	diagnoses.diagnosis_is_primary_disease	diagnoses.figo_stage	diagnoses.figo_staging_edition_year	diagnoses.icd_10_code	diagnoses.laterality	diagnoses.morphology	diagnoses.primary_diagnosis	diagnoses.prior_malignancy	diagnoses.prior_treatment	diagnoses.residual_disease	diagnoses.site_of_resection_or_biopsy	diagnoses.sites_of_involvement	diagnoses.submitter_id	diagnoses.synchronous_malignancy	diagnoses.tissue_or_organ_of_origin	diagnoses.tumor_of_origin	diagnoses.year_of_diagnosis	treatments.clinical_trial_indicator	treatments.course_number	treatments.days_to_treatment_end	treatments.days_to_treatment_start	treatments.initial_disease_status	treatments.number_of_cycles	treatments.number_of_fractions	treatments.prescribed_dose	treatments.prescribed_dose_units	treatments.route_of_administration	treatments.submitter_id	treatments.therapeutic_agents	treatments.treatment_anatomic_sites	treatments.treatment_dose	treatments.treatment_dose_units	treatments.treatment_id	treatments.treatment_intent_type	treatments.treatment_or_therapy	treatments.treatment_outcome	treatments.treatment_type
TCGA-LUAD	0075437e-ba1a-46be-86d6-9773209a2b5e	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A471	64	false	Germany	-23689	NA	407caae1-7c07-52e1-bca7-1e60cac760eb	not hispanic or latino	male	white	TCGA-62-A471_demographic	Alive	23689	M0	N1	Stage IIB	T2b	7th	primary	0	1246.0	9d67b469-c047-55a5-a9df-5637f9f086f8	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A471_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	115	41	NA	NA	NA	NA	NA	NA	TCGA-62-A471_treatment3	Gemcitabine	NA	NA	NA	6ed4e391-74f1-4a56-8fbe-b7a10081d85b	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	0075437e-ba1a-46be-86d6-9773209a2b5e	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A471	64	false	Germany	-23689	NA	407caae1-7c07-52e1-bca7-1e60cac760eb	not hispanic or latino	male	white	TCGA-62-A471_demographic	Alive	23689	M0	N1	Stage IIB	T2b	7th	primary	0	1246.0	9d67b469-c047-55a5-a9df-5637f9f086f8	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A471_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	115	41	NA	NA	NA	NA	NA	NA	TCGA-62-A471_treatment2	Vinorelbine	NA	NA	NA	7f648a1d-7e98-496e-afff-66cf765d49e0	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	0075437e-ba1a-46be-86d6-9773209a2b5e	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A471	64	false	Germany	-23689	NA	407caae1-7c07-52e1-bca7-1e60cac760eb	not hispanic or latino	male	white	TCGA-62-A471_demographic	Alive	23689	M0	N1	Stage IIB	T2b	7th	primary	0	1246.0	9d67b469-c047-55a5-a9df-5637f9f086f8	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A471_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	115	41	NA	NA	NA	NA	NA	NA	TCGA-62-A471_treatment	Cisplatin	NA	NA	NA	a5872c92-954a-5007-a67c-79c357655640	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	0075437e-ba1a-46be-86d6-9773209a2b5e	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A471	64	false	Germany	-23689	NA	407caae1-7c07-52e1-bca7-1e60cac760eb	not hispanic or latino	male	white	TCGA-62-A471_demographic	Alive	23689	M0	N1	Stage IIB	T2b	7th	primary	0	1246.0	9d67b469-c047-55a5-a9df-5637f9f086f8	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A471_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A471_treatment4	NA	NA	NA	NA	d26f5579-57be-4e36-af37-304b01c797ad	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	009be09b-f9f6-43b7-8f45-4a648f8123ce	Informed Consent	50	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-3773	84	false	United States	-30706	NA	22e32c54-e038-5b18-8f1e-8184b923c34d	not hispanic or latino	female	white	TCGA-67-3773_demographic	Alive	30706	M0	N0	Stage IB	T2	6th	primary	0	427.0	cc1a07f6-2771-53a6-a02b-d2a52e063776	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-3773_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	0147edcf-0ca5-4136-bd01-43d05e2843f4	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z038	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	01e9888d-b5b9-48f1-8ba6-8a89af108a04	Informed Consent	-35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-NJ-A7XG	49	false	United States	-18127	NA	ee21825a-40dd-5de1-b004-a94d75b4afa1	not hispanic or latino	male	black or african american	TCGA-NJ-A7XG_demographic	Alive	18127	M0	N1	Stage IIIA	T4	7th	primary	0	617.0	69ddef8c-88d5-51ce-bb91-010fa2059f66	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-NJ-A7XG_diagnosis	No	Upper lobe, lung	NA	2013	No	NA	128	30	NA	NA	NA	NA	NA	NA	TCGA-NJ-A7XG_treatment3	Pemetrexed	NA	NA	NA	0377ef38-910c-4067-9772-63ae7b82c6d5	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	01e9888d-b5b9-48f1-8ba6-8a89af108a04	Informed Consent	-35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-NJ-A7XG	49	false	United States	-18127	NA	ee21825a-40dd-5de1-b004-a94d75b4afa1	not hispanic or latino	male	black or african american	TCGA-NJ-A7XG_demographic	Alive	18127	M0	N1	Stage IIIA	T4	7th	primary	0	617.0	69ddef8c-88d5-51ce-bb91-010fa2059f66	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-NJ-A7XG_diagnosis	No	Upper lobe, lung	NA	2013	No	NA	100	30	NA	NA	NA	NA	NA	NA	TCGA-NJ-A7XG_treatment	Cisplatin	NA	NA	NA	34e2f442-ecfd-565d-9050-1fd9142f7337	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	01e9888d-b5b9-48f1-8ba6-8a89af108a04	Informed Consent	-35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-NJ-A7XG	49	false	United States	-18127	NA	ee21825a-40dd-5de1-b004-a94d75b4afa1	not hispanic or latino	male	black or african american	TCGA-NJ-A7XG_demographic	Alive	18127	M0	N1	Stage IIIA	T4	7th	primary	0	617.0	69ddef8c-88d5-51ce-bb91-010fa2059f66	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-NJ-A7XG_diagnosis	No	Upper lobe, lung	NA	2013	No	NA	128	100	NA	NA	NA	NA	NA	NA	TCGA-NJ-A7XG_treatment2	Carboplatin	NA	NA	NA	a660cc53-c9d5-47b0-b2d2-068cec1961d9	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	01e9888d-b5b9-48f1-8ba6-8a89af108a04	Informed Consent	-35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-NJ-A7XG	49	false	United States	-18127	NA	ee21825a-40dd-5de1-b004-a94d75b4afa1	not hispanic or latino	male	black or african american	TCGA-NJ-A7XG_demographic	Alive	18127	M0	N1	Stage IIIA	T4	7th	primary	0	617.0	69ddef8c-88d5-51ce-bb91-010fa2059f66	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-NJ-A7XG_diagnosis	No	Upper lobe, lung	NA	2013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A7XG_treatment4	NA	NA	NA	NA	d3a3a55e-6f32-43c5-895f-41380c0e86ca	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0232d299-4cdf-4fd7-9a5e-8d13c208b40c	Informed Consent	55	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6848	59	false	United States	-21829	NA	11393761-c520-5389-9d2a-e6ce8821cad4	not hispanic or latino	male	white	TCGA-91-6848_demographic	Alive	21829	MX	N2	Stage IIIA	T2	6th	primary	0	224.0	34dc1c12-dcc9-5753-b1ae-39ef95eb3d17	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6848_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	154	91	NA	NA	NA	NA	NA	NA	TCGA-91-6848_treatment2	Docetaxel	NA	NA	NA	50c3338b-6b21-4c4b-a423-775c87319bec	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	0232d299-4cdf-4fd7-9a5e-8d13c208b40c	Informed Consent	55	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6848	59	false	United States	-21829	NA	11393761-c520-5389-9d2a-e6ce8821cad4	not hispanic or latino	male	white	TCGA-91-6848_demographic	Alive	21829	MX	N2	Stage IIIA	T2	6th	primary	0	224.0	34dc1c12-dcc9-5753-b1ae-39ef95eb3d17	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6848_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6848_treatment3	NA	NA	NA	NA	666f5498-412e-400a-8e8b-cc5a282dfffd	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0232d299-4cdf-4fd7-9a5e-8d13c208b40c	Informed Consent	55	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6848	59	false	United States	-21829	NA	11393761-c520-5389-9d2a-e6ce8821cad4	not hispanic or latino	male	white	TCGA-91-6848_demographic	Alive	21829	MX	N2	Stage IIIA	T2	6th	primary	0	224.0	34dc1c12-dcc9-5753-b1ae-39ef95eb3d17	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6848_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	154	91	NA	NA	NA	NA	NA	NA	TCGA-91-6848_treatment	Cisplatin	NA	NA	NA	ce75b61d-ec8f-5c73-b2a5-f02062c93d47	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	028e99e9-5b9a-4954-bb6e-6d4709a3cea8	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6986	74	false	United States	NA	NA	da8cdcae-beae-5745-b739-df6f304f4973	not reported	female	white	TCGA-55-6986_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	0	3261.0	8f6f13a3-c7f2-5028-b188-909c5cc21afe	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	NA	TCGA-55-6986_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6986_treatment2	NA	NA	NA	NA	3d94e4fe-487e-40fa-8530-d7b87e0304d8	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	028e99e9-5b9a-4954-bb6e-6d4709a3cea8	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6986	74	false	United States	NA	NA	da8cdcae-beae-5745-b739-df6f304f4973	not reported	female	white	TCGA-55-6986_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	0	3261.0	8f6f13a3-c7f2-5028-b188-909c5cc21afe	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	NA	TCGA-55-6986_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6986_treatment	NA	NA	NA	NA	53aa0c70-1494-5911-a9e8-01aaf0c51bf7	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	035c0b2b-c722-443b-8962-db4ee92c7532	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-86-6851	73	false	United States	-26808	NA	16c96efd-37eb-5252-b4d3-15240417dd78	not hispanic or latino	female	white	TCGA-86-6851_demographic	Alive	26808	M0	N1	Stage IIA	T1b	7th	primary	0	179.0	4ae81c97-6be6-57ab-9b3f-7384aedeaa02	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-86-6851_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-6851_treatment	NA	NA	NA	NA	cc6d362a-e0fc-5ab7-8716-ef60116e1b1b	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	035c0b2b-c722-443b-8962-db4ee92c7532	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-86-6851	73	false	United States	-26808	NA	16c96efd-37eb-5252-b4d3-15240417dd78	not hispanic or latino	female	white	TCGA-86-6851_demographic	Alive	26808	M0	N1	Stage IIA	T1b	7th	primary	0	179.0	4ae81c97-6be6-57ab-9b3f-7384aedeaa02	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-86-6851_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-6851_treatment2	NA	NA	NA	NA	cdb02cb8-ecd9-42fc-8dc5-a28679c7c28b	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	03c3409a-9d16-41d0-9e26-f9fc2547a4c8	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4677	74	false	United States	-27381	38	c27ea253-5c73-5863-8f8a-c4b6074d72e9	not hispanic or latino	male	white	TCGA-73-4677_demographic	Dead	27381	M0	N0	NA	T2a	NA	primary	0	38.0	75628f1d-03f8-5e64-bcd4-7ffbc7d54fd5	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-4677_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4677_treatment2	NA	NA	NA	NA	5c694dd3-8665-4578-803b-e6249f40f9b2	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	03c3409a-9d16-41d0-9e26-f9fc2547a4c8	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4677	74	false	United States	-27381	38	c27ea253-5c73-5863-8f8a-c4b6074d72e9	not hispanic or latino	male	white	TCGA-73-4677_demographic	Dead	27381	M0	N0	NA	T2a	NA	primary	0	38.0	75628f1d-03f8-5e64-bcd4-7ffbc7d54fd5	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-4677_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4677_treatment	NA	NA	NA	NA	872e3096-dc7f-509a-8b73-45cdceb461f6	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	03d09c05-49ab-4ba6-a8d7-e7ccf71fafd2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4245	81	false	Germany	-29647	NA	3ec79286-1857-5eeb-a778-0c86ff2a13f6	not reported	male	not reported	TCGA-05-4245_demographic	Alive	NA	M0	N1	NA	T3	NA	Prior primary	NA	NA	5c3a8110-08d4-4636-876c-44918ea75142	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4245_diagnosis3	NA	Descending colon	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4245_treatment4	NA	NA	NA	NA	1ed15bbc-5b53-4ccd-b396-79f4ff903d1e	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	03d09c05-49ab-4ba6-a8d7-e7ccf71fafd2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4245	81	false	Germany	-29647	NA	3ec79286-1857-5eeb-a778-0c86ff2a13f6	not reported	male	not reported	TCGA-05-4245_demographic	Alive	NA	M0	N1	NA	T3	NA	Prior primary	NA	NA	5c3a8110-08d4-4636-876c-44918ea75142	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4245_diagnosis3	NA	Descending colon	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4245_treatment3	NA	Body, total	NA	NA	4023a0de-1f70-494a-baec-1de93dcdfdfe	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	03d09c05-49ab-4ba6-a8d7-e7ccf71fafd2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4245	81	false	Germany	-29647	NA	3ec79286-1857-5eeb-a778-0c86ff2a13f6	not reported	male	not reported	TCGA-05-4245_demographic	Alive	29647	M0	N2	Stage IIIA	T2	6th	primary	0	730.0	e2fb63d6-2eac-535c-bcd0-e9575ebaf006	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R2	Lung, NOS	NA	TCGA-05-4245_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4245_treatment2	NA	NA	NA	NA	3ec619d0-eaee-4215-8485-a43eec72d75f	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	03d09c05-49ab-4ba6-a8d7-e7ccf71fafd2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4245	81	false	Germany	-29647	NA	3ec79286-1857-5eeb-a778-0c86ff2a13f6	not reported	male	not reported	TCGA-05-4245_demographic	Alive	29647	M0	N2	Stage IIIA	T2	6th	primary	0	730.0	e2fb63d6-2eac-535c-bcd0-e9575ebaf006	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R2	Lung, NOS	NA	TCGA-05-4245_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4245_treatment	NA	NA	NA	NA	85506557-5c39-5d73-ba25-228aee1aea2a	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	03d09c05-49ab-4ba6-a8d7-e7ccf71fafd2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4245	81	false	Germany	-29647	NA	3ec79286-1857-5eeb-a778-0c86ff2a13f6	not reported	male	not reported	TCGA-05-4245_demographic	Alive	29981	NA	NA	NA	NA	NA	not reported	334	NA	e44c216b-dbff-42b5-af6d-ee43a0e825ea	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-4245_diagnosis2	NA	Not Reported	TCGA-05-4245_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-4245_treatment6	NA	NA	NA	NA	99134141-18c3-4e5b-9619-02606eaf88bd	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	03d09c05-49ab-4ba6-a8d7-e7ccf71fafd2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4245	81	false	Germany	-29647	NA	3ec79286-1857-5eeb-a778-0c86ff2a13f6	not reported	male	not reported	TCGA-05-4245_demographic	Alive	29981	NA	NA	NA	NA	NA	not reported	334	NA	e44c216b-dbff-42b5-af6d-ee43a0e825ea	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-4245_diagnosis2	NA	Not Reported	TCGA-05-4245_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-4245_treatment5	NA	NA	NA	NA	dd27994f-168c-4604-aa8a-ea1030f915ef	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	05534064-8b43-4c82-95da-70fd83bd6560	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7540	66	false	Australia	-24440	1197	6ef63a78-1326-575c-8a64-95f8057c2007	not reported	female	white	TCGA-78-7540_demographic	Dead	24440	M0	N0	Stage IB	T2	6th	primary	0	1197.0	ae43688c-a21e-53af-9704-abcd6cd72db3	true	NA	NA	C34.3	Left	8253/3	Bronchio-alveolar carcinoma, mucinous	no	No	R0	Lung, NOS	NA	TCGA-78-7540_diagnosis	No	Lower lobe, lung	NA	1999	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7540_treatment2	NA	NA	NA	NA	12a4a973-f9b9-4648-86a1-5238cc5b7880	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	05534064-8b43-4c82-95da-70fd83bd6560	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7540	66	false	Australia	-24440	1197	6ef63a78-1326-575c-8a64-95f8057c2007	not reported	female	white	TCGA-78-7540_demographic	Dead	24440	M0	N0	Stage IB	T2	6th	primary	0	1197.0	ae43688c-a21e-53af-9704-abcd6cd72db3	true	NA	NA	C34.3	Left	8253/3	Bronchio-alveolar carcinoma, mucinous	no	No	R0	Lung, NOS	NA	TCGA-78-7540_diagnosis	No	Lower lobe, lung	NA	1999	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7540_treatment	NA	NA	NA	NA	190b4edf-4ab4-5f27-b130-47f098a53d6b	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	055e9a43-3c00-4110-a303-e4407676bec0	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7576	54	false	United States	-19917	NA	5f5b5d26-4dc8-5e9c-88e8-75326a26a97e	not hispanic or latino	male	black or african american	TCGA-55-7576_demographic	Alive	19917	M0	N0	Stage IB	T2a	7th	primary	0	670.0	21a3220a-2919-5653-8c9a-42b49b2c8f2b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7576_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	168	104	NA	NA	NA	NA	NA	NA	TCGA-55-7576_treatment	Pemetrexed Disodium	NA	NA	NA	4e09e973-b1c2-5ab7-ad6e-14c32bb42db3	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	055e9a43-3c00-4110-a303-e4407676bec0	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7576	54	false	United States	-19917	NA	5f5b5d26-4dc8-5e9c-88e8-75326a26a97e	not hispanic or latino	male	black or african american	TCGA-55-7576_demographic	Alive	19917	M0	N0	Stage IB	T2a	7th	primary	0	670.0	21a3220a-2919-5653-8c9a-42b49b2c8f2b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7576_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7576_treatment3	NA	NA	NA	NA	5df9a5d1-4a7b-4d6e-8961-c1bbf3724d31	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	055e9a43-3c00-4110-a303-e4407676bec0	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7576	54	false	United States	-19917	NA	5f5b5d26-4dc8-5e9c-88e8-75326a26a97e	not hispanic or latino	male	black or african american	TCGA-55-7576_demographic	Alive	19917	M0	N0	Stage IB	T2a	7th	primary	0	670.0	21a3220a-2919-5653-8c9a-42b49b2c8f2b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7576_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	168	104	NA	NA	NA	NA	NA	NA	TCGA-55-7576_treatment2	Cisplatin	NA	NA	NA	8cc15b16-c787-4044-82ad-d070d8252579	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	06fe7f3e-4edd-4150-981c-93787ea19b39	Informed Consent	15	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8615	67	false	United States	-24786	NA	0948c018-0a80-5822-b435-758d4ba23af5	not hispanic or latino	male	white	TCGA-55-8615_demographic	Alive	25010	NA	NA	NA	NA	NA	metastasis	224	NA	468da9cd-716e-4c14-9a99-c058cc9560c5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8615_diagnosis2	NA	Not Reported	TCGA-55-8615_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8615_treatment8	NA	Locoregional Site	NA	NA	20364e8f-dab5-444a-aa3b-867945552ca4	NA	no	NA	Surgery, NOS
TCGA-LUAD	06fe7f3e-4edd-4150-981c-93787ea19b39	Informed Consent	15	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8615	67	false	United States	-24786	NA	0948c018-0a80-5822-b435-758d4ba23af5	not hispanic or latino	male	white	TCGA-55-8615_demographic	Alive	25010	NA	NA	NA	NA	NA	metastasis	224	NA	468da9cd-716e-4c14-9a99-c058cc9560c5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8615_diagnosis2	NA	Not Reported	TCGA-55-8615_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8615_treatment7	NA	NA	NA	NA	9c644b32-9ad5-4100-82a7-460e58549c61	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	06fe7f3e-4edd-4150-981c-93787ea19b39	Informed Consent	15	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8615	67	false	United States	-24786	NA	0948c018-0a80-5822-b435-758d4ba23af5	not hispanic or latino	male	white	TCGA-55-8615_demographic	Alive	25010	NA	NA	NA	NA	NA	metastasis	224	NA	468da9cd-716e-4c14-9a99-c058cc9560c5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8615_diagnosis2	NA	Not Reported	TCGA-55-8615_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8615_treatment9	NA	Distant Site	NA	NA	b98fb351-2ab0-44a5-abe0-88a4777c8fcc	NA	no	NA	Surgery, NOS
TCGA-LUAD	06fe7f3e-4edd-4150-981c-93787ea19b39	Informed Consent	15	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8615	67	false	United States	-24786	NA	0948c018-0a80-5822-b435-758d4ba23af5	not hispanic or latino	male	white	TCGA-55-8615_demographic	Alive	25010	NA	NA	NA	NA	NA	metastasis	224	NA	468da9cd-716e-4c14-9a99-c058cc9560c5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8615_diagnosis2	NA	Not Reported	TCGA-55-8615_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8615_treatment6	NA	NA	NA	NA	dd138343-6848-407f-aeab-84036cce20aa	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	06fe7f3e-4edd-4150-981c-93787ea19b39	Informed Consent	15	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8615	67	false	United States	-24786	NA	0948c018-0a80-5822-b435-758d4ba23af5	not hispanic or latino	male	white	TCGA-55-8615_demographic	Alive	24786	MX	N2	Stage IIIA	T3	7th	primary	0	446.0	6dbc0170-58ff-560a-800e-781837e97b76	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8615_diagnosis	No	Middle lobe, lung	NA	2012	No	NA	324	234	NA	NA	NA	NA	NA	NA	TCGA-55-8615_treatment4	Carboplatin	NA	NA	NA	069198ec-97f1-4770-b831-fdad61b01f7e	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	06fe7f3e-4edd-4150-981c-93787ea19b39	Informed Consent	15	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8615	67	false	United States	-24786	NA	0948c018-0a80-5822-b435-758d4ba23af5	not hispanic or latino	male	white	TCGA-55-8615_demographic	Alive	24786	MX	N2	Stage IIIA	T3	7th	primary	0	446.0	6dbc0170-58ff-560a-800e-781837e97b76	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8615_diagnosis	No	Middle lobe, lung	NA	2012	No	NA	NA	89	NA	NA	NA	NA	NA	NA	TCGA-55-8615_treatment3	Paclitaxel	NA	NA	NA	56bd57e5-c0f6-4f8d-8569-684add37b3ef	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	06fe7f3e-4edd-4150-981c-93787ea19b39	Informed Consent	15	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8615	67	false	United States	-24786	NA	0948c018-0a80-5822-b435-758d4ba23af5	not hispanic or latino	male	white	TCGA-55-8615_demographic	Alive	24786	MX	N2	Stage IIIA	T3	7th	primary	0	446.0	6dbc0170-58ff-560a-800e-781837e97b76	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8615_diagnosis	No	Middle lobe, lung	NA	2012	NA	NA	446	426	NA	NA	NA	NA	NA	NA	TCGA-55-8615_treatment	NA	Distant Site	NA	NA	8f1597e7-bbd8-560d-bc63-ceaffdfaaee3	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	06fe7f3e-4edd-4150-981c-93787ea19b39	Informed Consent	15	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8615	67	false	United States	-24786	NA	0948c018-0a80-5822-b435-758d4ba23af5	not hispanic or latino	male	white	TCGA-55-8615_demographic	Alive	24786	MX	N2	Stage IIIA	T3	7th	primary	0	446.0	6dbc0170-58ff-560a-800e-781837e97b76	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8615_diagnosis	No	Middle lobe, lung	NA	2012	No	NA	NA	89	NA	NA	NA	NA	NA	NA	TCGA-55-8615_treatment2	Carboplatin	NA	NA	NA	e3af409a-f809-4fba-819f-64844470215d	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	06fe7f3e-4edd-4150-981c-93787ea19b39	Informed Consent	15	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8615	67	false	United States	-24786	NA	0948c018-0a80-5822-b435-758d4ba23af5	not hispanic or latino	male	white	TCGA-55-8615_demographic	Alive	24786	MX	N2	Stage IIIA	T3	7th	primary	0	446.0	6dbc0170-58ff-560a-800e-781837e97b76	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8615_diagnosis	No	Middle lobe, lung	NA	2012	No	NA	416	234	NA	NA	NA	NA	NA	NA	TCGA-55-8615_treatment5	Pemetrexed Disodium	NA	NA	NA	ef37eb38-c1e9-463c-8f65-deeabe049cd5	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	07119baf-64a7-454c-b1b0-c769b506a63d	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z055	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	0780eb43-d5b5-4c3d-9825-beacba5cc723	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4501	67	false	United States	-24817	1421	4471689a-e8f3-53d8-8454-82d16ae6ca5c	not hispanic or latino	female	white	TCGA-49-4501_demographic	Dead	25362	NA	NA	NA	NA	NA	not reported	545	NA	05ce8054-b03c-4432-8c29-6219c25192f3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4501_diagnosis2	NA	Not Reported	TCGA-49-4501_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4501_treatment7	NA	Locoregional Site	NA	NA	22faaaf6-deb6-4cc6-a421-b8b4ea762aa8	NA	no	NA	Surgery, NOS
TCGA-LUAD	0780eb43-d5b5-4c3d-9825-beacba5cc723	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4501	67	false	United States	-24817	1421	4471689a-e8f3-53d8-8454-82d16ae6ca5c	not hispanic or latino	female	white	TCGA-49-4501_demographic	Dead	25362	NA	NA	NA	NA	NA	not reported	545	NA	05ce8054-b03c-4432-8c29-6219c25192f3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4501_diagnosis2	NA	Not Reported	TCGA-49-4501_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-49-4501_treatment6	NA	NA	NA	NA	dd216dde-2cdb-4a99-b8e1-b39ccebfb796	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0780eb43-d5b5-4c3d-9825-beacba5cc723	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4501	67	false	United States	-24817	1421	4471689a-e8f3-53d8-8454-82d16ae6ca5c	not hispanic or latino	female	white	TCGA-49-4501_demographic	Dead	25362	NA	NA	NA	NA	NA	not reported	545	NA	05ce8054-b03c-4432-8c29-6219c25192f3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4501_diagnosis2	NA	Not Reported	TCGA-49-4501_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-49-4501_treatment5	NA	NA	NA	NA	dfb5ddb4-0161-4936-9251-3aa2c9450ef2	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0780eb43-d5b5-4c3d-9825-beacba5cc723	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4501	67	false	United States	-24817	1421	4471689a-e8f3-53d8-8454-82d16ae6ca5c	not hispanic or latino	female	white	TCGA-49-4501_demographic	Dead	24817	M0	N0	Stage IB	T2	NA	primary	0	1421.0	74e75f07-36d4-5da6-be38-ec398f1923f9	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-49-4501_diagnosis	No	Upper lobe, lung	NA	1996	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4501_treatment2	NA	NA	NA	NA	862694b1-e74c-405f-a465-453771616686	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0780eb43-d5b5-4c3d-9825-beacba5cc723	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4501	67	false	United States	-24817	1421	4471689a-e8f3-53d8-8454-82d16ae6ca5c	not hispanic or latino	female	white	TCGA-49-4501_demographic	Dead	24817	M0	N0	Stage IB	T2	NA	primary	0	1421.0	74e75f07-36d4-5da6-be38-ec398f1923f9	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-49-4501_diagnosis	No	Upper lobe, lung	NA	1996	NA	NA	694	664	Recurrent Disease	2	NA	NA	NA	Intravenous	TCGA-49-4501_treatment	Gemcitabine Hydrochloride	NA	NA	NA	b8d506c0-15e0-5632-b298-7fdce3ea4417	NA	yes	NA	Chemotherapy
TCGA-LUAD	0780eb43-d5b5-4c3d-9825-beacba5cc723	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4501	67	false	United States	-24817	1421	4471689a-e8f3-53d8-8454-82d16ae6ca5c	not hispanic or latino	female	white	TCGA-49-4501_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ec599a21-5d37-4a75-9ee5-39da44e923fe	false	NA	NA	NA	NA	9590/3	Malignant lymphoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-49-4501_diagnosis3	NA	Lymph nodes of head, face and neck	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4501_treatment4	NA	NA	NA	NA	7f28be7f-b612-42f1-829d-9d0b3f13f60b	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0780eb43-d5b5-4c3d-9825-beacba5cc723	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4501	67	false	United States	-24817	1421	4471689a-e8f3-53d8-8454-82d16ae6ca5c	not hispanic or latino	female	white	TCGA-49-4501_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ec599a21-5d37-4a75-9ee5-39da44e923fe	false	NA	NA	NA	NA	9590/3	Malignant lymphoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-49-4501_diagnosis3	NA	Lymph nodes of head, face and neck	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4501_treatment3	NA	NA	NA	NA	87ddf624-8ca4-4401-92e5-33bcb9830927	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	079ae0b3-b64b-4b8e-ab7d-225b8046568c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7954	68	false	United States	-25062	NA	4a936274-cbc3-5d09-bf42-db14c6eb59a3	not hispanic or latino	female	white	TCGA-86-7954_demographic	Alive	25062	M0	N0	Stage IB	T2	7th	primary	0	605.0	e535e3e2-9698-5f2e-9497-32c556c09f49	true	NA	NA	C34.3	Right	8250/3	Bronchiolo-alveolar adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7954_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-7954_treatment3	NA	NA	NA	NA	0264e6a2-8bf1-430e-ac57-6760805fc956	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	079ae0b3-b64b-4b8e-ab7d-225b8046568c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7954	68	false	United States	-25062	NA	4a936274-cbc3-5d09-bf42-db14c6eb59a3	not hispanic or latino	female	white	TCGA-86-7954_demographic	Alive	25062	M0	N0	Stage IB	T2	7th	primary	0	605.0	e535e3e2-9698-5f2e-9497-32c556c09f49	true	NA	NA	C34.3	Right	8250/3	Bronchiolo-alveolar adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7954_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	81	55	NA	NA	NA	NA	NA	NA	TCGA-86-7954_treatment	Carboplatin	NA	NA	NA	bb7ab458-3a7e-5c08-a221-00c8c577b11f	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	079ae0b3-b64b-4b8e-ab7d-225b8046568c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7954	68	false	United States	-25062	NA	4a936274-cbc3-5d09-bf42-db14c6eb59a3	not hispanic or latino	female	white	TCGA-86-7954_demographic	Alive	25062	M0	N0	Stage IB	T2	7th	primary	0	605.0	e535e3e2-9698-5f2e-9497-32c556c09f49	true	NA	NA	C34.3	Right	8250/3	Bronchiolo-alveolar adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7954_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	81	55	NA	NA	NA	NA	NA	NA	TCGA-86-7954_treatment2	Paclitaxel	NA	NA	NA	cf469952-a885-4dcb-9b4f-347033da4548	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	07b5663f-9a54-4462-b6c1-6fc8116b8714	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2655	65	false	United States	-23854	NA	20d4b4f8-697e-5657-acea-ce48bceca1d9	not hispanic or latino	female	white	TCGA-44-2655_demographic	Alive	23854	M0	N0	Stage IA	T1	6th	primary	0	1324.0	5672187c-4648-5de5-8cad-903c919ef1f8	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-44-2655_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2655_treatment	NA	NA	NA	NA	212f9202-90a1-55ab-aaac-51271c5d03b0	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	07b5663f-9a54-4462-b6c1-6fc8116b8714	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2655	65	false	United States	-23854	NA	20d4b4f8-697e-5657-acea-ce48bceca1d9	not hispanic or latino	female	white	TCGA-44-2655_demographic	Alive	23854	M0	N0	Stage IA	T1	6th	primary	0	1324.0	5672187c-4648-5de5-8cad-903c919ef1f8	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-44-2655_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2655_treatment2	NA	NA	NA	NA	5959362c-e79e-46bc-ae93-518a3477bba0	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	07b5663f-9a54-4462-b6c1-6fc8116b8714	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2655	65	false	United States	-23854	NA	20d4b4f8-697e-5657-acea-ce48bceca1d9	not hispanic or latino	female	white	TCGA-44-2655_demographic	Alive	24863	NA	NA	NA	NA	NA	Subsequent Primary	1009	NA	b0c1a03a-cfab-4536-ba58-ded759e99f02	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2655_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-44-2655_treatment6	NA	NA	NA	NA	0a73160d-6246-434d-982f-edc4965fbc67	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	07b5663f-9a54-4462-b6c1-6fc8116b8714	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2655	65	false	United States	-23854	NA	20d4b4f8-697e-5657-acea-ce48bceca1d9	not hispanic or latino	female	white	TCGA-44-2655_demographic	Alive	24863	NA	NA	NA	NA	NA	Subsequent Primary	1009	NA	b0c1a03a-cfab-4536-ba58-ded759e99f02	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2655_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-44-2655_treatment7	NA	NA	NA	NA	7e6714c7-34cb-4164-a7df-c5d8d1831d86	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	07b5663f-9a54-4462-b6c1-6fc8116b8714	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2655	65	false	United States	-23854	NA	20d4b4f8-697e-5657-acea-ce48bceca1d9	not hispanic or latino	female	white	TCGA-44-2655_demographic	Alive	24863	NA	NA	NA	NA	NA	Subsequent Primary	1009	NA	b0c1a03a-cfab-4536-ba58-ded759e99f02	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2655_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2655_treatment8	NA	Locoregional Site	NA	NA	c6c6d399-78c8-4ff8-b672-962f56bc2239	NA	no	NA	Surgery, NOS
TCGA-LUAD	07b5663f-9a54-4462-b6c1-6fc8116b8714	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2655	65	false	United States	-23854	NA	20d4b4f8-697e-5657-acea-ce48bceca1d9	not hispanic or latino	female	white	TCGA-44-2655_demographic	Alive	24863	NA	NA	NA	NA	NA	Subsequent Primary	1009	NA	b0c1a03a-cfab-4536-ba58-ded759e99f02	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2655_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2655_treatment9	NA	Distant Site	NA	NA	cfad7f75-d919-4089-8087-9a02b18e5a3a	NA	no	NA	Surgery, NOS
TCGA-LUAD	07b5663f-9a54-4462-b6c1-6fc8116b8714	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2655	65	false	United States	-23854	NA	20d4b4f8-697e-5657-acea-ce48bceca1d9	not hispanic or latino	female	white	TCGA-44-2655_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d0c65f15-69ca-43ca-bc1d-2721a4e289e9	false	NA	NA	NA	Left	8500/2	Intraductal carcinoma, noninfiltrating, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-2655_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2655_treatment5	NA	Breast	NA	NA	10dc02ac-4a69-4e91-8809-cda3d75683cc	NA	yes	NA	Surgery, NOS
TCGA-LUAD	07b5663f-9a54-4462-b6c1-6fc8116b8714	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2655	65	false	United States	-23854	NA	20d4b4f8-697e-5657-acea-ce48bceca1d9	not hispanic or latino	female	white	TCGA-44-2655_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d0c65f15-69ca-43ca-bc1d-2721a4e289e9	false	NA	NA	NA	Left	8500/2	Intraductal carcinoma, noninfiltrating, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-2655_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2655_treatment3	NA	NA	NA	NA	572f00da-4386-45a8-8037-ca6f18f96c04	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	07b5663f-9a54-4462-b6c1-6fc8116b8714	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2655	65	false	United States	-23854	NA	20d4b4f8-697e-5657-acea-ce48bceca1d9	not hispanic or latino	female	white	TCGA-44-2655_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d0c65f15-69ca-43ca-bc1d-2721a4e289e9	false	NA	NA	NA	Left	8500/2	Intraductal carcinoma, noninfiltrating, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-2655_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2655_treatment4	NA	NA	NA	NA	cd37a4b3-79fd-407b-8956-da72b448aef9	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	088edf89-d2b5-40c7-b066-df3bd383f7ea	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4505	61	false	United States	-22628	428	80c26b12-8fac-5d8f-bea3-91c247f2232d	not hispanic or latino	female	white	TCGA-49-4505_demographic	Dead	22628	M0	N1	Stage IIB	T2	4th	primary	0	428.0	067c116f-104e-5dd9-a0a6-03858d2f7b07	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4505_diagnosis	No	Lower lobe, lung	NA	1996	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4505_treatment	NA	NA	NA	NA	4a3e1059-0bbd-5f4a-a372-ededb84951fe	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	088edf89-d2b5-40c7-b066-df3bd383f7ea	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4505	61	false	United States	-22628	428	80c26b12-8fac-5d8f-bea3-91c247f2232d	not hispanic or latino	female	white	TCGA-49-4505_demographic	Dead	22628	M0	N1	Stage IIB	T2	4th	primary	0	428.0	067c116f-104e-5dd9-a0a6-03858d2f7b07	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4505_diagnosis	No	Lower lobe, lung	NA	1996	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4505_treatment2	NA	NA	NA	NA	6ce8e8ff-66a6-4ada-9ae9-d07e75620038	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	088edf89-d2b5-40c7-b066-df3bd383f7ea	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4505	61	false	United States	-22628	428	80c26b12-8fac-5d8f-bea3-91c247f2232d	not hispanic or latino	female	white	TCGA-49-4505_demographic	Dead	23045	NA	NA	NA	NA	NA	Subsequent Primary	417	NA	2a032bfe-caf6-4f3d-a920-1400d9fbfcef	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4505_diagnosis3	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-49-4505_treatment7	NA	NA	NA	NA	0ad3b146-779c-46ba-9bbc-c25c5cd633a7	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	088edf89-d2b5-40c7-b066-df3bd383f7ea	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4505	61	false	United States	-22628	428	80c26b12-8fac-5d8f-bea3-91c247f2232d	not hispanic or latino	female	white	TCGA-49-4505_demographic	Dead	23045	NA	NA	NA	NA	NA	Subsequent Primary	417	NA	2a032bfe-caf6-4f3d-a920-1400d9fbfcef	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4505_diagnosis3	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-49-4505_treatment6	NA	NA	NA	NA	3a711c93-9d52-4f08-950e-988c19468a5e	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	088edf89-d2b5-40c7-b066-df3bd383f7ea	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4505	61	false	United States	-22628	428	80c26b12-8fac-5d8f-bea3-91c247f2232d	not hispanic or latino	female	white	TCGA-49-4505_demographic	Dead	23045	NA	NA	NA	NA	NA	Subsequent Primary	417	NA	2a032bfe-caf6-4f3d-a920-1400d9fbfcef	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4505_diagnosis3	NA	Not Reported	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4505_treatment8	NA	Locoregional Site	NA	NA	4fa1e814-ce34-4de9-a980-0805cc93ec5d	NA	unknown	NA	Surgery, NOS
TCGA-LUAD	088edf89-d2b5-40c7-b066-df3bd383f7ea	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4505	61	false	United States	-22628	428	80c26b12-8fac-5d8f-bea3-91c247f2232d	not hispanic or latino	female	white	TCGA-49-4505_demographic	Dead	23045	NA	NA	NA	NA	NA	metastasis	417	NA	5d7aae45-779b-4d2e-8456-6d0f47a97fac	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4505_diagnosis2	NA	Not Reported	TCGA-49-4505_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-49-4505_treatment3	NA	NA	NA	NA	4b161275-c182-4a5f-a736-7b616757e9cc	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	088edf89-d2b5-40c7-b066-df3bd383f7ea	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4505	61	false	United States	-22628	428	80c26b12-8fac-5d8f-bea3-91c247f2232d	not hispanic or latino	female	white	TCGA-49-4505_demographic	Dead	23045	NA	NA	NA	NA	NA	metastasis	417	NA	5d7aae45-779b-4d2e-8456-6d0f47a97fac	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4505_diagnosis2	NA	Not Reported	TCGA-49-4505_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4505_treatment5	NA	Locoregional Site	NA	NA	6b4c92df-612e-4488-b53d-410fbe8b1b69	NA	unknown	NA	Surgery, NOS
TCGA-LUAD	088edf89-d2b5-40c7-b066-df3bd383f7ea	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4505	61	false	United States	-22628	428	80c26b12-8fac-5d8f-bea3-91c247f2232d	not hispanic or latino	female	white	TCGA-49-4505_demographic	Dead	23045	NA	NA	NA	NA	NA	metastasis	417	NA	5d7aae45-779b-4d2e-8456-6d0f47a97fac	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4505_diagnosis2	NA	Not Reported	TCGA-49-4505_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-49-4505_treatment4	NA	NA	NA	NA	a66f5a21-7c76-45ef-af01-0c5d4685109a	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	09078761-1c14-4d01-8e15-535c19a9b0f9	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8177	59	false	United States	-21648	NA	7fcd8882-f338-5643-a7a0-184902014715	not hispanic or latino	female	white	TCGA-97-8177_demographic	Alive	21648	M0	N0	Stage IB	T2a	7th	primary	0	499.0	06391f78-eb30-5803-87b4-0a0c5a555399	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-8177_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	NA	205	NA	NA	NA	NA	NA	NA	TCGA-97-8177_treatment3	Erlotinib Hydrochloride	NA	NA	NA	0c04c6b2-ca1c-45fc-aefe-beda307e1a8f	NA	yes	Treatment Ongoing	Targeted Molecular Therapy
TCGA-LUAD	09078761-1c14-4d01-8e15-535c19a9b0f9	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8177	59	false	United States	-21648	NA	7fcd8882-f338-5643-a7a0-184902014715	not hispanic or latino	female	white	TCGA-97-8177_demographic	Alive	21648	M0	N0	Stage IB	T2a	7th	primary	0	499.0	06391f78-eb30-5803-87b4-0a0c5a555399	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-8177_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8177_treatment4	NA	NA	NA	NA	14d36464-4aeb-4c79-aac0-0838a5a3f858	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	09078761-1c14-4d01-8e15-535c19a9b0f9	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8177	59	false	United States	-21648	NA	7fcd8882-f338-5643-a7a0-184902014715	not hispanic or latino	female	white	TCGA-97-8177_demographic	Alive	21648	M0	N0	Stage IB	T2a	7th	primary	0	499.0	06391f78-eb30-5803-87b4-0a0c5a555399	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-8177_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	NA	93	NA	NA	NA	NA	NA	NA	TCGA-97-8177_treatment2	Carboplatin	NA	NA	NA	237df22b-9311-4e5d-a4a2-8db3e3898042	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	09078761-1c14-4d01-8e15-535c19a9b0f9	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8177	59	false	United States	-21648	NA	7fcd8882-f338-5643-a7a0-184902014715	not hispanic or latino	female	white	TCGA-97-8177_demographic	Alive	21648	M0	N0	Stage IB	T2a	7th	primary	0	499.0	06391f78-eb30-5803-87b4-0a0c5a555399	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-8177_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	NA	93	NA	NA	NA	NA	NA	NA	TCGA-97-8177_treatment	Pemetrexed Disodium	NA	NA	NA	b7b40225-12e8-544d-8a0c-473eda3c318f	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	096bd95f-9900-4db2-b1c4-103902c3b31f	Informed Consent	-26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-A4AD	61	false	United States	-22414	550	4c7d0cf8-e1b3-5c33-aa46-a2d6c87401fa	not hispanic or latino	female	white	TCGA-J2-A4AD_demographic	Dead	22938	NA	NA	NA	NA	NA	recurrence	524	NA	122d5120-3fc3-4ac1-9c1d-74db312a346c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-J2-A4AD_diagnosis2	NA	Not Reported	TCGA-J2-A4AD_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-J2-A4AD_treatment3	NA	NA	NA	NA	94c8c110-603f-461a-ab2e-6e01d283910e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	096bd95f-9900-4db2-b1c4-103902c3b31f	Informed Consent	-26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-A4AD	61	false	United States	-22414	550	4c7d0cf8-e1b3-5c33-aa46-a2d6c87401fa	not hispanic or latino	female	white	TCGA-J2-A4AD_demographic	Dead	22938	NA	NA	NA	NA	NA	recurrence	524	NA	122d5120-3fc3-4ac1-9c1d-74db312a346c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-J2-A4AD_diagnosis2	NA	Not Reported	TCGA-J2-A4AD_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-J2-A4AD_treatment4	NA	NA	NA	NA	a4de7fe4-c801-4f0b-90b9-1e06377db92f	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	096bd95f-9900-4db2-b1c4-103902c3b31f	Informed Consent	-26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-A4AD	61	false	United States	-22414	550	4c7d0cf8-e1b3-5c33-aa46-a2d6c87401fa	not hispanic or latino	female	white	TCGA-J2-A4AD_demographic	Dead	22414	MX	N0	Stage IA	T1a	7th	primary	0	550.0	3f5b76d8-fcc0-5859-bc23-e9dec05d649a	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-J2-A4AD_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-A4AD_treatment	NA	NA	NA	NA	cdb78779-eab3-5a8f-9863-d51617f6b825	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	096bd95f-9900-4db2-b1c4-103902c3b31f	Informed Consent	-26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-A4AD	61	false	United States	-22414	550	4c7d0cf8-e1b3-5c33-aa46-a2d6c87401fa	not hispanic or latino	female	white	TCGA-J2-A4AD_demographic	Dead	22414	MX	N0	Stage IA	T1a	7th	primary	0	550.0	3f5b76d8-fcc0-5859-bc23-e9dec05d649a	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-J2-A4AD_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-A4AD_treatment2	NA	NA	NA	NA	d69f8867-61a5-43c3-9e0b-81eb50a50019	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	096bd95f-9900-4db2-b1c4-103902c3b31f	Informed Consent	-26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-A4AD	61	false	United States	-22414	550	4c7d0cf8-e1b3-5c33-aa46-a2d6c87401fa	not hispanic or latino	female	white	TCGA-J2-A4AD_demographic	Dead	22938	NA	NA	NA	NA	NA	metastasis	524	NA	5322d4b2-0ecd-44c6-99ca-efbe4fb461f3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-J2-A4AD_diagnosis3	NA	Not Reported	TCGA-J2-A4AD_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-J2-A4AD_treatment5	NA	NA	NA	NA	8b5d24e4-e647-4978-81b5-4a549fb3b79b	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	096bd95f-9900-4db2-b1c4-103902c3b31f	Informed Consent	-26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-A4AD	61	false	United States	-22414	550	4c7d0cf8-e1b3-5c33-aa46-a2d6c87401fa	not hispanic or latino	female	white	TCGA-J2-A4AD_demographic	Dead	22938	NA	NA	NA	NA	NA	metastasis	524	NA	5322d4b2-0ecd-44c6-99ca-efbe4fb461f3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-J2-A4AD_diagnosis3	NA	Not Reported	TCGA-J2-A4AD_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-J2-A4AD_treatment6	NA	NA	NA	NA	9198f09c-04c2-4e5b-8a71-682d50c370b6	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	09918b81-4696-4cba-a45a-5fe7407c2337	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6592	71	false	United States	-26191	777	5c3faf64-6f26-5441-93c5-8d2e159a7aaa	not hispanic or latino	female	white	TCGA-50-6592_demographic	Dead	26191	M0	N0	Stage IB	T2	6th	primary	0	777.0	b89ba4ef-d685-5252-bef2-37da1dcf917f	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-6592_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6592_treatment2	NA	NA	NA	NA	975a048d-e22e-4c33-99a8-4550bfa02e3a	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	09918b81-4696-4cba-a45a-5fe7407c2337	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6592	71	false	United States	-26191	777	5c3faf64-6f26-5441-93c5-8d2e159a7aaa	not hispanic or latino	female	white	TCGA-50-6592_demographic	Dead	26191	M0	N0	Stage IB	T2	6th	primary	0	777.0	b89ba4ef-d685-5252-bef2-37da1dcf917f	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-6592_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	39	39	NA	NA	NA	NA	NA	NA	TCGA-50-6592_treatment	NA	Primary Tumor Field	NA	NA	ee3f0f84-5fb8-559b-8dd4-c909568ff240	NA	yes	Progressive Disease	Radiation, Internal
TCGA-LUAD	0a1eea76-e19a-4547-9b24-abf7051cc4db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8674	50	false	Ukraine	-18479	NA	ad6667b4-3628-544e-88b1-e293e30ab0a7	not hispanic or latino	male	white	TCGA-86-8674_demographic	Alive	18479	M0	N1	Stage IIA	T2a	7th	primary	0	806.0	4c0e582e-885b-55e5-821c-d814fab28660	true	NA	NA	C34.2	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8674_diagnosis	No	Middle lobe, lung	NA	2012	No	NA	81	57	NA	NA	NA	NA	NA	NA	TCGA-86-8674_treatment2	Cisplatin	NA	NA	NA	0963ca4d-fd2a-4688-aaab-022df6fe11b0	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	0a1eea76-e19a-4547-9b24-abf7051cc4db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8674	50	false	Ukraine	-18479	NA	ad6667b4-3628-544e-88b1-e293e30ab0a7	not hispanic or latino	male	white	TCGA-86-8674_demographic	Alive	18479	M0	N1	Stage IIA	T2a	7th	primary	0	806.0	4c0e582e-885b-55e5-821c-d814fab28660	true	NA	NA	C34.2	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8674_diagnosis	No	Middle lobe, lung	NA	2012	No	NA	81	57	NA	NA	NA	NA	NA	NA	TCGA-86-8674_treatment	Vinblastine	NA	NA	NA	88080c80-d79b-52c4-8bac-2239b62a206a	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	0a1eea76-e19a-4547-9b24-abf7051cc4db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8674	50	false	Ukraine	-18479	NA	ad6667b4-3628-544e-88b1-e293e30ab0a7	not hispanic or latino	male	white	TCGA-86-8674_demographic	Alive	18479	M0	N1	Stage IIA	T2a	7th	primary	0	806.0	4c0e582e-885b-55e5-821c-d814fab28660	true	NA	NA	C34.2	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8674_diagnosis	No	Middle lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8674_treatment3	NA	NA	NA	NA	b1cb9e6d-d04d-4ff4-982e-25989218d710	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	0a1eea76-e19a-4547-9b24-abf7051cc4db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8674	50	false	Ukraine	-18479	NA	ad6667b4-3628-544e-88b1-e293e30ab0a7	not hispanic or latino	male	white	TCGA-86-8674_demographic	Alive	18813	NA	NA	NA	NA	NA	recurrence	334	NA	f745cfd4-dd32-4b31-92d2-8bbe90427876	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-8674_diagnosis2	NA	Not Reported	TCGA-86-8674_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-86-8674_treatment5	NA	NA	NA	NA	8f0f35d8-f80d-4d34-a5b2-da8cf9a544bb	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0a1eea76-e19a-4547-9b24-abf7051cc4db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8674	50	false	Ukraine	-18479	NA	ad6667b4-3628-544e-88b1-e293e30ab0a7	not hispanic or latino	male	white	TCGA-86-8674_demographic	Alive	18813	NA	NA	NA	NA	NA	recurrence	334	NA	f745cfd4-dd32-4b31-92d2-8bbe90427876	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-8674_diagnosis2	NA	Not Reported	TCGA-86-8674_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-86-8674_treatment4	NA	NA	NA	NA	a1331663-b9f4-47b4-a9b6-bbb4e588af72	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0a1eea76-e19a-4547-9b24-abf7051cc4db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8674	50	false	Ukraine	-18479	NA	ad6667b4-3628-544e-88b1-e293e30ab0a7	not hispanic or latino	male	white	TCGA-86-8674_demographic	Alive	18813	NA	NA	NA	NA	NA	recurrence	334	NA	f745cfd4-dd32-4b31-92d2-8bbe90427876	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-8674_diagnosis2	NA	Not Reported	TCGA-86-8674_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8674_treatment6	NA	Locoregional Site	NA	NA	e52c0ba3-c877-4ebf-8eec-a4ece2817d22	NA	no	NA	Surgery, NOS
TCGA-LUAD	0a45f302-5748-48f3-9dc9-66c01843a68e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6981	53	false	United States	-19497	1379	b83b4b15-c0b6-540b-837d-884f7d5010b8	not hispanic or latino	female	white	TCGA-55-6981_demographic	Dead	19497	M0	N2	Stage IIIA	T1	6th	primary	0	1379.0	b820c514-c82e-5e8b-b77b-27770a72268e	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-6981_diagnosis	No	Upper lobe, lung	NA	2005	No	NA	NA	25	NA	NA	NA	NA	NA	NA	TCGA-55-6981_treatment2	Unknown	NA	NA	NA	66debda7-000a-474f-a6f4-5b8170b04901	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	0a45f302-5748-48f3-9dc9-66c01843a68e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6981	53	false	United States	-19497	1379	b83b4b15-c0b6-540b-837d-884f7d5010b8	not hispanic or latino	female	white	TCGA-55-6981_demographic	Dead	19497	M0	N2	Stage IIIA	T1	6th	primary	0	1379.0	b820c514-c82e-5e8b-b77b-27770a72268e	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-6981_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	114	65	NA	NA	34.0	NA	NA	NA	TCGA-55-6981_treatment	NA	Primary Tumor Field	6120	cGy	ad53f76e-6f19-5365-b2d4-998344a41f61	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	0b15fcb8-1fb7-497e-80b9-d3db66a3c0a2	Informed Consent	121	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7284	74	false	United States	-27087	243	e66795ef-93ed-527f-a215-30a941446f50	not hispanic or latino	male	white	TCGA-55-7284_demographic	Dead	27087	MX	N0	Stage IIB	T3	7th	primary	0	243.0	2c7b5588-2db0-532a-a441-3951f93b40e6	true	NA	NA	C34.8	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-55-7284_diagnosis	Yes	Overlapping lesion of lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7284_treatment2	NA	NA	NA	NA	464e57fe-cf44-4bb2-8d6e-3646ef002124	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	0b15fcb8-1fb7-497e-80b9-d3db66a3c0a2	Informed Consent	121	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7284	74	false	United States	-27087	243	e66795ef-93ed-527f-a215-30a941446f50	not hispanic or latino	male	white	TCGA-55-7284_demographic	Dead	27087	MX	N0	Stage IIB	T3	7th	primary	0	243.0	2c7b5588-2db0-532a-a441-3951f93b40e6	true	NA	NA	C34.8	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-55-7284_diagnosis	Yes	Overlapping lesion of lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7284_treatment	NA	NA	NA	NA	94540d7f-b16e-5ba2-ba24-1794212b620f	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0b15fcb8-1fb7-497e-80b9-d3db66a3c0a2	Informed Consent	121	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7284	74	false	United States	-27087	243	e66795ef-93ed-527f-a215-30a941446f50	not hispanic or latino	male	white	TCGA-55-7284_demographic	Dead	27318	NA	NA	NA	NA	NA	metastasis	231	NA	c5d89c77-405b-4513-bc68-647f9802626d	false	NA	NA	NA	NA	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	Yes	NA	Not Reported	NA	TCGA-55-7284_diagnosis2	NA	Not Reported	TCGA-55-7284_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7284_treatment9	NA	Distant Site	NA	NA	05b7d30d-6cf0-4c52-8d9f-b1b52736b684	NA	no	NA	Surgery, NOS
TCGA-LUAD	0b15fcb8-1fb7-497e-80b9-d3db66a3c0a2	Informed Consent	121	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7284	74	false	United States	-27087	243	e66795ef-93ed-527f-a215-30a941446f50	not hispanic or latino	male	white	TCGA-55-7284_demographic	Dead	27318	NA	NA	NA	NA	NA	metastasis	231	NA	c5d89c77-405b-4513-bc68-647f9802626d	false	NA	NA	NA	NA	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	Yes	NA	Not Reported	NA	TCGA-55-7284_diagnosis2	NA	Not Reported	TCGA-55-7284_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7284_treatment8	NA	Locoregional Site	NA	NA	25efb9d5-15e8-469f-be22-9d543c17d600	NA	no	NA	Surgery, NOS
TCGA-LUAD	0b15fcb8-1fb7-497e-80b9-d3db66a3c0a2	Informed Consent	121	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7284	74	false	United States	-27087	243	e66795ef-93ed-527f-a215-30a941446f50	not hispanic or latino	male	white	TCGA-55-7284_demographic	Dead	27318	NA	NA	NA	NA	NA	metastasis	231	NA	c5d89c77-405b-4513-bc68-647f9802626d	false	NA	NA	NA	NA	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	Yes	NA	Not Reported	NA	TCGA-55-7284_diagnosis2	NA	Not Reported	TCGA-55-7284_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7284_treatment7	NA	NA	NA	NA	c879e035-f1c4-4cd4-9bbf-043812eb2324	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0b15fcb8-1fb7-497e-80b9-d3db66a3c0a2	Informed Consent	121	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7284	74	false	United States	-27087	243	e66795ef-93ed-527f-a215-30a941446f50	not hispanic or latino	male	white	TCGA-55-7284_demographic	Dead	27318	NA	NA	NA	NA	NA	metastasis	231	NA	c5d89c77-405b-4513-bc68-647f9802626d	false	NA	NA	NA	NA	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	Yes	NA	Not Reported	NA	TCGA-55-7284_diagnosis2	NA	Not Reported	TCGA-55-7284_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7284_treatment6	NA	NA	NA	NA	e6b2e39b-9501-4864-995b-1e86d4f6db46	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0b15fcb8-1fb7-497e-80b9-d3db66a3c0a2	Informed Consent	121	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7284	74	false	United States	-27087	243	e66795ef-93ed-527f-a215-30a941446f50	not hispanic or latino	male	white	TCGA-55-7284_demographic	Dead	27212	MX	N0	Stage IA	T1a	7th	Synchronous primary	125	NA	d71674c7-6760-481f-90f8-8e4658f18f52	false	NA	NA	NA	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	NA	NA	Not Reported	NA	TCGA-55-7284_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	125	NA	NA	NA	NA	NA	NA	TCGA-55-7284_treatment5	NA	Not Reported	NA	NA	bc7c1d07-dc23-457f-b233-9ae96d4c3663	NA	yes	NA	Surgery, NOS
TCGA-LUAD	0b15fcb8-1fb7-497e-80b9-d3db66a3c0a2	Informed Consent	121	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7284	74	false	United States	-27087	243	e66795ef-93ed-527f-a215-30a941446f50	not hispanic or latino	male	white	TCGA-55-7284_demographic	Dead	27212	MX	N0	Stage IA	T1a	7th	Synchronous primary	125	NA	d71674c7-6760-481f-90f8-8e4658f18f52	false	NA	NA	NA	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	NA	NA	Not Reported	NA	TCGA-55-7284_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7284_treatment4	NA	NA	NA	NA	d19091cd-b066-4f31-a76d-e97823431229	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0b15fcb8-1fb7-497e-80b9-d3db66a3c0a2	Informed Consent	121	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7284	74	false	United States	-27087	243	e66795ef-93ed-527f-a215-30a941446f50	not hispanic or latino	male	white	TCGA-55-7284_demographic	Dead	27212	MX	N0	Stage IA	T1a	7th	Synchronous primary	125	NA	d71674c7-6760-481f-90f8-8e4658f18f52	false	NA	NA	NA	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	NA	NA	Not Reported	NA	TCGA-55-7284_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7284_treatment3	NA	NA	NA	NA	fb20bbdb-a588-46e9-88cb-eaf0dda7b17d	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0b31dbdf-0623-48e4-a0ec-017650dceda7	Informed Consent	11	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-6836	52	false	United States	-19216	NA	9cdf7d98-55e9-5f7e-91d4-e509fdb3acc0	not hispanic or latino	female	white	TCGA-91-6836_demographic	Alive	19202	NA	NA	NA	NA	NA	Synchronous primary	-14	NA	6c533715-9836-4419-beef-8f7e7bec2183	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-91-6836_diagnosis2	NA	Thyroid gland	NA	NA	NA	NA	NA	200	NA	NA	NA	NA	NA	NA	TCGA-91-6836_treatment5	NA	Thyroid	NA	NA	4578e273-9084-4a4d-9c91-d202d48ed648	NA	yes	NA	Surgery, NOS
TCGA-LUAD	0b31dbdf-0623-48e4-a0ec-017650dceda7	Informed Consent	11	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-6836	52	false	United States	-19216	NA	9cdf7d98-55e9-5f7e-91d4-e509fdb3acc0	not hispanic or latino	female	white	TCGA-91-6836_demographic	Alive	19202	NA	NA	NA	NA	NA	Synchronous primary	-14	NA	6c533715-9836-4419-beef-8f7e7bec2183	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-91-6836_diagnosis2	NA	Thyroid gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6836_treatment4	NA	NA	NA	NA	4ee516ca-eb97-4423-8fc1-70b6f5556e22	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0b31dbdf-0623-48e4-a0ec-017650dceda7	Informed Consent	11	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-6836	52	false	United States	-19216	NA	9cdf7d98-55e9-5f7e-91d4-e509fdb3acc0	not hispanic or latino	female	white	TCGA-91-6836_demographic	Alive	19202	NA	NA	NA	NA	NA	Synchronous primary	-14	NA	6c533715-9836-4419-beef-8f7e7bec2183	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-91-6836_diagnosis2	NA	Thyroid gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6836_treatment3	NA	NA	NA	NA	a5b4401d-84de-4e7a-a145-112c5b96b594	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0b31dbdf-0623-48e4-a0ec-017650dceda7	Informed Consent	11	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-6836	52	false	United States	-19216	NA	9cdf7d98-55e9-5f7e-91d4-e509fdb3acc0	not hispanic or latino	female	white	TCGA-91-6836_demographic	Alive	19216	MX	N0	Stage IB	T2	7th	primary	0	417.0	c485bf5a-cb4f-5c44-baab-f366d0da530e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6836_diagnosis	Yes	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6836_treatment2	NA	NA	NA	NA	23d8e6f1-ac4a-4364-b51e-b7130301686b	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0b31dbdf-0623-48e4-a0ec-017650dceda7	Informed Consent	11	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-6836	52	false	United States	-19216	NA	9cdf7d98-55e9-5f7e-91d4-e509fdb3acc0	not hispanic or latino	female	white	TCGA-91-6836_demographic	Alive	19216	MX	N0	Stage IB	T2	7th	primary	0	417.0	c485bf5a-cb4f-5c44-baab-f366d0da530e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6836_diagnosis	Yes	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6836_treatment	NA	NA	NA	NA	8ffa6965-4252-50a9-be5d-261f8d239eb6	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5	Informed Consent	-3	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-44-6146	64	false	United States	-23378	NA	d0bfd66b-9e46-58f9-9ba9-1d98d9dd5d7d	not hispanic or latino	male	white	TCGA-44-6146_demographic	Alive	24009	NA	NA	NA	NA	NA	recurrence	631	NA	091e64a3-5db4-4838-9e80-80c9d4a2588d	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-44-6146_diagnosis2	NA	Not Reported	TCGA-44-6146_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-6146_treatment7	NA	NA	NA	NA	1dc6fa02-00f7-4f87-9f7c-bc37e2fab960	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5	Informed Consent	-3	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-44-6146	64	false	United States	-23378	NA	d0bfd66b-9e46-58f9-9ba9-1d98d9dd5d7d	not hispanic or latino	male	white	TCGA-44-6146_demographic	Alive	24009	NA	NA	NA	NA	NA	recurrence	631	NA	091e64a3-5db4-4838-9e80-80c9d4a2588d	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-44-6146_diagnosis2	NA	Not Reported	TCGA-44-6146_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-6146_treatment8	NA	NA	NA	NA	704b64c4-5945-47d2-985d-9dc042f37e65	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5	Informed Consent	-3	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-44-6146	64	false	United States	-23378	NA	d0bfd66b-9e46-58f9-9ba9-1d98d9dd5d7d	not hispanic or latino	male	white	TCGA-44-6146_demographic	Alive	24009	NA	NA	NA	NA	NA	recurrence	631	NA	091e64a3-5db4-4838-9e80-80c9d4a2588d	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-44-6146_diagnosis2	NA	Not Reported	TCGA-44-6146_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6146_treatment9	NA	Locoregional Site	NA	NA	a0f9cad7-2eaf-4d9b-a48e-8d1cadc268a1	NA	no	NA	Surgery, NOS
TCGA-LUAD	0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5	Informed Consent	-3	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-44-6146	64	false	United States	-23378	NA	d0bfd66b-9e46-58f9-9ba9-1d98d9dd5d7d	not hispanic or latino	male	white	TCGA-44-6146_demographic	Alive	23378	M0	N0	Stage IIB	T3	7th	primary	0	728.0	2f032269-4670-5aa1-bf10-9fd2f2f38265	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	yes	No	NA	Lung, NOS	NA	TCGA-44-6146_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	44	44	NA	1	NA	165.0	mg	Intravenous	TCGA-44-6146_treatment3	Cisplatin	NA	165	mg	181eddbe-42fa-4ee5-aba3-75b5aab8f302	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5	Informed Consent	-3	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-44-6146	64	false	United States	-23378	NA	d0bfd66b-9e46-58f9-9ba9-1d98d9dd5d7d	not hispanic or latino	male	white	TCGA-44-6146_demographic	Alive	23378	M0	N0	Stage IIB	T3	7th	primary	0	728.0	2f032269-4670-5aa1-bf10-9fd2f2f38265	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	yes	No	NA	Lung, NOS	NA	TCGA-44-6146_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6146_treatment4	NA	NA	NA	NA	44ca4bdc-f51d-4410-b128-d3c752db495c	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5	Informed Consent	-3	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-44-6146	64	false	United States	-23378	NA	d0bfd66b-9e46-58f9-9ba9-1d98d9dd5d7d	not hispanic or latino	male	white	TCGA-44-6146_demographic	Alive	23378	M0	N0	Stage IIB	T3	7th	primary	0	728.0	2f032269-4670-5aa1-bf10-9fd2f2f38265	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	yes	No	NA	Lung, NOS	NA	TCGA-44-6146_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	107	44	NA	4	NA	1100.0	mg	Intravenous	TCGA-44-6146_treatment	Pemetrexed Disodium	NA	4400	mg	6e41249d-ffde-545f-a83e-7f9cc6cac613	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5	Informed Consent	-3	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-44-6146	64	false	United States	-23378	NA	d0bfd66b-9e46-58f9-9ba9-1d98d9dd5d7d	not hispanic or latino	male	white	TCGA-44-6146_demographic	Alive	23378	M0	N0	Stage IIB	T3	7th	primary	0	728.0	2f032269-4670-5aa1-bf10-9fd2f2f38265	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	yes	No	NA	Lung, NOS	NA	TCGA-44-6146_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	107	66	NA	3	NA	NA	NA	Intravenous	TCGA-44-6146_treatment2	Carboplatin	NA	1600	mg	99734cc7-6964-49a4-a63c-6645c5b3f304	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5	Informed Consent	-3	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-44-6146	64	false	United States	-23378	NA	d0bfd66b-9e46-58f9-9ba9-1d98d9dd5d7d	not hispanic or latino	male	white	TCGA-44-6146_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	885f0541-f182-405b-ac5a-b1ae48edb91b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-6146_diagnosis3	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6146_treatment6	NA	NA	NA	NA	28607a21-f8be-4699-a369-230591c8eb3c	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0c0b610e-fe4c-406d-a5ed-5cc3b11dabf5	Informed Consent	-3	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-44-6146	64	false	United States	-23378	NA	d0bfd66b-9e46-58f9-9ba9-1d98d9dd5d7d	not hispanic or latino	male	white	TCGA-44-6146_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	885f0541-f182-405b-ac5a-b1ae48edb91b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-6146_diagnosis3	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6146_treatment5	NA	NA	NA	NA	3d142e91-25ee-407b-9207-8e20601d4df5	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0c59ff96-5e4a-4664-a0b1-d057b4725483	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46P	65	false	Germany	-23993	594	f712a4a0-8c9c-55f8-9628-75a83809e7f8	not hispanic or latino	male	white	TCGA-62-A46P_demographic	Dead	24260	NA	NA	NA	NA	NA	metastasis	267	NA	6f4dffce-568a-44e4-880c-7c5b2926e48e	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-A46P_diagnosis2	NA	Not Reported	TCGA-62-A46P_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-A46P_treatment3	NA	NA	NA	NA	97dc85c6-4954-4f1b-8c96-eec8656d94a0	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0c59ff96-5e4a-4664-a0b1-d057b4725483	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46P	65	false	Germany	-23993	594	f712a4a0-8c9c-55f8-9628-75a83809e7f8	not hispanic or latino	male	white	TCGA-62-A46P_demographic	Dead	24260	NA	NA	NA	NA	NA	metastasis	267	NA	6f4dffce-568a-44e4-880c-7c5b2926e48e	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-A46P_diagnosis2	NA	Not Reported	TCGA-62-A46P_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-A46P_treatment4	NA	NA	NA	NA	99f584a4-07e2-4608-9ac5-0b98aedac387	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0c59ff96-5e4a-4664-a0b1-d057b4725483	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46P	65	false	Germany	-23993	594	f712a4a0-8c9c-55f8-9628-75a83809e7f8	not hispanic or latino	male	white	TCGA-62-A46P_demographic	Dead	24260	NA	NA	NA	NA	NA	metastasis	267	NA	6f4dffce-568a-44e4-880c-7c5b2926e48e	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-A46P_diagnosis2	NA	Not Reported	TCGA-62-A46P_diagnosis	NA	NA	NA	NA	267	NA	NA	NA	NA	NA	NA	TCGA-62-A46P_treatment5	NA	Distant Site	NA	NA	d99961dc-8067-43fc-9e75-67c7837447c9	NA	yes	NA	Surgery, NOS
TCGA-LUAD	0c59ff96-5e4a-4664-a0b1-d057b4725483	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46P	65	false	Germany	-23993	594	f712a4a0-8c9c-55f8-9628-75a83809e7f8	not hispanic or latino	male	white	TCGA-62-A46P_demographic	Dead	23993	M0	N0	Stage IB	T2	6th	primary	0	594.0	ba355f69-be35-55f4-b4ad-aa06f614698f	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A46P_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46P_treatment2	NA	NA	NA	NA	4220febf-88e9-449d-b8d0-b92454699a35	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0c59ff96-5e4a-4664-a0b1-d057b4725483	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46P	65	false	Germany	-23993	594	f712a4a0-8c9c-55f8-9628-75a83809e7f8	not hispanic or latino	male	white	TCGA-62-A46P_demographic	Dead	23993	M0	N0	Stage IB	T2	6th	primary	0	594.0	ba355f69-be35-55f4-b4ad-aa06f614698f	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A46P_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46P_treatment	NA	NA	NA	NA	b29d7932-9154-5937-a775-3de78e3307f8	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0d0d83d9-d558-4d38-977b-6f1b2471beda	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7955	62	false	Russia	-22772	NA	1abb3b3f-3a1e-5b0a-92b5-afb8907a9a8e	not hispanic or latino	male	white	TCGA-86-7955_demographic	Alive	23592	NA	NA	NA	NA	NA	recurrence	820	NA	055b1148-dcb7-4b35-928c-c323e14ee5f3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-7955_diagnosis2	NA	Not Reported	TCGA-86-7955_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-86-7955_treatment8	NA	NA	NA	NA	a67515da-75e2-4d0f-8f46-31d2df87ba55	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	0d0d83d9-d558-4d38-977b-6f1b2471beda	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7955	62	false	Russia	-22772	NA	1abb3b3f-3a1e-5b0a-92b5-afb8907a9a8e	not hispanic or latino	male	white	TCGA-86-7955_demographic	Alive	23592	NA	NA	NA	NA	NA	recurrence	820	NA	055b1148-dcb7-4b35-928c-c323e14ee5f3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-7955_diagnosis2	NA	Not Reported	TCGA-86-7955_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-86-7955_treatment7	NA	NA	NA	NA	d0b09660-006e-4d6b-88bc-439a26f25a69	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0d0d83d9-d558-4d38-977b-6f1b2471beda	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7955	62	false	Russia	-22772	NA	1abb3b3f-3a1e-5b0a-92b5-afb8907a9a8e	not hispanic or latino	male	white	TCGA-86-7955_demographic	Alive	23592	NA	NA	NA	NA	NA	recurrence	820	NA	055b1148-dcb7-4b35-928c-c323e14ee5f3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-7955_diagnosis2	NA	Not Reported	TCGA-86-7955_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-7955_treatment9	NA	Locoregional Site	NA	NA	f5ee6dae-d6a9-49c4-8f0d-281f45fb143d	NA	no	NA	Surgery, NOS
TCGA-LUAD	0d0d83d9-d558-4d38-977b-6f1b2471beda	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7955	62	false	Russia	-22772	NA	1abb3b3f-3a1e-5b0a-92b5-afb8907a9a8e	not hispanic or latino	male	white	TCGA-86-7955_demographic	Alive	22772	M0	N0	Stage IB	T2a	7th	primary	0	1072.0	5203d103-43ce-5799-b6b6-07aa9cf959bd	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-86-7955_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	190	114	NA	NA	31.0	NA	NA	NA	TCGA-86-7955_treatment	NA	Primary Tumor Field	62	Gy	2113b478-7c10-5f77-9e21-f7a70cfa16f5	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	0d0d83d9-d558-4d38-977b-6f1b2471beda	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7955	62	false	Russia	-22772	NA	1abb3b3f-3a1e-5b0a-92b5-afb8907a9a8e	not hispanic or latino	male	white	TCGA-86-7955_demographic	Alive	22772	M0	N0	Stage IB	T2a	7th	primary	0	1072.0	5203d103-43ce-5799-b6b6-07aa9cf959bd	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-86-7955_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	922	823	NA	NA	NA	NA	NA	NA	TCGA-86-7955_treatment6	Cisplatin	NA	NA	NA	6524e15a-77f3-437f-b0f8-f50ef5366d84	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	0d0d83d9-d558-4d38-977b-6f1b2471beda	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7955	62	false	Russia	-22772	NA	1abb3b3f-3a1e-5b0a-92b5-afb8907a9a8e	not hispanic or latino	male	white	TCGA-86-7955_demographic	Alive	22772	M0	N0	Stage IB	T2a	7th	primary	0	1072.0	5203d103-43ce-5799-b6b6-07aa9cf959bd	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-86-7955_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	922	823	NA	NA	NA	NA	NA	NA	TCGA-86-7955_treatment5	Gemcitabine	NA	NA	NA	67a8f129-58d4-43ed-9115-4544dd238466	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	0d0d83d9-d558-4d38-977b-6f1b2471beda	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7955	62	false	Russia	-22772	NA	1abb3b3f-3a1e-5b0a-92b5-afb8907a9a8e	not hispanic or latino	male	white	TCGA-86-7955_demographic	Alive	22772	M0	N0	Stage IB	T2a	7th	primary	0	1072.0	5203d103-43ce-5799-b6b6-07aa9cf959bd	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-86-7955_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	1057	1027	NA	NA	18.0	NA	NA	NA	TCGA-86-7955_treatment2	NA	Regional Site	36	Gy	78cf4ef3-b398-4299-a482-0083ec15e4ba	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	0d0d83d9-d558-4d38-977b-6f1b2471beda	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7955	62	false	Russia	-22772	NA	1abb3b3f-3a1e-5b0a-92b5-afb8907a9a8e	not hispanic or latino	male	white	TCGA-86-7955_demographic	Alive	22772	M0	N0	Stage IB	T2a	7th	primary	0	1072.0	5203d103-43ce-5799-b6b6-07aa9cf959bd	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-86-7955_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	274	27	NA	NA	NA	NA	NA	NA	TCGA-86-7955_treatment3	Etoposide	NA	NA	NA	92fa9fe6-c5a5-43a1-b36b-cb931f8d6a42	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	0d0d83d9-d558-4d38-977b-6f1b2471beda	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7955	62	false	Russia	-22772	NA	1abb3b3f-3a1e-5b0a-92b5-afb8907a9a8e	not hispanic or latino	male	white	TCGA-86-7955_demographic	Alive	22772	M0	N0	Stage IB	T2a	7th	primary	0	1072.0	5203d103-43ce-5799-b6b6-07aa9cf959bd	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-86-7955_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	274	27	NA	NA	NA	NA	NA	NA	TCGA-86-7955_treatment4	Cisplatin	NA	NA	NA	a8ed2e55-8582-4ab2-b7f4-cabc7f7843a8	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	0d66bf6c-eed0-4726-bd5b-3bf6d610b4e0	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6597	79	false	United States	-29195	1268	820f1280-2833-5942-9e9a-d331ab1d835a	not hispanic or latino	female	white	TCGA-50-6597_demographic	Dead	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	91396f0d-4e9d-45e4-a4fd-86f20de858ba	false	NA	NA	NA	Right	8240/3	Carcinoid tumor, NOS	NA	NA	NA	Not Reported	NA	TCGA-50-6597_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6597_treatment4	NA	NA	NA	NA	862df867-fd2a-4bcf-951b-b3152098f427	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0d66bf6c-eed0-4726-bd5b-3bf6d610b4e0	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6597	79	false	United States	-29195	1268	820f1280-2833-5942-9e9a-d331ab1d835a	not hispanic or latino	female	white	TCGA-50-6597_demographic	Dead	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	91396f0d-4e9d-45e4-a4fd-86f20de858ba	false	NA	NA	NA	Right	8240/3	Carcinoid tumor, NOS	NA	NA	NA	Not Reported	NA	TCGA-50-6597_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6597_treatment3	NA	NA	NA	NA	e4589ce3-198d-48f2-9dac-17019781c118	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0d66bf6c-eed0-4726-bd5b-3bf6d610b4e0	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6597	79	false	United States	-29195	1268	820f1280-2833-5942-9e9a-d331ab1d835a	not hispanic or latino	female	white	TCGA-50-6597_demographic	Dead	29195	M0	N0	Stage IB	T2	6th	primary	0	1268.0	9babcfd6-a4de-5b90-9aa9-feb27a873807	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-6597_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6597_treatment2	NA	NA	NA	NA	227a5152-5808-4f72-9bb8-4ff82b1f3cd0	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0d66bf6c-eed0-4726-bd5b-3bf6d610b4e0	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6597	79	false	United States	-29195	1268	820f1280-2833-5942-9e9a-d331ab1d835a	not hispanic or latino	female	white	TCGA-50-6597_demographic	Dead	29195	M0	N0	Stage IB	T2	6th	primary	0	1268.0	9babcfd6-a4de-5b90-9aa9-feb27a873807	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-6597_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6597_treatment	NA	NA	NA	NA	cc810e81-0fa6-5db5-9a1c-02ce09b19530	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0d96def2-cf0a-4659-94e5-f08744c57cc6	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	0d980584-4484-4063-8243-c3cd67f6f588	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-A4BD	78	false	United States	-28544	NA	d8f62981-7ba3-59c9-a194-721cec2c1c9c	not hispanic or latino	male	white	TCGA-91-A4BD_demographic	Alive	28544	MX	N1	Stage IIA	T1b	7th	primary	0	603.0	e003e871-9b5f-5ebd-9ce7-b6fc9e4bf18c	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-91-A4BD_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-A4BD_treatment2	NA	NA	NA	NA	a69d7aa1-b56d-4ae5-a723-6ccab634d6c7	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0d980584-4484-4063-8243-c3cd67f6f588	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-A4BD	78	false	United States	-28544	NA	d8f62981-7ba3-59c9-a194-721cec2c1c9c	not hispanic or latino	male	white	TCGA-91-A4BD_demographic	Alive	28544	MX	N1	Stage IIA	T1b	7th	primary	0	603.0	e003e871-9b5f-5ebd-9ce7-b6fc9e4bf18c	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-91-A4BD_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-A4BD_treatment	NA	NA	NA	NA	f3cf86fe-3d61-5985-9aad-61df67dcb9e5	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0df573ee-28f0-4244-b434-09e6ca59fbf0	Informed Consent	59	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-3771	77	false	United States	-28406	NA	3c6aa20d-a39a-527e-801a-84b39a65cd3a	not hispanic or latino	female	black or african american	TCGA-67-3771_demographic	Alive	28406	M0	N0	Stage IA	T1	6th	primary	0	610.0	ab934a99-5aef-5a9b-af8b-72e47f4823a6	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-3771_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	0ea4920f-f4c8-4590-84b3-eb419824e144	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-38-4625	66	false	United States	-24241	NA	aabddee2-26e4-5acc-b96b-3c53c82b5b2a	not hispanic or latino	female	white	TCGA-38-4625_demographic	Alive	24241	M0	N0	Stage IB	T2a	5th	primary	0	2973.0	ce35d76e-7b03-5008-bbcc-2342f465bc74	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4625_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4625_treatment	NA	NA	NA	NA	999361f7-2469-5c78-ba2e-d873fd85514b	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	0ea4920f-f4c8-4590-84b3-eb419824e144	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-38-4625	66	false	United States	-24241	NA	aabddee2-26e4-5acc-b96b-3c53c82b5b2a	not hispanic or latino	female	white	TCGA-38-4625_demographic	Alive	24241	M0	N0	Stage IB	T2a	5th	primary	0	2973.0	ce35d76e-7b03-5008-bbcc-2342f465bc74	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4625_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4625_treatment2	NA	NA	NA	NA	ec635a7d-3350-4b9b-aa51-287af7840197	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	0fe909ea-d52c-4b71-816f-57f62d4a5744	Informed Consent	-1	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-86-8054	61	false	Russia	-22584	NA	5d3cceec-bb94-5bc6-8ef6-0528c6e58960	not hispanic or latino	male	white	TCGA-86-8054_demographic	Alive	22584	M0	N1	Stage IIB	T2b	7th	primary	0	1148.0	061f07e3-8916-50f9-b18f-f36f18d960f6	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-86-8054_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8054_treatment3	NA	NA	NA	NA	7315f319-cdb3-475e-8414-7dc77a052c3f	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	0fe909ea-d52c-4b71-816f-57f62d4a5744	Informed Consent	-1	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-86-8054	61	false	Russia	-22584	NA	5d3cceec-bb94-5bc6-8ef6-0528c6e58960	not hispanic or latino	male	white	TCGA-86-8054_demographic	Alive	22584	M0	N1	Stage IIB	T2b	7th	primary	0	1148.0	061f07e3-8916-50f9-b18f-f36f18d960f6	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-86-8054_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	136	65	NA	NA	NA	NA	NA	NA	TCGA-86-8054_treatment2	Cisplatin	NA	NA	NA	b28481ff-af98-4d7b-b938-92be1cc2c578	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	0fe909ea-d52c-4b71-816f-57f62d4a5744	Informed Consent	-1	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-86-8054	61	false	Russia	-22584	NA	5d3cceec-bb94-5bc6-8ef6-0528c6e58960	not hispanic or latino	male	white	TCGA-86-8054_demographic	Alive	22584	M0	N1	Stage IIB	T2b	7th	primary	0	1148.0	061f07e3-8916-50f9-b18f-f36f18d960f6	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-86-8054_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	136	65	NA	NA	NA	NA	NA	NA	TCGA-86-8054_treatment	Paclitaxel	NA	NA	NA	e9960e6f-0228-57c8-ad0e-928cf8903279	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	100430c8-1446-45c8-af36-b6dbb3ddd0c1	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5935	86	false	United States	-31610	653	a226e070-84ae-5168-aaa5-785a27a906a1	not hispanic or latino	female	white	TCGA-50-5935_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	0c609d27-92c4-447b-bfde-73b4ebc1b6a8	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-50-5935_diagnosis2	NA	Cervix uteri	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5935_treatment4	NA	NA	NA	NA	6704ec43-ffc8-4132-87ca-88466434a639	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	100430c8-1446-45c8-af36-b6dbb3ddd0c1	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5935	86	false	United States	-31610	653	a226e070-84ae-5168-aaa5-785a27a906a1	not hispanic or latino	female	white	TCGA-50-5935_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	0c609d27-92c4-447b-bfde-73b4ebc1b6a8	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-50-5935_diagnosis2	NA	Cervix uteri	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5935_treatment3	NA	NA	NA	NA	adc6af65-3ef9-4efe-a6d4-81ee305e80c6	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	100430c8-1446-45c8-af36-b6dbb3ddd0c1	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5935	86	false	United States	-31610	653	a226e070-84ae-5168-aaa5-785a27a906a1	not hispanic or latino	female	white	TCGA-50-5935_demographic	Dead	31610	M0	N0	Stage IA	T1	6th	primary	0	653.0	c71f111f-9128-56cb-954b-cb853f3f6247	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-50-5935_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5935_treatment2	NA	NA	NA	NA	15440e69-ed35-4246-a7fc-af41d3f5d8c4	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	100430c8-1446-45c8-af36-b6dbb3ddd0c1	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5935	86	false	United States	-31610	653	a226e070-84ae-5168-aaa5-785a27a906a1	not hispanic or latino	female	white	TCGA-50-5935_demographic	Dead	31610	M0	N0	Stage IA	T1	6th	primary	0	653.0	c71f111f-9128-56cb-954b-cb853f3f6247	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-50-5935_diagnosis	No	Upper lobe, lung	NA	2006	NA	1.0	0	0	NA	NA	NA	NA	NA	NA	TCGA-50-5935_treatment	NA	Primary Tumor Field	100	cGy	c56d526a-6b83-53c2-9372-5ad5038c8a27	Adjuvant	yes	NA	Radiation, Implants
TCGA-LUAD	102fba48-b23a-46d4-8371-71c11c1a6654	Informed Consent	64	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-3776	57	false	United States	-20940	NA	6cac6e6f-e267-5329-832f-1d6ce99ac768	not hispanic or latino	female	white	TCGA-67-3776_demographic	Alive	20940	M0	N1	Stage IIB	T2	NA	primary	0	61.0	fa24d4fd-b966-52d2-bce5-47546ebf182e	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-3776_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	1070ff27-17c9-43dd-a4f6-daa643eb9123	Informed Consent	100	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8089	56	false	United States	-20576	702	c5204a17-1d50-54fa-94e5-0f4c03fa560c	not hispanic or latino	male	white	TCGA-55-8089_demographic	Dead	20576	M0	N0	Stage IA	T1a	7th	primary	0	702.0	343a9122-61c4-5172-a24f-2908b03c6ae5	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-8089_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8089_treatment2	NA	NA	NA	NA	79ff4a72-cd2a-4293-83a8-6ecd13b09e0a	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	1070ff27-17c9-43dd-a4f6-daa643eb9123	Informed Consent	100	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8089	56	false	United States	-20576	702	c5204a17-1d50-54fa-94e5-0f4c03fa560c	not hispanic or latino	male	white	TCGA-55-8089_demographic	Dead	20576	M0	N0	Stage IA	T1a	7th	primary	0	702.0	343a9122-61c4-5172-a24f-2908b03c6ae5	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-8089_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8089_treatment	NA	NA	NA	NA	f8881c99-bd49-5858-aa5e-f93c8455771d	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	108a71cf-b9db-47cd-aa74-c03ec989b41b	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6217	73	false	United States	-26920	NA	468502cd-b9e7-5c70-bcf8-3622ddd59f08	not hispanic or latino	female	white	TCGA-67-6217_demographic	Alive	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	11322b55-0ab8-4366-9836-6f047accee93	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-67-6217_diagnosis3	NA	Thymus	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-67-6217_treatment3	NA	NA	NA	NA	350a41d3-4870-43e7-9b45-90f40497bc39	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	108a71cf-b9db-47cd-aa74-c03ec989b41b	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6217	73	false	United States	-26920	NA	468502cd-b9e7-5c70-bcf8-3622ddd59f08	not hispanic or latino	female	white	TCGA-67-6217_demographic	Alive	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	11322b55-0ab8-4366-9836-6f047accee93	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-67-6217_diagnosis3	NA	Thymus	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-67-6217_treatment4	NA	NA	NA	NA	6f34bc58-04d7-4cee-92c3-ac08369b5ca7	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	108a71cf-b9db-47cd-aa74-c03ec989b41b	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6217	73	false	United States	-26920	NA	468502cd-b9e7-5c70-bcf8-3622ddd59f08	not hispanic or latino	female	white	TCGA-67-6217_demographic	Alive	26920	M0	N1	Stage IIA	T2a	7th	primary	0	422.0	4933f703-8512-55e4-b887-9045a402b0b8	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-6217_diagnosis	Yes	Upper lobe, lung	NA	2010	NA	NA	443	399	Progressive Disease	1	NA	100.0	mg	Oral	TCGA-67-6217_treatment	Erlotinib Hydrochloride	NA	NA	NA	810143e1-f660-5efa-ac3b-3126954d5ff2	NA	yes	NA	Chemotherapy
TCGA-LUAD	108a71cf-b9db-47cd-aa74-c03ec989b41b	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6217	73	false	United States	-26920	NA	468502cd-b9e7-5c70-bcf8-3622ddd59f08	not hispanic or latino	female	white	TCGA-67-6217_demographic	Alive	26920	M0	N1	Stage IIA	T2a	7th	primary	0	422.0	4933f703-8512-55e4-b887-9045a402b0b8	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-6217_diagnosis	Yes	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-67-6217_treatment2	NA	NA	NA	NA	eac420c3-bc71-4b59-9038-428a8528edc9	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	108a71cf-b9db-47cd-aa74-c03ec989b41b	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6217	73	false	United States	-26920	NA	468502cd-b9e7-5c70-bcf8-3622ddd59f08	not hispanic or latino	female	white	TCGA-67-6217_demographic	Alive	27216	NA	NA	NA	NA	NA	not reported	296	NA	ea4798c3-6152-45d8-b421-988709b3a02e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-67-6217_diagnosis2	NA	Not Reported	TCGA-67-6217_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-67-6217_treatment5	NA	NA	NA	NA	5911e70d-eaee-46a2-b61e-bc85456ce23d	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	108a71cf-b9db-47cd-aa74-c03ec989b41b	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6217	73	false	United States	-26920	NA	468502cd-b9e7-5c70-bcf8-3622ddd59f08	not hispanic or latino	female	white	TCGA-67-6217_demographic	Alive	27216	NA	NA	NA	NA	NA	not reported	296	NA	ea4798c3-6152-45d8-b421-988709b3a02e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-67-6217_diagnosis2	NA	Not Reported	TCGA-67-6217_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-67-6217_treatment7	NA	Distant Site	NA	NA	8e24530e-9222-4a07-a61d-72a3846e7fe7	NA	no	NA	Surgery, NOS
TCGA-LUAD	108a71cf-b9db-47cd-aa74-c03ec989b41b	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6217	73	false	United States	-26920	NA	468502cd-b9e7-5c70-bcf8-3622ddd59f08	not hispanic or latino	female	white	TCGA-67-6217_demographic	Alive	27216	NA	NA	NA	NA	NA	not reported	296	NA	ea4798c3-6152-45d8-b421-988709b3a02e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-67-6217_diagnosis2	NA	Not Reported	TCGA-67-6217_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-67-6217_treatment6	NA	Locoregional Site	NA	NA	ed15e786-ef78-43c8-a7ef-f7adf54af71b	NA	no	NA	Surgery, NOS
TCGA-LUAD	114a34c0-983b-4d90-9181-1823c9637a63	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6590	72	false	United States	-26444	1288	ae6f4078-be1f-5ac9-b2ee-43d7eca561bd	not hispanic or latino	female	white	TCGA-50-6590_demographic	Dead	26444	M0	N0	Stage IB	T2	6th	primary	0	1288.0	8aa5f27d-3c63-53ff-9479-ed22aae00ab3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-6590_diagnosis	No	Upper lobe, lung	NA	2005	No	NA	189	92	NA	NA	NA	NA	NA	NA	TCGA-50-6590_treatment2	Carboplatin	NA	NA	NA	35cd22fd-bf95-4c48-91c6-145293b1f5e3	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	114a34c0-983b-4d90-9181-1823c9637a63	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6590	72	false	United States	-26444	1288	ae6f4078-be1f-5ac9-b2ee-43d7eca561bd	not hispanic or latino	female	white	TCGA-50-6590_demographic	Dead	26444	M0	N0	Stage IB	T2	6th	primary	0	1288.0	8aa5f27d-3c63-53ff-9479-ed22aae00ab3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-6590_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6590_treatment3	NA	NA	NA	NA	75502d28-0aff-4cdc-84d5-b1b2af1d6062	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	114a34c0-983b-4d90-9181-1823c9637a63	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6590	72	false	United States	-26444	1288	ae6f4078-be1f-5ac9-b2ee-43d7eca561bd	not hispanic or latino	female	white	TCGA-50-6590_demographic	Dead	26444	M0	N0	Stage IB	T2	6th	primary	0	1288.0	8aa5f27d-3c63-53ff-9479-ed22aae00ab3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-6590_diagnosis	No	Upper lobe, lung	NA	2005	No	NA	189	92	NA	NA	NA	NA	NA	NA	TCGA-50-6590_treatment	Paclitaxel	NA	NA	NA	9f802b18-3e7b-5789-9257-40bd128d9aa9	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	11c2e619-8aeb-4f86-b03b-78f9a8099263	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8179	72	false	United States	-26305	NA	37012cee-2b8e-5a4a-b8de-a846d68f7478	not hispanic or latino	male	white	TCGA-97-8179_demographic	Alive	26305	M0	N0	Stage IA	T1a	7th	primary	0	435.0	a3486809-df24-54e4-b59f-e6aece70eebc	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-97-8179_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8179_treatment2	NA	NA	NA	NA	440d56a8-c9b5-4bb9-be11-2ab3718aabd6	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	11c2e619-8aeb-4f86-b03b-78f9a8099263	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8179	72	false	United States	-26305	NA	37012cee-2b8e-5a4a-b8de-a846d68f7478	not hispanic or latino	male	white	TCGA-97-8179_demographic	Alive	26305	M0	N0	Stage IA	T1a	7th	primary	0	435.0	a3486809-df24-54e4-b59f-e6aece70eebc	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-97-8179_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8179_treatment	NA	NA	NA	NA	d342e048-d4ef-5535-b9e0-ade32fba00a7	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	127bf818-f7e5-46b5-a9de-39f6d96b8b83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4629	68	false	United States	-25104	864	9ea1f795-9510-5acc-a9a5-bf1379e6635a	not hispanic or latino	male	white	TCGA-38-4629_demographic	Dead	25104	M0	N0	Stage IIB	T3	NA	primary	0	864.0	9381672b-0c48-55a7-8712-ad58483c1f69	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4629_diagnosis	No	Upper lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4629_treatment2	NA	NA	NA	NA	279b7f5a-8467-4461-8a12-1597013a2db7	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	127bf818-f7e5-46b5-a9de-39f6d96b8b83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4629	68	false	United States	-25104	864	9ea1f795-9510-5acc-a9a5-bf1379e6635a	not hispanic or latino	male	white	TCGA-38-4629_demographic	Dead	25104	M0	N0	Stage IIB	T3	NA	primary	0	864.0	9381672b-0c48-55a7-8712-ad58483c1f69	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4629_diagnosis	No	Upper lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4629_treatment	NA	NA	NA	NA	2b8bd926-f6fa-5509-a8ee-4fa5371f6e0f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	127bf818-f7e5-46b5-a9de-39f6d96b8b83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4629	68	false	United States	-25104	864	9ea1f795-9510-5acc-a9a5-bf1379e6635a	not hispanic or latino	male	white	TCGA-38-4629_demographic	Dead	25483	NA	NA	NA	NA	NA	not reported	379	NA	afa8fa4e-b1f5-4218-9efb-32f4d1ac0fa3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4629_diagnosis2	NA	Not Reported	TCGA-38-4629_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4629_treatment7	NA	Locoregional Site	NA	NA	66258d38-a055-4a5e-9c60-874a61f9c287	NA	no	NA	Surgery, NOS
TCGA-LUAD	127bf818-f7e5-46b5-a9de-39f6d96b8b83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4629	68	false	United States	-25104	864	9ea1f795-9510-5acc-a9a5-bf1379e6635a	not hispanic or latino	male	white	TCGA-38-4629_demographic	Dead	25483	NA	NA	NA	NA	NA	not reported	379	NA	afa8fa4e-b1f5-4218-9efb-32f4d1ac0fa3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4629_diagnosis2	NA	Not Reported	TCGA-38-4629_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4629_treatment6	NA	NA	NA	NA	93641708-b8a4-41aa-b89d-81d2aed99633	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	127bf818-f7e5-46b5-a9de-39f6d96b8b83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4629	68	false	United States	-25104	864	9ea1f795-9510-5acc-a9a5-bf1379e6635a	not hispanic or latino	male	white	TCGA-38-4629_demographic	Dead	25483	NA	NA	NA	NA	NA	not reported	379	NA	afa8fa4e-b1f5-4218-9efb-32f4d1ac0fa3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4629_diagnosis2	NA	Not Reported	TCGA-38-4629_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4629_treatment5	NA	NA	NA	NA	d8fd1bcb-f945-4719-bff4-9d5a1fc701f8	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	127bf818-f7e5-46b5-a9de-39f6d96b8b83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4629	68	false	United States	-25104	864	9ea1f795-9510-5acc-a9a5-bf1379e6635a	not hispanic or latino	male	white	TCGA-38-4629_demographic	Dead	25483	NA	NA	NA	NA	NA	not reported	379	NA	afa8fa4e-b1f5-4218-9efb-32f4d1ac0fa3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4629_diagnosis2	NA	Not Reported	TCGA-38-4629_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4629_treatment8	NA	Distant Site	NA	NA	fab0d7c1-7f07-4d27-95e7-0b1844af3cb6	NA	no	NA	Surgery, NOS
TCGA-LUAD	127bf818-f7e5-46b5-a9de-39f6d96b8b83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4629	68	false	United States	-25104	864	9ea1f795-9510-5acc-a9a5-bf1379e6635a	not hispanic or latino	male	white	TCGA-38-4629_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d269f785-c893-4374-a3e7-89c251c28a50	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-38-4629_diagnosis3	NA	Larynx, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4629_treatment4	NA	Body, total	NA	NA	606116ca-98f8-4a85-87de-4c513e78ec1d	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	127bf818-f7e5-46b5-a9de-39f6d96b8b83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4629	68	false	United States	-25104	864	9ea1f795-9510-5acc-a9a5-bf1379e6635a	not hispanic or latino	male	white	TCGA-38-4629_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d269f785-c893-4374-a3e7-89c251c28a50	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-38-4629_diagnosis3	NA	Larynx, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4629_treatment3	Unknown	Body, total	NA	NA	aa03daa5-2612-48d7-bda9-90bbf8f32e1a	NA	yes	NA	Unknown
TCGA-LUAD	12b79b4f-c28c-418e-a1e7-e622f33fdcc2	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-50-5939	85	false	United States	-31236	460	b868f8d3-6c2c-519b-9d63-6d7a244c80bd	not hispanic or latino	male	white	TCGA-50-5939_demographic	Dead	31236	M0	N0	Stage IB	T2	6th	primary	0	460.0	6cfa3dca-9733-57cf-bfb9-5b44e0da6357	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-50-5939_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5939_treatment	NA	NA	NA	NA	0cdc4e5b-f937-51b4-b4b9-7bb9854ef0c9	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	12b79b4f-c28c-418e-a1e7-e622f33fdcc2	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-50-5939	85	false	United States	-31236	460	b868f8d3-6c2c-519b-9d63-6d7a244c80bd	not hispanic or latino	male	white	TCGA-50-5939_demographic	Dead	31236	M0	N0	Stage IB	T2	6th	primary	0	460.0	6cfa3dca-9733-57cf-bfb9-5b44e0da6357	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-50-5939_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5939_treatment2	NA	NA	NA	NA	b6a5c20e-ff59-42a7-abae-777eafcf4c67	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	12c07138-e3fa-418a-89e3-628da12bc99e	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48Y	69	false	United States	-25384	NA	eaf3468c-18b6-5688-8f83-3cfcf26e16fb	not hispanic or latino	male	white	TCGA-55-A48Y_demographic	Alive	25384	M0	N0	Stage IIA	T2b	7th	primary	0	630.0	6fb13ae9-37d4-5cdc-a372-9ca0fb8cf696	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-A48Y_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	163	91	NA	NA	NA	NA	NA	NA	TCGA-55-A48Y_treatment2	Pemetrexed Disodium	NA	NA	NA	0ea4051f-7259-4f1b-b0a3-66c244682c99	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	12c07138-e3fa-418a-89e3-628da12bc99e	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48Y	69	false	United States	-25384	NA	eaf3468c-18b6-5688-8f83-3cfcf26e16fb	not hispanic or latino	male	white	TCGA-55-A48Y_demographic	Alive	25384	M0	N0	Stage IIA	T2b	7th	primary	0	630.0	6fb13ae9-37d4-5cdc-a372-9ca0fb8cf696	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-A48Y_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	163	91	NA	NA	NA	NA	NA	NA	TCGA-55-A48Y_treatment	Carboplatin	NA	NA	NA	700dfce4-5a35-5237-8cc6-176bf7d637dc	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	12c07138-e3fa-418a-89e3-628da12bc99e	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48Y	69	false	United States	-25384	NA	eaf3468c-18b6-5688-8f83-3cfcf26e16fb	not hispanic or latino	male	white	TCGA-55-A48Y_demographic	Alive	25384	M0	N0	Stage IIA	T2b	7th	primary	0	630.0	6fb13ae9-37d4-5cdc-a372-9ca0fb8cf696	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-A48Y_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A48Y_treatment3	NA	NA	NA	NA	bd83f27b-99ed-4af6-b691-dcdfaa7b4c0c	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	12c27db5-db2f-48dc-a2ca-9557b951f43e	Informed Consent	-32	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8176	63	false	United States	-23170	468	ad8e8d0e-5eea-5ae6-81cd-84cb081b7361	not hispanic or latino	male	white	TCGA-97-8176_demographic	Dead	23170	M0	N1	Stage IIIA	T3	7th	primary	0	468.0	4144f3b6-8fcb-5fef-a485-3d698052b251	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-8176_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	64	51	NA	NA	5.0	NA	NA	NA	TCGA-97-8176_treatment3	NA	Distant Site	3000	cGy	4b8e8ed0-4d07-490a-856e-82abece48134	NA	yes	Partial Response	Radiation, External Beam
TCGA-LUAD	12c27db5-db2f-48dc-a2ca-9557b951f43e	Informed Consent	-32	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8176	63	false	United States	-23170	468	ad8e8d0e-5eea-5ae6-81cd-84cb081b7361	not hispanic or latino	male	white	TCGA-97-8176_demographic	Dead	23170	M0	N1	Stage IIIA	T3	7th	primary	0	468.0	4144f3b6-8fcb-5fef-a485-3d698052b251	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-8176_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	105	91	NA	NA	10.0	NA	NA	NA	TCGA-97-8176_treatment2	NA	Distant Site	3000	cGy	4d2b1159-dd8e-47c9-95a0-d24840d60409	NA	yes	Partial Response	Radiation, External Beam
TCGA-LUAD	12c27db5-db2f-48dc-a2ca-9557b951f43e	Informed Consent	-32	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8176	63	false	United States	-23170	468	ad8e8d0e-5eea-5ae6-81cd-84cb081b7361	not hispanic or latino	male	white	TCGA-97-8176_demographic	Dead	23170	M0	N1	Stage IIIA	T3	7th	primary	0	468.0	4144f3b6-8fcb-5fef-a485-3d698052b251	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-8176_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	105	91	NA	NA	5.0	NA	NA	NA	TCGA-97-8176_treatment	NA	Distant Site	1500	cGy	67f5cedf-388e-59ce-9f58-1a24fc2eccf3	NA	yes	Partial Response	Radiation, External Beam
TCGA-LUAD	12c27db5-db2f-48dc-a2ca-9557b951f43e	Informed Consent	-32	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8176	63	false	United States	-23170	468	ad8e8d0e-5eea-5ae6-81cd-84cb081b7361	not hispanic or latino	male	white	TCGA-97-8176_demographic	Dead	23170	M0	N1	Stage IIIA	T3	7th	primary	0	468.0	4144f3b6-8fcb-5fef-a485-3d698052b251	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-8176_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	417	77	NA	NA	NA	NA	NA	NA	TCGA-97-8176_treatment6	Cyanocobalamin	NA	NA	NA	9fe116da-2429-476b-a46f-f8a19109cad3	NA	yes	Partial Response	Ancillary Treatment
TCGA-LUAD	12c27db5-db2f-48dc-a2ca-9557b951f43e	Informed Consent	-32	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8176	63	false	United States	-23170	468	ad8e8d0e-5eea-5ae6-81cd-84cb081b7361	not hispanic or latino	male	white	TCGA-97-8176_demographic	Dead	23170	M0	N1	Stage IIIA	T3	7th	primary	0	468.0	4144f3b6-8fcb-5fef-a485-3d698052b251	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-8176_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	417	77	NA	NA	NA	NA	NA	NA	TCGA-97-8176_treatment8	Denosumab	NA	NA	NA	c7159ca2-6573-4688-a075-0ff3ef28bcbb	NA	yes	Unknown	Ancillary Treatment
TCGA-LUAD	12c27db5-db2f-48dc-a2ca-9557b951f43e	Informed Consent	-32	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8176	63	false	United States	-23170	468	ad8e8d0e-5eea-5ae6-81cd-84cb081b7361	not hispanic or latino	male	white	TCGA-97-8176_demographic	Dead	23170	M0	N1	Stage IIIA	T3	7th	primary	0	468.0	4144f3b6-8fcb-5fef-a485-3d698052b251	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-8176_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	417	77	NA	NA	NA	NA	NA	NA	TCGA-97-8176_treatment7	Pegfilgrastim	NA	NA	NA	d8114899-3144-4724-8fd2-10f3482d7685	NA	yes	Unknown	Ancillary Treatment
TCGA-LUAD	12c27db5-db2f-48dc-a2ca-9557b951f43e	Informed Consent	-32	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8176	63	false	United States	-23170	468	ad8e8d0e-5eea-5ae6-81cd-84cb081b7361	not hispanic or latino	male	white	TCGA-97-8176_demographic	Dead	23170	M0	N1	Stage IIIA	T3	7th	primary	0	468.0	4144f3b6-8fcb-5fef-a485-3d698052b251	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-8176_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	417	77	NA	NA	NA	NA	NA	NA	TCGA-97-8176_treatment5	Pemetrexed Disodium	NA	NA	NA	f0b5ae58-06db-4d47-b166-db8ff03f1f1f	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	12c27db5-db2f-48dc-a2ca-9557b951f43e	Informed Consent	-32	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8176	63	false	United States	-23170	468	ad8e8d0e-5eea-5ae6-81cd-84cb081b7361	not hispanic or latino	male	white	TCGA-97-8176_demographic	Dead	23170	M0	N1	Stage IIIA	T3	7th	primary	0	468.0	4144f3b6-8fcb-5fef-a485-3d698052b251	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-8176_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	161	77	NA	NA	NA	NA	NA	NA	TCGA-97-8176_treatment4	Carboplatin	NA	NA	NA	f3a6e50d-23c2-4910-9eb7-9594335b49b9	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	12c27db5-db2f-48dc-a2ca-9557b951f43e	Informed Consent	-32	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8176	63	false	United States	-23170	468	ad8e8d0e-5eea-5ae6-81cd-84cb081b7361	not hispanic or latino	male	white	TCGA-97-8176_demographic	Dead	23209	NA	NA	NA	NA	NA	metastasis	39	NA	d320e241-7f9e-4a3c-96f8-d20c99721927	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-97-8176_diagnosis2	NA	Not Reported	TCGA-97-8176_diagnosis	NA	NA	NA	NA	171	NA	NA	NA	NA	NA	NA	TCGA-97-8176_treatment11	NA	Distant Site	NA	NA	c8c884b8-b712-47be-9399-4920eba1e49a	NA	yes	NA	Surgery, NOS
TCGA-LUAD	12c27db5-db2f-48dc-a2ca-9557b951f43e	Informed Consent	-32	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8176	63	false	United States	-23170	468	ad8e8d0e-5eea-5ae6-81cd-84cb081b7361	not hispanic or latino	male	white	TCGA-97-8176_demographic	Dead	23209	NA	NA	NA	NA	NA	metastasis	39	NA	d320e241-7f9e-4a3c-96f8-d20c99721927	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-97-8176_diagnosis2	NA	Not Reported	TCGA-97-8176_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-97-8176_treatment10	NA	NA	NA	NA	d00e1728-ae76-4030-9f0e-398fc4ca8748	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	12c27db5-db2f-48dc-a2ca-9557b951f43e	Informed Consent	-32	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8176	63	false	United States	-23170	468	ad8e8d0e-5eea-5ae6-81cd-84cb081b7361	not hispanic or latino	male	white	TCGA-97-8176_demographic	Dead	23209	NA	NA	NA	NA	NA	metastasis	39	NA	d320e241-7f9e-4a3c-96f8-d20c99721927	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-97-8176_diagnosis2	NA	Not Reported	TCGA-97-8176_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-97-8176_treatment9	NA	NA	NA	NA	edc68c26-fe83-4569-9314-a35cea359033	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	12ccd581-a921-41bc-bcee-4e9be54532cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5931	75	false	United States	-27733	434	33fdf1e3-0bc7-5f09-bc2c-950ff85dac27	not hispanic or latino	female	white	TCGA-50-5931_demographic	Dead	27733	M0	N0	Stage IB	T2	5th	primary	0	434.0	092609c0-775f-5e17-b321-19bb903bc65d	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-50-5931_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5931_treatment	NA	NA	NA	NA	5137f897-1702-5370-8593-f6e165a556c3	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	12ccd581-a921-41bc-bcee-4e9be54532cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5931	75	false	United States	-27733	434	33fdf1e3-0bc7-5f09-bc2c-950ff85dac27	not hispanic or latino	female	white	TCGA-50-5931_demographic	Dead	27733	M0	N0	Stage IB	T2	5th	primary	0	434.0	092609c0-775f-5e17-b321-19bb903bc65d	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-50-5931_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5931_treatment2	NA	NA	NA	NA	d9abd467-c61c-4088-9210-4bebbce97109	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	12ccd581-a921-41bc-bcee-4e9be54532cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5931	75	false	United States	-27733	434	33fdf1e3-0bc7-5f09-bc2c-950ff85dac27	not hispanic or latino	female	white	TCGA-50-5931_demographic	Dead	28158	NA	NA	NA	NA	NA	metastasis	425	NA	e510feac-4e24-4f62-9490-5cd0512f65d0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5931_diagnosis2	NA	Not Reported	TCGA-50-5931_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5931_treatment4	NA	NA	NA	NA	82432f00-4484-4783-b533-9914996bf4a6	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	12ccd581-a921-41bc-bcee-4e9be54532cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5931	75	false	United States	-27733	434	33fdf1e3-0bc7-5f09-bc2c-950ff85dac27	not hispanic or latino	female	white	TCGA-50-5931_demographic	Dead	28158	NA	NA	NA	NA	NA	metastasis	425	NA	e510feac-4e24-4f62-9490-5cd0512f65d0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5931_diagnosis2	NA	Not Reported	TCGA-50-5931_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5931_treatment5	NA	Distant Site	NA	NA	bbe82475-ef48-45cc-a0d3-598874340452	NA	no	NA	Surgery, NOS
TCGA-LUAD	12ccd581-a921-41bc-bcee-4e9be54532cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5931	75	false	United States	-27733	434	33fdf1e3-0bc7-5f09-bc2c-950ff85dac27	not hispanic or latino	female	white	TCGA-50-5931_demographic	Dead	28158	NA	NA	NA	NA	NA	metastasis	425	NA	e510feac-4e24-4f62-9490-5cd0512f65d0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5931_diagnosis2	NA	Not Reported	TCGA-50-5931_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5931_treatment3	NA	NA	NA	NA	e89e94b3-6fa7-4fc5-9413-13e4ebd03aaa	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1427cd18-5ad3-491a-9981-908e31ae49db	Informed Consent	52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-6829	78	false	United States	-28841	1258	8e582293-9ff2-532d-b1a7-8cb53102d06c	not hispanic or latino	male	white	TCGA-91-6829_demographic	Dead	28841	MX	N0	Stage IB	T2	5th	primary	0	1258.0	2efc8eba-e7c5-5d91-9b2a-90c8e24a40ae	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-91-6829_diagnosis	No	Lower lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6829_treatment2	NA	NA	NA	NA	04623855-8d5d-4135-b427-3dada53312ad	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1427cd18-5ad3-491a-9981-908e31ae49db	Informed Consent	52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-6829	78	false	United States	-28841	1258	8e582293-9ff2-532d-b1a7-8cb53102d06c	not hispanic or latino	male	white	TCGA-91-6829_demographic	Dead	28841	MX	N0	Stage IB	T2	5th	primary	0	1258.0	2efc8eba-e7c5-5d91-9b2a-90c8e24a40ae	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-91-6829_diagnosis	No	Lower lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6829_treatment	NA	NA	NA	NA	9fe41aa6-2b28-5edf-8747-89f6e7477a54	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	15340dd3-84ae-49fb-989a-eb212f3e73da	Informed Consent	-11	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-6744	64	false	United States	-23484	NA	d0e66cc5-32bd-5a01-8057-4ac557d5f5a9	not reported	female	white	TCGA-49-6744_demographic	Alive	23484	MX	N1	Stage IIA	T2a	7th	primary	0	1683.0	4a84a8c9-ca7d-5349-b914-fc25cac0c101	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-49-6744_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	108	16	NA	NA	NA	NA	NA	Intravenous	TCGA-49-6744_treatment	NA	NA	NA	NA	5ede5d3f-3af4-53a8-9a83-9c0e9b4924bb	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	15340dd3-84ae-49fb-989a-eb212f3e73da	Informed Consent	-11	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-6744	64	false	United States	-23484	NA	d0e66cc5-32bd-5a01-8057-4ac557d5f5a9	not reported	female	white	TCGA-49-6744_demographic	Alive	23484	MX	N1	Stage IIA	T2a	7th	primary	0	1683.0	4a84a8c9-ca7d-5349-b914-fc25cac0c101	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-49-6744_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6744_treatment2	NA	NA	NA	NA	6afe3756-3cc2-4483-a794-d0018ab7f7be	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1575148b-0f63-44ee-86fd-93ae1a02be0b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5072	74	false	United States	-27036	250	22d244c9-79a3-5df2-8709-086253cd595f	not hispanic or latino	male	white	TCGA-50-5072_demographic	Dead	27249	NA	NA	NA	NA	NA	metastasis	213	NA	cc061ea8-d1f1-44cb-bc17-b4c4b05dd520	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5072_diagnosis2	NA	Not Reported	TCGA-50-5072_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5072_treatment8	NA	Distant Site	NA	NA	1f0f5b45-89cf-49eb-8c72-d4f10afbf9d9	NA	no	NA	Surgery, NOS
TCGA-LUAD	1575148b-0f63-44ee-86fd-93ae1a02be0b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5072	74	false	United States	-27036	250	22d244c9-79a3-5df2-8709-086253cd595f	not hispanic or latino	male	white	TCGA-50-5072_demographic	Dead	27249	NA	NA	NA	NA	NA	metastasis	213	NA	cc061ea8-d1f1-44cb-bc17-b4c4b05dd520	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5072_diagnosis2	NA	Not Reported	TCGA-50-5072_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5072_treatment7	NA	NA	NA	NA	8e5741fc-355a-4df9-9178-6266277abd45	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	1575148b-0f63-44ee-86fd-93ae1a02be0b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5072	74	false	United States	-27036	250	22d244c9-79a3-5df2-8709-086253cd595f	not hispanic or latino	male	white	TCGA-50-5072_demographic	Dead	27249	NA	NA	NA	NA	NA	metastasis	213	NA	cc061ea8-d1f1-44cb-bc17-b4c4b05dd520	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5072_diagnosis2	NA	Not Reported	TCGA-50-5072_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5072_treatment6	NA	NA	NA	NA	900dddb6-818a-4167-8fc7-91d5bfccf66d	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1575148b-0f63-44ee-86fd-93ae1a02be0b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5072	74	false	United States	-27036	250	22d244c9-79a3-5df2-8709-086253cd595f	not hispanic or latino	male	white	TCGA-50-5072_demographic	Dead	27036	M0	N2	Stage IIIA	T2	6th	primary	0	250.0	d2580490-8128-5fe3-91ce-b9f142e936f9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Yes	NA	Lung, NOS	NA	TCGA-50-5072_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	182	152	NA	NA	29.0	NA	NA	NA	TCGA-50-5072_treatment	NA	Primary Tumor Field	5800	cGy	295d784f-f1ca-59e7-8c16-578f555e3ad0	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	1575148b-0f63-44ee-86fd-93ae1a02be0b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5072	74	false	United States	-27036	250	22d244c9-79a3-5df2-8709-086253cd595f	not hispanic or latino	male	white	TCGA-50-5072_demographic	Dead	27036	M0	N2	Stage IIIA	T2	6th	primary	0	250.0	d2580490-8128-5fe3-91ce-b9f142e936f9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Yes	NA	Lung, NOS	NA	TCGA-50-5072_diagnosis	No	Upper lobe, lung	NA	2009	No	NA	182	121	NA	NA	NA	NA	NA	NA	TCGA-50-5072_treatment5	Paclitaxel	NA	NA	NA	4c3a270c-a545-41d4-b99f-0d73b0d128a7	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	1575148b-0f63-44ee-86fd-93ae1a02be0b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5072	74	false	United States	-27036	250	22d244c9-79a3-5df2-8709-086253cd595f	not hispanic or latino	male	white	TCGA-50-5072_demographic	Dead	27036	M0	N2	Stage IIIA	T2	6th	primary	0	250.0	d2580490-8128-5fe3-91ce-b9f142e936f9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Yes	NA	Lung, NOS	NA	TCGA-50-5072_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	68	22	NA	3	NA	4.0	mg/m2	Intravenous	TCGA-50-5072_treatment2	Cisplatin	NA	225	mg/m2	8a354cd0-287f-4a58-bb09-573632639e09	Neoadjuvant	yes	NA	Chemotherapy
TCGA-LUAD	1575148b-0f63-44ee-86fd-93ae1a02be0b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5072	74	false	United States	-27036	250	22d244c9-79a3-5df2-8709-086253cd595f	not hispanic or latino	male	white	TCGA-50-5072_demographic	Dead	27036	M0	N2	Stage IIIA	T2	6th	primary	0	250.0	d2580490-8128-5fe3-91ce-b9f142e936f9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Yes	NA	Lung, NOS	NA	TCGA-50-5072_diagnosis	No	Upper lobe, lung	NA	2009	No	NA	182	121	NA	NA	NA	NA	NA	NA	TCGA-50-5072_treatment4	Carboplatin	NA	NA	NA	97495d73-2af9-492b-b200-02ae63b3c792	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	1575148b-0f63-44ee-86fd-93ae1a02be0b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5072	74	false	United States	-27036	250	22d244c9-79a3-5df2-8709-086253cd595f	not hispanic or latino	male	white	TCGA-50-5072_demographic	Dead	27036	M0	N2	Stage IIIA	T2	6th	primary	0	250.0	d2580490-8128-5fe3-91ce-b9f142e936f9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Yes	NA	Lung, NOS	NA	TCGA-50-5072_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	68	22	NA	3	NA	4.0	mg/m2	Intravenous	TCGA-50-5072_treatment3	Docetaxel	NA	225	mg/m2	989be844-77d3-4575-8bb8-e10078d6cacf	Neoadjuvant	yes	NA	Chemotherapy
TCGA-LUAD	15f12d2c-b834-4bfc-b526-f03bf85bfe96	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4SW	53	false	United States	-19640	1778	00257e88-d0d6-5353-bd34-6a422aefc63c	Unknown	male	white	TCGA-MP-A4SW_demographic	Dead	19640	M0	N1	Stage IIB	T2	5th	primary	0	1778.0	4cf676c8-6ab5-50cc-8a21-3bfe2cc9baa0	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4SW_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4SW_treatment	NA	NA	NA	NA	be4d9128-f92d-57af-ab0f-f00d0064e0cb	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	15f12d2c-b834-4bfc-b526-f03bf85bfe96	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4SW	53	false	United States	-19640	1778	00257e88-d0d6-5353-bd34-6a422aefc63c	Unknown	male	white	TCGA-MP-A4SW_demographic	Dead	19640	M0	N1	Stage IIB	T2	5th	primary	0	1778.0	4cf676c8-6ab5-50cc-8a21-3bfe2cc9baa0	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4SW_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4SW_treatment2	NA	NA	NA	NA	deff3cdf-d01b-4253-943d-3e82b6b82202	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	16cd58db-d52c-403e-9e9c-6da2e99f6bad	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7162	75	false	Australia	-27593	3169	698c38d0-80d8-57a7-9067-1af35d48b109	not reported	male	white	TCGA-78-7162_demographic	Dead	29811	NA	NA	NA	NA	NA	not reported	2218	NA	9acc3d6b-f56a-4fe2-be7a-119d212b1dd3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7162_diagnosis2	NA	Not Reported	TCGA-78-7162_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7162_treatment3	NA	NA	NA	NA	61be4a51-0086-4597-a362-744fbe488003	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	16cd58db-d52c-403e-9e9c-6da2e99f6bad	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7162	75	false	Australia	-27593	3169	698c38d0-80d8-57a7-9067-1af35d48b109	not reported	male	white	TCGA-78-7162_demographic	Dead	29811	NA	NA	NA	NA	NA	not reported	2218	NA	9acc3d6b-f56a-4fe2-be7a-119d212b1dd3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7162_diagnosis2	NA	Not Reported	TCGA-78-7162_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7162_treatment6	NA	Distant Site	NA	NA	a2639fa5-64ae-43b4-95cf-96072c503d98	NA	no	NA	Surgery, NOS
TCGA-LUAD	16cd58db-d52c-403e-9e9c-6da2e99f6bad	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7162	75	false	Australia	-27593	3169	698c38d0-80d8-57a7-9067-1af35d48b109	not reported	male	white	TCGA-78-7162_demographic	Dead	29811	NA	NA	NA	NA	NA	not reported	2218	NA	9acc3d6b-f56a-4fe2-be7a-119d212b1dd3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7162_diagnosis2	NA	Not Reported	TCGA-78-7162_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7162_treatment4	NA	NA	NA	NA	df566ac5-2337-49da-a8be-a80461d93bd7	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	16cd58db-d52c-403e-9e9c-6da2e99f6bad	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7162	75	false	Australia	-27593	3169	698c38d0-80d8-57a7-9067-1af35d48b109	not reported	male	white	TCGA-78-7162_demographic	Dead	29811	NA	NA	NA	NA	NA	not reported	2218	NA	9acc3d6b-f56a-4fe2-be7a-119d212b1dd3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7162_diagnosis2	NA	Not Reported	TCGA-78-7162_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7162_treatment5	NA	Locoregional Site	NA	NA	f6bf78bc-155c-452a-bb73-5d7058e4b574	NA	no	NA	Surgery, NOS
TCGA-LUAD	16cd58db-d52c-403e-9e9c-6da2e99f6bad	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7162	75	false	Australia	-27593	3169	698c38d0-80d8-57a7-9067-1af35d48b109	not reported	male	white	TCGA-78-7162_demographic	Dead	27593	M0	N0	Stage IA	T1	6th	primary	0	3169.0	b35db765-a1e7-58c6-ad85-2c368e7c24c2	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7162_diagnosis	No	Upper lobe, lung	NA	1991	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7162_treatment2	NA	NA	NA	NA	45a52810-9148-437d-9011-62a7c098f1b1	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	16cd58db-d52c-403e-9e9c-6da2e99f6bad	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7162	75	false	Australia	-27593	3169	698c38d0-80d8-57a7-9067-1af35d48b109	not reported	male	white	TCGA-78-7162_demographic	Dead	27593	M0	N0	Stage IA	T1	6th	primary	0	3169.0	b35db765-a1e7-58c6-ad85-2c368e7c24c2	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7162_diagnosis	No	Upper lobe, lung	NA	1991	NA	1.0	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-78-7162_treatment	NA	Regional Site	NA	NA	5731c23a-1710-5b63-a45c-72f46876baf5	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	16cd58db-d52c-403e-9e9c-6da2e99f6bad	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7162	75	false	Australia	-27593	3169	698c38d0-80d8-57a7-9067-1af35d48b109	not reported	male	white	TCGA-78-7162_demographic	Dead	30333	NA	NA	NA	NA	NA	not reported	2740	NA	e5cf1fe4-53e0-4c34-aa37-f4d137175a3d	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7162_diagnosis3	NA	Not Reported	TCGA-78-7162_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7162_treatment7	NA	NA	NA	NA	3d553486-9dd9-475f-aa9f-e324b1b716b7	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	16cd58db-d52c-403e-9e9c-6da2e99f6bad	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7162	75	false	Australia	-27593	3169	698c38d0-80d8-57a7-9067-1af35d48b109	not reported	male	white	TCGA-78-7162_demographic	Dead	30333	NA	NA	NA	NA	NA	not reported	2740	NA	e5cf1fe4-53e0-4c34-aa37-f4d137175a3d	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7162_diagnosis3	NA	Not Reported	TCGA-78-7162_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7162_treatment8	NA	NA	NA	NA	66c6618c-0462-46dd-bead-dfaf8990b198	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	16cd58db-d52c-403e-9e9c-6da2e99f6bad	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7162	75	false	Australia	-27593	3169	698c38d0-80d8-57a7-9067-1af35d48b109	not reported	male	white	TCGA-78-7162_demographic	Dead	30333	NA	NA	NA	NA	NA	not reported	2740	NA	e5cf1fe4-53e0-4c34-aa37-f4d137175a3d	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7162_diagnosis3	NA	Not Reported	TCGA-78-7162_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7162_treatment10	NA	Distant Site	NA	NA	bcdb5165-d333-491c-8245-6bf49bec54fb	NA	no	NA	Surgery, NOS
TCGA-LUAD	16cd58db-d52c-403e-9e9c-6da2e99f6bad	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7162	75	false	Australia	-27593	3169	698c38d0-80d8-57a7-9067-1af35d48b109	not reported	male	white	TCGA-78-7162_demographic	Dead	30333	NA	NA	NA	NA	NA	not reported	2740	NA	e5cf1fe4-53e0-4c34-aa37-f4d137175a3d	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7162_diagnosis3	NA	Not Reported	TCGA-78-7162_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7162_treatment9	NA	Locoregional Site	NA	NA	fe618c90-74b7-4d8e-9cf2-8238587d9f0e	NA	no	NA	Surgery, NOS
TCGA-LUAD	16d3c1c1-cf3a-44b6-b564-8ae5464b243d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48Z	60	false	United States	-22056	NA	f6e8fc6a-9338-5156-9ccc-371d37beca7f	not hispanic or latino	female	white	TCGA-55-A48Z_demographic	Alive	22592	NA	NA	NA	NA	NA	metastasis	536	NA	28969624-25e3-47e8-90dd-136da482d027	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-55-A48Z_diagnosis2	NA	Not Reported	TCGA-55-A48Z_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A48Z_treatment7	NA	Locoregional Site	NA	NA	086b60e2-31da-4bcc-bff3-bafc3f176b13	NA	no	NA	Surgery, NOS
TCGA-LUAD	16d3c1c1-cf3a-44b6-b564-8ae5464b243d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48Z	60	false	United States	-22056	NA	f6e8fc6a-9338-5156-9ccc-371d37beca7f	not hispanic or latino	female	white	TCGA-55-A48Z_demographic	Alive	22592	NA	NA	NA	NA	NA	metastasis	536	NA	28969624-25e3-47e8-90dd-136da482d027	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-55-A48Z_diagnosis2	NA	Not Reported	TCGA-55-A48Z_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A48Z_treatment8	NA	Distant Site	NA	NA	a5194030-1009-42b9-a066-eed4c884d7e5	NA	no	NA	Surgery, NOS
TCGA-LUAD	16d3c1c1-cf3a-44b6-b564-8ae5464b243d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48Z	60	false	United States	-22056	NA	f6e8fc6a-9338-5156-9ccc-371d37beca7f	not hispanic or latino	female	white	TCGA-55-A48Z_demographic	Alive	22592	NA	NA	NA	NA	NA	metastasis	536	NA	28969624-25e3-47e8-90dd-136da482d027	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-55-A48Z_diagnosis2	NA	Not Reported	TCGA-55-A48Z_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-A48Z_treatment5	NA	NA	NA	NA	e787ddb7-1251-4afd-93df-2b437d00840d	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	16d3c1c1-cf3a-44b6-b564-8ae5464b243d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48Z	60	false	United States	-22056	NA	f6e8fc6a-9338-5156-9ccc-371d37beca7f	not hispanic or latino	female	white	TCGA-55-A48Z_demographic	Alive	22592	NA	NA	NA	NA	NA	metastasis	536	NA	28969624-25e3-47e8-90dd-136da482d027	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-55-A48Z_diagnosis2	NA	Not Reported	TCGA-55-A48Z_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-A48Z_treatment6	NA	NA	NA	NA	f82a1385-b09f-4964-b7ef-efed87e0414b	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	16d3c1c1-cf3a-44b6-b564-8ae5464b243d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48Z	60	false	United States	-22056	NA	f6e8fc6a-9338-5156-9ccc-371d37beca7f	not hispanic or latino	female	white	TCGA-55-A48Z_demographic	Alive	22056	MX	N3	Stage IIIB	T1a	7th	primary	0	651.0	46b945ea-68aa-52d4-8fe2-d6886e4c7e16	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-55-A48Z_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	202	58	NA	NA	NA	NA	NA	NA	TCGA-55-A48Z_treatment4	Pemetrexed Disodium	NA	NA	NA	169e4594-348e-477c-9bf3-836340ff23bb	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	16d3c1c1-cf3a-44b6-b564-8ae5464b243d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48Z	60	false	United States	-22056	NA	f6e8fc6a-9338-5156-9ccc-371d37beca7f	not hispanic or latino	female	white	TCGA-55-A48Z_demographic	Alive	22056	MX	N3	Stage IIIB	T1a	7th	primary	0	651.0	46b945ea-68aa-52d4-8fe2-d6886e4c7e16	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-55-A48Z_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	202	58	NA	NA	NA	NA	NA	NA	TCGA-55-A48Z_treatment3	Cisplatin	NA	NA	NA	a9efaa09-ce49-4c0b-ab59-ddde1e829dfc	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	16d3c1c1-cf3a-44b6-b564-8ae5464b243d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48Z	60	false	United States	-22056	NA	f6e8fc6a-9338-5156-9ccc-371d37beca7f	not hispanic or latino	female	white	TCGA-55-A48Z_demographic	Alive	22056	MX	N3	Stage IIIB	T1a	7th	primary	0	651.0	46b945ea-68aa-52d4-8fe2-d6886e4c7e16	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-55-A48Z_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	195	154	NA	NA	NA	NA	NA	NA	TCGA-55-A48Z_treatment	NA	Primary Tumor Field	5040	cGy	ddc5ee0a-eefc-56d7-9ddf-75f5757e7b43	NA	yes	Stable Disease	Radiation, External Beam
TCGA-LUAD	16d3c1c1-cf3a-44b6-b564-8ae5464b243d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48Z	60	false	United States	-22056	NA	f6e8fc6a-9338-5156-9ccc-371d37beca7f	not hispanic or latino	female	white	TCGA-55-A48Z_demographic	Alive	22056	MX	N3	Stage IIIB	T1a	7th	primary	0	651.0	46b945ea-68aa-52d4-8fe2-d6886e4c7e16	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-55-A48Z_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	567	539	NA	NA	NA	NA	NA	NA	TCGA-55-A48Z_treatment2	NA	Distant Site	NA	NA	fa281a58-88f9-4a45-9f14-2241972968cd	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	16e64a1e-08b0-4c27-8c69-fa64551f8ca4	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8662	53	false	Australia	-19563	3361	a3cfa3f4-22d3-56b3-875a-003820834fad	not reported	female	not reported	TCGA-78-8662_demographic	Dead	19563	M0	N0	Stage IB	T2	6th	primary	0	3361.0	232bb62b-8eee-5677-8272-b8f2bf929f8d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-8662_diagnosis	No	Upper lobe, lung	NA	2000	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8662_treatment	NA	NA	NA	NA	5c202de0-c13f-5012-a9a6-7339fa94500f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	16e64a1e-08b0-4c27-8c69-fa64551f8ca4	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8662	53	false	Australia	-19563	3361	a3cfa3f4-22d3-56b3-875a-003820834fad	not reported	female	not reported	TCGA-78-8662_demographic	Dead	19563	M0	N0	Stage IB	T2	6th	primary	0	3361.0	232bb62b-8eee-5677-8272-b8f2bf929f8d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-8662_diagnosis	No	Upper lobe, lung	NA	2000	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8662_treatment2	NA	NA	NA	NA	cde31311-0780-4290-903d-850a79df5266	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	16e64a1e-08b0-4c27-8c69-fa64551f8ca4	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8662	53	false	Australia	-19563	3361	a3cfa3f4-22d3-56b3-875a-003820834fad	not reported	female	not reported	TCGA-78-8662_demographic	Dead	22607	NA	NA	NA	NA	NA	recurrence	3044	NA	703fec3f-8fb9-4990-bba7-7074a6448a6d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-78-8662_diagnosis2	NA	Not Reported	TCGA-78-8662_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-78-8662_treatment3	NA	NA	NA	NA	3242b1f0-c135-4962-ab69-4eb1c90c63a2	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	16e64a1e-08b0-4c27-8c69-fa64551f8ca4	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8662	53	false	Australia	-19563	3361	a3cfa3f4-22d3-56b3-875a-003820834fad	not reported	female	not reported	TCGA-78-8662_demographic	Dead	22607	NA	NA	NA	NA	NA	recurrence	3044	NA	703fec3f-8fb9-4990-bba7-7074a6448a6d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-78-8662_diagnosis2	NA	Not Reported	TCGA-78-8662_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-78-8662_treatment4	NA	NA	NA	NA	c3b0f22f-3995-411f-b080-e7ea57ffb0b4	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	16e64a1e-08b0-4c27-8c69-fa64551f8ca4	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8662	53	false	Australia	-19563	3361	a3cfa3f4-22d3-56b3-875a-003820834fad	not reported	female	not reported	TCGA-78-8662_demographic	Dead	22607	NA	NA	NA	NA	NA	recurrence	3044	NA	703fec3f-8fb9-4990-bba7-7074a6448a6d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-78-8662_diagnosis2	NA	Not Reported	TCGA-78-8662_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8662_treatment5	NA	Locoregional Site	NA	NA	c7daea77-8489-4e51-bdf2-de982cca9766	NA	no	NA	Surgery, NOS
TCGA-LUAD	175cb088-9b10-4fa9-95c0-7837fdc7bcf9	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z037	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	17e09b0d-eab2-40ec-ae3c-be9ab63fcef0	Informed Consent	56	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-MN-A4N5	63	false	United States	-23257	NA	15b2b231-873e-5c9b-9855-7b737013f229	not hispanic or latino	male	white	TCGA-MN-A4N5_demographic	Alive	23257	M0	N0	Stage IA	T1a	7th	primary	0	84.0	748e8de2-a428-5538-bd63-53e5e86c8811	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MN-A4N5_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MN-A4N5_treatment2	NA	NA	NA	NA	8487c804-8917-4ede-90c2-202e466b49c4	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	17e09b0d-eab2-40ec-ae3c-be9ab63fcef0	Informed Consent	56	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-MN-A4N5	63	false	United States	-23257	NA	15b2b231-873e-5c9b-9855-7b737013f229	not hispanic or latino	male	white	TCGA-MN-A4N5_demographic	Alive	23257	M0	N0	Stage IA	T1a	7th	primary	0	84.0	748e8de2-a428-5538-bd63-53e5e86c8811	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MN-A4N5_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MN-A4N5_treatment	NA	NA	NA	NA	dfae418f-91d4-5ae8-b40b-ccc2ef6caaf4	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	18478121-f1d1-4bdd-9511-8ab22f4a0660	Informed Consent	5200	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-8640	59	false	Australia	-21832	NA	4702b786-e026-5f0c-92da-b633119f7bdf	not reported	male	not reported	TCGA-78-8640_demographic	Alive	21832	M0	N1	Stage IIA	T1	6th	primary	0	7062.0	2ac56abc-1dc9-5582-af8e-7da4d87cf5d4	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-8640_diagnosis	No	Upper lobe, lung	NA	1994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8640_treatment2	NA	NA	NA	NA	915de2da-5f95-43cc-9df7-6749db9ce012	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	18478121-f1d1-4bdd-9511-8ab22f4a0660	Informed Consent	5200	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-8640	59	false	Australia	-21832	NA	4702b786-e026-5f0c-92da-b633119f7bdf	not reported	male	not reported	TCGA-78-8640_demographic	Alive	21832	M0	N1	Stage IIA	T1	6th	primary	0	7062.0	2ac56abc-1dc9-5582-af8e-7da4d87cf5d4	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-8640_diagnosis	No	Upper lobe, lung	NA	1994	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8640_treatment	NA	NA	NA	NA	dcc231f7-90bc-513c-9045-5f1d0782dbad	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	193201a3-1447-47b1-bdf1-11ae0eb3b2f3	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7562	71	false	United States	-26000	87	c33d8bcf-eeb4-54dc-9b06-4b2f26c7803a	not hispanic or latino	male	black or african american	TCGA-95-7562_demographic	Dead	26000	M0	N1	Stage IIA	T2a	7th	primary	0	87.0	61057583-c7a0-59e9-bd5d-fb4377596695	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	RX	Lung, NOS	NA	TCGA-95-7562_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7562_treatment3	NA	NA	NA	NA	1c72fce6-b3b9-4f58-87c7-ac5ec4b9c0dc	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	193201a3-1447-47b1-bdf1-11ae0eb3b2f3	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7562	71	false	United States	-26000	87	c33d8bcf-eeb4-54dc-9b06-4b2f26c7803a	not hispanic or latino	male	black or african american	TCGA-95-7562_demographic	Dead	26000	M0	N1	Stage IIA	T2a	7th	primary	0	87.0	61057583-c7a0-59e9-bd5d-fb4377596695	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	RX	Lung, NOS	NA	TCGA-95-7562_diagnosis	No	Lower lobe, lung	NA	2011	Yes	NA	81	60	NA	NA	NA	NA	NA	NA	TCGA-95-7562_treatment	Cisplatin	NA	NA	NA	3e839fb7-8442-5928-8f86-533374e98405	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	193201a3-1447-47b1-bdf1-11ae0eb3b2f3	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7562	71	false	United States	-26000	87	c33d8bcf-eeb4-54dc-9b06-4b2f26c7803a	not hispanic or latino	male	black or african american	TCGA-95-7562_demographic	Dead	26000	M0	N1	Stage IIA	T2a	7th	primary	0	87.0	61057583-c7a0-59e9-bd5d-fb4377596695	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	RX	Lung, NOS	NA	TCGA-95-7562_diagnosis	No	Lower lobe, lung	NA	2011	Yes	NA	81	60	NA	NA	NA	NA	NA	NA	TCGA-95-7562_treatment2	Pemetrexed Disodium	NA	NA	NA	58acea5c-68df-475b-b527-3e65755bbcf8	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	193201a3-1447-47b1-bdf1-11ae0eb3b2f3	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7562	71	false	United States	-26000	87	c33d8bcf-eeb4-54dc-9b06-4b2f26c7803a	not hispanic or latino	male	black or african american	TCGA-95-7562_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	fd657cc0-77a5-4dc1-a147-c231dd7af544	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-95-7562_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7562_treatment5	NA	Locoregional Site	NA	NA	3e098044-8c9e-4837-8f79-40b21a0832ae	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	193201a3-1447-47b1-bdf1-11ae0eb3b2f3	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7562	71	false	United States	-26000	87	c33d8bcf-eeb4-54dc-9b06-4b2f26c7803a	not hispanic or latino	male	black or african american	TCGA-95-7562_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	fd657cc0-77a5-4dc1-a147-c231dd7af544	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-95-7562_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7562_treatment4	NA	NA	NA	NA	991b4e82-1e4e-434d-866c-dfc958eabb19	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	195a5afb-b79f-44d2-9d12-884487630c2b	Informed Consent	-14	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4676	45	false	United States	-16746	281	dc1eb6e7-0e99-52de-86a1-a531b17b5b7b	not hispanic or latino	male	white	TCGA-73-4676_demographic	Dead	16746	M0	N1	Stage IIA	T2a	7th	primary	0	281.0	c62947d2-f0d1-532c-a837-472e16667015	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	Yes	R0	Lung, NOS	Peripheral Lung	TCGA-73-4676_diagnosis	No	Upper lobe, lung	NA	2010	NA	1.0	125	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4676_treatment	NA	Primary Tumor Field	NA	NA	187de799-5925-5193-a8f7-1350017ab35a	Adjuvant	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	195a5afb-b79f-44d2-9d12-884487630c2b	Informed Consent	-14	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4676	45	false	United States	-16746	281	dc1eb6e7-0e99-52de-86a1-a531b17b5b7b	not hispanic or latino	male	white	TCGA-73-4676_demographic	Dead	16746	M0	N1	Stage IIA	T2a	7th	primary	0	281.0	c62947d2-f0d1-532c-a837-472e16667015	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	Yes	R0	Lung, NOS	Peripheral Lung	TCGA-73-4676_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	-40	-74	Not Reported	3	NA	75.0	mg/m2	Intravenous	TCGA-73-4676_treatment3	Cisplatin	NA	225	mg/m2	36a6f65a-d1ce-47aa-947f-ae31e379a996	Neoadjuvant	yes	NA	Chemotherapy
TCGA-LUAD	195a5afb-b79f-44d2-9d12-884487630c2b	Informed Consent	-14	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4676	45	false	United States	-16746	281	dc1eb6e7-0e99-52de-86a1-a531b17b5b7b	not hispanic or latino	male	white	TCGA-73-4676_demographic	Dead	16746	M0	N1	Stage IIA	T2a	7th	primary	0	281.0	c62947d2-f0d1-532c-a837-472e16667015	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	Yes	R0	Lung, NOS	Peripheral Lung	TCGA-73-4676_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	-40	-74	Not Reported	3	NA	75.0	mg/m2	Intravenous	TCGA-73-4676_treatment5	Docetaxel	NA	225	mg/m2	939c3a4a-afbc-4b9a-8f05-995296ee6664	Neoadjuvant	yes	NA	Chemotherapy
TCGA-LUAD	195a5afb-b79f-44d2-9d12-884487630c2b	Informed Consent	-14	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4676	45	false	United States	-16746	281	dc1eb6e7-0e99-52de-86a1-a531b17b5b7b	not hispanic or latino	male	white	TCGA-73-4676_demographic	Dead	16746	M0	N1	Stage IIA	T2a	7th	primary	0	281.0	c62947d2-f0d1-532c-a837-472e16667015	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	Yes	R0	Lung, NOS	Peripheral Lung	TCGA-73-4676_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	66	45	NA	2	NA	NA	NA	Intravenous	TCGA-73-4676_treatment2	Docetaxel	NA	NA	NA	a5bd4de0-b04a-4c77-9652-df45adf7ca69	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	195a5afb-b79f-44d2-9d12-884487630c2b	Informed Consent	-14	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4676	45	false	United States	-16746	281	dc1eb6e7-0e99-52de-86a1-a531b17b5b7b	not hispanic or latino	male	white	TCGA-73-4676_demographic	Dead	16746	M0	N1	Stage IIA	T2a	7th	primary	0	281.0	c62947d2-f0d1-532c-a837-472e16667015	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	Yes	R0	Lung, NOS	Peripheral Lung	TCGA-73-4676_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	66	45	NA	2	NA	NA	NA	Intravenous	TCGA-73-4676_treatment4	Cisplatin	NA	NA	NA	acacb4c6-21fc-413c-b4f1-27757070c5f7	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	199386c2-bb53-4fad-a1b6-59ab216a4a50	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-1596	55	false	United States	-20381	NA	7c7fd12f-84c7-56aa-b172-8d17eef37e9d	not hispanic or latino	male	asian	TCGA-55-1596_demographic	Alive	20381	M0	N1	Stage IIB	T2	6th	primary	0	2065.0	0739cd68-912e-57a9-b686-98d51a38cecc	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-1596_diagnosis	No	Upper lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-1596_treatment3	NA	NA	NA	NA	437cc7a5-0452-4713-a7b7-3031ef029237	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	199386c2-bb53-4fad-a1b6-59ab216a4a50	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-1596	55	false	United States	-20381	NA	7c7fd12f-84c7-56aa-b172-8d17eef37e9d	not hispanic or latino	male	asian	TCGA-55-1596_demographic	Alive	20381	M0	N1	Stage IIB	T2	6th	primary	0	2065.0	0739cd68-912e-57a9-b686-98d51a38cecc	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-1596_diagnosis	No	Upper lobe, lung	NA	2004	No	NA	NA	34	NA	NA	NA	NA	NA	NA	TCGA-55-1596_treatment2	Paclitaxel	NA	NA	NA	9bf53866-2c7f-49d8-ab39-aff7d410911f	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	199386c2-bb53-4fad-a1b6-59ab216a4a50	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-1596	55	false	United States	-20381	NA	7c7fd12f-84c7-56aa-b172-8d17eef37e9d	not hispanic or latino	male	asian	TCGA-55-1596_demographic	Alive	20381	M0	N1	Stage IIB	T2	6th	primary	0	2065.0	0739cd68-912e-57a9-b686-98d51a38cecc	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-1596_diagnosis	No	Upper lobe, lung	NA	2004	No	NA	NA	34	NA	NA	NA	NA	NA	NA	TCGA-55-1596_treatment	Carboplatin	NA	NA	NA	dde7bd8d-3cf9-5ca5-b0d0-47af225d6fe6	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	19ca36e6-2154-4224-89b1-117a4a4407f6	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z050	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	1ab7ad70-0f80-41d8-8efa-3baebc8223cc	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1680	63	false	United States	-23267	NA	86837914-8555-529e-8bf6-7a4e3304d152	not hispanic or latino	male	white	TCGA-64-1680_demographic	Alive	23267	M1	N2	Stage IV	T2a	6th	primary	0	1126.0	08cbc5b4-e4ab-5cea-ae51-d6c5bfc715bc	true	NA	NA	C34.8	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-64-1680_diagnosis	No	Overlapping lesion of lung	NA	2007	NA	1.0	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-1680_treatment	NA	NA	NA	NA	4582bc89-bc40-5b1c-81a7-07b4c5ff9f77	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	1ab7ad70-0f80-41d8-8efa-3baebc8223cc	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1680	63	false	United States	-23267	NA	86837914-8555-529e-8bf6-7a4e3304d152	not hispanic or latino	male	white	TCGA-64-1680_demographic	Alive	23267	M1	N2	Stage IV	T2a	6th	primary	0	1126.0	08cbc5b4-e4ab-5cea-ae51-d6c5bfc715bc	true	NA	NA	C34.8	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-64-1680_diagnosis	No	Overlapping lesion of lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-1680_treatment2	NA	NA	NA	NA	528253a5-0075-45b3-ad68-bb4a8dc8b433	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	1b110eb4-a01d-4c50-ba18-77da4dedd549	Informed Consent	1393	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7552	70	false	United States	-25578	NA	307a671d-e9ed-5e9c-8fec-8aa8bdbb2b60	not hispanic or latino	male	white	TCGA-97-7552_demographic	Alive	25578	MX	N0	Stage IB	T2	6th	primary	0	1932.0	6f14f84a-0f24-5da2-bb30-47e3554cdc40	true	NA	NA	C34.3	Left	8253/3	Bronchio-alveolar carcinoma, mucinous	no	No	NA	Lung, NOS	NA	TCGA-97-7552_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7552_treatment	NA	NA	NA	NA	0df206cd-67e7-57f6-b9d8-911b40234868	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1b110eb4-a01d-4c50-ba18-77da4dedd549	Informed Consent	1393	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7552	70	false	United States	-25578	NA	307a671d-e9ed-5e9c-8fec-8aa8bdbb2b60	not hispanic or latino	male	white	TCGA-97-7552_demographic	Alive	25578	MX	N0	Stage IB	T2	6th	primary	0	1932.0	6f14f84a-0f24-5da2-bb30-47e3554cdc40	true	NA	NA	C34.3	Left	8253/3	Bronchio-alveolar carcinoma, mucinous	no	No	NA	Lung, NOS	NA	TCGA-97-7552_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7552_treatment2	NA	NA	NA	NA	e715aea4-338b-4917-b9b0-91d668a4ca3a	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1b110eb4-a01d-4c50-ba18-77da4dedd549	Informed Consent	1393	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7552	70	false	United States	-25578	NA	307a671d-e9ed-5e9c-8fec-8aa8bdbb2b60	not hispanic or latino	male	white	TCGA-97-7552_demographic	Alive	26376	NA	NA	NA	NA	NA	Subsequent Primary	798	NA	da3570f5-9461-40be-8c51-f422bbea70a3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-7552_diagnosis3	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-97-7552_treatment6	NA	NA	NA	NA	784c57a2-da38-4978-97fb-cb9598259bdc	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1b110eb4-a01d-4c50-ba18-77da4dedd549	Informed Consent	1393	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7552	70	false	United States	-25578	NA	307a671d-e9ed-5e9c-8fec-8aa8bdbb2b60	not hispanic or latino	male	white	TCGA-97-7552_demographic	Alive	26376	NA	NA	NA	NA	NA	Subsequent Primary	798	NA	da3570f5-9461-40be-8c51-f422bbea70a3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-7552_diagnosis3	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-97-7552_treatment5	NA	NA	NA	NA	87e0b3fc-12d1-4a60-b8c7-10ac6365ac86	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1b110eb4-a01d-4c50-ba18-77da4dedd549	Informed Consent	1393	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7552	70	false	United States	-25578	NA	307a671d-e9ed-5e9c-8fec-8aa8bdbb2b60	not hispanic or latino	male	white	TCGA-97-7552_demographic	Alive	26376	NA	NA	NA	NA	NA	not reported	798	NA	df5bb49c-5190-4fdc-9169-36f2a7516016	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-7552_diagnosis2	NA	Not Reported	TCGA-97-7552_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-97-7552_treatment4	NA	NA	NA	NA	358f7ec1-04f1-4da0-a86f-905fd1360560	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1b110eb4-a01d-4c50-ba18-77da4dedd549	Informed Consent	1393	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7552	70	false	United States	-25578	NA	307a671d-e9ed-5e9c-8fec-8aa8bdbb2b60	not hispanic or latino	male	white	TCGA-97-7552_demographic	Alive	26376	NA	NA	NA	NA	NA	not reported	798	NA	df5bb49c-5190-4fdc-9169-36f2a7516016	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-7552_diagnosis2	NA	Not Reported	TCGA-97-7552_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-97-7552_treatment3	NA	NA	NA	NA	a56e2c59-0e7d-47da-bd02-612e42534d19	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1b31cdb3-1837-49d6-a857-1830f8800299	Informed Consent	598	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-69-7763	69	false	United States	-25316	NA	216dcf02-35f9-50ec-a037-ebe93fc93c3b	not hispanic or latino	male	white	TCGA-69-7763_demographic	Alive	25316	M0	N0	Stage IA	T1b	7th	primary	0	690.0	b5edede1-4d79-57fa-b759-fa9f57514129	true	NA	NA	C34.2	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7763_diagnosis	No	Middle lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7763_treatment	NA	NA	NA	NA	386c2eb6-1615-565a-9e51-f7cda14f6919	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1b31cdb3-1837-49d6-a857-1830f8800299	Informed Consent	598	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-69-7763	69	false	United States	-25316	NA	216dcf02-35f9-50ec-a037-ebe93fc93c3b	not hispanic or latino	male	white	TCGA-69-7763_demographic	Alive	25316	M0	N0	Stage IA	T1b	7th	primary	0	690.0	b5edede1-4d79-57fa-b759-fa9f57514129	true	NA	NA	C34.2	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7763_diagnosis	No	Middle lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7763_treatment2	NA	NA	NA	NA	5b96e3eb-d653-416b-8616-e8d7ce40ef67	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1b354837-4925-4480-ac32-6b44d0957314	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4670	69	false	United States	-25526	NA	6ea84966-1f86-5292-87e8-488178baf244	not hispanic or latino	female	white	TCGA-73-4670_demographic	Alive	25526	M1	N0	Stage IV	T2	NA	primary	0	131.0	30c0f977-3d80-57c1-83b5-cbb91935790a	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Not Reported	R0	Lung, NOS	Peripheral Lung	TCGA-73-4670_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	110	33	NA	4	NA	538.0	mg	Intravenous	TCGA-73-4670_treatment	Carboplatin	NA	2152	mg	90520b59-100c-5b84-94f0-b5019d533ac8	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	1b354837-4925-4480-ac32-6b44d0957314	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4670	69	false	United States	-25526	NA	6ea84966-1f86-5292-87e8-488178baf244	not hispanic or latino	female	white	TCGA-73-4670_demographic	Alive	25526	M1	N0	Stage IV	T2	NA	primary	0	131.0	30c0f977-3d80-57c1-83b5-cbb91935790a	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Not Reported	R0	Lung, NOS	Peripheral Lung	TCGA-73-4670_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	54	33	NA	1	NA	308.0	mg	Intravenous	TCGA-73-4670_treatment4	Paclitaxel	NA	308	mg	91c85295-d9b0-4b81-8a09-ac7962b3b644	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	1b354837-4925-4480-ac32-6b44d0957314	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4670	69	false	United States	-25526	NA	6ea84966-1f86-5292-87e8-488178baf244	not hispanic or latino	female	white	TCGA-73-4670_demographic	Alive	25526	M1	N0	Stage IV	T2	NA	primary	0	131.0	30c0f977-3d80-57c1-83b5-cbb91935790a	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Not Reported	R0	Lung, NOS	Peripheral Lung	TCGA-73-4670_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	110	33	NA	4	NA	930.0	mg	Intravenous	TCGA-73-4670_treatment2	Bevacizumab	NA	3720	mg	a5ffdf20-921b-429e-a393-f38eaf33927d	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	1b354837-4925-4480-ac32-6b44d0957314	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4670	69	false	United States	-25526	NA	6ea84966-1f86-5292-87e8-488178baf244	not hispanic or latino	female	white	TCGA-73-4670_demographic	Alive	25526	M1	N0	Stage IV	T2	NA	primary	0	131.0	30c0f977-3d80-57c1-83b5-cbb91935790a	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Not Reported	R0	Lung, NOS	Peripheral Lung	TCGA-73-4670_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	110	54	NA	4	NA	680.0	mg	Intravenous	TCGA-73-4670_treatment3	Pemetrexed Disodium	NA	2720	mg	bc21025a-5e19-4f64-80f2-bbe6bf4e9634	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	1b354837-4925-4480-ac32-6b44d0957314	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4670	69	false	United States	-25526	NA	6ea84966-1f86-5292-87e8-488178baf244	not hispanic or latino	female	white	TCGA-73-4670_demographic	Alive	25526	M1	N0	Stage IV	T2	NA	primary	0	131.0	30c0f977-3d80-57c1-83b5-cbb91935790a	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Not Reported	R0	Lung, NOS	Peripheral Lung	TCGA-73-4670_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4670_treatment5	NA	NA	NA	NA	d367e138-1241-4bcd-9062-7b1c0e8bb569	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1c339545-c08a-4a77-b8e9-a7e49e53853f	Informed Consent	-19	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-5944	69	false	United States	-25440	NA	a600f5b0-ae60-54b7-b7af-fc1c69c17c1c	not reported	female	white	TCGA-50-5944_demographic	Alive	25440	M0	N0	Stage IA	T1	7th	primary	0	1750.0	94e55e39-c05e-5ac7-9efb-3946906b2c38	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-50-5944_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5944_treatment	NA	NA	NA	NA	ebf98d9f-188a-57db-be21-ba48d0aea7b8	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1c339545-c08a-4a77-b8e9-a7e49e53853f	Informed Consent	-19	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-5944	69	false	United States	-25440	NA	a600f5b0-ae60-54b7-b7af-fc1c69c17c1c	not reported	female	white	TCGA-50-5944_demographic	Alive	25440	M0	N0	Stage IA	T1	7th	primary	0	1750.0	94e55e39-c05e-5ac7-9efb-3946906b2c38	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-50-5944_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5944_treatment2	NA	NA	NA	NA	ef5e7806-d8c7-4e1d-983b-c2f1c9f05010	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a	Informed Consent	47	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-64-5779	61	false	United States	-22305	NA	8a22f732-2b83-5d29-8201-056ac0b36f0c	not hispanic or latino	male	white	TCGA-64-5779_demographic	Alive	22305	M0	N2	Stage IIIA	T2	6th	primary	0	864.0	c5d1f02d-fc4a-5cac-8f62-b67807532d62	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5779_diagnosis	No	Lower lobe, lung	NA	2009	NA	1.0	241	201	NA	NA	28.0	NA	NA	NA	TCGA-64-5779_treatment2	NA	Primary Tumor Field	5040	cGy	0671e316-6dec-416b-a03c-e2c904479def	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a	Informed Consent	47	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-64-5779	61	false	United States	-22305	NA	8a22f732-2b83-5d29-8201-056ac0b36f0c	not hispanic or latino	male	white	TCGA-64-5779_demographic	Alive	22305	M0	N2	Stage IIIA	T2	6th	primary	0	864.0	c5d1f02d-fc4a-5cac-8f62-b67807532d62	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5779_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	157	94	NA	4	NA	500.0	mg/m2	Intravenous	TCGA-64-5779_treatment5	Pemetrexed	NA	NA	NA	35277264-6257-468d-94a5-68b6477a71fa	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a	Informed Consent	47	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-64-5779	61	false	United States	-22305	NA	8a22f732-2b83-5d29-8201-056ac0b36f0c	not hispanic or latino	male	white	TCGA-64-5779_demographic	Alive	22305	M0	N2	Stage IIIA	T2	6th	primary	0	864.0	c5d1f02d-fc4a-5cac-8f62-b67807532d62	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5779_diagnosis	No	Lower lobe, lung	NA	2009	NA	2.0	864	852	Recurrent Disease	NA	9.0	NA	NA	NA	TCGA-64-5779_treatment3	NA	Distant Site	2700	cGy	3d1996c1-aa83-461d-9c37-22f2a703f67e	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a	Informed Consent	47	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-64-5779	61	false	United States	-22305	NA	8a22f732-2b83-5d29-8201-056ac0b36f0c	not hispanic or latino	male	white	TCGA-64-5779_demographic	Alive	22305	M0	N2	Stage IIIA	T2	6th	primary	0	864.0	c5d1f02d-fc4a-5cac-8f62-b67807532d62	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5779_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	157	94	NA	4	NA	75.0	mg/m2	Intravenous	TCGA-64-5779_treatment4	Cisplatin	NA	NA	NA	8241597c-947c-4010-8d9c-7a8c26135286	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a	Informed Consent	47	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-64-5779	61	false	United States	-22305	NA	8a22f732-2b83-5d29-8201-056ac0b36f0c	not hispanic or latino	male	white	TCGA-64-5779_demographic	Alive	22305	M0	N2	Stage IIIA	T2	6th	primary	0	864.0	c5d1f02d-fc4a-5cac-8f62-b67807532d62	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5779_diagnosis	No	Lower lobe, lung	NA	2009	Yes	NA	157	94	NA	NA	NA	NA	NA	NA	TCGA-64-5779_treatment7	Pemetrexed	NA	NA	NA	9f32b1fb-b4e8-4203-9cbb-dc7e9ef335f4	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a	Informed Consent	47	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-64-5779	61	false	United States	-22305	NA	8a22f732-2b83-5d29-8201-056ac0b36f0c	not hispanic or latino	male	white	TCGA-64-5779_demographic	Alive	22305	M0	N2	Stage IIIA	T2	6th	primary	0	864.0	c5d1f02d-fc4a-5cac-8f62-b67807532d62	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5779_diagnosis	No	Lower lobe, lung	NA	2009	NA	1.0	241	NA	NA	NA	28.0	NA	NA	NA	TCGA-64-5779_treatment	NA	Primary Tumor Field	NA	NA	ae653ac6-03f6-5f27-83e9-8e0ae6880ebe	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a	Informed Consent	47	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-64-5779	61	false	United States	-22305	NA	8a22f732-2b83-5d29-8201-056ac0b36f0c	not hispanic or latino	male	white	TCGA-64-5779_demographic	Alive	22305	M0	N2	Stage IIIA	T2	6th	primary	0	864.0	c5d1f02d-fc4a-5cac-8f62-b67807532d62	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5779_diagnosis	No	Lower lobe, lung	NA	2009	Yes	NA	157	94	NA	NA	NA	NA	NA	NA	TCGA-64-5779_treatment6	Cisplatin	NA	NA	NA	bfc8cd74-844b-4161-9182-776f76ce0db2	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a	Informed Consent	47	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-64-5779	61	false	United States	-22305	NA	8a22f732-2b83-5d29-8201-056ac0b36f0c	not hispanic or latino	male	white	TCGA-64-5779_demographic	Alive	23100	NA	NA	NA	NA	NA	metastasis	795	NA	d99b390e-0630-416f-acb6-92b8fae3acef	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-64-5779_diagnosis2	NA	Not Reported	TCGA-64-5779_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-64-5779_treatment9	NA	NA	NA	NA	2ea71356-1da0-408f-951a-fe235aebf6fa	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a	Informed Consent	47	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-64-5779	61	false	United States	-22305	NA	8a22f732-2b83-5d29-8201-056ac0b36f0c	not hispanic or latino	male	white	TCGA-64-5779_demographic	Alive	23100	NA	NA	NA	NA	NA	metastasis	795	NA	d99b390e-0630-416f-acb6-92b8fae3acef	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-64-5779_diagnosis2	NA	Not Reported	TCGA-64-5779_diagnosis	NA	NA	NA	NA	797	NA	NA	NA	NA	NA	NA	TCGA-64-5779_treatment10	NA	Distant Site	NA	NA	81ce1fd2-a4c9-4fa6-845d-08941dc9d32c	NA	yes	NA	Surgery, NOS
TCGA-LUAD	1c58d9b8-17a2-4fc6-9898-fe6f47bd2c2a	Informed Consent	47	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-64-5779	61	false	United States	-22305	NA	8a22f732-2b83-5d29-8201-056ac0b36f0c	not hispanic or latino	male	white	TCGA-64-5779_demographic	Alive	23100	NA	NA	NA	NA	NA	metastasis	795	NA	d99b390e-0630-416f-acb6-92b8fae3acef	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-64-5779_diagnosis2	NA	Not Reported	TCGA-64-5779_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-64-5779_treatment8	NA	NA	NA	NA	9ab7ea2b-5071-4938-9be1-01ee5fce5ea3	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1d276b62-5e64-48fb-b2ce-5192b511fe37	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-5146	NA	false	Canada	NA	NA	52706201-23eb-52c9-85b9-8c44ea591368	not reported	male	not reported	TCGA-75-5146_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	2368.0	2c3a37f2-2037-5260-ab7a-d4ca3e3e2dd6	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-5146_diagnosis	No	Lower lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5146_treatment	NA	NA	NA	NA	6b9c84e0-1497-5b8a-9d40-1e63b3113039	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1d276b62-5e64-48fb-b2ce-5192b511fe37	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-5146	NA	false	Canada	NA	NA	52706201-23eb-52c9-85b9-8c44ea591368	not reported	male	not reported	TCGA-75-5146_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	2368.0	2c3a37f2-2037-5260-ab7a-d4ca3e3e2dd6	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-5146_diagnosis	No	Lower lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5146_treatment2	NA	NA	NA	NA	d674f821-dd05-4a82-a6e9-b6fb890d36e3	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1d276b62-5e64-48fb-b2ce-5192b511fe37	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-5146	NA	false	Canada	NA	NA	52706201-23eb-52c9-85b9-8c44ea591368	not reported	male	not reported	TCGA-75-5146_demographic	Alive	NA	NA	NA	NA	NA	NA	Subsequent Primary	1773	NA	b6c9e5ad-71b5-4713-97f3-60f25ada4cd1	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-5146_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-75-5146_treatment4	NA	NA	NA	NA	3c392e53-c9eb-4ae4-9763-a1b8731c9e8e	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1d276b62-5e64-48fb-b2ce-5192b511fe37	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-5146	NA	false	Canada	NA	NA	52706201-23eb-52c9-85b9-8c44ea591368	not reported	male	not reported	TCGA-75-5146_demographic	Alive	NA	NA	NA	NA	NA	NA	Subsequent Primary	1773	NA	b6c9e5ad-71b5-4713-97f3-60f25ada4cd1	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-5146_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-75-5146_treatment3	NA	NA	NA	NA	676408af-97c2-426d-ba03-866a3f30972c	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1d90c9f3-5025-4867-a2f0-e455b6a254fa	Informed Consent	945	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-7546	76	false	United States	-27913	NA	326556eb-b578-5451-b412-649e3351808e	not hispanic or latino	female	white	TCGA-97-7546_demographic	Alive	27913	MX	N0	Stage IA	T1	6th	primary	0	1285.0	4024dcf2-1acb-5640-9549-5e7d1392b2f0	true	NA	NA	C34.1	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-7546_diagnosis	No	Upper lobe, lung	NA	2008	NA	1.0	1255	1255	NA	NA	NA	NA	NA	NA	TCGA-97-7546_treatment	NA	Primary Tumor Field	NA	NA	0bcdc210-e5f1-5e07-b95b-8eb3be379177	Adjuvant	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	1d90c9f3-5025-4867-a2f0-e455b6a254fa	Informed Consent	945	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-7546	76	false	United States	-27913	NA	326556eb-b578-5451-b412-649e3351808e	not hispanic or latino	female	white	TCGA-97-7546_demographic	Alive	27913	MX	N0	Stage IA	T1	6th	primary	0	1285.0	4024dcf2-1acb-5640-9549-5e7d1392b2f0	true	NA	NA	C34.1	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-7546_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	NA	1255	NA	NA	NA	NA	NA	NA	TCGA-97-7546_treatment2	Erlotinib Hydrochloride	NA	NA	NA	a46220c5-6cfc-4ff1-b1a6-7ead33e21296	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	1d90c9f3-5025-4867-a2f0-e455b6a254fa	Informed Consent	945	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-7546	76	false	United States	-27913	NA	326556eb-b578-5451-b412-649e3351808e	not hispanic or latino	female	white	TCGA-97-7546_demographic	Alive	29168	NA	NA	NA	NA	NA	Subsequent Primary	1255	NA	ce8acd16-096c-4dc8-8417-0a25c98175d4	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-7546_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-97-7546_treatment3	NA	NA	NA	NA	6bee400c-738a-4782-be33-65c3ffe95e0d	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1d90c9f3-5025-4867-a2f0-e455b6a254fa	Informed Consent	945	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-7546	76	false	United States	-27913	NA	326556eb-b578-5451-b412-649e3351808e	not hispanic or latino	female	white	TCGA-97-7546_demographic	Alive	29168	NA	NA	NA	NA	NA	Subsequent Primary	1255	NA	ce8acd16-096c-4dc8-8417-0a25c98175d4	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-7546_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-97-7546_treatment4	NA	NA	NA	NA	f2a69514-ca5b-42b1-9a2c-22d01900da4f	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	1f0a5312-0590-4230-9da9-fd0cfe693586	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7911	70	false	United States	-25746	NA	80d045b9-bfcd-5500-8814-6356d1a9afc0	not hispanic or latino	female	white	TCGA-55-7911_demographic	Alive	25746	MX	N0	Stage IA	T1a	7th	primary	0	537.0	226630d6-0bc6-5f1c-aa96-72d26c65c7a7	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7911_diagnosis	No	Middle lobe, lung	NA	2011	NA	NA	536	524	NA	NA	5.0	NA	NA	NA	TCGA-55-7911_treatment	NA	Primary Tumor Field	6000	cGy	05857150-a29f-58d5-9dc1-447e359d06ff	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	1f0a5312-0590-4230-9da9-fd0cfe693586	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7911	70	false	United States	-25746	NA	80d045b9-bfcd-5500-8814-6356d1a9afc0	not hispanic or latino	female	white	TCGA-55-7911_demographic	Alive	25746	MX	N0	Stage IA	T1a	7th	primary	0	537.0	226630d6-0bc6-5f1c-aa96-72d26c65c7a7	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7911_diagnosis	No	Middle lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7911_treatment2	NA	NA	NA	NA	1917c17f-b319-4814-801f-df7ac65aa152	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1f0a5312-0590-4230-9da9-fd0cfe693586	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7911	70	false	United States	-25746	NA	80d045b9-bfcd-5500-8814-6356d1a9afc0	not hispanic or latino	female	white	TCGA-55-7911_demographic	Alive	26261	NA	NA	NA	NA	NA	Subsequent Primary	515	NA	73338f6d-bce0-45de-a2f5-2c923e719b8a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-7911_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-55-7911_treatment4	NA	NA	NA	NA	14096b8c-a14e-4b88-b49d-f4f5d8f741b5	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	1f0a5312-0590-4230-9da9-fd0cfe693586	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7911	70	false	United States	-25746	NA	80d045b9-bfcd-5500-8814-6356d1a9afc0	not hispanic or latino	female	white	TCGA-55-7911_demographic	Alive	26261	NA	NA	NA	NA	NA	Subsequent Primary	515	NA	73338f6d-bce0-45de-a2f5-2c923e719b8a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-7911_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-55-7911_treatment3	NA	NA	NA	NA	194751e4-80e4-492c-9de5-a4ed642607d4	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1f0a5312-0590-4230-9da9-fd0cfe693586	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7911	70	false	United States	-25746	NA	80d045b9-bfcd-5500-8814-6356d1a9afc0	not hispanic or latino	female	white	TCGA-55-7911_demographic	Alive	26261	NA	NA	NA	NA	NA	Subsequent Primary	515	NA	73338f6d-bce0-45de-a2f5-2c923e719b8a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-7911_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7911_treatment5	NA	Locoregional Site	NA	NA	92209f69-9e83-4160-8371-46a159ae144c	NA	no	NA	Surgery, NOS
TCGA-LUAD	1f0a5312-0590-4230-9da9-fd0cfe693586	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7911	70	false	United States	-25746	NA	80d045b9-bfcd-5500-8814-6356d1a9afc0	not hispanic or latino	female	white	TCGA-55-7911_demographic	Alive	26261	NA	NA	NA	NA	NA	Subsequent Primary	515	NA	73338f6d-bce0-45de-a2f5-2c923e719b8a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-7911_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7911_treatment6	NA	Distant Site	NA	NA	c035524c-8910-4e1a-b94d-8a6797ee9fd3	NA	no	NA	Surgery, NOS
TCGA-LUAD	1f1df7ea-00b9-4432-86de-da773d1451e5	Informed Consent	9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8511	73	false	United States	-26986	NA	7c71ea2d-ffa9-54d8-8ec1-9af7d2c868c2	not hispanic or latino	female	white	TCGA-55-8511_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	0c77ddc5-6668-4df4-9f6c-ba4eaadaf98b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-8511_diagnosis3	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8511_treatment3	NA	NA	NA	NA	4a56f3a1-7f34-421a-ac76-28c611bd594e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1f1df7ea-00b9-4432-86de-da773d1451e5	Informed Consent	9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8511	73	false	United States	-26986	NA	7c71ea2d-ffa9-54d8-8ec1-9af7d2c868c2	not hispanic or latino	female	white	TCGA-55-8511_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	0c77ddc5-6668-4df4-9f6c-ba4eaadaf98b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-8511_diagnosis3	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8511_treatment5	NA	NA	NA	NA	6cf85121-27a7-41d7-9c27-0d5de908e5e6	NA	yes	NA	Surgery, NOS
TCGA-LUAD	1f1df7ea-00b9-4432-86de-da773d1451e5	Informed Consent	9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8511	73	false	United States	-26986	NA	7c71ea2d-ffa9-54d8-8ec1-9af7d2c868c2	not hispanic or latino	female	white	TCGA-55-8511_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	0c77ddc5-6668-4df4-9f6c-ba4eaadaf98b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-8511_diagnosis3	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8511_treatment4	NA	NA	NA	NA	b38203e6-57e6-4a89-9cb8-fdbaf095bbd9	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1f1df7ea-00b9-4432-86de-da773d1451e5	Informed Consent	9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8511	73	false	United States	-26986	NA	7c71ea2d-ffa9-54d8-8ec1-9af7d2c868c2	not hispanic or latino	female	white	TCGA-55-8511_demographic	Alive	26986	MX	N0	Stage IB	T2a	7th	primary	0	552.0	8af20d6d-40a9-5ef5-91fb-cf8f2b67f61d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-8511_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8511_treatment	NA	NA	NA	NA	7acaaa3a-f4fb-55e1-8e43-053a5d9a0d87	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1f1df7ea-00b9-4432-86de-da773d1451e5	Informed Consent	9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8511	73	false	United States	-26986	NA	7c71ea2d-ffa9-54d8-8ec1-9af7d2c868c2	not hispanic or latino	female	white	TCGA-55-8511_demographic	Alive	26986	MX	N0	Stage IB	T2a	7th	primary	0	552.0	8af20d6d-40a9-5ef5-91fb-cf8f2b67f61d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-8511_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8511_treatment2	NA	NA	NA	NA	a5bdfd12-2f25-4959-a9b7-7dad7bd108b6	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1f1df7ea-00b9-4432-86de-da773d1451e5	Informed Consent	9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8511	73	false	United States	-26986	NA	7c71ea2d-ffa9-54d8-8ec1-9af7d2c868c2	not hispanic or latino	female	white	TCGA-55-8511_demographic	Alive	27446	NA	NA	NA	NA	NA	not reported	460	NA	9b2bf17a-37de-43d5-a7d7-9486c0238a6e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-8511_diagnosis2	NA	Not Reported	TCGA-55-8511_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8511_treatment8	NA	Locoregional Site	NA	NA	1d97cb20-9a1f-46e8-a56d-4943caafbce3	NA	no	NA	Surgery, NOS
TCGA-LUAD	1f1df7ea-00b9-4432-86de-da773d1451e5	Informed Consent	9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8511	73	false	United States	-26986	NA	7c71ea2d-ffa9-54d8-8ec1-9af7d2c868c2	not hispanic or latino	female	white	TCGA-55-8511_demographic	Alive	27446	NA	NA	NA	NA	NA	not reported	460	NA	9b2bf17a-37de-43d5-a7d7-9486c0238a6e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-8511_diagnosis2	NA	Not Reported	TCGA-55-8511_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-55-8511_treatment6	NA	NA	NA	NA	a1145f1a-26aa-47de-bba6-96319e041da4	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	1f1df7ea-00b9-4432-86de-da773d1451e5	Informed Consent	9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8511	73	false	United States	-26986	NA	7c71ea2d-ffa9-54d8-8ec1-9af7d2c868c2	not hispanic or latino	female	white	TCGA-55-8511_demographic	Alive	27446	NA	NA	NA	NA	NA	not reported	460	NA	9b2bf17a-37de-43d5-a7d7-9486c0238a6e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-8511_diagnosis2	NA	Not Reported	TCGA-55-8511_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8511_treatment9	NA	Distant Site	NA	NA	b94cad05-6169-48f1-9046-4849e4921e52	NA	no	NA	Surgery, NOS
TCGA-LUAD	1f1df7ea-00b9-4432-86de-da773d1451e5	Informed Consent	9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8511	73	false	United States	-26986	NA	7c71ea2d-ffa9-54d8-8ec1-9af7d2c868c2	not hispanic or latino	female	white	TCGA-55-8511_demographic	Alive	27446	NA	NA	NA	NA	NA	not reported	460	NA	9b2bf17a-37de-43d5-a7d7-9486c0238a6e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-8511_diagnosis2	NA	Not Reported	TCGA-55-8511_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-55-8511_treatment7	NA	NA	NA	NA	e6db9d0c-2f41-41e3-9897-ee17c9c274fb	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	1fc81cd4-fa89-4135-8c3c-027ffae82b05	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-5644	51	false	United States	-18644	NA	2c838b0d-8ec3-5287-9e96-8754af942186	not hispanic or latino	female	white	TCGA-44-5644_demographic	Alive	18644	NA	N0	Stage IB	T2a	7th	primary	0	863.0	a584fdee-e0b5-5dc5-8e46-5129d9ea5f02	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-5644_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-5644_treatment2	NA	NA	NA	NA	89483d5a-0f75-452d-bdf4-708a0b0ac166	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	1fc81cd4-fa89-4135-8c3c-027ffae82b05	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-5644	51	false	United States	-18644	NA	2c838b0d-8ec3-5287-9e96-8754af942186	not hispanic or latino	female	white	TCGA-44-5644_demographic	Alive	18644	NA	N0	Stage IB	T2a	7th	primary	0	863.0	a584fdee-e0b5-5dc5-8e46-5129d9ea5f02	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-5644_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-5644_treatment	NA	NA	NA	NA	c9c4ecc6-c295-5850-9ca8-9bb731e19c8d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	202e5df9-69f2-432c-a59d-cc5aa176e973	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8512	41	false	United States	-15266	607	5a135925-3682-58ea-a02f-df18eb36e0f4	not hispanic or latino	male	white	TCGA-55-8512_demographic	Dead	15266	M1b	N1	Stage IV	T1a	7th	primary	0	607.0	6f9f9ac1-7196-5082-ab41-7dbbc241b618	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-55-8512_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8512_treatment	NA	NA	NA	NA	9195aa8b-9c45-5bb4-a18f-bed97a2ae53a	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	202e5df9-69f2-432c-a59d-cc5aa176e973	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8512	41	false	United States	-15266	607	5a135925-3682-58ea-a02f-df18eb36e0f4	not hispanic or latino	male	white	TCGA-55-8512_demographic	Dead	15266	M1b	N1	Stage IV	T1a	7th	primary	0	607.0	6f9f9ac1-7196-5082-ab41-7dbbc241b618	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-55-8512_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8512_treatment2	NA	NA	NA	NA	a7b4db8a-a6f6-422c-8ddc-5b86143cce3b	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	205759a6-6391-491b-9857-0080c3a5871e	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-5125	NA	false	Canada	NA	2027	432e85d9-462a-559b-9c57-5db0138ce3c8	not reported	male	not reported	TCGA-75-5125_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	1752	NA	d890c4e6-1de9-4fc3-81ac-067d5835da03	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-5125_diagnosis2	NA	Not Reported	TCGA-75-5125_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-75-5125_treatment3	NA	NA	NA	NA	8d5dab49-ef2e-47fa-8f81-770b93d0cef8	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	205759a6-6391-491b-9857-0080c3a5871e	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-5125	NA	false	Canada	NA	2027	432e85d9-462a-559b-9c57-5db0138ce3c8	not reported	male	not reported	TCGA-75-5125_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	1752	NA	d890c4e6-1de9-4fc3-81ac-067d5835da03	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-5125_diagnosis2	NA	Not Reported	TCGA-75-5125_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5125_treatment5	NA	Locoregional Site	NA	NA	cc14bd07-93ac-4cee-b58e-8d37bb1343a7	NA	no	NA	Surgery, NOS
TCGA-LUAD	205759a6-6391-491b-9857-0080c3a5871e	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-5125	NA	false	Canada	NA	2027	432e85d9-462a-559b-9c57-5db0138ce3c8	not reported	male	not reported	TCGA-75-5125_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	1752	NA	d890c4e6-1de9-4fc3-81ac-067d5835da03	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-5125_diagnosis2	NA	Not Reported	TCGA-75-5125_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-75-5125_treatment4	NA	NA	NA	NA	ff2bd8e3-919f-410f-835e-6e315a38b9d3	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	205759a6-6391-491b-9857-0080c3a5871e	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-5125	NA	false	Canada	NA	2027	432e85d9-462a-559b-9c57-5db0138ce3c8	not reported	male	not reported	TCGA-75-5125_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	NA	2027.0	e59a8484-7219-5bde-922e-45c227837d46	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-5125_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5125_treatment2	NA	NA	NA	NA	5e2ff79a-6c67-433d-a8ba-911adc1111fc	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	205759a6-6391-491b-9857-0080c3a5871e	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-5125	NA	false	Canada	NA	2027	432e85d9-462a-559b-9c57-5db0138ce3c8	not reported	male	not reported	TCGA-75-5125_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	NA	2027.0	e59a8484-7219-5bde-922e-45c227837d46	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-5125_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5125_treatment	NA	NA	NA	NA	7c676dd5-1bb4-5ec3-9bee-742651926d60	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2079155a-d91d-4246-a038-01934a580f32	Informed Consent	-36	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-38-4626	57	false	United States	-20903	NA	9396dcdc-045a-5ef3-9f41-efe3902f0dd0	not hispanic or latino	female	white	TCGA-38-4626_demographic	Alive	23421	NA	NA	NA	NA	NA	Subsequent Primary	2518	NA	2f1edd16-7e3f-4dcf-bc34-cfa51770ef2b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4626_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-38-4626_treatment3	NA	NA	NA	NA	26a2061d-b508-4b65-bbfd-4e28531488d7	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2079155a-d91d-4246-a038-01934a580f32	Informed Consent	-36	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-38-4626	57	false	United States	-20903	NA	9396dcdc-045a-5ef3-9f41-efe3902f0dd0	not hispanic or latino	female	white	TCGA-38-4626_demographic	Alive	23421	NA	NA	NA	NA	NA	Subsequent Primary	2518	NA	2f1edd16-7e3f-4dcf-bc34-cfa51770ef2b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4626_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4626_treatment5	NA	Locoregional Site	NA	NA	36a12944-5cc2-4bab-8a58-b5633fd475b7	NA	no	NA	Surgery, NOS
TCGA-LUAD	2079155a-d91d-4246-a038-01934a580f32	Informed Consent	-36	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-38-4626	57	false	United States	-20903	NA	9396dcdc-045a-5ef3-9f41-efe3902f0dd0	not hispanic or latino	female	white	TCGA-38-4626_demographic	Alive	23421	NA	NA	NA	NA	NA	Subsequent Primary	2518	NA	2f1edd16-7e3f-4dcf-bc34-cfa51770ef2b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4626_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-38-4626_treatment4	NA	NA	NA	NA	4a38e350-2494-4ea8-8bb1-d1e51d151c91	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2079155a-d91d-4246-a038-01934a580f32	Informed Consent	-36	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-38-4626	57	false	United States	-20903	NA	9396dcdc-045a-5ef3-9f41-efe3902f0dd0	not hispanic or latino	female	white	TCGA-38-4626_demographic	Alive	20903	M0	N0	NA	T2b	6th	primary	0	3674.0	9d7b9152-61ec-5cd7-b3bc-a5604728c3ac	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-38-4626_diagnosis	No	Upper lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4626_treatment	NA	NA	NA	NA	03838326-3d38-5151-9616-f86a1fdd4404	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2079155a-d91d-4246-a038-01934a580f32	Informed Consent	-36	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-38-4626	57	false	United States	-20903	NA	9396dcdc-045a-5ef3-9f41-efe3902f0dd0	not hispanic or latino	female	white	TCGA-38-4626_demographic	Alive	20903	M0	N0	NA	T2b	6th	primary	0	3674.0	9d7b9152-61ec-5cd7-b3bc-a5604728c3ac	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-38-4626_diagnosis	No	Upper lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4626_treatment2	NA	NA	NA	NA	4aaf16cf-1ea4-41f8-bc50-21494554f83d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	26053	NA	NA	NA	NA	NA	metastasis	214	NA	14f08e55-99e4-41b6-9107-8e4fbecfdbf8	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-49-6742_diagnosis3	NA	Not Reported	TCGA-49-6742_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-49-6742_treatment13	NA	NA	NA	NA	33e97c46-b63a-4fba-b6c1-17e58617f033	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	26053	NA	NA	NA	NA	NA	metastasis	214	NA	14f08e55-99e4-41b6-9107-8e4fbecfdbf8	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-49-6742_diagnosis3	NA	Not Reported	TCGA-49-6742_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6742_treatment14	NA	Locoregional Site	NA	NA	3bc7a076-79ec-4f40-a524-c63786a46565	NA	no	NA	Surgery, NOS
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	26053	NA	NA	NA	NA	NA	metastasis	214	NA	14f08e55-99e4-41b6-9107-8e4fbecfdbf8	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-49-6742_diagnosis3	NA	Not Reported	TCGA-49-6742_diagnosis	NA	NA	NA	NA	214	NA	NA	NA	NA	NA	NA	TCGA-49-6742_treatment15	NA	Distant Site	NA	NA	64f3f4d3-d55f-4a9a-8d90-2584192ff656	NA	yes	NA	Surgery, NOS
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	26053	NA	NA	NA	NA	NA	metastasis	214	NA	14f08e55-99e4-41b6-9107-8e4fbecfdbf8	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-49-6742_diagnosis3	NA	Not Reported	TCGA-49-6742_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-49-6742_treatment12	NA	NA	NA	NA	ee7f55ff-d829-46b9-865b-f6af7229ce78	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	26053	NA	NA	NA	NA	NA	not reported	214	NA	26a0290e-19dd-46bb-9a84-e55e09ab608e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-6742_diagnosis2	NA	Not Reported	TCGA-49-6742_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6742_treatment10	NA	Locoregional Site	NA	NA	1e49d6e5-61c4-4d85-9806-87cd674e3536	NA	no	NA	Surgery, NOS
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	26053	NA	NA	NA	NA	NA	not reported	214	NA	26a0290e-19dd-46bb-9a84-e55e09ab608e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-6742_diagnosis2	NA	Not Reported	TCGA-49-6742_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-49-6742_treatment9	NA	NA	NA	NA	314509aa-b306-482d-ab7b-2aa751e06742	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	26053	NA	NA	NA	NA	NA	not reported	214	NA	26a0290e-19dd-46bb-9a84-e55e09ab608e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-6742_diagnosis2	NA	Not Reported	TCGA-49-6742_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-49-6742_treatment8	NA	NA	NA	NA	b2665cb8-aed2-47eb-9492-159488f9d42a	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	26053	NA	NA	NA	NA	NA	not reported	214	NA	26a0290e-19dd-46bb-9a84-e55e09ab608e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-6742_diagnosis2	NA	Not Reported	TCGA-49-6742_diagnosis	NA	NA	NA	NA	214	NA	NA	NA	NA	NA	NA	TCGA-49-6742_treatment11	NA	Distant Site	NA	NA	bc1908ea-fbdd-4e52-b8ac-6514b4d46f71	NA	yes	NA	Surgery, NOS
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	25839	M0	N1	Stage IIA	T2a	7th	primary	0	488.0	4cab7bb7-bb86-5420-a1da-ca533f3c701a	true	NA	NA	C34.1	Left	8480/3	Mucinous adenocarcinoma	yes	No	R0	Lung, NOS	NA	TCGA-49-6742_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	396	335	Progressive Disease	1	NA	NA	NA	Intravenous	TCGA-49-6742_treatment4	Clinical Trial	NA	NA	NA	2cedc0dd-ea03-4ee5-a9be-1e9bdcfd97e6	NA	yes	NA	Immunotherapy (Including Vaccines)
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	25839	M0	N1	Stage IIA	T2a	7th	primary	0	488.0	4cab7bb7-bb86-5420-a1da-ca533f3c701a	true	NA	NA	C34.1	Left	8480/3	Mucinous adenocarcinoma	yes	No	R0	Lung, NOS	NA	TCGA-49-6742_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	184	31	NA	3	NA	NA	NA	Intravenous	TCGA-49-6742_treatment3	Cisplatin	NA	NA	NA	4ff68317-3ea3-481a-976c-b123f69d07d9	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	25839	M0	N1	Stage IIA	T2a	7th	primary	0	488.0	4cab7bb7-bb86-5420-a1da-ca533f3c701a	true	NA	NA	C34.1	Left	8480/3	Mucinous adenocarcinoma	yes	No	R0	Lung, NOS	NA	TCGA-49-6742_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6742_treatment5	NA	NA	NA	NA	8e08b501-b1b1-45bf-bcce-5fea926ad6fa	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	25839	M0	N1	Stage IIA	T2a	7th	primary	0	488.0	4cab7bb7-bb86-5420-a1da-ca533f3c701a	true	NA	NA	C34.1	Left	8480/3	Mucinous adenocarcinoma	yes	No	R0	Lung, NOS	NA	TCGA-49-6742_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	184	31	NA	3	NA	NA	NA	Intravenous	TCGA-49-6742_treatment2	Pemetrexed	NA	NA	NA	93dcdb64-a09c-4643-bdd3-66930ef18792	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	25839	M0	N1	Stage IIA	T2a	7th	primary	0	488.0	4cab7bb7-bb86-5420-a1da-ca533f3c701a	true	NA	NA	C34.1	Left	8480/3	Mucinous adenocarcinoma	yes	No	R0	Lung, NOS	NA	TCGA-49-6742_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	184	31	NA	3	NA	NA	NA	Intravenous	TCGA-49-6742_treatment	Pemetrexed Disodium	NA	NA	NA	d0274205-f04d-5400-9233-0a55aa6edc76	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d6311503-603f-47b9-97af-a5fcd4470278	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-49-6742_diagnosis4	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6742_treatment6	NA	NA	NA	NA	0be3b5c8-a16d-423c-ae88-cd293051b56a	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	21fb46f9-4bbb-441c-af19-a687e9138344	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-6742	70	false	United States	-25839	488	1c1ef8f9-8850-52b2-a367-233addd65369	not hispanic or latino	male	white	TCGA-49-6742_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d6311503-603f-47b9-97af-a5fcd4470278	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-49-6742_diagnosis4	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6742_treatment7	NA	NA	NA	NA	9bddd917-9f06-486a-98bc-73915d293180	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	22302e92-fdfa-462a-9249-efdaa26ee5ed	Informed Consent	-52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6144	58	false	United States	-21283	NA	f5d20dcd-18f0-590f-b34a-3c72b8680fe3	not hispanic or latino	male	white	TCGA-44-6144_demographic	Alive	21682	NA	NA	NA	NA	NA	recurrence	399	NA	09b6f583-c836-40cc-b61c-6f7fb13e7aa8	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-6144_diagnosis3	NA	Not Reported	TCGA-44-6144_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6144_treatment6	NA	Distant Site	NA	NA	163c30dd-b6af-4f64-8e24-91f028b59b5b	NA	no	NA	Surgery, NOS
TCGA-LUAD	22302e92-fdfa-462a-9249-efdaa26ee5ed	Informed Consent	-52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6144	58	false	United States	-21283	NA	f5d20dcd-18f0-590f-b34a-3c72b8680fe3	not hispanic or latino	male	white	TCGA-44-6144_demographic	Alive	21682	NA	NA	NA	NA	NA	recurrence	399	NA	09b6f583-c836-40cc-b61c-6f7fb13e7aa8	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-6144_diagnosis3	NA	Not Reported	TCGA-44-6144_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6144_treatment5	NA	Locoregional Site	NA	NA	4c1d04d6-b162-4b6a-afc9-516a66486bb9	NA	no	NA	Surgery, NOS
TCGA-LUAD	22302e92-fdfa-462a-9249-efdaa26ee5ed	Informed Consent	-52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6144	58	false	United States	-21283	NA	f5d20dcd-18f0-590f-b34a-3c72b8680fe3	not hispanic or latino	male	white	TCGA-44-6144_demographic	Alive	21682	NA	NA	NA	NA	NA	recurrence	399	NA	09b6f583-c836-40cc-b61c-6f7fb13e7aa8	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-6144_diagnosis3	NA	Not Reported	TCGA-44-6144_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-6144_treatment3	NA	NA	NA	NA	89a5e185-22fc-456e-b3c4-5ff078923884	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	22302e92-fdfa-462a-9249-efdaa26ee5ed	Informed Consent	-52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6144	58	false	United States	-21283	NA	f5d20dcd-18f0-590f-b34a-3c72b8680fe3	not hispanic or latino	male	white	TCGA-44-6144_demographic	Alive	21682	NA	NA	NA	NA	NA	recurrence	399	NA	09b6f583-c836-40cc-b61c-6f7fb13e7aa8	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-6144_diagnosis3	NA	Not Reported	TCGA-44-6144_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-6144_treatment4	NA	NA	NA	NA	d6c9d562-a248-4f78-bd0a-69d38a8f0954	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	22302e92-fdfa-462a-9249-efdaa26ee5ed	Informed Consent	-52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6144	58	false	United States	-21283	NA	f5d20dcd-18f0-590f-b34a-3c72b8680fe3	not hispanic or latino	male	white	TCGA-44-6144_demographic	Alive	21682	NA	NA	NA	NA	NA	metastasis	399	NA	31015c6a-9fd5-4b95-aa0c-d6ac1dc18492	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-6144_diagnosis4	NA	Not Reported	TCGA-44-6144_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6144_treatment9	NA	Locoregional Site	NA	NA	16310cf0-5817-422b-be1d-286fe400dd26	NA	no	NA	Surgery, NOS
TCGA-LUAD	22302e92-fdfa-462a-9249-efdaa26ee5ed	Informed Consent	-52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6144	58	false	United States	-21283	NA	f5d20dcd-18f0-590f-b34a-3c72b8680fe3	not hispanic or latino	male	white	TCGA-44-6144_demographic	Alive	21682	NA	NA	NA	NA	NA	metastasis	399	NA	31015c6a-9fd5-4b95-aa0c-d6ac1dc18492	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-6144_diagnosis4	NA	Not Reported	TCGA-44-6144_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-44-6144_treatment8	NA	NA	NA	NA	20e9bbd0-1712-4000-8514-e69f50c4f5ae	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	22302e92-fdfa-462a-9249-efdaa26ee5ed	Informed Consent	-52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6144	58	false	United States	-21283	NA	f5d20dcd-18f0-590f-b34a-3c72b8680fe3	not hispanic or latino	male	white	TCGA-44-6144_demographic	Alive	21682	NA	NA	NA	NA	NA	metastasis	399	NA	31015c6a-9fd5-4b95-aa0c-d6ac1dc18492	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-6144_diagnosis4	NA	Not Reported	TCGA-44-6144_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6144_treatment10	NA	Distant Site	NA	NA	4692442e-9f04-4c0a-b64b-622f17bc0a93	NA	no	NA	Surgery, NOS
TCGA-LUAD	22302e92-fdfa-462a-9249-efdaa26ee5ed	Informed Consent	-52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6144	58	false	United States	-21283	NA	f5d20dcd-18f0-590f-b34a-3c72b8680fe3	not hispanic or latino	male	white	TCGA-44-6144_demographic	Alive	21682	NA	NA	NA	NA	NA	metastasis	399	NA	31015c6a-9fd5-4b95-aa0c-d6ac1dc18492	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-6144_diagnosis4	NA	Not Reported	TCGA-44-6144_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-44-6144_treatment7	NA	NA	NA	NA	72c22faf-708e-405f-b89f-3ff427f46f79	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	22302e92-fdfa-462a-9249-efdaa26ee5ed	Informed Consent	-52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6144	58	false	United States	-21283	NA	f5d20dcd-18f0-590f-b34a-3c72b8680fe3	not hispanic or latino	male	white	TCGA-44-6144_demographic	Alive	21283	M0	N0	Stage IA	T1a	7th	primary	0	723.0	69fa6b22-98e5-5f03-9e91-363e1e8fffbb	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-44-6144_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6144_treatment2	NA	NA	NA	NA	ac0f8fd7-65ac-4f86-9cc8-57630df1282a	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	22302e92-fdfa-462a-9249-efdaa26ee5ed	Informed Consent	-52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6144	58	false	United States	-21283	NA	f5d20dcd-18f0-590f-b34a-3c72b8680fe3	not hispanic or latino	male	white	TCGA-44-6144_demographic	Alive	21283	M0	N0	Stage IA	T1a	7th	primary	0	723.0	69fa6b22-98e5-5f03-9e91-363e1e8fffbb	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-44-6144_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6144_treatment	NA	NA	NA	NA	c76a9f4c-ee91-59fe-ab53-796759167612	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	22302e92-fdfa-462a-9249-efdaa26ee5ed	Informed Consent	-52	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6144	58	false	United States	-21283	NA	f5d20dcd-18f0-590f-b34a-3c72b8680fe3	not hispanic or latino	male	white	TCGA-44-6144_demographic	Alive	21682	NA	NA	NA	NA	NA	not reported	399	NA	aacdada4-7efc-4c04-8362-cb822f2e0843	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-6144_diagnosis2	NA	Not Reported	TCGA-44-6144_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	23069f19-eba5-4ea5-ae7d-1ee4399ce7c1	Informed Consent	NA	Ductal and Lobular Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-75-6212	NA	false	Canada	NA	1516	5016e82c-d591-5df5-8a14-e62af5bc184c	not reported	female	not reported	TCGA-75-6212_demographic	Dead	NA	NA	NA	NA	NA	NA	Subsequent Primary	1340	NA	56cbe52e-ec72-46a7-9371-869de8d61b05	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-6212_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-75-6212_treatment5	NA	NA	NA	NA	6ee7cd79-d3f6-48af-ba69-1e47738b633c	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	23069f19-eba5-4ea5-ae7d-1ee4399ce7c1	Informed Consent	NA	Ductal and Lobular Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-75-6212	NA	false	Canada	NA	1516	5016e82c-d591-5df5-8a14-e62af5bc184c	not reported	female	not reported	TCGA-75-6212_demographic	Dead	NA	NA	NA	NA	NA	NA	Subsequent Primary	1340	NA	56cbe52e-ec72-46a7-9371-869de8d61b05	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-6212_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-75-6212_treatment6	NA	NA	NA	NA	e68277fd-588f-4509-acaa-bd0aef7d249f	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	23069f19-eba5-4ea5-ae7d-1ee4399ce7c1	Informed Consent	NA	Ductal and Lobular Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-75-6212	NA	false	Canada	NA	1516	5016e82c-d591-5df5-8a14-e62af5bc184c	not reported	female	not reported	TCGA-75-6212_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	NA	1516.0	8291b2be-60f4-5e54-849d-a3942a268aec	true	NA	NA	C34.3	Left	8507/3	Invasive micropapillary carcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6212_diagnosis	No	Lower lobe, lung	NA	NA	NA	NA	NA	NA	NA	1	NA	437.0	mg	Intravenous	TCGA-75-6212_treatment3	Carboplatin	NA	437	mg	1ea5f720-d128-4fa1-9a00-9209e4407ffc	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	23069f19-eba5-4ea5-ae7d-1ee4399ce7c1	Informed Consent	NA	Ductal and Lobular Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-75-6212	NA	false	Canada	NA	1516	5016e82c-d591-5df5-8a14-e62af5bc184c	not reported	female	not reported	TCGA-75-6212_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	NA	1516.0	8291b2be-60f4-5e54-849d-a3942a268aec	true	NA	NA	C34.3	Left	8507/3	Invasive micropapillary carcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6212_diagnosis	No	Lower lobe, lung	NA	NA	NA	NA	NA	NA	NA	3	NA	70.0	mg	Intravenous	TCGA-75-6212_treatment	Cisplatin	NA	210	mg	2082d5e0-dfe1-5e7c-a603-bd779d2567ba	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	23069f19-eba5-4ea5-ae7d-1ee4399ce7c1	Informed Consent	NA	Ductal and Lobular Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-75-6212	NA	false	Canada	NA	1516	5016e82c-d591-5df5-8a14-e62af5bc184c	not reported	female	not reported	TCGA-75-6212_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	NA	1516.0	8291b2be-60f4-5e54-849d-a3942a268aec	true	NA	NA	C34.3	Left	8507/3	Invasive micropapillary carcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6212_diagnosis	No	Lower lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6212_treatment4	NA	NA	NA	NA	493b98f2-420e-46ec-81b8-d612c1078b9a	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	23069f19-eba5-4ea5-ae7d-1ee4399ce7c1	Informed Consent	NA	Ductal and Lobular Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-75-6212	NA	false	Canada	NA	1516	5016e82c-d591-5df5-8a14-e62af5bc184c	not reported	female	not reported	TCGA-75-6212_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	NA	1516.0	8291b2be-60f4-5e54-849d-a3942a268aec	true	NA	NA	C34.3	Left	8507/3	Invasive micropapillary carcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6212_diagnosis	No	Lower lobe, lung	NA	NA	NA	NA	NA	NA	NA	4	NA	42.0	mg	Intravenous	TCGA-75-6212_treatment2	Vinorelbine Tartrate	NA	572	mg	65449707-160c-4766-9d3e-1dc1600868be	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	230dc42d-681c-4e31-9d2e-c724e61829fb	Informed Consent	-29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-8119	73	false	United States	-27003	NA	9e5df9af-504d-5b60-881e-0557f2f15dfd	not hispanic or latino	male	white	TCGA-44-8119_demographic	Alive	27003	M0	N0	Stage IIB	T3	7th	primary	0	285.0	020a308e-3a52-56c1-bc28-109b7c47af01	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-8119_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-8119_treatment	NA	NA	NA	NA	0f8fbb86-16a5-5787-aab7-f20764e0e9be	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	230dc42d-681c-4e31-9d2e-c724e61829fb	Informed Consent	-29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-8119	73	false	United States	-27003	NA	9e5df9af-504d-5b60-881e-0557f2f15dfd	not hispanic or latino	male	white	TCGA-44-8119_demographic	Alive	27003	M0	N0	Stage IIB	T3	7th	primary	0	285.0	020a308e-3a52-56c1-bc28-109b7c47af01	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-8119_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-8119_treatment2	NA	NA	NA	NA	99458b4a-e7b3-4a53-9f39-4e08a0f439ab	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	230dc42d-681c-4e31-9d2e-c724e61829fb	Informed Consent	-29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-8119	73	false	United States	-27003	NA	9e5df9af-504d-5b60-881e-0557f2f15dfd	not hispanic or latino	male	white	TCGA-44-8119_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	4fbe2870-8562-46a5-be88-13a91bf560a3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-8119_diagnosis2	NA	Skin of lip, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-8119_treatment3	NA	NA	NA	NA	6daa82af-a2d1-409f-93a6-d8690b838116	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	230dc42d-681c-4e31-9d2e-c724e61829fb	Informed Consent	-29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-8119	73	false	United States	-27003	NA	9e5df9af-504d-5b60-881e-0557f2f15dfd	not hispanic or latino	male	white	TCGA-44-8119_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	4fbe2870-8562-46a5-be88-13a91bf560a3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-8119_diagnosis2	NA	Skin of lip, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-8119_treatment4	NA	NA	NA	NA	bbc94728-093f-4398-bb63-b64361f9767b	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	243c6fd6-5516-46e5-bcef-292d93d7b7d3	Informed Consent	323	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7764	75	false	United States	-27693	NA	651de13e-b00e-5aa6-80cc-c1bf9ff0719a	not hispanic or latino	male	white	TCGA-69-7764_demographic	Alive	27693	M0	N0	Stage IA	T1b	7th	primary	0	414.0	1e1593d3-3806-53fb-8402-33ce19ad9ba9	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7764_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7764_treatment	NA	NA	NA	NA	043323e2-fa25-5075-b7cb-c0e7f6633bda	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	243c6fd6-5516-46e5-bcef-292d93d7b7d3	Informed Consent	323	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7764	75	false	United States	-27693	NA	651de13e-b00e-5aa6-80cc-c1bf9ff0719a	not hispanic or latino	male	white	TCGA-69-7764_demographic	Alive	27693	M0	N0	Stage IA	T1b	7th	primary	0	414.0	1e1593d3-3806-53fb-8402-33ce19ad9ba9	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7764_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7764_treatment2	NA	NA	NA	NA	9b23abb0-f764-434f-8873-7565ea676e24	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2483621a-4db3-41ab-aa33-b9427ea8a0af	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4631	72	false	United States	-26538	354	03dc8f12-cfed-52bf-afe7-7397a1b7a3ac	not hispanic or latino	female	white	TCGA-38-4631_demographic	Dead	26538	M0	N0	Stage IB	T2	NA	primary	0	354.0	071ab696-7bad-5db0-b23b-d3dc176f4560	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4631_diagnosis	No	Upper lobe, lung	NA	1997	NA	1.0	115	87	NA	NA	NA	NA	NA	NA	TCGA-38-4631_treatment	NA	Distant Site	NA	NA	7803642b-3e18-59fb-b207-726758afba47	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	2483621a-4db3-41ab-aa33-b9427ea8a0af	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4631	72	false	United States	-26538	354	03dc8f12-cfed-52bf-afe7-7397a1b7a3ac	not hispanic or latino	female	white	TCGA-38-4631_demographic	Dead	26538	M0	N0	Stage IB	T2	NA	primary	0	354.0	071ab696-7bad-5db0-b23b-d3dc176f4560	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4631_diagnosis	No	Upper lobe, lung	NA	1997	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4631_treatment2	NA	NA	NA	NA	83531b52-2bee-4a66-a0d9-f10824271908	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2483621a-4db3-41ab-aa33-b9427ea8a0af	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4631	72	false	United States	-26538	354	03dc8f12-cfed-52bf-afe7-7397a1b7a3ac	not hispanic or latino	female	white	TCGA-38-4631_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	2055c5f7-b158-4e02-8a67-a5340083e29a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4631_diagnosis2	NA	Not Reported	TCGA-38-4631_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4631_treatment10	NA	Distant Site	NA	NA	1c78928b-47b5-43af-8191-13dec7760ca5	NA	no	NA	Surgery, NOS
TCGA-LUAD	2483621a-4db3-41ab-aa33-b9427ea8a0af	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4631	72	false	United States	-26538	354	03dc8f12-cfed-52bf-afe7-7397a1b7a3ac	not hispanic or latino	female	white	TCGA-38-4631_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	2055c5f7-b158-4e02-8a67-a5340083e29a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4631_diagnosis2	NA	Not Reported	TCGA-38-4631_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4631_treatment9	NA	Locoregional Site	NA	NA	45bf2235-c188-4bd6-8bbb-4f2b83e1c37b	NA	no	NA	Surgery, NOS
TCGA-LUAD	2483621a-4db3-41ab-aa33-b9427ea8a0af	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4631	72	false	United States	-26538	354	03dc8f12-cfed-52bf-afe7-7397a1b7a3ac	not hispanic or latino	female	white	TCGA-38-4631_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	2055c5f7-b158-4e02-8a67-a5340083e29a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4631_diagnosis2	NA	Not Reported	TCGA-38-4631_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4631_treatment7	NA	NA	NA	NA	e3417548-e40f-49f5-8111-2d4efe69064f	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2483621a-4db3-41ab-aa33-b9427ea8a0af	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4631	72	false	United States	-26538	354	03dc8f12-cfed-52bf-afe7-7397a1b7a3ac	not hispanic or latino	female	white	TCGA-38-4631_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	2055c5f7-b158-4e02-8a67-a5340083e29a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4631_diagnosis2	NA	Not Reported	TCGA-38-4631_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4631_treatment8	NA	NA	NA	NA	e7eb9dbc-f569-48cb-9ca4-fad927034059	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	2483621a-4db3-41ab-aa33-b9427ea8a0af	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4631	72	false	United States	-26538	354	03dc8f12-cfed-52bf-afe7-7397a1b7a3ac	not hispanic or latino	female	white	TCGA-38-4631_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	2ba2069f-d3b5-4cdc-bdb6-69c350e0e15e	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-38-4631_diagnosis4	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4631_treatment5	NA	NA	NA	NA	286e8c08-f499-483c-9742-b245e45305ca	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2483621a-4db3-41ab-aa33-b9427ea8a0af	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4631	72	false	United States	-26538	354	03dc8f12-cfed-52bf-afe7-7397a1b7a3ac	not hispanic or latino	female	white	TCGA-38-4631_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	2ba2069f-d3b5-4cdc-bdb6-69c350e0e15e	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-38-4631_diagnosis4	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4631_treatment6	NA	NA	NA	NA	2b324262-d16d-4dc3-bc16-1e8344067030	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2483621a-4db3-41ab-aa33-b9427ea8a0af	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4631	72	false	United States	-26538	354	03dc8f12-cfed-52bf-afe7-7397a1b7a3ac	not hispanic or latino	female	white	TCGA-38-4631_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	8ab3c3f8-0268-4f24-a8d5-dd94635adb3c	false	NA	NA	NA	Left	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-38-4631_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4631_treatment4	NA	NA	NA	NA	1bb5a250-2120-4dde-a2c0-b61c05c32373	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2483621a-4db3-41ab-aa33-b9427ea8a0af	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4631	72	false	United States	-26538	354	03dc8f12-cfed-52bf-afe7-7397a1b7a3ac	not hispanic or latino	female	white	TCGA-38-4631_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	8ab3c3f8-0268-4f24-a8d5-dd94635adb3c	false	NA	NA	NA	Left	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-38-4631_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4631_treatment3	NA	NA	NA	NA	adaa3311-5b65-44c0-b35a-19b5e85c3015	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	257c9416-e86a-4c71-9dee-7212c2e56351	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z060	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	258a3a41-211b-4c66-bd3b-ef03014a6967	Informed Consent	27	Acinar Cell Neoplasms	Diagnosis	Yes	Bronchus and lung	TCGA-38-A44F	80	false	United States	-29534	NA	0d71918d-d17d-5726-a5ce-c9e65d7ae4dc	not hispanic or latino	male	white	TCGA-38-A44F_demographic	Alive	29534	M0	N0	Stage IB	T2a	7th	primary	0	133.0	da0e718e-d622-5e8a-874f-b7f3d74832cd	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-A44F_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-A44F_treatment2	NA	NA	NA	NA	34fd0594-8192-476c-be6d-2e303765cc60	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	258a3a41-211b-4c66-bd3b-ef03014a6967	Informed Consent	27	Acinar Cell Neoplasms	Diagnosis	Yes	Bronchus and lung	TCGA-38-A44F	80	false	United States	-29534	NA	0d71918d-d17d-5726-a5ce-c9e65d7ae4dc	not hispanic or latino	male	white	TCGA-38-A44F_demographic	Alive	29534	M0	N0	Stage IB	T2a	7th	primary	0	133.0	da0e718e-d622-5e8a-874f-b7f3d74832cd	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-A44F_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-A44F_treatment	NA	NA	NA	NA	8061d45a-3a27-5e60-8069-6a5dca2af5b9	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	25c9f984-1a5a-4cca-9ad1-39f759ea7174	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z039	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	25d4ea9e-f773-4f11-bac9-64efdad73211	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-83-5908	59	false	United States	-21760	NA	46a2dc0b-b1ad-5523-a34c-d980f4ff152f	not hispanic or latino	female	white	TCGA-83-5908_demographic	Alive	21760	M0	N0	Stage IA	T1	6th	primary	0	824.0	fc4e4284-d2d0-5574-ab4b-3540fc619feb	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-83-5908_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-83-5908_treatment2	NA	NA	NA	NA	8950dbed-ac9a-4297-9270-823a7cd5ac36	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	25d4ea9e-f773-4f11-bac9-64efdad73211	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-83-5908	59	false	United States	-21760	NA	46a2dc0b-b1ad-5523-a34c-d980f4ff152f	not hispanic or latino	female	white	TCGA-83-5908_demographic	Alive	21760	M0	N0	Stage IA	T1	6th	primary	0	824.0	fc4e4284-d2d0-5574-ab4b-3540fc619feb	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-83-5908_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-83-5908_treatment	NA	NA	NA	NA	99e3c665-409b-58d8-8e95-6733b9969013	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	26a92e1b-08d8-45cd-af0c-eaf2514808a2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L4-A4E6	67	false	United States	-24631	NA	32609a4d-e274-5a8f-b9ea-aa0f11cdcdef	not hispanic or latino	male	white	TCGA-L4-A4E6_demographic	Alive	24631	M0	N0	Stage IA	T1	7th	primary	0	435.0	f9171c82-7835-55ca-85fa-e3f9351a99da	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-L4-A4E6_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L4-A4E6_treatment	NA	NA	NA	NA	58d912b4-8b02-516c-90ee-8422ba754ba3	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	26a92e1b-08d8-45cd-af0c-eaf2514808a2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L4-A4E6	67	false	United States	-24631	NA	32609a4d-e274-5a8f-b9ea-aa0f11cdcdef	not hispanic or latino	male	white	TCGA-L4-A4E6_demographic	Alive	24631	M0	N0	Stage IA	T1	7th	primary	0	435.0	f9171c82-7835-55ca-85fa-e3f9351a99da	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-L4-A4E6_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L4-A4E6_treatment2	NA	NA	NA	NA	e90589e8-e27d-42dd-a39e-a271f31ba352	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	27fceec1-3298-4cdd-a4e6-8f5cf34604f0	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-5643	53	false	United States	-19426	NA	cd7e4b52-9505-5d35-94b7-1f86a51c3593	not hispanic or latino	male	black or african american	TCGA-44-5643_demographic	Alive	19426	M0	N2	Stage IIIA	T2b	7th	primary	0	1013.0	f64eda59-f893-5c25-8323-8f2e4f242e84	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-5643_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	208	131	NA	8	NA	NA	NA	Intravenous	TCGA-44-5643_treatment4	Paclitaxel	NA	1505	mg	58f724be-c384-4358-9043-d72ca3b8e0cd	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	27fceec1-3298-4cdd-a4e6-8f5cf34604f0	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-5643	53	false	United States	-19426	NA	cd7e4b52-9505-5d35-94b7-1f86a51c3593	not hispanic or latino	male	black or african american	TCGA-44-5643_demographic	Alive	19426	M0	N2	Stage IIIA	T2b	7th	primary	0	1013.0	f64eda59-f893-5c25-8323-8f2e4f242e84	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-5643_diagnosis	No	Lower lobe, lung	NA	2010	NA	1.0	168	129	NA	NA	25.0	NA	NA	NA	TCGA-44-5643_treatment	NA	Primary Tumor Field	60	cGy	5aafbd21-efa0-5642-98ab-3b2831e00f57	Adjuvant	yes	NA	Radiation, Intensity-Modulated Radiotherapy
TCGA-LUAD	27fceec1-3298-4cdd-a4e6-8f5cf34604f0	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-5643	53	false	United States	-19426	NA	cd7e4b52-9505-5d35-94b7-1f86a51c3593	not hispanic or latino	male	black or african american	TCGA-44-5643_demographic	Alive	19426	M0	N2	Stage IIIA	T2b	7th	primary	0	1013.0	f64eda59-f893-5c25-8323-8f2e4f242e84	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-5643_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	223	NA	132	NA	150.0	mg	Oral	TCGA-44-5643_treatment3	Erlotinib Hydrochloride	NA	19800	mg	78fdcf90-4052-4b4b-a120-594079dafd85	Adjuvant	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	27fceec1-3298-4cdd-a4e6-8f5cf34604f0	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-5643	53	false	United States	-19426	NA	cd7e4b52-9505-5d35-94b7-1f86a51c3593	not hispanic or latino	male	black or african american	TCGA-44-5643_demographic	Alive	19426	M0	N2	Stage IIIA	T2b	7th	primary	0	1013.0	f64eda59-f893-5c25-8323-8f2e4f242e84	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-5643_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	208	131	NA	8	NA	NA	NA	Intravenous	TCGA-44-5643_treatment2	Carboplatin	NA	2035	mg	79af8a82-2da4-44ab-ac87-00f28e903d24	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	2923e404-38f2-437a-b57e-23401fbe0273	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8279	46	false	Russia	-17032	NA	6a3c8ab8-04cb-5092-8931-49fe9cd25fc4	not hispanic or latino	male	white	TCGA-86-8279_demographic	Alive	17032	M0	N1	Stage IIA	T2a	7th	primary	0	949.0	1ce170a2-177a-5d2f-8c16-289164954105	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8279_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	119	28	NA	NA	NA	NA	NA	NA	TCGA-86-8279_treatment2	Etoposide	NA	NA	NA	10d8261c-6e0a-439e-9a87-e0abaf5000d6	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	2923e404-38f2-437a-b57e-23401fbe0273	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8279	46	false	Russia	-17032	NA	6a3c8ab8-04cb-5092-8931-49fe9cd25fc4	not hispanic or latino	male	white	TCGA-86-8279_demographic	Alive	17032	M0	N1	Stage IIA	T2a	7th	primary	0	949.0	1ce170a2-177a-5d2f-8c16-289164954105	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8279_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	208	139	NA	NA	33.0	NA	NA	NA	TCGA-86-8279_treatment	NA	Primary Tumor Field	66	Gy	ebb409a1-0498-5ce2-827d-d4d03426ad56	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	2923e404-38f2-437a-b57e-23401fbe0273	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8279	46	false	Russia	-17032	NA	6a3c8ab8-04cb-5092-8931-49fe9cd25fc4	not hispanic or latino	male	white	TCGA-86-8279_demographic	Alive	17032	M0	N1	Stage IIA	T2a	7th	primary	0	949.0	1ce170a2-177a-5d2f-8c16-289164954105	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8279_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	119	28	NA	NA	NA	NA	NA	NA	TCGA-86-8279_treatment3	Cisplatin	NA	NA	NA	f61f2e67-78dd-412e-9364-92a65a810120	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	294cb595-0907-44c7-bbef-985a27c1e6e2	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7724	76	false	United States	-27891	NA	47771b7f-5c06-538e-836d-a57cae09b77d	not hispanic or latino	female	white	TCGA-55-7724_demographic	Alive	27891	MX	N0	Stage IB	T2a	7th	primary	0	705.0	0cab436d-13d9-589c-9a49-f2792b176380	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-7724_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7724_treatment2	NA	NA	NA	NA	57deb6cb-9b96-4da7-88aa-5180d8f49fbf	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	294cb595-0907-44c7-bbef-985a27c1e6e2	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7724	76	false	United States	-27891	NA	47771b7f-5c06-538e-836d-a57cae09b77d	not hispanic or latino	female	white	TCGA-55-7724_demographic	Alive	27891	MX	N0	Stage IB	T2a	7th	primary	0	705.0	0cab436d-13d9-589c-9a49-f2792b176380	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-7724_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7724_treatment	NA	NA	NA	NA	5b4795c4-3579-512c-a759-4282ab6f8632	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	294cb595-0907-44c7-bbef-985a27c1e6e2	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7724	76	false	United States	-27891	NA	47771b7f-5c06-538e-836d-a57cae09b77d	not hispanic or latino	female	white	TCGA-55-7724_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	908572f1-e8d3-497e-a1e9-6fffeede18cf	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-7724_diagnosis2	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7724_treatment3	NA	NA	NA	NA	644c247b-c590-4eb6-b40e-08c4fe0d885c	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	294cb595-0907-44c7-bbef-985a27c1e6e2	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7724	76	false	United States	-27891	NA	47771b7f-5c06-538e-836d-a57cae09b77d	not hispanic or latino	female	white	TCGA-55-7724_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	908572f1-e8d3-497e-a1e9-6fffeede18cf	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-7724_diagnosis2	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7724_treatment4	NA	NA	NA	NA	883d213e-7e2a-4598-a5d5-a408c2a228d0	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	294ff941-aea1-4588-9a0e-e9f5393e2bb6	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4662	65	false	United States	-23762	NA	76544ae1-4778-501e-9619-c506a34bfdb5	not hispanic or latino	female	white	TCGA-73-4662_demographic	Alive	NA	M0	N0	Stage I	T1c	6th	Synchronous primary	NA	NA	546dcdd8-61e5-460e-be1d-9468003ce5cc	false	NA	NA	NA	Left	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-73-4662_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4662_treatment4	Cyclophosphamide	Body, total	NA	NA	382722b2-e050-4b0a-867e-073da3673527	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	294ff941-aea1-4588-9a0e-e9f5393e2bb6	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4662	65	false	United States	-23762	NA	76544ae1-4778-501e-9619-c506a34bfdb5	not hispanic or latino	female	white	TCGA-73-4662_demographic	Alive	NA	M0	N0	Stage I	T1c	6th	Synchronous primary	NA	NA	546dcdd8-61e5-460e-be1d-9468003ce5cc	false	NA	NA	NA	Left	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-73-4662_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4662_treatment3	Anastrozole	Body, total	NA	NA	b1375c84-6e30-4445-b5b4-db0173dea347	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	294ff941-aea1-4588-9a0e-e9f5393e2bb6	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4662	65	false	United States	-23762	NA	76544ae1-4778-501e-9619-c506a34bfdb5	not hispanic or latino	female	white	TCGA-73-4662_demographic	Alive	NA	M0	N0	Stage I	T1c	6th	Synchronous primary	NA	NA	546dcdd8-61e5-460e-be1d-9468003ce5cc	false	NA	NA	NA	Left	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-73-4662_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	181	NA	NA	NA	NA	NA	NA	TCGA-73-4662_treatment6	NA	Locoregional Site	NA	NA	c04deb5b-d904-47b9-9ff0-228ac83dc15b	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	294ff941-aea1-4588-9a0e-e9f5393e2bb6	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4662	65	false	United States	-23762	NA	76544ae1-4778-501e-9619-c506a34bfdb5	not hispanic or latino	female	white	TCGA-73-4662_demographic	Alive	NA	M0	N0	Stage I	T1c	6th	Synchronous primary	NA	NA	546dcdd8-61e5-460e-be1d-9468003ce5cc	false	NA	NA	NA	Left	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-73-4662_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4662_treatment5	Docetaxel	Body, total	NA	NA	fa6a6c8f-4ccd-4f99-81ec-a7bb1d14c3c8	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	294ff941-aea1-4588-9a0e-e9f5393e2bb6	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4662	65	false	United States	-23762	NA	76544ae1-4778-501e-9619-c506a34bfdb5	not hispanic or latino	female	white	TCGA-73-4662_demographic	Alive	23783	NA	NA	NA	NA	NA	not reported	21	NA	643ac32b-054c-44ba-a544-1d01fe865778	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4662_diagnosis2	NA	Not Reported	TCGA-73-4662_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-73-4662_treatment8	NA	NA	NA	NA	0f59d144-df89-4e91-80fc-08bafb1a0203	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	294ff941-aea1-4588-9a0e-e9f5393e2bb6	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4662	65	false	United States	-23762	NA	76544ae1-4778-501e-9619-c506a34bfdb5	not hispanic or latino	female	white	TCGA-73-4662_demographic	Alive	23783	NA	NA	NA	NA	NA	not reported	21	NA	643ac32b-054c-44ba-a544-1d01fe865778	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4662_diagnosis2	NA	Not Reported	TCGA-73-4662_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4662_treatment10	NA	Distant Site	NA	NA	178c0938-38e6-4473-828f-cee9fd2f55a9	NA	no	NA	Surgery, NOS
TCGA-LUAD	294ff941-aea1-4588-9a0e-e9f5393e2bb6	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4662	65	false	United States	-23762	NA	76544ae1-4778-501e-9619-c506a34bfdb5	not hispanic or latino	female	white	TCGA-73-4662_demographic	Alive	23783	NA	NA	NA	NA	NA	not reported	21	NA	643ac32b-054c-44ba-a544-1d01fe865778	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4662_diagnosis2	NA	Not Reported	TCGA-73-4662_diagnosis	NA	NA	NA	NA	36	NA	NA	NA	NA	NA	NA	TCGA-73-4662_treatment9	NA	Locoregional Site	NA	NA	287ab057-6b15-4e83-95fe-ee37c1520752	NA	yes	NA	Surgery, NOS
TCGA-LUAD	294ff941-aea1-4588-9a0e-e9f5393e2bb6	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4662	65	false	United States	-23762	NA	76544ae1-4778-501e-9619-c506a34bfdb5	not hispanic or latino	female	white	TCGA-73-4662_demographic	Alive	23783	NA	NA	NA	NA	NA	not reported	21	NA	643ac32b-054c-44ba-a544-1d01fe865778	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4662_diagnosis2	NA	Not Reported	TCGA-73-4662_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-73-4662_treatment7	NA	NA	NA	NA	43a3b194-b3da-4aa2-8df0-1903bdc71b44	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	294ff941-aea1-4588-9a0e-e9f5393e2bb6	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4662	65	false	United States	-23762	NA	76544ae1-4778-501e-9619-c506a34bfdb5	not hispanic or latino	female	white	TCGA-73-4662_demographic	Alive	23762	M0	N0	Stage IA	T1	6th	primary	0	2515.0	73c5fd2f-6888-5615-b87d-d4d87ca9a600	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-4662_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4662_treatment2	NA	NA	NA	NA	26409d99-a620-4b61-9578-70497eddff74	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	294ff941-aea1-4588-9a0e-e9f5393e2bb6	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4662	65	false	United States	-23762	NA	76544ae1-4778-501e-9619-c506a34bfdb5	not hispanic or latino	female	white	TCGA-73-4662_demographic	Alive	23762	M0	N0	Stage IA	T1	6th	primary	0	2515.0	73c5fd2f-6888-5615-b87d-d4d87ca9a600	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-4662_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4662_treatment	NA	NA	NA	NA	39844ed2-a52d-5101-a2cd-fd93ef3032df	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2a394996-809f-459f-a647-d209921ccbd2	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-73-A9RS	41	false	United States	-15162	340	87e12b9f-8a72-553f-bd89-9cc4e39c5023	not hispanic or latino	male	black or african american	TCGA-73-A9RS_demographic	Dead	15162	M0	N0	Stage IIB	T3	7th	primary	0	340.0	0712357d-8c2c-5649-93c6-698532352122	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-A9RS_diagnosis	No	Upper lobe, lung	NA	2013	NA	NA	53	53	NA	NA	1.0	NA	NA	NA	TCGA-73-A9RS_treatment	NA	Primary Tumor Field	12	Gy	74df6fc6-fa5e-548f-a979-5f68d1dc77ae	NA	yes	Progressive Disease	Radiation, Internal
TCGA-LUAD	2a394996-809f-459f-a647-d209921ccbd2	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-73-A9RS	41	false	United States	-15162	340	87e12b9f-8a72-553f-bd89-9cc4e39c5023	not hispanic or latino	male	black or african american	TCGA-73-A9RS_demographic	Dead	15162	M0	N0	Stage IIB	T3	7th	primary	0	340.0	0712357d-8c2c-5649-93c6-698532352122	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-A9RS_diagnosis	No	Upper lobe, lung	NA	2013	No	NA	242	200	NA	NA	NA	NA	NA	NA	TCGA-73-A9RS_treatment5	Pemetrexed	NA	NA	NA	77f4736a-3034-452c-a2ca-42433049a748	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	2a394996-809f-459f-a647-d209921ccbd2	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-73-A9RS	41	false	United States	-15162	340	87e12b9f-8a72-553f-bd89-9cc4e39c5023	not hispanic or latino	male	black or african american	TCGA-73-A9RS_demographic	Dead	15162	M0	N0	Stage IIB	T3	7th	primary	0	340.0	0712357d-8c2c-5649-93c6-698532352122	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-A9RS_diagnosis	No	Upper lobe, lung	NA	2013	No	NA	186	130	NA	NA	NA	NA	NA	NA	TCGA-73-A9RS_treatment3	Paclitaxel	NA	NA	NA	7efc1188-dbd0-4bda-ad61-c14fcf1d9cbd	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	2a394996-809f-459f-a647-d209921ccbd2	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-73-A9RS	41	false	United States	-15162	340	87e12b9f-8a72-553f-bd89-9cc4e39c5023	not hispanic or latino	male	black or african american	TCGA-73-A9RS_demographic	Dead	15162	M0	N0	Stage IIB	T3	7th	primary	0	340.0	0712357d-8c2c-5649-93c6-698532352122	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-A9RS_diagnosis	No	Upper lobe, lung	NA	2013	No	NA	NA	284	NA	NA	NA	NA	NA	NA	TCGA-73-A9RS_treatment7	Gemcitabine	NA	NA	NA	8c341974-311c-4365-bb55-a229cbe678e0	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	2a394996-809f-459f-a647-d209921ccbd2	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-73-A9RS	41	false	United States	-15162	340	87e12b9f-8a72-553f-bd89-9cc4e39c5023	not hispanic or latino	male	black or african american	TCGA-73-A9RS_demographic	Dead	15162	M0	N0	Stage IIB	T3	7th	primary	0	340.0	0712357d-8c2c-5649-93c6-698532352122	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-A9RS_diagnosis	No	Upper lobe, lung	NA	2013	No	NA	186	130	NA	NA	NA	NA	NA	NA	TCGA-73-A9RS_treatment2	Carboplatin	NA	NA	NA	da30f768-4133-4a96-9195-cfc89dfb36ad	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	2a394996-809f-459f-a647-d209921ccbd2	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-73-A9RS	41	false	United States	-15162	340	87e12b9f-8a72-553f-bd89-9cc4e39c5023	not hispanic or latino	male	black or african american	TCGA-73-A9RS_demographic	Dead	15162	M0	N0	Stage IIB	T3	7th	primary	0	340.0	0712357d-8c2c-5649-93c6-698532352122	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-A9RS_diagnosis	No	Upper lobe, lung	NA	2013	No	NA	284	242	NA	NA	NA	NA	NA	NA	TCGA-73-A9RS_treatment6	Docetaxel	NA	NA	NA	e5ff6543-fb07-49b2-b257-b2936721d15a	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	2a394996-809f-459f-a647-d209921ccbd2	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-73-A9RS	41	false	United States	-15162	340	87e12b9f-8a72-553f-bd89-9cc4e39c5023	not hispanic or latino	male	black or african american	TCGA-73-A9RS_demographic	Dead	15162	M0	N0	Stage IIB	T3	7th	primary	0	340.0	0712357d-8c2c-5649-93c6-698532352122	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-A9RS_diagnosis	No	Upper lobe, lung	NA	2013	Yes	NA	186	130	NA	NA	NA	NA	NA	NA	TCGA-73-A9RS_treatment4	Bevacizumab	NA	NA	NA	ed9d682a-b2f3-4e81-9cd8-ae3edf35edd1	NA	yes	Progressive Disease	Immunotherapy (Including Vaccines)
TCGA-LUAD	2a394996-809f-459f-a647-d209921ccbd2	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-73-A9RS	41	false	United States	-15162	340	87e12b9f-8a72-553f-bd89-9cc4e39c5023	not hispanic or latino	male	black or african american	TCGA-73-A9RS_demographic	Dead	15269	NA	NA	NA	NA	NA	recurrence	107	NA	a747a222-32b3-4322-80e1-83d7c1955746	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-73-A9RS_diagnosis2	NA	Not Reported	TCGA-73-A9RS_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-73-A9RS_treatment9	NA	NA	NA	NA	7dc5b68a-aa29-42a3-b787-fe1f23f2d5f9	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2a394996-809f-459f-a647-d209921ccbd2	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-73-A9RS	41	false	United States	-15162	340	87e12b9f-8a72-553f-bd89-9cc4e39c5023	not hispanic or latino	male	black or african american	TCGA-73-A9RS_demographic	Dead	15269	NA	NA	NA	NA	NA	recurrence	107	NA	a747a222-32b3-4322-80e1-83d7c1955746	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-73-A9RS_diagnosis2	NA	Not Reported	TCGA-73-A9RS_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-A9RS_treatment10	NA	Locoregional Site	NA	NA	88e8a6e9-a512-4252-bbc4-6346307e5e7b	NA	no	NA	Surgery, NOS
TCGA-LUAD	2a394996-809f-459f-a647-d209921ccbd2	Informed Consent	-10	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-73-A9RS	41	false	United States	-15162	340	87e12b9f-8a72-553f-bd89-9cc4e39c5023	not hispanic or latino	male	black or african american	TCGA-73-A9RS_demographic	Dead	15269	NA	NA	NA	NA	NA	recurrence	107	NA	a747a222-32b3-4322-80e1-83d7c1955746	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-73-A9RS_diagnosis2	NA	Not Reported	TCGA-73-A9RS_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-73-A9RS_treatment8	NA	NA	NA	NA	8e1f2ded-7b8f-48bd-b177-4fa319ebd5b4	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2a43e61e-2151-4c5a-b062-74ce9dfd8d4a	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-L9-A5IP	40	false	United States	-14681	58	827e1e33-6c20-5130-9ce4-ecca1f9fb1ff	not hispanic or latino	female	black or african american	TCGA-L9-A5IP_demographic	Dead	14681	M1b	N2	Stage IV	T3	7th	primary	0	58.0	367c677e-8f69-577c-81f8-0b490bf6b4f3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-L9-A5IP_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A5IP_treatment	NA	NA	NA	NA	b5f5d1ba-636b-5f8e-b61e-e82554fca2d3	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2a43e61e-2151-4c5a-b062-74ce9dfd8d4a	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-L9-A5IP	40	false	United States	-14681	58	827e1e33-6c20-5130-9ce4-ecca1f9fb1ff	not hispanic or latino	female	black or african american	TCGA-L9-A5IP_demographic	Dead	14681	M1b	N2	Stage IV	T3	7th	primary	0	58.0	367c677e-8f69-577c-81f8-0b490bf6b4f3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-L9-A5IP_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A5IP_treatment2	NA	NA	NA	NA	d51c9dcf-251d-49d4-963b-3f32ea2757bd	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2a43e61e-2151-4c5a-b062-74ce9dfd8d4a	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-L9-A5IP	40	false	United States	-14681	58	827e1e33-6c20-5130-9ce4-ecca1f9fb1ff	not hispanic or latino	female	black or african american	TCGA-L9-A5IP_demographic	Dead	14730	NA	NA	NA	NA	NA	recurrence	49	NA	497a5b18-a43a-4ad0-acd2-1b55472faa7a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-L9-A5IP_diagnosis2	NA	Not Reported	TCGA-L9-A5IP_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A5IP_treatment5	NA	Locoregional Site	NA	NA	2f01cfb1-3c8c-45c8-a3ba-b9955467b7cc	NA	no	NA	Surgery, NOS
TCGA-LUAD	2a43e61e-2151-4c5a-b062-74ce9dfd8d4a	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-L9-A5IP	40	false	United States	-14681	58	827e1e33-6c20-5130-9ce4-ecca1f9fb1ff	not hispanic or latino	female	black or african american	TCGA-L9-A5IP_demographic	Dead	14730	NA	NA	NA	NA	NA	recurrence	49	NA	497a5b18-a43a-4ad0-acd2-1b55472faa7a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-L9-A5IP_diagnosis2	NA	Not Reported	TCGA-L9-A5IP_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-L9-A5IP_treatment3	NA	NA	NA	NA	5f6df221-df3a-4818-8f31-1f7dd9cd8b7b	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2a43e61e-2151-4c5a-b062-74ce9dfd8d4a	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-L9-A5IP	40	false	United States	-14681	58	827e1e33-6c20-5130-9ce4-ecca1f9fb1ff	not hispanic or latino	female	black or african american	TCGA-L9-A5IP_demographic	Dead	14730	NA	NA	NA	NA	NA	recurrence	49	NA	497a5b18-a43a-4ad0-acd2-1b55472faa7a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-L9-A5IP_diagnosis2	NA	Not Reported	TCGA-L9-A5IP_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-L9-A5IP_treatment4	NA	NA	NA	NA	854f9484-3505-48d8-a1f3-66fc575faa56	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2a43e61e-2151-4c5a-b062-74ce9dfd8d4a	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-L9-A5IP	40	false	United States	-14681	58	827e1e33-6c20-5130-9ce4-ecca1f9fb1ff	not hispanic or latino	female	black or african american	TCGA-L9-A5IP_demographic	Dead	14730	NA	NA	NA	NA	NA	recurrence	49	NA	497a5b18-a43a-4ad0-acd2-1b55472faa7a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-L9-A5IP_diagnosis2	NA	Not Reported	TCGA-L9-A5IP_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A5IP_treatment6	NA	Distant Site	NA	NA	c59519f4-4d0d-4ba0-8c2f-7b9cc2b1e1a3	NA	no	NA	Surgery, NOS
TCGA-LUAD	2a43e61e-2151-4c5a-b062-74ce9dfd8d4a	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-L9-A5IP	40	false	United States	-14681	58	827e1e33-6c20-5130-9ce4-ecca1f9fb1ff	not hispanic or latino	female	black or african american	TCGA-L9-A5IP_demographic	Dead	14730	NA	NA	NA	NA	NA	metastasis	49	NA	e453924a-3fa6-43ae-9524-cdb561a0a292	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-L9-A5IP_diagnosis3	NA	Not Reported	TCGA-L9-A5IP_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-L9-A5IP_treatment8	NA	NA	NA	NA	5f8c4489-2fc3-4018-baa6-33e1ba9dadd9	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2a43e61e-2151-4c5a-b062-74ce9dfd8d4a	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-L9-A5IP	40	false	United States	-14681	58	827e1e33-6c20-5130-9ce4-ecca1f9fb1ff	not hispanic or latino	female	black or african american	TCGA-L9-A5IP_demographic	Dead	14730	NA	NA	NA	NA	NA	metastasis	49	NA	e453924a-3fa6-43ae-9524-cdb561a0a292	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-L9-A5IP_diagnosis3	NA	Not Reported	TCGA-L9-A5IP_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A5IP_treatment10	NA	Distant Site	NA	NA	9178da1d-9a7e-4bad-9b98-d9c2bb900fb0	NA	no	NA	Surgery, NOS
TCGA-LUAD	2a43e61e-2151-4c5a-b062-74ce9dfd8d4a	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-L9-A5IP	40	false	United States	-14681	58	827e1e33-6c20-5130-9ce4-ecca1f9fb1ff	not hispanic or latino	female	black or african american	TCGA-L9-A5IP_demographic	Dead	14730	NA	NA	NA	NA	NA	metastasis	49	NA	e453924a-3fa6-43ae-9524-cdb561a0a292	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-L9-A5IP_diagnosis3	NA	Not Reported	TCGA-L9-A5IP_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-L9-A5IP_treatment7	NA	NA	NA	NA	bfd3f88e-d2e7-4ab1-ab23-28f39728ea13	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2a43e61e-2151-4c5a-b062-74ce9dfd8d4a	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-L9-A5IP	40	false	United States	-14681	58	827e1e33-6c20-5130-9ce4-ecca1f9fb1ff	not hispanic or latino	female	black or african american	TCGA-L9-A5IP_demographic	Dead	14730	NA	NA	NA	NA	NA	metastasis	49	NA	e453924a-3fa6-43ae-9524-cdb561a0a292	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-L9-A5IP_diagnosis3	NA	Not Reported	TCGA-L9-A5IP_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A5IP_treatment9	NA	Locoregional Site	NA	NA	d5344f6b-fdf9-4f63-a78e-8c9baabb5f62	NA	no	NA	Surgery, NOS
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	25911	NA	NA	NA	NA	NA	metastasis	470	NA	5bbc1e9d-4bae-443e-a249-5367aa03e977	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-J2-8194_diagnosis2	NA	Not Reported	TCGA-J2-8194_diagnosis	NA	NA	NA	NA	518	NA	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment13	NA	Distant Site	NA	NA	186e1424-fdb8-4da9-8fcb-d543f2c5492c	NA	yes	NA	Surgery, NOS
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	25911	NA	NA	NA	NA	NA	metastasis	470	NA	5bbc1e9d-4bae-443e-a249-5367aa03e977	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-J2-8194_diagnosis2	NA	Not Reported	TCGA-J2-8194_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment10	NA	NA	NA	NA	58462eee-a2de-41a0-bea2-7b42ab6e18cd	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	25911	NA	NA	NA	NA	NA	metastasis	470	NA	5bbc1e9d-4bae-443e-a249-5367aa03e977	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-J2-8194_diagnosis2	NA	Not Reported	TCGA-J2-8194_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment11	NA	NA	NA	NA	7dad04cd-45db-471a-9216-e61952a3ff6f	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	25911	NA	NA	NA	NA	NA	metastasis	470	NA	5bbc1e9d-4bae-443e-a249-5367aa03e977	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-J2-8194_diagnosis2	NA	Not Reported	TCGA-J2-8194_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment12	NA	Locoregional Site	NA	NA	8180b2e3-32f7-4e1c-86dc-387e43341d76	NA	no	NA	Surgery, NOS
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	e61e7a12-e213-4b96-88fd-53b69a0b0140	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-J2-8194_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment8	NA	NA	NA	NA	22c7e5c6-8d11-4c64-ab5b-ab9077a95715	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	e61e7a12-e213-4b96-88fd-53b69a0b0140	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-J2-8194_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment9	NA	NA	NA	NA	ddfd3270-d46d-4caa-834c-37f5190e2f8d	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	25441	MX	N0	Stage IIB	T3	7th	primary	0	724.0	edbf63ba-10a3-5800-8ad8-f4e06e596370	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-J2-8194_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	NA	72	NA	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment2	Carboplatin	NA	NA	NA	08436872-ceeb-47ce-8e13-f7fe6f6369a4	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	25441	MX	N0	Stage IIB	T3	7th	primary	0	724.0	edbf63ba-10a3-5800-8ad8-f4e06e596370	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-J2-8194_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	NA	72	NA	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment3	Pemetrexed Disodium	NA	NA	NA	47ddc850-fc8c-4e53-9dc7-d76169d3aed2	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	25441	MX	N0	Stage IIB	T3	7th	primary	0	724.0	edbf63ba-10a3-5800-8ad8-f4e06e596370	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-J2-8194_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	640	597	NA	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment6	Docetaxel	NA	NA	NA	732d7d31-a584-4ac6-9b16-6048615807c3	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	25441	MX	N0	Stage IIB	T3	7th	primary	0	724.0	edbf63ba-10a3-5800-8ad8-f4e06e596370	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-J2-8194_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	584	546	NA	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment4	Carboplatin	NA	NA	NA	7bdc4fc3-1829-41ac-a5cd-9b48d8e1b107	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	25441	MX	N0	Stage IIB	T3	7th	primary	0	724.0	edbf63ba-10a3-5800-8ad8-f4e06e596370	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-J2-8194_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	271	240	NA	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment	NA	Unknown	NA	NA	951c6d62-527e-5490-954d-b27677ed79d6	NA	yes	Unknown	Radiation Therapy, NOS
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	25441	MX	N0	Stage IIB	T3	7th	primary	0	724.0	edbf63ba-10a3-5800-8ad8-f4e06e596370	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-J2-8194_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	584	546	NA	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment5	Gemcitabine	NA	NA	NA	bf02cabb-91b0-4543-9528-7eb83f5deb57	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	2b68b51f-bd4c-4bbb-b4e6-2eead53da2a4	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8194	69	false	United States	-25441	NA	485118d7-fbdd-5b4d-aeda-bcb84afeea51	not hispanic or latino	female	white	TCGA-J2-8194_demographic	Alive	25441	MX	N0	Stage IIB	T3	7th	primary	0	724.0	edbf63ba-10a3-5800-8ad8-f4e06e596370	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-J2-8194_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	NA	663	NA	NA	NA	NA	NA	NA	TCGA-J2-8194_treatment7	Erlotinib	NA	NA	NA	d4e4683c-6b24-4761-8404-d22c2dca5136	NA	yes	Treatment Ongoing	Targeted Molecular Therapy
TCGA-LUAD	2c03141e-a0bd-4e8d-91e4-9744d139ccce	Informed Consent	-23	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-NJ-A4YI	87	false	United States	-31867	4	a4ec21d9-a4c0-5d08-aca4-a4600fa64a42	not reported	female	white	TCGA-NJ-A4YI_demographic	Dead	31867	M0	N2	Stage IIIA	T2	6th	primary	0	4.0	af9c219e-d0fe-509f-b2ac-f55010ecdecd	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-NJ-A4YI_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A4YI_treatment	NA	NA	NA	NA	45ad60ec-e26e-5065-90c2-f13aae187548	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2c03141e-a0bd-4e8d-91e4-9744d139ccce	Informed Consent	-23	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-NJ-A4YI	87	false	United States	-31867	4	a4ec21d9-a4c0-5d08-aca4-a4600fa64a42	not reported	female	white	TCGA-NJ-A4YI_demographic	Dead	31867	M0	N2	Stage IIIA	T2	6th	primary	0	4.0	af9c219e-d0fe-509f-b2ac-f55010ecdecd	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-NJ-A4YI_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A4YI_treatment2	NA	NA	NA	NA	fdac1a35-fe4f-411a-9821-e9f94a217381	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2cd8ea73-cb3f-4b17-9b97-fa12eb03b85b	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8299	61	false	United States	-22626	469	74f32004-7449-59e0-8aef-d1a908075782	not hispanic or latino	female	white	TCGA-55-8299_demographic	Dead	22626	MX	N0	Stage IA	T1b	7th	primary	0	469.0	1124d16c-368e-542e-b2f3-3ef0bb0fba50	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8299_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	320	304	NA	NA	13.0	NA	NA	NA	TCGA-55-8299_treatment	NA	Distant Site	NA	NA	09bb7544-59a7-5f9b-9b18-5cdf8e223391	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	2cd8ea73-cb3f-4b17-9b97-fa12eb03b85b	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8299	61	false	United States	-22626	469	74f32004-7449-59e0-8aef-d1a908075782	not hispanic or latino	female	white	TCGA-55-8299_demographic	Dead	22626	MX	N0	Stage IA	T1b	7th	primary	0	469.0	1124d16c-368e-542e-b2f3-3ef0bb0fba50	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8299_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8299_treatment2	NA	NA	NA	NA	de06afcf-473d-4836-810b-f6c50c7bee99	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2cd8ea73-cb3f-4b17-9b97-fa12eb03b85b	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8299	61	false	United States	-22626	469	74f32004-7449-59e0-8aef-d1a908075782	not hispanic or latino	female	white	TCGA-55-8299_demographic	Dead	22900	NA	NA	NA	NA	NA	metastasis	274	NA	e8b302be-b70a-4a27-9e9c-b77f64d736c6	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8299_diagnosis2	NA	Not Reported	TCGA-55-8299_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8299_treatment3	NA	NA	NA	NA	17effbad-3576-4ab6-b680-7990630d412a	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2cd8ea73-cb3f-4b17-9b97-fa12eb03b85b	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8299	61	false	United States	-22626	469	74f32004-7449-59e0-8aef-d1a908075782	not hispanic or latino	female	white	TCGA-55-8299_demographic	Dead	22900	NA	NA	NA	NA	NA	metastasis	274	NA	e8b302be-b70a-4a27-9e9c-b77f64d736c6	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8299_diagnosis2	NA	Not Reported	TCGA-55-8299_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8299_treatment5	NA	Locoregional Site	NA	NA	1c6c6dc4-8ac4-44fa-8f2e-4e389619a2a1	NA	no	NA	Surgery, NOS
TCGA-LUAD	2cd8ea73-cb3f-4b17-9b97-fa12eb03b85b	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8299	61	false	United States	-22626	469	74f32004-7449-59e0-8aef-d1a908075782	not hispanic or latino	female	white	TCGA-55-8299_demographic	Dead	22900	NA	NA	NA	NA	NA	metastasis	274	NA	e8b302be-b70a-4a27-9e9c-b77f64d736c6	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8299_diagnosis2	NA	Not Reported	TCGA-55-8299_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8299_treatment4	NA	NA	NA	NA	83f8f700-524c-420a-a8f7-7d02b76b0844	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	2cd8ea73-cb3f-4b17-9b97-fa12eb03b85b	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8299	61	false	United States	-22626	469	74f32004-7449-59e0-8aef-d1a908075782	not hispanic or latino	female	white	TCGA-55-8299_demographic	Dead	22900	NA	NA	NA	NA	NA	metastasis	274	NA	e8b302be-b70a-4a27-9e9c-b77f64d736c6	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8299_diagnosis2	NA	Not Reported	TCGA-55-8299_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8299_treatment6	NA	Distant Site	NA	NA	9a31fa89-0cf1-43a3-92bf-db07a1c63955	NA	no	NA	Surgery, NOS
TCGA-LUAD	2db08267-d346-4d42-aac0-b76831903253	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6211	NA	false	Canada	NA	NA	a1c31b47-c1aa-51c4-b868-6e736c2fd25a	not reported	female	not reported	TCGA-75-6211_demographic	Dead	NA	M0	N0	Stage IB	T2	6th	primary	NA	NA	32701a28-c6c0-53d9-87ad-83e700e9af4a	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-75-6211_diagnosis	No	Lung, NOS	NA	2009	NA	1.0	NA	NA	NA	NA	5.0	NA	NA	NA	TCGA-75-6211_treatment	NA	Distant Site	2000	cGy	844513ff-458f-50e4-b8f8-2809f7d21fbf	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	2db08267-d346-4d42-aac0-b76831903253	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6211	NA	false	Canada	NA	NA	a1c31b47-c1aa-51c4-b868-6e736c2fd25a	not reported	female	not reported	TCGA-75-6211_demographic	Dead	NA	M0	N0	Stage IB	T2	6th	primary	NA	NA	32701a28-c6c0-53d9-87ad-83e700e9af4a	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-75-6211_diagnosis	No	Lung, NOS	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6211_treatment2	NA	NA	NA	NA	f0fc5ea1-4e34-4ec4-8045-1c39f8b4b264	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2db08267-d346-4d42-aac0-b76831903253	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6211	NA	false	Canada	NA	NA	a1c31b47-c1aa-51c4-b868-6e736c2fd25a	not reported	female	not reported	TCGA-75-6211_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	bb22ca74-ee22-4467-a1bc-24e5a709192e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-6211_diagnosis2	NA	Not Reported	TCGA-75-6211_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-75-6211_treatment3	NA	NA	NA	NA	10c8e1a0-ec73-4939-8e4d-0791265298f1	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2db08267-d346-4d42-aac0-b76831903253	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6211	NA	false	Canada	NA	NA	a1c31b47-c1aa-51c4-b868-6e736c2fd25a	not reported	female	not reported	TCGA-75-6211_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	bb22ca74-ee22-4467-a1bc-24e5a709192e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-6211_diagnosis2	NA	Not Reported	TCGA-75-6211_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6211_treatment5	NA	Distant Site	NA	NA	5dafd0a2-e82f-4c12-b4f1-081e645bdd4d	NA	no	NA	Surgery, NOS
TCGA-LUAD	2db08267-d346-4d42-aac0-b76831903253	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6211	NA	false	Canada	NA	NA	a1c31b47-c1aa-51c4-b868-6e736c2fd25a	not reported	female	not reported	TCGA-75-6211_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	bb22ca74-ee22-4467-a1bc-24e5a709192e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-6211_diagnosis2	NA	Not Reported	TCGA-75-6211_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-75-6211_treatment4	NA	NA	NA	NA	65d07f2b-179b-4fab-8e5f-623b79be1c09	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	2dca3588-51e1-48f7-8c9b-7b7e53c3fb33	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z053	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	2de1ba51-eae1-4a54-b7cd-d6d739fdc39d	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7149	71	false	Australia	-26285	NA	216dcb98-a462-571b-bcea-fe244b2e7f24	not reported	male	white	TCGA-78-7149_demographic	Alive	26285	M0	N0	Stage IIIB	T4	6th	primary	0	3940.0	1edf6855-04fa-5e2f-b492-b1e6a0a4d7de	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-78-7149_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7149_treatment2	NA	NA	NA	NA	e105fdcf-7db5-44b8-a39e-272a7e9421bf	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2de1ba51-eae1-4a54-b7cd-d6d739fdc39d	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7149	71	false	Australia	-26285	NA	216dcb98-a462-571b-bcea-fe244b2e7f24	not reported	male	white	TCGA-78-7149_demographic	Alive	26285	M0	N0	Stage IIIB	T4	6th	primary	0	3940.0	1edf6855-04fa-5e2f-b492-b1e6a0a4d7de	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-78-7149_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7149_treatment	NA	NA	NA	NA	ed083cb9-0eff-53b2-b6c5-678d7b771999	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2efc156c-464a-4c2f-a854-39fefe32081c	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6987	77	false	United States	-28382	NA	1e8c8a78-b0b8-5708-b2e7-a71608dffa9b	not hispanic or latino	male	white	TCGA-55-6987_demographic	Alive	28382	M0	N0	Stage IA	T1	6th	primary	0	2137.0	10de9d0c-8af2-5d13-b24e-a535f66c71e8	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6987_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6987_treatment2	NA	NA	NA	NA	372a9061-ab0a-4c2e-bb5d-89c1fc39d89d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2efc156c-464a-4c2f-a854-39fefe32081c	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6987	77	false	United States	-28382	NA	1e8c8a78-b0b8-5708-b2e7-a71608dffa9b	not hispanic or latino	male	white	TCGA-55-6987_demographic	Alive	28382	M0	N0	Stage IA	T1	6th	primary	0	2137.0	10de9d0c-8af2-5d13-b24e-a535f66c71e8	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6987_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6987_treatment	NA	NA	NA	NA	5fb6d709-3b07-5675-967b-db1216cf47c6	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2f0710f4-827b-45b2-9b7e-c27385b481a7	Informed Consent	67	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6980	56	false	United States	NA	NA	455823f7-cebf-5b1f-ad79-0313db98beaa	not reported	male	white	TCGA-55-6980_demographic	Alive	NA	M0	N0	Stage IA	T1	6th	primary	0	2109.0	e51edf54-e9d5-53ec-ac36-623ffc7593d0	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-55-6980_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6980_treatment	NA	NA	NA	NA	326c7601-2f8d-53bf-a4a9-19119a75d60c	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2f0710f4-827b-45b2-9b7e-c27385b481a7	Informed Consent	67	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6980	56	false	United States	NA	NA	455823f7-cebf-5b1f-ad79-0313db98beaa	not reported	male	white	TCGA-55-6980_demographic	Alive	NA	M0	N0	Stage IA	T1	6th	primary	0	2109.0	e51edf54-e9d5-53ec-ac36-623ffc7593d0	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-55-6980_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6980_treatment2	NA	NA	NA	NA	96435e2d-02f6-425b-b7f4-9c17a6828d41	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2f09479f-87fc-4c34-8e2c-333e970a3681	Informed Consent	78	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6835	81	false	United States	-29887	NA	0b03a690-750a-5645-85f8-e73456109315	not hispanic or latino	female	white	TCGA-91-6835_demographic	Alive	29887	M0	N0	Stage IA	T1	7th	primary	0	79.0	c0c58186-4b17-5cba-bd56-5de255a664bb	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-91-6835_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6835_treatment	NA	NA	NA	NA	677d1aea-8113-56dc-94ec-a2b5ec871794	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2f09479f-87fc-4c34-8e2c-333e970a3681	Informed Consent	78	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6835	81	false	United States	-29887	NA	0b03a690-750a-5645-85f8-e73456109315	not hispanic or latino	female	white	TCGA-91-6835_demographic	Alive	29887	M0	N0	Stage IA	T1	7th	primary	0	79.0	c0c58186-4b17-5cba-bd56-5de255a664bb	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-91-6835_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6835_treatment2	NA	NA	NA	NA	e908911d-07ce-40a4-b64e-639e04db5e27	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2f1a4b16-104c-40eb-8114-8245847bb716	Informed Consent	34	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-86-8585	57	false	Ukraine	-20918	NA	31d74813-2f4a-5e7b-bc3e-c064092e386f	not hispanic or latino	male	white	TCGA-86-8585_demographic	Alive	20918	M0	N0	Stage IB	T2a	7th	primary	0	353.0	078482c8-5765-5fdc-9dde-3ebc2cc7d9b0	true	NA	NA	C34.1	Left	8230/3	Solid carcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8585_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8585_treatment2	NA	NA	NA	NA	70a3b231-3f7b-4495-b0b1-601d9fe61696	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	2f1a4b16-104c-40eb-8114-8245847bb716	Informed Consent	34	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-86-8585	57	false	Ukraine	-20918	NA	31d74813-2f4a-5e7b-bc3e-c064092e386f	not hispanic or latino	male	white	TCGA-86-8585_demographic	Alive	20918	M0	N0	Stage IB	T2a	7th	primary	0	353.0	078482c8-5765-5fdc-9dde-3ebc2cc7d9b0	true	NA	NA	C34.1	Left	8230/3	Solid carcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8585_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8585_treatment	NA	NA	NA	NA	89e7cc55-43a1-5df1-97a3-120893d1d4fa	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	2fabeb98-05e3-4f55-97f5-fbc675e25a3d	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-8398	55	false	Germany	-20197	444	a9f71f08-7c0e-5370-abd5-ca4916855bd9	not hispanic or latino	male	white	TCGA-62-8398_demographic	Dead	20197	M0	N2	Stage IIIA	T2	6th	primary	0	444.0	ae904d7e-f854-52e2-98fe-0ac8ecf1500e	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-8398_diagnosis	No	Lower lobe, lung	NA	2007	No	NA	113	41	NA	NA	NA	NA	NA	NA	TCGA-62-8398_treatment2	Vinorelbine	NA	NA	NA	48d61904-6863-4c7f-be03-03edb98b0fd9	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	2fabeb98-05e3-4f55-97f5-fbc675e25a3d	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-8398	55	false	Germany	-20197	444	a9f71f08-7c0e-5370-abd5-ca4916855bd9	not hispanic or latino	male	white	TCGA-62-8398_demographic	Dead	20197	M0	N2	Stage IIIA	T2	6th	primary	0	444.0	ae904d7e-f854-52e2-98fe-0ac8ecf1500e	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-8398_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8398_treatment3	NA	NA	NA	NA	e5e7aab9-f188-4b0d-9adf-2486f96ca649	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	2fabeb98-05e3-4f55-97f5-fbc675e25a3d	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-8398	55	false	Germany	-20197	444	a9f71f08-7c0e-5370-abd5-ca4916855bd9	not hispanic or latino	male	white	TCGA-62-8398_demographic	Dead	20197	M0	N2	Stage IIIA	T2	6th	primary	0	444.0	ae904d7e-f854-52e2-98fe-0ac8ecf1500e	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-8398_diagnosis	No	Lower lobe, lung	NA	2007	No	NA	113	41	NA	NA	NA	NA	NA	NA	TCGA-62-8398_treatment	Carboplatin	NA	NA	NA	eedb688c-5766-59ee-be06-c6752a1ef780	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	301ca6e8-7981-4264-b4ae-38f56f7f9225	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T4	68	false	United States	-25052	2617	b528c492-808d-5baf-9f37-068bf6f97bbc	Unknown	female	white	TCGA-MP-A4T4_demographic	Dead	25052	M0	N1	Stage IIB	T2	6th	primary	0	2617.0	4be9a6da-961b-5fe3-99ed-b69c5b1dff39	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4T4_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T4_treatment2	NA	NA	NA	NA	b87ce2d1-87e5-4f3f-bbeb-f8a179fc06b7	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	301ca6e8-7981-4264-b4ae-38f56f7f9225	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T4	68	false	United States	-25052	2617	b528c492-808d-5baf-9f37-068bf6f97bbc	Unknown	female	white	TCGA-MP-A4T4_demographic	Dead	25052	M0	N1	Stage IIB	T2	6th	primary	0	2617.0	4be9a6da-961b-5fe3-99ed-b69c5b1dff39	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4T4_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T4_treatment	NA	NA	NA	NA	cfbedf72-c351-54a6-8f50-7997b6dccc17	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3037e91e-213e-43e3-92e4-2fcd68988bde	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	30f276a8-3a4b-4de8-aea0-7f605d100401	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-A4JP	64	false	United States	-23620	NA	5772671a-b7ce-5d1b-948b-db696dcbee1a	not hispanic or latino	male	asian	TCGA-93-A4JP_demographic	Alive	23620	M1b	NX	Stage IV	TX	7th	primary	0	578.0	e7e8a97c-8b10-5bb3-9de2-f73180293080	true	NA	NA	C34.3	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-93-A4JP_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-A4JP_treatment2	NA	NA	NA	NA	5c96ca7c-a500-4ed8-99e6-a1d30d3e33d5	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	30f276a8-3a4b-4de8-aea0-7f605d100401	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-A4JP	64	false	United States	-23620	NA	5772671a-b7ce-5d1b-948b-db696dcbee1a	not hispanic or latino	male	asian	TCGA-93-A4JP_demographic	Alive	23620	M1b	NX	Stage IV	TX	7th	primary	0	578.0	e7e8a97c-8b10-5bb3-9de2-f73180293080	true	NA	NA	C34.3	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-93-A4JP_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	101	17	NA	NA	NA	NA	NA	NA	TCGA-93-A4JP_treatment	Carboplatin	NA	NA	NA	af5a7abc-dfa5-52b7-8e6b-67a609247848	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	30f276a8-3a4b-4de8-aea0-7f605d100401	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-A4JP	64	false	United States	-23620	NA	5772671a-b7ce-5d1b-948b-db696dcbee1a	not hispanic or latino	male	asian	TCGA-93-A4JP_demographic	Alive	24117	NA	NA	NA	NA	NA	metastasis	497	NA	e9877a51-0f04-45a5-9b8d-4e47056afe6d	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-93-A4JP_diagnosis2	NA	Not Reported	TCGA-93-A4JP_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-A4JP_treatment5	NA	Distant Site	NA	NA	41958bb6-a6c5-46e1-b80b-cc11bd67d264	NA	no	NA	Surgery, NOS
TCGA-LUAD	30f276a8-3a4b-4de8-aea0-7f605d100401	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-A4JP	64	false	United States	-23620	NA	5772671a-b7ce-5d1b-948b-db696dcbee1a	not hispanic or latino	male	asian	TCGA-93-A4JP_demographic	Alive	24117	NA	NA	NA	NA	NA	metastasis	497	NA	e9877a51-0f04-45a5-9b8d-4e47056afe6d	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-93-A4JP_diagnosis2	NA	Not Reported	TCGA-93-A4JP_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-93-A4JP_treatment3	NA	NA	NA	NA	a144589e-dbb0-4043-9618-46d2616640a9	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	30f276a8-3a4b-4de8-aea0-7f605d100401	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-A4JP	64	false	United States	-23620	NA	5772671a-b7ce-5d1b-948b-db696dcbee1a	not hispanic or latino	male	asian	TCGA-93-A4JP_demographic	Alive	24117	NA	NA	NA	NA	NA	metastasis	497	NA	e9877a51-0f04-45a5-9b8d-4e47056afe6d	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-93-A4JP_diagnosis2	NA	Not Reported	TCGA-93-A4JP_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-93-A4JP_treatment4	NA	NA	NA	NA	f4a77c08-c88c-4200-9a0f-58c2077f6516	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	3136b041-24b9-42c5-b4a8-70f04c63a177	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	31458638-e19c-43e5-ab13-9c64b3b3681d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-S2-AA1A	68	false	United States	-24903	NA	e4fee1c1-f2fd-5901-9d8b-b450bcd06794	not hispanic or latino	female	black or african american	TCGA-S2-AA1A_demographic	Alive	24903	M0	N0	Stage IA	T1b	7th	primary	0	513.0	2f09467b-ba83-5054-952e-d2b377a72e27	true	NA	NA	C34.1	Right	8253/3	Bronchio-alveolar carcinoma, mucinous	no	No	R0	Lung, NOS	NA	TCGA-S2-AA1A_diagnosis	No	Upper lobe, lung	NA	2013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-S2-AA1A_treatment2	NA	NA	NA	NA	db84b6b8-ee99-4d3f-b7d9-3ad900dacc30	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	31458638-e19c-43e5-ab13-9c64b3b3681d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-S2-AA1A	68	false	United States	-24903	NA	e4fee1c1-f2fd-5901-9d8b-b450bcd06794	not hispanic or latino	female	black or african american	TCGA-S2-AA1A_demographic	Alive	24903	M0	N0	Stage IA	T1b	7th	primary	0	513.0	2f09467b-ba83-5054-952e-d2b377a72e27	true	NA	NA	C34.1	Right	8253/3	Bronchio-alveolar carcinoma, mucinous	no	No	R0	Lung, NOS	NA	TCGA-S2-AA1A_diagnosis	No	Upper lobe, lung	NA	2013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-S2-AA1A_treatment	NA	NA	NA	NA	ddf6340b-dc17-5596-af41-5eb342f52390	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3199cfe5-3be3-43cd-a36b-5cf2c7a9929f	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5066	72	false	United States	-26385	NA	3b5f1bce-4312-57de-a2df-7924103c370e	not hispanic or latino	male	black or african american	TCGA-50-5066_demographic	Alive	26862	NA	NA	NA	NA	NA	metastasis	477	NA	0af6d9d1-a2ad-4056-8ccd-7a53e9645013	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5066_diagnosis2	NA	Not Reported	TCGA-50-5066_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5066_treatment7	NA	Locoregional Site	NA	NA	0289995d-a5a3-4eb5-9b87-b209333d1f07	NA	no	NA	Surgery, NOS
TCGA-LUAD	3199cfe5-3be3-43cd-a36b-5cf2c7a9929f	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5066	72	false	United States	-26385	NA	3b5f1bce-4312-57de-a2df-7924103c370e	not hispanic or latino	male	black or african american	TCGA-50-5066_demographic	Alive	26862	NA	NA	NA	NA	NA	metastasis	477	NA	0af6d9d1-a2ad-4056-8ccd-7a53e9645013	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5066_diagnosis2	NA	Not Reported	TCGA-50-5066_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5066_treatment6	NA	NA	NA	NA	1c996b2e-66a6-41e0-bd89-f1eed3948846	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3199cfe5-3be3-43cd-a36b-5cf2c7a9929f	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5066	72	false	United States	-26385	NA	3b5f1bce-4312-57de-a2df-7924103c370e	not hispanic or latino	male	black or african american	TCGA-50-5066_demographic	Alive	26862	NA	NA	NA	NA	NA	metastasis	477	NA	0af6d9d1-a2ad-4056-8ccd-7a53e9645013	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5066_diagnosis2	NA	Not Reported	TCGA-50-5066_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5066_treatment5	NA	NA	NA	NA	3c1affca-0a37-42b2-b172-1891b627d56f	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3199cfe5-3be3-43cd-a36b-5cf2c7a9929f	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5066	72	false	United States	-26385	NA	3b5f1bce-4312-57de-a2df-7924103c370e	not hispanic or latino	male	black or african american	TCGA-50-5066_demographic	Alive	26862	NA	NA	NA	NA	NA	metastasis	477	NA	0af6d9d1-a2ad-4056-8ccd-7a53e9645013	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5066_diagnosis2	NA	Not Reported	TCGA-50-5066_diagnosis	NA	NA	NA	NA	598	NA	NA	NA	NA	NA	NA	TCGA-50-5066_treatment8	NA	Distant Site	NA	NA	c2d9be84-d051-4686-8fa4-768c885d9e88	NA	yes	NA	Surgery, NOS
TCGA-LUAD	3199cfe5-3be3-43cd-a36b-5cf2c7a9929f	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5066	72	false	United States	-26385	NA	3b5f1bce-4312-57de-a2df-7924103c370e	not hispanic or latino	male	black or african american	TCGA-50-5066_demographic	Alive	26385	M0	N0	Stage IB	T2	6th	primary	0	1442.0	1f05d063-3131-5940-9bcf-cdff4c7391d4	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-5066_diagnosis	No	Upper lobe, lung	NA	2009	No	NA	567	508	NA	NA	NA	NA	NA	NA	TCGA-50-5066_treatment	Carboplatin	NA	NA	NA	34b88baa-fe17-5f2b-ac77-f7d9b52cb01a	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	3199cfe5-3be3-43cd-a36b-5cf2c7a9929f	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5066	72	false	United States	-26385	NA	3b5f1bce-4312-57de-a2df-7924103c370e	not hispanic or latino	male	black or african american	TCGA-50-5066_demographic	Alive	26385	M0	N0	Stage IB	T2	6th	primary	0	1442.0	1f05d063-3131-5940-9bcf-cdff4c7391d4	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-5066_diagnosis	No	Upper lobe, lung	NA	2009	No	NA	567	508	NA	NA	NA	NA	NA	NA	TCGA-50-5066_treatment2	Paclitaxel	NA	NA	NA	b8903c9b-8b97-433d-86a6-9ffc93fac2eb	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	3199cfe5-3be3-43cd-a36b-5cf2c7a9929f	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5066	72	false	United States	-26385	NA	3b5f1bce-4312-57de-a2df-7924103c370e	not hispanic or latino	male	black or african american	TCGA-50-5066_demographic	Alive	26385	M0	N0	Stage IB	T2	6th	primary	0	1442.0	1f05d063-3131-5940-9bcf-cdff4c7391d4	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-5066_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5066_treatment4	NA	NA	NA	NA	e801909e-7d4a-4eba-8fda-96e5159c1f97	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3199cfe5-3be3-43cd-a36b-5cf2c7a9929f	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5066	72	false	United States	-26385	NA	3b5f1bce-4312-57de-a2df-7924103c370e	not hispanic or latino	male	black or african american	TCGA-50-5066_demographic	Alive	26385	M0	N0	Stage IB	T2	6th	primary	0	1442.0	1f05d063-3131-5940-9bcf-cdff4c7391d4	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-5066_diagnosis	No	Upper lobe, lung	NA	2009	No	NA	567	508	NA	NA	NA	NA	NA	NA	TCGA-50-5066_treatment3	Bevacizumab	NA	NA	NA	f3b60e37-4326-4f36-88f7-856d43901d82	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	31c96e35-5e2f-429c-b12a-7bc5a497a300	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4398	47	false	Germany	-17471	NA	983b8254-3ed9-5282-9e65-52ab01cf7cf3	not reported	female	not reported	TCGA-05-4398_demographic	Alive	17471	M0	N3	Stage IIIB	T4	5th	primary	0	1431.0	1610896c-b01c-5504-8b62-888c8765fd8c	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4398_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4398_treatment3	NA	NA	NA	NA	11f07c19-650f-4628-a121-75561f1371d7	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	31c96e35-5e2f-429c-b12a-7bc5a497a300	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4398	47	false	Germany	-17471	NA	983b8254-3ed9-5282-9e65-52ab01cf7cf3	not reported	female	not reported	TCGA-05-4398_demographic	Alive	17471	M0	N3	Stage IIIB	T4	5th	primary	0	1431.0	1610896c-b01c-5504-8b62-888c8765fd8c	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4398_diagnosis	No	Upper lobe, lung	NA	2006	No	NA	92	0	NA	NA	NA	NA	NA	NA	TCGA-05-4398_treatment2	Etoposide	NA	NA	NA	1dc6a4f3-b2b4-4f1a-ae8c-f7591d6958e3	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	31c96e35-5e2f-429c-b12a-7bc5a497a300	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4398	47	false	Germany	-17471	NA	983b8254-3ed9-5282-9e65-52ab01cf7cf3	not reported	female	not reported	TCGA-05-4398_demographic	Alive	17471	M0	N3	Stage IIIB	T4	5th	primary	0	1431.0	1610896c-b01c-5504-8b62-888c8765fd8c	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4398_diagnosis	No	Upper lobe, lung	NA	2006	No	NA	92	0	NA	NA	NA	NA	NA	NA	TCGA-05-4398_treatment	Carboplatin	NA	NA	NA	440e3191-97d7-57a5-b6b7-113ee1d7ea5f	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	31ff69b5-9e58-44da-8326-bdfc7ee495c4	Informed Consent	-18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M6	45	false	United States	-16764	NA	ca17a86b-7423-5e2b-a843-2199a3b89d62	not hispanic or latino	female	white	TCGA-97-A4M6_demographic	Alive	16764	M0	N0	Stage IA	T1a	7th	primary	0	568.0	79b1427f-979b-5284-9661-a18c237f8b32	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-A4M6_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M6_treatment2	NA	NA	NA	NA	58098e76-c754-4a3b-8e05-e983535cf6f1	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	31ff69b5-9e58-44da-8326-bdfc7ee495c4	Informed Consent	-18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M6	45	false	United States	-16764	NA	ca17a86b-7423-5e2b-a843-2199a3b89d62	not hispanic or latino	female	white	TCGA-97-A4M6_demographic	Alive	16764	M0	N0	Stage IA	T1a	7th	primary	0	568.0	79b1427f-979b-5284-9661-a18c237f8b32	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-A4M6_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M6_treatment	NA	NA	NA	NA	d3f6b4f9-530e-56ab-a27b-f59e6bc3f909	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	32592562-11fa-435a-b40b-2b242bae53aa	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-6214	NA	false	Canada	NA	1115	f7e66da1-3d10-5cf1-9152-9fb12dd7d505	not reported	female	not reported	TCGA-75-6214_demographic	Dead	NA	NA	NA	NA	NA	NA	metastasis	419	NA	762360cf-a876-48f7-882e-54047bf5a703	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-6214_diagnosis2	NA	Not Reported	TCGA-75-6214_diagnosis	NA	NA	NA	NA	524	NA	NA	NA	NA	NA	NA	TCGA-75-6214_treatment5	NA	Distant Site	NA	NA	14387738-3f29-438f-b1e3-d7a82e5b83c6	NA	yes	NA	Surgery, NOS
TCGA-LUAD	32592562-11fa-435a-b40b-2b242bae53aa	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-6214	NA	false	Canada	NA	1115	f7e66da1-3d10-5cf1-9152-9fb12dd7d505	not reported	female	not reported	TCGA-75-6214_demographic	Dead	NA	NA	NA	NA	NA	NA	metastasis	419	NA	762360cf-a876-48f7-882e-54047bf5a703	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-6214_diagnosis2	NA	Not Reported	TCGA-75-6214_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-75-6214_treatment3	NA	NA	NA	NA	9ecd5233-326c-453a-9edc-783d7314791f	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	32592562-11fa-435a-b40b-2b242bae53aa	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-6214	NA	false	Canada	NA	1115	f7e66da1-3d10-5cf1-9152-9fb12dd7d505	not reported	female	not reported	TCGA-75-6214_demographic	Dead	NA	NA	NA	NA	NA	NA	metastasis	419	NA	762360cf-a876-48f7-882e-54047bf5a703	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-6214_diagnosis2	NA	Not Reported	TCGA-75-6214_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-75-6214_treatment4	NA	NA	NA	NA	cef54865-30b6-464f-b74a-59c70deba400	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	32592562-11fa-435a-b40b-2b242bae53aa	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-6214	NA	false	Canada	NA	1115	f7e66da1-3d10-5cf1-9152-9fb12dd7d505	not reported	female	not reported	TCGA-75-6214_demographic	Dead	NA	M0	N2	Stage IIIA	T2	6th	primary	NA	1115.0	cfb2c98a-8d39-51da-be16-ca3bc885942b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6214_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6214_treatment2	NA	NA	NA	NA	b276b372-635d-46f6-bf5f-2fb052f015de	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	32592562-11fa-435a-b40b-2b242bae53aa	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-6214	NA	false	Canada	NA	1115	f7e66da1-3d10-5cf1-9152-9fb12dd7d505	not reported	female	not reported	TCGA-75-6214_demographic	Dead	NA	M0	N2	Stage IIIA	T2	6th	primary	NA	1115.0	cfb2c98a-8d39-51da-be16-ca3bc885942b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6214_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6214_treatment	NA	NA	NA	NA	e3ba2da0-87b6-5459-abcb-2ef9aa2e4f87	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	32a7b827-c3f9-4607-ae63-dae8caa2bc97	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L4-A4E5	48	false	United States	-17680	NA	e6a231ed-e267-5fe6-80e1-86f3c660f507	not hispanic or latino	female	white	TCGA-L4-A4E5_demographic	Alive	17680	M0	N0	Stage I	T1	7th	primary	0	578.0	3499c77e-1d25-5ea3-9465-94216b079e8c	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-L4-A4E5_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L4-A4E5_treatment2	NA	NA	NA	NA	3c8abcfc-e75c-4355-98cb-c7fc689fa39e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	32a7b827-c3f9-4607-ae63-dae8caa2bc97	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L4-A4E5	48	false	United States	-17680	NA	e6a231ed-e267-5fe6-80e1-86f3c660f507	not hispanic or latino	female	white	TCGA-L4-A4E5_demographic	Alive	17680	M0	N0	Stage I	T1	7th	primary	0	578.0	3499c77e-1d25-5ea3-9465-94216b079e8c	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-L4-A4E5_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L4-A4E5_treatment	NA	NA	NA	NA	f8ba718a-9bb6-5b06-a79a-ec74471a4b54	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	32d9935a-f5cd-43b3-88bd-09e6e2b9090d	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48X	63	false	United States	-23341	NA	e095eb8f-faff-502b-bb15-4ff105080ba0	not hispanic or latino	female	white	TCGA-55-A48X_demographic	Alive	23956	NA	NA	NA	NA	NA	Subsequent Primary	615	NA	3bc2b8cc-af9f-4310-9aef-c0ab6a9429cd	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-A48X_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	615	NA	NA	NA	NA	NA	NA	TCGA-55-A48X_treatment9	NA	Locoregional Site	NA	NA	335fd035-a921-45d4-a9a7-f4b0832b307a	NA	yes	NA	Surgery, NOS
TCGA-LUAD	32d9935a-f5cd-43b3-88bd-09e6e2b9090d	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48X	63	false	United States	-23341	NA	e095eb8f-faff-502b-bb15-4ff105080ba0	not hispanic or latino	female	white	TCGA-55-A48X_demographic	Alive	23956	NA	NA	NA	NA	NA	Subsequent Primary	615	NA	3bc2b8cc-af9f-4310-9aef-c0ab6a9429cd	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-A48X_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-55-A48X_treatment7	NA	NA	NA	NA	56f67477-3128-4449-8c27-0572ecbfd163	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	32d9935a-f5cd-43b3-88bd-09e6e2b9090d	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48X	63	false	United States	-23341	NA	e095eb8f-faff-502b-bb15-4ff105080ba0	not hispanic or latino	female	white	TCGA-55-A48X_demographic	Alive	23956	NA	NA	NA	NA	NA	Subsequent Primary	615	NA	3bc2b8cc-af9f-4310-9aef-c0ab6a9429cd	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-A48X_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-55-A48X_treatment8	NA	NA	NA	NA	efee634b-8c85-4930-93ca-2339b797313b	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	32d9935a-f5cd-43b3-88bd-09e6e2b9090d	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48X	63	false	United States	-23341	NA	e095eb8f-faff-502b-bb15-4ff105080ba0	not hispanic or latino	female	white	TCGA-55-A48X_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	992bf7c1-7266-4408-8e7a-37f3ae92d686	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-A48X_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A48X_treatment5	NA	Locoregional Site	NA	NA	56956bd2-64f0-41bf-bc32-1701fbcd80bf	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	32d9935a-f5cd-43b3-88bd-09e6e2b9090d	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48X	63	false	United States	-23341	NA	e095eb8f-faff-502b-bb15-4ff105080ba0	not hispanic or latino	female	white	TCGA-55-A48X_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	992bf7c1-7266-4408-8e7a-37f3ae92d686	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-A48X_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A48X_treatment4	NA	NA	NA	NA	c8d1dc2a-640f-4fba-be57-691d6fce6807	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	32d9935a-f5cd-43b3-88bd-09e6e2b9090d	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48X	63	false	United States	-23341	NA	e095eb8f-faff-502b-bb15-4ff105080ba0	not hispanic or latino	female	white	TCGA-55-A48X_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	992bf7c1-7266-4408-8e7a-37f3ae92d686	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-A48X_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A48X_treatment6	NA	NA	NA	NA	c97972bd-05a0-40d0-b28f-67ea7dc4d6a6	NA	yes	NA	Surgery, NOS
TCGA-LUAD	32d9935a-f5cd-43b3-88bd-09e6e2b9090d	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48X	63	false	United States	-23341	NA	e095eb8f-faff-502b-bb15-4ff105080ba0	not hispanic or latino	female	white	TCGA-55-A48X_demographic	Alive	23341	M0	N1	Stage IIA	T1b	7th	primary	0	689.0	b40b0b2e-be0a-5a95-a43a-518b8311f611	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-A48X_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	150	66	NA	NA	NA	NA	NA	NA	TCGA-55-A48X_treatment2	Pemetrexed Disodium	NA	NA	NA	72e018ca-8c9e-43d5-9d20-ab881e2009dd	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	32d9935a-f5cd-43b3-88bd-09e6e2b9090d	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48X	63	false	United States	-23341	NA	e095eb8f-faff-502b-bb15-4ff105080ba0	not hispanic or latino	female	white	TCGA-55-A48X_demographic	Alive	23341	M0	N1	Stage IIA	T1b	7th	primary	0	689.0	b40b0b2e-be0a-5a95-a43a-518b8311f611	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-A48X_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A48X_treatment3	NA	NA	NA	NA	896771bb-9562-4fea-86d4-fcc9d4a4f454	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	32d9935a-f5cd-43b3-88bd-09e6e2b9090d	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A48X	63	false	United States	-23341	NA	e095eb8f-faff-502b-bb15-4ff105080ba0	not hispanic or latino	female	white	TCGA-55-A48X_demographic	Alive	23341	M0	N1	Stage IIA	T1b	7th	primary	0	689.0	b40b0b2e-be0a-5a95-a43a-518b8311f611	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-A48X_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	160	66	NA	NA	NA	NA	NA	NA	TCGA-55-A48X_treatment	Carboplatin	NA	NA	NA	f4f5773c-c84a-5424-9f37-be733d29a815	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	33c71ead-4c2a-476d-85ef-885dbbfc2cbd	Informed Consent	36	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6774	56	false	United States	-20462	NA	955fd29d-7a28-5c9a-a5f1-6ef7a891dcd1	not hispanic or latino	female	white	TCGA-44-6774_demographic	Alive	20462	M0	N2	Stage IIIA	T1	7th	primary	0	658.0	fd8ad6ea-9ebc-57d4-8d4a-5d07d5b69bf5	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6774_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	154	133	NA	2	NA	NA	NA	Intravenous	TCGA-44-6774_treatment3	Carboplatin	NA	1085	mg	67fe17fa-6053-4b8a-a6a9-957b4ea4e477	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	33c71ead-4c2a-476d-85ef-885dbbfc2cbd	Informed Consent	36	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6774	56	false	United States	-20462	NA	955fd29d-7a28-5c9a-a5f1-6ef7a891dcd1	not hispanic or latino	female	white	TCGA-44-6774_demographic	Alive	20462	M0	N2	Stage IIIA	T1	7th	primary	0	658.0	fd8ad6ea-9ebc-57d4-8d4a-5d07d5b69bf5	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6774_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	112	91	NA	2	NA	150.0	mg	Intravenous	TCGA-44-6774_treatment4	Cisplatin	NA	300	mg	889c539a-c1a4-4b04-a023-429ee401fe10	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	33c71ead-4c2a-476d-85ef-885dbbfc2cbd	Informed Consent	36	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6774	56	false	United States	-20462	NA	955fd29d-7a28-5c9a-a5f1-6ef7a891dcd1	not hispanic or latino	female	white	TCGA-44-6774_demographic	Alive	20462	M0	N2	Stage IIIA	T1	7th	primary	0	658.0	fd8ad6ea-9ebc-57d4-8d4a-5d07d5b69bf5	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6774_diagnosis	No	Lower lobe, lung	NA	2011	NA	1.0	228	193	NA	NA	25.0	NA	NA	NA	TCGA-44-6774_treatment	NA	Primary Tumor Field	5000	cGy	ab06adbc-c878-5a8e-9bfe-6065eef72362	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	33c71ead-4c2a-476d-85ef-885dbbfc2cbd	Informed Consent	36	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6774	56	false	United States	-20462	NA	955fd29d-7a28-5c9a-a5f1-6ef7a891dcd1	not hispanic or latino	female	white	TCGA-44-6774_demographic	Alive	20462	M0	N2	Stage IIIA	T1	7th	primary	0	658.0	fd8ad6ea-9ebc-57d4-8d4a-5d07d5b69bf5	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6774_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	154	91	NA	4	NA	1000.0	mg	Intravenous	TCGA-44-6774_treatment2	Pemetrexed Disodium	NA	4000	mg	ac58b47e-c695-4b63-86c3-815b7b8e56c0	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	33e3f736-7990-4f7a-ac35-863247566541	Informed Consent	123	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-5423	65	false	Germany	-23863	NA	f1d0f75a-b1b1-59d3-bdea-5d26cfc5003f	not reported	male	not reported	TCGA-05-5423_demographic	Alive	23863	M0	N1	Stage IIB	T2	6th	primary	0	151.0	0f0eeb38-d54e-579f-972e-fd361e4ac218	true	NA	NA	C34.9	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-5423_diagnosis	No	Lung, NOS	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	34040b83-7e8a-4264-a551-b16621843e28	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4244	70	false	Germany	-25752	NA	139ab7b9-af85-58e3-ac01-933eeae4afb9	not reported	male	not reported	TCGA-05-4244_demographic	Alive	25752	M1	N2	Stage IV	T2	6th	primary	0	0.0	71222be8-573b-5d40-a15e-57649e0aec0a	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-05-4244_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	3434b91a-c05f-460f-a078-7b1bb6e7085d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4382	68	false	Germany	-24868	NA	c2f0c511-8275-502d-b819-2405c10d0fbd	not reported	male	not reported	TCGA-05-4382_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	190a3da6-fa47-4eb4-94a1-8f0a7f306288	false	NA	NA	NA	NA	8010/2	Carcinoma in situ, NOS	NA	NA	NA	Not Reported	NA	TCGA-05-4382_diagnosis3	NA	Penis, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4382_treatment4	NA	NA	NA	NA	96d68007-c81d-4378-ac29-f29184ed92b7	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3434b91a-c05f-460f-a078-7b1bb6e7085d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4382	68	false	Germany	-24868	NA	c2f0c511-8275-502d-b819-2405c10d0fbd	not reported	male	not reported	TCGA-05-4382_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	190a3da6-fa47-4eb4-94a1-8f0a7f306288	false	NA	NA	NA	NA	8010/2	Carcinoma in situ, NOS	NA	NA	NA	Not Reported	NA	TCGA-05-4382_diagnosis3	NA	Penis, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4382_treatment3	NA	NA	NA	NA	b19b4cc8-4396-46dc-8887-0c3412249332	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3434b91a-c05f-460f-a078-7b1bb6e7085d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4382	68	false	Germany	-24868	NA	c2f0c511-8275-502d-b819-2405c10d0fbd	not reported	male	not reported	TCGA-05-4382_demographic	Alive	25202	NA	NA	NA	NA	NA	metastasis	334	NA	8f12ece1-7eaa-45d5-9a40-c034e8f9ce21	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-05-4382_diagnosis2	NA	Not Reported	TCGA-05-4382_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-05-4382_treatment5	NA	NA	NA	NA	01394bbf-c968-41d8-8132-a414aa9063c9	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3434b91a-c05f-460f-a078-7b1bb6e7085d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4382	68	false	Germany	-24868	NA	c2f0c511-8275-502d-b819-2405c10d0fbd	not reported	male	not reported	TCGA-05-4382_demographic	Alive	25202	NA	NA	NA	NA	NA	metastasis	334	NA	8f12ece1-7eaa-45d5-9a40-c034e8f9ce21	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-05-4382_diagnosis2	NA	Not Reported	TCGA-05-4382_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-05-4382_treatment6	NA	NA	NA	NA	dc52dee0-c3f2-4a81-932f-cc41ae558635	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	3434b91a-c05f-460f-a078-7b1bb6e7085d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4382	68	false	Germany	-24868	NA	c2f0c511-8275-502d-b819-2405c10d0fbd	not reported	male	not reported	TCGA-05-4382_demographic	Alive	24868	M0	N0	Stage IB	T2	6th	primary	0	607.0	eece3e4c-7790-5d2a-bfa5-68bfb23ab769	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-05-4382_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4382_treatment2	NA	NA	NA	NA	07b4a0bb-66af-4953-bdf7-6151b8656148	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3434b91a-c05f-460f-a078-7b1bb6e7085d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4382	68	false	Germany	-24868	NA	c2f0c511-8275-502d-b819-2405c10d0fbd	not reported	male	not reported	TCGA-05-4382_demographic	Alive	24868	M0	N0	Stage IB	T2	6th	primary	0	607.0	eece3e4c-7790-5d2a-bfa5-68bfb23ab769	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-05-4382_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	393	365	NA	NA	NA	NA	NA	NA	TCGA-05-4382_treatment	NA	Distant Site	NA	NA	4f8e2c3e-77c1-5313-967b-0eac6e3fafac	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	345aef28-d49b-491b-a337-b1ac55c37d35	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M2	66	false	United States	-24313	NA	7c805bb3-1050-5a84-8739-51ca25988358	not hispanic or latino	male	white	TCGA-97-A4M2_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	2a1f7c44-9c23-45d1-af80-83ff5072dd3c	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-97-A4M2_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M2_treatment4	NA	NA	NA	NA	28a68e7d-3c41-4f8b-b401-1b0889258955	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	345aef28-d49b-491b-a337-b1ac55c37d35	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M2	66	false	United States	-24313	NA	7c805bb3-1050-5a84-8739-51ca25988358	not hispanic or latino	male	white	TCGA-97-A4M2_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	2a1f7c44-9c23-45d1-af80-83ff5072dd3c	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-97-A4M2_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M2_treatment5	NA	NA	NA	NA	542b2c57-81ca-4b75-9a79-4dad795fb22d	NA	yes	NA	Surgery, NOS
TCGA-LUAD	345aef28-d49b-491b-a337-b1ac55c37d35	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M2	66	false	United States	-24313	NA	7c805bb3-1050-5a84-8739-51ca25988358	not hispanic or latino	male	white	TCGA-97-A4M2_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	2a1f7c44-9c23-45d1-af80-83ff5072dd3c	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-97-A4M2_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M2_treatment3	NA	NA	NA	NA	871b45c0-1ca9-413c-b7fa-c953f2dc5c6c	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	345aef28-d49b-491b-a337-b1ac55c37d35	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M2	66	false	United States	-24313	NA	7c805bb3-1050-5a84-8739-51ca25988358	not hispanic or latino	male	white	TCGA-97-A4M2_demographic	Alive	24313	M0	N0	Stage IA	T1a	7th	primary	0	624.0	5fa9e24c-3e7a-5caf-959f-9951e9916040	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-97-A4M2_diagnosis	No	Middle lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M2_treatment	NA	NA	NA	NA	24361b72-8b36-5ad1-b6bc-b1d2d8a82655	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	345aef28-d49b-491b-a337-b1ac55c37d35	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M2	66	false	United States	-24313	NA	7c805bb3-1050-5a84-8739-51ca25988358	not hispanic or latino	male	white	TCGA-97-A4M2_demographic	Alive	24313	M0	N0	Stage IA	T1a	7th	primary	0	624.0	5fa9e24c-3e7a-5caf-959f-9951e9916040	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-97-A4M2_diagnosis	No	Middle lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M2_treatment2	NA	NA	NA	NA	db2ebcde-26b4-447d-8240-3bc702f448c4	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	349e6f38-2c67-4a69-a777-b9173a2a27cf	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-6777	85	false	United States	-31234	987	d5a9284a-4c59-524e-b16a-034372f38c0a	not reported	female	white	TCGA-44-6777_demographic	Dead	31234	MX	NX	Stage IB	T2	6th	primary	0	987.0	80c9783a-3449-5a05-80c7-8b3d3ae0529b	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6777_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6777_treatment2	NA	NA	NA	NA	0fd639d6-f368-4a5d-b124-a4ccd5e4e9c8	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	349e6f38-2c67-4a69-a777-b9173a2a27cf	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-6777	85	false	United States	-31234	987	d5a9284a-4c59-524e-b16a-034372f38c0a	not reported	female	white	TCGA-44-6777_demographic	Dead	31234	MX	NX	Stage IB	T2	6th	primary	0	987.0	80c9783a-3449-5a05-80c7-8b3d3ae0529b	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6777_diagnosis	No	Upper lobe, lung	NA	2006	NA	1.0	356	306	NA	NA	37.0	NA	NA	NA	TCGA-44-6777_treatment	NA	Primary Tumor Field	7400	cGy	d55cde2d-062f-5c82-b5d1-81ac644fc120	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	34d8e84e-c3e1-417d-8b9b-8563d9fa0f8e	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8055	79	false	Russia	-29124	124	0b1ac271-b27c-5146-b73c-32bf223229c8	not hispanic or latino	male	white	TCGA-86-8055_demographic	Dead	29124	M0	N1	Stage IIA	T2a	7th	primary	0	124.0	04088d4f-55ec-5c32-9dc1-eb6af85f2883	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8055_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8055_treatment2	NA	NA	NA	NA	32c05cf8-a0b4-4707-8d83-c2c5a0dc5d7e	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	34d8e84e-c3e1-417d-8b9b-8563d9fa0f8e	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8055	79	false	Russia	-29124	124	0b1ac271-b27c-5146-b73c-32bf223229c8	not hispanic or latino	male	white	TCGA-86-8055_demographic	Dead	29124	M0	N1	Stage IIA	T2a	7th	primary	0	124.0	04088d4f-55ec-5c32-9dc1-eb6af85f2883	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8055_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8055_treatment	NA	NA	NA	NA	9f084500-14eb-5579-9023-a19935ebdc6f	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	35cb7841-9b09-465a-90c5-e3b8a9faad49	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6982	79	false	United States	NA	995	0fe268b0-fcba-5ee9-a593-d484d7e9324d	not reported	female	white	TCGA-55-6982_demographic	Dead	NA	NA	NA	NA	NA	NA	metastasis	183	NA	70d56cb8-2dd8-49e2-b31c-6f9d552d1f90	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-6982_diagnosis2	NA	Not Reported	TCGA-55-6982_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-6982_treatment6	NA	NA	NA	NA	1b022c96-dd6a-41f2-bcab-59f42240901e	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	35cb7841-9b09-465a-90c5-e3b8a9faad49	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6982	79	false	United States	NA	995	0fe268b0-fcba-5ee9-a593-d484d7e9324d	not reported	female	white	TCGA-55-6982_demographic	Dead	NA	NA	NA	NA	NA	NA	metastasis	183	NA	70d56cb8-2dd8-49e2-b31c-6f9d552d1f90	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-6982_diagnosis2	NA	Not Reported	TCGA-55-6982_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6982_treatment7	NA	Locoregional Site	NA	NA	bdf2eb30-597e-452e-ae70-4c98788b960c	NA	no	NA	Surgery, NOS
TCGA-LUAD	35cb7841-9b09-465a-90c5-e3b8a9faad49	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6982	79	false	United States	NA	995	0fe268b0-fcba-5ee9-a593-d484d7e9324d	not reported	female	white	TCGA-55-6982_demographic	Dead	NA	NA	NA	NA	NA	NA	metastasis	183	NA	70d56cb8-2dd8-49e2-b31c-6f9d552d1f90	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-6982_diagnosis2	NA	Not Reported	TCGA-55-6982_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-6982_treatment5	NA	NA	NA	NA	be889221-2628-4bc0-b824-24d791d5d4bc	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	35cb7841-9b09-465a-90c5-e3b8a9faad49	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6982	79	false	United States	NA	995	0fe268b0-fcba-5ee9-a593-d484d7e9324d	not reported	female	white	TCGA-55-6982_demographic	Dead	NA	NA	NA	NA	NA	NA	metastasis	183	NA	70d56cb8-2dd8-49e2-b31c-6f9d552d1f90	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-6982_diagnosis2	NA	Not Reported	TCGA-55-6982_diagnosis	NA	NA	NA	NA	183	NA	NA	NA	NA	NA	NA	TCGA-55-6982_treatment8	NA	Distant Site	NA	NA	f4699a36-111c-4d17-b5be-f009e09a3e5c	NA	yes	NA	Surgery, NOS
TCGA-LUAD	35cb7841-9b09-465a-90c5-e3b8a9faad49	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6982	79	false	United States	NA	995	0fe268b0-fcba-5ee9-a593-d484d7e9324d	not reported	female	white	TCGA-55-6982_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	0	995.0	78008708-c100-5080-8d97-4666f0840a4b	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6982_diagnosis	No	Lower lobe, lung	NA	2004	No	NA	NA	397	NA	NA	NA	NA	NA	NA	TCGA-55-6982_treatment2	Gemcitabine Hydrochloride	NA	NA	NA	7719cb58-68e7-4c59-8bef-f0a915e6274b	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	35cb7841-9b09-465a-90c5-e3b8a9faad49	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6982	79	false	United States	NA	995	0fe268b0-fcba-5ee9-a593-d484d7e9324d	not reported	female	white	TCGA-55-6982_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	0	995.0	78008708-c100-5080-8d97-4666f0840a4b	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6982_diagnosis	No	Lower lobe, lung	NA	2004	No	NA	939	698	NA	NA	NA	NA	NA	NA	TCGA-55-6982_treatment4	Erlotinib Hydrochloride	NA	NA	NA	789692b3-c21e-478b-9818-ce551d3c4748	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	35cb7841-9b09-465a-90c5-e3b8a9faad49	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6982	79	false	United States	NA	995	0fe268b0-fcba-5ee9-a593-d484d7e9324d	not reported	female	white	TCGA-55-6982_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	0	995.0	78008708-c100-5080-8d97-4666f0840a4b	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6982_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	687	642	NA	NA	25.0	NA	NA	NA	TCGA-55-6982_treatment	NA	Distant Site	3500	cGy	e1329d9a-9160-586c-a231-51d4de73af02	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	35cb7841-9b09-465a-90c5-e3b8a9faad49	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6982	79	false	United States	NA	995	0fe268b0-fcba-5ee9-a593-d484d7e9324d	not reported	female	white	TCGA-55-6982_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	0	995.0	78008708-c100-5080-8d97-4666f0840a4b	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6982_diagnosis	No	Lower lobe, lung	NA	2004	No	NA	NA	397	NA	NA	NA	NA	NA	NA	TCGA-55-6982_treatment3	Vinorelbine Tartrate	NA	NA	NA	f1c7f31a-00b9-4be9-8088-4991cd9651aa	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	362000e4-cf7c-48fc-93cc-8f5994b442ea	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A4DF	88	true	United States	-32432	440	307dffc4-ab2f-52b2-b1bb-c2ebfab9caef	not hispanic or latino	male	white	TCGA-55-A4DF_demographic	Dead	32454	MX	N0	Stage IA	T1a	7th	Synchronous primary	22	NA	09390ff0-b6ba-476b-8cdd-ed5a48d9c847	false	NA	NA	NA	Right	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-A4DF_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	22	NA	NA	NA	NA	NA	NA	TCGA-55-A4DF_treatment5	NA	Not Reported	NA	NA	285f07ad-3ea1-44f8-bfc3-b4beeeb6b6bd	NA	yes	NA	Surgery, NOS
TCGA-LUAD	362000e4-cf7c-48fc-93cc-8f5994b442ea	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A4DF	88	true	United States	-32432	440	307dffc4-ab2f-52b2-b1bb-c2ebfab9caef	not hispanic or latino	male	white	TCGA-55-A4DF_demographic	Dead	32454	MX	N0	Stage IA	T1a	7th	Synchronous primary	22	NA	09390ff0-b6ba-476b-8cdd-ed5a48d9c847	false	NA	NA	NA	Right	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-A4DF_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A4DF_treatment4	NA	NA	NA	NA	4da90c56-05e7-4ff7-b02e-1c8d88c4500d	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	362000e4-cf7c-48fc-93cc-8f5994b442ea	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A4DF	88	true	United States	-32432	440	307dffc4-ab2f-52b2-b1bb-c2ebfab9caef	not hispanic or latino	male	white	TCGA-55-A4DF_demographic	Dead	32454	MX	N0	Stage IA	T1a	7th	Synchronous primary	22	NA	09390ff0-b6ba-476b-8cdd-ed5a48d9c847	false	NA	NA	NA	Right	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-A4DF_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A4DF_treatment3	NA	NA	NA	NA	cc43b59a-6093-4e3f-84b9-9ceeed7425fe	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	362000e4-cf7c-48fc-93cc-8f5994b442ea	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A4DF	88	true	United States	-32432	440	307dffc4-ab2f-52b2-b1bb-c2ebfab9caef	not hispanic or latino	male	white	TCGA-55-A4DF_demographic	Dead	32872	NA	NA	NA	NA	NA	metastasis	440	NA	4bce93af-95f6-4c1e-8e98-41e5e797ba51	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-A4DF_diagnosis2	NA	Not Reported	TCGA-55-A4DF_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-A4DF_treatment7	NA	NA	NA	NA	65e44198-96a0-410b-8965-21f717eb06f4	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	362000e4-cf7c-48fc-93cc-8f5994b442ea	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A4DF	88	true	United States	-32432	440	307dffc4-ab2f-52b2-b1bb-c2ebfab9caef	not hispanic or latino	male	white	TCGA-55-A4DF_demographic	Dead	32872	NA	NA	NA	NA	NA	metastasis	440	NA	4bce93af-95f6-4c1e-8e98-41e5e797ba51	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-A4DF_diagnosis2	NA	Not Reported	TCGA-55-A4DF_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A4DF_treatment9	NA	Distant Site	NA	NA	e2901ce2-1519-46c1-ab99-b512d19a4f10	NA	no	NA	Surgery, NOS
TCGA-LUAD	362000e4-cf7c-48fc-93cc-8f5994b442ea	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A4DF	88	true	United States	-32432	440	307dffc4-ab2f-52b2-b1bb-c2ebfab9caef	not hispanic or latino	male	white	TCGA-55-A4DF_demographic	Dead	32872	NA	NA	NA	NA	NA	metastasis	440	NA	4bce93af-95f6-4c1e-8e98-41e5e797ba51	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-A4DF_diagnosis2	NA	Not Reported	TCGA-55-A4DF_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A4DF_treatment8	NA	Locoregional Site	NA	NA	e8a497ab-becf-49bc-9eba-61aa9cf0476b	NA	no	NA	Surgery, NOS
TCGA-LUAD	362000e4-cf7c-48fc-93cc-8f5994b442ea	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A4DF	88	true	United States	-32432	440	307dffc4-ab2f-52b2-b1bb-c2ebfab9caef	not hispanic or latino	male	white	TCGA-55-A4DF_demographic	Dead	32872	NA	NA	NA	NA	NA	metastasis	440	NA	4bce93af-95f6-4c1e-8e98-41e5e797ba51	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-A4DF_diagnosis2	NA	Not Reported	TCGA-55-A4DF_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-A4DF_treatment6	NA	NA	NA	NA	e9f5852d-dd62-49bd-94e8-3dd5ebd04431	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	362000e4-cf7c-48fc-93cc-8f5994b442ea	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A4DF	88	true	United States	-32432	440	307dffc4-ab2f-52b2-b1bb-c2ebfab9caef	not hispanic or latino	male	white	TCGA-55-A4DF_demographic	Dead	32432	MX	N0	Stage IA	T1b	7th	primary	0	440.0	b45126e3-d938-5845-ac4f-2ebcabbfe03e	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-A4DF_diagnosis	Yes	Lower lobe, lung	NA	2012	NA	NA	440	440	NA	NA	NA	NA	NA	NA	TCGA-55-A4DF_treatment	NA	Distant Site	3500	cGy	845e717a-fb21-5830-b644-c3822bd33ba4	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	362000e4-cf7c-48fc-93cc-8f5994b442ea	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A4DF	88	true	United States	-32432	440	307dffc4-ab2f-52b2-b1bb-c2ebfab9caef	not hispanic or latino	male	white	TCGA-55-A4DF_demographic	Dead	32432	MX	N0	Stage IA	T1b	7th	primary	0	440.0	b45126e3-d938-5845-ac4f-2ebcabbfe03e	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-A4DF_diagnosis	Yes	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A4DF_treatment2	NA	NA	NA	NA	c87c1cd3-ead5-402f-82b9-9d744779a912	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	36470b30-a3b3-4d28-851b-918a7ff88011	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8096	67	false	United States	-24684	719	8dde4198-4ce1-592f-b7e2-7839d5e16478	not hispanic or latino	female	white	TCGA-55-8096_demographic	Dead	24684	MX	N0	Stage IB	T2a	7th	primary	0	719.0	54081f92-6879-567b-a617-1fb4f2c5351f	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	Central Lung	TCGA-55-8096_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	679	641	NA	NA	NA	NA	NA	NA	TCGA-55-8096_treatment2	NA	Distant Site	NA	NA	64993976-6bc2-411d-a61a-d4668f526689	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	36470b30-a3b3-4d28-851b-918a7ff88011	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8096	67	false	United States	-24684	719	8dde4198-4ce1-592f-b7e2-7839d5e16478	not hispanic or latino	female	white	TCGA-55-8096_demographic	Dead	24684	MX	N0	Stage IB	T2a	7th	primary	0	719.0	54081f92-6879-567b-a617-1fb4f2c5351f	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	Central Lung	TCGA-55-8096_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	600	579	NA	NA	14.0	NA	NA	NA	TCGA-55-8096_treatment	NA	Distant Site	3500	cGy	709bc3b5-14f9-51bb-b917-0dbd13398850	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	36470b30-a3b3-4d28-851b-918a7ff88011	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8096	67	false	United States	-24684	719	8dde4198-4ce1-592f-b7e2-7839d5e16478	not hispanic or latino	female	white	TCGA-55-8096_demographic	Dead	24684	MX	N0	Stage IB	T2a	7th	primary	0	719.0	54081f92-6879-567b-a617-1fb4f2c5351f	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	Central Lung	TCGA-55-8096_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8096_treatment3	NA	NA	NA	NA	7a2770d5-bab2-43be-94bf-20198d4959f9	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	36470b30-a3b3-4d28-851b-918a7ff88011	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8096	67	false	United States	-24684	719	8dde4198-4ce1-592f-b7e2-7839d5e16478	not hispanic or latino	female	white	TCGA-55-8096_demographic	Dead	25250	NA	NA	NA	NA	NA	metastasis	566	NA	9397543d-e71e-4642-9591-98484a516475	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8096_diagnosis2	NA	Not Reported	TCGA-55-8096_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8096_treatment6	NA	Distant Site	NA	NA	06a2c03f-c92c-4eaf-9f67-6ac1a32c82d9	NA	no	NA	Surgery, NOS
TCGA-LUAD	36470b30-a3b3-4d28-851b-918a7ff88011	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8096	67	false	United States	-24684	719	8dde4198-4ce1-592f-b7e2-7839d5e16478	not hispanic or latino	female	white	TCGA-55-8096_demographic	Dead	25250	NA	NA	NA	NA	NA	metastasis	566	NA	9397543d-e71e-4642-9591-98484a516475	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8096_diagnosis2	NA	Not Reported	TCGA-55-8096_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8096_treatment4	NA	NA	NA	NA	547a953e-07df-4b14-9708-57ecf214f222	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	36470b30-a3b3-4d28-851b-918a7ff88011	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8096	67	false	United States	-24684	719	8dde4198-4ce1-592f-b7e2-7839d5e16478	not hispanic or latino	female	white	TCGA-55-8096_demographic	Dead	25250	NA	NA	NA	NA	NA	metastasis	566	NA	9397543d-e71e-4642-9591-98484a516475	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8096_diagnosis2	NA	Not Reported	TCGA-55-8096_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8096_treatment5	NA	NA	NA	NA	60341345-cea5-461f-a8e3-ec01c1c6352b	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	3650e5b2-ef58-4b14-97b2-8698f2c160f8	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z058	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	368e23f0-e573-4547-bf5a-14080baf737b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5930	47	false	United States	-17238	282	305f22ba-d378-52e8-9f52-a53a111b0ed6	not hispanic or latino	male	white	TCGA-50-5930_demographic	Dead	17238	M0	N2	Stage IIIA	T2	5th	primary	0	282.0	228f4e4e-28cb-5d4b-896d-adba54b0c856	true	NA	NA	C34.3	NA	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-50-5930_diagnosis	No	Lower lobe, lung	NA	2001	NA	NA	177	177	NA	NA	NA	NA	NA	NA	TCGA-50-5930_treatment	NA	Primary Tumor Field	2520	cGy	3dc1cb30-fd51-59a8-983f-919c4d222cb4	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	368e23f0-e573-4547-bf5a-14080baf737b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5930	47	false	United States	-17238	282	305f22ba-d378-52e8-9f52-a53a111b0ed6	not hispanic or latino	male	white	TCGA-50-5930_demographic	Dead	17238	M0	N2	Stage IIIA	T2	5th	primary	0	282.0	228f4e4e-28cb-5d4b-896d-adba54b0c856	true	NA	NA	C34.3	NA	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-50-5930_diagnosis	No	Lower lobe, lung	NA	2001	No	NA	146	85	NA	NA	NA	NA	NA	NA	TCGA-50-5930_treatment2	Docetaxel	NA	NA	NA	5f2dfa34-de5b-47d9-99e2-42384ffcb596	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	368e23f0-e573-4547-bf5a-14080baf737b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5930	47	false	United States	-17238	282	305f22ba-d378-52e8-9f52-a53a111b0ed6	not hispanic or latino	male	white	TCGA-50-5930_demographic	Dead	17415	NA	NA	NA	NA	NA	metastasis	177	NA	e415aa5a-f3d4-4727-b1ed-84099e9887dc	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5930_diagnosis2	NA	Not Reported	TCGA-50-5930_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5930_treatment5	NA	Distant Site	NA	NA	21f4b602-e283-49e5-8a0a-aea76197fec2	NA	no	NA	Surgery, NOS
TCGA-LUAD	368e23f0-e573-4547-bf5a-14080baf737b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5930	47	false	United States	-17238	282	305f22ba-d378-52e8-9f52-a53a111b0ed6	not hispanic or latino	male	white	TCGA-50-5930_demographic	Dead	17415	NA	NA	NA	NA	NA	metastasis	177	NA	e415aa5a-f3d4-4727-b1ed-84099e9887dc	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5930_diagnosis2	NA	Not Reported	TCGA-50-5930_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5930_treatment4	NA	NA	NA	NA	be7f43a0-b8ca-40fa-8c79-56d2181a3621	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	368e23f0-e573-4547-bf5a-14080baf737b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5930	47	false	United States	-17238	282	305f22ba-d378-52e8-9f52-a53a111b0ed6	not hispanic or latino	male	white	TCGA-50-5930_demographic	Dead	17415	NA	NA	NA	NA	NA	metastasis	177	NA	e415aa5a-f3d4-4727-b1ed-84099e9887dc	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5930_diagnosis2	NA	Not Reported	TCGA-50-5930_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5930_treatment3	NA	NA	NA	NA	e054cfe5-8183-48e7-a710-bc908c6b8a82	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	23892	MX	N1	Stage IIA	T2a	7th	primary	0	739.0	0b243d04-60c0-5961-8df7-2485f29fbb3b	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-J2-8192_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	NA	105	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment2	Pemetrexed	NA	NA	NA	73a81ac6-0b4b-4a92-9f65-ae2180e3bf63	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	23892	MX	N1	Stage IIA	T2a	7th	primary	0	739.0	0b243d04-60c0-5961-8df7-2485f29fbb3b	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-J2-8192_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	NA	105	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment	Cisplatin	NA	NA	NA	a13c1418-9393-5735-89ae-c4f92cbda679	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	23892	MX	N1	Stage IIA	T2a	7th	primary	0	739.0	0b243d04-60c0-5961-8df7-2485f29fbb3b	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-J2-8192_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	NA	641	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment3	Erlotinib	NA	NA	NA	d5631e9f-6085-4eab-b87b-46b3c13d04cb	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	23892	MX	N1	Stage IIA	T2a	7th	primary	0	739.0	0b243d04-60c0-5961-8df7-2485f29fbb3b	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-J2-8192_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment4	NA	NA	NA	NA	ef0347a3-545e-4075-b8e2-d881cdbd0593	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	0ebb6c6f-7d74-447c-87da-d1c0ca02731f	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-J2-8192_diagnosis4	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment7	NA	NA	NA	NA	b7d99790-1ae1-4e97-8fa4-4922f101c98e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	0ebb6c6f-7d74-447c-87da-d1c0ca02731f	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-J2-8192_diagnosis4	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment8	NA	NA	NA	NA	e9156588-0adc-42e6-82da-a849337ca3ab	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	24374	NA	NA	NA	NA	NA	recurrence	482	NA	2f5c7498-6b0f-442c-b143-71e7c4b5cbe7	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-J2-8192_diagnosis2	NA	Not Reported	TCGA-J2-8192_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment13	NA	Locoregional Site	NA	NA	048b2889-623e-4c63-9561-9ca749e1c208	NA	no	NA	Surgery, NOS
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	24374	NA	NA	NA	NA	NA	recurrence	482	NA	2f5c7498-6b0f-442c-b143-71e7c4b5cbe7	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-J2-8192_diagnosis2	NA	Not Reported	TCGA-J2-8192_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment11	NA	NA	NA	NA	25d547c9-fc75-45d3-beb6-c92c0d9d26c5	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	24374	NA	NA	NA	NA	NA	recurrence	482	NA	2f5c7498-6b0f-442c-b143-71e7c4b5cbe7	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-J2-8192_diagnosis2	NA	Not Reported	TCGA-J2-8192_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment14	NA	Distant Site	NA	NA	b5946109-1d08-45e3-a764-974facb9c8e3	NA	no	NA	Surgery, NOS
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	24374	NA	NA	NA	NA	NA	recurrence	482	NA	2f5c7498-6b0f-442c-b143-71e7c4b5cbe7	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-J2-8192_diagnosis2	NA	Not Reported	TCGA-J2-8192_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment12	NA	NA	NA	NA	f70b0ae9-6cf6-47be-9b48-117a9357acbf	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	31387f41-fea8-4e51-a2cd-d66f053f87c8	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-J2-8192_diagnosis5	NA	Cervix uteri	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment10	NA	NA	NA	NA	9056667a-2905-40cd-a945-15475103ae1c	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	31387f41-fea8-4e51-a2cd-d66f053f87c8	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-J2-8192_diagnosis5	NA	Cervix uteri	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment9	NA	NA	NA	NA	b1f4f379-322e-4168-9e5c-d81bbbd02313	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	3db89b3f-9b2c-4dde-ae2e-d9d2d969cc47	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-J2-8192_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment5	NA	NA	NA	NA	e77463c0-67db-4451-8684-e0b930d5c58a	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	369f14c4-2191-4962-a309-3e23ddc4e5fc	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-8192	65	false	United States	-23892	NA	9e1d6085-d578-5c88-9fbb-6fc8ca114a72	not hispanic or latino	female	white	TCGA-J2-8192_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	3db89b3f-9b2c-4dde-ae2e-d9d2d969cc47	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-J2-8192_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-8192_treatment6	NA	NA	NA	NA	f5b37f9e-4da7-4589-8cc7-872204f31ed9	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	36ad7fc7-0cc1-4f01-aef1-f89b3cb4feac	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-3774	73	false	United States	-26704	NA	dc8df7d5-f087-5c8f-b2b7-2edaf2b11cb9	not hispanic or latino	female	white	TCGA-67-3774_demographic	Alive	26704	M0	N0	Stage IB	T2	6th	primary	0	385.0	7eea3d05-c171-5706-baea-d2c1cb1179ef	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-67-3774_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	36bf02f8-c1c8-49f9-a417-adf88a205c70	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4426	71	false	Germany	-26084	NA	2dcc0d6b-0fb4-5d50-82c5-2b3000fd02d5	not reported	male	not reported	TCGA-05-4426_demographic	Alive	26084	M0	N0	Stage IB	T2	6th	primary	0	791.0	2de5d1c1-2942-505e-8081-471f45188690	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4426_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4426_treatment2	NA	NA	NA	NA	1210a268-c539-4eef-afbc-f77a7c4e12cb	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	36bf02f8-c1c8-49f9-a417-adf88a205c70	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4426	71	false	Germany	-26084	NA	2dcc0d6b-0fb4-5d50-82c5-2b3000fd02d5	not reported	male	not reported	TCGA-05-4426_demographic	Alive	26084	M0	N0	Stage IB	T2	6th	primary	0	791.0	2de5d1c1-2942-505e-8081-471f45188690	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4426_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4426_treatment	NA	NA	NA	NA	14377244-d169-5a3e-a8bc-d12968b4c50a	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	36bf02f8-c1c8-49f9-a417-adf88a205c70	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4426	71	false	Germany	-26084	NA	2dcc0d6b-0fb4-5d50-82c5-2b3000fd02d5	not reported	male	not reported	TCGA-05-4426_demographic	Alive	26541	NA	NA	NA	NA	NA	not reported	457	NA	459f43d5-25fc-4ce9-892e-52b1b0a308a2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-4426_diagnosis2	NA	Not Reported	TCGA-05-4426_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-4426_treatment4	NA	NA	NA	NA	708084c2-64a0-4b5d-9cea-088031682638	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	36bf02f8-c1c8-49f9-a417-adf88a205c70	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4426	71	false	Germany	-26084	NA	2dcc0d6b-0fb4-5d50-82c5-2b3000fd02d5	not reported	male	not reported	TCGA-05-4426_demographic	Alive	26541	NA	NA	NA	NA	NA	not reported	457	NA	459f43d5-25fc-4ce9-892e-52b1b0a308a2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-4426_diagnosis2	NA	Not Reported	TCGA-05-4426_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-4426_treatment3	NA	NA	NA	NA	ed6ad959-0100-4096-8855-7a81ad632d3e	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	37884d39-64e8-4242-b6bd-4c0a1daa21cd	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-71-8520	60	false	Vietnam	-21921	210	b239ce8c-dc25-565a-adce-0f8a95992f39	not hispanic or latino	female	asian	TCGA-71-8520_demographic	Dead	21921	M0	N0	Stage IB	T2	7th	primary	0	210.0	a130c25a-6f37-58e9-b32a-d8a2e4db79ff	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-71-8520_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	80	51	NA	NA	22.0	NA	NA	NA	TCGA-71-8520_treatment	NA	Regional Site	44	Gy	2238b95a-f4fa-5fa9-810b-5b0787d3ccf9	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	37884d39-64e8-4242-b6bd-4c0a1daa21cd	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-71-8520	60	false	Vietnam	-21921	210	b239ce8c-dc25-565a-adce-0f8a95992f39	not hispanic or latino	female	asian	TCGA-71-8520_demographic	Dead	21921	M0	N0	Stage IB	T2	7th	primary	0	210.0	a130c25a-6f37-58e9-b32a-d8a2e4db79ff	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-71-8520_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-71-8520_treatment2	NA	NA	NA	NA	f2f3149a-7157-44ed-8631-8561bd72fa67	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	37884d39-64e8-4242-b6bd-4c0a1daa21cd	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-71-8520	60	false	Vietnam	-21921	210	b239ce8c-dc25-565a-adce-0f8a95992f39	not hispanic or latino	female	asian	TCGA-71-8520_demographic	Dead	22100	NA	NA	NA	NA	NA	recurrence	179	NA	b9e40cec-53f4-4954-b3dc-bbac45262965	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-71-8520_diagnosis2	NA	Not Reported	TCGA-71-8520_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-71-8520_treatment3	NA	NA	NA	NA	935ad5bf-2450-4307-ad44-22cda61d01b4	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	37884d39-64e8-4242-b6bd-4c0a1daa21cd	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-71-8520	60	false	Vietnam	-21921	210	b239ce8c-dc25-565a-adce-0f8a95992f39	not hispanic or latino	female	asian	TCGA-71-8520_demographic	Dead	22100	NA	NA	NA	NA	NA	recurrence	179	NA	b9e40cec-53f4-4954-b3dc-bbac45262965	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-71-8520_diagnosis2	NA	Not Reported	TCGA-71-8520_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-71-8520_treatment4	NA	NA	NA	NA	eac24cc4-e7ed-4761-b7ee-a0c527a86ccf	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	37884d39-64e8-4242-b6bd-4c0a1daa21cd	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-71-8520	60	false	Vietnam	-21921	210	b239ce8c-dc25-565a-adce-0f8a95992f39	not hispanic or latino	female	asian	TCGA-71-8520_demographic	Dead	22100	NA	NA	NA	NA	NA	recurrence	179	NA	b9e40cec-53f4-4954-b3dc-bbac45262965	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-71-8520_diagnosis2	NA	Not Reported	TCGA-71-8520_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-71-8520_treatment5	NA	Locoregional Site	NA	NA	eea47eba-6d6b-4f2d-b684-af63bfcd2510	NA	no	NA	Surgery, NOS
TCGA-LUAD	37c8d73a-45ae-40fc-ba9a-721b755c1160	Informed Consent	1332	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7553	58	false	United States	-21518	NA	6086c8df-afb2-5edc-bfbe-f4721ff34a07	not hispanic or latino	female	white	TCGA-97-7553_demographic	Alive	21518	MX	N0	Stage IA	T1	6th	primary	0	1870.0	d111d053-f0c5-5ead-98b9-292c2d2b2276	true	NA	NA	C34.3	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	Central Lung	TCGA-97-7553_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7553_treatment	NA	NA	NA	NA	39a09d01-37b0-5e34-ae5e-a3e9f5df6d83	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	37c8d73a-45ae-40fc-ba9a-721b755c1160	Informed Consent	1332	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7553	58	false	United States	-21518	NA	6086c8df-afb2-5edc-bfbe-f4721ff34a07	not hispanic or latino	female	white	TCGA-97-7553_demographic	Alive	21518	MX	N0	Stage IA	T1	6th	primary	0	1870.0	d111d053-f0c5-5ead-98b9-292c2d2b2276	true	NA	NA	C34.3	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	Central Lung	TCGA-97-7553_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7553_treatment2	NA	NA	NA	NA	f238a5e4-d7d1-4181-b6f2-a1f4a7e464f1	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	383d1253-349f-43b3-bebd-9f1d1cf14b3d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TD	71	false	United States	-25983	307	87a3df12-0fa8-504f-982d-94d0878c89a5	Unknown	male	white	TCGA-MP-A4TD_demographic	Dead	26209	NA	NA	NA	NA	NA	recurrence	226	NA	c5112ec2-3adf-4beb-8419-7357e085ebcc	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TD_diagnosis2	NA	Not Reported	TCGA-MP-A4TD_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TD_treatment7	NA	NA	NA	NA	20615c50-49f6-45a6-9eb7-236b9d6fc5a3	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	383d1253-349f-43b3-bebd-9f1d1cf14b3d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TD	71	false	United States	-25983	307	87a3df12-0fa8-504f-982d-94d0878c89a5	Unknown	male	white	TCGA-MP-A4TD_demographic	Dead	26209	NA	NA	NA	NA	NA	recurrence	226	NA	c5112ec2-3adf-4beb-8419-7357e085ebcc	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TD_diagnosis2	NA	Not Reported	TCGA-MP-A4TD_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TD_treatment9	NA	Locoregional Site	NA	NA	dfe85a59-2e02-42aa-b952-bdcf30b6e0fc	NA	no	NA	Surgery, NOS
TCGA-LUAD	383d1253-349f-43b3-bebd-9f1d1cf14b3d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TD	71	false	United States	-25983	307	87a3df12-0fa8-504f-982d-94d0878c89a5	Unknown	male	white	TCGA-MP-A4TD_demographic	Dead	26209	NA	NA	NA	NA	NA	recurrence	226	NA	c5112ec2-3adf-4beb-8419-7357e085ebcc	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TD_diagnosis2	NA	Not Reported	TCGA-MP-A4TD_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TD_treatment8	NA	NA	NA	NA	fc26a14f-65f4-422f-834b-ef3a04516721	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	383d1253-349f-43b3-bebd-9f1d1cf14b3d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TD	71	false	United States	-25983	307	87a3df12-0fa8-504f-982d-94d0878c89a5	Unknown	male	white	TCGA-MP-A4TD_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d6598d00-b63a-4f02-9611-ad23cc3666e8	false	NA	NA	NA	NA	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MP-A4TD_diagnosis3	NA	Thorax, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TD_treatment5	NA	NA	NA	NA	4d53079f-0b31-4a61-ad0b-6cb85554b011	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	383d1253-349f-43b3-bebd-9f1d1cf14b3d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TD	71	false	United States	-25983	307	87a3df12-0fa8-504f-982d-94d0878c89a5	Unknown	male	white	TCGA-MP-A4TD_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d6598d00-b63a-4f02-9611-ad23cc3666e8	false	NA	NA	NA	NA	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MP-A4TD_diagnosis3	NA	Thorax, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TD_treatment4	NA	NA	NA	NA	9efd05e9-ed32-4c2e-abfd-4626cf9f4437	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	383d1253-349f-43b3-bebd-9f1d1cf14b3d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TD	71	false	United States	-25983	307	87a3df12-0fa8-504f-982d-94d0878c89a5	Unknown	male	white	TCGA-MP-A4TD_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d6598d00-b63a-4f02-9611-ad23cc3666e8	false	NA	NA	NA	NA	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MP-A4TD_diagnosis3	NA	Thorax, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TD_treatment6	NA	Not Reported	NA	NA	c351c5fb-937e-4ebf-b541-344a2c67c355	NA	yes	NA	Surgery, NOS
TCGA-LUAD	383d1253-349f-43b3-bebd-9f1d1cf14b3d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TD	71	false	United States	-25983	307	87a3df12-0fa8-504f-982d-94d0878c89a5	Unknown	male	white	TCGA-MP-A4TD_demographic	Dead	25983	M0	N2	Stage IIIA	T2	6th	primary	0	307.0	e56fe5b5-29ba-5370-b1f7-7fb93f4e0968	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	RX	Lung, NOS	Peripheral Lung	TCGA-MP-A4TD_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	165	75	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TD_treatment2	Gemcitabine	NA	NA	NA	6537f0ee-dc99-456e-bd92-49327d04f410	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	383d1253-349f-43b3-bebd-9f1d1cf14b3d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TD	71	false	United States	-25983	307	87a3df12-0fa8-504f-982d-94d0878c89a5	Unknown	male	white	TCGA-MP-A4TD_demographic	Dead	25983	M0	N2	Stage IIIA	T2	6th	primary	0	307.0	e56fe5b5-29ba-5370-b1f7-7fb93f4e0968	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	RX	Lung, NOS	Peripheral Lung	TCGA-MP-A4TD_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TD_treatment3	NA	NA	NA	NA	a5287745-20d3-49fc-98f5-51c6b68bc186	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	383d1253-349f-43b3-bebd-9f1d1cf14b3d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TD	71	false	United States	-25983	307	87a3df12-0fa8-504f-982d-94d0878c89a5	Unknown	male	white	TCGA-MP-A4TD_demographic	Dead	25983	M0	N2	Stage IIIA	T2	6th	primary	0	307.0	e56fe5b5-29ba-5370-b1f7-7fb93f4e0968	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	RX	Lung, NOS	Peripheral Lung	TCGA-MP-A4TD_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	165	75	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TD_treatment	Cisplatin	NA	NA	NA	ff2e9e92-ac0d-5e83-9c45-003d8b8b2bc2	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	389f78a3-fa0b-406c-9434-aa0298341a8c	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VN	62	false	United States	-22927	NA	0f6fdab7-f076-58ff-af92-321a4e44ed05	not hispanic or latino	female	white	TCGA-95-A4VN_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	37803c0a-7dfb-47e8-bf8b-d2b800a24124	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-95-A4VN_diagnosis2	NA	Female genital tract, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VN_treatment3	NA	NA	NA	NA	56e75eb7-44b2-4136-91f9-6b984428b11f	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	389f78a3-fa0b-406c-9434-aa0298341a8c	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VN	62	false	United States	-22927	NA	0f6fdab7-f076-58ff-af92-321a4e44ed05	not hispanic or latino	female	white	TCGA-95-A4VN_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	37803c0a-7dfb-47e8-bf8b-d2b800a24124	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-95-A4VN_diagnosis2	NA	Female genital tract, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VN_treatment5	NA	Vulva|Vagina	NA	NA	8fea48f5-4746-4da3-8b7a-104719d4ac40	NA	yes	NA	Surgery, NOS
TCGA-LUAD	389f78a3-fa0b-406c-9434-aa0298341a8c	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VN	62	false	United States	-22927	NA	0f6fdab7-f076-58ff-af92-321a4e44ed05	not hispanic or latino	female	white	TCGA-95-A4VN_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	37803c0a-7dfb-47e8-bf8b-d2b800a24124	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-95-A4VN_diagnosis2	NA	Female genital tract, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VN_treatment4	NA	NA	NA	NA	ae75bc70-5b22-4343-90af-9a0215ed3221	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	389f78a3-fa0b-406c-9434-aa0298341a8c	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VN	62	false	United States	-22927	NA	0f6fdab7-f076-58ff-af92-321a4e44ed05	not hispanic or latino	female	white	TCGA-95-A4VN_demographic	Alive	22927	M0	N1	Stage IIA	T2a	7th	primary	0	553.0	6ba6b2a9-31ed-5ec2-b918-9b337b796c12	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-95-A4VN_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VN_treatment	NA	NA	NA	NA	2591968e-cc42-5483-a023-1f2f1e102840	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	389f78a3-fa0b-406c-9434-aa0298341a8c	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VN	62	false	United States	-22927	NA	0f6fdab7-f076-58ff-af92-321a4e44ed05	not hispanic or latino	female	white	TCGA-95-A4VN_demographic	Alive	22927	M0	N1	Stage IIA	T2a	7th	primary	0	553.0	6ba6b2a9-31ed-5ec2-b918-9b337b796c12	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-95-A4VN_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VN_treatment2	NA	NA	NA	NA	7343ab0b-9287-4fce-b21d-ace993dc837a	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	389f78a3-fa0b-406c-9434-aa0298341a8c	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VN	62	false	United States	-22927	NA	0f6fdab7-f076-58ff-af92-321a4e44ed05	not hispanic or latino	female	white	TCGA-95-A4VN_demographic	Alive	22882	NA	NA	NA	NA	NA	Synchronous primary	-45	NA	7fba5668-df8c-4186-b7d9-95913a980465	false	NA	NA	NA	Right	8550/3	Acinar adenocarcinoma	NA	NA	NA	Not Reported	NA	TCGA-95-A4VN_diagnosis4	NA	Lung, NOS	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA	NA	TCGA-95-A4VN_treatment11	NA	Not Reported	NA	NA	1726bee3-ddb2-46a1-92c7-0bcd7a44d92c	NA	yes	NA	Surgery, NOS
TCGA-LUAD	389f78a3-fa0b-406c-9434-aa0298341a8c	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VN	62	false	United States	-22927	NA	0f6fdab7-f076-58ff-af92-321a4e44ed05	not hispanic or latino	female	white	TCGA-95-A4VN_demographic	Alive	22882	NA	NA	NA	NA	NA	Synchronous primary	-45	NA	7fba5668-df8c-4186-b7d9-95913a980465	false	NA	NA	NA	Right	8550/3	Acinar adenocarcinoma	NA	NA	NA	Not Reported	NA	TCGA-95-A4VN_diagnosis4	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VN_treatment10	NA	NA	NA	NA	8624f9e9-7cd1-4026-8043-5a7930a2aea4	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	389f78a3-fa0b-406c-9434-aa0298341a8c	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VN	62	false	United States	-22927	NA	0f6fdab7-f076-58ff-af92-321a4e44ed05	not hispanic or latino	female	white	TCGA-95-A4VN_demographic	Alive	22882	NA	NA	NA	NA	NA	Synchronous primary	-45	NA	7fba5668-df8c-4186-b7d9-95913a980465	false	NA	NA	NA	Right	8550/3	Acinar adenocarcinoma	NA	NA	NA	Not Reported	NA	TCGA-95-A4VN_diagnosis4	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VN_treatment9	NA	NA	NA	NA	956e91ab-786b-4283-bd89-9d3aa17a8156	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	389f78a3-fa0b-406c-9434-aa0298341a8c	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VN	62	false	United States	-22927	NA	0f6fdab7-f076-58ff-af92-321a4e44ed05	not hispanic or latino	female	white	TCGA-95-A4VN_demographic	Alive	21883	NA	NA	NA	NA	NA	Prior primary	-1044	NA	f6611abb-0cd9-4a8f-9322-6d7d8e951408	false	NA	NA	NA	Left	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-A4VN_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	-1050	NA	NA	NA	NA	NA	NA	TCGA-95-A4VN_treatment8	NA	Lung	NA	NA	1a3c6d4a-3de7-4fe7-b6c8-649c3f33cd15	NA	yes	NA	Surgery, NOS
TCGA-LUAD	389f78a3-fa0b-406c-9434-aa0298341a8c	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VN	62	false	United States	-22927	NA	0f6fdab7-f076-58ff-af92-321a4e44ed05	not hispanic or latino	female	white	TCGA-95-A4VN_demographic	Alive	21883	NA	NA	NA	NA	NA	Prior primary	-1044	NA	f6611abb-0cd9-4a8f-9322-6d7d8e951408	false	NA	NA	NA	Left	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-A4VN_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VN_treatment7	NA	NA	NA	NA	4d9cead6-5ca7-435b-84c5-def10aeea7fe	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	389f78a3-fa0b-406c-9434-aa0298341a8c	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VN	62	false	United States	-22927	NA	0f6fdab7-f076-58ff-af92-321a4e44ed05	not hispanic or latino	female	white	TCGA-95-A4VN_demographic	Alive	21883	NA	NA	NA	NA	NA	Prior primary	-1044	NA	f6611abb-0cd9-4a8f-9322-6d7d8e951408	false	NA	NA	NA	Left	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-A4VN_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VN_treatment6	NA	NA	NA	NA	ada5ef80-1b3b-4e5f-a68e-b64e3c963b85	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	392ca7f3-d52e-4aa7-a9ba-4c7d9aa6401c	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z056	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	397d3f69-1453-4057-b177-8723eec923d1	Informed Consent	-20	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8171	81	false	United States	-29627	NA	5db4f68e-66b5-5838-ae52-3d71bbe93778	not hispanic or latino	male	asian	TCGA-97-8171_demographic	Alive	29627	M1a	N2	Stage IV	T2a	7th	primary	0	568.0	29b91989-0436-5fa5-80b0-ddfe2eea3116	true	NA	NA	C34.8	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-97-8171_diagnosis	No	Overlapping lesion of lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8171_treatment2	NA	NA	NA	NA	491207a1-cf18-49d4-b40d-79c3e99a20a7	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	397d3f69-1453-4057-b177-8723eec923d1	Informed Consent	-20	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8171	81	false	United States	-29627	NA	5db4f68e-66b5-5838-ae52-3d71bbe93778	not hispanic or latino	male	asian	TCGA-97-8171_demographic	Alive	29627	M1a	N2	Stage IV	T2a	7th	primary	0	568.0	29b91989-0436-5fa5-80b0-ddfe2eea3116	true	NA	NA	C34.8	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-97-8171_diagnosis	No	Overlapping lesion of lung	NA	2011	No	NA	NA	16	NA	NA	NA	NA	NA	NA	TCGA-97-8171_treatment	Erlotinib Hydrochloride	NA	NA	NA	ecfb1365-6e2c-5e99-ab71-7bbf7410fb3b	NA	yes	Treatment Ongoing	Targeted Molecular Therapy
TCGA-LUAD	397d3f69-1453-4057-b177-8723eec923d1	Informed Consent	-20	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8171	81	false	United States	-29627	NA	5db4f68e-66b5-5838-ae52-3d71bbe93778	not hispanic or latino	male	asian	TCGA-97-8171_demographic	Alive	30068	NA	NA	NA	NA	NA	metastasis	441	NA	6f42476a-1f3a-4010-92e7-58b483546260	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-97-8171_diagnosis2	NA	Not Reported	TCGA-97-8171_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-97-8171_treatment4	NA	NA	NA	NA	028ad8b6-7654-4a17-8179-0e1a303a0eb2	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	397d3f69-1453-4057-b177-8723eec923d1	Informed Consent	-20	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8171	81	false	United States	-29627	NA	5db4f68e-66b5-5838-ae52-3d71bbe93778	not hispanic or latino	male	asian	TCGA-97-8171_demographic	Alive	30068	NA	NA	NA	NA	NA	metastasis	441	NA	6f42476a-1f3a-4010-92e7-58b483546260	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-97-8171_diagnosis2	NA	Not Reported	TCGA-97-8171_diagnosis	NA	NA	NA	NA	441	NA	NA	NA	NA	NA	NA	TCGA-97-8171_treatment5	NA	Distant Site	NA	NA	654a7703-616e-4b1e-a2e7-975fce3882e1	NA	yes	NA	Surgery, NOS
TCGA-LUAD	397d3f69-1453-4057-b177-8723eec923d1	Informed Consent	-20	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8171	81	false	United States	-29627	NA	5db4f68e-66b5-5838-ae52-3d71bbe93778	not hispanic or latino	male	asian	TCGA-97-8171_demographic	Alive	30068	NA	NA	NA	NA	NA	metastasis	441	NA	6f42476a-1f3a-4010-92e7-58b483546260	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-97-8171_diagnosis2	NA	Not Reported	TCGA-97-8171_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-97-8171_treatment3	NA	NA	NA	NA	a7b28c9d-126b-43ff-b6aa-0a55097ed3d0	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	39ab7174-5707-498d-9959-523680e04198	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A492	70	false	United States	-25719	NA	abe0ff65-042f-5ca8-a2ca-d03042c0707a	not hispanic or latino	female	white	TCGA-55-A492_demographic	Alive	25080	M0	N0	Stage IIA	T3	7th	Prior primary	-639	NA	1a3c3451-77bf-42ea-9540-6184563cd398	false	NA	NA	NA	Right	8510/3	Medullary carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-A492_diagnosis2	NA	Colon, NOS	NA	NA	NA	NA	NA	-639	NA	NA	NA	NA	NA	NA	TCGA-55-A492_treatment5	NA	NA	NA	NA	0317c99b-6d46-4c4f-ae02-17d0260b1a2e	NA	yes	NA	Surgery, NOS
TCGA-LUAD	39ab7174-5707-498d-9959-523680e04198	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A492	70	false	United States	-25719	NA	abe0ff65-042f-5ca8-a2ca-d03042c0707a	not hispanic or latino	female	white	TCGA-55-A492_demographic	Alive	25080	M0	N0	Stage IIA	T3	7th	Prior primary	-639	NA	1a3c3451-77bf-42ea-9540-6184563cd398	false	NA	NA	NA	Right	8510/3	Medullary carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-A492_diagnosis2	NA	Colon, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A492_treatment4	NA	NA	NA	NA	53b67edc-86cf-4b05-b760-254eb009a926	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	39ab7174-5707-498d-9959-523680e04198	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A492	70	false	United States	-25719	NA	abe0ff65-042f-5ca8-a2ca-d03042c0707a	not hispanic or latino	female	white	TCGA-55-A492_demographic	Alive	25080	M0	N0	Stage IIA	T3	7th	Prior primary	-639	NA	1a3c3451-77bf-42ea-9540-6184563cd398	false	NA	NA	NA	Right	8510/3	Medullary carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-A492_diagnosis2	NA	Colon, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A492_treatment3	NA	NA	NA	NA	70399f65-4951-47ec-ae0f-418b3e9257ba	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	39ab7174-5707-498d-9959-523680e04198	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A492	70	false	United States	-25719	NA	abe0ff65-042f-5ca8-a2ca-d03042c0707a	not hispanic or latino	female	white	TCGA-55-A492_demographic	Alive	25719	MX	N0	Stage IA	T1a	7th	primary	0	596.0	47ca2ddb-ce79-5bfe-bb82-e627df77391d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-A492_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A492_treatment2	NA	NA	NA	NA	1f639ef5-decb-4f1d-b9bf-75c370358e47	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	39ab7174-5707-498d-9959-523680e04198	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A492	70	false	United States	-25719	NA	abe0ff65-042f-5ca8-a2ca-d03042c0707a	not hispanic or latino	female	white	TCGA-55-A492_demographic	Alive	25719	MX	N0	Stage IA	T1a	7th	primary	0	596.0	47ca2ddb-ce79-5bfe-bb82-e627df77391d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-A492_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A492_treatment	NA	NA	NA	NA	d1a3f38b-4772-5c0f-8d71-e3fa67f8eb86	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3a23cdb5-2327-45ac-b0b5-d4afe038c757	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4430	59	false	Germany	-21884	NA	21bf2794-df78-5399-9976-47954c4db38d	not reported	female	not reported	TCGA-05-4430_demographic	Alive	21884	M0	N0	Stage IB	T2	6th	primary	0	761.0	74704674-6949-54e9-ad83-ec8028f45cc0	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4430_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4430_treatment2	NA	NA	NA	NA	10991c2c-fd93-475b-82ea-33fd145dc46a	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	3a23cdb5-2327-45ac-b0b5-d4afe038c757	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4430	59	false	Germany	-21884	NA	21bf2794-df78-5399-9976-47954c4db38d	not reported	female	not reported	TCGA-05-4430_demographic	Alive	21884	M0	N0	Stage IB	T2	6th	primary	0	761.0	74704674-6949-54e9-ad83-ec8028f45cc0	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4430_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4430_treatment	NA	NA	NA	NA	7abb933c-db22-5136-8b97-4fd034e12271	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3afa5045-a1ee-4a07-8aad-2e252b2f7d7a	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AAR0	57	false	United States	-20932	NA	9d331b83-e9de-5fc6-8133-a40ef3bc787c	not hispanic or latino	male	black or african american	TCGA-49-AAR0_demographic	Alive	20552	NA	NA	NA	NA	NA	Prior primary	-380	NA	2a9e7e7a-3208-4960-a314-1d0bc7644d3c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-49-AAR0_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAR0_treatment5	NA	NA	NA	NA	43b793b2-8089-434e-b6b3-93827d54fc66	NA	no	NA	Surgery, NOS
TCGA-LUAD	3afa5045-a1ee-4a07-8aad-2e252b2f7d7a	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AAR0	57	false	United States	-20932	NA	9d331b83-e9de-5fc6-8133-a40ef3bc787c	not hispanic or latino	male	black or african american	TCGA-49-AAR0_demographic	Alive	20552	NA	NA	NA	NA	NA	Prior primary	-380	NA	2a9e7e7a-3208-4960-a314-1d0bc7644d3c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-49-AAR0_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAR0_treatment3	NA	NA	NA	NA	7e0d2ae6-b5b3-4c31-9d33-117505abc0cd	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3afa5045-a1ee-4a07-8aad-2e252b2f7d7a	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AAR0	57	false	United States	-20932	NA	9d331b83-e9de-5fc6-8133-a40ef3bc787c	not hispanic or latino	male	black or african american	TCGA-49-AAR0_demographic	Alive	20552	NA	NA	NA	NA	NA	Prior primary	-380	NA	2a9e7e7a-3208-4960-a314-1d0bc7644d3c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-49-AAR0_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAR0_treatment4	NA	NA	NA	NA	8c7c59d7-6e29-42d7-92c0-4683defdc349	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3afa5045-a1ee-4a07-8aad-2e252b2f7d7a	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AAR0	57	false	United States	-20932	NA	9d331b83-e9de-5fc6-8133-a40ef3bc787c	not hispanic or latino	male	black or african american	TCGA-49-AAR0_demographic	Alive	20932	MX	N0	Stage IA	T1	5th	primary	0	4765.0	6f50fcfc-034c-5dda-a7c9-378451ecd93c	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-49-AAR0_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAR0_treatment	NA	NA	NA	NA	022f38d0-182e-5a03-87ac-de9d2779f3ff	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3afa5045-a1ee-4a07-8aad-2e252b2f7d7a	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AAR0	57	false	United States	-20932	NA	9d331b83-e9de-5fc6-8133-a40ef3bc787c	not hispanic or latino	male	black or african american	TCGA-49-AAR0_demographic	Alive	20932	MX	N0	Stage IA	T1	5th	primary	0	4765.0	6f50fcfc-034c-5dda-a7c9-378451ecd93c	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-49-AAR0_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAR0_treatment2	NA	NA	NA	NA	9f5f868d-ac15-462a-80db-20d9d729a38c	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3b21b982-dba2-45f4-ad8d-21dc86fcaaa7	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A57B	80	false	United States	-29452	NA	fc758e79-2d45-5ae0-a153-f3392c8f9f5a	not hispanic or latino	female	black or african american	TCGA-55-A57B_demographic	Alive	29452	M0	N0	Stage IA	T1b	7th	primary	0	546.0	4a33e80e-26c6-5740-89f1-a806245cdee4	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-A57B_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A57B_treatment	NA	NA	NA	NA	40ef46bd-f960-564b-b71e-f75a2aecb20f	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3b21b982-dba2-45f4-ad8d-21dc86fcaaa7	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A57B	80	false	United States	-29452	NA	fc758e79-2d45-5ae0-a153-f3392c8f9f5a	not hispanic or latino	female	black or african american	TCGA-55-A57B_demographic	Alive	29452	M0	N0	Stage IA	T1b	7th	primary	0	546.0	4a33e80e-26c6-5740-89f1-a806245cdee4	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-A57B_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A57B_treatment2	NA	NA	NA	NA	5f487dc3-4a6f-4ae5-90a9-0d0e94e5e7cd	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	3b89ac82-63f6-41b9-a03d-34b9ffc1550d	Informed Consent	26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A443	63	false	United States	-23062	193	f440aff4-6068-5d83-8c09-0c6bcbf15c99	not hispanic or latino	female	white	TCGA-L9-A443_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	39d88235-ddf7-4c3a-89bc-1277dbf93160	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-L9-A443_diagnosis2	NA	Cervix uteri	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A443_treatment5	NA	NA	NA	NA	0788c8a9-507c-4d3f-b77a-3785280bfc67	NA	yes	NA	Surgery, NOS
TCGA-LUAD	3b89ac82-63f6-41b9-a03d-34b9ffc1550d	Informed Consent	26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A443	63	false	United States	-23062	193	f440aff4-6068-5d83-8c09-0c6bcbf15c99	not hispanic or latino	female	white	TCGA-L9-A443_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	39d88235-ddf7-4c3a-89bc-1277dbf93160	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-L9-A443_diagnosis2	NA	Cervix uteri	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A443_treatment3	NA	NA	NA	NA	475b7bab-923a-4494-953d-d813d6e743ca	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3b89ac82-63f6-41b9-a03d-34b9ffc1550d	Informed Consent	26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A443	63	false	United States	-23062	193	f440aff4-6068-5d83-8c09-0c6bcbf15c99	not hispanic or latino	female	white	TCGA-L9-A443_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	39d88235-ddf7-4c3a-89bc-1277dbf93160	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-L9-A443_diagnosis2	NA	Cervix uteri	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A443_treatment4	NA	NA	NA	NA	e96b2a2b-e9a1-4ffa-8545-eb029e947c38	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3b89ac82-63f6-41b9-a03d-34b9ffc1550d	Informed Consent	26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A443	63	false	United States	-23062	193	f440aff4-6068-5d83-8c09-0c6bcbf15c99	not hispanic or latino	female	white	TCGA-L9-A443_demographic	Dead	23062	MX	N0	Stage IA	T1a	7th	primary	0	193.0	b4550694-6b07-55eb-aa1c-a22ef9346cd2	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-L9-A443_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A443_treatment	NA	NA	NA	NA	22cf426d-4a8f-5391-b51b-4be8cd05b66f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3b89ac82-63f6-41b9-a03d-34b9ffc1550d	Informed Consent	26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A443	63	false	United States	-23062	193	f440aff4-6068-5d83-8c09-0c6bcbf15c99	not hispanic or latino	female	white	TCGA-L9-A443_demographic	Dead	23062	MX	N0	Stage IA	T1a	7th	primary	0	193.0	b4550694-6b07-55eb-aa1c-a22ef9346cd2	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-L9-A443_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A443_treatment2	NA	NA	NA	NA	36ba21b0-e612-4906-8dbd-3010aae8cc53	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3bc7026f-73f2-418b-bd62-f4768582b790	Informed Consent	28	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7567	61	false	United States	-22437	NA	03a19794-cc3e-54af-bab8-a9e081a99c63	not hispanic or latino	male	white	TCGA-95-7567_demographic	Alive	22437	M0	N1	Stage IIB	T2b	7th	primary	0	568.0	1f0b06cb-03db-5027-a304-74f7eb9a6de1	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-95-7567_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	149	79	NA	4	NA	155.0	mg	Intravenous	TCGA-95-7567_treatment	Cisplatin	NA	620	mg	1c980d4e-e612-5ac2-871e-43bfb9f813f5	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	3bc7026f-73f2-418b-bd62-f4768582b790	Informed Consent	28	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7567	61	false	United States	-22437	NA	03a19794-cc3e-54af-bab8-a9e081a99c63	not hispanic or latino	male	white	TCGA-95-7567_demographic	Alive	22437	M0	N1	Stage IIB	T2b	7th	primary	0	568.0	1f0b06cb-03db-5027-a304-74f7eb9a6de1	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-95-7567_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	149	89	NA	4	NA	155.0	mg	Intravenous	TCGA-95-7567_treatment2	Docetaxel	NA	620	mg	2d885b78-9062-4c9c-a641-91741d3128be	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	3bc7026f-73f2-418b-bd62-f4768582b790	Informed Consent	28	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7567	61	false	United States	-22437	NA	03a19794-cc3e-54af-bab8-a9e081a99c63	not hispanic or latino	male	white	TCGA-95-7567_demographic	Alive	22437	M0	N1	Stage IIB	T2b	7th	primary	0	568.0	1f0b06cb-03db-5027-a304-74f7eb9a6de1	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-95-7567_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7567_treatment3	NA	NA	NA	NA	824c9733-59ef-463b-b342-68bf4073decd	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3bd6badb-27ff-4d8d-b206-4d28dc264862	Informed Consent	25	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3396	74	false	United States	-27073	NA	a54ecb19-24f7-50cd-8d5d-8ac3985ef3ef	not hispanic or latino	female	white	TCGA-44-3396_demographic	Alive	27073	M0	N2	Stage IIIA	T2	7th	primary	0	1130.0	c115f80b-56a4-54e6-b67f-e40ad3e57d67	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3396_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	192	129	NA	4	NA	850.0	mg	Intravenous	TCGA-44-3396_treatment	Pemetrexed Disodium	NA	3400	mg	3a61dffd-2937-5f8c-a709-d6f772f5a43e	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	3bd6badb-27ff-4d8d-b206-4d28dc264862	Informed Consent	25	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3396	74	false	United States	-27073	NA	a54ecb19-24f7-50cd-8d5d-8ac3985ef3ef	not hispanic or latino	female	white	TCGA-44-3396_demographic	Alive	27073	M0	N2	Stage IIIA	T2	7th	primary	0	1130.0	c115f80b-56a4-54e6-b67f-e40ad3e57d67	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3396_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3396_treatment3	NA	NA	NA	NA	4e844f15-1651-4ad1-a897-10ff97346f7d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3bd6badb-27ff-4d8d-b206-4d28dc264862	Informed Consent	25	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3396	74	false	United States	-27073	NA	a54ecb19-24f7-50cd-8d5d-8ac3985ef3ef	not hispanic or latino	female	white	TCGA-44-3396_demographic	Alive	27073	M0	N2	Stage IIIA	T2	7th	primary	0	1130.0	c115f80b-56a4-54e6-b67f-e40ad3e57d67	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3396_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	192	129	NA	4	NA	600.0	mg	Intravenous	TCGA-44-3396_treatment2	Carboplatin	NA	2100	mg	c0caf610-f6ed-448e-8e95-b28c4602a2fc	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	3c4ff061-d214-4d1c-8d2e-3034f207c252	Informed Consent	27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6775	72	false	United States	-26415	NA	deeef152-7fe9-569b-bf26-70aac2d5aa75	hispanic or latino	female	white	TCGA-44-6775_demographic	Alive	27099	NA	NA	NA	NA	NA	recurrence	684	NA	1e48dc77-b219-49bc-a0d9-787c8b56e883	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-6775_diagnosis2	NA	Not Reported	TCGA-44-6775_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6775_treatment5	NA	Locoregional Site	NA	NA	0fd5bf75-9b9d-4adc-bbec-6aaa55e39513	NA	no	NA	Surgery, NOS
TCGA-LUAD	3c4ff061-d214-4d1c-8d2e-3034f207c252	Informed Consent	27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6775	72	false	United States	-26415	NA	deeef152-7fe9-569b-bf26-70aac2d5aa75	hispanic or latino	female	white	TCGA-44-6775_demographic	Alive	27099	NA	NA	NA	NA	NA	recurrence	684	NA	1e48dc77-b219-49bc-a0d9-787c8b56e883	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-6775_diagnosis2	NA	Not Reported	TCGA-44-6775_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-6775_treatment3	NA	NA	NA	NA	6071fa8b-9326-4ea8-b9fc-ea38b0e2a0c0	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3c4ff061-d214-4d1c-8d2e-3034f207c252	Informed Consent	27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6775	72	false	United States	-26415	NA	deeef152-7fe9-569b-bf26-70aac2d5aa75	hispanic or latino	female	white	TCGA-44-6775_demographic	Alive	27099	NA	NA	NA	NA	NA	recurrence	684	NA	1e48dc77-b219-49bc-a0d9-787c8b56e883	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-6775_diagnosis2	NA	Not Reported	TCGA-44-6775_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-6775_treatment4	NA	NA	NA	NA	b52cfdd2-7a3b-403f-ae33-f552e5f1c9b9	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3c4ff061-d214-4d1c-8d2e-3034f207c252	Informed Consent	27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6775	72	false	United States	-26415	NA	deeef152-7fe9-569b-bf26-70aac2d5aa75	hispanic or latino	female	white	TCGA-44-6775_demographic	Alive	26415	MX	N0	Stage IB	T2a	7th	primary	0	705.0	9091c61b-4cbb-5536-b743-d932aa15f9df	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-44-6775_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6775_treatment	NA	NA	NA	NA	67945b56-67b4-561a-955e-17bec8ba70a7	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3c4ff061-d214-4d1c-8d2e-3034f207c252	Informed Consent	27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6775	72	false	United States	-26415	NA	deeef152-7fe9-569b-bf26-70aac2d5aa75	hispanic or latino	female	white	TCGA-44-6775_demographic	Alive	26415	MX	N0	Stage IB	T2a	7th	primary	0	705.0	9091c61b-4cbb-5536-b743-d932aa15f9df	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-44-6775_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6775_treatment2	NA	NA	NA	NA	8677eee6-1176-4255-99b7-afe70462592d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3d0cbd55-4eda-4c52-93cc-a74381ea7c59	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z035	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	3d2aa654-1b5f-4eb4-a1c2-af31f5760069	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4420	41	false	Germany	-15159	NA	18e816f3-2dd0-53e8-aa68-de7dc0f5bfca	not reported	male	not reported	TCGA-05-4420_demographic	Alive	15159	M0	N0	Stage IB	T2	6th	primary	0	912.0	4d16c466-c1d0-52e9-b3ce-a7a867c527f4	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4420_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4420_treatment	NA	NA	NA	NA	2b1557d5-90fa-5cc5-87ff-7c53225359b7	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3d2aa654-1b5f-4eb4-a1c2-af31f5760069	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4420	41	false	Germany	-15159	NA	18e816f3-2dd0-53e8-aa68-de7dc0f5bfca	not reported	male	not reported	TCGA-05-4420_demographic	Alive	15159	M0	N0	Stage IB	T2	6th	primary	0	912.0	4d16c466-c1d0-52e9-b3ce-a7a867c527f4	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4420_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4420_treatment2	NA	NA	NA	NA	a71a164a-7945-4d4a-8f1b-aacc46842d48	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3daebe75-c6df-478e-8a4c-11186fd5ead9	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-93-A4JO	70	false	United States	-25898	33	083c00df-8520-5001-9a59-9916e4114927	not hispanic or latino	male	white	TCGA-93-A4JO_demographic	Dead	25898	MX	N0	Stage IA	T1a	7th	primary	0	33.0	f4223802-a76b-5dde-8ec5-0e82114711d1	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	RX	Lung, NOS	NA	TCGA-93-A4JO_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-A4JO_treatment2	NA	NA	NA	NA	4e2a79ab-821b-47da-be66-f06412aeb9fb	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3daebe75-c6df-478e-8a4c-11186fd5ead9	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-93-A4JO	70	false	United States	-25898	33	083c00df-8520-5001-9a59-9916e4114927	not hispanic or latino	male	white	TCGA-93-A4JO_demographic	Dead	25898	MX	N0	Stage IA	T1a	7th	primary	0	33.0	f4223802-a76b-5dde-8ec5-0e82114711d1	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	RX	Lung, NOS	NA	TCGA-93-A4JO_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-A4JO_treatment	NA	NA	NA	NA	f71cb03a-e13f-5fd3-a8ac-eb27138331f1	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3e1df30f-744a-41e9-a169-7dbbff66622e	Informed Consent	72	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7974	54	false	United States	-20021	NA	aabaf95f-ffe0-5191-bbd0-f4173d82df73	not hispanic or latino	female	white	TCGA-69-7974_demographic	Alive	20021	MX	N2	Stage IIIA	T2a	7th	primary	0	184.0	8285b0b6-9484-52ed-b473-65c9fab90376	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7974_diagnosis	No	Upper lobe, lung	NA	2011	NA	1.0	NA	141	NA	NA	30.0	NA	NA	NA	TCGA-69-7974_treatment	NA	Regional Site	6000	cGy	0fca7fb7-567b-5314-a6e8-45d292df7c71	Adjuvant	yes	Treatment Ongoing	Radiation, External Beam
TCGA-LUAD	3e1df30f-744a-41e9-a169-7dbbff66622e	Informed Consent	72	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7974	54	false	United States	-20021	NA	aabaf95f-ffe0-5191-bbd0-f4173d82df73	not hispanic or latino	female	white	TCGA-69-7974_demographic	Alive	20021	MX	N2	Stage IIIA	T2a	7th	primary	0	184.0	8285b0b6-9484-52ed-b473-65c9fab90376	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7974_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	96	75	NA	NA	NA	NA	NA	NA	TCGA-69-7974_treatment4	Carboplatin	NA	NA	NA	2d044e3b-78ac-4c63-b21b-b0d4db041ebd	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	3e1df30f-744a-41e9-a169-7dbbff66622e	Informed Consent	72	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7974	54	false	United States	-20021	NA	aabaf95f-ffe0-5191-bbd0-f4173d82df73	not hispanic or latino	female	white	TCGA-69-7974_demographic	Alive	20021	MX	N2	Stage IIIA	T2a	7th	primary	0	184.0	8285b0b6-9484-52ed-b473-65c9fab90376	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7974_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	96	33	NA	NA	NA	NA	NA	NA	TCGA-69-7974_treatment3	Pemetrexed	NA	NA	NA	98bed272-fe2b-48d8-8e56-3f58a989a595	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	3e1df30f-744a-41e9-a169-7dbbff66622e	Informed Consent	72	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7974	54	false	United States	-20021	NA	aabaf95f-ffe0-5191-bbd0-f4173d82df73	not hispanic or latino	female	white	TCGA-69-7974_demographic	Alive	20021	MX	N2	Stage IIIA	T2a	7th	primary	0	184.0	8285b0b6-9484-52ed-b473-65c9fab90376	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7974_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	54	33	NA	NA	NA	NA	NA	NA	TCGA-69-7974_treatment2	Cisplatin	NA	NA	NA	bbdcc870-d466-4f9d-9ccf-3c57432c403f	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	3e34c7d9-90fa-41e2-ba6b-4bbc332adc4e	Informed Consent	162	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A4DG	71	false	United States	-26044	NA	af6e31aa-3d32-5d03-b25b-cd51de1ed563	not hispanic or latino	male	white	TCGA-55-A4DG_demographic	Alive	26044	MX	N0	Stage IA	T1b	7th	primary	0	608.0	ed66bcf7-1a57-5445-98b0-a1c8538ea40b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-A4DG_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A4DG_treatment	NA	NA	NA	NA	194bf039-e2e4-5297-8c3c-88a4c7d685ac	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3e34c7d9-90fa-41e2-ba6b-4bbc332adc4e	Informed Consent	162	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A4DG	71	false	United States	-26044	NA	af6e31aa-3d32-5d03-b25b-cd51de1ed563	not hispanic or latino	male	white	TCGA-55-A4DG_demographic	Alive	26044	MX	N0	Stage IA	T1b	7th	primary	0	608.0	ed66bcf7-1a57-5445-98b0-a1c8538ea40b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-A4DG_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A4DG_treatment2	NA	NA	NA	NA	7a4b29dc-7efa-40d8-98cb-c9f68432e757	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	3e635902-5310-4406-8b4d-a238ce382639	Informed Consent	7	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-4679	68	false	United States	-25202	NA	b7684fed-3503-5d6d-8912-df6a45563ec3	not hispanic or latino	male	white	TCGA-67-4679_demographic	Alive	25202	M0	N0	NA	T3	NA	primary	0	448.0	124e50cd-fb62-51f8-a554-7e12e5c2533e	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-4679_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	3ed05070-6633-4de5-9f72-090f93aa2e4d	Informed Consent	11	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-8506	62	false	United States	-22850	NA	9a307bd1-a3de-570d-8093-a744620305e0	not hispanic or latino	female	white	TCGA-55-8506_demographic	Alive	22850	MX	N0	Stage IIB	T3	7th	primary	0	11.0	da00435d-d08b-5cff-a5cb-e450ac38b4a5	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-8506_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8506_treatment2	NA	NA	NA	NA	855910be-84ef-46c0-95ef-1af23e801385	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	3ed05070-6633-4de5-9f72-090f93aa2e4d	Informed Consent	11	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-8506	62	false	United States	-22850	NA	9a307bd1-a3de-570d-8093-a744620305e0	not hispanic or latino	female	white	TCGA-55-8506_demographic	Alive	22850	MX	N0	Stage IIB	T3	7th	primary	0	11.0	da00435d-d08b-5cff-a5cb-e450ac38b4a5	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-8506_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8506_treatment	NA	NA	NA	NA	978bdeb9-13d4-50dd-ba6e-e406c9645009	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	3fe8f8e4-5396-4362-82f5-366e2fb69db2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5428	57	false	Germany	-21061	NA	99b9b9a4-3f15-5d69-a197-f3da55b6ae3e	not reported	male	not reported	TCGA-05-5428_demographic	Alive	21061	M0	N1	Stage IIA	T1b	7th	primary	0	670.0	03ad29be-90ed-56cf-9a2b-a4ddde89341f	true	NA	NA	C34.9	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-5428_diagnosis	No	Lung, NOS	NA	2010	No	NA	153	62	NA	NA	NA	NA	NA	NA	TCGA-05-5428_treatment2	Cisplatin	NA	NA	NA	316b5435-f262-4579-9f2d-4ca114a9b1ef	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	3fe8f8e4-5396-4362-82f5-366e2fb69db2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5428	57	false	Germany	-21061	NA	99b9b9a4-3f15-5d69-a197-f3da55b6ae3e	not reported	male	not reported	TCGA-05-5428_demographic	Alive	21061	M0	N1	Stage IIA	T1b	7th	primary	0	670.0	03ad29be-90ed-56cf-9a2b-a4ddde89341f	true	NA	NA	C34.9	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-5428_diagnosis	No	Lung, NOS	NA	2010	No	NA	153	62	NA	NA	NA	NA	NA	NA	TCGA-05-5428_treatment3	Vinorelbine	NA	NA	NA	59ec81b9-0c45-4a05-975e-95053960d2e0	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	3fe8f8e4-5396-4362-82f5-366e2fb69db2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5428	57	false	Germany	-21061	NA	99b9b9a4-3f15-5d69-a197-f3da55b6ae3e	not reported	male	not reported	TCGA-05-5428_demographic	Alive	21061	M0	N1	Stage IIA	T1b	7th	primary	0	670.0	03ad29be-90ed-56cf-9a2b-a4ddde89341f	true	NA	NA	C34.9	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-5428_diagnosis	No	Lung, NOS	NA	2010	NA	NA	274	215	NA	NA	NA	NA	NA	NA	TCGA-05-5428_treatment	NA	Primary Tumor Field	64	Gy	bfd00da5-04ee-5edb-a9cd-d2a73bb28ad9	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	4036c6fc-c82e-47bb-a384-6f299dc30b52	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7672	52	false	United States	-19200	NA	115b6c10-0c47-5bbe-928c-42cdf44d54d0	not hispanic or latino	female	white	TCGA-44-7672_demographic	Alive	19200	M0	N0	Stage IA	T1b	7th	primary	0	719.0	eb4f5f7f-1497-55ea-b8b0-fb666839ea12	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7672_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7672_treatment2	NA	NA	NA	NA	78c0fba9-334e-4f76-b911-c4b5f95f323d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4036c6fc-c82e-47bb-a384-6f299dc30b52	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7672	52	false	United States	-19200	NA	115b6c10-0c47-5bbe-928c-42cdf44d54d0	not hispanic or latino	female	white	TCGA-44-7672_demographic	Alive	19200	M0	N0	Stage IA	T1b	7th	primary	0	719.0	eb4f5f7f-1497-55ea-b8b0-fb666839ea12	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7672_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7672_treatment	NA	NA	NA	NA	7cc855c5-190b-54b4-b0d8-dbfbc114d41d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20315	NA	NA	NA	NA	NA	not reported	96	NA	3690102f-4579-4ef1-a1fe-fa9e588d012a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-5781_diagnosis2	NA	Not Reported	TCGA-64-5781_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-5781_treatment10	NA	Locoregional Site	NA	NA	0d2df474-bd06-4b27-8a16-fb80ebce7a10	NA	no	NA	Surgery, NOS
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20315	NA	NA	NA	NA	NA	not reported	96	NA	3690102f-4579-4ef1-a1fe-fa9e588d012a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-5781_diagnosis2	NA	Not Reported	TCGA-64-5781_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-64-5781_treatment9	NA	NA	NA	NA	3aa954e6-1c38-4523-8aba-3dd7b2ceaa6c	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20315	NA	NA	NA	NA	NA	not reported	96	NA	3690102f-4579-4ef1-a1fe-fa9e588d012a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-5781_diagnosis2	NA	Not Reported	TCGA-64-5781_diagnosis	NA	NA	NA	NA	112	NA	NA	NA	NA	NA	NA	TCGA-64-5781_treatment11	NA	Distant Site	NA	NA	7075b85e-ee49-4c40-a063-9a29132724d5	NA	yes	NA	Surgery, NOS
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20315	NA	NA	NA	NA	NA	not reported	96	NA	3690102f-4579-4ef1-a1fe-fa9e588d012a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-5781_diagnosis2	NA	Not Reported	TCGA-64-5781_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-64-5781_treatment8	NA	NA	NA	NA	f445cdb7-9d14-448f-9b9a-34906fbe5f9d	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20315	NA	NA	NA	NA	NA	metastasis	96	NA	40b3853a-52fe-4acc-899f-eafe0fb85a44	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-64-5781_diagnosis3	NA	Not Reported	TCGA-64-5781_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-64-5781_treatment12	NA	NA	NA	NA	37922104-d73c-4e11-9926-a2d0fff3d78e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20315	NA	NA	NA	NA	NA	metastasis	96	NA	40b3853a-52fe-4acc-899f-eafe0fb85a44	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-64-5781_diagnosis3	NA	Not Reported	TCGA-64-5781_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-5781_treatment14	NA	Locoregional Site	NA	NA	5f927637-74d7-4183-9b64-ed3bbf861220	NA	no	NA	Surgery, NOS
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20315	NA	NA	NA	NA	NA	metastasis	96	NA	40b3853a-52fe-4acc-899f-eafe0fb85a44	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-64-5781_diagnosis3	NA	Not Reported	TCGA-64-5781_diagnosis	NA	NA	NA	NA	112	NA	NA	NA	NA	NA	NA	TCGA-64-5781_treatment15	NA	Distant Site	NA	NA	9b90d85d-742c-4af3-a480-7e51a627571e	NA	yes	NA	Surgery, NOS
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20315	NA	NA	NA	NA	NA	metastasis	96	NA	40b3853a-52fe-4acc-899f-eafe0fb85a44	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-64-5781_diagnosis3	NA	Not Reported	TCGA-64-5781_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-64-5781_treatment13	NA	NA	NA	NA	b8b60683-cbc7-412d-bcbb-67c9f93e5ff2	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20219	M0	N0	Stage IB	T2	6th	primary	0	1559.0	48c591c9-e727-5bee-83d2-a3091864178d	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5781_diagnosis	No	Upper lobe, lung	NA	2007	No	NA	187	159	NA	NA	NA	NA	NA	NA	TCGA-64-5781_treatment6	Bevacizumab	NA	NA	NA	3c543d6b-f306-4c78-bdb2-1eae57f5919c	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20219	M0	N0	Stage IB	T2	6th	primary	0	1559.0	48c591c9-e727-5bee-83d2-a3091864178d	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5781_diagnosis	No	Upper lobe, lung	NA	2007	No	NA	215	131	NA	NA	NA	NA	NA	NA	TCGA-64-5781_treatment5	Gemcitabine	NA	NA	NA	788415bc-4688-41f1-b5c5-8c5918721c4f	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20219	M0	N0	Stage IB	T2	6th	primary	0	1559.0	48c591c9-e727-5bee-83d2-a3091864178d	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5781_diagnosis	No	Upper lobe, lung	NA	2007	No	NA	215	131	NA	NA	NA	NA	NA	NA	TCGA-64-5781_treatment4	Cisplatin	NA	NA	NA	a1f2b2a0-7b6b-48b2-af2d-7ab5de262e88	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20219	M0	N0	Stage IB	T2	6th	primary	0	1559.0	48c591c9-e727-5bee-83d2-a3091864178d	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5781_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	215	101	Progressive Disease	4	NA	1250.0	mg/m2	Intravenous	TCGA-64-5781_treatment3	Gemcitabine	NA	NA	NA	b21f2d8c-998f-4084-8331-a84124e36b60	NA	yes	NA	Chemotherapy
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20219	M0	N0	Stage IB	T2	6th	primary	0	1559.0	48c591c9-e727-5bee-83d2-a3091864178d	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5781_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	215	101	NA	4	NA	75.0	mg/m2	Intravenous	TCGA-64-5781_treatment2	Cisplatin	NA	NA	NA	c92c7a01-f42d-4664-90c1-ce2137f814f9	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20219	M0	N0	Stage IB	T2	6th	primary	0	1559.0	48c591c9-e727-5bee-83d2-a3091864178d	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5781_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	187	159	Progressive Disease	3	NA	15.0	mg/kg	Intravenous	TCGA-64-5781_treatment	Bevacizumab	NA	NA	NA	ea000239-5230-59d1-9ba0-2603367efe8d	NA	yes	NA	Chemotherapy
TCGA-LUAD	41c4c704-825e-49f5-9d54-dbd7d30725e0	Informed Consent	57	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5781	55	false	United States	-20219	NA	4afc640f-9d5c-5dea-8e29-b1acbe37f5fc	not hispanic or latino	female	white	TCGA-64-5781_demographic	Alive	20219	M0	N0	Stage IB	T2	6th	primary	0	1559.0	48c591c9-e727-5bee-83d2-a3091864178d	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5781_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-5781_treatment7	NA	NA	NA	NA	fe9f5b11-4f8a-468b-8591-390c97188191	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	42259aa6-c9f5-4309-a956-dbf930312f44	Informed Consent	27	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-NJ-A4YP	52	false	United States	-19106	NA	6a5fd2ae-f86f-5c75-adcb-627abd999e62	not hispanic or latino	male	white	TCGA-NJ-A4YP_demographic	Alive	19106	M0	N0	Stage IB	T2a	7th	primary	0	50.0	7e57e93c-f465-5090-917a-f2d9acaf64b2	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-NJ-A4YP_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A4YP_treatment	NA	NA	NA	NA	dce77a3d-8eb7-5db9-884e-9a210a0264cb	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	42259aa6-c9f5-4309-a956-dbf930312f44	Informed Consent	27	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-NJ-A4YP	52	false	United States	-19106	NA	6a5fd2ae-f86f-5c75-adcb-627abd999e62	not hispanic or latino	male	white	TCGA-NJ-A4YP_demographic	Alive	19106	M0	N0	Stage IB	T2a	7th	primary	0	50.0	7e57e93c-f465-5090-917a-f2d9acaf64b2	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-NJ-A4YP_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A4YP_treatment2	NA	NA	NA	NA	fc4620f5-50bc-4d74-bd82-7644958c67fe	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	42432463-8e92-4f25-b72a-f03953527aa5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-O1-A52J	74	false	United States	-27223	1798	4af716fd-37b1-51f4-88bd-c547044d38f8	not hispanic or latino	female	white	TCGA-O1-A52J_demographic	Dead	28121	NA	NA	NA	NA	NA	recurrence	898	NA	508bbe9c-8c04-40b2-9a5b-f18941eb965d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-O1-A52J_diagnosis2	NA	Not Reported	TCGA-O1-A52J_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-O1-A52J_treatment3	NA	NA	NA	NA	9c79e63b-972f-4b84-bd1b-e3d3c2b677f5	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	42432463-8e92-4f25-b72a-f03953527aa5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-O1-A52J	74	false	United States	-27223	1798	4af716fd-37b1-51f4-88bd-c547044d38f8	not hispanic or latino	female	white	TCGA-O1-A52J_demographic	Dead	28121	NA	NA	NA	NA	NA	recurrence	898	NA	508bbe9c-8c04-40b2-9a5b-f18941eb965d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-O1-A52J_diagnosis2	NA	Not Reported	TCGA-O1-A52J_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-O1-A52J_treatment5	NA	Locoregional Site	NA	NA	9f377105-ab3c-4325-99c9-4b48eea51e03	NA	no	NA	Surgery, NOS
TCGA-LUAD	42432463-8e92-4f25-b72a-f03953527aa5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-O1-A52J	74	false	United States	-27223	1798	4af716fd-37b1-51f4-88bd-c547044d38f8	not hispanic or latino	female	white	TCGA-O1-A52J_demographic	Dead	28121	NA	NA	NA	NA	NA	recurrence	898	NA	508bbe9c-8c04-40b2-9a5b-f18941eb965d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-O1-A52J_diagnosis2	NA	Not Reported	TCGA-O1-A52J_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-O1-A52J_treatment4	NA	NA	NA	NA	c56b00b9-6177-43c3-8a2b-0c7467183c99	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	42432463-8e92-4f25-b72a-f03953527aa5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-O1-A52J	74	false	United States	-27223	1798	4af716fd-37b1-51f4-88bd-c547044d38f8	not hispanic or latino	female	white	TCGA-O1-A52J_demographic	Dead	27223	MX	N0	Stage IA	T1	6th	primary	0	1798.0	f579574b-5bce-57c3-95ae-4496f16b8d79	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-O1-A52J_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-O1-A52J_treatment	NA	NA	NA	NA	1ad89ca3-d915-51ce-bf28-6fd30cd3c30b	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	42432463-8e92-4f25-b72a-f03953527aa5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-O1-A52J	74	false	United States	-27223	1798	4af716fd-37b1-51f4-88bd-c547044d38f8	not hispanic or latino	female	white	TCGA-O1-A52J_demographic	Dead	27223	MX	N0	Stage IA	T1	6th	primary	0	1798.0	f579574b-5bce-57c3-95ae-4496f16b8d79	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-O1-A52J_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-O1-A52J_treatment2	NA	NA	NA	NA	83e13616-03a9-40e2-ac07-08da54339ac9	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	42ca54fc-c1ae-41cd-bca1-7fe9810db460	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2656	59	false	United States	-21766	NA	d118d77d-b3f5-592d-be04-d4b229010e91	not hispanic or latino	male	white	TCGA-44-2656_demographic	Alive	22334	NA	NA	NA	NA	NA	Subsequent Primary	568	NA	1129a5e0-8ae7-4506-8d9c-88ad668f4011	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2656_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-44-2656_treatment4	NA	NA	NA	NA	4b6d5009-f6fa-492b-b4f4-0c9188559dea	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	42ca54fc-c1ae-41cd-bca1-7fe9810db460	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2656	59	false	United States	-21766	NA	d118d77d-b3f5-592d-be04-d4b229010e91	not hispanic or latino	male	white	TCGA-44-2656_demographic	Alive	22334	NA	NA	NA	NA	NA	Subsequent Primary	568	NA	1129a5e0-8ae7-4506-8d9c-88ad668f4011	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2656_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-44-2656_treatment3	NA	NA	NA	NA	b9e65d04-daae-41ae-a874-772ef1ae1ec1	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	42ca54fc-c1ae-41cd-bca1-7fe9810db460	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2656	59	false	United States	-21766	NA	d118d77d-b3f5-592d-be04-d4b229010e91	not hispanic or latino	male	white	TCGA-44-2656_demographic	Alive	21766	M0	N0	Stage IB	T2	6th	primary	0	1429.0	6737f52c-ac28-5c60-aa8c-b1deca5eb3a0	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-2656_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2656_treatment	NA	NA	NA	NA	36b11917-8664-5db0-816f-b6d636da7624	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	42ca54fc-c1ae-41cd-bca1-7fe9810db460	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2656	59	false	United States	-21766	NA	d118d77d-b3f5-592d-be04-d4b229010e91	not hispanic or latino	male	white	TCGA-44-2656_demographic	Alive	21766	M0	N0	Stage IB	T2	6th	primary	0	1429.0	6737f52c-ac28-5c60-aa8c-b1deca5eb3a0	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-2656_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2656_treatment2	NA	NA	NA	NA	9474d66d-4e74-4099-8076-17e8644874cb	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	42d208bd-cd77-4bfb-ad53-9fc072a87393	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-53-7813	51	false	United States	-18875	NA	d7718e48-cd2d-56c3-9803-1ca47ab24656	not hispanic or latino	female	white	TCGA-53-7813_demographic	Alive	18875	M0	N0	Stage IIIB	T4	6th	primary	0	424.0	24f44b3f-bba2-535b-b0ec-4e4281035c5e	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	NA	TCGA-53-7813_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	40	40	NA	NA	NA	NA	NA	NA	TCGA-53-7813_treatment	Cisplatin	NA	NA	NA	0a3260e3-c556-5709-a931-8e667e944575	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	42d208bd-cd77-4bfb-ad53-9fc072a87393	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-53-7813	51	false	United States	-18875	NA	d7718e48-cd2d-56c3-9803-1ca47ab24656	not hispanic or latino	female	white	TCGA-53-7813_demographic	Alive	18875	M0	N0	Stage IIIB	T4	6th	primary	0	424.0	24f44b3f-bba2-535b-b0ec-4e4281035c5e	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	NA	TCGA-53-7813_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	146	62	NA	NA	NA	NA	NA	NA	TCGA-53-7813_treatment3	Carboplatin	NA	NA	NA	609c70fb-ef00-494b-834c-2771c20c4f8c	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	42d208bd-cd77-4bfb-ad53-9fc072a87393	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-53-7813	51	false	United States	-18875	NA	d7718e48-cd2d-56c3-9803-1ca47ab24656	not hispanic or latino	female	white	TCGA-53-7813_demographic	Alive	18875	M0	N0	Stage IIIB	T4	6th	primary	0	424.0	24f44b3f-bba2-535b-b0ec-4e4281035c5e	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	NA	TCGA-53-7813_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	40	40	NA	NA	NA	NA	NA	NA	TCGA-53-7813_treatment2	Docetaxel	NA	NA	NA	70973c2f-1f55-4a41-a684-fcb98dfb4f3b	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	42d208bd-cd77-4bfb-ad53-9fc072a87393	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-53-7813	51	false	United States	-18875	NA	d7718e48-cd2d-56c3-9803-1ca47ab24656	not hispanic or latino	female	white	TCGA-53-7813_demographic	Alive	18875	M0	N0	Stage IIIB	T4	6th	primary	0	424.0	24f44b3f-bba2-535b-b0ec-4e4281035c5e	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	NA	TCGA-53-7813_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	146	62	NA	NA	NA	NA	NA	NA	TCGA-53-7813_treatment4	Paclitaxel	NA	NA	NA	97c41dd5-9e8f-4878-99d0-abab41acaa89	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	42d208bd-cd77-4bfb-ad53-9fc072a87393	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-53-7813	51	false	United States	-18875	NA	d7718e48-cd2d-56c3-9803-1ca47ab24656	not hispanic or latino	female	white	TCGA-53-7813_demographic	Alive	18875	M0	N0	Stage IIIB	T4	6th	primary	0	424.0	24f44b3f-bba2-535b-b0ec-4e4281035c5e	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	NA	TCGA-53-7813_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-53-7813_treatment5	NA	NA	NA	NA	db3bfcd8-8e10-472e-91f6-2517a7544811	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	26934	M0	N2	Stage IIIA	T2	6th	primary	0	1498.0	5ad10d3b-89a4-52d0-8144-5d5b49af8753	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-8402_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	73	28	NA	NA	25.0	NA	NA	NA	TCGA-62-8402_treatment	NA	Regional Site	50	Gy	167c440e-3464-5a64-b9a1-11e886c780f3	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	26934	M0	N2	Stage IIIA	T2	6th	primary	0	1498.0	5ad10d3b-89a4-52d0-8144-5d5b49af8753	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-8402_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8402_treatment2	NA	NA	NA	NA	81ac42ee-db89-4991-889e-a579897202e0	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	27706	NA	NA	NA	NA	NA	metastasis	772	NA	7f3c6f75-5082-4d2a-9119-b4cf43d40949	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8402_diagnosis3	NA	Not Reported	TCGA-62-8402_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8402_treatment9	NA	Locoregional Site	NA	NA	483e84b3-9f49-4b90-8314-da33969d2346	NA	no	NA	Surgery, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	27706	NA	NA	NA	NA	NA	metastasis	772	NA	7f3c6f75-5082-4d2a-9119-b4cf43d40949	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8402_diagnosis3	NA	Not Reported	TCGA-62-8402_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-8402_treatment7	NA	NA	NA	NA	76cf708d-f147-4c86-96d1-7625bedd4905	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	27706	NA	NA	NA	NA	NA	metastasis	772	NA	7f3c6f75-5082-4d2a-9119-b4cf43d40949	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8402_diagnosis3	NA	Not Reported	TCGA-62-8402_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8402_treatment10	NA	Distant Site	NA	NA	7892cab4-b01f-4eb8-a3ed-8d9f32dfbc0a	NA	no	NA	Surgery, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	27706	NA	NA	NA	NA	NA	metastasis	772	NA	7f3c6f75-5082-4d2a-9119-b4cf43d40949	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8402_diagnosis3	NA	Not Reported	TCGA-62-8402_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-8402_treatment8	NA	NA	NA	NA	efca1ef9-53b5-4898-b01a-65f0c332f3c2	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	27706	NA	NA	NA	NA	NA	metastasis	772	NA	957a5031-cd31-484b-b304-bdd618b17a19	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8402_diagnosis4	NA	Not Reported	TCGA-62-8402_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-8402_treatment11	NA	NA	NA	NA	7a6bb85d-185b-4efc-a5d1-d0564a8b0a7e	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	27706	NA	NA	NA	NA	NA	metastasis	772	NA	957a5031-cd31-484b-b304-bdd618b17a19	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8402_diagnosis4	NA	Not Reported	TCGA-62-8402_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-8402_treatment12	NA	NA	NA	NA	841ec22c-21e4-49cb-a05b-77b08394b156	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	27706	NA	NA	NA	NA	NA	metastasis	772	NA	957a5031-cd31-484b-b304-bdd618b17a19	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8402_diagnosis4	NA	Not Reported	TCGA-62-8402_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8402_treatment13	NA	Distant Site	NA	NA	adccc66c-df29-4035-a77a-3eb94760eb7a	NA	no	NA	Surgery, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	27706	NA	NA	NA	NA	NA	recurrence	772	NA	bf636365-7819-4170-aea0-c4e21a718082	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8402_diagnosis2	NA	Not Reported	TCGA-62-8402_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-8402_treatment4	NA	NA	NA	NA	6e719f14-9367-40c4-a971-00ae335be23f	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	27706	NA	NA	NA	NA	NA	recurrence	772	NA	bf636365-7819-4170-aea0-c4e21a718082	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8402_diagnosis2	NA	Not Reported	TCGA-62-8402_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-8402_treatment3	NA	NA	NA	NA	92f1dc99-31eb-4d07-b0a9-6ffbe1a5c14a	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	27706	NA	NA	NA	NA	NA	recurrence	772	NA	bf636365-7819-4170-aea0-c4e21a718082	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8402_diagnosis2	NA	Not Reported	TCGA-62-8402_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8402_treatment5	NA	Locoregional Site	NA	NA	dbc08c48-a67e-40cc-9e5c-166ab325b27f	NA	no	NA	Surgery, NOS
TCGA-LUAD	433a32d0-93d1-4897-8e36-beb1ec1d998e	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8402	73	false	Germany	-26934	1498	667d2f41-3c4d-5e3f-8859-f0d751a6ed2e	not hispanic or latino	female	white	TCGA-62-8402_demographic	Dead	27706	NA	NA	NA	NA	NA	recurrence	772	NA	bf636365-7819-4170-aea0-c4e21a718082	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8402_diagnosis2	NA	Not Reported	TCGA-62-8402_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8402_treatment6	NA	Distant Site	NA	NA	e61156d3-2956-4466-b15d-c45ae6b933f7	NA	no	NA	Surgery, NOS
TCGA-LUAD	44218b35-219c-4ad9-a01e-fde14067c4c0	Informed Consent	-71	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7633	67	false	Australia	-24713	1528	39da446c-66c3-52fe-b75a-496fcb33c028	not reported	male	white	TCGA-78-7633_demographic	Dead	24713	M0	N0	Stage IB	T2	6th	primary	0	1528.0	4c3871ca-bf56-5db5-9f9e-0c76146c0e78	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-78-7633_diagnosis	Yes	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7633_treatment	NA	NA	NA	NA	0c7c8b8d-12c8-5541-a219-0b8c7f5455a0	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	44218b35-219c-4ad9-a01e-fde14067c4c0	Informed Consent	-71	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7633	67	false	Australia	-24713	1528	39da446c-66c3-52fe-b75a-496fcb33c028	not reported	male	white	TCGA-78-7633_demographic	Dead	24713	M0	N0	Stage IB	T2	6th	primary	0	1528.0	4c3871ca-bf56-5db5-9f9e-0c76146c0e78	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-78-7633_diagnosis	Yes	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7633_treatment2	NA	NA	NA	NA	6220ee2b-31fe-410e-be59-6a2c09b2ff24	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	44218b35-219c-4ad9-a01e-fde14067c4c0	Informed Consent	-71	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7633	67	false	Australia	-24713	1528	39da446c-66c3-52fe-b75a-496fcb33c028	not reported	male	white	TCGA-78-7633_demographic	Dead	26163	NA	NA	NA	NA	NA	recurrence	1450	NA	911c321c-5334-4cf1-8f52-09511c562257	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-78-7633_diagnosis2	NA	Not Reported	TCGA-78-7633_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-78-7633_treatment6	NA	NA	NA	NA	15b9b8a9-6f3f-4a44-9849-f75100ce6fbe	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	44218b35-219c-4ad9-a01e-fde14067c4c0	Informed Consent	-71	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7633	67	false	Australia	-24713	1528	39da446c-66c3-52fe-b75a-496fcb33c028	not reported	male	white	TCGA-78-7633_demographic	Dead	26163	NA	NA	NA	NA	NA	recurrence	1450	NA	911c321c-5334-4cf1-8f52-09511c562257	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-78-7633_diagnosis2	NA	Not Reported	TCGA-78-7633_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-78-7633_treatment5	NA	NA	NA	NA	1c39cb7d-fc6a-4767-9a70-f13d3f004c86	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	44218b35-219c-4ad9-a01e-fde14067c4c0	Informed Consent	-71	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7633	67	false	Australia	-24713	1528	39da446c-66c3-52fe-b75a-496fcb33c028	not reported	male	white	TCGA-78-7633_demographic	Dead	NA	M0	N0	Stage IA	T1	6th	Synchronous primary	NA	NA	b01a3642-1f39-4dea-9f7b-065618dea74c	false	NA	NA	NA	Left	8260/3	Papillary adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-78-7633_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7633_treatment3	NA	NA	NA	NA	71f37082-7194-4c8f-ba73-51f5d46165b1	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	44218b35-219c-4ad9-a01e-fde14067c4c0	Informed Consent	-71	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7633	67	false	Australia	-24713	1528	39da446c-66c3-52fe-b75a-496fcb33c028	not reported	male	white	TCGA-78-7633_demographic	Dead	NA	M0	N0	Stage IA	T1	6th	Synchronous primary	NA	NA	b01a3642-1f39-4dea-9f7b-065618dea74c	false	NA	NA	NA	Left	8260/3	Papillary adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-78-7633_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7633_treatment4	NA	NA	NA	NA	f5355a44-6193-4892-b2e9-53efdf7cf717	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4432a02d-91de-4a7d-875f-684865f3c95d	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z027	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	44adf4cb-2829-4153-80fd-a8b7ee0e654a	Informed Consent	28	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-35-4122	69	false	Russia	-25491	NA	81930e25-3f07-5e53-a82f-6be5914dd691	not hispanic or latino	male	white	TCGA-35-4122_demographic	Alive	25491	M0	N0	Stage IA	T1	7th	primary	0	225.0	47b11af9-8c8d-5872-bd97-0aaf6f0c4b68	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-35-4122_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-35-4122_treatment2	NA	NA	NA	NA	819e9ab1-ee87-466f-9758-33477279bb23	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	44adf4cb-2829-4153-80fd-a8b7ee0e654a	Informed Consent	28	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-35-4122	69	false	Russia	-25491	NA	81930e25-3f07-5e53-a82f-6be5914dd691	not hispanic or latino	male	white	TCGA-35-4122_demographic	Alive	25491	M0	N0	Stage IA	T1	7th	primary	0	225.0	47b11af9-8c8d-5872-bd97-0aaf6f0c4b68	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-35-4122_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-35-4122_treatment	NA	NA	NA	NA	99d0c232-7b3e-58d9-b40d-81219c7ff888	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	44d8c859-4b7a-4e9d-bffc-0de0e6afdcc4	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-8253	59	false	United States	-21771	NA	5f632719-d9e2-5de2-a5ab-d97865b9dc6d	not hispanic or latino	female	black or african american	TCGA-69-8253_demographic	Alive	21771	MX	N1	Stage IIA	T1a	7th	primary	0	426.0	1960ade3-e423-50ec-8664-de7f0cd12b76	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-69-8253_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	NA	55	NA	NA	NA	NA	NA	NA	TCGA-69-8253_treatment2	Pemetrexed	NA	NA	NA	06a1fed9-ec41-4a05-bd95-c8704681dc55	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	44d8c859-4b7a-4e9d-bffc-0de0e6afdcc4	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-8253	59	false	United States	-21771	NA	5f632719-d9e2-5de2-a5ab-d97865b9dc6d	not hispanic or latino	female	black or african american	TCGA-69-8253_demographic	Alive	21771	MX	N1	Stage IIA	T1a	7th	primary	0	426.0	1960ade3-e423-50ec-8664-de7f0cd12b76	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-69-8253_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-8253_treatment3	NA	NA	NA	NA	c26e16cb-d698-4d47-9bc8-c8473a290f36	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	44d8c859-4b7a-4e9d-bffc-0de0e6afdcc4	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-8253	59	false	United States	-21771	NA	5f632719-d9e2-5de2-a5ab-d97865b9dc6d	not hispanic or latino	female	black or african american	TCGA-69-8253_demographic	Alive	21771	MX	N1	Stage IIA	T1a	7th	primary	0	426.0	1960ade3-e423-50ec-8664-de7f0cd12b76	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-69-8253_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	NA	55	NA	NA	NA	NA	NA	NA	TCGA-69-8253_treatment	Cisplatin	NA	NA	NA	d8d9a6ad-a9d7-524f-a200-6db7f2a08694	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	44dec838-b653-42a7-a58b-a1fd232cd68c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4422	68	false	Germany	-24837	NA	ce2bfd12-41fa-57bc-aa81-f0cee843dfe3	not reported	male	not reported	TCGA-05-4422_demographic	Alive	24837	M0	N0	Stage IB	T2	6th	primary	0	365.0	c06d2d33-16a2-5075-a9a2-2c7ad44c7f43	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4422_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	46592b7b-6968-42a6-83af-0917c9f4a9a5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7535	45	false	Australia	-16571	949	964f7631-37b8-5566-b118-d5d5b0c0f01c	not reported	male	white	TCGA-78-7535_demographic	Dead	17380	NA	NA	NA	NA	NA	not reported	809	NA	ab05d39b-0de0-4ded-95dc-a7a2a628ec05	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7535_diagnosis2	NA	Not Reported	TCGA-78-7535_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7535_treatment6	NA	Locoregional Site	NA	NA	7dd9df63-228d-40ba-b370-ef4e29e5a4e1	NA	no	NA	Surgery, NOS
TCGA-LUAD	46592b7b-6968-42a6-83af-0917c9f4a9a5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7535	45	false	Australia	-16571	949	964f7631-37b8-5566-b118-d5d5b0c0f01c	not reported	male	white	TCGA-78-7535_demographic	Dead	17380	NA	NA	NA	NA	NA	not reported	809	NA	ab05d39b-0de0-4ded-95dc-a7a2a628ec05	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7535_diagnosis2	NA	Not Reported	TCGA-78-7535_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7535_treatment5	NA	NA	NA	NA	c60dc61c-ed66-474a-bccb-e12931341c19	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	46592b7b-6968-42a6-83af-0917c9f4a9a5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7535	45	false	Australia	-16571	949	964f7631-37b8-5566-b118-d5d5b0c0f01c	not reported	male	white	TCGA-78-7535_demographic	Dead	17380	NA	NA	NA	NA	NA	not reported	809	NA	ab05d39b-0de0-4ded-95dc-a7a2a628ec05	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7535_diagnosis2	NA	Not Reported	TCGA-78-7535_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7535_treatment4	NA	NA	NA	NA	e6741619-e98b-4fc9-ad7c-35995783f822	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	46592b7b-6968-42a6-83af-0917c9f4a9a5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7535	45	false	Australia	-16571	949	964f7631-37b8-5566-b118-d5d5b0c0f01c	not reported	male	white	TCGA-78-7535_demographic	Dead	17380	NA	NA	NA	NA	NA	not reported	809	NA	ab05d39b-0de0-4ded-95dc-a7a2a628ec05	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7535_diagnosis2	NA	Not Reported	TCGA-78-7535_diagnosis	NA	NA	NA	NA	809	NA	NA	NA	NA	NA	NA	TCGA-78-7535_treatment7	NA	Distant Site	NA	NA	ec440fac-c0da-4854-bf3d-c8a7aadbdc2b	NA	yes	NA	Surgery, NOS
TCGA-LUAD	46592b7b-6968-42a6-83af-0917c9f4a9a5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7535	45	false	Australia	-16571	949	964f7631-37b8-5566-b118-d5d5b0c0f01c	not reported	male	white	TCGA-78-7535_demographic	Dead	16571	M0	N0	Stage IB	T2	6th	primary	0	949.0	d68fb3ef-ec0f-5fb2-ad5f-a347a3e736ed	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-78-7535_diagnosis	No	Upper lobe, lung	NA	2000	NA	NA	130	60	NA	4	NA	160.0	mg	Intravenous	TCGA-78-7535_treatment2	Cisplatin	NA	640	mg	8c16f506-3aa1-4def-be30-b2de78813790	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	46592b7b-6968-42a6-83af-0917c9f4a9a5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7535	45	false	Australia	-16571	949	964f7631-37b8-5566-b118-d5d5b0c0f01c	not reported	male	white	TCGA-78-7535_demographic	Dead	16571	M0	N0	Stage IB	T2	6th	primary	0	949.0	d68fb3ef-ec0f-5fb2-ad5f-a347a3e736ed	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-78-7535_diagnosis	No	Upper lobe, lung	NA	2000	NA	NA	124	60	NA	3	NA	8.0	mg	Intravenous	TCGA-78-7535_treatment	Vinblastine	NA	56	mg	92fc4a6c-3bec-5e73-9ee6-810a4d95757b	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	46592b7b-6968-42a6-83af-0917c9f4a9a5	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7535	45	false	Australia	-16571	949	964f7631-37b8-5566-b118-d5d5b0c0f01c	not reported	male	white	TCGA-78-7535_demographic	Dead	16571	M0	N0	Stage IB	T2	6th	primary	0	949.0	d68fb3ef-ec0f-5fb2-ad5f-a347a3e736ed	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-78-7535_diagnosis	No	Upper lobe, lung	NA	2000	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7535_treatment3	NA	NA	NA	NA	fe22eb0f-b2cc-4db5-baf1-96c12e655ab6	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	467d96d7-4a42-4116-8c32-0e4b34f96d8a	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8358	44	false	Russia	-16409	NA	eb154e63-06b0-540e-858c-ccec75e53d91	not hispanic or latino	male	white	TCGA-86-8358_demographic	Alive	16409	M0	N0	Stage IB	T2a	7th	primary	0	653.0	508c5f4e-0e67-5914-9236-49f917cfa6d2	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8358_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8358_treatment2	NA	NA	NA	NA	3187e134-b83f-4095-a231-398f6629f2be	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	467d96d7-4a42-4116-8c32-0e4b34f96d8a	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8358	44	false	Russia	-16409	NA	eb154e63-06b0-540e-858c-ccec75e53d91	not hispanic or latino	male	white	TCGA-86-8358_demographic	Alive	16409	M0	N0	Stage IB	T2a	7th	primary	0	653.0	508c5f4e-0e67-5914-9236-49f917cfa6d2	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8358_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8358_treatment	NA	NA	NA	NA	8833f322-c537-5ed4-9a50-05fb3a0e9f54	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	47062ad2-ba82-45c8-a871-bdea84f0c405	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T7	75	false	United States	-27603	167	93d9011b-1780-5bbe-935e-39287122bb21	Unknown	female	Unknown	TCGA-MP-A4T7_demographic	Dead	27603	M1	N0	Stage IV	T2	6th	primary	0	167.0	0a5d9d72-1d94-50dd-ab41-295ede29bd15	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4T7_diagnosis	No	Lower lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T7_treatment	NA	NA	NA	NA	53ed19f4-3b1a-50de-b81c-ee11decf246f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	47062ad2-ba82-45c8-a871-bdea84f0c405	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T7	75	false	United States	-27603	167	93d9011b-1780-5bbe-935e-39287122bb21	Unknown	female	Unknown	TCGA-MP-A4T7_demographic	Dead	27603	M1	N0	Stage IV	T2	6th	primary	0	167.0	0a5d9d72-1d94-50dd-ab41-295ede29bd15	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4T7_diagnosis	No	Lower lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T7_treatment2	NA	NA	NA	NA	cd1f748a-da4a-4f88-a513-b04cc4c2a18d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	472337c2-a2fc-403a-8c17-69511193128b	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-86-8056	63	false	United States	-23369	NA	f4dc1013-6c1f-5f31-8758-8fc25b5653f7	not hispanic or latino	female	white	TCGA-86-8056_demographic	Alive	23369	M0	N0	Stage IIIA	T4	7th	primary	0	139.0	b74531ab-1cfc-58a1-b6c8-a6afa52b215f	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8056_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8056_treatment	NA	NA	NA	NA	1894baca-b975-531a-bac8-5e902aaab445	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	472337c2-a2fc-403a-8c17-69511193128b	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-86-8056	63	false	United States	-23369	NA	f4dc1013-6c1f-5f31-8758-8fc25b5653f7	not hispanic or latino	female	white	TCGA-86-8056_demographic	Alive	23369	M0	N0	Stage IIIA	T4	7th	primary	0	139.0	b74531ab-1cfc-58a1-b6c8-a6afa52b215f	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8056_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8056_treatment2	NA	NA	NA	NA	3eaf4471-bba6-4bb8-887e-c72e3846aa68	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	474b86d9-d897-467d-85d4-51dfa26ea107	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6642	63	false	United States	-23107	NA	d0fc6788-7b80-58ac-a9e8-89d851ee4b4b	not reported	male	white	TCGA-55-6642_demographic	Alive	23107	MX	N0	Stage IB	T2	6th	primary	0	2449.0	01c652a0-b98e-549e-8a1f-fd09ea8c06ed	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-6642_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6642_treatment	NA	NA	NA	NA	aa39f77b-f392-5586-82fd-8321b561a811	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	474b86d9-d897-467d-85d4-51dfa26ea107	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6642	63	false	United States	-23107	NA	d0fc6788-7b80-58ac-a9e8-89d851ee4b4b	not reported	male	white	TCGA-55-6642_demographic	Alive	23107	MX	N0	Stage IB	T2	6th	primary	0	2449.0	01c652a0-b98e-549e-8a1f-fd09ea8c06ed	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-6642_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6642_treatment2	NA	NA	NA	NA	ceb8a25f-4946-4028-a8e5-bb657c050251	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	47b749e6-e060-4aa1-8f29-976e489ba789	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AAR9	61	false	United States	-22510	260	d5bf178f-c507-5549-a57c-1c702b9ee2b5	not hispanic or latino	male	black or african american	TCGA-49-AAR9_demographic	Dead	22510	MX	N0	Stage IIB	T3	5th	primary	0	260.0	047c24cd-4e89-52f5-8e9d-ca8f6d7e9ba6	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AAR9_diagnosis	No	Lung, NOS	NA	1999	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAR9_treatment2	NA	NA	NA	NA	86755945-4a32-4b19-864e-d428f4222bbc	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	47b749e6-e060-4aa1-8f29-976e489ba789	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AAR9	61	false	United States	-22510	260	d5bf178f-c507-5549-a57c-1c702b9ee2b5	not hispanic or latino	male	black or african american	TCGA-49-AAR9_demographic	Dead	22510	MX	N0	Stage IIB	T3	5th	primary	0	260.0	047c24cd-4e89-52f5-8e9d-ca8f6d7e9ba6	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AAR9_diagnosis	No	Lung, NOS	NA	1999	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAR9_treatment	NA	NA	NA	NA	f714a5e9-0852-50c9-8155-bdf706e8991a	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	482eb2a7-6fed-4e4c-b1b6-14d6d869f855	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-86-8074	62	false	Russia	-22862	NA	0f2db51a-7c78-5138-b101-e68cafba56ac	not hispanic or latino	female	white	TCGA-86-8074_demographic	Alive	22862	M0	N1	Stage IIA	T1b	7th	primary	0	24.0	e178ebc2-6b71-5624-a685-64c239260104	true	NA	NA	C34.3	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8074_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8074_treatment	NA	NA	NA	NA	036409de-4bf9-55a1-8f53-4291c7ad823d	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	482eb2a7-6fed-4e4c-b1b6-14d6d869f855	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-86-8074	62	false	Russia	-22862	NA	0f2db51a-7c78-5138-b101-e68cafba56ac	not hispanic or latino	female	white	TCGA-86-8074_demographic	Alive	22862	M0	N1	Stage IIA	T1b	7th	primary	0	24.0	e178ebc2-6b71-5624-a685-64c239260104	true	NA	NA	C34.3	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8074_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8074_treatment2	NA	NA	NA	NA	2182bd76-4848-4137-b2a1-a9c0169a6504	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	488646a1-0bdb-45f8-8c30-bef006924511	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7027	NA	false	Canada	NA	NA	5a9d85d2-022a-5cbb-8345-f29516e8a55d	not reported	male	not reported	TCGA-75-7027_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	3059.0	121bf179-a530-513f-88e2-0334cadacec1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-7027_diagnosis	No	Lower lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-7027_treatment2	NA	NA	NA	NA	be35d28b-b085-44db-b880-8fe7e34c0c6e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	488646a1-0bdb-45f8-8c30-bef006924511	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7027	NA	false	Canada	NA	NA	5a9d85d2-022a-5cbb-8345-f29516e8a55d	not reported	male	not reported	TCGA-75-7027_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	3059.0	121bf179-a530-513f-88e2-0334cadacec1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-7027_diagnosis	No	Lower lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-7027_treatment	NA	NA	NA	NA	d99839be-4376-5ae3-8d41-84eacb76fc87	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	488646a1-0bdb-45f8-8c30-bef006924511	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7027	NA	false	Canada	NA	NA	5a9d85d2-022a-5cbb-8345-f29516e8a55d	not reported	male	not reported	TCGA-75-7027_demographic	Alive	NA	NA	NA	NA	NA	NA	recurrence	2949	NA	85eb2cc1-903b-4936-9c6c-ea188a953283	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-7027_diagnosis2	NA	Not Reported	TCGA-75-7027_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-75-7027_treatment4	NA	NA	NA	NA	2b6f805b-a0e4-493e-aa18-1c87ae81552c	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	488646a1-0bdb-45f8-8c30-bef006924511	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7027	NA	false	Canada	NA	NA	5a9d85d2-022a-5cbb-8345-f29516e8a55d	not reported	male	not reported	TCGA-75-7027_demographic	Alive	NA	NA	NA	NA	NA	NA	recurrence	2949	NA	85eb2cc1-903b-4936-9c6c-ea188a953283	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-7027_diagnosis2	NA	Not Reported	TCGA-75-7027_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-7027_treatment5	NA	Locoregional Site	NA	NA	67125763-c098-41e9-b74d-83ee3c9f9e9b	NA	no	NA	Surgery, NOS
TCGA-LUAD	488646a1-0bdb-45f8-8c30-bef006924511	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7027	NA	false	Canada	NA	NA	5a9d85d2-022a-5cbb-8345-f29516e8a55d	not reported	male	not reported	TCGA-75-7027_demographic	Alive	NA	NA	NA	NA	NA	NA	recurrence	2949	NA	85eb2cc1-903b-4936-9c6c-ea188a953283	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-7027_diagnosis2	NA	Not Reported	TCGA-75-7027_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-75-7027_treatment3	NA	NA	NA	NA	a014e083-a431-4238-ab3d-1ebf7ffc36c4	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	494d50b6-578e-441b-8195-4b4d26c0d810	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z016	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	497cc506-03fe-4ffa-860b-5a12adb1bc7d	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-8460	74	false	United States	-27270	NA	440a0994-82af-549c-b467-570094ef587b	not hispanic or latino	male	white	TCGA-50-8460_demographic	Alive	27270	M0	N0	Stage IA	T1a	7th	primary	0	829.0	87105ffb-a680-53c0-80ce-977494017914	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-8460_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-8460_treatment2	NA	NA	NA	NA	2e100dfe-520f-435c-8f14-14b137871d2a	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	497cc506-03fe-4ffa-860b-5a12adb1bc7d	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-8460	74	false	United States	-27270	NA	440a0994-82af-549c-b467-570094ef587b	not hispanic or latino	male	white	TCGA-50-8460_demographic	Alive	27270	M0	N0	Stage IA	T1a	7th	primary	0	829.0	87105ffb-a680-53c0-80ce-977494017914	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-8460_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	49	49	NA	NA	NA	NA	NA	NA	TCGA-50-8460_treatment	NA	Primary Tumor Field	NA	NA	cb9c3316-b42b-5d66-b399-95bb51f893f6	NA	yes	Complete Response	Radiation, Internal
TCGA-LUAD	4999df33-3a47-4feb-a264-c5d71b271d8c	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z024	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	4a1d30e8-e93a-41ed-8e54-08eaff6556a7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A444	60	false	United States	-22202	NA	d4b52ec5-0be9-5f31-9c12-3f84893df656	not hispanic or latino	female	white	TCGA-L9-A444_demographic	Alive	20597	MX	NX	Stage IB	T1b	6th	Prior primary	-1605	NA	0371488e-c46c-47ff-bd3f-ac6d5f7efd09	false	NA	NA	NA	NA	8380/3	Endometrioid adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-L9-A444_diagnosis2	NA	Endometrium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A444_treatment3	NA	NA	NA	NA	492e0c4a-e114-422c-8024-d512000a297e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4a1d30e8-e93a-41ed-8e54-08eaff6556a7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A444	60	false	United States	-22202	NA	d4b52ec5-0be9-5f31-9c12-3f84893df656	not hispanic or latino	female	white	TCGA-L9-A444_demographic	Alive	20597	MX	NX	Stage IB	T1b	6th	Prior primary	-1605	NA	0371488e-c46c-47ff-bd3f-ac6d5f7efd09	false	NA	NA	NA	NA	8380/3	Endometrioid adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-L9-A444_diagnosis2	NA	Endometrium	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A444_treatment4	NA	NA	NA	NA	cbf70edd-67ad-4a8d-92e4-a38050540261	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4a1d30e8-e93a-41ed-8e54-08eaff6556a7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A444	60	false	United States	-22202	NA	d4b52ec5-0be9-5f31-9c12-3f84893df656	not hispanic or latino	female	white	TCGA-L9-A444_demographic	Alive	20597	MX	NX	Stage IB	T1b	6th	Prior primary	-1605	NA	0371488e-c46c-47ff-bd3f-ac6d5f7efd09	false	NA	NA	NA	NA	8380/3	Endometrioid adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-L9-A444_diagnosis2	NA	Endometrium	NA	NA	NA	NA	NA	-1605	NA	NA	NA	NA	NA	NA	TCGA-L9-A444_treatment5	NA	NA	NA	NA	efe398f4-bdfc-42c1-825e-a403b0f24ef3	NA	yes	NA	Surgery, NOS
TCGA-LUAD	4a1d30e8-e93a-41ed-8e54-08eaff6556a7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A444	60	false	United States	-22202	NA	d4b52ec5-0be9-5f31-9c12-3f84893df656	not hispanic or latino	female	white	TCGA-L9-A444_demographic	Alive	22202	MX	N0	Stage IA	T1a	7th	primary	0	307.0	55ed2a57-44cf-5190-ab0e-af71ec48e0c0	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-L9-A444_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A444_treatment	NA	NA	NA	NA	d168db03-8911-5029-887c-92b566c5b1e0	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4a1d30e8-e93a-41ed-8e54-08eaff6556a7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A444	60	false	United States	-22202	NA	d4b52ec5-0be9-5f31-9c12-3f84893df656	not hispanic or latino	female	white	TCGA-L9-A444_demographic	Alive	22202	MX	N0	Stage IA	T1a	7th	primary	0	307.0	55ed2a57-44cf-5190-ab0e-af71ec48e0c0	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-L9-A444_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A444_treatment2	NA	NA	NA	NA	f9da01d4-42c5-44a7-84fb-aae20b03d8e1	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4ad63dac-76a7-4527-abce-d7a0184e8739	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-8497	75	false	United States	-27632	434	20c62420-c29e-52b7-a3a4-dec52516c28d	not hispanic or latino	female	white	TCGA-91-8497_demographic	Dead	27632	MX	N0	Stage IA	T1a	7th	primary	0	434.0	e8e2df0d-b8d7-5d30-b10f-75b0adc57671	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-8497_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-8497_treatment	NA	NA	NA	NA	03ec0d99-6013-5c54-a319-21c9786ce8be	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4ad63dac-76a7-4527-abce-d7a0184e8739	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-8497	75	false	United States	-27632	434	20c62420-c29e-52b7-a3a4-dec52516c28d	not hispanic or latino	female	white	TCGA-91-8497_demographic	Dead	27632	MX	N0	Stage IA	T1a	7th	primary	0	434.0	e8e2df0d-b8d7-5d30-b10f-75b0adc57671	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-8497_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-8497_treatment2	NA	NA	NA	NA	8c2edbe1-f60b-4003-ab37-d7189256b37c	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4addf05f-3668-4b3f-a17f-c0227329ca52	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4249	67	false	Germany	-24532	NA	e7595506-7ece-5135-8271-17f3b1b340bd	not reported	male	not reported	TCGA-05-4249_demographic	Alive	24532	M0	N0	Stage IB	T2	6th	primary	0	1523.0	c53e1e0c-f270-5739-badb-81ae50b90d15	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-05-4249_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4249_treatment2	NA	NA	NA	NA	68219478-3ed4-452e-a643-05324deda9ce	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4addf05f-3668-4b3f-a17f-c0227329ca52	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4249	67	false	Germany	-24532	NA	e7595506-7ece-5135-8271-17f3b1b340bd	not reported	male	not reported	TCGA-05-4249_demographic	Alive	24532	M0	N0	Stage IB	T2	6th	primary	0	1523.0	c53e1e0c-f270-5739-badb-81ae50b90d15	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-05-4249_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4249_treatment	NA	NA	NA	NA	7e0ec2e5-724b-5661-9b44-92b73528531a	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	22418	NA	NA	NA	NA	NA	not reported	525	NA	487724af-63ef-43f2-9b79-4cef9c4d0f4e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-7669_diagnosis4	NA	Not Reported	TCGA-44-7669_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7669_treatment16	NA	Locoregional Site	NA	NA	5c032c81-2434-41e4-8b63-97d5d76eff1d	NA	no	NA	Surgery, NOS
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	22418	NA	NA	NA	NA	NA	not reported	525	NA	487724af-63ef-43f2-9b79-4cef9c4d0f4e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-7669_diagnosis4	NA	Not Reported	TCGA-44-7669_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-7669_treatment14	NA	NA	NA	NA	7dd65d90-c761-46b7-b390-db04600bde16	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	22418	NA	NA	NA	NA	NA	not reported	525	NA	487724af-63ef-43f2-9b79-4cef9c4d0f4e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-7669_diagnosis4	NA	Not Reported	TCGA-44-7669_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-7669_treatment15	NA	NA	NA	NA	b7c7ddbe-45cf-446f-a45a-9202b4ff4d5b	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	22418	NA	NA	NA	NA	NA	not reported	525	NA	487724af-63ef-43f2-9b79-4cef9c4d0f4e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-7669_diagnosis4	NA	Not Reported	TCGA-44-7669_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7669_treatment17	NA	Distant Site	NA	NA	d49d6aa9-0c0c-4b4f-8b77-70b8c0cc04d9	NA	no	NA	Surgery, NOS
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	21893	MX	N1	Stage IIA	T1b	7th	primary	0	574.0	896e1bf2-350d-5a47-95ba-38f010ea99b3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7669_diagnosis	No	Upper lobe, lung	NA	2010	NA	1.0	474	474	Progressive Disease	NA	1.0	NA	NA	NA	TCGA-44-7669_treatment	NA	Distant Site	2000	cGy	33f6988d-70d1-5265-986b-3bcac1a62283	NA	yes	NA	Radiation, Cyberknife
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	21893	MX	N1	Stage IIA	T1b	7th	primary	0	574.0	896e1bf2-350d-5a47-95ba-38f010ea99b3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7669_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	539	539	NA	1	NA	460.0	mg	Intravenous	TCGA-44-7669_treatment4	Carboplatin	NA	460	mg	3d87a03e-b6fa-40da-81a3-b4436f6bc2a9	Palliative	yes	NA	Chemotherapy
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	21893	MX	N1	Stage IIA	T1b	7th	primary	0	574.0	896e1bf2-350d-5a47-95ba-38f010ea99b3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7669_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	180	117	NA	4	NA	145.0	mg	Intravenous	TCGA-44-7669_treatment5	Cisplatin	NA	580	mg	841b1b9d-cf1c-4d0f-894c-d8dd91764ca1	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	21893	MX	N1	Stage IIA	T1b	7th	primary	0	574.0	896e1bf2-350d-5a47-95ba-38f010ea99b3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7669_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	180	117	NA	4	NA	975.0	mg	Intravenous	TCGA-44-7669_treatment3	Pemetrexed Disodium	NA	3900	mg	903a1df0-5983-4eac-8782-588c1959a965	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	21893	MX	N1	Stage IIA	T1b	7th	primary	0	574.0	896e1bf2-350d-5a47-95ba-38f010ea99b3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7669_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	539	539	NA	1	NA	1900.0	mg	Intravenous	TCGA-44-7669_treatment6	Gemcitabine Hydrochloride	NA	1900	mg	fd49cbbc-3045-4c9d-a0e0-14cf81ed208b	Palliative	yes	NA	Chemotherapy
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	21893	MX	N1	Stage IIA	T1b	7th	primary	0	574.0	896e1bf2-350d-5a47-95ba-38f010ea99b3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7669_diagnosis	No	Upper lobe, lung	NA	2010	NA	2.0	532	526	NA	NA	5.0	NA	NA	NA	TCGA-44-7669_treatment2	NA	Distant Site	2000	cGy	ffe67302-7743-46c4-8245-d17de0fad4c7	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	22311	NA	NA	NA	NA	NA	not reported	418	NA	8de9543c-6110-4523-a1a2-5d46246f91fb	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-7669_diagnosis3	NA	Not Reported	TCGA-44-7669_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-7669_treatment12	NA	NA	NA	NA	1e176e99-eeff-4394-b406-5a00d2894fd3	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	22311	NA	NA	NA	NA	NA	not reported	418	NA	8de9543c-6110-4523-a1a2-5d46246f91fb	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-7669_diagnosis3	NA	Not Reported	TCGA-44-7669_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-7669_treatment11	NA	NA	NA	NA	54f19412-75d7-4d56-87e3-403b3ae73f6e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	22311	NA	NA	NA	NA	NA	not reported	418	NA	8de9543c-6110-4523-a1a2-5d46246f91fb	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-7669_diagnosis3	NA	Not Reported	TCGA-44-7669_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7669_treatment13	NA	Distant Site	NA	NA	86580f5d-7aae-45f8-abae-a66872906d17	NA	no	NA	Surgery, NOS
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	22283	NA	NA	NA	NA	NA	not reported	390	NA	fa7dc680-335b-4851-a81e-a597fa1be1be	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-7669_diagnosis2	NA	Not Reported	TCGA-44-7669_diagnosis	NA	NA	NA	NA	390	NA	NA	NA	NA	NA	NA	TCGA-44-7669_treatment10	NA	Distant Site	NA	NA	27ff1841-0bae-4a23-b256-93d231d71f4d	NA	yes	NA	Surgery, NOS
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	22283	NA	NA	NA	NA	NA	not reported	390	NA	fa7dc680-335b-4851-a81e-a597fa1be1be	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-7669_diagnosis2	NA	Not Reported	TCGA-44-7669_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-7669_treatment7	NA	NA	NA	NA	5d946c7b-c4f1-4c0d-94d3-20cff8fd8519	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	22283	NA	NA	NA	NA	NA	not reported	390	NA	fa7dc680-335b-4851-a81e-a597fa1be1be	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-7669_diagnosis2	NA	Not Reported	TCGA-44-7669_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-7669_treatment8	NA	NA	NA	NA	d0eb05cf-dfb4-47af-b745-13be455dc073	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4b22ad71-c585-4077-ad3c-c6e026d0c7fa	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-7669	59	false	United States	-21893	574	1d8e1ef9-4672-5c0f-a666-10d2e0767d4d	not hispanic or latino	male	black or african american	TCGA-44-7669_demographic	Dead	22283	NA	NA	NA	NA	NA	not reported	390	NA	fa7dc680-335b-4851-a81e-a597fa1be1be	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-7669_diagnosis2	NA	Not Reported	TCGA-44-7669_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7669_treatment9	NA	Locoregional Site	NA	NA	e4418aad-e9b4-4392-a936-9f9e9477934a	NA	no	NA	Surgery, NOS
TCGA-LUAD	4b5ff30e-65fc-4434-b174-9d699594c658	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	4b7cd595-e7f9-45a8-b736-a8c7c42d9539	Informed Consent	61	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-71-6725	48	false	Vietnam	-17793	NA	926be778-dafa-583b-ab44-194c2a63cef3	not hispanic or latino	female	asian	TCGA-71-6725_demographic	Alive	17957	NA	NA	NA	NA	NA	recurrence	164	NA	4ff20329-cca6-4c98-8701-b82011c5b98e	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-71-6725_diagnosis2	NA	Not Reported	TCGA-71-6725_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-71-6725_treatment5	NA	NA	NA	NA	11f6ca4e-bca5-4fff-bc48-cf071b51ccf1	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	4b7cd595-e7f9-45a8-b736-a8c7c42d9539	Informed Consent	61	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-71-6725	48	false	Vietnam	-17793	NA	926be778-dafa-583b-ab44-194c2a63cef3	not hispanic or latino	female	asian	TCGA-71-6725_demographic	Alive	17957	NA	NA	NA	NA	NA	recurrence	164	NA	4ff20329-cca6-4c98-8701-b82011c5b98e	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-71-6725_diagnosis2	NA	Not Reported	TCGA-71-6725_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-71-6725_treatment6	NA	Locoregional Site	NA	NA	ad6767ac-9f83-42f1-a004-4a7682dd8f82	NA	no	NA	Surgery, NOS
TCGA-LUAD	4b7cd595-e7f9-45a8-b736-a8c7c42d9539	Informed Consent	61	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-71-6725	48	false	Vietnam	-17793	NA	926be778-dafa-583b-ab44-194c2a63cef3	not hispanic or latino	female	asian	TCGA-71-6725_demographic	Alive	17957	NA	NA	NA	NA	NA	recurrence	164	NA	4ff20329-cca6-4c98-8701-b82011c5b98e	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-71-6725_diagnosis2	NA	Not Reported	TCGA-71-6725_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-71-6725_treatment4	NA	NA	NA	NA	beebe25c-6952-472d-b9c0-5737257ef852	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4b7cd595-e7f9-45a8-b736-a8c7c42d9539	Informed Consent	61	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-71-6725	48	false	Vietnam	-17793	NA	926be778-dafa-583b-ab44-194c2a63cef3	not hispanic or latino	female	asian	TCGA-71-6725_demographic	Alive	17793	M0	N0	Stage IB	T2	6th	primary	0	256.0	71b3c9c2-e113-506c-ab80-1b5c13dd0ff6	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-71-6725_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	127	107	NA	NA	NA	NA	NA	NA	TCGA-71-6725_treatment2	Cisplatin	NA	NA	NA	32e79f6a-e09a-40c1-883b-d7152948d3ee	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	4b7cd595-e7f9-45a8-b736-a8c7c42d9539	Informed Consent	61	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-71-6725	48	false	Vietnam	-17793	NA	926be778-dafa-583b-ab44-194c2a63cef3	not hispanic or latino	female	asian	TCGA-71-6725_demographic	Alive	17793	M0	N0	Stage IB	T2	6th	primary	0	256.0	71b3c9c2-e113-506c-ab80-1b5c13dd0ff6	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-71-6725_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	204	159	NA	NA	35.0	NA	NA	NA	TCGA-71-6725_treatment	NA	Primary Tumor Field	70	Gy	35331b88-01a5-5052-97bd-eef72a9c266b	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	4b7cd595-e7f9-45a8-b736-a8c7c42d9539	Informed Consent	61	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-71-6725	48	false	Vietnam	-17793	NA	926be778-dafa-583b-ab44-194c2a63cef3	not hispanic or latino	female	asian	TCGA-71-6725_demographic	Alive	17793	M0	N0	Stage IB	T2	6th	primary	0	256.0	71b3c9c2-e113-506c-ab80-1b5c13dd0ff6	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-71-6725_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	127	107	NA	NA	NA	NA	NA	NA	TCGA-71-6725_treatment3	Etoposide	NA	NA	NA	bcb3ebae-c416-49e9-90f2-5fc0e16fa2f0	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	4b92fce2-3772-40eb-ab34-a27937b58590	Informed Consent	26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8092	75	false	United States	-27597	154	2a25d38d-1bc7-5f4c-a662-6b1202364dfa	not hispanic or latino	male	white	TCGA-55-8092_demographic	Dead	27597	MX	N0	Stage IIB	T3	7th	primary	0	154.0	0b0c066b-927f-5a1f-9701-075211ab5f33	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8092_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8092_treatment	NA	NA	NA	NA	a3b9e153-aafd-51e5-87a1-fb05f7c47b58	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4b92fce2-3772-40eb-ab34-a27937b58590	Informed Consent	26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8092	75	false	United States	-27597	154	2a25d38d-1bc7-5f4c-a662-6b1202364dfa	not hispanic or latino	male	white	TCGA-55-8092_demographic	Dead	27597	MX	N0	Stage IIB	T3	7th	primary	0	154.0	0b0c066b-927f-5a1f-9701-075211ab5f33	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8092_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8092_treatment2	NA	NA	NA	NA	cd4d40d0-927a-4183-b467-102d94bcd64f	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	4b92fce2-3772-40eb-ab34-a27937b58590	Informed Consent	26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8092	75	false	United States	-27597	154	2a25d38d-1bc7-5f4c-a662-6b1202364dfa	not hispanic or latino	male	white	TCGA-55-8092_demographic	Dead	27724	NA	NA	NA	NA	NA	recurrence	127	NA	3a37a65c-1151-4c19-99d3-add6bc8ccec0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8092_diagnosis2	NA	Not Reported	TCGA-55-8092_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8092_treatment5	NA	Locoregional Site	NA	NA	3786ab51-8042-4376-81e8-fb162906d595	NA	no	NA	Surgery, NOS
TCGA-LUAD	4b92fce2-3772-40eb-ab34-a27937b58590	Informed Consent	26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8092	75	false	United States	-27597	154	2a25d38d-1bc7-5f4c-a662-6b1202364dfa	not hispanic or latino	male	white	TCGA-55-8092_demographic	Dead	27724	NA	NA	NA	NA	NA	recurrence	127	NA	3a37a65c-1151-4c19-99d3-add6bc8ccec0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8092_diagnosis2	NA	Not Reported	TCGA-55-8092_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-8092_treatment3	NA	NA	NA	NA	52ecce17-c9b6-40ea-b21b-d509411128d0	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4b92fce2-3772-40eb-ab34-a27937b58590	Informed Consent	26	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8092	75	false	United States	-27597	154	2a25d38d-1bc7-5f4c-a662-6b1202364dfa	not hispanic or latino	male	white	TCGA-55-8092_demographic	Dead	27724	NA	NA	NA	NA	NA	recurrence	127	NA	3a37a65c-1151-4c19-99d3-add6bc8ccec0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8092_diagnosis2	NA	Not Reported	TCGA-55-8092_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-8092_treatment4	NA	NA	NA	NA	9d66c99b-f78e-47db-aa42-99e1a790350d	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4c31127e-d095-4978-9dac-35153c27f6ed	Informed Consent	-81	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4666	52	false	United States	-19074	NA	63bc2ee0-7b89-5ef8-a2ee-0d878468a51e	not hispanic or latino	female	white	TCGA-73-4666_demographic	Alive	19074	M1	N0	Stage IV	T1	NA	primary	0	800.0	1b23581a-b60b-54f5-a4ec-5c07bc278a10	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4666_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	119	56	NA	4	NA	NA	NA	Intravenous	TCGA-73-4666_treatment3	Paclitaxel	NA	NA	NA	24000450-8223-41c7-b716-ccc944a96a57	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	4c31127e-d095-4978-9dac-35153c27f6ed	Informed Consent	-81	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4666	52	false	United States	-19074	NA	63bc2ee0-7b89-5ef8-a2ee-0d878468a51e	not hispanic or latino	female	white	TCGA-73-4666_demographic	Alive	19074	M1	N0	Stage IV	T1	NA	primary	0	800.0	1b23581a-b60b-54f5-a4ec-5c07bc278a10	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4666_diagnosis	No	Upper lobe, lung	NA	2009	NA	1.0	70	70	NA	NA	1.0	NA	NA	NA	TCGA-73-4666_treatment	NA	Distant Site	1800	cGy	4d61825d-a173-5945-a1c2-c387c49b4c74	Adjuvant	yes	NA	Radiation, Stereotactic/Gamma Knife/SRS
TCGA-LUAD	4c31127e-d095-4978-9dac-35153c27f6ed	Informed Consent	-81	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4666	52	false	United States	-19074	NA	63bc2ee0-7b89-5ef8-a2ee-0d878468a51e	not hispanic or latino	female	white	TCGA-73-4666_demographic	Alive	19074	M1	N0	Stage IV	T1	NA	primary	0	800.0	1b23581a-b60b-54f5-a4ec-5c07bc278a10	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4666_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	119	56	NA	4	NA	NA	NA	Intravenous	TCGA-73-4666_treatment2	Carboplatin	NA	NA	NA	7e687e81-6a53-4d83-9f14-7c7942ec5a67	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	4c31127e-d095-4978-9dac-35153c27f6ed	Informed Consent	-81	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4666	52	false	United States	-19074	NA	63bc2ee0-7b89-5ef8-a2ee-0d878468a51e	not hispanic or latino	female	white	TCGA-73-4666_demographic	Alive	NA	NA	NA	NA	NA	NA	not reported	NA	NA	fd1f450b-33c5-4f33-b8d9-8f072488afb2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4666_diagnosis2	NA	Not Reported	TCGA-73-4666_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4666_treatment6	NA	Locoregional Site	NA	NA	1cbc64ba-b7b2-4936-b3f2-47c2eaeb1d7d	NA	no	NA	Surgery, NOS
TCGA-LUAD	4c31127e-d095-4978-9dac-35153c27f6ed	Informed Consent	-81	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4666	52	false	United States	-19074	NA	63bc2ee0-7b89-5ef8-a2ee-0d878468a51e	not hispanic or latino	female	white	TCGA-73-4666_demographic	Alive	NA	NA	NA	NA	NA	NA	not reported	NA	NA	fd1f450b-33c5-4f33-b8d9-8f072488afb2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4666_diagnosis2	NA	Not Reported	TCGA-73-4666_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-73-4666_treatment5	NA	NA	NA	NA	7c831ad6-ae47-4a0e-885f-ef6c32a7032e	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	4c31127e-d095-4978-9dac-35153c27f6ed	Informed Consent	-81	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4666	52	false	United States	-19074	NA	63bc2ee0-7b89-5ef8-a2ee-0d878468a51e	not hispanic or latino	female	white	TCGA-73-4666_demographic	Alive	NA	NA	NA	NA	NA	NA	not reported	NA	NA	fd1f450b-33c5-4f33-b8d9-8f072488afb2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4666_diagnosis2	NA	Not Reported	TCGA-73-4666_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-73-4666_treatment4	NA	NA	NA	NA	e81dc44b-d0bd-4ed2-b21f-cfe666003a68	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4c31127e-d095-4978-9dac-35153c27f6ed	Informed Consent	-81	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4666	52	false	United States	-19074	NA	63bc2ee0-7b89-5ef8-a2ee-0d878468a51e	not hispanic or latino	female	white	TCGA-73-4666_demographic	Alive	NA	NA	NA	NA	NA	NA	not reported	NA	NA	fd1f450b-33c5-4f33-b8d9-8f072488afb2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4666_diagnosis2	NA	Not Reported	TCGA-73-4666_diagnosis	NA	NA	NA	NA	-43	NA	NA	NA	NA	NA	NA	TCGA-73-4666_treatment7	NA	Distant Site	NA	NA	fda2de29-43af-4e13-a7c7-131c5de1611e	NA	yes	NA	Surgery, NOS
TCGA-LUAD	4cd3d483-2283-4c6a-a57a-444216119d34	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-6761	68	false	United States	-24849	NA	30882d0d-1d34-5ef3-bfe6-49cf6d22f345	not hispanic or latino	female	white	TCGA-49-6761_demographic	Alive	20499	NA	NA	NA	NA	NA	Prior primary	-4350	NA	697be52f-6682-4492-a19c-20e38f5fe658	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-49-6761_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6761_treatment3	NA	NA	NA	NA	253778cd-640a-4d8e-baa7-9eaa045e3ba8	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4cd3d483-2283-4c6a-a57a-444216119d34	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-6761	68	false	United States	-24849	NA	30882d0d-1d34-5ef3-bfe6-49cf6d22f345	not hispanic or latino	female	white	TCGA-49-6761_demographic	Alive	20499	NA	NA	NA	NA	NA	Prior primary	-4350	NA	697be52f-6682-4492-a19c-20e38f5fe658	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-49-6761_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6761_treatment5	NA	NA	NA	NA	a65f650a-0599-4309-bbc8-a4a9040d07a4	NA	yes	NA	Surgery, NOS
TCGA-LUAD	4cd3d483-2283-4c6a-a57a-444216119d34	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-6761	68	false	United States	-24849	NA	30882d0d-1d34-5ef3-bfe6-49cf6d22f345	not hispanic or latino	female	white	TCGA-49-6761_demographic	Alive	20499	NA	NA	NA	NA	NA	Prior primary	-4350	NA	697be52f-6682-4492-a19c-20e38f5fe658	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-49-6761_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6761_treatment4	NA	Locoregional Site	NA	NA	c5c5e08d-2b49-49a9-8e45-96160eab227d	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	4cd3d483-2283-4c6a-a57a-444216119d34	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-6761	68	false	United States	-24849	NA	30882d0d-1d34-5ef3-bfe6-49cf6d22f345	not hispanic or latino	female	white	TCGA-49-6761_demographic	Alive	24849	MX	N2	Stage IIIA	T1	6th	primary	0	354.0	f346fa45-ef61-5ff7-9e8a-242fa8cbd5a2	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-6761_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6761_treatment	NA	NA	NA	NA	4217bcf4-5b9e-5d64-8f43-5438eb065dcb	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4cd3d483-2283-4c6a-a57a-444216119d34	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-6761	68	false	United States	-24849	NA	30882d0d-1d34-5ef3-bfe6-49cf6d22f345	not hispanic or latino	female	white	TCGA-49-6761_demographic	Alive	24849	MX	N2	Stage IIIA	T1	6th	primary	0	354.0	f346fa45-ef61-5ff7-9e8a-242fa8cbd5a2	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-6761_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6761_treatment2	NA	NA	NA	NA	4adeb700-5d14-42a0-babe-cb927bf9c262	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4d153600-81f9-44fb-b485-6355ec306d6a	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7159	60	false	Australia	-22261	NA	9d623b7f-13c5-5e0d-b0f0-614c0a6716ec	not reported	female	white	TCGA-78-7159_demographic	Alive	22261	M0	NX	Stage IA	T1	6th	primary	0	1974.0	10da95ae-ab8c-5ecb-bef8-a6ba28b2e22a	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7159_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7159_treatment2	NA	NA	NA	NA	0764e867-8c8d-49d7-8124-38483a6737da	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4d153600-81f9-44fb-b485-6355ec306d6a	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7159	60	false	Australia	-22261	NA	9d623b7f-13c5-5e0d-b0f0-614c0a6716ec	not reported	female	white	TCGA-78-7159_demographic	Alive	22261	M0	NX	Stage IA	T1	6th	primary	0	1974.0	10da95ae-ab8c-5ecb-bef8-a6ba28b2e22a	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7159_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7159_treatment	NA	NA	NA	NA	a646b213-4249-59b1-a624-f63493ba6bde	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4d51ee44-e6f4-4bcb-be28-e9df54b39a8d	Informed Consent	6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8090	80	false	United States	-29235	598	7d287232-a790-5a9c-af46-f211c09a360d	not hispanic or latino	male	white	TCGA-55-8090_demographic	Dead	29783	NA	NA	NA	NA	NA	metastasis	548	NA	78fd8ef1-99be-42dc-b6b1-821d7787b132	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8090_diagnosis2	NA	Not Reported	TCGA-55-8090_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8090_treatment6	NA	NA	NA	NA	a78c34b3-0aef-4ec6-abd0-cdf1b3fefd30	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4d51ee44-e6f4-4bcb-be28-e9df54b39a8d	Informed Consent	6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8090	80	false	United States	-29235	598	7d287232-a790-5a9c-af46-f211c09a360d	not hispanic or latino	male	white	TCGA-55-8090_demographic	Dead	29783	NA	NA	NA	NA	NA	metastasis	548	NA	78fd8ef1-99be-42dc-b6b1-821d7787b132	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8090_diagnosis2	NA	Not Reported	TCGA-55-8090_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8090_treatment5	NA	NA	NA	NA	b7c8176b-8320-4782-a242-4848858deb90	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4d51ee44-e6f4-4bcb-be28-e9df54b39a8d	Informed Consent	6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8090	80	false	United States	-29235	598	7d287232-a790-5a9c-af46-f211c09a360d	not hispanic or latino	male	white	TCGA-55-8090_demographic	Dead	29783	NA	NA	NA	NA	NA	metastasis	548	NA	78fd8ef1-99be-42dc-b6b1-821d7787b132	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8090_diagnosis2	NA	Not Reported	TCGA-55-8090_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8090_treatment7	NA	Distant Site	NA	NA	e0186478-d3b8-40cc-9623-1cda619a1e03	NA	no	NA	Surgery, NOS
TCGA-LUAD	4d51ee44-e6f4-4bcb-be28-e9df54b39a8d	Informed Consent	6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8090	80	false	United States	-29235	598	7d287232-a790-5a9c-af46-f211c09a360d	not hispanic or latino	male	white	TCGA-55-8090_demographic	Dead	NA	M0	NX	Stage IB	T2a	7th	Synchronous primary	NA	NA	7fc7b41b-8631-4834-91fa-4cb78a590295	false	NA	NA	NA	Left	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8090_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8090_treatment3	NA	NA	NA	NA	4e6141a4-d782-414f-8b75-a97194ee43da	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4d51ee44-e6f4-4bcb-be28-e9df54b39a8d	Informed Consent	6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8090	80	false	United States	-29235	598	7d287232-a790-5a9c-af46-f211c09a360d	not hispanic or latino	male	white	TCGA-55-8090_demographic	Dead	NA	M0	NX	Stage IB	T2a	7th	Synchronous primary	NA	NA	7fc7b41b-8631-4834-91fa-4cb78a590295	false	NA	NA	NA	Left	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8090_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8090_treatment4	NA	NA	NA	NA	efc138d9-60b1-48ab-971b-cb472f403b93	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4d51ee44-e6f4-4bcb-be28-e9df54b39a8d	Informed Consent	6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8090	80	false	United States	-29235	598	7d287232-a790-5a9c-af46-f211c09a360d	not hispanic or latino	male	white	TCGA-55-8090_demographic	Dead	29235	M0	N0	Stage IA	T1a	7th	primary	0	598.0	dc4593dc-7f70-5db1-8d8d-e2773aa73009	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8090_diagnosis	Yes	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8090_treatment2	NA	NA	NA	NA	108c2044-ef85-4bac-bc86-bf0add252e70	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	4d51ee44-e6f4-4bcb-be28-e9df54b39a8d	Informed Consent	6	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8090	80	false	United States	-29235	598	7d287232-a790-5a9c-af46-f211c09a360d	not hispanic or latino	male	white	TCGA-55-8090_demographic	Dead	29235	M0	N0	Stage IA	T1a	7th	primary	0	598.0	dc4593dc-7f70-5db1-8d8d-e2773aa73009	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8090_diagnosis	Yes	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8090_treatment	NA	NA	NA	NA	b74dc3ca-c7d1-5255-8c8c-52790e293730	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4e7b2af4-b158-41a7-be22-bea227a759e6	Informed Consent	53	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7227	77	false	United States	-28458	952	451546ca-3ae1-5e07-8beb-7a7c4fab3896	not hispanic or latino	male	white	TCGA-55-7227_demographic	Dead	28458	MX	N1	Stage IIIA	T3	7th	primary	0	952.0	dbfb84ca-a01c-5a96-8fd3-99f3e3314902	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7227_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7227_treatment4	NA	NA	NA	NA	3172a432-ee85-43ea-aca9-67e6ea78c873	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4e7b2af4-b158-41a7-be22-bea227a759e6	Informed Consent	53	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7227	77	false	United States	-28458	952	451546ca-3ae1-5e07-8beb-7a7c4fab3896	not hispanic or latino	male	white	TCGA-55-7227_demographic	Dead	28458	MX	N1	Stage IIIA	T3	7th	primary	0	952.0	dbfb84ca-a01c-5a96-8fd3-99f3e3314902	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7227_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	409	289	NA	NA	NA	NA	NA	NA	TCGA-55-7227_treatment2	Pemetrexed	NA	NA	NA	7d2404d2-5500-4ed9-aa46-6240670a55f6	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	4e7b2af4-b158-41a7-be22-bea227a759e6	Informed Consent	53	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7227	77	false	United States	-28458	952	451546ca-3ae1-5e07-8beb-7a7c4fab3896	not hispanic or latino	male	white	TCGA-55-7227_demographic	Dead	28458	MX	N1	Stage IIIA	T3	7th	primary	0	952.0	dbfb84ca-a01c-5a96-8fd3-99f3e3314902	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7227_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	409	289	NA	NA	NA	NA	NA	NA	TCGA-55-7227_treatment	Carboplatin	NA	NA	NA	dc44e753-4e15-5515-9f6c-53d09643d94c	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	4e7b2af4-b158-41a7-be22-bea227a759e6	Informed Consent	53	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7227	77	false	United States	-28458	952	451546ca-3ae1-5e07-8beb-7a7c4fab3896	not hispanic or latino	male	white	TCGA-55-7227_demographic	Dead	28458	MX	N1	Stage IIIA	T3	7th	primary	0	952.0	dbfb84ca-a01c-5a96-8fd3-99f3e3314902	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7227_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	876	442	NA	NA	NA	NA	NA	NA	TCGA-55-7227_treatment3	Pemetrexed	NA	NA	NA	f00f0eac-8484-43ce-af84-013a4947c375	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	4e7b2af4-b158-41a7-be22-bea227a759e6	Informed Consent	53	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7227	77	false	United States	-28458	952	451546ca-3ae1-5e07-8beb-7a7c4fab3896	not hispanic or latino	male	white	TCGA-55-7227_demographic	Dead	28713	NA	NA	NA	NA	NA	recurrence	255	NA	def94d61-83df-45d0-8a58-3b556763a305	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7227_diagnosis2	NA	Not Reported	TCGA-55-7227_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7227_treatment7	NA	Locoregional Site	NA	NA	7547f734-0450-4cee-b993-f51423af8f28	NA	no	NA	Surgery, NOS
TCGA-LUAD	4e7b2af4-b158-41a7-be22-bea227a759e6	Informed Consent	53	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7227	77	false	United States	-28458	952	451546ca-3ae1-5e07-8beb-7a7c4fab3896	not hispanic or latino	male	white	TCGA-55-7227_demographic	Dead	28713	NA	NA	NA	NA	NA	recurrence	255	NA	def94d61-83df-45d0-8a58-3b556763a305	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7227_diagnosis2	NA	Not Reported	TCGA-55-7227_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-7227_treatment5	NA	NA	NA	NA	8b66a222-c8d0-4b54-a952-61d5d9d2dc58	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4e7b2af4-b158-41a7-be22-bea227a759e6	Informed Consent	53	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7227	77	false	United States	-28458	952	451546ca-3ae1-5e07-8beb-7a7c4fab3896	not hispanic or latino	male	white	TCGA-55-7227_demographic	Dead	28713	NA	NA	NA	NA	NA	recurrence	255	NA	def94d61-83df-45d0-8a58-3b556763a305	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7227_diagnosis2	NA	Not Reported	TCGA-55-7227_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-7227_treatment6	NA	NA	NA	NA	9292c675-6497-4eac-9aaa-950fe8206c34	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	4ef872e1-82c9-4939-9248-41ed9d3085b2	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7145	52	false	Australia	-19080	826	ce8c003b-3be0-5dd2-b870-5e1e4d84360e	not reported	female	white	TCGA-78-7145_demographic	Dead	19080	M1	N1	Stage IV	T4	6th	primary	0	826.0	96303884-5c42-5b04-b05a-d811ecc338c3	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7145_diagnosis	No	Middle lobe, lung	NA	2000	NA	NA	NA	716	Progressive Disease	NA	NA	NA	NA	Intramuscular	TCGA-78-7145_treatment2	NA	NA	NA	NA	13dec1f4-d765-4925-bc9f-a505abd6cefa	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4ef872e1-82c9-4939-9248-41ed9d3085b2	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7145	52	false	Australia	-19080	826	ce8c003b-3be0-5dd2-b870-5e1e4d84360e	not reported	female	white	TCGA-78-7145_demographic	Dead	19080	M1	N1	Stage IV	T4	6th	primary	0	826.0	96303884-5c42-5b04-b05a-d811ecc338c3	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7145_diagnosis	No	Middle lobe, lung	NA	2000	NA	NA	161	28	NA	6	NA	NA	NA	Intravenous	TCGA-78-7145_treatment6	Gemcitabine	NA	NA	NA	5cd6264a-8821-4e19-a2a0-3abc7afe4337	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	4ef872e1-82c9-4939-9248-41ed9d3085b2	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7145	52	false	Australia	-19080	826	ce8c003b-3be0-5dd2-b870-5e1e4d84360e	not reported	female	white	TCGA-78-7145_demographic	Dead	19080	M1	N1	Stage IV	T4	6th	primary	0	826.0	96303884-5c42-5b04-b05a-d811ecc338c3	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7145_diagnosis	No	Middle lobe, lung	NA	2000	NA	NA	161	28	NA	6	NA	NA	NA	Intravenous	TCGA-78-7145_treatment3	Cisplatin	NA	NA	NA	6f7cd0a9-674e-488e-9684-443857583632	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	4ef872e1-82c9-4939-9248-41ed9d3085b2	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7145	52	false	Australia	-19080	826	ce8c003b-3be0-5dd2-b870-5e1e4d84360e	not reported	female	white	TCGA-78-7145_demographic	Dead	19080	M1	N1	Stage IV	T4	6th	primary	0	826.0	96303884-5c42-5b04-b05a-d811ecc338c3	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7145_diagnosis	No	Middle lobe, lung	NA	2000	NA	NA	685	605	Progressive Disease	NA	NA	NA	NA	Oral	TCGA-78-7145_treatment4	Gefitinib	NA	NA	NA	924964cf-b605-458c-ac3b-354f1ee682ed	NA	yes	NA	Targeted Molecular Therapy
TCGA-LUAD	4ef872e1-82c9-4939-9248-41ed9d3085b2	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7145	52	false	Australia	-19080	826	ce8c003b-3be0-5dd2-b870-5e1e4d84360e	not reported	female	white	TCGA-78-7145_demographic	Dead	19080	M1	N1	Stage IV	T4	6th	primary	0	826.0	96303884-5c42-5b04-b05a-d811ecc338c3	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7145_diagnosis	No	Middle lobe, lung	NA	2000	NA	1.0	644	644	NA	NA	1.0	NA	NA	NA	TCGA-78-7145_treatment	NA	Regional Site	800	cGy	a1250094-da96-5b88-abee-da18b4b2e027	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	4ef872e1-82c9-4939-9248-41ed9d3085b2	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7145	52	false	Australia	-19080	826	ce8c003b-3be0-5dd2-b870-5e1e4d84360e	not reported	female	white	TCGA-78-7145_demographic	Dead	19080	M1	N1	Stage IV	T4	6th	primary	0	826.0	96303884-5c42-5b04-b05a-d811ecc338c3	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7145_diagnosis	No	Middle lobe, lung	NA	2000	NA	NA	547	440	Progressive Disease	6	NA	NA	NA	Intravenous	TCGA-78-7145_treatment5	Docetaxel	NA	NA	NA	bdac78cb-0235-47c7-8d4c-7d95590ab942	NA	yes	NA	Chemotherapy
TCGA-LUAD	4ef872e1-82c9-4939-9248-41ed9d3085b2	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7145	52	false	Australia	-19080	826	ce8c003b-3be0-5dd2-b870-5e1e4d84360e	not reported	female	white	TCGA-78-7145_demographic	Dead	19502	NA	NA	NA	NA	NA	not reported	422	NA	f4945586-8389-4bd1-ac4e-260c48c2e0ad	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7145_diagnosis2	NA	Not Reported	TCGA-78-7145_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7145_treatment8	NA	NA	NA	NA	0ed22053-ce18-4730-9b24-3e59cd775f68	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	4ef872e1-82c9-4939-9248-41ed9d3085b2	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7145	52	false	Australia	-19080	826	ce8c003b-3be0-5dd2-b870-5e1e4d84360e	not reported	female	white	TCGA-78-7145_demographic	Dead	19502	NA	NA	NA	NA	NA	not reported	422	NA	f4945586-8389-4bd1-ac4e-260c48c2e0ad	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7145_diagnosis2	NA	Not Reported	TCGA-78-7145_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7145_treatment7	NA	NA	NA	NA	4df9cb44-c73a-45b2-b41e-2f089ccbb58b	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4ef872e1-82c9-4939-9248-41ed9d3085b2	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7145	52	false	Australia	-19080	826	ce8c003b-3be0-5dd2-b870-5e1e4d84360e	not reported	female	white	TCGA-78-7145_demographic	Dead	19502	NA	NA	NA	NA	NA	not reported	422	NA	f4945586-8389-4bd1-ac4e-260c48c2e0ad	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7145_diagnosis2	NA	Not Reported	TCGA-78-7145_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7145_treatment10	NA	Distant Site	NA	NA	7ed52001-517b-4c00-82c3-f9faed090aeb	NA	no	NA	Surgery, NOS
TCGA-LUAD	4ef872e1-82c9-4939-9248-41ed9d3085b2	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7145	52	false	Australia	-19080	826	ce8c003b-3be0-5dd2-b870-5e1e4d84360e	not reported	female	white	TCGA-78-7145_demographic	Dead	19502	NA	NA	NA	NA	NA	not reported	422	NA	f4945586-8389-4bd1-ac4e-260c48c2e0ad	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7145_diagnosis2	NA	Not Reported	TCGA-78-7145_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7145_treatment9	NA	Locoregional Site	NA	NA	8763e8b0-944e-43ab-9dba-ef84ceff2cfb	NA	no	NA	Surgery, NOS
TCGA-LUAD	4efc2dac-6330-4b7a-a529-a27285f5fc23	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-7031	NA	false	Canada	NA	NA	3a5a7b6f-bfbf-5919-88e4-99020b8cf69b	not reported	female	not reported	TCGA-75-7031_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	NA	dcc856d9-2a2c-5541-b9c3-a9c7157e62f0	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-7031_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-7031_treatment	NA	NA	NA	NA	11cd5e38-9099-5894-b7c2-b0884d9f2cd6	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	4efc2dac-6330-4b7a-a529-a27285f5fc23	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-7031	NA	false	Canada	NA	NA	3a5a7b6f-bfbf-5919-88e4-99020b8cf69b	not reported	female	not reported	TCGA-75-7031_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	NA	dcc856d9-2a2c-5541-b9c3-a9c7157e62f0	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-7031_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-7031_treatment2	NA	NA	NA	NA	525d67ec-c037-4dc2-a99d-70cc595ea458	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	501c987e-d1eb-48a9-89eb-72a5062c90b4	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7158	59	false	Australia	-21742	179	be4a13cc-5e86-5c34-8b11-cb0847116d85	not reported	female	white	TCGA-78-7158_demographic	Dead	21742	M0	N2	Stage IIIB	T4	6th	primary	0	179.0	d790de49-2bd7-563a-87c4-4e7914498be9	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7158_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	103	54	NA	3	NA	NA	NA	Intravenous	TCGA-78-7158_treatment2	Paclitaxel	NA	620	mg	6c56c104-fe85-4629-9d1f-43e49609e00b	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	501c987e-d1eb-48a9-89eb-72a5062c90b4	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7158	59	false	Australia	-21742	179	be4a13cc-5e86-5c34-8b11-cb0847116d85	not reported	female	white	TCGA-78-7158_demographic	Dead	21742	M0	N2	Stage IIIB	T4	6th	primary	0	179.0	d790de49-2bd7-563a-87c4-4e7914498be9	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7158_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7158_treatment3	NA	NA	NA	NA	b01f9ed7-3218-4045-b89f-adc26a561ba1	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	501c987e-d1eb-48a9-89eb-72a5062c90b4	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7158	59	false	Australia	-21742	179	be4a13cc-5e86-5c34-8b11-cb0847116d85	not reported	female	white	TCGA-78-7158_demographic	Dead	21742	M0	N2	Stage IIIB	T4	6th	primary	0	179.0	d790de49-2bd7-563a-87c4-4e7914498be9	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7158_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	103	54	NA	3	NA	NA	NA	Intravenous	TCGA-78-7158_treatment	Carboplatin	NA	1220	mg	ca7c5a47-cc95-5d70-a1ad-849f88df546a	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	501c987e-d1eb-48a9-89eb-72a5062c90b4	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7158	59	false	Australia	-21742	179	be4a13cc-5e86-5c34-8b11-cb0847116d85	not reported	female	white	TCGA-78-7158_demographic	Dead	21874	NA	NA	NA	NA	NA	not reported	132	NA	dd803c8d-db0e-4547-bee7-0afcf8a71eef	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7158_diagnosis2	NA	Not Reported	TCGA-78-7158_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7158_treatment5	NA	Distant Site	NA	NA	5a31d545-2a77-46b1-b836-777cb55b5743	NA	no	NA	Surgery, NOS
TCGA-LUAD	501c987e-d1eb-48a9-89eb-72a5062c90b4	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7158	59	false	Australia	-21742	179	be4a13cc-5e86-5c34-8b11-cb0847116d85	not reported	female	white	TCGA-78-7158_demographic	Dead	21874	NA	NA	NA	NA	NA	not reported	132	NA	dd803c8d-db0e-4547-bee7-0afcf8a71eef	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7158_diagnosis2	NA	Not Reported	TCGA-78-7158_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7158_treatment4	NA	Locoregional Site	NA	NA	af3517db-c348-4695-8b1e-0460e1f895de	NA	no	NA	Surgery, NOS
TCGA-LUAD	50b2c647-aecd-4c81-af22-0d8116593552	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4507	73	false	United States	-26851	268	b81498da-06d3-5013-a374-39017dc2444e	not hispanic or latino	female	white	TCGA-49-4507_demographic	Dead	26851	M0	N1	Stage IIIA	T3	NA	primary	0	268.0	80211151-a7ea-50e1-a23d-fd566d85f2b7	true	NA	NA	C34.0	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4507_diagnosis	No	Main bronchus	NA	1997	NA	1.0	95	46	NA	NA	34.0	NA	NA	NA	TCGA-49-4507_treatment	NA	Primary Tumor Field	1620	cGy	0c11c159-f2c2-5a0e-b5b4-ee493892446f	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	50b2c647-aecd-4c81-af22-0d8116593552	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4507	73	false	United States	-26851	268	b81498da-06d3-5013-a374-39017dc2444e	not hispanic or latino	female	white	TCGA-49-4507_demographic	Dead	26851	M0	N1	Stage IIIA	T3	NA	primary	0	268.0	80211151-a7ea-50e1-a23d-fd566d85f2b7	true	NA	NA	C34.0	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4507_diagnosis	No	Main bronchus	NA	1997	NA	NA	110	47	NA	4	NA	NA	NA	Intravenous	TCGA-49-4507_treatment2	Paclitaxel	NA	NA	NA	26804c05-59ad-4613-9c68-2d1032217b13	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	50b2c647-aecd-4c81-af22-0d8116593552	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4507	73	false	United States	-26851	268	b81498da-06d3-5013-a374-39017dc2444e	not hispanic or latino	female	white	TCGA-49-4507_demographic	Dead	26851	M0	N1	Stage IIIA	T3	NA	primary	0	268.0	80211151-a7ea-50e1-a23d-fd566d85f2b7	true	NA	NA	C34.0	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4507_diagnosis	No	Main bronchus	NA	1997	NA	NA	110	47	NA	4	NA	NA	NA	Intravenous	TCGA-49-4507_treatment3	Carboplatin	NA	4	g/m2	323f7328-80d8-4090-bdf5-fd499421abd1	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	50b2c647-aecd-4c81-af22-0d8116593552	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4507	73	false	United States	-26851	268	b81498da-06d3-5013-a374-39017dc2444e	not hispanic or latino	female	white	TCGA-49-4507_demographic	Dead	26851	M0	N1	Stage IIIA	T3	NA	primary	0	268.0	80211151-a7ea-50e1-a23d-fd566d85f2b7	true	NA	NA	C34.0	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4507_diagnosis	No	Main bronchus	NA	1997	NA	NA	NA	174	Recurrent Disease	NA	NA	NA	NA	Intravenous	TCGA-49-4507_treatment4	Gemcitabine	NA	NA	NA	d28c34b0-04c1-4e95-8922-d6ce237d019f	NA	yes	NA	Chemotherapy
TCGA-LUAD	50b2c647-aecd-4c81-af22-0d8116593552	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4507	73	false	United States	-26851	268	b81498da-06d3-5013-a374-39017dc2444e	not hispanic or latino	female	white	TCGA-49-4507_demographic	Dead	27009	NA	NA	NA	NA	NA	not reported	158	NA	b61579d5-f37c-4cf2-b094-d477f1943ef4	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4507_diagnosis2	NA	Not Reported	TCGA-49-4507_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-49-4507_treatment6	NA	NA	NA	NA	45b8a26f-12c2-4bae-8fd8-7d9fe44dcfa6	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	50b2c647-aecd-4c81-af22-0d8116593552	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4507	73	false	United States	-26851	268	b81498da-06d3-5013-a374-39017dc2444e	not hispanic or latino	female	white	TCGA-49-4507_demographic	Dead	27009	NA	NA	NA	NA	NA	not reported	158	NA	b61579d5-f37c-4cf2-b094-d477f1943ef4	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4507_diagnosis2	NA	Not Reported	TCGA-49-4507_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-49-4507_treatment5	NA	NA	NA	NA	ac400ce4-d482-4525-a22b-7a4f0f87f96f	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	50b2c647-aecd-4c81-af22-0d8116593552	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4507	73	false	United States	-26851	268	b81498da-06d3-5013-a374-39017dc2444e	not hispanic or latino	female	white	TCGA-49-4507_demographic	Dead	27009	NA	NA	NA	NA	NA	not reported	158	NA	b61579d5-f37c-4cf2-b094-d477f1943ef4	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4507_diagnosis2	NA	Not Reported	TCGA-49-4507_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4507_treatment7	NA	Locoregional Site	NA	NA	c1b4aa3a-a90c-40f4-aebb-4595f842cb71	NA	no	NA	Surgery, NOS
TCGA-LUAD	50b2c647-aecd-4c81-af22-0d8116593552	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4507	73	false	United States	-26851	268	b81498da-06d3-5013-a374-39017dc2444e	not hispanic or latino	female	white	TCGA-49-4507_demographic	Dead	27009	NA	NA	NA	NA	NA	not reported	158	NA	b61579d5-f37c-4cf2-b094-d477f1943ef4	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4507_diagnosis2	NA	Not Reported	TCGA-49-4507_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4507_treatment8	NA	Distant Site	NA	NA	eaf7a512-5ef9-479f-b690-aabfb8d5c734	NA	no	NA	Surgery, NOS
TCGA-LUAD	5134c56f-8286-4ec8-8348-237cee7dad5e	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6978	81	false	United States	NA	176	00e3632b-e860-5b1e-bfa8-eba5fc3d3f3f	not hispanic or latino	male	white	TCGA-55-6978_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	42	NA	1212ef53-0dcc-45a2-9d89-9217ce4d85aa	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-6978_diagnosis2	NA	Not Reported	TCGA-55-6978_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6978_treatment7	NA	Locoregional Site	NA	NA	153950c9-c48b-4368-8c28-cb66e92bc9a6	NA	no	NA	Surgery, NOS
TCGA-LUAD	5134c56f-8286-4ec8-8348-237cee7dad5e	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6978	81	false	United States	NA	176	00e3632b-e860-5b1e-bfa8-eba5fc3d3f3f	not hispanic or latino	male	white	TCGA-55-6978_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	42	NA	1212ef53-0dcc-45a2-9d89-9217ce4d85aa	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-6978_diagnosis2	NA	Not Reported	TCGA-55-6978_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-55-6978_treatment6	NA	NA	NA	NA	bf0dd2ca-b2cd-452a-b71a-0edc98f076fa	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	5134c56f-8286-4ec8-8348-237cee7dad5e	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6978	81	false	United States	NA	176	00e3632b-e860-5b1e-bfa8-eba5fc3d3f3f	not hispanic or latino	male	white	TCGA-55-6978_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	42	NA	1212ef53-0dcc-45a2-9d89-9217ce4d85aa	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-6978_diagnosis2	NA	Not Reported	TCGA-55-6978_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6978_treatment8	NA	Distant Site	NA	NA	e4eab645-0f46-42a0-9bc6-1f0dad63d911	NA	no	NA	Surgery, NOS
TCGA-LUAD	5134c56f-8286-4ec8-8348-237cee7dad5e	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6978	81	false	United States	NA	176	00e3632b-e860-5b1e-bfa8-eba5fc3d3f3f	not hispanic or latino	male	white	TCGA-55-6978_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	42	NA	1212ef53-0dcc-45a2-9d89-9217ce4d85aa	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-6978_diagnosis2	NA	Not Reported	TCGA-55-6978_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-55-6978_treatment5	NA	NA	NA	NA	fb085676-b528-4138-8131-4c3ab5580529	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5134c56f-8286-4ec8-8348-237cee7dad5e	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6978	81	false	United States	NA	176	00e3632b-e860-5b1e-bfa8-eba5fc3d3f3f	not hispanic or latino	male	white	TCGA-55-6978_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	73f2bcdf-a362-45ea-9a0f-4a8f852998b7	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-6978_diagnosis3	NA	Bladder, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6978_treatment4	NA	NA	NA	NA	67db0dbf-dfd2-4fe9-8ba9-371adeab02fe	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5134c56f-8286-4ec8-8348-237cee7dad5e	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6978	81	false	United States	NA	176	00e3632b-e860-5b1e-bfa8-eba5fc3d3f3f	not hispanic or latino	male	white	TCGA-55-6978_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	73f2bcdf-a362-45ea-9a0f-4a8f852998b7	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-6978_diagnosis3	NA	Bladder, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6978_treatment3	NA	NA	NA	NA	81fb2044-f52b-4526-bcaa-6e292290cd94	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5134c56f-8286-4ec8-8348-237cee7dad5e	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6978	81	false	United States	NA	176	00e3632b-e860-5b1e-bfa8-eba5fc3d3f3f	not hispanic or latino	male	white	TCGA-55-6978_demographic	Dead	NA	MX	N0	Stage IIA	T2b	7th	primary	0	176.0	81664726-52e2-55f5-8e93-af5facbc7922	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-55-6978_diagnosis	No	Middle lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6978_treatment2	NA	NA	NA	NA	6aea93fa-37a6-44f6-8b4d-f7f182b00b8d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5134c56f-8286-4ec8-8348-237cee7dad5e	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6978	81	false	United States	NA	176	00e3632b-e860-5b1e-bfa8-eba5fc3d3f3f	not hispanic or latino	male	white	TCGA-55-6978_demographic	Dead	NA	MX	N0	Stage IIA	T2b	7th	primary	0	176.0	81664726-52e2-55f5-8e93-af5facbc7922	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-55-6978_diagnosis	No	Middle lobe, lung	NA	2010	NA	NA	95	60	NA	NA	11.0	NA	NA	NA	TCGA-55-6978_treatment	NA	Distant Site	3200	cGy	94dc54fa-fefa-52af-89a2-ee00455b008d	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	51e49548-1ad0-4c83-ae8a-2fa95bf4712a	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z054	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	5202458b-c38a-47c0-a0ba-5f1a59a762a0	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARO	39	false	United States	-14527	NA	b3d47408-1a9f-5b79-9ea8-b9994f655f53	not hispanic or latino	female	black or african american	TCGA-49-AARO_demographic	Alive	14527	MX	N0	Stage IA	T1a	6th	primary	0	3759.0	05b6bdaa-2900-5044-841f-7d861b9ec907	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AARO_diagnosis	No	Upper lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARO_treatment2	NA	NA	NA	NA	83314642-91aa-43e7-b8f6-c5c228d1c705	Adjuvant	yes	Complete Response	Radiation Therapy, NOS
TCGA-LUAD	5202458b-c38a-47c0-a0ba-5f1a59a762a0	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARO	39	false	United States	-14527	NA	b3d47408-1a9f-5b79-9ea8-b9994f655f53	not hispanic or latino	female	black or african american	TCGA-49-AARO_demographic	Alive	14527	MX	N0	Stage IA	T1a	6th	primary	0	3759.0	05b6bdaa-2900-5044-841f-7d861b9ec907	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AARO_diagnosis	No	Upper lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARO_treatment	NA	NA	NA	NA	b17b2937-df90-5827-a5ec-35ef8dca7075	Adjuvant	yes	Complete Response	Pharmaceutical Therapy, NOS
TCGA-LUAD	5202458b-c38a-47c0-a0ba-5f1a59a762a0	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARO	39	false	United States	-14527	NA	b3d47408-1a9f-5b79-9ea8-b9994f655f53	not hispanic or latino	female	black or african american	TCGA-49-AARO_demographic	Alive	18048	NA	NA	NA	NA	NA	recurrence	3521	NA	42f1f40b-9431-40ba-be0b-441c6a78c895	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARO_diagnosis3	NA	Not Reported	TCGA-49-AARO_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-AARO_treatment6	NA	NA	NA	NA	20334075-f4b1-4239-b181-c09cb8b4e768	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5202458b-c38a-47c0-a0ba-5f1a59a762a0	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARO	39	false	United States	-14527	NA	b3d47408-1a9f-5b79-9ea8-b9994f655f53	not hispanic or latino	female	black or african american	TCGA-49-AARO_demographic	Alive	18048	NA	NA	NA	NA	NA	recurrence	3521	NA	42f1f40b-9431-40ba-be0b-441c6a78c895	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARO_diagnosis3	NA	Not Reported	TCGA-49-AARO_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARO_treatment8	NA	Locoregional Site	NA	NA	3486a8d9-6712-4d76-91d6-b701354bb3e5	NA	no	NA	Surgery, NOS
TCGA-LUAD	5202458b-c38a-47c0-a0ba-5f1a59a762a0	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARO	39	false	United States	-14527	NA	b3d47408-1a9f-5b79-9ea8-b9994f655f53	not hispanic or latino	female	black or african american	TCGA-49-AARO_demographic	Alive	18048	NA	NA	NA	NA	NA	recurrence	3521	NA	42f1f40b-9431-40ba-be0b-441c6a78c895	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARO_diagnosis3	NA	Not Reported	TCGA-49-AARO_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-AARO_treatment7	NA	NA	NA	NA	46f31153-8f69-4e5e-92d8-24066cae75de	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5202458b-c38a-47c0-a0ba-5f1a59a762a0	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARO	39	false	United States	-14527	NA	b3d47408-1a9f-5b79-9ea8-b9994f655f53	not hispanic or latino	female	black or african american	TCGA-49-AARO_demographic	Alive	15671	NA	NA	NA	NA	NA	recurrence	1144	NA	9f040fce-8c1d-4a86-bf8a-11c2f51aa456	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARO_diagnosis2	NA	Not Reported	TCGA-49-AARO_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-AARO_treatment3	NA	NA	NA	NA	5772e14b-202f-4d7e-b98f-fc20f9e71360	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5202458b-c38a-47c0-a0ba-5f1a59a762a0	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARO	39	false	United States	-14527	NA	b3d47408-1a9f-5b79-9ea8-b9994f655f53	not hispanic or latino	female	black or african american	TCGA-49-AARO_demographic	Alive	15671	NA	NA	NA	NA	NA	recurrence	1144	NA	9f040fce-8c1d-4a86-bf8a-11c2f51aa456	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARO_diagnosis2	NA	Not Reported	TCGA-49-AARO_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-AARO_treatment4	NA	NA	NA	NA	798cd014-7020-4dd6-b5b5-66432eef1314	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5202458b-c38a-47c0-a0ba-5f1a59a762a0	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARO	39	false	United States	-14527	NA	b3d47408-1a9f-5b79-9ea8-b9994f655f53	not hispanic or latino	female	black or african american	TCGA-49-AARO_demographic	Alive	15671	NA	NA	NA	NA	NA	recurrence	1144	NA	9f040fce-8c1d-4a86-bf8a-11c2f51aa456	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARO_diagnosis2	NA	Not Reported	TCGA-49-AARO_diagnosis	NA	NA	NA	NA	3664	NA	NA	NA	NA	NA	NA	TCGA-49-AARO_treatment5	NA	Locoregional Site	NA	NA	c3a76e2f-dcc0-4600-91a5-824cebc5d033	NA	yes	NA	Surgery, NOS
TCGA-LUAD	528a0fce-0719-4b19-a69d-3f18681696c5	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4D0	48	false	Russia	-17607	116	9a67a93d-c302-5fd4-8d45-2463fcde771c	not hispanic or latino	male	white	TCGA-86-A4D0_demographic	Dead	17607	M0	N0	Stage IIA	T2b	7th	primary	0	116.0	ad92c9c5-ec25-5e86-b611-41df4fd41e1a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-86-A4D0_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	80	76	NA	NA	NA	NA	NA	NA	TCGA-86-A4D0_treatment2	Cisplatin	NA	NA	NA	b0550f8b-96df-467f-8886-a46efcb5ff54	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	528a0fce-0719-4b19-a69d-3f18681696c5	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4D0	48	false	Russia	-17607	116	9a67a93d-c302-5fd4-8d45-2463fcde771c	not hispanic or latino	male	white	TCGA-86-A4D0_demographic	Dead	17607	M0	N0	Stage IIA	T2b	7th	primary	0	116.0	ad92c9c5-ec25-5e86-b611-41df4fd41e1a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-86-A4D0_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-A4D0_treatment3	NA	NA	NA	NA	c59556ab-7bf9-438a-a502-bf4566315d52	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	528a0fce-0719-4b19-a69d-3f18681696c5	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4D0	48	false	Russia	-17607	116	9a67a93d-c302-5fd4-8d45-2463fcde771c	not hispanic or latino	male	white	TCGA-86-A4D0_demographic	Dead	17607	M0	N0	Stage IIA	T2b	7th	primary	0	116.0	ad92c9c5-ec25-5e86-b611-41df4fd41e1a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-86-A4D0_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	80	76	NA	NA	NA	NA	NA	NA	TCGA-86-A4D0_treatment	Etoposide	NA	NA	NA	ee5c10ae-51dc-57b0-8dd4-deabc238c52b	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	52df074f-a402-4b78-9472-f8eb268efded	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-NJ-A4YQ	69	false	United States	-25427	NA	7ce298f8-a1dd-5871-9b10-9d87d79a2b18	not hispanic or latino	female	white	TCGA-NJ-A4YQ_demographic	Alive	25427	M0	N0	Stage IA	T1b	7th	primary	0	1432.0	d604a933-ff13-5933-a6ed-ece785f7a270	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	RX	Lung, NOS	NA	TCGA-NJ-A4YQ_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A4YQ_treatment2	NA	NA	NA	NA	d0710424-ca39-4350-b5e7-4abb61afde95	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	52df074f-a402-4b78-9472-f8eb268efded	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-NJ-A4YQ	69	false	United States	-25427	NA	7ce298f8-a1dd-5871-9b10-9d87d79a2b18	not hispanic or latino	female	white	TCGA-NJ-A4YQ_demographic	Alive	25427	M0	N0	Stage IA	T1b	7th	primary	0	1432.0	d604a933-ff13-5933-a6ed-ece785f7a270	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	RX	Lung, NOS	NA	TCGA-NJ-A4YQ_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A4YQ_treatment	NA	NA	NA	NA	d69dbe4a-e8b9-5777-97e3-2f404b2b6505	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	532c1852-76dd-489f-9380-36766d6e3c34	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7714	61	false	United States	-22619	625	6ab970bb-90db-57f8-bf0b-fe99a1e3aac9	not hispanic or latino	female	black or african american	TCGA-86-7714_demographic	Dead	22619	M0	N2	Stage IIIA	T1b	7th	primary	0	625.0	eca6e0b2-f470-5fe8-a9f3-1e4304bf5aa2	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7714_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-7714_treatment	NA	NA	NA	NA	27cf6f12-a465-5488-ad34-a3e6568f92a4	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	532c1852-76dd-489f-9380-36766d6e3c34	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7714	61	false	United States	-22619	625	6ab970bb-90db-57f8-bf0b-fe99a1e3aac9	not hispanic or latino	female	black or african american	TCGA-86-7714_demographic	Dead	22619	M0	N2	Stage IIIA	T1b	7th	primary	0	625.0	eca6e0b2-f470-5fe8-a9f3-1e4304bf5aa2	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7714_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-7714_treatment2	NA	NA	NA	NA	313fdb1a-8d9e-4197-8fc8-1b0e49a8f004	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	53d7b0c2-b8ed-43c8-9ffd-a586e0a68086	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	54254f5a-50e8-4150-a9b7-56a0470d2a56	Informed Consent	4607	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7143	62	false	Australia	-22673	4961	6431275e-fb63-585b-9942-4b89b05b940f	not reported	female	white	TCGA-78-7143_demographic	Dead	22673	M0	N0	Stage IB	T2	6th	primary	0	4961.0	02cfbecb-9e58-5563-94b9-43becbab6367	true	NA	NA	C34.1	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Central Lung	TCGA-78-7143_diagnosis	No	Upper lobe, lung	NA	1992	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7143_treatment	NA	NA	NA	NA	dda93ff6-e37e-5cfe-b3d6-b20c822edfee	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	54254f5a-50e8-4150-a9b7-56a0470d2a56	Informed Consent	4607	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7143	62	false	Australia	-22673	4961	6431275e-fb63-585b-9942-4b89b05b940f	not reported	female	white	TCGA-78-7143_demographic	Dead	22673	M0	N0	Stage IB	T2	6th	primary	0	4961.0	02cfbecb-9e58-5563-94b9-43becbab6367	true	NA	NA	C34.1	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Central Lung	TCGA-78-7143_diagnosis	No	Upper lobe, lung	NA	1992	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7143_treatment2	NA	NA	NA	NA	fd199265-4366-442f-bf72-001f0c1627df	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	54254f5a-50e8-4150-a9b7-56a0470d2a56	Informed Consent	4607	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7143	62	false	Australia	-22673	4961	6431275e-fb63-585b-9942-4b89b05b940f	not reported	female	white	TCGA-78-7143_demographic	Dead	24173	NA	NA	NA	NA	NA	not reported	1500	NA	51c72a83-7001-4a84-b2d0-00a7d7723beb	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7143_diagnosis3	NA	Not Reported	TCGA-78-7143_diagnosis	NA	NA	NA	NA	1577	NA	NA	NA	NA	NA	NA	TCGA-78-7143_treatment9	NA	Locoregional Site	NA	NA	02b4bd86-563d-4e03-b057-618aa070da9e	NA	yes	NA	Surgery, NOS
TCGA-LUAD	54254f5a-50e8-4150-a9b7-56a0470d2a56	Informed Consent	4607	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7143	62	false	Australia	-22673	4961	6431275e-fb63-585b-9942-4b89b05b940f	not reported	female	white	TCGA-78-7143_demographic	Dead	24173	NA	NA	NA	NA	NA	not reported	1500	NA	51c72a83-7001-4a84-b2d0-00a7d7723beb	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7143_diagnosis3	NA	Not Reported	TCGA-78-7143_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7143_treatment7	NA	NA	NA	NA	3f6e41bb-0740-4c03-a5d0-edf13f9b9ea6	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	54254f5a-50e8-4150-a9b7-56a0470d2a56	Informed Consent	4607	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7143	62	false	Australia	-22673	4961	6431275e-fb63-585b-9942-4b89b05b940f	not reported	female	white	TCGA-78-7143_demographic	Dead	24173	NA	NA	NA	NA	NA	not reported	1500	NA	51c72a83-7001-4a84-b2d0-00a7d7723beb	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7143_diagnosis3	NA	Not Reported	TCGA-78-7143_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7143_treatment10	NA	Distant Site	NA	NA	e1a75d0f-548b-4d34-80c4-d13257751280	NA	no	NA	Surgery, NOS
TCGA-LUAD	54254f5a-50e8-4150-a9b7-56a0470d2a56	Informed Consent	4607	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7143	62	false	Australia	-22673	4961	6431275e-fb63-585b-9942-4b89b05b940f	not reported	female	white	TCGA-78-7143_demographic	Dead	24173	NA	NA	NA	NA	NA	not reported	1500	NA	51c72a83-7001-4a84-b2d0-00a7d7723beb	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7143_diagnosis3	NA	Not Reported	TCGA-78-7143_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7143_treatment8	NA	NA	NA	NA	e985a1f7-f886-4d83-90d2-eefce94213ce	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	54254f5a-50e8-4150-a9b7-56a0470d2a56	Informed Consent	4607	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7143	62	false	Australia	-22673	4961	6431275e-fb63-585b-9942-4b89b05b940f	not reported	female	white	TCGA-78-7143_demographic	Dead	27281	NA	NA	NA	NA	NA	not reported	4608	NA	f87dc46e-44c3-4675-818a-5ec0a6f09a1d	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7143_diagnosis2	NA	Not Reported	TCGA-78-7143_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7143_treatment4	NA	NA	NA	NA	1d10a536-5660-43fb-b48d-8203244f4d6f	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	54254f5a-50e8-4150-a9b7-56a0470d2a56	Informed Consent	4607	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7143	62	false	Australia	-22673	4961	6431275e-fb63-585b-9942-4b89b05b940f	not reported	female	white	TCGA-78-7143_demographic	Dead	27281	NA	NA	NA	NA	NA	not reported	4608	NA	f87dc46e-44c3-4675-818a-5ec0a6f09a1d	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7143_diagnosis2	NA	Not Reported	TCGA-78-7143_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7143_treatment6	NA	Distant Site	NA	NA	575e0797-c656-4db5-b525-04db2a6ae898	NA	no	NA	Surgery, NOS
TCGA-LUAD	54254f5a-50e8-4150-a9b7-56a0470d2a56	Informed Consent	4607	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7143	62	false	Australia	-22673	4961	6431275e-fb63-585b-9942-4b89b05b940f	not reported	female	white	TCGA-78-7143_demographic	Dead	27281	NA	NA	NA	NA	NA	not reported	4608	NA	f87dc46e-44c3-4675-818a-5ec0a6f09a1d	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7143_diagnosis2	NA	Not Reported	TCGA-78-7143_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7143_treatment3	NA	NA	NA	NA	773a7abb-ea16-406d-a171-afd94d5520df	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	54254f5a-50e8-4150-a9b7-56a0470d2a56	Informed Consent	4607	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7143	62	false	Australia	-22673	4961	6431275e-fb63-585b-9942-4b89b05b940f	not reported	female	white	TCGA-78-7143_demographic	Dead	27281	NA	NA	NA	NA	NA	not reported	4608	NA	f87dc46e-44c3-4675-818a-5ec0a6f09a1d	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7143_diagnosis2	NA	Not Reported	TCGA-78-7143_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7143_treatment5	NA	Locoregional Site	NA	NA	e077355c-d320-4728-a828-024cbcb3924d	NA	no	NA	Surgery, NOS
TCGA-LUAD	54480f58-7e63-4aed-a116-c2c2252e8364	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-8499	76	false	United States	-27853	NA	b3e19ce2-786f-54be-be21-25358a061d2f	not hispanic or latino	female	white	TCGA-91-8499_demographic	Alive	27853	MX	N0	Stage IA	T1b	7th	primary	0	36.0	d72fed61-3633-5cdb-acc4-be8763dfac85	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-8499_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-8499_treatment	NA	NA	NA	NA	3bcdd613-b449-5d2b-b38b-96ea8d7183c7	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	54480f58-7e63-4aed-a116-c2c2252e8364	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-8499	76	false	United States	-27853	NA	b3e19ce2-786f-54be-be21-25358a061d2f	not hispanic or latino	female	white	TCGA-91-8499_demographic	Alive	27853	MX	N0	Stage IA	T1b	7th	primary	0	36.0	d72fed61-3633-5cdb-acc4-be8763dfac85	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-8499_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-8499_treatment2	NA	NA	NA	NA	bc6545db-d2ed-460f-ac8b-4b26d5b8e874	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	54775a66-08cc-4f38-98f2-e7b2b5cec994	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7953	69	false	Russia	-25315	NA	1df00baa-cc61-5c70-9abb-9055f8c08636	not hispanic or latino	female	white	TCGA-86-7953_demographic	Alive	25315	M0	N0	Stage IA	T1b	7th	primary	0	997.0	a0d1ec57-e0bd-5c1f-8939-1947c769afb2	true	NA	NA	C34.1	Left	8250/3	Bronchiolo-alveolar adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-86-7953_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-7953_treatment2	NA	NA	NA	NA	027dc14c-ea06-41db-9b91-3d6b0450f50f	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	54775a66-08cc-4f38-98f2-e7b2b5cec994	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7953	69	false	Russia	-25315	NA	1df00baa-cc61-5c70-9abb-9055f8c08636	not hispanic or latino	female	white	TCGA-86-7953_demographic	Alive	25315	M0	N0	Stage IA	T1b	7th	primary	0	997.0	a0d1ec57-e0bd-5c1f-8939-1947c769afb2	true	NA	NA	C34.1	Left	8250/3	Bronchiolo-alveolar adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-86-7953_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-7953_treatment	NA	NA	NA	NA	77b33545-050d-58a7-8931-87a7766a75b2	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	548b0b68-ff45-4d45-adbe-984259e4a68b	Informed Consent	44	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7816	49	false	United States	-18170	468	9aa7914e-3c0f-5961-83dd-84095f4cc2be	not hispanic or latino	female	white	TCGA-55-7816_demographic	Dead	18170	MX	NX	Stage IV	TX	7th	primary	0	468.0	b20d3757-8632-544b-8a96-c72fd9aaf189	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-7816_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7816_treatment2	NA	NA	NA	NA	3cb722ca-08f7-4388-b8d5-1da1b0fb09f0	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	548b0b68-ff45-4d45-adbe-984259e4a68b	Informed Consent	44	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7816	49	false	United States	-18170	468	9aa7914e-3c0f-5961-83dd-84095f4cc2be	not hispanic or latino	female	white	TCGA-55-7816_demographic	Dead	18170	MX	NX	Stage IV	TX	7th	primary	0	468.0	b20d3757-8632-544b-8a96-c72fd9aaf189	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-7816_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7816_treatment	NA	NA	NA	NA	44c05cb2-7977-5bb8-b34a-8f837760043c	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	54a0e4d7-c274-4569-9c25-45bbe26d7f21	Informed Consent	37	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-6983	81	false	United States	NA	NA	346e013f-b034-5536-8f2c-c3674d39dc1e	not hispanic or latino	male	white	TCGA-55-6983_demographic	Alive	NA	M0	N1	Stage IIB	T2	6th	primary	0	2823.0	3377a3ed-2d60-5d32-b546-ddfa73564aa6	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	NA	TCGA-55-6983_diagnosis	No	Lower lobe, lung	NA	2005	No	NA	365	142	NA	NA	NA	NA	NA	NA	TCGA-55-6983_treatment	Unknown	NA	NA	NA	1764121a-3e23-5039-8050-9a1147fe1239	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	54a0e4d7-c274-4569-9c25-45bbe26d7f21	Informed Consent	37	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-6983	81	false	United States	NA	NA	346e013f-b034-5536-8f2c-c3674d39dc1e	not hispanic or latino	male	white	TCGA-55-6983_demographic	Alive	NA	M0	N1	Stage IIB	T2	6th	primary	0	2823.0	3377a3ed-2d60-5d32-b546-ddfa73564aa6	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	NA	TCGA-55-6983_diagnosis	No	Lower lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6983_treatment2	NA	NA	NA	NA	3889855e-c979-40d5-9e7b-4b19ce5120b1	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	15194	NA	NA	NA	NA	NA	metastasis	400	NA	a9f37269-e104-40bc-b2d8-bbde1bcb1ee8	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-53-7624_diagnosis2	NA	Not Reported	TCGA-53-7624_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-53-7624_treatment13	NA	NA	NA	NA	1ed38b7c-bbc6-4470-b520-fd822855e8a9	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	15194	NA	NA	NA	NA	NA	metastasis	400	NA	a9f37269-e104-40bc-b2d8-bbde1bcb1ee8	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-53-7624_diagnosis2	NA	Not Reported	TCGA-53-7624_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-53-7624_treatment12	NA	NA	NA	NA	8a8a1d34-6653-462b-82d2-1e5fdcaac9b4	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	15194	NA	NA	NA	NA	NA	metastasis	400	NA	a9f37269-e104-40bc-b2d8-bbde1bcb1ee8	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-53-7624_diagnosis2	NA	Not Reported	TCGA-53-7624_diagnosis	NA	NA	NA	NA	593	NA	NA	NA	NA	NA	NA	TCGA-53-7624_treatment14	NA	Distant Site	NA	NA	fc7814fb-7da3-49e9-9628-b960623f3fa6	NA	yes	NA	Surgery, NOS
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	14794	M1	N0	Stage IV	T2	6th	primary	0	1043.0	dea71bba-b373-5d9e-ada2-856caa91338d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7624_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	186	66	NA	NA	NA	NA	NA	NA	TCGA-53-7624_treatment7	Cisplatin	NA	NA	NA	0b44e356-d10e-4d61-bd62-d35f65b2bdcf	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	14794	M1	N0	Stage IV	T2	6th	primary	0	1043.0	dea71bba-b373-5d9e-ada2-856caa91338d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7624_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	490	339	NA	NA	NA	NA	NA	NA	TCGA-53-7624_treatment11	Pemetrexed	NA	NA	NA	10b1cc51-f6f7-4f2e-831b-9ae7a3290288	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	14794	M1	N0	Stage IV	T2	6th	primary	0	1043.0	dea71bba-b373-5d9e-ada2-856caa91338d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7624_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	490	339	NA	NA	NA	NA	NA	NA	TCGA-53-7624_treatment10	Bevacizumab	NA	NA	NA	85cb7ef9-af8a-4372-b743-0a54f8cefafd	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	14794	M1	N0	Stage IV	T2	6th	primary	0	1043.0	dea71bba-b373-5d9e-ada2-856caa91338d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7624_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	861	803	NA	NA	NA	NA	NA	NA	TCGA-53-7624_treatment5	Docetaxel	NA	NA	NA	85f250fc-ba64-43f3-b238-a70849b4fed8	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	14794	M1	N0	Stage IV	T2	6th	primary	0	1043.0	dea71bba-b373-5d9e-ada2-856caa91338d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7624_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	922	880	NA	NA	NA	NA	NA	NA	TCGA-53-7624_treatment3	Erlotinib	NA	NA	NA	88627591-b419-4e21-b2a0-92f7459a8167	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	14794	M1	N0	Stage IV	T2	6th	primary	0	1043.0	dea71bba-b373-5d9e-ada2-856caa91338d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7624_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	490	339	NA	NA	NA	NA	NA	NA	TCGA-53-7624_treatment9	Carboplatin	NA	NA	NA	8cdb08a6-0d30-41c3-8513-003749d15b65	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	14794	M1	N0	Stage IV	T2	6th	primary	0	1043.0	dea71bba-b373-5d9e-ada2-856caa91338d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7624_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	624	613	NA	NA	10.0	NA	NA	NA	TCGA-53-7624_treatment	NA	Distant Site	30	Gy	a01b0fbf-630e-553e-86a2-5379b4885f5d	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	14794	M1	N0	Stage IV	T2	6th	primary	0	1043.0	dea71bba-b373-5d9e-ada2-856caa91338d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7624_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	980	980	NA	NA	NA	NA	NA	NA	TCGA-53-7624_treatment4	Nab-paclitaxel	NA	NA	NA	a2a9ead0-1fae-4282-b5e7-b82e89c1e9e0	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	14794	M1	N0	Stage IV	T2	6th	primary	0	1043.0	dea71bba-b373-5d9e-ada2-856caa91338d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7624_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	782	726	NA	NA	NA	NA	NA	NA	TCGA-53-7624_treatment6	Gemcitabine	NA	NA	NA	cb732b3f-40da-4352-aa42-8982be30c01c	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	14794	M1	N0	Stage IV	T2	6th	primary	0	1043.0	dea71bba-b373-5d9e-ada2-856caa91338d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7624_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	186	66	NA	NA	NA	NA	NA	NA	TCGA-53-7624_treatment8	Vinorelbine	NA	NA	NA	f9ce0969-3e35-4b87-97d1-76fd05ca618a	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	54a9cc9e-3eee-4caa-9f33-4ea64a2999ba	Informed Consent	40	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7624	40	false	United States	-14794	1043	cc6b2140-2358-5184-b24a-4a7cad3daef4	hispanic or latino	female	white	TCGA-53-7624_demographic	Dead	14794	M1	N0	Stage IV	T2	6th	primary	0	1043.0	dea71bba-b373-5d9e-ada2-856caa91338d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7624_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	966	924	NA	NA	NA	NA	NA	NA	TCGA-53-7624_treatment2	Irinotecan	NA	NA	NA	fbe71f49-6f26-4250-8452-8ef88c99267c	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	54e90433-5218-4d83-848f-f995ecba2a63	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A7SV	69	false	United States	-25298	NA	baf8d896-ff23-5478-b919-63bf1c0703db	not hispanic or latino	male	black or african american	TCGA-L9-A7SV_demographic	Alive	25298	M0	N1	Stage IIA	T2a	7th	primary	0	565.0	4fda9f89-8fe6-5072-aa28-068f8188dcd1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-L9-A7SV_diagnosis	No	Lower lobe, lung	NA	2013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A7SV_treatment3	NA	NA	NA	NA	5d21ead7-0064-4ed7-bed2-20ca1985dc12	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	54e90433-5218-4d83-848f-f995ecba2a63	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A7SV	69	false	United States	-25298	NA	baf8d896-ff23-5478-b919-63bf1c0703db	not hispanic or latino	male	black or african american	TCGA-L9-A7SV_demographic	Alive	25298	M0	N1	Stage IIA	T2a	7th	primary	0	565.0	4fda9f89-8fe6-5072-aa28-068f8188dcd1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-L9-A7SV_diagnosis	No	Lower lobe, lung	NA	2013	No	NA	104	41	NA	NA	NA	NA	NA	NA	TCGA-L9-A7SV_treatment	Cisplatin	NA	NA	NA	6294aa06-4f7f-5d09-80f2-32b337d9d5d1	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	54e90433-5218-4d83-848f-f995ecba2a63	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A7SV	69	false	United States	-25298	NA	baf8d896-ff23-5478-b919-63bf1c0703db	not hispanic or latino	male	black or african american	TCGA-L9-A7SV_demographic	Alive	25298	M0	N1	Stage IIA	T2a	7th	primary	0	565.0	4fda9f89-8fe6-5072-aa28-068f8188dcd1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-L9-A7SV_diagnosis	No	Lower lobe, lung	NA	2013	No	NA	104	41	NA	NA	NA	NA	NA	NA	TCGA-L9-A7SV_treatment2	Pemetrexed Disodium	NA	NA	NA	65878503-c972-46e2-b29a-f18e271f65ee	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	5510ad32-62fd-4adc-964a-ae4e997c2f4b	Informed Consent	66	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8620	60	false	United States	-22091	375	ff2ea5b3-8ea4-53ba-9d7f-0542e9dc3f72	not hispanic or latino	male	white	TCGA-55-8620_demographic	Dead	22091	M1b	N1	Stage IV	T1a	7th	primary	0	375.0	33c66148-14bf-5acd-b2cf-9981dc81e702	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-55-8620_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	161	132	NA	NA	18.0	NA	NA	NA	TCGA-55-8620_treatment	NA	Distant Site	3600	cGy	5a6f1473-9c70-593f-b6ee-32215807d1f8	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	5510ad32-62fd-4adc-964a-ae4e997c2f4b	Informed Consent	66	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8620	60	false	United States	-22091	375	ff2ea5b3-8ea4-53ba-9d7f-0542e9dc3f72	not hispanic or latino	male	white	TCGA-55-8620_demographic	Dead	22091	M1b	N1	Stage IV	T1a	7th	primary	0	375.0	33c66148-14bf-5acd-b2cf-9981dc81e702	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-55-8620_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8620_treatment2	NA	NA	NA	NA	c3b0ba1b-f902-4717-b989-b4089deed657	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	552712d3-da16-441e-ba93-11810793d598	Informed Consent	77	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-8255	71	false	United States	-26289	NA	2689800d-9349-535c-b022-60c173bc4150	hispanic or latino	male	white	TCGA-69-8255_demographic	Alive	26289	M0	N0	Stage IA	T1a	7th	primary	0	129.0	542a465e-6dd1-57a2-8f64-bd05584b2a73	true	NA	NA	C34.1	Right	8230/3	Solid carcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-69-8255_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-8255_treatment	NA	NA	NA	NA	ce1b75e1-014b-5c28-98b7-d0d83ab82767	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	552712d3-da16-441e-ba93-11810793d598	Informed Consent	77	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-8255	71	false	United States	-26289	NA	2689800d-9349-535c-b022-60c173bc4150	hispanic or latino	male	white	TCGA-69-8255_demographic	Alive	26289	M0	N0	Stage IA	T1a	7th	primary	0	129.0	542a465e-6dd1-57a2-8f64-bd05584b2a73	true	NA	NA	C34.1	Right	8230/3	Solid carcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-69-8255_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-8255_treatment2	NA	NA	NA	NA	f84be56c-b7dc-4b28-9a5c-82ae43111eb6	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	56027785-fb10-492c-b021-ea9e3a1979db	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z042	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	562a562b-ca03-44ac-b282-b51b457d8dae	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46Y	70	false	Germany	-25905	414	c37d1188-a100-5a34-9535-d8461861efc0	not hispanic or latino	female	white	TCGA-62-A46Y_demographic	Dead	26219	NA	NA	NA	NA	NA	metastasis	314	NA	677f5c2c-c27b-4392-93da-36ca49a58603	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-A46Y_diagnosis2	NA	Not Reported	TCGA-62-A46Y_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-A46Y_treatment5	NA	NA	NA	NA	1817156f-cbf3-4f86-8a59-e3b1f4c480b0	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	562a562b-ca03-44ac-b282-b51b457d8dae	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46Y	70	false	Germany	-25905	414	c37d1188-a100-5a34-9535-d8461861efc0	not hispanic or latino	female	white	TCGA-62-A46Y_demographic	Dead	26219	NA	NA	NA	NA	NA	metastasis	314	NA	677f5c2c-c27b-4392-93da-36ca49a58603	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-A46Y_diagnosis2	NA	Not Reported	TCGA-62-A46Y_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-A46Y_treatment4	NA	NA	NA	NA	56a590e9-9d5e-4241-9b34-18ce178bf74b	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	562a562b-ca03-44ac-b282-b51b457d8dae	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46Y	70	false	Germany	-25905	414	c37d1188-a100-5a34-9535-d8461861efc0	not hispanic or latino	female	white	TCGA-62-A46Y_demographic	Dead	26219	NA	NA	NA	NA	NA	metastasis	314	NA	677f5c2c-c27b-4392-93da-36ca49a58603	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-A46Y_diagnosis2	NA	Not Reported	TCGA-62-A46Y_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46Y_treatment6	NA	Distant Site	NA	NA	a1469a0f-4daf-46c3-8811-2bbeef2868c2	NA	no	NA	Surgery, NOS
TCGA-LUAD	562a562b-ca03-44ac-b282-b51b457d8dae	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46Y	70	false	Germany	-25905	414	c37d1188-a100-5a34-9535-d8461861efc0	not hispanic or latino	female	white	TCGA-62-A46Y_demographic	Dead	25905	M0	N2	Stage IIIA	T2	6th	primary	0	414.0	f2664da6-bf48-5600-8383-5b5b591d3789	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A46Y_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	256	74	NA	NA	NA	NA	NA	NA	TCGA-62-A46Y_treatment2	Cisplatin	NA	NA	NA	24eb184e-c584-4376-abf2-233b8885d99b	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	562a562b-ca03-44ac-b282-b51b457d8dae	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46Y	70	false	Germany	-25905	414	c37d1188-a100-5a34-9535-d8461861efc0	not hispanic or latino	female	white	TCGA-62-A46Y_demographic	Dead	25905	M0	N2	Stage IIIA	T2	6th	primary	0	414.0	f2664da6-bf48-5600-8383-5b5b591d3789	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A46Y_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	256	227	NA	NA	NA	NA	NA	NA	TCGA-62-A46Y_treatment	NA	Regional Site	50	Gy	4cce4b80-4f54-52aa-9c8b-a7f639431ae2	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	562a562b-ca03-44ac-b282-b51b457d8dae	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46Y	70	false	Germany	-25905	414	c37d1188-a100-5a34-9535-d8461861efc0	not hispanic or latino	female	white	TCGA-62-A46Y_demographic	Dead	25905	M0	N2	Stage IIIA	T2	6th	primary	0	414.0	f2664da6-bf48-5600-8383-5b5b591d3789	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A46Y_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	256	74	NA	NA	NA	NA	NA	NA	TCGA-62-A46Y_treatment3	Vinorelbine Tartrate	NA	NA	NA	5803f09f-fac7-4a7e-81e1-dbc9956364e7	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	5730b09c-a69f-425a-8af9-61172f9dfe56	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z020	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	575752f8-2788-43cd-afde-f0f600f39d18	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M3	69	false	United States	-25384	NA	bd36cb1c-13ff-5618-b435-74cd1765ba05	not hispanic or latino	female	white	TCGA-97-A4M3_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	076c3ff3-095f-4cc2-9132-4ffb3a5d0d34	false	NA	NA	NA	NA	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-97-A4M3_diagnosis3	NA	Head, face or neck, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M3_treatment4	NA	NA	NA	NA	35fe83a7-a1d5-43ab-b248-2ab7b54a58bb	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	575752f8-2788-43cd-afde-f0f600f39d18	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M3	69	false	United States	-25384	NA	bd36cb1c-13ff-5618-b435-74cd1765ba05	not hispanic or latino	female	white	TCGA-97-A4M3_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	076c3ff3-095f-4cc2-9132-4ffb3a5d0d34	false	NA	NA	NA	NA	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-97-A4M3_diagnosis3	NA	Head, face or neck, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M3_treatment3	NA	NA	NA	NA	fac407c0-1fb1-450c-a7a1-5d6c0f6b4f7d	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	575752f8-2788-43cd-afde-f0f600f39d18	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M3	69	false	United States	-25384	NA	bd36cb1c-13ff-5618-b435-74cd1765ba05	not hispanic or latino	female	white	TCGA-97-A4M3_demographic	Alive	25438	NA	NA	NA	NA	NA	Subsequent Primary	54	NA	244120ff-a172-4081-beec-2d7ab30b60ed	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-A4M3_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-97-A4M3_treatment8	NA	NA	NA	NA	0006415f-ef81-4921-97e9-355c1ef200fe	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	575752f8-2788-43cd-afde-f0f600f39d18	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M3	69	false	United States	-25384	NA	bd36cb1c-13ff-5618-b435-74cd1765ba05	not hispanic or latino	female	white	TCGA-97-A4M3_demographic	Alive	25438	NA	NA	NA	NA	NA	Subsequent Primary	54	NA	244120ff-a172-4081-beec-2d7ab30b60ed	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-A4M3_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-97-A4M3_treatment7	NA	NA	NA	NA	176ae1a8-c614-4c06-b9a6-36c28d622971	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	575752f8-2788-43cd-afde-f0f600f39d18	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M3	69	false	United States	-25384	NA	bd36cb1c-13ff-5618-b435-74cd1765ba05	not hispanic or latino	female	white	TCGA-97-A4M3_demographic	Alive	25384	M0	N0	Stage IA	T1b	7th	primary	0	540.0	8e3a7e81-9afb-5009-a120-f75724e34693	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-97-A4M3_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M3_treatment2	NA	NA	NA	NA	98c9e84b-0f33-4401-96eb-9c356b7fc239	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	575752f8-2788-43cd-afde-f0f600f39d18	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M3	69	false	United States	-25384	NA	bd36cb1c-13ff-5618-b435-74cd1765ba05	not hispanic or latino	female	white	TCGA-97-A4M3_demographic	Alive	25384	M0	N0	Stage IA	T1b	7th	primary	0	540.0	8e3a7e81-9afb-5009-a120-f75724e34693	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-97-A4M3_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M3_treatment	NA	NA	NA	NA	e741b24e-36f0-5b83-846e-44532705e4f8	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	575752f8-2788-43cd-afde-f0f600f39d18	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M3	69	false	United States	-25384	NA	bd36cb1c-13ff-5618-b435-74cd1765ba05	not hispanic or latino	female	white	TCGA-97-A4M3_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	b2d6cca5-8a00-4561-a609-6fc2fdfe6559	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-97-A4M3_diagnosis4	NA	Head, face or neck, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M3_treatment6	NA	NA	NA	NA	00c1e434-42bf-4df6-bb2b-0406067962dc	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	575752f8-2788-43cd-afde-f0f600f39d18	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M3	69	false	United States	-25384	NA	bd36cb1c-13ff-5618-b435-74cd1765ba05	not hispanic or latino	female	white	TCGA-97-A4M3_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	b2d6cca5-8a00-4561-a609-6fc2fdfe6559	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-97-A4M3_diagnosis4	NA	Head, face or neck, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M3_treatment5	NA	NA	NA	NA	e9a6ab6a-5d3f-4eaa-b6a4-e9df2aeb07a0	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5813997a-d7dc-4f7c-8d4b-e979832168a9	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AAR3	69	false	United States	-25469	NA	f3aff213-b01f-51fd-a1d9-bdd04c1d1ebf	not hispanic or latino	male	black or african american	TCGA-49-AAR3_demographic	Alive	27362	NA	NA	NA	NA	NA	recurrence	1893	NA	069ab215-5851-4f1a-836e-148842560187	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AAR3_diagnosis2	NA	Not Reported	TCGA-49-AAR3_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-AAR3_treatment4	NA	NA	NA	NA	a32776ba-41ef-4492-ac4b-9d50b1cce0bb	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5813997a-d7dc-4f7c-8d4b-e979832168a9	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AAR3	69	false	United States	-25469	NA	f3aff213-b01f-51fd-a1d9-bdd04c1d1ebf	not hispanic or latino	male	black or african american	TCGA-49-AAR3_demographic	Alive	27362	NA	NA	NA	NA	NA	recurrence	1893	NA	069ab215-5851-4f1a-836e-148842560187	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AAR3_diagnosis2	NA	Not Reported	TCGA-49-AAR3_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAR3_treatment5	NA	Locoregional Site	NA	NA	a75634c2-5550-4032-b0d0-15e28b594f86	NA	no	NA	Surgery, NOS
TCGA-LUAD	5813997a-d7dc-4f7c-8d4b-e979832168a9	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AAR3	69	false	United States	-25469	NA	f3aff213-b01f-51fd-a1d9-bdd04c1d1ebf	not hispanic or latino	male	black or african american	TCGA-49-AAR3_demographic	Alive	27362	NA	NA	NA	NA	NA	recurrence	1893	NA	069ab215-5851-4f1a-836e-148842560187	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AAR3_diagnosis2	NA	Not Reported	TCGA-49-AAR3_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-AAR3_treatment3	NA	NA	NA	NA	a9d5a780-6378-43b3-9126-b36b32d48020	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5813997a-d7dc-4f7c-8d4b-e979832168a9	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AAR3	69	false	United States	-25469	NA	f3aff213-b01f-51fd-a1d9-bdd04c1d1ebf	not hispanic or latino	male	black or african american	TCGA-49-AAR3_demographic	Alive	25469	MX	N1	Stage IIB	T2	6th	primary	0	1893.0	c09eea7c-e303-50c9-9cf8-6586094714d4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AAR3_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAR3_treatment2	NA	NA	NA	NA	2b621be9-c612-41bb-a68c-6e2bd60fc3cc	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5813997a-d7dc-4f7c-8d4b-e979832168a9	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AAR3	69	false	United States	-25469	NA	f3aff213-b01f-51fd-a1d9-bdd04c1d1ebf	not hispanic or latino	male	black or african american	TCGA-49-AAR3_demographic	Alive	25469	MX	N1	Stage IIB	T2	6th	primary	0	1893.0	c09eea7c-e303-50c9-9cf8-6586094714d4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AAR3_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAR3_treatment	NA	NA	NA	NA	a8a555bf-b05e-5c45-9c82-4e730866adee	Adjuvant	yes	Complete Response	Pharmaceutical Therapy, NOS
TCGA-LUAD	58babefe-7e81-4594-ba29-50d1de92a5ab	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6207	NA	false	Canada	NA	NA	3710fd61-4841-5015-bc6f-1e21eeebf885	not reported	male	not reported	TCGA-75-6207_demographic	Dead	NA	M0	N2	Stage IIIA	T2	6th	primary	NA	NA	a70d1af1-a56d-521e-8917-88cb0b350570	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6207_diagnosis	No	Lung, NOS	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6207_treatment2	NA	NA	NA	NA	5e5fc94f-0520-4a82-9b62-68a615f382a7	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	58babefe-7e81-4594-ba29-50d1de92a5ab	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6207	NA	false	Canada	NA	NA	3710fd61-4841-5015-bc6f-1e21eeebf885	not reported	male	not reported	TCGA-75-6207_demographic	Dead	NA	M0	N2	Stage IIIA	T2	6th	primary	NA	NA	a70d1af1-a56d-521e-8917-88cb0b350570	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6207_diagnosis	No	Lung, NOS	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6207_treatment	NA	NA	NA	NA	75b63d24-1700-52dc-98c2-18ba0597cf4f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	591c068f-bbb1-4df2-9abb-d1a2e4a58372	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5068	59	false	United States	-21728	1499	95fcab07-1ed9-5508-bd0f-038e2dc49628	not hispanic or latino	female	white	TCGA-50-5068_demographic	Dead	21728	MX	N1	Stage IIB	T2	6th	primary	0	1499.0	472ac503-de3f-5918-8c48-71a8542cbbec	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5068_diagnosis	No	Lower lobe, lung	NA	2003	No	NA	140	99	NA	NA	NA	NA	NA	NA	TCGA-50-5068_treatment	Paclitaxel	NA	NA	NA	9d515939-b51f-57f7-90f7-ff3f831b70f7	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	591c068f-bbb1-4df2-9abb-d1a2e4a58372	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5068	59	false	United States	-21728	1499	95fcab07-1ed9-5508-bd0f-038e2dc49628	not hispanic or latino	female	white	TCGA-50-5068_demographic	Dead	21728	MX	N1	Stage IIB	T2	6th	primary	0	1499.0	472ac503-de3f-5918-8c48-71a8542cbbec	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5068_diagnosis	No	Lower lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5068_treatment2	NA	NA	NA	NA	cdd3e9a7-4865-4fe9-8bf2-31bbe074685d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	591c068f-bbb1-4df2-9abb-d1a2e4a58372	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5068	59	false	United States	-21728	1499	95fcab07-1ed9-5508-bd0f-038e2dc49628	not hispanic or latino	female	white	TCGA-50-5068_demographic	Dead	22414	NA	NA	NA	NA	NA	metastasis	686	NA	9b6941b6-f874-4b2d-abf1-fb8fda2c550b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5068_diagnosis2	NA	Not Reported	TCGA-50-5068_diagnosis	NA	NA	NA	NA	686	NA	NA	NA	NA	NA	NA	TCGA-50-5068_treatment5	NA	Locoregional Site	NA	NA	20abbfee-b14a-48c1-9048-24bb4121c9de	NA	yes	NA	Surgery, NOS
TCGA-LUAD	591c068f-bbb1-4df2-9abb-d1a2e4a58372	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5068	59	false	United States	-21728	1499	95fcab07-1ed9-5508-bd0f-038e2dc49628	not hispanic or latino	female	white	TCGA-50-5068_demographic	Dead	22414	NA	NA	NA	NA	NA	metastasis	686	NA	9b6941b6-f874-4b2d-abf1-fb8fda2c550b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5068_diagnosis2	NA	Not Reported	TCGA-50-5068_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5068_treatment3	NA	NA	NA	NA	3470d4af-930c-450c-9cc4-150b470e213d	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	591c068f-bbb1-4df2-9abb-d1a2e4a58372	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5068	59	false	United States	-21728	1499	95fcab07-1ed9-5508-bd0f-038e2dc49628	not hispanic or latino	female	white	TCGA-50-5068_demographic	Dead	22414	NA	NA	NA	NA	NA	metastasis	686	NA	9b6941b6-f874-4b2d-abf1-fb8fda2c550b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5068_diagnosis2	NA	Not Reported	TCGA-50-5068_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5068_treatment4	NA	NA	NA	NA	3a96e10a-fe71-4ca4-9dec-3e999d9e081e	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	591c068f-bbb1-4df2-9abb-d1a2e4a58372	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5068	59	false	United States	-21728	1499	95fcab07-1ed9-5508-bd0f-038e2dc49628	not hispanic or latino	female	white	TCGA-50-5068_demographic	Dead	22414	NA	NA	NA	NA	NA	metastasis	686	NA	9b6941b6-f874-4b2d-abf1-fb8fda2c550b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5068_diagnosis2	NA	Not Reported	TCGA-50-5068_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5068_treatment6	NA	Distant Site	NA	NA	6b6156f1-561c-403b-b500-0cce10621311	NA	no	NA	Surgery, NOS
TCGA-LUAD	595fc3ad-f603-421b-b130-52f1f617050b	Informed Consent	-16	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-NJ-A4YF	50	false	United States	-18584	NA	bc7068cd-16c2-57ca-8c86-e7f8a1541d10	not hispanic or latino	female	black or african american	TCGA-NJ-A4YF_demographic	Alive	18584	M0	N0	Stage IA	T1	6th	primary	0	2161.0	1813a5e5-353c-5dae-a0fc-f7963c763002	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-NJ-A4YF_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A4YF_treatment2	NA	NA	NA	NA	372dbec5-da17-4a55-94e9-6969f6ebfa9a	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	595fc3ad-f603-421b-b130-52f1f617050b	Informed Consent	-16	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-NJ-A4YF	50	false	United States	-18584	NA	bc7068cd-16c2-57ca-8c86-e7f8a1541d10	not hispanic or latino	female	black or african american	TCGA-NJ-A4YF_demographic	Alive	18584	M0	N0	Stage IA	T1	6th	primary	0	2161.0	1813a5e5-353c-5dae-a0fc-f7963c763002	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-NJ-A4YF_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A4YF_treatment	NA	NA	NA	NA	fdf867ed-b6e9-522d-8415-93cf87b2febd	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5a2f8140-8f90-4e94-b703-5fa5aa96be7b	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6830	65	false	United States	-23922	NA	169219e7-d79e-5540-b208-e41e4cd7fd17	not hispanic or latino	female	white	TCGA-91-6830_demographic	Alive	23922	MX	N1	Stage IIA	T1	5th	primary	0	60.0	5e4bb363-fd0c-5357-831d-a311b878fd38	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6830_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	60	60	NA	NA	1.0	NA	NA	NA	TCGA-91-6830_treatment	NA	Distant Site	2000	cGy	2484e623-6f7a-5af8-9355-55107de1faeb	NA	yes	Unknown	Radiation, External Beam
TCGA-LUAD	5a2f8140-8f90-4e94-b703-5fa5aa96be7b	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6830	65	false	United States	-23922	NA	169219e7-d79e-5540-b208-e41e4cd7fd17	not hispanic or latino	female	white	TCGA-91-6830_demographic	Alive	23922	MX	N1	Stage IIA	T1	5th	primary	0	60.0	5e4bb363-fd0c-5357-831d-a311b878fd38	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6830_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6830_treatment2	NA	NA	NA	NA	8fe75a1a-375d-4c98-8a2e-ddd4040dae42	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5a2f8140-8f90-4e94-b703-5fa5aa96be7b	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6830	65	false	United States	-23922	NA	169219e7-d79e-5540-b208-e41e4cd7fd17	not hispanic or latino	female	white	TCGA-91-6830_demographic	Alive	23940	NA	NA	NA	NA	NA	metastasis	18	NA	dad94f13-16a5-4547-87c6-5bfd89a3ea23	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-91-6830_diagnosis2	NA	Not Reported	TCGA-91-6830_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-91-6830_treatment3	NA	NA	NA	NA	2aa32265-4646-450f-9109-6f67f80d82ee	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5a2f8140-8f90-4e94-b703-5fa5aa96be7b	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6830	65	false	United States	-23922	NA	169219e7-d79e-5540-b208-e41e4cd7fd17	not hispanic or latino	female	white	TCGA-91-6830_demographic	Alive	23940	NA	NA	NA	NA	NA	metastasis	18	NA	dad94f13-16a5-4547-87c6-5bfd89a3ea23	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-91-6830_diagnosis2	NA	Not Reported	TCGA-91-6830_diagnosis	NA	NA	NA	NA	18	NA	NA	NA	NA	NA	NA	TCGA-91-6830_treatment5	NA	Distant Site	NA	NA	8875e4c9-02e1-4212-ab5c-27f4352e064a	NA	yes	NA	Surgery, NOS
TCGA-LUAD	5a2f8140-8f90-4e94-b703-5fa5aa96be7b	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6830	65	false	United States	-23922	NA	169219e7-d79e-5540-b208-e41e4cd7fd17	not hispanic or latino	female	white	TCGA-91-6830_demographic	Alive	23940	NA	NA	NA	NA	NA	metastasis	18	NA	dad94f13-16a5-4547-87c6-5bfd89a3ea23	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-91-6830_diagnosis2	NA	Not Reported	TCGA-91-6830_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-91-6830_treatment4	NA	NA	NA	NA	c93af67d-f65a-44a9-8436-ab41f1a82ced	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	5abd6651-69be-42f8-bdc0-308e68136d31	Informed Consent	6812	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7163	60	false	Australia	-22002	NA	42424e03-7ba9-58ba-a770-bcf8467ee17f	not reported	male	white	TCGA-78-7163_demographic	Alive	22002	M0	N0	Stage IB	T2	6th	primary	0	7248.0	06c8ee8d-3c9b-5db5-ab50-424492059dd8	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7163_diagnosis	No	Lower lobe, lung	NA	1992	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7163_treatment2	NA	NA	NA	NA	1812c27b-05a4-408e-b76e-f5b7568476e0	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5abd6651-69be-42f8-bdc0-308e68136d31	Informed Consent	6812	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7163	60	false	Australia	-22002	NA	42424e03-7ba9-58ba-a770-bcf8467ee17f	not reported	male	white	TCGA-78-7163_demographic	Alive	22002	M0	N0	Stage IB	T2	6th	primary	0	7248.0	06c8ee8d-3c9b-5db5-ab50-424492059dd8	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7163_diagnosis	No	Lower lobe, lung	NA	1992	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7163_treatment	NA	NA	NA	NA	ef4bfded-6745-5b57-a5f1-ebdcf28ee6a6	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5ace9608-d38a-42f2-a877-ec7c9d211808	Informed Consent	-29	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8648	58	false	Australia	-21443	1209	61c984b3-e40b-5749-841b-030385b2d769	not reported	female	not reported	TCGA-78-8648_demographic	Dead	21443	M0	N0	Stage IIB	T3	6th	primary	0	1209.0	62708d61-1152-5bc9-92b4-5889fb7452d0	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-8648_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8648_treatment	NA	NA	NA	NA	621581f4-4da1-5a6d-9f82-b8b668585911	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5ace9608-d38a-42f2-a877-ec7c9d211808	Informed Consent	-29	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8648	58	false	Australia	-21443	1209	61c984b3-e40b-5749-841b-030385b2d769	not reported	female	not reported	TCGA-78-8648_demographic	Dead	21443	M0	N0	Stage IIB	T3	6th	primary	0	1209.0	62708d61-1152-5bc9-92b4-5889fb7452d0	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-8648_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8648_treatment2	NA	NA	NA	NA	79b367ed-f4fd-4988-8a5d-8449c82140b7	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5ace9608-d38a-42f2-a877-ec7c9d211808	Informed Consent	-29	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8648	58	false	Australia	-21443	1209	61c984b3-e40b-5749-841b-030385b2d769	not reported	female	not reported	TCGA-78-8648_demographic	Dead	22163	NA	NA	NA	NA	NA	recurrence	720	NA	dc8303ab-d565-4356-be67-80294b3506d3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-78-8648_diagnosis2	NA	Not Reported	TCGA-78-8648_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8648_treatment5	NA	Locoregional Site	NA	NA	ca4db356-3d7d-467e-9933-57814cbb2309	NA	unknown	NA	Surgery, NOS
TCGA-LUAD	5ace9608-d38a-42f2-a877-ec7c9d211808	Informed Consent	-29	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8648	58	false	Australia	-21443	1209	61c984b3-e40b-5749-841b-030385b2d769	not reported	female	not reported	TCGA-78-8648_demographic	Dead	22163	NA	NA	NA	NA	NA	recurrence	720	NA	dc8303ab-d565-4356-be67-80294b3506d3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-78-8648_diagnosis2	NA	Not Reported	TCGA-78-8648_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-78-8648_treatment3	NA	NA	NA	NA	fc2444a7-502a-47c9-9021-f38fe8b2fdd2	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5ace9608-d38a-42f2-a877-ec7c9d211808	Informed Consent	-29	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8648	58	false	Australia	-21443	1209	61c984b3-e40b-5749-841b-030385b2d769	not reported	female	not reported	TCGA-78-8648_demographic	Dead	22163	NA	NA	NA	NA	NA	recurrence	720	NA	dc8303ab-d565-4356-be67-80294b3506d3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-78-8648_diagnosis2	NA	Not Reported	TCGA-78-8648_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-78-8648_treatment4	NA	NA	NA	NA	fe7992d5-a6c1-4b9a-a33f-d74d9119ff7c	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	5af499be-d2b9-4eaf-9a9f-435dccb51917	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6979	59	false	United States	-21780	237	2f74fbca-6aad-5c2a-9ba1-4df0c5f572bc	not reported	female	white	TCGA-55-6979_demographic	Dead	21975	NA	NA	NA	NA	NA	metastasis	195	NA	14573b30-642a-4522-aaa0-1f67f197eeb0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-6979_diagnosis2	NA	Not Reported	TCGA-55-6979_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6979_treatment8	NA	Distant Site	NA	NA	3c479dea-67c5-47a2-8733-33951090c6ce	NA	no	NA	Surgery, NOS
TCGA-LUAD	5af499be-d2b9-4eaf-9a9f-435dccb51917	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6979	59	false	United States	-21780	237	2f74fbca-6aad-5c2a-9ba1-4df0c5f572bc	not reported	female	white	TCGA-55-6979_demographic	Dead	21975	NA	NA	NA	NA	NA	metastasis	195	NA	14573b30-642a-4522-aaa0-1f67f197eeb0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-6979_diagnosis2	NA	Not Reported	TCGA-55-6979_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-6979_treatment7	NA	NA	NA	NA	67ba31f6-637b-4472-b484-848add19d070	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	5af499be-d2b9-4eaf-9a9f-435dccb51917	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6979	59	false	United States	-21780	237	2f74fbca-6aad-5c2a-9ba1-4df0c5f572bc	not reported	female	white	TCGA-55-6979_demographic	Dead	21975	NA	NA	NA	NA	NA	metastasis	195	NA	14573b30-642a-4522-aaa0-1f67f197eeb0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-6979_diagnosis2	NA	Not Reported	TCGA-55-6979_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-6979_treatment6	NA	NA	NA	NA	6d8b43b4-ef09-481b-9f16-92629d719110	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5af499be-d2b9-4eaf-9a9f-435dccb51917	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6979	59	false	United States	-21780	237	2f74fbca-6aad-5c2a-9ba1-4df0c5f572bc	not reported	female	white	TCGA-55-6979_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	2752b688-ebf4-44e1-9a76-66dfa5ed39e2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-6979_diagnosis3	NA	Thyroid gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6979_treatment5	NA	NA	NA	NA	3c3eb137-783b-49da-8940-528e37de09fa	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5af499be-d2b9-4eaf-9a9f-435dccb51917	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6979	59	false	United States	-21780	237	2f74fbca-6aad-5c2a-9ba1-4df0c5f572bc	not reported	female	white	TCGA-55-6979_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	2752b688-ebf4-44e1-9a76-66dfa5ed39e2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-6979_diagnosis3	NA	Thyroid gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6979_treatment4	NA	NA	NA	NA	8c43054e-d7d7-48d9-b5ae-7b776eed3499	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5af499be-d2b9-4eaf-9a9f-435dccb51917	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6979	59	false	United States	-21780	237	2f74fbca-6aad-5c2a-9ba1-4df0c5f572bc	not reported	female	white	TCGA-55-6979_demographic	Dead	21780	M0	N1	Stage IIB	T2	6th	primary	0	237.0	a327a5b6-b6b1-54f1-ade0-148081f87cac	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-55-6979_diagnosis	No	Upper lobe, lung	NA	2006	No	NA	149	57	NA	NA	NA	NA	NA	NA	TCGA-55-6979_treatment	Carboplatin	NA	NA	NA	6b7a5af4-f931-5548-be75-319a1bda489a	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	5af499be-d2b9-4eaf-9a9f-435dccb51917	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6979	59	false	United States	-21780	237	2f74fbca-6aad-5c2a-9ba1-4df0c5f572bc	not reported	female	white	TCGA-55-6979_demographic	Dead	21780	M0	N1	Stage IIB	T2	6th	primary	0	237.0	a327a5b6-b6b1-54f1-ade0-148081f87cac	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-55-6979_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6979_treatment3	NA	NA	NA	NA	fba21ff1-c298-4a21-9085-b07c91575220	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5af499be-d2b9-4eaf-9a9f-435dccb51917	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6979	59	false	United States	-21780	237	2f74fbca-6aad-5c2a-9ba1-4df0c5f572bc	not reported	female	white	TCGA-55-6979_demographic	Dead	21780	M0	N1	Stage IIB	T2	6th	primary	0	237.0	a327a5b6-b6b1-54f1-ade0-148081f87cac	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-55-6979_diagnosis	No	Upper lobe, lung	NA	2006	No	NA	149	57	NA	NA	NA	NA	NA	NA	TCGA-55-6979_treatment2	Paclitaxel	NA	NA	NA	fc6f0c9b-e2b6-444f-aeb3-67d674e6b740	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	5c06d97f-2aaa-43de-b085-09d7829356ba	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-80-5608	NA	false	Canada	NA	NA	13c5edd5-8bd3-5f6e-a681-f2da56315734	not reported	female	not reported	TCGA-80-5608_demographic	Alive	NA	M0	N0	Stage IA	T1	6th	primary	NA	2832.0	01ba99c3-ec89-57df-b596-6bf327aab26e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-80-5608_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-80-5608_treatment2	NA	NA	NA	NA	e58c64ee-a205-488b-9488-f37d0a5ccd78	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5c06d97f-2aaa-43de-b085-09d7829356ba	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-80-5608	NA	false	Canada	NA	NA	13c5edd5-8bd3-5f6e-a681-f2da56315734	not reported	female	not reported	TCGA-80-5608_demographic	Alive	NA	M0	N0	Stage IA	T1	6th	primary	NA	2832.0	01ba99c3-ec89-57df-b596-6bf327aab26e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-80-5608_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-80-5608_treatment	NA	NA	NA	NA	ff57c355-af02-5d71-8073-f8c2ee2c8aa7	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29811	NA	NA	NA	NA	NA	recurrence	500	NA	026868e7-ebfb-4e6e-9339-bd8d536054f0	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8395_diagnosis2	NA	Not Reported	TCGA-62-8395_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-8395_treatment3	NA	NA	NA	NA	7a1c6008-96f4-424d-8cf0-36cb7acf454f	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29811	NA	NA	NA	NA	NA	recurrence	500	NA	026868e7-ebfb-4e6e-9339-bd8d536054f0	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8395_diagnosis2	NA	Not Reported	TCGA-62-8395_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8395_treatment5	NA	Locoregional Site	NA	NA	94c7cd33-d2b7-435a-809c-41f949e48ec5	NA	no	NA	Surgery, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29811	NA	NA	NA	NA	NA	recurrence	500	NA	026868e7-ebfb-4e6e-9339-bd8d536054f0	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8395_diagnosis2	NA	Not Reported	TCGA-62-8395_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-8395_treatment4	NA	NA	NA	NA	afb26ef9-514c-42ef-ba6b-a6ac797d36d2	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29811	NA	NA	NA	NA	NA	recurrence	500	NA	026868e7-ebfb-4e6e-9339-bd8d536054f0	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8395_diagnosis2	NA	Not Reported	TCGA-62-8395_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8395_treatment6	NA	Distant Site	NA	NA	fb2f272b-08e7-42b0-abc0-17897d3de1cb	NA	no	NA	Surgery, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29311	M0	N0	Stage IIB	T3	6th	primary	0	1216.0	670282dd-3508-58ca-bee0-47851419bc47	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-8395_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8395_treatment2	NA	NA	NA	NA	71826e7a-2f78-4c6d-9ced-bc11a2e69879	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29311	M0	N0	Stage IIB	T3	6th	primary	0	1216.0	670282dd-3508-58ca-bee0-47851419bc47	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-8395_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8395_treatment	NA	NA	NA	NA	ab289755-f68c-5228-8510-6245b99af33d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29811	NA	NA	NA	NA	NA	metastasis	500	NA	a50bba90-0007-43dd-b9b8-259c2af9c770	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8395_diagnosis3	NA	Not Reported	TCGA-62-8395_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-8395_treatment8	NA	NA	NA	NA	38a73f40-0ae2-4923-b645-ce8da5324313	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29811	NA	NA	NA	NA	NA	metastasis	500	NA	a50bba90-0007-43dd-b9b8-259c2af9c770	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8395_diagnosis3	NA	Not Reported	TCGA-62-8395_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8395_treatment9	NA	Locoregional Site	NA	NA	60ed7cb7-4598-40fc-835b-c6fd0f5ef7fe	NA	no	NA	Surgery, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29811	NA	NA	NA	NA	NA	metastasis	500	NA	a50bba90-0007-43dd-b9b8-259c2af9c770	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8395_diagnosis3	NA	Not Reported	TCGA-62-8395_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-8395_treatment7	NA	NA	NA	NA	b226de96-38e6-4a44-a32b-a940ae1a877b	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29811	NA	NA	NA	NA	NA	metastasis	500	NA	a50bba90-0007-43dd-b9b8-259c2af9c770	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8395_diagnosis3	NA	Not Reported	TCGA-62-8395_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8395_treatment10	NA	Distant Site	NA	NA	c92920bb-59ef-428f-bda7-3a7c5380c7a5	NA	no	NA	Surgery, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29706	NA	NA	NA	NA	NA	recurrence	395	NA	ee94a8a0-d755-4930-a8c2-943ddc77dff5	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8395_diagnosis4	NA	Not Reported	TCGA-62-8395_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-8395_treatment12	NA	NA	NA	NA	35e5a5bc-bdd4-41b9-a81a-09ce076159f7	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29706	NA	NA	NA	NA	NA	recurrence	395	NA	ee94a8a0-d755-4930-a8c2-943ddc77dff5	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8395_diagnosis4	NA	Not Reported	TCGA-62-8395_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8395_treatment13	NA	Locoregional Site	NA	NA	7bdf1d36-2322-4a27-a04a-b040b9430e27	NA	no	NA	Surgery, NOS
TCGA-LUAD	5c266025-e590-457c-af86-4c2dc9797267	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8395	80	false	Germany	-29311	NA	acfabbbc-cec6-5604-8ddb-62b2497099a1	not hispanic or latino	female	white	TCGA-62-8395_demographic	Alive	29706	NA	NA	NA	NA	NA	recurrence	395	NA	ee94a8a0-d755-4930-a8c2-943ddc77dff5	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-62-8395_diagnosis4	NA	Not Reported	TCGA-62-8395_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-8395_treatment11	NA	NA	NA	NA	e5e48f53-440d-49af-ab92-f363c6989c3f	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5d2a9a4f-678d-4089-a8c5-81a5cb696629	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-35-5375	61	false	Russia	-22628	NA	c8ad7b77-7783-5b5e-9eac-8ae1582300a8	not hispanic or latino	male	white	TCGA-35-5375_demographic	Alive	22628	M0	N2	Stage IIIA	T2	NA	primary	0	264.0	469b13f1-2748-563e-8031-1a3122608ae0	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-35-5375_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	5d5cc436-6e57-4d23-a164-7f5153c2e666	Informed Consent	-34	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6778	59	false	United States	-21725	NA	7df4ee63-943c-582a-840b-dd4c57186e6f	not reported	male	black or african american	TCGA-44-6778_demographic	Alive	21725	MX	N0	Stage IA	T1	6th	primary	0	1864.0	22bbe635-aa66-5c49-b066-d80722c7d4d6	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6778_diagnosis	No	Lung, NOS	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6778_treatment2	NA	NA	NA	NA	0aec099e-eb47-4368-a419-8ee5a10f4e85	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5d5cc436-6e57-4d23-a164-7f5153c2e666	Informed Consent	-34	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6778	59	false	United States	-21725	NA	7df4ee63-943c-582a-840b-dd4c57186e6f	not reported	male	black or african american	TCGA-44-6778_demographic	Alive	21725	MX	N0	Stage IA	T1	6th	primary	0	1864.0	22bbe635-aa66-5c49-b066-d80722c7d4d6	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6778_diagnosis	No	Lung, NOS	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6778_treatment	NA	NA	NA	NA	3f089026-4b2f-5d5f-b34c-fdc8b4a681bd	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5d7ec32a-049f-4997-9882-1b3ac157e02d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-86-8281	75	false	United States	-27409	NA	4436c869-b9ea-510e-932b-3a1b565225e2	not hispanic or latino	male	white	TCGA-86-8281_demographic	Alive	27409	M0	NX	Stage IA	T1	7th	primary	0	0.0	f8f81ccb-8b71-5b41-9efa-c5cd2fc1729a	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-86-8281_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8281_treatment	NA	NA	NA	NA	6e34ed94-c0c9-5f2b-b64c-b721c71917da	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5d7ec32a-049f-4997-9882-1b3ac157e02d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-86-8281	75	false	United States	-27409	NA	4436c869-b9ea-510e-932b-3a1b565225e2	not hispanic or latino	male	white	TCGA-86-8281_demographic	Alive	27409	M0	NX	Stage IA	T1	7th	primary	0	0.0	f8f81ccb-8b71-5b41-9efa-c5cd2fc1729a	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-86-8281_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8281_treatment2	NA	NA	NA	NA	c16f4a24-0bb6-4588-9fad-f0fd10045264	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	5f4934be-eee3-40e1-8838-38103badc898	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T6	76	false	United States	-27993	1790	db9bfbbd-39c4-5c3a-ae9f-c3175206227b	not hispanic or latino	female	white	TCGA-MP-A4T6_demographic	Dead	27993	MX	N2	Stage IIIA	T1	6th	primary	0	1790.0	024827f3-e59c-5c4e-802e-b4e712d9a2e8	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-MP-A4T6_diagnosis	No	Lower lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T6_treatment2	NA	NA	NA	NA	3f57ccc4-ce94-42a8-ae2a-7b5558ca5b1d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	5f4934be-eee3-40e1-8838-38103badc898	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T6	76	false	United States	-27993	1790	db9bfbbd-39c4-5c3a-ae9f-c3175206227b	not hispanic or latino	female	white	TCGA-MP-A4T6_demographic	Dead	27993	MX	N2	Stage IIIA	T1	6th	primary	0	1790.0	024827f3-e59c-5c4e-802e-b4e712d9a2e8	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-MP-A4T6_diagnosis	No	Lower lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T6_treatment	NA	NA	NA	NA	97f462a2-74d6-5b71-bf28-fb4ed1a2eb0f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5fd0f07b-8bb9-4378-bd26-28a26057e8fe	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8085	64	false	United States	-23596	NA	9ac8816d-dce5-5649-b62b-18a50f046dd1	not hispanic or latino	male	white	TCGA-55-8085_demographic	Alive	23596	M0	N0	Stage IA	T1b	7th	primary	0	904.0	76478ed3-e7d9-5406-bbc3-75ca2d5a12dc	true	NA	NA	C34.3	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8085_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8085_treatment	NA	NA	NA	NA	9bb75441-d319-5513-aa4b-9a66a7b9af98	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5fd0f07b-8bb9-4378-bd26-28a26057e8fe	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8085	64	false	United States	-23596	NA	9ac8816d-dce5-5649-b62b-18a50f046dd1	not hispanic or latino	male	white	TCGA-55-8085_demographic	Alive	23596	M0	N0	Stage IA	T1b	7th	primary	0	904.0	76478ed3-e7d9-5406-bbc3-75ca2d5a12dc	true	NA	NA	C34.3	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8085_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8085_treatment2	NA	NA	NA	NA	aeccc38a-1120-429c-b0e0-ca07e3681d20	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	5fe77d4a-a8a5-4c90-8ff2-9c3bbbb309ef	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M5	83	false	United States	-30665	NA	75592919-7f31-5bdf-9df5-e3a4f96d8afe	not hispanic or latino	male	white	TCGA-97-A4M5_demographic	Alive	30665	M0	N0	Stage IA	T1b	7th	primary	0	634.0	8bae00a6-f0da-59e7-a7e3-fc02336c202a	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-A4M5_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M5_treatment	NA	NA	NA	NA	2d4fb9a0-af64-5522-91d7-e9e0f635c33c	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	5fe77d4a-a8a5-4c90-8ff2-9c3bbbb309ef	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M5	83	false	United States	-30665	NA	75592919-7f31-5bdf-9df5-e3a4f96d8afe	not hispanic or latino	male	white	TCGA-97-A4M5_demographic	Alive	30665	M0	N0	Stage IA	T1b	7th	primary	0	634.0	8bae00a6-f0da-59e7-a7e3-fc02336c202a	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-A4M5_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M5_treatment2	NA	NA	NA	NA	e9e63d57-5e10-40ed-86f3-da4c82a38a11	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	24737	MX	N0	Stage IB	T2	6th	primary	0	1965.0	a2f5a405-2f6b-52d8-9c21-12cecb0d50b6	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-97-7547_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	110	103	NA	1	NA	40.0	mg	Intravenous	TCGA-97-7547_treatment4	Cisplatin	NA	40	mg	01ef9fe7-0563-4cbc-9b3e-b4dbafc20455	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	24737	MX	N0	Stage IB	T2	6th	primary	0	1965.0	a2f5a405-2f6b-52d8-9c21-12cecb0d50b6	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-97-7547_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	124	96	NA	1	NA	20.0	mg	Intravenous	TCGA-97-7547_treatment	Vinorelbine	NA	20	mg	3dd510ad-360f-5855-a2f3-7c9e59d612fd	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	24737	MX	N0	Stage IB	T2	6th	primary	0	1965.0	a2f5a405-2f6b-52d8-9c21-12cecb0d50b6	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-97-7547_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	75	47	NA	1	NA	75.0	mg	Intravenous	TCGA-97-7547_treatment3	Cisplatin	NA	75	mg	6cd3c31b-fce5-4cfc-9c2b-e8274b59bfb5	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	24737	MX	N0	Stage IB	T2	6th	primary	0	1965.0	a2f5a405-2f6b-52d8-9c21-12cecb0d50b6	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-97-7547_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	89	33	NA	1	NA	39.0	mg	Intravenous	TCGA-97-7547_treatment5	Vinorelbine	NA	39	mg	8fa52ee0-232d-4848-8fb3-17163ed7651a	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	24737	MX	N0	Stage IB	T2	6th	primary	0	1965.0	a2f5a405-2f6b-52d8-9c21-12cecb0d50b6	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-97-7547_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7547_treatment6	NA	NA	NA	NA	aee5bab9-4af1-4fe7-a39e-2a83f028abaf	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	24737	MX	N0	Stage IB	T2	6th	primary	0	1965.0	a2f5a405-2f6b-52d8-9c21-12cecb0d50b6	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-97-7547_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	866	824	Recurrent Disease	4	NA	788.0	mg	Intravenous	TCGA-97-7547_treatment2	Pemetrexed Disodium	NA	3152	mg	d80dbc8e-d385-4cee-a874-29b402dbd768	NA	yes	NA	Chemotherapy
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	25512	NA	NA	NA	NA	NA	not reported	775	NA	d1e5e2e2-52c2-4a6e-96b4-e1a050bbe472	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-7547_diagnosis2	NA	Not Reported	TCGA-97-7547_diagnosis	NA	NA	NA	NA	776	NA	NA	NA	NA	NA	NA	TCGA-97-7547_treatment9	NA	Locoregional Site	NA	NA	22f1ea22-2e99-467a-a23b-f5bed486877f	NA	yes	NA	Surgery, NOS
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	25512	NA	NA	NA	NA	NA	not reported	775	NA	d1e5e2e2-52c2-4a6e-96b4-e1a050bbe472	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-7547_diagnosis2	NA	Not Reported	TCGA-97-7547_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-97-7547_treatment8	NA	NA	NA	NA	2f882e74-da15-4131-8e86-c49f8c9fa8cc	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	25512	NA	NA	NA	NA	NA	not reported	775	NA	d1e5e2e2-52c2-4a6e-96b4-e1a050bbe472	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-7547_diagnosis2	NA	Not Reported	TCGA-97-7547_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7547_treatment10	NA	Distant Site	NA	NA	45ca6658-0336-43c0-8f43-e693f00d9270	NA	no	NA	Surgery, NOS
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	25512	NA	NA	NA	NA	NA	not reported	775	NA	d1e5e2e2-52c2-4a6e-96b4-e1a050bbe472	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-97-7547_diagnosis2	NA	Not Reported	TCGA-97-7547_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-97-7547_treatment7	NA	NA	NA	NA	54cc85c3-f49a-4fa0-b409-aa9b68ae0dce	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	25884	NA	NA	NA	NA	NA	recurrence	1147	NA	f7ea46f4-2e43-4856-bfc8-30d63d5ad7b7	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-97-7547_diagnosis3	NA	Not Reported	TCGA-97-7547_diagnosis	NA	NA	NA	NA	1894	NA	NA	NA	NA	NA	NA	TCGA-97-7547_treatment13	NA	Locoregional Site	NA	NA	53f08bd5-917b-48d7-a3fc-342c597d97e0	NA	yes	NA	Surgery, NOS
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	25884	NA	NA	NA	NA	NA	recurrence	1147	NA	f7ea46f4-2e43-4856-bfc8-30d63d5ad7b7	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-97-7547_diagnosis3	NA	Not Reported	TCGA-97-7547_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-97-7547_treatment12	NA	NA	NA	NA	832936d3-4f4f-4638-be2c-6da8dd11ca38	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	6092bd5c-e97c-4a77-a4ad-c87623b17507	Informed Consent	1435	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7547	67	false	United States	-24737	NA	77f019ea-5621-5481-9dce-10eda902c629	not hispanic or latino	female	white	TCGA-97-7547_demographic	Alive	25884	NA	NA	NA	NA	NA	recurrence	1147	NA	f7ea46f4-2e43-4856-bfc8-30d63d5ad7b7	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-97-7547_diagnosis3	NA	Not Reported	TCGA-97-7547_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-97-7547_treatment11	NA	NA	NA	NA	9028e846-c56e-4b03-85d3-4a26dd13707b	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	6144d666-8f77-4efe-95f1-f9e5c4e5e056	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6145	62	false	United States	-22745	NA	592254fc-6c4f-56e3-92db-8b3e3d3906ed	not hispanic or latino	female	white	TCGA-44-6145_demographic	Alive	22745	M0	N0	Stage IA	T1	7th	primary	0	595.0	bd5a3c1a-fb57-5da3-954c-273512e6858c	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6145_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6145_treatment	NA	NA	NA	NA	15a602a5-f6bb-5e75-9aef-39150f6f99f8	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	6144d666-8f77-4efe-95f1-f9e5c4e5e056	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6145	62	false	United States	-22745	NA	592254fc-6c4f-56e3-92db-8b3e3d3906ed	not hispanic or latino	female	white	TCGA-44-6145_demographic	Alive	22745	M0	N0	Stage IA	T1	7th	primary	0	595.0	bd5a3c1a-fb57-5da3-954c-273512e6858c	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6145_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6145_treatment2	NA	NA	NA	NA	6fb06cd4-7023-4a0f-b055-334eeda3555d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	61c655ec-52b5-453f-a6cc-b2aba445b027	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4486	72	false	United States	-26415	2318	bfc9fb80-e9e8-548c-ac95-0e3c258345a8	not hispanic or latino	male	white	TCGA-49-4486_demographic	Dead	28460	NA	NA	NA	NA	NA	metastasis	2045	NA	531618e3-afb2-408d-b53c-4a7019e7ebbd	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4486_diagnosis2	NA	Not Reported	TCGA-49-4486_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-49-4486_treatment3	NA	NA	NA	NA	5c605b7b-2281-4f7a-a992-e83e60a7c5d6	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	61c655ec-52b5-453f-a6cc-b2aba445b027	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4486	72	false	United States	-26415	2318	bfc9fb80-e9e8-548c-ac95-0e3c258345a8	not hispanic or latino	male	white	TCGA-49-4486_demographic	Dead	28460	NA	NA	NA	NA	NA	metastasis	2045	NA	531618e3-afb2-408d-b53c-4a7019e7ebbd	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4486_diagnosis2	NA	Not Reported	TCGA-49-4486_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4486_treatment5	NA	Locoregional Site	NA	NA	7d2a878d-089d-48c1-bda3-dafba01767ff	NA	no	NA	Surgery, NOS
TCGA-LUAD	61c655ec-52b5-453f-a6cc-b2aba445b027	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4486	72	false	United States	-26415	2318	bfc9fb80-e9e8-548c-ac95-0e3c258345a8	not hispanic or latino	male	white	TCGA-49-4486_demographic	Dead	28460	NA	NA	NA	NA	NA	metastasis	2045	NA	531618e3-afb2-408d-b53c-4a7019e7ebbd	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4486_diagnosis2	NA	Not Reported	TCGA-49-4486_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4486_treatment6	NA	Distant Site	NA	NA	82f6a99b-64b2-46e7-9adf-f4d8c594c15c	NA	no	NA	Surgery, NOS
TCGA-LUAD	61c655ec-52b5-453f-a6cc-b2aba445b027	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4486	72	false	United States	-26415	2318	bfc9fb80-e9e8-548c-ac95-0e3c258345a8	not hispanic or latino	male	white	TCGA-49-4486_demographic	Dead	28460	NA	NA	NA	NA	NA	metastasis	2045	NA	531618e3-afb2-408d-b53c-4a7019e7ebbd	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4486_diagnosis2	NA	Not Reported	TCGA-49-4486_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-49-4486_treatment4	NA	NA	NA	NA	e8cce713-99b3-4055-8843-828590632b0a	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	61c655ec-52b5-453f-a6cc-b2aba445b027	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4486	72	false	United States	-26415	2318	bfc9fb80-e9e8-548c-ac95-0e3c258345a8	not hispanic or latino	male	white	TCGA-49-4486_demographic	Dead	26415	M0	N0	Stage IA	T1	3rd	primary	0	2318.0	6b9cc1c5-cd17-5f8c-9784-0bd83f36a78c	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4486_diagnosis	No	Lower lobe, lung	NA	1992	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4486_treatment2	NA	NA	NA	NA	e80d7704-b011-428c-bce9-f5f836828169	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	61c655ec-52b5-453f-a6cc-b2aba445b027	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4486	72	false	United States	-26415	2318	bfc9fb80-e9e8-548c-ac95-0e3c258345a8	not hispanic or latino	male	white	TCGA-49-4486_demographic	Dead	26415	M0	N0	Stage IA	T1	3rd	primary	0	2318.0	6b9cc1c5-cd17-5f8c-9784-0bd83f36a78c	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4486_diagnosis	No	Lower lobe, lung	NA	1992	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4486_treatment	NA	NA	NA	NA	f7db4cb8-58d2-5f03-a051-629bd9eacacf	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	61cd3ef8-eee4-4266-b01d-09338c89740a	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z052	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	62380447-3b94-4e7c-823a-72dd7b4ccf3a	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8399	62	false	Germany	-22952	NA	891e6a44-2fb9-57e9-81e4-bc00012bfcf1	not hispanic or latino	male	white	TCGA-62-8399_demographic	Alive	22952	M0	N2	Stage IIIA	T2	6th	primary	0	2696.0	d5f52504-752a-5a44-bee8-cde3eb953665	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-8399_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8399_treatment2	NA	NA	NA	NA	54f629d8-0cc2-440e-975b-40c4e142deb2	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	62380447-3b94-4e7c-823a-72dd7b4ccf3a	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8399	62	false	Germany	-22952	NA	891e6a44-2fb9-57e9-81e4-bc00012bfcf1	not hispanic or latino	male	white	TCGA-62-8399_demographic	Alive	22952	M0	N2	Stage IIIA	T2	6th	primary	0	2696.0	d5f52504-752a-5a44-bee8-cde3eb953665	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-8399_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8399_treatment	NA	NA	NA	NA	6af4cee0-9091-5ce5-8131-5784bc5bc1fb	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	62633a11-db23-481f-add3-853b2acac1bf	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z045	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	6313c7cb-5631-42b2-93e2-592f86e84551	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z036	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	631dbd88-fc3e-4ed8-b4a7-2da137a49a11	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	63bd2175-4b7c-44c9-aef3-9efc8f79837b	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5429	60	false	Germany	-22066	275	97dbd192-260d-5a7b-a942-2f5117d24934	not reported	male	not reported	TCGA-05-5429_demographic	Dead	22066	M0	N2	Stage IIIA	T3	7th	primary	0	275.0	06eed07a-e385-5f1c-a0e6-c57bbe8a5aae	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-05-5429_diagnosis	No	Lung, NOS	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-5429_treatment2	NA	NA	NA	NA	15638a8f-3346-4c79-aaf2-a53a7778e720	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	63bd2175-4b7c-44c9-aef3-9efc8f79837b	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5429	60	false	Germany	-22066	275	97dbd192-260d-5a7b-a942-2f5117d24934	not reported	male	not reported	TCGA-05-5429_demographic	Dead	22066	M0	N2	Stage IIIA	T3	7th	primary	0	275.0	06eed07a-e385-5f1c-a0e6-c57bbe8a5aae	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-05-5429_diagnosis	No	Lung, NOS	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-5429_treatment	NA	NA	NA	NA	38042830-ed8d-571e-8c6a-921e9c75eace	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	645903b5-ba37-48a1-985b-a019b8db3236	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-80-5607	NA	false	Canada	NA	NA	1db2c0de-6c5a-5949-acde-6899fd293014	not reported	female	not reported	TCGA-80-5607_demographic	Alive	NA	M0	N1	Stage IIB	T2	6th	primary	NA	NA	1fae78ae-d165-526f-ac22-2de95d0046ed	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-80-5607_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-80-5607_treatment2	NA	NA	NA	NA	27c387a6-a312-4367-9641-d4215b3aa4a4	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	645903b5-ba37-48a1-985b-a019b8db3236	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-80-5607	NA	false	Canada	NA	NA	1db2c0de-6c5a-5949-acde-6899fd293014	not reported	female	not reported	TCGA-80-5607_demographic	Alive	NA	M0	N1	Stage IIB	T2	6th	primary	NA	NA	1fae78ae-d165-526f-ac22-2de95d0046ed	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-80-5607_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-80-5607_treatment	NA	NA	NA	NA	f0424090-4e21-5a1c-89ec-ca5794f1435d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	645903b5-ba37-48a1-985b-a019b8db3236	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-80-5607	NA	false	Canada	NA	NA	1db2c0de-6c5a-5949-acde-6899fd293014	not reported	female	not reported	TCGA-80-5607_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	a62106c9-27ed-4458-9058-74dbf112e359	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-80-5607_diagnosis3	NA	Colon, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-80-5607_treatment4	NA	NA	NA	NA	96915431-ac1a-4805-8143-5e2b340653b0	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	645903b5-ba37-48a1-985b-a019b8db3236	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-80-5607	NA	false	Canada	NA	NA	1db2c0de-6c5a-5949-acde-6899fd293014	not reported	female	not reported	TCGA-80-5607_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	a62106c9-27ed-4458-9058-74dbf112e359	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-80-5607_diagnosis3	NA	Colon, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-80-5607_treatment3	NA	NA	NA	NA	9cc4868a-c8ff-4040-9cdf-5410bce00e3d	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	645903b5-ba37-48a1-985b-a019b8db3236	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-80-5607	NA	false	Canada	NA	NA	1db2c0de-6c5a-5949-acde-6899fd293014	not reported	female	not reported	TCGA-80-5607_demographic	Alive	NA	NA	NA	NA	NA	NA	not reported	NA	NA	ee4109b3-70a4-40ef-a697-26fc00e415fc	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-80-5607_diagnosis2	NA	Not Reported	TCGA-80-5607_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-80-5607_treatment8	NA	Distant Site	NA	NA	1aafb497-f02c-4c97-9d6d-02266721663d	NA	no	NA	Surgery, NOS
TCGA-LUAD	645903b5-ba37-48a1-985b-a019b8db3236	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-80-5607	NA	false	Canada	NA	NA	1db2c0de-6c5a-5949-acde-6899fd293014	not reported	female	not reported	TCGA-80-5607_demographic	Alive	NA	NA	NA	NA	NA	NA	not reported	NA	NA	ee4109b3-70a4-40ef-a697-26fc00e415fc	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-80-5607_diagnosis2	NA	Not Reported	TCGA-80-5607_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-80-5607_treatment5	NA	NA	NA	NA	21da9560-4939-4ae6-8f82-a03c678839b7	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	645903b5-ba37-48a1-985b-a019b8db3236	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-80-5607	NA	false	Canada	NA	NA	1db2c0de-6c5a-5949-acde-6899fd293014	not reported	female	not reported	TCGA-80-5607_demographic	Alive	NA	NA	NA	NA	NA	NA	not reported	NA	NA	ee4109b3-70a4-40ef-a697-26fc00e415fc	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-80-5607_diagnosis2	NA	Not Reported	TCGA-80-5607_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-80-5607_treatment7	NA	Locoregional Site	NA	NA	418ffc9b-2701-4ba3-9511-3a5303ca6930	NA	no	NA	Surgery, NOS
TCGA-LUAD	645903b5-ba37-48a1-985b-a019b8db3236	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-80-5607	NA	false	Canada	NA	NA	1db2c0de-6c5a-5949-acde-6899fd293014	not reported	female	not reported	TCGA-80-5607_demographic	Alive	NA	NA	NA	NA	NA	NA	not reported	NA	NA	ee4109b3-70a4-40ef-a697-26fc00e415fc	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-80-5607_diagnosis2	NA	Not Reported	TCGA-80-5607_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-80-5607_treatment6	NA	NA	NA	NA	b3119675-5f5a-4cfc-b5be-355ffb05c977	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	646910ee-5f5d-40ac-a21a-75790f89430a	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4P8	59	false	United States	-21738	NA	f6f8850a-9ef8-55c3-9da2-4ce24d11c4fb	not hispanic or latino	female	white	TCGA-86-A4P8_demographic	Alive	21738	MX	N2	Stage IIIA	T1b	7th	primary	0	805.0	cff5b508-2d4c-5cf5-8dbc-0443a996a2ee	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-86-A4P8_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	186	145	NA	NA	28.0	NA	NA	NA	TCGA-86-A4P8_treatment	NA	Primary Tumor Field	50	Gy	108606ab-6e09-5315-b643-38bd85c47720	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	646910ee-5f5d-40ac-a21a-75790f89430a	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4P8	59	false	United States	-21738	NA	f6f8850a-9ef8-55c3-9da2-4ce24d11c4fb	not hispanic or latino	female	white	TCGA-86-A4P8_demographic	Alive	21738	MX	N2	Stage IIIA	T1b	7th	primary	0	805.0	cff5b508-2d4c-5cf5-8dbc-0443a996a2ee	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-86-A4P8_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	106	43	NA	NA	NA	NA	NA	NA	TCGA-86-A4P8_treatment3	Pemetrexed Disodium	NA	NA	NA	267089f3-5ef4-41b2-98cb-bf18dc9f23f6	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	646910ee-5f5d-40ac-a21a-75790f89430a	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4P8	59	false	United States	-21738	NA	f6f8850a-9ef8-55c3-9da2-4ce24d11c4fb	not hispanic or latino	female	white	TCGA-86-A4P8_demographic	Alive	21738	MX	N2	Stage IIIA	T1b	7th	primary	0	805.0	cff5b508-2d4c-5cf5-8dbc-0443a996a2ee	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-86-A4P8_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	106	43	NA	NA	NA	NA	NA	NA	TCGA-86-A4P8_treatment2	Cisplatin	NA	NA	NA	a395095d-c08c-4db4-8bee-62f53a9d60a2	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	654affac-f8ed-40bb-9f9f-a293227b06a6	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	656a5eb4-e4a5-4d21-a800-3586f4d6588b	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-8496	63	false	United States	-23358	NA	c9e861cd-8881-5842-a889-50878a68fe35	not hispanic or latino	female	white	TCGA-91-8496_demographic	Alive	23358	MX	NX	Stage IB	T2a	7th	primary	0	505.0	b3ce35c0-19ef-5f2b-a6f4-33b6ded70426	true	NA	NA	C34.3	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	NA	TCGA-91-8496_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-8496_treatment2	NA	NA	NA	NA	99e6cae9-aaa0-476c-abdd-bcc6203841f8	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	656a5eb4-e4a5-4d21-a800-3586f4d6588b	Informed Consent	30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-8496	63	false	United States	-23358	NA	c9e861cd-8881-5842-a889-50878a68fe35	not hispanic or latino	female	white	TCGA-91-8496_demographic	Alive	23358	MX	NX	Stage IB	T2a	7th	primary	0	505.0	b3ce35c0-19ef-5f2b-a6f4-33b6ded70426	true	NA	NA	C34.3	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	NA	TCGA-91-8496_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-8496_treatment	NA	NA	NA	NA	a31bd6fe-3141-5dfd-b9e2-1e1b9fa03c0b	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	25870	M0	N0	Stage IA	T1b	7th	primary	0	872.0	162141dd-71bb-5073-8779-254db57ecf61	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7281_diagnosis	No	Middle lobe, lung	NA	2011	NA	NA	647	634	NA	NA	10.0	NA	NA	NA	TCGA-55-7281_treatment2	NA	Distant Site	3000	cGy	071bc351-05e1-468f-ade6-131690be7462	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	25870	M0	N0	Stage IA	T1b	7th	primary	0	872.0	162141dd-71bb-5073-8779-254db57ecf61	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7281_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	474	424	NA	NA	NA	NA	NA	NA	TCGA-55-7281_treatment3	Carboplatin	NA	NA	NA	08551bdc-518b-486c-80b3-710c65282546	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	25870	M0	N0	Stage IA	T1b	7th	primary	0	872.0	162141dd-71bb-5073-8779-254db57ecf61	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7281_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	NA	712	NA	NA	NA	NA	NA	NA	TCGA-55-7281_treatment6	Carboplatin	NA	NA	NA	20dc73f7-68b5-4d18-bef3-bb4d1269e957	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	25870	M0	N0	Stage IA	T1b	7th	primary	0	872.0	162141dd-71bb-5073-8779-254db57ecf61	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7281_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	579	508	NA	NA	NA	NA	NA	NA	TCGA-55-7281_treatment5	Pemetrexed Disodium	NA	NA	NA	295c1b8f-ead5-4184-b583-7e57fc26c569	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	25870	M0	N0	Stage IA	T1b	7th	primary	0	872.0	162141dd-71bb-5073-8779-254db57ecf61	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7281_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	NA	712	NA	NA	NA	NA	NA	NA	TCGA-55-7281_treatment8	Bevacizumab	NA	NA	NA	35f6d3c0-ea8b-4ae1-b023-b97b0ebb95dd	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	25870	M0	N0	Stage IA	T1b	7th	primary	0	872.0	162141dd-71bb-5073-8779-254db57ecf61	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7281_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	NA	712	NA	NA	NA	NA	NA	NA	TCGA-55-7281_treatment7	Paclitaxel	NA	NA	NA	8c92287f-fffb-4013-9a48-4e98477bf414	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	25870	M0	N0	Stage IA	T1b	7th	primary	0	872.0	162141dd-71bb-5073-8779-254db57ecf61	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7281_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	579	508	NA	NA	NA	NA	NA	NA	TCGA-55-7281_treatment4	Carboplatin	NA	NA	NA	e7d2d1b0-3620-45ba-bda3-3ea8ed18f5a5	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	25870	M0	N0	Stage IA	T1b	7th	primary	0	872.0	162141dd-71bb-5073-8779-254db57ecf61	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7281_diagnosis	No	Middle lobe, lung	NA	2011	NA	NA	370	339	NA	NA	NA	NA	NA	NA	TCGA-55-7281_treatment	NA	Regional Site	NA	NA	f0487604-787a-53fa-829a-4a6b5401a2dd	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	26209	NA	NA	NA	NA	NA	metastasis	339	NA	83ffe76b-b89a-41eb-b7a5-a5135a0772f5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7281_diagnosis2	NA	Not Reported	TCGA-55-7281_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7281_treatment10	NA	NA	NA	NA	0bd42b92-3573-4419-a280-cb1731fd5b47	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	26209	NA	NA	NA	NA	NA	metastasis	339	NA	83ffe76b-b89a-41eb-b7a5-a5135a0772f5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7281_diagnosis2	NA	Not Reported	TCGA-55-7281_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7281_treatment12	NA	Distant Site	NA	NA	b71edc56-dc3d-40bb-89bc-350cab9c7ef7	NA	no	NA	Surgery, NOS
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	26209	NA	NA	NA	NA	NA	metastasis	339	NA	83ffe76b-b89a-41eb-b7a5-a5135a0772f5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7281_diagnosis2	NA	Not Reported	TCGA-55-7281_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7281_treatment11	NA	Locoregional Site	NA	NA	b7e82a1f-abc7-41ca-bbe5-8eaa92fa8db4	NA	no	NA	Surgery, NOS
TCGA-LUAD	659668e8-f0d9-4ff2-bbc8-9246f2ef49ab	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7281	70	false	United States	-25870	NA	a83da846-9397-5228-9bdd-9820666674a0	not reported	female	white	TCGA-55-7281_demographic	Alive	26209	NA	NA	NA	NA	NA	metastasis	339	NA	83ffe76b-b89a-41eb-b7a5-a5135a0772f5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7281_diagnosis2	NA	Not Reported	TCGA-55-7281_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7281_treatment9	NA	NA	NA	NA	dbd7d5ba-d12a-4fd5-b4dd-73602431cef4	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	66763a0c-6cda-4832-a0cc-e7b496d78eaa	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4424	70	false	Germany	-25689	NA	4dd3d381-bab8-5bdd-9aa0-e12ce470f8e9	not reported	male	not reported	TCGA-05-4424_demographic	Alive	25689	M0	N0	Stage IIB	T3	6th	primary	0	913.0	5a43f918-0c02-5c0b-b8ff-40b0eed416e2	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	NA	TCGA-05-4424_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	NA	699	NA	NA	NA	NA	NA	NA	TCGA-05-4424_treatment4	Erlotinib	NA	NA	NA	1b6a9aea-bbea-499e-9f97-08a43fc7ee40	NA	yes	Treatment Ongoing	Immunotherapy (Including Vaccines)
TCGA-LUAD	66763a0c-6cda-4832-a0cc-e7b496d78eaa	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4424	70	false	Germany	-25689	NA	4dd3d381-bab8-5bdd-9aa0-e12ce470f8e9	not reported	male	not reported	TCGA-05-4424_demographic	Alive	25689	M0	N0	Stage IIB	T3	6th	primary	0	913.0	5a43f918-0c02-5c0b-b8ff-40b0eed416e2	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	NA	TCGA-05-4424_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	699	NA	NA	NA	NA	NA	NA	TCGA-05-4424_treatment3	NA	Distant Site	30	Gy	4964da67-a4b4-46ff-9ac4-bda9cc8a12d9	NA	yes	Treatment Ongoing	Radiation Therapy, NOS
TCGA-LUAD	66763a0c-6cda-4832-a0cc-e7b496d78eaa	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4424	70	false	Germany	-25689	NA	4dd3d381-bab8-5bdd-9aa0-e12ce470f8e9	not reported	male	not reported	TCGA-05-4424_demographic	Alive	25689	M0	N0	Stage IIB	T3	6th	primary	0	913.0	5a43f918-0c02-5c0b-b8ff-40b0eed416e2	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	NA	TCGA-05-4424_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	30	30	NA	NA	NA	NA	NA	NA	TCGA-05-4424_treatment	NA	Primary Tumor Field	60	Gy	6410e122-75b3-5ab9-8f0a-dc788512a598	NA	yes	Partial Response	Radiation, External Beam
TCGA-LUAD	66763a0c-6cda-4832-a0cc-e7b496d78eaa	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4424	70	false	Germany	-25689	NA	4dd3d381-bab8-5bdd-9aa0-e12ce470f8e9	not reported	male	not reported	TCGA-05-4424_demographic	Alive	25689	M0	N0	Stage IIB	T3	6th	primary	0	913.0	5a43f918-0c02-5c0b-b8ff-40b0eed416e2	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	NA	TCGA-05-4424_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	153	NA	NA	NA	NA	NA	NA	TCGA-05-4424_treatment2	NA	Distant Site	3	Gy	ea1d40d4-482f-496e-833a-b2b7bcb97820	NA	yes	Treatment Ongoing	Radiation Therapy, NOS
TCGA-LUAD	66763a0c-6cda-4832-a0cc-e7b496d78eaa	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4424	70	false	Germany	-25689	NA	4dd3d381-bab8-5bdd-9aa0-e12ce470f8e9	not reported	male	not reported	TCGA-05-4424_demographic	Alive	25842	NA	NA	NA	NA	NA	metastasis	153	NA	b9844319-fd71-4945-a92a-c4042a0894b7	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-05-4424_diagnosis2	NA	Not Reported	TCGA-05-4424_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-05-4424_treatment5	NA	NA	NA	NA	6a93a826-abbf-4b65-b7c2-6d00e2d2e10a	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	66763a0c-6cda-4832-a0cc-e7b496d78eaa	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4424	70	false	Germany	-25689	NA	4dd3d381-bab8-5bdd-9aa0-e12ce470f8e9	not reported	male	not reported	TCGA-05-4424_demographic	Alive	25842	NA	NA	NA	NA	NA	metastasis	153	NA	b9844319-fd71-4945-a92a-c4042a0894b7	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-05-4424_diagnosis2	NA	Not Reported	TCGA-05-4424_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-05-4424_treatment6	NA	NA	NA	NA	bbdf6c3c-1874-492c-ada6-0274b30b1fe5	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	66ed89f6-8ba2-49d0-af0f-4b6ebf2381bf	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3919	71	false	United States	-26081	1026	a6190cba-783a-5387-a88a-13a20d64ae1e	not hispanic or latino	female	white	TCGA-44-3919_demographic	Dead	26081	M0	N0	Stage IA	T1	7th	primary	0	1026.0	a355eae9-c742-533d-96dd-f68d0b6f5df7	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3919_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3919_treatment	NA	NA	NA	NA	9d9cf820-1274-52b7-bbea-93898a54bb36	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	66ed89f6-8ba2-49d0-af0f-4b6ebf2381bf	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3919	71	false	United States	-26081	1026	a6190cba-783a-5387-a88a-13a20d64ae1e	not hispanic or latino	female	white	TCGA-44-3919_demographic	Dead	26081	M0	N0	Stage IA	T1	7th	primary	0	1026.0	a355eae9-c742-533d-96dd-f68d0b6f5df7	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3919_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3919_treatment2	NA	NA	NA	NA	c01fee19-2199-4c97-8bd8-9b4b4cb7a929	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	66ed89f6-8ba2-49d0-af0f-4b6ebf2381bf	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3919	71	false	United States	-26081	1026	a6190cba-783a-5387-a88a-13a20d64ae1e	not hispanic or latino	female	white	TCGA-44-3919_demographic	Dead	27002	NA	NA	NA	NA	NA	recurrence	921	NA	d92208f8-6e14-4f3d-a548-f928bb5e917b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-3919_diagnosis2	NA	Not Reported	TCGA-44-3919_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3919_treatment5	NA	Locoregional Site	NA	NA	1e6dbdb5-f01f-464d-80ca-7fd2b3e04886	NA	no	NA	Surgery, NOS
TCGA-LUAD	66ed89f6-8ba2-49d0-af0f-4b6ebf2381bf	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3919	71	false	United States	-26081	1026	a6190cba-783a-5387-a88a-13a20d64ae1e	not hispanic or latino	female	white	TCGA-44-3919_demographic	Dead	27002	NA	NA	NA	NA	NA	recurrence	921	NA	d92208f8-6e14-4f3d-a548-f928bb5e917b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-3919_diagnosis2	NA	Not Reported	TCGA-44-3919_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3919_treatment6	NA	Distant Site	NA	NA	21d3c2d6-2aaf-4d2b-95b9-7777016bc5f1	NA	no	NA	Surgery, NOS
TCGA-LUAD	66ed89f6-8ba2-49d0-af0f-4b6ebf2381bf	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3919	71	false	United States	-26081	1026	a6190cba-783a-5387-a88a-13a20d64ae1e	not hispanic or latino	female	white	TCGA-44-3919_demographic	Dead	27002	NA	NA	NA	NA	NA	recurrence	921	NA	d92208f8-6e14-4f3d-a548-f928bb5e917b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-3919_diagnosis2	NA	Not Reported	TCGA-44-3919_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-3919_treatment4	NA	NA	NA	NA	81fa32a3-05ab-4c01-8117-78a6749b1d41	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	66ed89f6-8ba2-49d0-af0f-4b6ebf2381bf	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3919	71	false	United States	-26081	1026	a6190cba-783a-5387-a88a-13a20d64ae1e	not hispanic or latino	female	white	TCGA-44-3919_demographic	Dead	27002	NA	NA	NA	NA	NA	recurrence	921	NA	d92208f8-6e14-4f3d-a548-f928bb5e917b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-3919_diagnosis2	NA	Not Reported	TCGA-44-3919_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-3919_treatment3	NA	NA	NA	NA	bd19bd27-f178-4b1d-8792-b3b49ae02d48	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	66ed89f6-8ba2-49d0-af0f-4b6ebf2381bf	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3919	71	false	United States	-26081	1026	a6190cba-783a-5387-a88a-13a20d64ae1e	not hispanic or latino	female	white	TCGA-44-3919_demographic	Dead	27065	NA	NA	NA	NA	NA	metastasis	984	NA	e61be1e7-e87b-43e8-9ba0-d66768cd0543	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-3919_diagnosis3	NA	Not Reported	TCGA-44-3919_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-44-3919_treatment8	NA	NA	NA	NA	38a66c79-b5e0-4522-989b-1cfed4919625	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	66ed89f6-8ba2-49d0-af0f-4b6ebf2381bf	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3919	71	false	United States	-26081	1026	a6190cba-783a-5387-a88a-13a20d64ae1e	not hispanic or latino	female	white	TCGA-44-3919_demographic	Dead	27065	NA	NA	NA	NA	NA	metastasis	984	NA	e61be1e7-e87b-43e8-9ba0-d66768cd0543	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-3919_diagnosis3	NA	Not Reported	TCGA-44-3919_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-44-3919_treatment7	NA	NA	NA	NA	43c41661-f851-466e-ae7d-9130b4ffb273	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	66ed89f6-8ba2-49d0-af0f-4b6ebf2381bf	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3919	71	false	United States	-26081	1026	a6190cba-783a-5387-a88a-13a20d64ae1e	not hispanic or latino	female	white	TCGA-44-3919_demographic	Dead	27065	NA	NA	NA	NA	NA	metastasis	984	NA	e61be1e7-e87b-43e8-9ba0-d66768cd0543	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-3919_diagnosis3	NA	Not Reported	TCGA-44-3919_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3919_treatment10	NA	Distant Site	NA	NA	bb5801dd-8740-43bb-97da-57c56cb20c45	NA	no	NA	Surgery, NOS
TCGA-LUAD	66ed89f6-8ba2-49d0-af0f-4b6ebf2381bf	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3919	71	false	United States	-26081	1026	a6190cba-783a-5387-a88a-13a20d64ae1e	not hispanic or latino	female	white	TCGA-44-3919_demographic	Dead	27065	NA	NA	NA	NA	NA	metastasis	984	NA	e61be1e7-e87b-43e8-9ba0-d66768cd0543	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-3919_diagnosis3	NA	Not Reported	TCGA-44-3919_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3919_treatment9	NA	Locoregional Site	NA	NA	db73a5db-5e56-4d3c-ac3d-be7373577c05	NA	no	NA	Surgery, NOS
TCGA-LUAD	673493f6-975c-49e8-934c-001e9a0fff90	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-3772	82	false	United States	-29989	NA	11f4b12c-5504-524a-a36b-f38c30dfbe89	not hispanic or latino	female	white	TCGA-67-3772_demographic	Alive	29989	M0	N0	Stage IB	T2	6th	primary	0	573.0	3bc27c15-deeb-5c14-a644-00f112160060	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-67-3772_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	67a2593d-b986-4f84-a51c-7f2fb12e54ad	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z044	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	67a2bc21-7c87-4678-997d-a434de672436	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7537	72	false	Australia	-26610	1622	e90be817-c47b-5637-a381-116f50c01706	not reported	male	not reported	TCGA-78-7537_demographic	Dead	26610	M0	N0	Stage IB	T2	6th	primary	0	1622.0	7617c2e3-f023-5ce5-b8ba-a0f6f142da74	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-78-7537_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7537_treatment	NA	NA	NA	NA	cf30a159-5290-50b4-9fcb-ebe700407d9d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	67a2bc21-7c87-4678-997d-a434de672436	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7537	72	false	Australia	-26610	1622	e90be817-c47b-5637-a381-116f50c01706	not reported	male	not reported	TCGA-78-7537_demographic	Dead	26610	M0	N0	Stage IB	T2	6th	primary	0	1622.0	7617c2e3-f023-5ce5-b8ba-a0f6f142da74	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-78-7537_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7537_treatment2	NA	NA	NA	NA	ed2f3754-14ab-4369-b7b8-e9d7b07d1fce	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	67b5fb5d-2484-4aa5-aa7c-c6c5ecbc91b2	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z048	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	67dbe286-edb3-4d07-8f74-9e5254f01945	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7994	81	false	United States	-29858	NA	fde1ca64-8a6a-5b99-b8bf-43dd3a4a0302	not hispanic or latino	male	white	TCGA-55-7994_demographic	Alive	29858	MX	N0	Stage IIB	T3	7th	primary	0	603.0	24c02c6b-fa32-513b-9ba0-e3efee7cf25b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7994_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	121	56	NA	NA	NA	NA	NA	NA	TCGA-55-7994_treatment2	Paclitaxel	NA	NA	NA	803c45bd-313c-466f-99fa-d964d86ae3a2	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	67dbe286-edb3-4d07-8f74-9e5254f01945	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7994	81	false	United States	-29858	NA	fde1ca64-8a6a-5b99-b8bf-43dd3a4a0302	not hispanic or latino	male	white	TCGA-55-7994_demographic	Alive	29858	MX	N0	Stage IIB	T3	7th	primary	0	603.0	24c02c6b-fa32-513b-9ba0-e3efee7cf25b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7994_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	121	56	NA	NA	NA	NA	NA	NA	TCGA-55-7994_treatment	Carboplatin	NA	NA	NA	cba4f96d-d9d2-5649-aabd-162cc4df8fa9	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	67dbe286-edb3-4d07-8f74-9e5254f01945	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7994	81	false	United States	-29858	NA	fde1ca64-8a6a-5b99-b8bf-43dd3a4a0302	not hispanic or latino	male	white	TCGA-55-7994_demographic	Alive	29858	MX	N0	Stage IIB	T3	7th	primary	0	603.0	24c02c6b-fa32-513b-9ba0-e3efee7cf25b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7994_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7994_treatment3	NA	NA	NA	NA	f4cd2ebd-32c7-440e-ad22-ec002e3e11a3	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	67fa3e41-c7c6-44c5-9e67-6bcb2715aacc	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-A59K	60	false	United States	-22093	NA	c56f35a1-7e2a-5695-bbeb-7c4f2f2d9b73	not hispanic or latino	female	black or african american	TCGA-69-A59K_demographic	Alive	22093	M0	N0	Stage IIB	T3	7th	primary	0	591.0	bed52277-f8ea-56a3-ae7f-a07f8f7bbc69	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-69-A59K_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-A59K_treatment3	NA	NA	NA	NA	14b31cae-b925-4713-83b7-bad3b4954e4a	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	67fa3e41-c7c6-44c5-9e67-6bcb2715aacc	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-A59K	60	false	United States	-22093	NA	c56f35a1-7e2a-5695-bbeb-7c4f2f2d9b73	not hispanic or latino	female	black or african american	TCGA-69-A59K_demographic	Alive	22093	M0	N0	Stage IIB	T3	7th	primary	0	591.0	bed52277-f8ea-56a3-ae7f-a07f8f7bbc69	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-69-A59K_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	135	72	NA	NA	NA	NA	NA	NA	TCGA-69-A59K_treatment2	Pemetrexed	NA	NA	NA	f3c69567-84b0-4537-bc9d-675d7d984627	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	67fa3e41-c7c6-44c5-9e67-6bcb2715aacc	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-A59K	60	false	United States	-22093	NA	c56f35a1-7e2a-5695-bbeb-7c4f2f2d9b73	not hispanic or latino	female	black or african american	TCGA-69-A59K_demographic	Alive	22093	M0	N0	Stage IIB	T3	7th	primary	0	591.0	bed52277-f8ea-56a3-ae7f-a07f8f7bbc69	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-69-A59K_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	135	72	NA	NA	NA	NA	NA	NA	TCGA-69-A59K_treatment	Cisplatin	NA	NA	NA	f3d20848-0248-509c-bf49-f734eea2f5e7	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	681b1176-9676-44d3-892c-1d5dba1ce25b	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7025	NA	false	Canada	NA	NA	419aeb65-b963-5c9d-bc12-45c5116c3000	not reported	male	not reported	TCGA-75-7025_demographic	Alive	NA	NA	NA	NA	NA	NA	metastasis	1481	NA	17d1bd07-b250-4a5d-af7a-40a98b470e0b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-7025_diagnosis3	NA	Not Reported	TCGA-75-7025_diagnosis	NA	NA	NA	NA	2092	NA	NA	NA	NA	NA	NA	TCGA-75-7025_treatment10	NA	Distant Site	NA	NA	0cddb8fd-ff5f-411a-a965-f58e00739a2d	NA	yes	NA	Surgery, NOS
TCGA-LUAD	681b1176-9676-44d3-892c-1d5dba1ce25b	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7025	NA	false	Canada	NA	NA	419aeb65-b963-5c9d-bc12-45c5116c3000	not reported	male	not reported	TCGA-75-7025_demographic	Alive	NA	NA	NA	NA	NA	NA	metastasis	1481	NA	17d1bd07-b250-4a5d-af7a-40a98b470e0b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-7025_diagnosis3	NA	Not Reported	TCGA-75-7025_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-75-7025_treatment7	NA	NA	NA	NA	1eaead31-c78d-45c9-94be-d690e84db883	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	681b1176-9676-44d3-892c-1d5dba1ce25b	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7025	NA	false	Canada	NA	NA	419aeb65-b963-5c9d-bc12-45c5116c3000	not reported	male	not reported	TCGA-75-7025_demographic	Alive	NA	NA	NA	NA	NA	NA	metastasis	1481	NA	17d1bd07-b250-4a5d-af7a-40a98b470e0b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-7025_diagnosis3	NA	Not Reported	TCGA-75-7025_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-75-7025_treatment8	NA	NA	NA	NA	1f3d6cfb-c306-4661-8ae0-2e3ac47a7fe7	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	681b1176-9676-44d3-892c-1d5dba1ce25b	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7025	NA	false	Canada	NA	NA	419aeb65-b963-5c9d-bc12-45c5116c3000	not reported	male	not reported	TCGA-75-7025_demographic	Alive	NA	NA	NA	NA	NA	NA	metastasis	1481	NA	17d1bd07-b250-4a5d-af7a-40a98b470e0b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-7025_diagnosis3	NA	Not Reported	TCGA-75-7025_diagnosis	NA	NA	NA	NA	1481	NA	NA	NA	NA	NA	NA	TCGA-75-7025_treatment9	NA	Locoregional Site	NA	NA	693f88be-a3b2-42c5-991a-34243201d7b8	NA	yes	NA	Surgery, NOS
TCGA-LUAD	681b1176-9676-44d3-892c-1d5dba1ce25b	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7025	NA	false	Canada	NA	NA	419aeb65-b963-5c9d-bc12-45c5116c3000	not reported	male	not reported	TCGA-75-7025_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	3305.0	97101227-3fa7-5704-b746-8cc7304565b9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-7025_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-7025_treatment2	NA	NA	NA	NA	4c9beb4a-5098-491c-a238-20dc57a34b02	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	681b1176-9676-44d3-892c-1d5dba1ce25b	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7025	NA	false	Canada	NA	NA	419aeb65-b963-5c9d-bc12-45c5116c3000	not reported	male	not reported	TCGA-75-7025_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	3305.0	97101227-3fa7-5704-b746-8cc7304565b9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-7025_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-7025_treatment	NA	NA	NA	NA	72a36fb2-eef2-5620-ac97-3eb8c4844e08	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	681b1176-9676-44d3-892c-1d5dba1ce25b	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7025	NA	false	Canada	NA	NA	419aeb65-b963-5c9d-bc12-45c5116c3000	not reported	male	not reported	TCGA-75-7025_demographic	Alive	NA	NA	NA	NA	NA	NA	recurrence	1481	NA	b4938976-08c7-40c0-8155-c9094ef3635e	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-7025_diagnosis2	NA	Not Reported	TCGA-75-7025_diagnosis	NA	NA	NA	NA	1481	NA	NA	NA	NA	NA	NA	TCGA-75-7025_treatment5	NA	Locoregional Site	NA	NA	6642e1a5-4dee-4e4d-bcfa-46ecc32b9a3a	NA	yes	NA	Surgery, NOS
TCGA-LUAD	681b1176-9676-44d3-892c-1d5dba1ce25b	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7025	NA	false	Canada	NA	NA	419aeb65-b963-5c9d-bc12-45c5116c3000	not reported	male	not reported	TCGA-75-7025_demographic	Alive	NA	NA	NA	NA	NA	NA	recurrence	1481	NA	b4938976-08c7-40c0-8155-c9094ef3635e	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-7025_diagnosis2	NA	Not Reported	TCGA-75-7025_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-75-7025_treatment4	NA	NA	NA	NA	70a23d7b-7e53-4b78-85c1-34abc04ca321	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	681b1176-9676-44d3-892c-1d5dba1ce25b	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7025	NA	false	Canada	NA	NA	419aeb65-b963-5c9d-bc12-45c5116c3000	not reported	male	not reported	TCGA-75-7025_demographic	Alive	NA	NA	NA	NA	NA	NA	recurrence	1481	NA	b4938976-08c7-40c0-8155-c9094ef3635e	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-7025_diagnosis2	NA	Not Reported	TCGA-75-7025_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-75-7025_treatment3	NA	NA	NA	NA	b05de23e-4f0a-4327-b506-b3cd8556cde3	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	681b1176-9676-44d3-892c-1d5dba1ce25b	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-7025	NA	false	Canada	NA	NA	419aeb65-b963-5c9d-bc12-45c5116c3000	not reported	male	not reported	TCGA-75-7025_demographic	Alive	NA	NA	NA	NA	NA	NA	recurrence	1481	NA	b4938976-08c7-40c0-8155-c9094ef3635e	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-75-7025_diagnosis2	NA	Not Reported	TCGA-75-7025_diagnosis	NA	NA	NA	NA	2092	NA	NA	NA	NA	NA	NA	TCGA-75-7025_treatment6	NA	Distant Site	NA	NA	dc1ae9ce-88da-43dc-8d86-82969e9ef095	NA	yes	NA	Surgery, NOS
TCGA-LUAD	6845099a-b2c9-48d8-b856-9903d39bb92e	Informed Consent	61	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8514	70	false	United States	-25608	NA	02ec80ed-7928-5022-90f6-bc5f54c645c6	not hispanic or latino	female	black or african american	TCGA-55-8514_demographic	Alive	25608	MX	N0	Stage IB	T2a	7th	primary	0	520.0	5164e66d-05a4-5657-ab59-77a4c9c13057	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8514_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8514_treatment	NA	NA	NA	NA	9856f0fa-5bdd-5319-84d8-6c9d812ae9d1	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	6845099a-b2c9-48d8-b856-9903d39bb92e	Informed Consent	61	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8514	70	false	United States	-25608	NA	02ec80ed-7928-5022-90f6-bc5f54c645c6	not hispanic or latino	female	black or african american	TCGA-55-8514_demographic	Alive	25608	MX	N0	Stage IB	T2a	7th	primary	0	520.0	5164e66d-05a4-5657-ab59-77a4c9c13057	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8514_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8514_treatment2	NA	NA	NA	NA	d8518e5e-e411-41c9-88a2-caa7556d7022	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	68b86559-38b2-41f2-b66e-c3c2b628b14d	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-4112	60	false	NA	-22106	808	a857f735-50e7-5608-8529-c9d73fe62f5b	not hispanic or latino	female	white	TCGA-44-4112_demographic	Dead	22106	M0	N0	Stage IB	T2a	6th	primary	0	808.0	65a20a17-bc12-5f5a-ab5f-003a7fe4846b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-4112_diagnosis	No	Upper lobe, lung	NA	2010	NA	1.0	675	654	Progressive Disease	NA	14.0	NA	NA	NA	TCGA-44-4112_treatment	NA	Distant Site	3500	cGy	4a2cd281-573b-5fae-8545-44b3f5595637	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	68b86559-38b2-41f2-b66e-c3c2b628b14d	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-4112	60	false	NA	-22106	808	a857f735-50e7-5608-8529-c9d73fe62f5b	not hispanic or latino	female	white	TCGA-44-4112_demographic	Dead	22106	M0	N0	Stage IB	T2a	6th	primary	0	808.0	65a20a17-bc12-5f5a-ab5f-003a7fe4846b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-4112_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	142	78	NA	4	NA	165.0	mg	Intravenous	TCGA-44-4112_treatment2	Cisplatin	NA	660	mg	52f7d3f3-7431-4601-973f-44519721b750	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	68b86559-38b2-41f2-b66e-c3c2b628b14d	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-4112	60	false	NA	-22106	808	a857f735-50e7-5608-8529-c9d73fe62f5b	not hispanic or latino	female	white	TCGA-44-4112_demographic	Dead	22106	M0	N0	Stage IB	T2a	6th	primary	0	808.0	65a20a17-bc12-5f5a-ab5f-003a7fe4846b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-4112_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	142	78	NA	4	NA	1100.0	mg	Intravenous	TCGA-44-4112_treatment3	Pemetrexed Disodium	NA	4400	mg	65a63122-5951-43f8-8001-64a8adc705e2	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	68b86559-38b2-41f2-b66e-c3c2b628b14d	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-4112	60	false	NA	-22106	808	a857f735-50e7-5608-8529-c9d73fe62f5b	not hispanic or latino	female	white	TCGA-44-4112_demographic	Dead	22725	NA	NA	NA	NA	NA	not reported	619	NA	b9e1785c-0127-4fb2-ba99-49f3314a2f46	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-4112_diagnosis2	NA	Not Reported	TCGA-44-4112_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-4112_treatment6	NA	Locoregional Site	NA	NA	0edb61fa-b118-4af7-a991-84eda86c45d3	NA	no	NA	Surgery, NOS
TCGA-LUAD	68b86559-38b2-41f2-b66e-c3c2b628b14d	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-4112	60	false	NA	-22106	808	a857f735-50e7-5608-8529-c9d73fe62f5b	not hispanic or latino	female	white	TCGA-44-4112_demographic	Dead	22725	NA	NA	NA	NA	NA	not reported	619	NA	b9e1785c-0127-4fb2-ba99-49f3314a2f46	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-4112_diagnosis2	NA	Not Reported	TCGA-44-4112_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-4112_treatment5	NA	NA	NA	NA	39db06fd-121b-4ed5-866b-ce7428f0be56	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	68b86559-38b2-41f2-b66e-c3c2b628b14d	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-4112	60	false	NA	-22106	808	a857f735-50e7-5608-8529-c9d73fe62f5b	not hispanic or latino	female	white	TCGA-44-4112_demographic	Dead	22725	NA	NA	NA	NA	NA	not reported	619	NA	b9e1785c-0127-4fb2-ba99-49f3314a2f46	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-4112_diagnosis2	NA	Not Reported	TCGA-44-4112_diagnosis	NA	NA	NA	NA	619	NA	NA	NA	NA	NA	NA	TCGA-44-4112_treatment7	NA	Distant Site	NA	NA	693dc4ff-92ba-46c3-a466-c46c92912b04	NA	yes	NA	Surgery, NOS
TCGA-LUAD	68b86559-38b2-41f2-b66e-c3c2b628b14d	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-4112	60	false	NA	-22106	808	a857f735-50e7-5608-8529-c9d73fe62f5b	not hispanic or latino	female	white	TCGA-44-4112_demographic	Dead	22725	NA	NA	NA	NA	NA	not reported	619	NA	b9e1785c-0127-4fb2-ba99-49f3314a2f46	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-4112_diagnosis2	NA	Not Reported	TCGA-44-4112_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-4112_treatment4	NA	NA	NA	NA	e63cbe9e-1692-412e-92b7-eb636195d1ec	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	69584d55-18f7-4786-b3cc-cd528500be44	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8094	51	false	United States	-18903	NA	cd20be39-6583-5832-87bd-bae177b6d2b8	not hispanic or latino	male	white	TCGA-55-8094_demographic	Alive	18903	M1b	N0	Stage IV	T2b	7th	primary	0	541.0	8e6bb36d-8645-5ec4-b159-5ea76de0e96e	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-8094_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8094_treatment	NA	NA	NA	NA	3e6cc041-cd4b-5f74-a236-ba0b849cf94f	Adjuvant	yes	Progressive Disease	Pharmaceutical Therapy, NOS
TCGA-LUAD	69584d55-18f7-4786-b3cc-cd528500be44	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8094	51	false	United States	-18903	NA	cd20be39-6583-5832-87bd-bae177b6d2b8	not hispanic or latino	male	white	TCGA-55-8094_demographic	Alive	18903	M1b	N0	Stage IV	T2b	7th	primary	0	541.0	8e6bb36d-8645-5ec4-b159-5ea76de0e96e	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-8094_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8094_treatment2	NA	NA	NA	NA	c938c908-09b9-47b3-a71f-ec7af6e4fbdd	Adjuvant	yes	Progressive Disease	Radiation Therapy, NOS
TCGA-LUAD	69b23036-add9-42c9-941f-02fb74d9b08c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4425	70	false	Germany	-25902	NA	133d6d60-54c7-5098-9d54-8f8288879cc1	not reported	female	not reported	TCGA-05-4425_demographic	Alive	25902	M1	N0	Stage IV	T2	6th	primary	0	669.0	0925da4f-1cd7-5a8c-9343-f017e2b1e8be	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	NA	TCGA-05-4425_diagnosis	No	Middle lobe, lung	NA	2008	No	NA	153	31	NA	NA	NA	NA	NA	NA	TCGA-05-4425_treatment2	Vinorelbine	NA	NA	NA	9e087ce9-737f-4ac6-972c-5b4b9ec69992	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	69b23036-add9-42c9-941f-02fb74d9b08c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4425	70	false	Germany	-25902	NA	133d6d60-54c7-5098-9d54-8f8288879cc1	not reported	female	not reported	TCGA-05-4425_demographic	Alive	25902	M1	N0	Stage IV	T2	6th	primary	0	669.0	0925da4f-1cd7-5a8c-9343-f017e2b1e8be	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	NA	TCGA-05-4425_diagnosis	No	Middle lobe, lung	NA	2008	No	NA	153	31	NA	NA	NA	NA	NA	NA	TCGA-05-4425_treatment	Cisplatin	NA	NA	NA	e334c240-e55b-5d85-95a7-38d33ec13b68	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	69dba721-a168-47a4-b7ff-80a448bad654	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7914	71	false	United States	-26105	187	4a3e3095-198f-5b9c-a0df-947b62d5db42	not hispanic or latino	female	white	TCGA-55-7914_demographic	Dead	26105	MX	N1	Stage IIA	T1b	7th	primary	0	187.0	719e74f6-bfc8-565d-8f04-d705fbc51e4d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-55-7914_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	132	27	NA	NA	NA	NA	NA	NA	TCGA-55-7914_treatment2	Pemetrexed Disodium	NA	NA	NA	3e912b02-7c8c-4e8a-95ce-da17e0c7d685	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	69dba721-a168-47a4-b7ff-80a448bad654	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7914	71	false	United States	-26105	187	4a3e3095-198f-5b9c-a0df-947b62d5db42	not hispanic or latino	female	white	TCGA-55-7914_demographic	Dead	26105	MX	N1	Stage IIA	T1b	7th	primary	0	187.0	719e74f6-bfc8-565d-8f04-d705fbc51e4d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-55-7914_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	132	27	NA	NA	NA	NA	NA	NA	TCGA-55-7914_treatment3	Bevacizumab	NA	NA	NA	43356101-f32c-4632-a3a6-3d3db8aa3c91	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	69dba721-a168-47a4-b7ff-80a448bad654	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7914	71	false	United States	-26105	187	4a3e3095-198f-5b9c-a0df-947b62d5db42	not hispanic or latino	female	white	TCGA-55-7914_demographic	Dead	26105	MX	N1	Stage IIA	T1b	7th	primary	0	187.0	719e74f6-bfc8-565d-8f04-d705fbc51e4d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-55-7914_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	132	27	NA	NA	NA	NA	NA	NA	TCGA-55-7914_treatment	Carboplatin	NA	NA	NA	7da6aa5b-e62f-500d-9555-34af69037840	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	69dba721-a168-47a4-b7ff-80a448bad654	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7914	71	false	United States	-26105	187	4a3e3095-198f-5b9c-a0df-947b62d5db42	not hispanic or latino	female	white	TCGA-55-7914_demographic	Dead	26105	MX	N1	Stage IIA	T1b	7th	primary	0	187.0	719e74f6-bfc8-565d-8f04-d705fbc51e4d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-55-7914_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7914_treatment4	NA	NA	NA	NA	f8d4caff-1a1c-48a6-b047-c7b66cf5848c	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	69dba721-a168-47a4-b7ff-80a448bad654	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7914	71	false	United States	-26105	187	4a3e3095-198f-5b9c-a0df-947b62d5db42	not hispanic or latino	female	white	TCGA-55-7914_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	bb8f7766-5590-4a4b-9661-f0af96fe335d	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-7914_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7914_treatment6	NA	NA	NA	NA	17df4fde-af13-460a-a2d9-0678d5a9f55b	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	69dba721-a168-47a4-b7ff-80a448bad654	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7914	71	false	United States	-26105	187	4a3e3095-198f-5b9c-a0df-947b62d5db42	not hispanic or latino	female	white	TCGA-55-7914_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	bb8f7766-5590-4a4b-9661-f0af96fe335d	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-7914_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7914_treatment5	NA	NA	NA	NA	25d238fa-128f-4a3d-8aa3-cb343acff0fa	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	6bffe800-ec2b-4638-9333-97fe85dcd91c	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-6767	46	false	United States	-17108	NA	fcadd633-ccce-577d-a1a3-be171e9128df	not reported	female	white	TCGA-49-6767_demographic	Alive	17108	MX	N0	Stage IIB	T3	7th	primary	0	677.0	7266a073-3136-5348-85d6-04625138a28a	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-6767_diagnosis	No	Middle lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6767_treatment	NA	NA	NA	NA	96260148-39c7-5bee-8a62-0603d8d8839c	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	6bffe800-ec2b-4638-9333-97fe85dcd91c	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-6767	46	false	United States	-17108	NA	fcadd633-ccce-577d-a1a3-be171e9128df	not reported	female	white	TCGA-49-6767_demographic	Alive	17108	MX	N0	Stage IIB	T3	7th	primary	0	677.0	7266a073-3136-5348-85d6-04625138a28a	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-6767_diagnosis	No	Middle lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6767_treatment2	NA	NA	NA	NA	d58318b2-f634-4b6b-8022-33e1beb80988	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	6c3655ca-8ae7-4ad7-b3e4-0c3ec293fba7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4490	45	false	United States	-16634	385	0393aec7-4bda-5842-b872-034e44c7e685	not hispanic or latino	female	white	TCGA-49-4490_demographic	Dead	16634	M0	N2	Stage IIIA	T3	4th	primary	0	385.0	6c4db7a9-8274-53cd-b2bd-2840a37c46fe	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-49-4490_diagnosis	No	Upper lobe, lung	NA	1993	NA	NA	163	79	NA	2	NA	NA	NA	Intravenous	TCGA-49-4490_treatment2	Cisplatin	NA	NA	NA	3cc70b98-f5a7-44df-8a21-db1ac973eb19	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	6c3655ca-8ae7-4ad7-b3e4-0c3ec293fba7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4490	45	false	United States	-16634	385	0393aec7-4bda-5842-b872-034e44c7e685	not hispanic or latino	female	white	TCGA-49-4490_demographic	Dead	16634	M0	N2	Stage IIIA	T3	4th	primary	0	385.0	6c4db7a9-8274-53cd-b2bd-2840a37c46fe	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-49-4490_diagnosis	No	Upper lobe, lung	NA	1993	NA	1.0	253	240	NA	NA	NA	NA	NA	NA	TCGA-49-4490_treatment	NA	Regional Site	3000	cGy	6b0f9198-a344-51a9-83c1-8b9ee6225eb8	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	6cf49cf0-de4c-4c90-8358-eae19c6206b0	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-35-4123	38	false	Russia	-14064	NA	8974bd6b-c0ec-5ef5-8619-00a89a49b409	not hispanic or latino	male	white	TCGA-35-4123_demographic	Alive	14064	M0	N0	Stage IA	T1	7th	primary	0	182.0	7e107122-58b5-5195-840f-6ea73b3e51fd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-35-4123_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	6d72de06-232a-4983-a06c-eba6d82cb3f1	Informed Consent	6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1594	68	false	United States	-25008	NA	e2476c10-4ccb-5a62-bc62-3025e649438d	not hispanic or latino	male	white	TCGA-55-1594_demographic	Alive	25008	M0	N2	Stage IIIA	T2	NA	primary	0	1178.0	9713e2e3-c7ed-5c84-b394-699a2c1fd360	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-1594_diagnosis	No	Lower lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	6d96a298-be5a-4e14-afe8-ca4b6ca298d6	Informed Consent	28	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-8117	54	false	United States	-19855	NA	37435a10-39c6-5b05-85dc-4511664352f2	not hispanic or latino	female	white	TCGA-44-8117_demographic	Alive	19855	M0	N0	Stage IB	T2a	7th	primary	0	385.0	f86b9b90-0009-56d6-afa2-b57635c9f168	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-8117_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	176	113	NA	NA	NA	NA	NA	NA	TCGA-44-8117_treatment	Cisplatin	NA	NA	NA	0df460db-e33a-529f-9883-a175753dec0c	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	6d96a298-be5a-4e14-afe8-ca4b6ca298d6	Informed Consent	28	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-8117	54	false	United States	-19855	NA	37435a10-39c6-5b05-85dc-4511664352f2	not hispanic or latino	female	white	TCGA-44-8117_demographic	Alive	19855	M0	N0	Stage IB	T2a	7th	primary	0	385.0	f86b9b90-0009-56d6-afa2-b57635c9f168	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-8117_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	133	113	NA	NA	NA	NA	NA	NA	TCGA-44-8117_treatment2	Docetaxel	NA	NA	NA	a3c74009-35f3-451d-89df-48a8c22fd55b	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	6d96a298-be5a-4e14-afe8-ca4b6ca298d6	Informed Consent	28	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-8117	54	false	United States	-19855	NA	37435a10-39c6-5b05-85dc-4511664352f2	not hispanic or latino	female	white	TCGA-44-8117_demographic	Alive	19855	M0	N0	Stage IB	T2a	7th	primary	0	385.0	f86b9b90-0009-56d6-afa2-b57635c9f168	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-8117_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-8117_treatment3	NA	NA	NA	NA	dec135bc-1c23-4954-a65e-93909475fd28	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	6dfd47d2-831a-4386-9051-f78199a16bb5	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4397	65	false	Germany	-23833	731	25f09b29-7d2b-58fe-8c05-c931ded41f9f	not reported	male	not reported	TCGA-05-4397_demographic	Dead	23833	M0	N1	Stage IIB	T2	5th	primary	0	731.0	e06998d3-3212-584e-9154-2727fb52e7c8	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4397_diagnosis	No	Middle lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	6e3b6b72-142d-4b8d-a462-28a205796e41	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3918	60	false	United States	-22236	NA	27dcdf60-4552-5837-a363-3a083d043522	not hispanic or latino	female	white	TCGA-44-3918_demographic	Alive	22236	M0	N0	Stage IA	T1	6th	primary	0	1036.0	009848db-f39d-5865-859c-8bb1a18292b7	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3918_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	648	543	Recurrent Disease	6	NA	930.0	mg	Intravenous	TCGA-44-3918_treatment3	Pemetrexed Disodium	NA	5660	mg	1415c7da-f252-44aa-a08c-ea743417e5e9	NA	yes	NA	Chemotherapy
TCGA-LUAD	6e3b6b72-142d-4b8d-a462-28a205796e41	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3918	60	false	United States	-22236	NA	27dcdf60-4552-5837-a363-3a083d043522	not hispanic or latino	female	white	TCGA-44-3918_demographic	Alive	22236	M0	N0	Stage IA	T1	6th	primary	0	1036.0	009848db-f39d-5865-859c-8bb1a18292b7	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3918_diagnosis	No	Upper lobe, lung	NA	2010	NA	1.0	697	686	NA	NA	10.0	NA	NA	NA	TCGA-44-3918_treatment	NA	Locoregional Site	3000	cGy	92e4d19c-3d5e-5c59-b151-270ed91b969e	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	6e3b6b72-142d-4b8d-a462-28a205796e41	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3918	60	false	United States	-22236	NA	27dcdf60-4552-5837-a363-3a083d043522	not hispanic or latino	female	white	TCGA-44-3918_demographic	Alive	22236	M0	N0	Stage IA	T1	6th	primary	0	1036.0	009848db-f39d-5865-859c-8bb1a18292b7	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3918_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	648	543	Recurrent Disease	6	NA	500.0	mg	Intravenous	TCGA-44-3918_treatment2	Carboplatin	NA	3380	mg	cb762541-9daf-42dc-be33-f628274f3ff6	NA	yes	NA	Chemotherapy
TCGA-LUAD	6e3b6b72-142d-4b8d-a462-28a205796e41	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3918	60	false	United States	-22236	NA	27dcdf60-4552-5837-a363-3a083d043522	not hispanic or latino	female	white	TCGA-44-3918_demographic	Alive	22747	NA	NA	NA	NA	NA	recurrence	511	NA	1d57c91b-aa16-4c7f-a7b3-2a505f418614	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-3918_diagnosis3	NA	Not Reported	TCGA-44-3918_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-3918_treatment7	NA	NA	NA	NA	68a448a9-a2b4-41b6-82a1-49355feeabec	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	6e3b6b72-142d-4b8d-a462-28a205796e41	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3918	60	false	United States	-22236	NA	27dcdf60-4552-5837-a363-3a083d043522	not hispanic or latino	female	white	TCGA-44-3918_demographic	Alive	22747	NA	NA	NA	NA	NA	recurrence	511	NA	1d57c91b-aa16-4c7f-a7b3-2a505f418614	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-3918_diagnosis3	NA	Not Reported	TCGA-44-3918_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-3918_treatment8	NA	NA	NA	NA	93f7cf93-6128-40a2-a21d-199d797a7761	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	6e3b6b72-142d-4b8d-a462-28a205796e41	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3918	60	false	United States	-22236	NA	27dcdf60-4552-5837-a363-3a083d043522	not hispanic or latino	female	white	TCGA-44-3918_demographic	Alive	22747	NA	NA	NA	NA	NA	recurrence	511	NA	1d57c91b-aa16-4c7f-a7b3-2a505f418614	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-3918_diagnosis3	NA	Not Reported	TCGA-44-3918_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3918_treatment9	NA	Locoregional Site	NA	NA	e598f5a3-2e63-43bb-a823-57055319dcd4	NA	no	NA	Surgery, NOS
TCGA-LUAD	6e3b6b72-142d-4b8d-a462-28a205796e41	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3918	60	false	United States	-22236	NA	27dcdf60-4552-5837-a363-3a083d043522	not hispanic or latino	female	white	TCGA-44-3918_demographic	Alive	22747	NA	NA	NA	NA	NA	not reported	511	NA	80a741f4-30e2-47dc-baf4-ecd6c75f75f7	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-3918_diagnosis2	NA	Not Reported	TCGA-44-3918_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-3918_treatment5	NA	NA	NA	NA	7772e271-c92b-43ef-87ce-16b768307274	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	6e3b6b72-142d-4b8d-a462-28a205796e41	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3918	60	false	United States	-22236	NA	27dcdf60-4552-5837-a363-3a083d043522	not hispanic or latino	female	white	TCGA-44-3918_demographic	Alive	22747	NA	NA	NA	NA	NA	not reported	511	NA	80a741f4-30e2-47dc-baf4-ecd6c75f75f7	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-3918_diagnosis2	NA	Not Reported	TCGA-44-3918_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3918_treatment6	NA	Locoregional Site	NA	NA	d52ec265-cd35-4368-a4a6-cff1eabec9ac	NA	no	NA	Surgery, NOS
TCGA-LUAD	6e3b6b72-142d-4b8d-a462-28a205796e41	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3918	60	false	United States	-22236	NA	27dcdf60-4552-5837-a363-3a083d043522	not hispanic or latino	female	white	TCGA-44-3918_demographic	Alive	22747	NA	NA	NA	NA	NA	not reported	511	NA	80a741f4-30e2-47dc-baf4-ecd6c75f75f7	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-3918_diagnosis2	NA	Not Reported	TCGA-44-3918_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-3918_treatment4	NA	NA	NA	NA	ee2fbfec-1091-473c-bec7-e7efc4a9d582	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	6ee9caec-65ac-46db-9426-ffaa31967ae2	Informed Consent	71	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-95-8494	67	false	United States	-24773	NA	908b0692-f28c-5786-b5ee-62f265b5e711	not hispanic or latino	male	white	TCGA-95-8494_demographic	Alive	24773	M0	N1	Stage IIA	T2a	7th	primary	0	84.0	63732e87-50c8-5d82-be56-e5d902140a93	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-95-8494_diagnosis	No	Middle lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-8494_treatment2	NA	NA	NA	NA	61462cfc-5385-49da-9c00-2cd16d1a7bc3	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	6ee9caec-65ac-46db-9426-ffaa31967ae2	Informed Consent	71	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-95-8494	67	false	United States	-24773	NA	908b0692-f28c-5786-b5ee-62f265b5e711	not hispanic or latino	male	white	TCGA-95-8494_demographic	Alive	24773	M0	N1	Stage IIA	T2a	7th	primary	0	84.0	63732e87-50c8-5d82-be56-e5d902140a93	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-95-8494_diagnosis	No	Middle lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-8494_treatment	NA	NA	NA	NA	dd5b26bf-0b7e-55dc-bab8-3bf5ec657876	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20185	NA	NA	NA	NA	NA	metastasis	418	NA	0528f5a5-ca58-4cac-8838-50f0557abab3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis4	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment14	NA	NA	NA	NA	8d9412fb-ad49-42ce-9422-44b8dc824167	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20185	NA	NA	NA	NA	NA	metastasis	418	NA	0528f5a5-ca58-4cac-8838-50f0557abab3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis4	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment13	NA	NA	NA	NA	8e0778d3-1e19-44b3-afe2-861c28a07d2d	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20185	NA	NA	NA	NA	NA	metastasis	418	NA	0528f5a5-ca58-4cac-8838-50f0557abab3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis4	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	938	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment15	NA	Distant Site	NA	NA	f2e78bb9-9a1f-4ae6-a48f-a3205c0f5232	NA	yes	NA	Surgery, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	19767	MX	N2	Stage IIIA	T2	6th	primary	0	1265.0	4534b5fa-4e21-5598-96b9-e9c0b073fb74	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-MP-A4T9_diagnosis	No	Upper lobe, lung	NA	2006	No	NA	55	34	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment2	Vinorelbine	NA	NA	NA	003d19c6-5539-4d8c-a7a5-a9e4180e8d74	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	19767	MX	N2	Stage IIIA	T2	6th	primary	0	1265.0	4534b5fa-4e21-5598-96b9-e9c0b073fb74	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-MP-A4T9_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	166	132	NA	NA	25.0	NA	NA	NA	TCGA-MP-A4T9_treatment	NA	Primary Tumor Field	5000	cGy	52eeff7a-a624-5dfe-84ff-267fa0934682	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	19767	MX	N2	Stage IIIA	T2	6th	primary	0	1265.0	4534b5fa-4e21-5598-96b9-e9c0b073fb74	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-MP-A4T9_diagnosis	No	Upper lobe, lung	NA	2006	No	NA	55	34	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment3	Cisplatin	NA	NA	NA	5458198d-9039-457c-b05d-dfe584da7741	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	19767	MX	N2	Stage IIIA	T2	6th	primary	0	1265.0	4534b5fa-4e21-5598-96b9-e9c0b073fb74	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	NA	TCGA-MP-A4T9_diagnosis	No	Upper lobe, lung	NA	2006	No	NA	62	62	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment4	Gemcitabine	NA	NA	NA	ef660cda-ea5f-408f-9377-c5cc1bbee753	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20108	NA	NA	NA	NA	NA	metastasis	341	NA	85516507-12f0-41e5-8f7b-f5f17817cafd	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis3	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment12	NA	Distant Site	NA	NA	607f37e7-74fd-429e-b657-77f6efd972e4	NA	no	NA	Surgery, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20108	NA	NA	NA	NA	NA	metastasis	341	NA	85516507-12f0-41e5-8f7b-f5f17817cafd	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis3	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment10	NA	NA	NA	NA	b8c9d89c-7084-4711-b0c6-9ce72f059c83	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20108	NA	NA	NA	NA	NA	metastasis	341	NA	85516507-12f0-41e5-8f7b-f5f17817cafd	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis3	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment9	NA	NA	NA	NA	caea70bb-44c4-4ca9-b27d-aefbb6fb399c	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20108	NA	NA	NA	NA	NA	metastasis	341	NA	85516507-12f0-41e5-8f7b-f5f17817cafd	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis3	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment11	NA	Locoregional Site	NA	NA	cc75234e-c5e4-45d0-a4da-a49205058ec3	NA	no	NA	Surgery, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20656	NA	NA	NA	NA	NA	metastasis	889	NA	a710bd1e-44ec-4009-a4f6-2460419ba81a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis5	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment16	NA	NA	NA	NA	06d12506-127a-41eb-b6a7-c4efeeb1fccb	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20656	NA	NA	NA	NA	NA	metastasis	889	NA	a710bd1e-44ec-4009-a4f6-2460419ba81a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis5	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment17	NA	NA	NA	NA	0df98bde-9e18-4bbc-afef-208bcfd09ceb	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20656	NA	NA	NA	NA	NA	metastasis	889	NA	a710bd1e-44ec-4009-a4f6-2460419ba81a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis5	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment18	NA	Distant Site	NA	NA	ec496b64-d261-4bbf-984b-9b26e79de0f3	NA	no	NA	Surgery, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20108	NA	NA	NA	NA	NA	recurrence	341	NA	b2652b85-c769-4a28-9772-aa23f6bf5a43	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis2	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment6	NA	NA	NA	NA	637325ff-9f2d-4715-98dc-30c9580fe294	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20108	NA	NA	NA	NA	NA	recurrence	341	NA	b2652b85-c769-4a28-9772-aa23f6bf5a43	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis2	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment5	NA	NA	NA	NA	6dcf7139-9b5c-44b0-b126-219d0ce181e4	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20108	NA	NA	NA	NA	NA	recurrence	341	NA	b2652b85-c769-4a28-9772-aa23f6bf5a43	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis2	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment8	NA	Distant Site	NA	NA	8e139634-26cf-4940-95c4-d0578444d954	NA	no	NA	Surgery, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	20108	NA	NA	NA	NA	NA	recurrence	341	NA	b2652b85-c769-4a28-9772-aa23f6bf5a43	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis2	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment7	NA	Locoregional Site	NA	NA	b4549265-8677-4050-9aa3-157d71aae83b	NA	no	NA	Surgery, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	21015	NA	NA	NA	NA	NA	recurrence	1248	NA	b7e5c036-5b1e-4abb-97c4-8dc668a1bd30	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis6	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	1255	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment21	NA	Locoregional Site	NA	NA	2dc053d4-1871-4a18-ba89-cf1d9c0e146d	NA	yes	NA	Surgery, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	21015	NA	NA	NA	NA	NA	recurrence	1248	NA	b7e5c036-5b1e-4abb-97c4-8dc668a1bd30	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis6	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment19	NA	NA	NA	NA	33aa0af2-c4e4-4d11-840e-63e45ab1d588	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	70081320-540f-41d2-8687-ee6d011f8eb0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T9	54	false	United States	-19767	1265	166fb5f8-67eb-5e90-81ad-5c02d3cd08b6	not hispanic or latino	female	white	TCGA-MP-A4T9_demographic	Dead	21015	NA	NA	NA	NA	NA	recurrence	1248	NA	b7e5c036-5b1e-4abb-97c4-8dc668a1bd30	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T9_diagnosis6	NA	Not Reported	TCGA-MP-A4T9_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T9_treatment20	NA	NA	NA	NA	d63d3e99-c91f-42f2-b8b2-c79298bdc05a	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	706420c4-8820-4b41-80d9-f3efd1d2a4f0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4SV	67	false	United States	-24516	2620	53ba217f-641e-5486-8cdc-985111493363	Unknown	male	Unknown	TCGA-MP-A4SV_demographic	Dead	24516	M0	N0	Stage IB	T2	5th	primary	0	2620.0	77c1cfc3-0a92-507b-80b5-edf20d005785	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4SV_diagnosis	No	Lower lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4SV_treatment2	NA	NA	NA	NA	547d6ca8-5ed5-40b1-bfd2-f16eb1fbdff5	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	706420c4-8820-4b41-80d9-f3efd1d2a4f0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4SV	67	false	United States	-24516	2620	53ba217f-641e-5486-8cdc-985111493363	Unknown	male	Unknown	TCGA-MP-A4SV_demographic	Dead	24516	M0	N0	Stage IB	T2	5th	primary	0	2620.0	77c1cfc3-0a92-507b-80b5-edf20d005785	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4SV_diagnosis	No	Lower lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4SV_treatment	NA	NA	NA	NA	850a4d99-3c2a-534c-bfe3-8fbd91530c3d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7093024b-cf56-4783-b973-b72573ed7f2b	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-93-A4JQ	49	false	United States	-17951	NA	5930ec0e-f54f-5692-bc0c-d9b6c98bd3e6	not hispanic or latino	male	white	TCGA-93-A4JQ_demographic	Alive	17951	MX	N0	Stage IA	T1b	7th	primary	0	526.0	56869005-7eb0-583f-a55b-c06856b622c1	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	yes	No	RX	Lung, NOS	NA	TCGA-93-A4JQ_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-A4JQ_treatment	NA	NA	NA	NA	3a1be7c4-8b5b-5ec5-9a2e-769459b14a0e	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7093024b-cf56-4783-b973-b72573ed7f2b	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-93-A4JQ	49	false	United States	-17951	NA	5930ec0e-f54f-5692-bc0c-d9b6c98bd3e6	not hispanic or latino	male	white	TCGA-93-A4JQ_demographic	Alive	17951	MX	N0	Stage IA	T1b	7th	primary	0	526.0	56869005-7eb0-583f-a55b-c06856b622c1	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	yes	No	RX	Lung, NOS	NA	TCGA-93-A4JQ_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-A4JQ_treatment2	NA	NA	NA	NA	44606860-76ee-4d3b-9846-e2b758d13abe	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7093024b-cf56-4783-b973-b72573ed7f2b	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-93-A4JQ	49	false	United States	-17951	NA	5930ec0e-f54f-5692-bc0c-d9b6c98bd3e6	not hispanic or latino	male	white	TCGA-93-A4JQ_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	a6acbb57-30e9-4e7c-9dff-13260df14dc1	false	NA	NA	NA	Left	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-93-A4JQ_diagnosis2	NA	Head, face or neck, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-A4JQ_treatment5	NA	NA	NA	NA	09af21e3-8090-4561-ac86-50794a0bd3eb	NA	no	NA	Surgery, NOS
TCGA-LUAD	7093024b-cf56-4783-b973-b72573ed7f2b	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-93-A4JQ	49	false	United States	-17951	NA	5930ec0e-f54f-5692-bc0c-d9b6c98bd3e6	not hispanic or latino	male	white	TCGA-93-A4JQ_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	a6acbb57-30e9-4e7c-9dff-13260df14dc1	false	NA	NA	NA	Left	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-93-A4JQ_diagnosis2	NA	Head, face or neck, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-A4JQ_treatment4	NA	NA	NA	NA	7957eca6-a5ce-4a6b-ad3b-f341ca2fa8ee	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7093024b-cf56-4783-b973-b72573ed7f2b	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-93-A4JQ	49	false	United States	-17951	NA	5930ec0e-f54f-5692-bc0c-d9b6c98bd3e6	not hispanic or latino	male	white	TCGA-93-A4JQ_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	a6acbb57-30e9-4e7c-9dff-13260df14dc1	false	NA	NA	NA	Left	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-93-A4JQ_diagnosis2	NA	Head, face or neck, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-A4JQ_treatment3	NA	NA	NA	NA	989b2b3b-9000-45d7-b877-f8693ff36b55	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7099597a-b208-45b5-b9e0-11ab40d5e497	Informed Consent	92	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3917	33	false	United States	-12179	NA	61b35222-2521-55c8-8ae7-178a77294bfb	not hispanic or latino	female	white	TCGA-44-3917_demographic	Alive	12179	M0	N0	Stage IB	T2	6th	primary	0	1183.0	81de2dc7-ddb4-5b5d-a9ae-29b6eae69f57	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3917_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3917_treatment	NA	NA	NA	NA	2d3f1c59-2c61-5925-b370-268871ebab4c	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7099597a-b208-45b5-b9e0-11ab40d5e497	Informed Consent	92	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3917	33	false	United States	-12179	NA	61b35222-2521-55c8-8ae7-178a77294bfb	not hispanic or latino	female	white	TCGA-44-3917_demographic	Alive	12179	M0	N0	Stage IB	T2	6th	primary	0	1183.0	81de2dc7-ddb4-5b5d-a9ae-29b6eae69f57	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3917_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3917_treatment2	NA	NA	NA	NA	3ca82ab7-ac2c-458a-9f13-4be1e649715e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	722d6818-f1cb-49f4-b68a-fd0a31304681	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4402	56	false	Germany	-20819	244	45355a25-5ae9-51ff-a828-e312a0bef1d0	not reported	female	not reported	TCGA-05-4402_demographic	Dead	20819	M1	NX	Stage IV	T2	6th	primary	0	244.0	60eca695-2f82-5e6e-bbe1-54fe4c42cb09	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R2	Lung, NOS	NA	TCGA-05-4402_diagnosis	No	Lower lobe, lung	NA	2007	No	NA	91	30	NA	NA	NA	NA	NA	NA	TCGA-05-4402_treatment2	Vinorelbine	NA	NA	NA	6590d81f-9e4e-4b7d-9042-c5d589aee970	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	722d6818-f1cb-49f4-b68a-fd0a31304681	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4402	56	false	Germany	-20819	244	45355a25-5ae9-51ff-a828-e312a0bef1d0	not reported	female	not reported	TCGA-05-4402_demographic	Dead	20819	M1	NX	Stage IV	T2	6th	primary	0	244.0	60eca695-2f82-5e6e-bbe1-54fe4c42cb09	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R2	Lung, NOS	NA	TCGA-05-4402_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4402_treatment4	NA	NA	NA	NA	925d4e3e-aa2a-42b0-b1f4-fad3272ddaa5	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	722d6818-f1cb-49f4-b68a-fd0a31304681	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4402	56	false	Germany	-20819	244	45355a25-5ae9-51ff-a828-e312a0bef1d0	not reported	female	not reported	TCGA-05-4402_demographic	Dead	20819	M1	NX	Stage IV	T2	6th	primary	0	244.0	60eca695-2f82-5e6e-bbe1-54fe4c42cb09	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R2	Lung, NOS	NA	TCGA-05-4402_diagnosis	No	Lower lobe, lung	NA	2007	No	NA	91	30	NA	NA	NA	NA	NA	NA	TCGA-05-4402_treatment	Carboplatin	NA	NA	NA	9c8209cb-6199-5c90-aadf-26fdcb844339	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	722d6818-f1cb-49f4-b68a-fd0a31304681	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4402	56	false	Germany	-20819	244	45355a25-5ae9-51ff-a828-e312a0bef1d0	not reported	female	not reported	TCGA-05-4402_demographic	Dead	20819	M1	NX	Stage IV	T2	6th	primary	0	244.0	60eca695-2f82-5e6e-bbe1-54fe4c42cb09	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R2	Lung, NOS	NA	TCGA-05-4402_diagnosis	No	Lower lobe, lung	NA	2007	No	NA	122	122	NA	NA	NA	NA	NA	NA	TCGA-05-4402_treatment3	Erlotinib	NA	NA	NA	cdfec112-1fb9-42a1-bbfe-fe45ede24f25	NA	yes	Complete Response	Immunotherapy (Including Vaccines)
TCGA-LUAD	722d6818-f1cb-49f4-b68a-fd0a31304681	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4402	56	false	Germany	-20819	244	45355a25-5ae9-51ff-a828-e312a0bef1d0	not reported	female	not reported	TCGA-05-4402_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	b28d9c87-90b5-4ee3-a079-49c96dac2691	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4402_diagnosis2	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4402_treatment6	NA	NA	NA	NA	17892230-323b-4418-8b8b-c07e0a421410	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	722d6818-f1cb-49f4-b68a-fd0a31304681	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4402	56	false	Germany	-20819	244	45355a25-5ae9-51ff-a828-e312a0bef1d0	not reported	female	not reported	TCGA-05-4402_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	b28d9c87-90b5-4ee3-a079-49c96dac2691	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4402_diagnosis2	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4402_treatment5	NA	NA	NA	NA	5928470d-2ef7-4de4-b13d-9655aa5fd9db	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	733087d2-98ed-4ac7-8b48-98f0fe1c4c0f	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z034	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	742e0e32-25b5-4d41-8bf5-364b571cfd93	Informed Consent	-15	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-8394	65	false	Germany	-23758	139	5d23259c-a9f2-59d6-9ff1-41437ff520e2	not hispanic or latino	female	white	TCGA-62-8394_demographic	Dead	23758	M0	N2	Stage IIIB	T4	6th	primary	0	139.0	cb7f9046-46c7-57ad-8a17-634cfcb56f80	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-8394_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8394_treatment3	NA	NA	NA	NA	3c296110-d8d5-40e3-98d9-59b6b7719612	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	742e0e32-25b5-4d41-8bf5-364b571cfd93	Informed Consent	-15	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-8394	65	false	Germany	-23758	139	5d23259c-a9f2-59d6-9ff1-41437ff520e2	not hispanic or latino	female	white	TCGA-62-8394_demographic	Dead	23758	M0	N2	Stage IIIB	T4	6th	primary	0	139.0	cb7f9046-46c7-57ad-8a17-634cfcb56f80	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-8394_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	124	54	NA	NA	NA	NA	NA	NA	TCGA-62-8394_treatment2	Gemcitabine	NA	NA	NA	89f511a2-d6d2-4f9c-9b61-bdd6945e9a7f	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	742e0e32-25b5-4d41-8bf5-364b571cfd93	Informed Consent	-15	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-8394	65	false	Germany	-23758	139	5d23259c-a9f2-59d6-9ff1-41437ff520e2	not hispanic or latino	female	white	TCGA-62-8394_demographic	Dead	23758	M0	N2	Stage IIIB	T4	6th	primary	0	139.0	cb7f9046-46c7-57ad-8a17-634cfcb56f80	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-8394_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	124	54	NA	NA	NA	NA	NA	NA	TCGA-62-8394_treatment	Carboplatin	NA	NA	NA	cffe3805-8977-5045-aff3-2b83439afcc0	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	75589307-f141-4d0d-b35d-adbbc77b3dec	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8204	87	false	United States	-31818	NA	118e4b61-8cac-52e6-8d08-66bcacc5a0f4	not hispanic or latino	female	white	TCGA-55-8204_demographic	Alive	31818	MX	N0	Stage IB	T2a	7th	primary	0	515.0	76a0306b-af08-5cdc-863a-622dc095d7ee	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-8204_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8204_treatment	NA	NA	NA	NA	b5d140f5-82d0-50d8-b77d-6ed86930645d	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	75589307-f141-4d0d-b35d-adbbc77b3dec	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8204	87	false	United States	-31818	NA	118e4b61-8cac-52e6-8d08-66bcacc5a0f4	not hispanic or latino	female	white	TCGA-55-8204_demographic	Alive	31818	MX	N0	Stage IB	T2a	7th	primary	0	515.0	76a0306b-af08-5cdc-863a-622dc095d7ee	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-8204_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8204_treatment2	NA	NA	NA	NA	c371d76a-2527-4011-b883-d1374194c410	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	75589307-f141-4d0d-b35d-adbbc77b3dec	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8204	87	false	United States	-31818	NA	118e4b61-8cac-52e6-8d08-66bcacc5a0f4	not hispanic or latino	female	white	TCGA-55-8204_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ccd68eb9-c15d-4009-ba45-e6cfec9d5c76	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-8204_diagnosis2	NA	Skin of lower limb and hip	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8204_treatment5	NA	Skin	NA	NA	784d845a-9bf1-4e4d-96ce-655932528829	NA	yes	NA	Surgery, NOS
TCGA-LUAD	75589307-f141-4d0d-b35d-adbbc77b3dec	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8204	87	false	United States	-31818	NA	118e4b61-8cac-52e6-8d08-66bcacc5a0f4	not hispanic or latino	female	white	TCGA-55-8204_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ccd68eb9-c15d-4009-ba45-e6cfec9d5c76	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-8204_diagnosis2	NA	Skin of lower limb and hip	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8204_treatment3	NA	NA	NA	NA	86aec5f6-1524-4810-8d6f-bbf1c021c4f4	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	75589307-f141-4d0d-b35d-adbbc77b3dec	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8204	87	false	United States	-31818	NA	118e4b61-8cac-52e6-8d08-66bcacc5a0f4	not hispanic or latino	female	white	TCGA-55-8204_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ccd68eb9-c15d-4009-ba45-e6cfec9d5c76	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-8204_diagnosis2	NA	Skin of lower limb and hip	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8204_treatment4	NA	NA	NA	NA	d295e6f9-0ae3-471a-bf7b-8d30c41f136e	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	75a0bb0b-6528-4fb8-a9e6-254905d21df4	Informed Consent	41	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MN-A4N1	60	false	United States	-21939	NA	ae552d53-287a-545d-b13c-81d9863f90dc	not hispanic or latino	male	black or african american	TCGA-MN-A4N1_demographic	Alive	19175	MX	N0	Stage II	T2	6th	Prior primary	-2764	NA	c5180f54-ab97-4d23-8bbc-0275f3550c7b	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MN-A4N1_diagnosis2	NA	Mouth, NOS	NA	NA	NA	NA	NA	-2668	NA	NA	NA	NA	NA	NA	TCGA-MN-A4N1_treatment4	NA	Locoregional Site	NA	NA	28d38095-96c5-4d54-b8d0-e175fd356e3e	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	75a0bb0b-6528-4fb8-a9e6-254905d21df4	Informed Consent	41	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MN-A4N1	60	false	United States	-21939	NA	ae552d53-287a-545d-b13c-81d9863f90dc	not hispanic or latino	male	black or african american	TCGA-MN-A4N1_demographic	Alive	19175	MX	N0	Stage II	T2	6th	Prior primary	-2764	NA	c5180f54-ab97-4d23-8bbc-0275f3550c7b	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MN-A4N1_diagnosis2	NA	Mouth, NOS	NA	NA	NA	NA	NA	-2729	NA	NA	NA	NA	NA	NA	TCGA-MN-A4N1_treatment5	NA	Floor of Mouth|Tongue	NA	NA	b3eabc24-25a2-438d-bf20-ae3b7851026c	NA	yes	NA	Surgery, NOS
TCGA-LUAD	75a0bb0b-6528-4fb8-a9e6-254905d21df4	Informed Consent	41	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MN-A4N1	60	false	United States	-21939	NA	ae552d53-287a-545d-b13c-81d9863f90dc	not hispanic or latino	male	black or african american	TCGA-MN-A4N1_demographic	Alive	19175	MX	N0	Stage II	T2	6th	Prior primary	-2764	NA	c5180f54-ab97-4d23-8bbc-0275f3550c7b	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MN-A4N1_diagnosis2	NA	Mouth, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MN-A4N1_treatment3	NA	NA	NA	NA	b4c07074-528a-46b9-90f2-62442ac5e497	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	75a0bb0b-6528-4fb8-a9e6-254905d21df4	Informed Consent	41	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MN-A4N1	60	false	United States	-21939	NA	ae552d53-287a-545d-b13c-81d9863f90dc	not hispanic or latino	male	black or african american	TCGA-MN-A4N1_demographic	Alive	21939	M0	N1	Stage IIA	T2a	7th	primary	0	827.0	d70eeda5-8288-53c4-b82d-9df1d4f005b2	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-MN-A4N1_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MN-A4N1_treatment	NA	NA	NA	NA	1d14f01e-dbeb-56e5-9aa2-5ffed512d799	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	75a0bb0b-6528-4fb8-a9e6-254905d21df4	Informed Consent	41	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MN-A4N1	60	false	United States	-21939	NA	ae552d53-287a-545d-b13c-81d9863f90dc	not hispanic or latino	male	black or african american	TCGA-MN-A4N1_demographic	Alive	21939	M0	N1	Stage IIA	T2a	7th	primary	0	827.0	d70eeda5-8288-53c4-b82d-9df1d4f005b2	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-MN-A4N1_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MN-A4N1_treatment2	NA	NA	NA	NA	6e5a90dc-52f0-42a5-8e35-21d02dc06b71	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	75dd635e-8e0c-4c0b-b21c-20f77770218d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5942	67	false	United States	-24781	NA	5571a03f-dfe7-5bc3-bff8-cdbeda1fc077	not hispanic or latino	female	white	TCGA-50-5942_demographic	Alive	26159	NA	NA	NA	NA	NA	recurrence	1378	NA	338fdb88-b64b-498a-b389-4a33c0a4343e	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5942_diagnosis2	NA	Not Reported	TCGA-50-5942_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5942_treatment4	NA	NA	NA	NA	35506643-dbe1-40e4-b22f-1269a00af975	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	75dd635e-8e0c-4c0b-b21c-20f77770218d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5942	67	false	United States	-24781	NA	5571a03f-dfe7-5bc3-bff8-cdbeda1fc077	not hispanic or latino	female	white	TCGA-50-5942_demographic	Alive	26159	NA	NA	NA	NA	NA	recurrence	1378	NA	338fdb88-b64b-498a-b389-4a33c0a4343e	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5942_diagnosis2	NA	Not Reported	TCGA-50-5942_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5942_treatment5	NA	NA	NA	NA	5300aa13-c4c9-4c2a-9252-7aea0374726f	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	75dd635e-8e0c-4c0b-b21c-20f77770218d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5942	67	false	United States	-24781	NA	5571a03f-dfe7-5bc3-bff8-cdbeda1fc077	not hispanic or latino	female	white	TCGA-50-5942_demographic	Alive	24781	M0	N0	Stage IA	T1	7th	primary	0	1847.0	841e3378-7fc1-582a-8e10-b32da1fa4cf7	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-5942_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5942_treatment3	NA	NA	NA	NA	185f5f98-fbc5-463e-931f-8b5ac719889f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	75dd635e-8e0c-4c0b-b21c-20f77770218d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5942	67	false	United States	-24781	NA	5571a03f-dfe7-5bc3-bff8-cdbeda1fc077	not hispanic or latino	female	white	TCGA-50-5942_demographic	Alive	24781	M0	N0	Stage IA	T1	7th	primary	0	1847.0	841e3378-7fc1-582a-8e10-b32da1fa4cf7	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-5942_diagnosis	No	Upper lobe, lung	NA	2009	NA	1.0	53	53	NA	NA	NA	NA	NA	NA	TCGA-50-5942_treatment	NA	Primary Tumor Field	NA	NA	32f4986b-8384-5ae3-ac83-0cf8f4051c03	Adjuvant	yes	NA	Radiation, Implants
TCGA-LUAD	75dd635e-8e0c-4c0b-b21c-20f77770218d	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5942	67	false	United States	-24781	NA	5571a03f-dfe7-5bc3-bff8-cdbeda1fc077	not hispanic or latino	female	white	TCGA-50-5942_demographic	Alive	24781	M0	N0	Stage IA	T1	7th	primary	0	1847.0	841e3378-7fc1-582a-8e10-b32da1fa4cf7	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-5942_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	1641	1641	NA	NA	NA	NA	NA	NA	TCGA-50-5942_treatment2	NA	Locoregional Site	NA	NA	e9289821-52fc-4a11-80b6-1fd29eb31177	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	762dea8a-5b41-4058-979a-b7876ed13d7e	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4395	76	false	Germany	-27971	0	11bc9cf2-76a1-5b47-ab46-934311e2e919	not reported	male	not reported	TCGA-05-4395_demographic	Dead	27971	M0	N2	Stage IIIB	T4	5th	primary	0	0.0	0d0b1a99-d024-57fb-8517-de831d09934c	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4395_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	765ad5a5-134b-4680-a6d4-1dd113dc47cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AAR4	51	false	United States	-18939	879	730745eb-bc2e-5a07-bb0a-a9dfb6e847b3	not hispanic or latino	male	black or african american	TCGA-49-AAR4_demographic	Dead	18939	MX	N2	Stage IIIA	T2	6th	primary	0	879.0	74ed8003-731a-5cf0-8539-93a7ccb9b7be	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AAR4_diagnosis	No	Upper lobe, lung	NA	2006	No	NA	61	57	NA	NA	NA	NA	NA	NA	TCGA-49-AAR4_treatment3	Carboplatin	NA	NA	NA	9496f664-c232-485d-840a-91d8d28244a7	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	765ad5a5-134b-4680-a6d4-1dd113dc47cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AAR4	51	false	United States	-18939	879	730745eb-bc2e-5a07-bb0a-a9dfb6e847b3	not hispanic or latino	male	black or african american	TCGA-49-AAR4_demographic	Dead	18939	MX	N2	Stage IIIA	T2	6th	primary	0	879.0	74ed8003-731a-5cf0-8539-93a7ccb9b7be	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AAR4_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	153	118	NA	NA	NA	NA	NA	NA	TCGA-49-AAR4_treatment	NA	Primary Tumor Field	NA	NA	9e298d03-e2ff-5336-ac9b-8922e61a03cb	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	765ad5a5-134b-4680-a6d4-1dd113dc47cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AAR4	51	false	United States	-18939	879	730745eb-bc2e-5a07-bb0a-a9dfb6e847b3	not hispanic or latino	male	black or african american	TCGA-49-AAR4_demographic	Dead	18939	MX	N2	Stage IIIA	T2	6th	primary	0	879.0	74ed8003-731a-5cf0-8539-93a7ccb9b7be	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AAR4_diagnosis	No	Upper lobe, lung	NA	2006	No	NA	61	57	NA	NA	NA	NA	NA	NA	TCGA-49-AAR4_treatment2	Paclitaxel	NA	NA	NA	aad83f1f-4769-4cc5-9c69-237bf45f851b	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	772324a5-5513-454d-ad6b-605798f69b73	Informed Consent	49	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8619	72	false	United States	-26616	NA	fff7adcb-b16b-5d8a-82be-6643e3ed7844	not hispanic or latino	female	white	TCGA-55-8619_demographic	Alive	26616	MX	N0	Stage IIB	T3	7th	primary	0	416.0	36efb06f-5000-5265-910f-67f1b3070d81	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	yes	No	R0	Lung, NOS	NA	TCGA-55-8619_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8619_treatment2	NA	NA	NA	NA	6eccf765-3ff9-4429-bbfa-3f5a22d42d4f	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	772324a5-5513-454d-ad6b-605798f69b73	Informed Consent	49	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8619	72	false	United States	-26616	NA	fff7adcb-b16b-5d8a-82be-6643e3ed7844	not hispanic or latino	female	white	TCGA-55-8619_demographic	Alive	26616	MX	N0	Stage IIB	T3	7th	primary	0	416.0	36efb06f-5000-5265-910f-67f1b3070d81	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	yes	No	R0	Lung, NOS	NA	TCGA-55-8619_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8619_treatment	NA	NA	NA	NA	dfe25492-1ab3-5307-9ed3-e46ff4d4c5f9	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	772324a5-5513-454d-ad6b-605798f69b73	Informed Consent	49	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8619	72	false	United States	-26616	NA	fff7adcb-b16b-5d8a-82be-6643e3ed7844	not hispanic or latino	female	white	TCGA-55-8619_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	400047f0-0140-43cf-a006-adbca8ee8f5c	false	NA	NA	NA	Left	8720/3	Melanoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8619_diagnosis2	NA	Upper limb, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8619_treatment4	NA	NA	NA	NA	12f2d783-f3cc-4155-804d-de1b6af06fe6	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	772324a5-5513-454d-ad6b-605798f69b73	Informed Consent	49	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8619	72	false	United States	-26616	NA	fff7adcb-b16b-5d8a-82be-6643e3ed7844	not hispanic or latino	female	white	TCGA-55-8619_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	400047f0-0140-43cf-a006-adbca8ee8f5c	false	NA	NA	NA	Left	8720/3	Melanoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8619_diagnosis2	NA	Upper limb, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8619_treatment3	NA	NA	NA	NA	b4ee7bb7-cf34-4d90-842a-aecb402ecddb	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	772324a5-5513-454d-ad6b-605798f69b73	Informed Consent	49	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8619	72	false	United States	-26616	NA	fff7adcb-b16b-5d8a-82be-6643e3ed7844	not hispanic or latino	female	white	TCGA-55-8619_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	400047f0-0140-43cf-a006-adbca8ee8f5c	false	NA	NA	NA	Left	8720/3	Melanoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8619_diagnosis2	NA	Upper limb, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8619_treatment5	NA	Not Reported	NA	NA	d9bbbec3-7299-4eb6-b57d-4498229e69d0	NA	yes	NA	Surgery, NOS
TCGA-LUAD	772324a5-5513-454d-ad6b-605798f69b73	Informed Consent	49	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8619	72	false	United States	-26616	NA	fff7adcb-b16b-5d8a-82be-6643e3ed7844	not hispanic or latino	female	white	TCGA-55-8619_demographic	Alive	26664	MX	N0	Stage IB	T2a	7th	Synchronous primary	48	NA	d179f4fd-3a87-4098-b7df-8716cae36055	false	NA	NA	NA	Right	8480/3	Mucinous adenocarcinoma	NA	NA	NA	Not Reported	NA	TCGA-55-8619_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8619_treatment6	NA	NA	NA	NA	32ce62f3-1cfb-44e9-9827-9fe209e4c656	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	772324a5-5513-454d-ad6b-605798f69b73	Informed Consent	49	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8619	72	false	United States	-26616	NA	fff7adcb-b16b-5d8a-82be-6643e3ed7844	not hispanic or latino	female	white	TCGA-55-8619_demographic	Alive	26664	MX	N0	Stage IB	T2a	7th	Synchronous primary	48	NA	d179f4fd-3a87-4098-b7df-8716cae36055	false	NA	NA	NA	Right	8480/3	Mucinous adenocarcinoma	NA	NA	NA	Not Reported	NA	TCGA-55-8619_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8619_treatment7	NA	NA	NA	NA	91284fd8-882d-43e9-80a1-0e395e5143c8	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	772324a5-5513-454d-ad6b-605798f69b73	Informed Consent	49	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8619	72	false	United States	-26616	NA	fff7adcb-b16b-5d8a-82be-6643e3ed7844	not hispanic or latino	female	white	TCGA-55-8619_demographic	Alive	26664	MX	N0	Stage IB	T2a	7th	Synchronous primary	48	NA	d179f4fd-3a87-4098-b7df-8716cae36055	false	NA	NA	NA	Right	8480/3	Mucinous adenocarcinoma	NA	NA	NA	Not Reported	NA	TCGA-55-8619_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	48	NA	NA	NA	NA	NA	NA	TCGA-55-8619_treatment8	NA	Lung	NA	NA	ceb806a6-61b7-4acc-895c-92df1580977a	NA	yes	NA	Surgery, NOS
TCGA-LUAD	77828a90-8e2a-4664-b674-d837e6e34fe4	Informed Consent	40	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-69-7761	84	false	United States	-31041	NA	7c2b0c0d-b6cc-5f43-b3c0-c314c5283065	not hispanic or latino	male	white	TCGA-69-7761_demographic	Alive	31041	MX	N0	Stage IB	T2a	7th	primary	0	186.0	9ff1cd3e-a85d-52a3-a14d-69ded8fcae1d	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7761_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	147	84	NA	4	NA	NA	NA	Intravenous	TCGA-69-7761_treatment	Pemetrexed Disodium	NA	NA	NA	54241e2c-64c0-585d-b7eb-ccf22382eff2	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	77828a90-8e2a-4664-b674-d837e6e34fe4	Informed Consent	40	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-69-7761	84	false	United States	-31041	NA	7c2b0c0d-b6cc-5f43-b3c0-c314c5283065	not hispanic or latino	male	white	TCGA-69-7761_demographic	Alive	31041	MX	N0	Stage IB	T2a	7th	primary	0	186.0	9ff1cd3e-a85d-52a3-a14d-69ded8fcae1d	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7761_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7761_treatment3	NA	NA	NA	NA	b9b703c9-8a2b-458c-bcf4-4c31b4ff88fc	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	77828a90-8e2a-4664-b674-d837e6e34fe4	Informed Consent	40	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-69-7761	84	false	United States	-31041	NA	7c2b0c0d-b6cc-5f43-b3c0-c314c5283065	not hispanic or latino	male	white	TCGA-69-7761_demographic	Alive	31041	MX	N0	Stage IB	T2a	7th	primary	0	186.0	9ff1cd3e-a85d-52a3-a14d-69ded8fcae1d	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7761_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	147	84	NA	4	NA	NA	NA	Intravenous	TCGA-69-7761_treatment2	Carboplatin	NA	NA	NA	c09ee8c3-2a61-4097-be8c-7b22ce577f2f	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	7782ceaa-da49-4232-8b3f-534971adaad8	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7499	81	false	United States	-29683	1531	01c817e6-1181-589f-97df-0cfdb06180be	not hispanic or latino	female	white	TCGA-73-7499_demographic	Dead	29683	M0	N0	Stage IB	T2a	7th	primary	0	1531.0	210bc386-fe08-5281-828d-f09756e0e765	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-7499_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-7499_treatment2	NA	NA	NA	NA	976c203c-cf4f-4326-92f7-7ece0181ffc0	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7782ceaa-da49-4232-8b3f-534971adaad8	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7499	81	false	United States	-29683	1531	01c817e6-1181-589f-97df-0cfdb06180be	not hispanic or latino	female	white	TCGA-73-7499_demographic	Dead	29683	M0	N0	Stage IB	T2a	7th	primary	0	1531.0	210bc386-fe08-5281-828d-f09756e0e765	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-7499_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-7499_treatment	NA	NA	NA	NA	b3d98ac6-dfc0-5219-9278-33c9fb6438c2	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7782ceaa-da49-4232-8b3f-534971adaad8	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7499	81	false	United States	-29683	1531	01c817e6-1181-589f-97df-0cfdb06180be	not hispanic or latino	female	white	TCGA-73-7499_demographic	Dead	31130	NA	NA	NA	NA	NA	metastasis	1447	NA	740c3133-26f8-430b-9aa1-00c5a697fd39	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-73-7499_diagnosis2	NA	Not Reported	TCGA-73-7499_diagnosis	NA	NA	NA	NA	1451	NA	NA	NA	NA	NA	NA	TCGA-73-7499_treatment5	NA	Distant Site	NA	NA	78eabbe5-0f71-4114-b376-6a08f481de6b	NA	yes	NA	Surgery, NOS
TCGA-LUAD	7782ceaa-da49-4232-8b3f-534971adaad8	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7499	81	false	United States	-29683	1531	01c817e6-1181-589f-97df-0cfdb06180be	not hispanic or latino	female	white	TCGA-73-7499_demographic	Dead	31130	NA	NA	NA	NA	NA	metastasis	1447	NA	740c3133-26f8-430b-9aa1-00c5a697fd39	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-73-7499_diagnosis2	NA	Not Reported	TCGA-73-7499_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-73-7499_treatment4	NA	NA	NA	NA	bb774611-872a-4437-bb62-cfec9a81fbeb	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7782ceaa-da49-4232-8b3f-534971adaad8	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7499	81	false	United States	-29683	1531	01c817e6-1181-589f-97df-0cfdb06180be	not hispanic or latino	female	white	TCGA-73-7499_demographic	Dead	31130	NA	NA	NA	NA	NA	metastasis	1447	NA	740c3133-26f8-430b-9aa1-00c5a697fd39	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-73-7499_diagnosis2	NA	Not Reported	TCGA-73-7499_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-73-7499_treatment3	NA	NA	NA	NA	c40ed3f1-f34d-4fff-bb90-92633e25eeb1	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	77bb204d-4e68-4c93-905f-9ef4c53b1ce2	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z059	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	77c4dbb2-eceb-4e0d-bcde-63dc817d5f35	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7903	64	false	United States	-23509	NA	1dff7864-7427-5412-98b1-1a24aeff6067	not hispanic or latino	male	white	TCGA-55-7903_demographic	Alive	23509	MX	N0	Stage IA	T1b	7th	primary	0	567.0	5e41971f-b23b-501c-9dca-ec978959c0d4	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7903_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7903_treatment2	NA	NA	NA	NA	462eb422-e759-4541-995b-05b8b4a0f8eb	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	77c4dbb2-eceb-4e0d-bcde-63dc817d5f35	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7903	64	false	United States	-23509	NA	1dff7864-7427-5412-98b1-1a24aeff6067	not hispanic or latino	male	white	TCGA-55-7903_demographic	Alive	23509	MX	N0	Stage IA	T1b	7th	primary	0	567.0	5e41971f-b23b-501c-9dca-ec978959c0d4	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7903_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7903_treatment	NA	NA	NA	NA	85652344-0161-577f-b917-c88235c5b0c2	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	77f8c850-b4e6-46a1-ab12-a50e0044a0c8	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-55-8208	73	false	United States	-26716	NA	e82790e2-ccdf-5d67-bfe3-971be629bd99	not hispanic or latino	female	white	TCGA-55-8208_demographic	Alive	26716	M0	N0	Stage IA	T1b	7th	primary	0	674.0	359759ce-2abe-52dd-8b33-6b328cf7eae2	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-8208_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8208_treatment	NA	NA	NA	NA	13d58739-2bf4-58ae-ad2f-9e2190f0629b	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	77f8c850-b4e6-46a1-ab12-a50e0044a0c8	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-55-8208	73	false	United States	-26716	NA	e82790e2-ccdf-5d67-bfe3-971be629bd99	not hispanic or latino	female	white	TCGA-55-8208_demographic	Alive	26716	M0	N0	Stage IA	T1b	7th	primary	0	674.0	359759ce-2abe-52dd-8b33-6b328cf7eae2	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-8208_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8208_treatment2	NA	NA	NA	NA	829e8174-afa8-4527-ba4c-e36736c5b93c	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	77f8c850-b4e6-46a1-ab12-a50e0044a0c8	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-55-8208	73	false	United States	-26716	NA	e82790e2-ccdf-5d67-bfe3-971be629bd99	not hispanic or latino	female	white	TCGA-55-8208_demographic	Alive	27227	NA	NA	NA	NA	NA	metastasis	511	NA	db30e818-b0d4-4903-948d-aab8d16fb7bf	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8208_diagnosis2	NA	Not Reported	TCGA-55-8208_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8208_treatment3	NA	NA	NA	NA	867d84d2-bc1d-48d1-962c-7485aef12c48	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	77f8c850-b4e6-46a1-ab12-a50e0044a0c8	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-55-8208	73	false	United States	-26716	NA	e82790e2-ccdf-5d67-bfe3-971be629bd99	not hispanic or latino	female	white	TCGA-55-8208_demographic	Alive	27227	NA	NA	NA	NA	NA	metastasis	511	NA	db30e818-b0d4-4903-948d-aab8d16fb7bf	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8208_diagnosis2	NA	Not Reported	TCGA-55-8208_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8208_treatment4	NA	NA	NA	NA	8c59841f-a125-4b98-8b59-1eded053c684	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	77f8c850-b4e6-46a1-ab12-a50e0044a0c8	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-55-8208	73	false	United States	-26716	NA	e82790e2-ccdf-5d67-bfe3-971be629bd99	not hispanic or latino	female	white	TCGA-55-8208_demographic	Alive	27227	NA	NA	NA	NA	NA	metastasis	511	NA	db30e818-b0d4-4903-948d-aab8d16fb7bf	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8208_diagnosis2	NA	Not Reported	TCGA-55-8208_diagnosis	NA	NA	NA	NA	536	NA	NA	NA	NA	NA	NA	TCGA-55-8208_treatment5	NA	Distant Site	NA	NA	b66f80e5-7ebd-4493-aebf-24ec4e411ec5	NA	yes	NA	Surgery, NOS
TCGA-LUAD	781f40c9-c099-4c96-8269-ebe2a449c93d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8660	69	false	Australia	-25422	321	469d2eb8-0c1a-5c86-87dd-f7c00d30ddfb	not reported	male	not reported	TCGA-78-8660_demographic	Dead	25664	NA	NA	NA	NA	NA	metastasis	242	NA	a9f69db1-1f9e-4e63-a682-5f8e3de31d36	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-78-8660_diagnosis2	NA	Not Reported	TCGA-78-8660_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-78-8660_treatment6	NA	NA	NA	NA	086193c1-699a-409b-a0ae-19b53f15d352	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	781f40c9-c099-4c96-8269-ebe2a449c93d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8660	69	false	Australia	-25422	321	469d2eb8-0c1a-5c86-87dd-f7c00d30ddfb	not reported	male	not reported	TCGA-78-8660_demographic	Dead	25664	NA	NA	NA	NA	NA	metastasis	242	NA	a9f69db1-1f9e-4e63-a682-5f8e3de31d36	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-78-8660_diagnosis2	NA	Not Reported	TCGA-78-8660_diagnosis	NA	NA	NA	NA	260	NA	NA	NA	NA	NA	NA	TCGA-78-8660_treatment7	NA	Distant Site	NA	NA	0ae48844-0b67-445b-a7a3-17f8f3b6f777	NA	yes	NA	Surgery, NOS
TCGA-LUAD	781f40c9-c099-4c96-8269-ebe2a449c93d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8660	69	false	Australia	-25422	321	469d2eb8-0c1a-5c86-87dd-f7c00d30ddfb	not reported	male	not reported	TCGA-78-8660_demographic	Dead	25664	NA	NA	NA	NA	NA	metastasis	242	NA	a9f69db1-1f9e-4e63-a682-5f8e3de31d36	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-78-8660_diagnosis2	NA	Not Reported	TCGA-78-8660_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-78-8660_treatment5	NA	NA	NA	NA	0d196d2f-99d9-4b94-b7df-f9c54ee60f8c	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	781f40c9-c099-4c96-8269-ebe2a449c93d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8660	69	false	Australia	-25422	321	469d2eb8-0c1a-5c86-87dd-f7c00d30ddfb	not reported	male	not reported	TCGA-78-8660_demographic	Dead	25422	M0	N1	Stage IIB	T2	6th	primary	0	321.0	b8da40af-b10c-56d7-8dd5-941a106bd179	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-8660_diagnosis	No	Lower lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8660_treatment2	NA	NA	NA	NA	6bdf372a-24bc-40a7-a06e-5e37b681dc7f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	781f40c9-c099-4c96-8269-ebe2a449c93d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8660	69	false	Australia	-25422	321	469d2eb8-0c1a-5c86-87dd-f7c00d30ddfb	not reported	male	not reported	TCGA-78-8660_demographic	Dead	25422	M0	N1	Stage IIB	T2	6th	primary	0	321.0	b8da40af-b10c-56d7-8dd5-941a106bd179	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-8660_diagnosis	No	Lower lobe, lung	NA	2005	NA	NA	97	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8660_treatment	NA	Primary Tumor Field	NA	NA	d4db6971-5524-5696-b6ec-465ddfb2d708	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	781f40c9-c099-4c96-8269-ebe2a449c93d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8660	69	false	Australia	-25422	321	469d2eb8-0c1a-5c86-87dd-f7c00d30ddfb	not reported	male	not reported	TCGA-78-8660_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	feb79dd0-45da-4241-8bf5-78bd7fe8be2f	false	NA	NA	NA	Right	8720/3	Malignant melanoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-78-8660_diagnosis3	NA	Upper limb, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8660_treatment3	NA	NA	NA	NA	2aa13306-168f-47cf-9836-0a447d3cdd5a	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	781f40c9-c099-4c96-8269-ebe2a449c93d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-8660	69	false	Australia	-25422	321	469d2eb8-0c1a-5c86-87dd-f7c00d30ddfb	not reported	male	not reported	TCGA-78-8660_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	feb79dd0-45da-4241-8bf5-78bd7fe8be2f	false	NA	NA	NA	Right	8720/3	Malignant melanoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-78-8660_diagnosis3	NA	Upper limb, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8660_treatment4	NA	NA	NA	NA	fa198548-6761-4e93-be7e-c2eef0c91ef0	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	78a24c56-576c-4245-bb42-6603b3d19897	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4427	65	false	Germany	-23893	NA	f3f5cae2-f37f-5348-9e5e-ce1a595dcc7e	not reported	female	not reported	TCGA-05-4427_demographic	Alive	23893	M0	N1	Stage IIB	T2	6th	primary	0	791.0	26f6e290-47ca-59b2-a7cf-d61e52f4a6e3	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-05-4427_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	122	61	NA	NA	NA	NA	NA	NA	TCGA-05-4427_treatment2	Vinorelbine	NA	NA	NA	438863be-ce70-431d-94dd-0a20567f576b	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	78a24c56-576c-4245-bb42-6603b3d19897	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4427	65	false	Germany	-23893	NA	f3f5cae2-f37f-5348-9e5e-ce1a595dcc7e	not reported	female	not reported	TCGA-05-4427_demographic	Alive	23893	M0	N1	Stage IIB	T2	6th	primary	0	791.0	26f6e290-47ca-59b2-a7cf-d61e52f4a6e3	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-05-4427_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4427_treatment3	NA	NA	NA	NA	8870a19d-3ae5-4094-a6c5-834fe8f54749	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	78a24c56-576c-4245-bb42-6603b3d19897	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4427	65	false	Germany	-23893	NA	f3f5cae2-f37f-5348-9e5e-ce1a595dcc7e	not reported	female	not reported	TCGA-05-4427_demographic	Alive	23893	M0	N1	Stage IIB	T2	6th	primary	0	791.0	26f6e290-47ca-59b2-a7cf-d61e52f4a6e3	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-05-4427_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	122	61	NA	NA	NA	NA	NA	NA	TCGA-05-4427_treatment	Cisplatin	NA	NA	NA	f77afdc9-d3d0-532a-b8e7-a60079ddbec2	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	78a24c56-576c-4245-bb42-6603b3d19897	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4427	65	false	Germany	-23893	NA	f3f5cae2-f37f-5348-9e5e-ce1a595dcc7e	not reported	female	not reported	TCGA-05-4427_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	6c184f5e-e90f-481e-abf8-29ebed846e8b	false	NA	NA	NA	NA	8720/3	Malignant melanoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-05-4427_diagnosis2	NA	Skin, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4427_treatment5	NA	NA	NA	NA	0194b700-91b5-417c-b5f2-8c87a943210d	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	78a24c56-576c-4245-bb42-6603b3d19897	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4427	65	false	Germany	-23893	NA	f3f5cae2-f37f-5348-9e5e-ce1a595dcc7e	not reported	female	not reported	TCGA-05-4427_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	6c184f5e-e90f-481e-abf8-29ebed846e8b	false	NA	NA	NA	NA	8720/3	Malignant melanoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-05-4427_diagnosis2	NA	Skin, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4427_treatment4	NA	NA	NA	NA	7441593d-f368-4fe3-b971-c0ee9f31356a	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	78ae716b-0ca5-4c01-a053-d41288385fcd	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-5122	NA	false	Canada	NA	NA	2ce0bb26-cba2-5918-94a6-ec802d33a348	not reported	male	not reported	TCGA-75-5122_demographic	Dead	NA	M0	N0	Stage IB	T2	NA	primary	NA	NA	9cd9aff0-18d3-5668-9df8-382fa3abc2ef	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-5122_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5122_treatment2	NA	NA	NA	NA	b019fb76-4dbc-43a9-95e2-ad9464da6d13	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	78ae716b-0ca5-4c01-a053-d41288385fcd	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-5122	NA	false	Canada	NA	NA	2ce0bb26-cba2-5918-94a6-ec802d33a348	not reported	male	not reported	TCGA-75-5122_demographic	Dead	NA	M0	N0	Stage IB	T2	NA	primary	NA	NA	9cd9aff0-18d3-5668-9df8-382fa3abc2ef	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-5122_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5122_treatment	NA	NA	NA	NA	d8995bc7-bfbe-54e6-aff8-c881935fd3a6	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	78ae716b-0ca5-4c01-a053-d41288385fcd	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-5122	NA	false	Canada	NA	NA	2ce0bb26-cba2-5918-94a6-ec802d33a348	not reported	male	not reported	TCGA-75-5122_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	fe797cf7-f6db-4f7d-a6d7-c984aa6154c0	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-5122_diagnosis2	NA	Not Reported	TCGA-75-5122_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5122_treatment5	NA	Distant Site	NA	NA	20549dcf-2e1f-425f-83a3-8e19e354193e	NA	no	NA	Surgery, NOS
TCGA-LUAD	78ae716b-0ca5-4c01-a053-d41288385fcd	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-5122	NA	false	Canada	NA	NA	2ce0bb26-cba2-5918-94a6-ec802d33a348	not reported	male	not reported	TCGA-75-5122_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	fe797cf7-f6db-4f7d-a6d7-c984aa6154c0	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-5122_diagnosis2	NA	Not Reported	TCGA-75-5122_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-75-5122_treatment4	NA	NA	NA	NA	282ccf01-44a1-4b5f-b09d-f3adb258c03f	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	78ae716b-0ca5-4c01-a053-d41288385fcd	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-5122	NA	false	Canada	NA	NA	2ce0bb26-cba2-5918-94a6-ec802d33a348	not reported	male	not reported	TCGA-75-5122_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	fe797cf7-f6db-4f7d-a6d7-c984aa6154c0	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-5122_diagnosis2	NA	Not Reported	TCGA-75-5122_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-75-5122_treatment3	NA	NA	NA	NA	63ee2661-348e-4254-b482-ded20c933909	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	793649e5-f479-4d64-8723-2ef488fe0fd9	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A46U	71	false	Germany	-25998	NA	5faa44d0-66b8-54ba-8f17-d7c130257df4	not hispanic or latino	female	white	TCGA-62-A46U_demographic	Alive	25998	M0	N1	Stage IIB	T2	6th	primary	0	2067.0	1951f39f-56b0-5f0d-b33b-474d12023894	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A46U_diagnosis	No	Lower lobe, lung	NA	2007	No	NA	161	71	NA	NA	NA	NA	NA	NA	TCGA-62-A46U_treatment2	Vinorelbine Tartrate	NA	NA	NA	4cb0b247-0845-4e7d-b9a5-512637c03de8	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	793649e5-f479-4d64-8723-2ef488fe0fd9	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A46U	71	false	Germany	-25998	NA	5faa44d0-66b8-54ba-8f17-d7c130257df4	not hispanic or latino	female	white	TCGA-62-A46U_demographic	Alive	25998	M0	N1	Stage IIB	T2	6th	primary	0	2067.0	1951f39f-56b0-5f0d-b33b-474d12023894	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A46U_diagnosis	No	Lower lobe, lung	NA	2007	No	NA	161	71	NA	NA	NA	NA	NA	NA	TCGA-62-A46U_treatment	Carboplatin	NA	NA	NA	c230d895-9aa7-5a9a-82fc-e8663614325a	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	793649e5-f479-4d64-8723-2ef488fe0fd9	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A46U	71	false	Germany	-25998	NA	5faa44d0-66b8-54ba-8f17-d7c130257df4	not hispanic or latino	female	white	TCGA-62-A46U_demographic	Alive	25998	M0	N1	Stage IIB	T2	6th	primary	0	2067.0	1951f39f-56b0-5f0d-b33b-474d12023894	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A46U_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46U_treatment3	NA	NA	NA	NA	f50bbe07-a15a-4da3-a6c9-6d2c19b4d5c2	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	79684460-f74c-4954-80fa-b418827bf2ef	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z057	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	7a0ea814-f0de-4bc4-a81a-daa000559369	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5933	72	false	United States	-26377	2393	665672bd-7f0f-5a4e-8969-e5f43861d39a	not hispanic or latino	male	white	TCGA-50-5933_demographic	Dead	26377	M0	N2	Stage IIIB	T4	5th	primary	0	2393.0	7e6fd4a9-b2ed-5db3-b684-8cf065483351	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	Central Lung	TCGA-50-5933_diagnosis	No	Lower lobe, lung	NA	2001	NA	1.0	215	171	NA	NA	30.0	NA	NA	NA	TCGA-50-5933_treatment	NA	Primary Tumor Field	5400	cGy	32d35992-52d0-50ee-baf8-b367bca71b60	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	7a0ea814-f0de-4bc4-a81a-daa000559369	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5933	72	false	United States	-26377	2393	665672bd-7f0f-5a4e-8969-e5f43861d39a	not hispanic or latino	male	white	TCGA-50-5933_demographic	Dead	26377	M0	N2	Stage IIIB	T4	5th	primary	0	2393.0	7e6fd4a9-b2ed-5db3-b684-8cf065483351	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	Central Lung	TCGA-50-5933_diagnosis	No	Lower lobe, lung	NA	2001	No	NA	210	189	NA	NA	NA	NA	NA	NA	TCGA-50-5933_treatment2	Carboplatin	NA	NA	NA	8960f8a9-c05e-4a15-b3f3-7dbe5c4ccf46	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	7a0ea814-f0de-4bc4-a81a-daa000559369	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5933	72	false	United States	-26377	2393	665672bd-7f0f-5a4e-8969-e5f43861d39a	not hispanic or latino	male	white	TCGA-50-5933_demographic	Dead	26377	M0	N2	Stage IIIB	T4	5th	primary	0	2393.0	7e6fd4a9-b2ed-5db3-b684-8cf065483351	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	Central Lung	TCGA-50-5933_diagnosis	No	Lower lobe, lung	NA	2001	No	NA	210	189	NA	NA	NA	NA	NA	NA	TCGA-50-5933_treatment3	Paclitaxel	NA	NA	NA	e62a3e5a-f0d1-4aa9-bd0a-58199df5969b	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	7a111b4f-46e9-4e34-8024-0b9fdc5cbcd8	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TH	70	false	United States	-25759	NA	cda074ca-aa64-5b06-ad68-128f82fa832b	not hispanic or latino	female	white	TCGA-MP-A4TH_demographic	Alive	25759	M0	N0	Stage IA	T1a	7th	primary	0	741.0	99555f51-9e00-502c-a421-9975c42dc878	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-MP-A4TH_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TH_treatment	NA	NA	NA	NA	20313812-37cd-531a-b5da-72237941673d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7a111b4f-46e9-4e34-8024-0b9fdc5cbcd8	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TH	70	false	United States	-25759	NA	cda074ca-aa64-5b06-ad68-128f82fa832b	not hispanic or latino	female	white	TCGA-MP-A4TH_demographic	Alive	25759	M0	N0	Stage IA	T1a	7th	primary	0	741.0	99555f51-9e00-502c-a421-9975c42dc878	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-MP-A4TH_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TH_treatment2	NA	NA	NA	NA	a472e960-ace3-4715-bab3-ffd791b22d2a	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7b0622ab-63ea-483f-ae40-d3ea587bdbba	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7156	62	false	Australia	-22720	976	6bf0bb30-7521-5c0d-9e33-52a4da2f7ab7	not reported	male	white	TCGA-78-7156_demographic	Dead	22720	M1	N1	Stage IV	T4	6th	primary	0	976.0	97664a21-64b8-5b98-b584-69cd01992ec2	true	NA	NA	C34.9	NA	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7156_diagnosis	No	Lung, NOS	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7156_treatment2	NA	NA	NA	NA	398269f5-8593-4307-b554-8c55f0c08d76	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7b0622ab-63ea-483f-ae40-d3ea587bdbba	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7156	62	false	Australia	-22720	976	6bf0bb30-7521-5c0d-9e33-52a4da2f7ab7	not reported	male	white	TCGA-78-7156_demographic	Dead	22720	M1	N1	Stage IV	T4	6th	primary	0	976.0	97664a21-64b8-5b98-b584-69cd01992ec2	true	NA	NA	C34.9	NA	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7156_diagnosis	No	Lung, NOS	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7156_treatment	NA	NA	NA	NA	fc4321b6-66f1-543c-8340-340a9ad8b50d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7b89166e-c5b8-481b-aa70-495141499b91	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8669	64	false	Russia	-23443	NA	ac985419-9a98-599a-9706-17c2c366624d	not hispanic or latino	male	white	TCGA-86-8669_demographic	Alive	23443	M0	N0	Stage IA	T1b	7th	primary	0	938.0	6dc5a6df-5a69-5282-91c4-11354be110e8	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8669_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	938	854	NA	NA	NA	NA	NA	NA	TCGA-86-8669_treatment	Cisplatin	NA	NA	NA	80727cb2-0bcd-5b34-bc3a-e424402047b5	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	7b89166e-c5b8-481b-aa70-495141499b91	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8669	64	false	Russia	-23443	NA	ac985419-9a98-599a-9706-17c2c366624d	not hispanic or latino	male	white	TCGA-86-8669_demographic	Alive	23443	M0	N0	Stage IA	T1b	7th	primary	0	938.0	6dc5a6df-5a69-5282-91c4-11354be110e8	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8669_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8669_treatment3	NA	NA	NA	NA	e2fd0060-fe92-4a99-ab17-83f7dfd47e4a	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	7b89166e-c5b8-481b-aa70-495141499b91	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8669	64	false	Russia	-23443	NA	ac985419-9a98-599a-9706-17c2c366624d	not hispanic or latino	male	white	TCGA-86-8669_demographic	Alive	23443	M0	N0	Stage IA	T1b	7th	primary	0	938.0	6dc5a6df-5a69-5282-91c4-11354be110e8	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8669_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	938	854	NA	NA	NA	NA	NA	NA	TCGA-86-8669_treatment2	Etoposide	NA	NA	NA	ea57696d-6451-4129-990f-c3fd46b64931	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	7b89166e-c5b8-481b-aa70-495141499b91	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8669	64	false	Russia	-23443	NA	ac985419-9a98-599a-9706-17c2c366624d	not hispanic or latino	male	white	TCGA-86-8669_demographic	Alive	24292	NA	NA	NA	NA	NA	metastasis	849	NA	943b60e5-4d2c-48a1-8f7c-9dc19a53bb99	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-8669_diagnosis2	NA	Not Reported	TCGA-86-8669_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-86-8669_treatment4	NA	NA	NA	NA	467d069b-59a1-4fec-b00f-91750538159c	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7b89166e-c5b8-481b-aa70-495141499b91	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8669	64	false	Russia	-23443	NA	ac985419-9a98-599a-9706-17c2c366624d	not hispanic or latino	male	white	TCGA-86-8669_demographic	Alive	24292	NA	NA	NA	NA	NA	metastasis	849	NA	943b60e5-4d2c-48a1-8f7c-9dc19a53bb99	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-8669_diagnosis2	NA	Not Reported	TCGA-86-8669_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-86-8669_treatment5	NA	NA	NA	NA	6b1fbdd0-dc9a-42a4-a91e-a43734619321	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7b89166e-c5b8-481b-aa70-495141499b91	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8669	64	false	Russia	-23443	NA	ac985419-9a98-599a-9706-17c2c366624d	not hispanic or latino	male	white	TCGA-86-8669_demographic	Alive	24292	NA	NA	NA	NA	NA	metastasis	849	NA	943b60e5-4d2c-48a1-8f7c-9dc19a53bb99	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-8669_diagnosis2	NA	Not Reported	TCGA-86-8669_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8669_treatment6	NA	Distant Site	NA	NA	9dd61e5a-b969-497b-971e-f8ad2413d5eb	NA	no	NA	Surgery, NOS
TCGA-LUAD	7b9479ff-23d6-4689-91f0-02efc94300f9	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47A	78	false	United States	-28782	NA	1cfac920-ddcd-55d4-9733-de8966f8d2a0	not hispanic or latino	female	white	TCGA-44-A47A_demographic	Alive	28782	MX	N0	Stage IB	T2a	7th	primary	0	466.0	027dc0f9-67eb-5ece-800b-e9061b2fe096	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-A47A_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47A_treatment2	NA	NA	NA	NA	aa9bbebd-4623-4248-93e3-606ce9ddac32	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7b9479ff-23d6-4689-91f0-02efc94300f9	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47A	78	false	United States	-28782	NA	1cfac920-ddcd-55d4-9733-de8966f8d2a0	not hispanic or latino	female	white	TCGA-44-A47A_demographic	Alive	28782	MX	N0	Stage IB	T2a	7th	primary	0	466.0	027dc0f9-67eb-5ece-800b-e9061b2fe096	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-A47A_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47A_treatment	NA	NA	NA	NA	fab975a4-81a9-5548-8d89-80bff562b649	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7b9479ff-23d6-4689-91f0-02efc94300f9	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47A	78	false	United States	-28782	NA	1cfac920-ddcd-55d4-9733-de8966f8d2a0	not hispanic or latino	female	white	TCGA-44-A47A_demographic	Alive	29182	NA	NA	NA	NA	NA	recurrence	400	NA	6bc739f0-ce63-4f2d-ab83-7b105dc4a6a9	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-A47A_diagnosis2	NA	Not Reported	TCGA-44-A47A_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47A_treatment5	NA	Locoregional Site	NA	NA	1df77ce9-456c-40ce-baad-56cbcd185ead	NA	no	NA	Surgery, NOS
TCGA-LUAD	7b9479ff-23d6-4689-91f0-02efc94300f9	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47A	78	false	United States	-28782	NA	1cfac920-ddcd-55d4-9733-de8966f8d2a0	not hispanic or latino	female	white	TCGA-44-A47A_demographic	Alive	29182	NA	NA	NA	NA	NA	recurrence	400	NA	6bc739f0-ce63-4f2d-ab83-7b105dc4a6a9	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-A47A_diagnosis2	NA	Not Reported	TCGA-44-A47A_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-A47A_treatment4	NA	NA	NA	NA	4271c28d-98a2-49a3-9729-d3edaf327bc5	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7b9479ff-23d6-4689-91f0-02efc94300f9	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47A	78	false	United States	-28782	NA	1cfac920-ddcd-55d4-9733-de8966f8d2a0	not hispanic or latino	female	white	TCGA-44-A47A_demographic	Alive	29182	NA	NA	NA	NA	NA	recurrence	400	NA	6bc739f0-ce63-4f2d-ab83-7b105dc4a6a9	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-A47A_diagnosis2	NA	Not Reported	TCGA-44-A47A_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47A_treatment6	NA	Distant Site	NA	NA	5d7ac2dc-1045-4915-87d8-119e6d98186e	NA	no	NA	Surgery, NOS
TCGA-LUAD	7b9479ff-23d6-4689-91f0-02efc94300f9	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47A	78	false	United States	-28782	NA	1cfac920-ddcd-55d4-9733-de8966f8d2a0	not hispanic or latino	female	white	TCGA-44-A47A_demographic	Alive	29182	NA	NA	NA	NA	NA	recurrence	400	NA	6bc739f0-ce63-4f2d-ab83-7b105dc4a6a9	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-A47A_diagnosis2	NA	Not Reported	TCGA-44-A47A_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-A47A_treatment3	NA	NA	NA	NA	a73ade67-3312-4728-8943-d89b9fcd3b8e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7b9479ff-23d6-4689-91f0-02efc94300f9	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47A	78	false	United States	-28782	NA	1cfac920-ddcd-55d4-9733-de8966f8d2a0	not hispanic or latino	female	white	TCGA-44-A47A_demographic	Alive	29179	NA	NA	NA	NA	NA	metastasis	397	NA	d6e03525-87c9-4dfb-8d8f-ee98c923140a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-A47A_diagnosis3	NA	Not Reported	TCGA-44-A47A_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-44-A47A_treatment8	NA	NA	NA	NA	09a4016f-5506-430c-bcca-ca945f631062	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	7b9479ff-23d6-4689-91f0-02efc94300f9	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47A	78	false	United States	-28782	NA	1cfac920-ddcd-55d4-9733-de8966f8d2a0	not hispanic or latino	female	white	TCGA-44-A47A_demographic	Alive	29179	NA	NA	NA	NA	NA	metastasis	397	NA	d6e03525-87c9-4dfb-8d8f-ee98c923140a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-A47A_diagnosis3	NA	Not Reported	TCGA-44-A47A_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47A_treatment9	NA	Locoregional Site	NA	NA	14f11493-c78a-4590-9d3f-9655a629d328	NA	no	NA	Surgery, NOS
TCGA-LUAD	7b9479ff-23d6-4689-91f0-02efc94300f9	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47A	78	false	United States	-28782	NA	1cfac920-ddcd-55d4-9733-de8966f8d2a0	not hispanic or latino	female	white	TCGA-44-A47A_demographic	Alive	29179	NA	NA	NA	NA	NA	metastasis	397	NA	d6e03525-87c9-4dfb-8d8f-ee98c923140a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-A47A_diagnosis3	NA	Not Reported	TCGA-44-A47A_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-44-A47A_treatment7	NA	NA	NA	NA	2d8e466f-ad40-4f44-9c5b-14a668ba52e4	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7b9479ff-23d6-4689-91f0-02efc94300f9	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47A	78	false	United States	-28782	NA	1cfac920-ddcd-55d4-9733-de8966f8d2a0	not hispanic or latino	female	white	TCGA-44-A47A_demographic	Alive	29179	NA	NA	NA	NA	NA	metastasis	397	NA	d6e03525-87c9-4dfb-8d8f-ee98c923140a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-A47A_diagnosis3	NA	Not Reported	TCGA-44-A47A_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47A_treatment10	NA	Distant Site	NA	NA	7fb80a2b-39b7-42c5-af2a-5f30d535ffef	NA	no	NA	Surgery, NOS
TCGA-LUAD	7be86a90-6da8-4c01-8a7a-bc5cfef9894f	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7539	75	false	Australia	-27445	NA	9fe97a10-6ea6-5b0e-9dd9-626a278d5b06	not reported	female	white	TCGA-78-7539_demographic	Alive	28133	NA	NA	NA	NA	NA	metastasis	688	NA	29d00728-1078-47e1-af03-9e3ff1f7b3ce	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-78-7539_diagnosis2	NA	Not Reported	TCGA-78-7539_diagnosis	NA	NA	NA	NA	688	NA	NA	NA	NA	NA	NA	TCGA-78-7539_treatment8	NA	Distant Site	NA	NA	0735f0e6-4837-4d11-8b5f-f308a6b7c3a0	NA	yes	NA	Surgery, NOS
TCGA-LUAD	7be86a90-6da8-4c01-8a7a-bc5cfef9894f	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7539	75	false	Australia	-27445	NA	9fe97a10-6ea6-5b0e-9dd9-626a278d5b06	not reported	female	white	TCGA-78-7539_demographic	Alive	28133	NA	NA	NA	NA	NA	metastasis	688	NA	29d00728-1078-47e1-af03-9e3ff1f7b3ce	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-78-7539_diagnosis2	NA	Not Reported	TCGA-78-7539_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-78-7539_treatment7	NA	NA	NA	NA	903667d5-5b3a-476e-89ee-bd0b86d40227	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	7be86a90-6da8-4c01-8a7a-bc5cfef9894f	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7539	75	false	Australia	-27445	NA	9fe97a10-6ea6-5b0e-9dd9-626a278d5b06	not reported	female	white	TCGA-78-7539_demographic	Alive	28133	NA	NA	NA	NA	NA	metastasis	688	NA	29d00728-1078-47e1-af03-9e3ff1f7b3ce	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-78-7539_diagnosis2	NA	Not Reported	TCGA-78-7539_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-78-7539_treatment6	NA	NA	NA	NA	b3e0de30-26a8-496a-a391-bdc832da227c	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7be86a90-6da8-4c01-8a7a-bc5cfef9894f	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7539	75	false	Australia	-27445	NA	9fe97a10-6ea6-5b0e-9dd9-626a278d5b06	not reported	female	white	TCGA-78-7539_demographic	Alive	27445	M0	N0	Stage IIA	T2b	7th	primary	0	791.0	9808f1e0-5269-5a65-bfe0-9de2354f2bf1	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-78-7539_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	133	70	NA	4	NA	284.0	mg	Intravenous	TCGA-78-7539_treatment4	Carboplatin	NA	1167	mg	0cb0d7b9-810a-4eed-8d40-b8eda3ce26b2	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	7be86a90-6da8-4c01-8a7a-bc5cfef9894f	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7539	75	false	Australia	-27445	NA	9fe97a10-6ea6-5b0e-9dd9-626a278d5b06	not reported	female	white	TCGA-78-7539_demographic	Alive	27445	M0	N0	Stage IIA	T2b	7th	primary	0	791.0	9808f1e0-5269-5a65-bfe0-9de2354f2bf1	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-78-7539_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	49	36	NA	1	NA	37.5	mg	Intravenous	TCGA-78-7539_treatment3	Vinorelbine	NA	113	mg	1ad1c024-ffb0-4ec4-bf38-165221e8d50e	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	7be86a90-6da8-4c01-8a7a-bc5cfef9894f	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7539	75	false	Australia	-27445	NA	9fe97a10-6ea6-5b0e-9dd9-626a278d5b06	not reported	female	white	TCGA-78-7539_demographic	Alive	27445	M0	N0	Stage IIA	T2b	7th	primary	0	791.0	9808f1e0-5269-5a65-bfe0-9de2354f2bf1	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-78-7539_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	133	70	NA	4	NA	262.0	mg	Intravenous	TCGA-78-7539_treatment2	Paclitaxel	NA	1048	mg	84cc1a25-f647-40d8-97af-3d21ed8cab60	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	7be86a90-6da8-4c01-8a7a-bc5cfef9894f	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7539	75	false	Australia	-27445	NA	9fe97a10-6ea6-5b0e-9dd9-626a278d5b06	not reported	female	white	TCGA-78-7539_demographic	Alive	27445	M0	N0	Stage IIA	T2b	7th	primary	0	791.0	9808f1e0-5269-5a65-bfe0-9de2354f2bf1	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-78-7539_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7539_treatment5	NA	NA	NA	NA	cfb2959d-6d50-46fe-a18d-31f49b9ce04b	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7be86a90-6da8-4c01-8a7a-bc5cfef9894f	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7539	75	false	Australia	-27445	NA	9fe97a10-6ea6-5b0e-9dd9-626a278d5b06	not reported	female	white	TCGA-78-7539_demographic	Alive	27445	M0	N0	Stage IIA	T2b	7th	primary	0	791.0	9808f1e0-5269-5a65-bfe0-9de2354f2bf1	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-78-7539_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	42	36	NA	1	NA	75.0	mg	Intravenous	TCGA-78-7539_treatment	Cisplatin	NA	150	mg	e18966a0-851b-5dd3-a639-3c79739a5eec	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	7c4ed533-ee66-48be-a84b-ff8607742818	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T8	68	false	United States	-25069	161	ee219a6a-618a-533a-b5c7-a114ad9100f3	Unknown	male	Unknown	TCGA-MP-A4T8_demographic	Dead	25069	M0	N2	Stage IIIA	T2	6th	primary	0	161.0	6bc9bea6-7892-5078-9c40-913621448bcd	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-MP-A4T8_diagnosis	No	Upper lobe, lung	NA	2006	No	NA	72	42	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T8_treatment	Vinorelbine Tartrate	NA	NA	NA	5ee7f886-a763-58ef-a94f-c34d3586a6f2	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	7c4ed533-ee66-48be-a84b-ff8607742818	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T8	68	false	United States	-25069	161	ee219a6a-618a-533a-b5c7-a114ad9100f3	Unknown	male	Unknown	TCGA-MP-A4T8_demographic	Dead	25069	M0	N2	Stage IIIA	T2	6th	primary	0	161.0	6bc9bea6-7892-5078-9c40-913621448bcd	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-MP-A4T8_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T8_treatment3	NA	NA	NA	NA	ba1b17f1-1bc4-45ac-8ff7-e9aa0f7bce75	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7c4ed533-ee66-48be-a84b-ff8607742818	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T8	68	false	United States	-25069	161	ee219a6a-618a-533a-b5c7-a114ad9100f3	Unknown	male	Unknown	TCGA-MP-A4T8_demographic	Dead	25069	M0	N2	Stage IIIA	T2	6th	primary	0	161.0	6bc9bea6-7892-5078-9c40-913621448bcd	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-MP-A4T8_diagnosis	No	Upper lobe, lung	NA	2006	No	NA	72	42	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T8_treatment2	Cisplatin	NA	NA	NA	cf0bc0f9-47d6-440f-8b17-ffbacef48450	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	7c4ed533-ee66-48be-a84b-ff8607742818	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T8	68	false	United States	-25069	161	ee219a6a-618a-533a-b5c7-a114ad9100f3	Unknown	male	Unknown	TCGA-MP-A4T8_demographic	Dead	24943	NA	NA	NA	NA	NA	Synchronous primary	-126	NA	cedfe789-2599-49ef-a8a0-9ad6d37ae936	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MP-A4T8_diagnosis3	NA	Prostate gland	NA	NA	NA	NA	NA	-50	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T8_treatment8	NA	Locoregional Site	NA	NA	1a610a68-0325-4b45-81d2-58baa7e6bed6	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	7c4ed533-ee66-48be-a84b-ff8607742818	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T8	68	false	United States	-25069	161	ee219a6a-618a-533a-b5c7-a114ad9100f3	Unknown	male	Unknown	TCGA-MP-A4T8_demographic	Dead	24943	NA	NA	NA	NA	NA	Synchronous primary	-126	NA	cedfe789-2599-49ef-a8a0-9ad6d37ae936	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MP-A4T8_diagnosis3	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T8_treatment7	NA	NA	NA	NA	2659fb4c-0c29-4a9e-af6d-1a17ca34cf67	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7c4ed533-ee66-48be-a84b-ff8607742818	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T8	68	false	United States	-25069	161	ee219a6a-618a-533a-b5c7-a114ad9100f3	Unknown	male	Unknown	TCGA-MP-A4T8_demographic	Dead	24943	NA	NA	NA	NA	NA	Synchronous primary	-126	NA	cedfe789-2599-49ef-a8a0-9ad6d37ae936	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MP-A4T8_diagnosis3	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T8_treatment9	NA	NA	NA	NA	8393b631-d657-4b0a-9776-bb6872d54b36	NA	no	NA	Surgery, NOS
TCGA-LUAD	7c4ed533-ee66-48be-a84b-ff8607742818	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T8	68	false	United States	-25069	161	ee219a6a-618a-533a-b5c7-a114ad9100f3	Unknown	male	Unknown	TCGA-MP-A4T8_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	f602766d-dbad-4989-8dde-fc6a33fb8f33	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-MP-A4T8_diagnosis2	NA	Rectum, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T8_treatment4	NA	NA	NA	NA	359bcf8f-1778-4554-b9e1-79475bbb6ec2	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7c4ed533-ee66-48be-a84b-ff8607742818	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T8	68	false	United States	-25069	161	ee219a6a-618a-533a-b5c7-a114ad9100f3	Unknown	male	Unknown	TCGA-MP-A4T8_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	f602766d-dbad-4989-8dde-fc6a33fb8f33	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-MP-A4T8_diagnosis2	NA	Rectum, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T8_treatment6	NA	Colon	NA	NA	e1ef00e5-a915-4be0-bea6-7a27e927a24c	NA	yes	NA	Surgery, NOS
TCGA-LUAD	7c4ed533-ee66-48be-a84b-ff8607742818	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4T8	68	false	United States	-25069	161	ee219a6a-618a-533a-b5c7-a114ad9100f3	Unknown	male	Unknown	TCGA-MP-A4T8_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	f602766d-dbad-4989-8dde-fc6a33fb8f33	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-MP-A4T8_diagnosis2	NA	Rectum, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T8_treatment5	NA	NA	NA	NA	fb0d09e3-d5d6-4a7a-be34-80f04f3239d6	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7c7d777b-bf00-4c24-97fc-922580d5605f	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-NJ-A55R	67	false	United States	-24738	NA	c52c986f-e6fc-55f7-b030-9d171f0c0841	not hispanic or latino	male	white	TCGA-NJ-A55R_demographic	Alive	24738	MX	N0	Stage IA	T1b	7th	primary	0	603.0	7bb70138-52ef-5255-9b2f-45f920605127	true	NA	NA	C34.1	Left	8230/3	Solid carcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-NJ-A55R_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A55R_treatment	NA	NA	NA	NA	5e6c9810-6fc5-58d8-b32c-c780f124ab07	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7c7d777b-bf00-4c24-97fc-922580d5605f	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-NJ-A55R	67	false	United States	-24738	NA	c52c986f-e6fc-55f7-b030-9d171f0c0841	not hispanic or latino	male	white	TCGA-NJ-A55R_demographic	Alive	24738	MX	N0	Stage IA	T1b	7th	primary	0	603.0	7bb70138-52ef-5255-9b2f-45f920605127	true	NA	NA	C34.1	Left	8230/3	Solid carcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-NJ-A55R_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A55R_treatment2	NA	NA	NA	NA	e96d50b5-f3a8-4276-9f09-7de051271790	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7ca711ec-9ac0-4fa7-8a60-32ae84b8789a	Informed Consent	93	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-53-A4EZ	63	false	United States	-23201	NA	87ea7db2-7ccf-57be-8d20-fd442627d5a3	hispanic or latino	male	white	TCGA-53-A4EZ_demographic	Alive	23201	MX	N1	Stage IIA	T2a	7th	primary	0	1071.0	5739ed3b-ccef-56f1-87ef-94d81b78c7b2	true	NA	NA	C34.1	Left	8550/3	Acinar cell carcinoma	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-53-A4EZ_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	428	NA	NA	NA	30.0	NA	NA	NA	TCGA-53-A4EZ_treatment	NA	Primary Tumor Field	2	Gy	2ed7aef8-9d9a-51dd-a6bf-ce72e058378c	NA	yes	NA	Radiation, Systemic
TCGA-LUAD	7ca711ec-9ac0-4fa7-8a60-32ae84b8789a	Informed Consent	93	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-53-A4EZ	63	false	United States	-23201	NA	87ea7db2-7ccf-57be-8d20-fd442627d5a3	hispanic or latino	male	white	TCGA-53-A4EZ_demographic	Alive	23201	MX	N1	Stage IIA	T2a	7th	primary	0	1071.0	5739ed3b-ccef-56f1-87ef-94d81b78c7b2	true	NA	NA	C34.1	Left	8550/3	Acinar cell carcinoma	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-53-A4EZ_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	226	132	NA	NA	NA	NA	NA	NA	TCGA-53-A4EZ_treatment3	Vinorelbine Tartrate	NA	NA	NA	61366ba7-3021-4338-a16e-73242cfd010f	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	7ca711ec-9ac0-4fa7-8a60-32ae84b8789a	Informed Consent	93	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-53-A4EZ	63	false	United States	-23201	NA	87ea7db2-7ccf-57be-8d20-fd442627d5a3	hispanic or latino	male	white	TCGA-53-A4EZ_demographic	Alive	23201	MX	N1	Stage IIA	T2a	7th	primary	0	1071.0	5739ed3b-ccef-56f1-87ef-94d81b78c7b2	true	NA	NA	C34.1	Left	8550/3	Acinar cell carcinoma	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-53-A4EZ_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	226	132	NA	NA	NA	NA	NA	NA	TCGA-53-A4EZ_treatment2	Cisplatin	NA	NA	NA	f27c00be-234c-43d7-9065-6d86de25d1e0	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	7cce924f-12a1-4895-9866-5d4b1869dde6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6970	67	false	United States	-24773	464	c4c98913-18ac-596a-a7e9-815a1dd40354	not reported	female	white	TCGA-55-6970_demographic	Dead	24773	MX	N2	Stage IIIA	T2	6th	primary	0	464.0	24fc9ab8-9159-51a7-8ec5-afe69fcafc53	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-6970_diagnosis	No	Upper lobe, lung	NA	2004	No	NA	183	162	NA	NA	NA	NA	NA	NA	TCGA-55-6970_treatment4	Docetaxel	NA	NA	NA	6468896a-d884-4d2d-ad5a-aa934039de0a	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	7cce924f-12a1-4895-9866-5d4b1869dde6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6970	67	false	United States	-24773	464	c4c98913-18ac-596a-a7e9-815a1dd40354	not reported	female	white	TCGA-55-6970_demographic	Dead	24773	MX	N2	Stage IIIA	T2	6th	primary	0	464.0	24fc9ab8-9159-51a7-8ec5-afe69fcafc53	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-6970_diagnosis	No	Upper lobe, lung	NA	2004	No	NA	117	89	NA	NA	NA	NA	NA	NA	TCGA-55-6970_treatment2	Cisplatin	NA	NA	NA	750c711b-f9ab-485c-a9fc-993d332e0c75	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	7cce924f-12a1-4895-9866-5d4b1869dde6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6970	67	false	United States	-24773	464	c4c98913-18ac-596a-a7e9-815a1dd40354	not reported	female	white	TCGA-55-6970_demographic	Dead	24773	MX	N2	Stage IIIA	T2	6th	primary	0	464.0	24fc9ab8-9159-51a7-8ec5-afe69fcafc53	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-6970_diagnosis	No	Upper lobe, lung	NA	2004	NA	NA	124	90	NA	NA	NA	NA	NA	NA	TCGA-55-6970_treatment	NA	Primary Tumor Field	NA	NA	d0c96f01-3351-55e7-a13d-e483ea91f498	NA	yes	Stable Disease	Radiation, External Beam
TCGA-LUAD	7cce924f-12a1-4895-9866-5d4b1869dde6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6970	67	false	United States	-24773	464	c4c98913-18ac-596a-a7e9-815a1dd40354	not reported	female	white	TCGA-55-6970_demographic	Dead	24773	MX	N2	Stage IIIA	T2	6th	primary	0	464.0	24fc9ab8-9159-51a7-8ec5-afe69fcafc53	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-6970_diagnosis	No	Upper lobe, lung	NA	2004	No	NA	117	89	NA	NA	NA	NA	NA	NA	TCGA-55-6970_treatment3	Etoposide	NA	NA	NA	f0c36d70-ef29-4f7b-8a31-9424706bf280	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	7cce924f-12a1-4895-9866-5d4b1869dde6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6970	67	false	United States	-24773	464	c4c98913-18ac-596a-a7e9-815a1dd40354	not reported	female	white	TCGA-55-6970_demographic	Dead	25230	NA	NA	NA	NA	NA	recurrence	457	NA	4df0f3ca-ba19-418a-83b5-70dfe439ed56	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-6970_diagnosis2	NA	Not Reported	TCGA-55-6970_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-6970_treatment6	NA	NA	NA	NA	61f1ffa1-5cf1-4457-a104-6ad505b0cd98	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7cce924f-12a1-4895-9866-5d4b1869dde6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6970	67	false	United States	-24773	464	c4c98913-18ac-596a-a7e9-815a1dd40354	not reported	female	white	TCGA-55-6970_demographic	Dead	25230	NA	NA	NA	NA	NA	recurrence	457	NA	4df0f3ca-ba19-418a-83b5-70dfe439ed56	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-6970_diagnosis2	NA	Not Reported	TCGA-55-6970_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6970_treatment7	NA	Locoregional Site	NA	NA	7e143020-dcfd-47dc-bf0a-63c13a5ad0a5	NA	no	NA	Surgery, NOS
TCGA-LUAD	7cce924f-12a1-4895-9866-5d4b1869dde6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6970	67	false	United States	-24773	464	c4c98913-18ac-596a-a7e9-815a1dd40354	not reported	female	white	TCGA-55-6970_demographic	Dead	25230	NA	NA	NA	NA	NA	recurrence	457	NA	4df0f3ca-ba19-418a-83b5-70dfe439ed56	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-6970_diagnosis2	NA	Not Reported	TCGA-55-6970_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-6970_treatment5	NA	NA	NA	NA	d51a277c-184c-467f-b389-1fd531aea092	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7e7f089c-25f7-4e14-aed5-d741047b9e42	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8359	52	false	Romania	-19088	444	471d2c3d-ae8a-5a05-852d-b8562cf661b0	not hispanic or latino	male	white	TCGA-86-8359_demographic	Dead	19088	M0	N2	Stage IIIA	T3	7th	primary	0	444.0	d5e70eb3-52de-5bb7-bcc4-62e59205fbc6	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8359_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8359_treatment	NA	NA	NA	NA	104d718a-350f-5746-83e4-e3649f64f1bb	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7e7f089c-25f7-4e14-aed5-d741047b9e42	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8359	52	false	Romania	-19088	444	471d2c3d-ae8a-5a05-852d-b8562cf661b0	not hispanic or latino	male	white	TCGA-86-8359_demographic	Dead	19088	M0	N2	Stage IIIA	T3	7th	primary	0	444.0	d5e70eb3-52de-5bb7-bcc4-62e59205fbc6	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8359_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8359_treatment2	NA	NA	NA	NA	a7b46253-c726-40c4-aea1-0b2ed16ada07	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	7e83f9dd-b038-497b-a113-a55605398b7b	Informed Consent	-12	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-99-8032	61	false	United States	-22635	NA	00a54e74-5fb7-51cd-8936-d38e8dde689a	not hispanic or latino	male	white	TCGA-99-8032_demographic	Alive	22635	M0	N0	Stage IA	T1a	7th	primary	0	44.0	f800f9cd-c2bc-5eff-85f3-e8569f42746d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-99-8032_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-99-8032_treatment2	NA	NA	NA	NA	7fe09976-75b9-43fd-8b6e-be8bc20949a3	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7e83f9dd-b038-497b-a113-a55605398b7b	Informed Consent	-12	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-99-8032	61	false	United States	-22635	NA	00a54e74-5fb7-51cd-8936-d38e8dde689a	not hispanic or latino	male	white	TCGA-99-8032_demographic	Alive	22635	M0	N0	Stage IA	T1a	7th	primary	0	44.0	f800f9cd-c2bc-5eff-85f3-e8569f42746d	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-99-8032_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-99-8032_treatment	NA	NA	NA	NA	a67d57a7-9313-5d59-b738-88d0896b122f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7eb540b4-8dd3-4382-a488-e48b1c7213b3	Informed Consent	-24	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-7109	60	false	United States	-21979	308	f08df7bd-9737-5bcf-beb0-c0ee763e373e	not hispanic or latino	male	white	TCGA-50-7109_demographic	Dead	21979	M0	N0	Stage IA	T1	7th	primary	0	308.0	acc4371c-2b87-53d1-9960-7a3695d7dfdf	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-7109_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-7109_treatment	NA	NA	NA	NA	42f10a74-02ae-5cfc-916c-b6b9b3d040a9	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7eb540b4-8dd3-4382-a488-e48b1c7213b3	Informed Consent	-24	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-7109	60	false	United States	-21979	308	f08df7bd-9737-5bcf-beb0-c0ee763e373e	not hispanic or latino	male	white	TCGA-50-7109_demographic	Dead	21979	M0	N0	Stage IA	T1	7th	primary	0	308.0	acc4371c-2b87-53d1-9960-7a3695d7dfdf	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-7109_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-7109_treatment2	NA	NA	NA	NA	5a2ccd68-cba1-4b60-b92c-c1beb439d27c	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7eb540b4-8dd3-4382-a488-e48b1c7213b3	Informed Consent	-24	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-7109	60	false	United States	-21979	308	f08df7bd-9737-5bcf-beb0-c0ee763e373e	not hispanic or latino	male	white	TCGA-50-7109_demographic	Dead	21994	NA	NA	NA	NA	NA	metastasis	15	NA	fb86093c-5f30-4550-961f-e6a4d74be172	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-7109_diagnosis2	NA	Not Reported	TCGA-50-7109_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-7109_treatment3	NA	NA	NA	NA	10c8d51a-82f7-43b1-bf38-065e2eac129e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7eb540b4-8dd3-4382-a488-e48b1c7213b3	Informed Consent	-24	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-7109	60	false	United States	-21979	308	f08df7bd-9737-5bcf-beb0-c0ee763e373e	not hispanic or latino	male	white	TCGA-50-7109_demographic	Dead	21994	NA	NA	NA	NA	NA	metastasis	15	NA	fb86093c-5f30-4550-961f-e6a4d74be172	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-7109_diagnosis2	NA	Not Reported	TCGA-50-7109_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-7109_treatment6	NA	Distant Site	NA	NA	16026828-17d3-4383-b4bb-8c740eeb7a07	NA	no	NA	Surgery, NOS
TCGA-LUAD	7eb540b4-8dd3-4382-a488-e48b1c7213b3	Informed Consent	-24	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-7109	60	false	United States	-21979	308	f08df7bd-9737-5bcf-beb0-c0ee763e373e	not hispanic or latino	male	white	TCGA-50-7109_demographic	Dead	21994	NA	NA	NA	NA	NA	metastasis	15	NA	fb86093c-5f30-4550-961f-e6a4d74be172	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-7109_diagnosis2	NA	Not Reported	TCGA-50-7109_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-7109_treatment5	NA	Locoregional Site	NA	NA	4ecd9e2b-56fd-4b69-852e-5447c55edaa4	NA	no	NA	Surgery, NOS
TCGA-LUAD	7eb540b4-8dd3-4382-a488-e48b1c7213b3	Informed Consent	-24	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-7109	60	false	United States	-21979	308	f08df7bd-9737-5bcf-beb0-c0ee763e373e	not hispanic or latino	male	white	TCGA-50-7109_demographic	Dead	21994	NA	NA	NA	NA	NA	metastasis	15	NA	fb86093c-5f30-4550-961f-e6a4d74be172	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-7109_diagnosis2	NA	Not Reported	TCGA-50-7109_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-7109_treatment4	NA	NA	NA	NA	f5f4126a-6a62-406a-a471-13b8679884e7	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7f6455e8-fa3d-4452-acb2-8c9995073072	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7667	49	false	United States	-18062	NA	e29d7604-eebd-56df-82ef-f477240332c5	not hispanic or latino	female	white	TCGA-44-7667_demographic	Alive	18062	MX	N0	Stage IIB	T3	6th	primary	0	1097.0	8c5f7c86-ca4d-5efe-b188-d733800e8bd2	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7667_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7667_treatment2	NA	NA	NA	NA	01acf9b9-ab4f-4a4e-a9e4-7b0353a9aba4	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7f6455e8-fa3d-4452-acb2-8c9995073072	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7667	49	false	United States	-18062	NA	e29d7604-eebd-56df-82ef-f477240332c5	not hispanic or latino	female	white	TCGA-44-7667_demographic	Alive	18062	MX	N0	Stage IIB	T3	6th	primary	0	1097.0	8c5f7c86-ca4d-5efe-b188-d733800e8bd2	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7667_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7667_treatment	NA	NA	NA	NA	e9a513b8-66e8-5639-a162-02014000242d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	7fd03220-531e-4ef8-beca-e9703e8c0ae1	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-NJ-A4YG	65	false	United States	-23812	NA	5851180c-3b8e-56bf-99e6-4eada9479cf9	not reported	male	white	TCGA-NJ-A4YG_demographic	Alive	23812	M0	N0	Stage IB	T2	6th	primary	0	2261.0	1135b193-cec7-5c5f-b620-f6c2ae0ce484	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-NJ-A4YG_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A4YG_treatment2	NA	NA	NA	NA	916aaa21-d8d5-401b-ad44-e02948cae4da	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	7fd03220-531e-4ef8-beca-e9703e8c0ae1	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-NJ-A4YG	65	false	United States	-23812	NA	5851180c-3b8e-56bf-99e6-4eada9479cf9	not reported	male	white	TCGA-NJ-A4YG_demographic	Alive	23812	M0	N0	Stage IB	T2	6th	primary	0	2261.0	1135b193-cec7-5c5f-b620-f6c2ae0ce484	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-NJ-A4YG_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A4YG_treatment	NA	NA	NA	NA	e52a2607-6b84-56a8-a8a6-9cfa1401375f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	807cc7d2-6e3b-4f2d-9531-0da994eeeada	Informed Consent	23	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8302	54	false	United States	-20011	NA	1c738e49-a19a-5439-9725-79bc8b17a233	not reported	male	white	TCGA-55-8302_demographic	Alive	20011	MX	N0	Stage IB	T2	7th	primary	0	478.0	cffab17b-e16f-52bb-b807-5b86eb8e8f90	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8302_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8302_treatment2	NA	NA	NA	NA	956037ad-09bc-46aa-ac25-8c4cc8d004af	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	807cc7d2-6e3b-4f2d-9531-0da994eeeada	Informed Consent	23	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8302	54	false	United States	-20011	NA	1c738e49-a19a-5439-9725-79bc8b17a233	not reported	male	white	TCGA-55-8302_demographic	Alive	20011	MX	N0	Stage IB	T2	7th	primary	0	478.0	cffab17b-e16f-52bb-b807-5b86eb8e8f90	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8302_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8302_treatment	NA	NA	NA	NA	f35f643d-66de-529d-9d6b-fa7ad21a8295	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	81a0b2ff-a3d3-41bb-9ce6-765e6ae894af	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-1679	58	false	United States	-21310	NA	d9d32430-d1f3-5a27-8c56-afc29a77e26d	not hispanic or latino	female	white	TCGA-64-1679_demographic	Alive	21310	M0	N2	Stage IIIA	T1	6th	primary	0	2488.0	c5e8ddb5-2800-534a-a327-151bcd9ac2cc	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-64-1679_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	139	55	NA	4	NA	1000.0	mg/m2	Intravenous	TCGA-64-1679_treatment2	Gemcitabine	NA	NA	NA	34eb1897-f686-4551-a950-397aa2455c36	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	81a0b2ff-a3d3-41bb-9ce6-765e6ae894af	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-1679	58	false	United States	-21310	NA	d9d32430-d1f3-5a27-8c56-afc29a77e26d	not hispanic or latino	female	white	TCGA-64-1679_demographic	Alive	21310	M0	N2	Stage IIIA	T1	6th	primary	0	2488.0	c5e8ddb5-2800-534a-a327-151bcd9ac2cc	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-64-1679_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-1679_treatment3	NA	NA	NA	NA	3fb264e1-2f35-4040-bc3d-a9e88af81bb4	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	81a0b2ff-a3d3-41bb-9ce6-765e6ae894af	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-1679	58	false	United States	-21310	NA	d9d32430-d1f3-5a27-8c56-afc29a77e26d	not hispanic or latino	female	white	TCGA-64-1679_demographic	Alive	21310	M0	N2	Stage IIIA	T1	6th	primary	0	2488.0	c5e8ddb5-2800-534a-a327-151bcd9ac2cc	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-64-1679_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	139	55	NA	4	NA	75.0	mg/m2	Intravenous	TCGA-64-1679_treatment	Cisplatin	NA	NA	NA	408f814e-26b3-5e8c-b310-62e7f893fc0f	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	81b71cff-da58-47cf-ad00-0a42489a7a0b	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z017	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	26744	NA	NA	NA	NA	NA	not reported	304	NA	139fb5e1-129c-408a-b723-7c9d3a8b7063	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-7271_diagnosis2	NA	Not Reported	TCGA-38-7271_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-7271_treatment10	NA	NA	NA	NA	7339b995-947a-47d0-a123-26f1f9d813f4	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	26744	NA	NA	NA	NA	NA	not reported	304	NA	139fb5e1-129c-408a-b723-7c9d3a8b7063	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-7271_diagnosis2	NA	Not Reported	TCGA-38-7271_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-7271_treatment9	NA	NA	NA	NA	c6b59fe4-ec07-41b9-90ac-66e4ec848ca1	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	26744	NA	NA	NA	NA	NA	not reported	304	NA	139fb5e1-129c-408a-b723-7c9d3a8b7063	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-7271_diagnosis2	NA	Not Reported	TCGA-38-7271_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-7271_treatment11	NA	Locoregional Site	NA	NA	fe047fc2-831f-416a-b61a-e579eacfb062	NA	no	NA	Surgery, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	27073	NA	NA	NA	NA	NA	not reported	633	NA	96ec6f7e-6498-447a-ba57-61e4c84f7398	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-7271_diagnosis4	NA	Not Reported	TCGA-38-7271_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-7271_treatment18	NA	Locoregional Site	NA	NA	5d7891b4-743b-4e65-8271-55c877d33aac	NA	no	NA	Surgery, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	27073	NA	NA	NA	NA	NA	not reported	633	NA	96ec6f7e-6498-447a-ba57-61e4c84f7398	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-7271_diagnosis4	NA	Not Reported	TCGA-38-7271_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-7271_treatment16	NA	NA	NA	NA	6afc9d1c-2668-47a7-b69a-42cb5f08f5d7	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	27073	NA	NA	NA	NA	NA	not reported	633	NA	96ec6f7e-6498-447a-ba57-61e4c84f7398	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-7271_diagnosis4	NA	Not Reported	TCGA-38-7271_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-7271_treatment19	NA	Distant Site	NA	NA	826666a4-9645-4c87-afb4-43db344bf2de	NA	no	NA	Surgery, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	27073	NA	NA	NA	NA	NA	not reported	633	NA	96ec6f7e-6498-447a-ba57-61e4c84f7398	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-7271_diagnosis4	NA	Not Reported	TCGA-38-7271_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-7271_treatment17	NA	NA	NA	NA	995cc16a-b96b-4736-8dc7-37c286f329fc	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	NA	MX	N0	Stage IIA	T2	6th	Synchronous primary	NA	NA	b8f2e5e4-3db9-4428-b5e3-f232f838b448	false	NA	NA	NA	Left	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-38-7271_diagnosis5	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-7271_treatment8	NA	NA	NA	NA	0ae9f020-61ef-40cf-8c34-5615b4aa510a	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	NA	MX	N0	Stage IIA	T2	6th	Synchronous primary	NA	NA	b8f2e5e4-3db9-4428-b5e3-f232f838b448	false	NA	NA	NA	Left	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-38-7271_diagnosis5	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-7271_treatment7	NA	NA	NA	NA	c035c440-c104-455d-a147-53a5c6e1d549	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	27001	NA	NA	NA	NA	NA	not reported	561	NA	dee0ee00-5ed2-4d5f-a83f-9e8b98e042fd	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-7271_diagnosis3	NA	Not Reported	TCGA-38-7271_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-7271_treatment14	NA	Locoregional Site	NA	NA	352070a4-e98c-4351-8fd5-8e618d2f83db	NA	no	NA	Surgery, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	27001	NA	NA	NA	NA	NA	not reported	561	NA	dee0ee00-5ed2-4d5f-a83f-9e8b98e042fd	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-7271_diagnosis3	NA	Not Reported	TCGA-38-7271_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-7271_treatment13	NA	NA	NA	NA	6d5b57eb-c09d-4a2b-abb5-0b014dc570fe	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	27001	NA	NA	NA	NA	NA	not reported	561	NA	dee0ee00-5ed2-4d5f-a83f-9e8b98e042fd	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-7271_diagnosis3	NA	Not Reported	TCGA-38-7271_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-7271_treatment15	NA	Distant Site	NA	NA	9523915f-6243-458b-9db6-e35358689964	NA	no	NA	Surgery, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	27001	NA	NA	NA	NA	NA	not reported	561	NA	dee0ee00-5ed2-4d5f-a83f-9e8b98e042fd	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-7271_diagnosis3	NA	Not Reported	TCGA-38-7271_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-7271_treatment12	NA	NA	NA	NA	e609b472-f00d-4bc3-80e3-6ebbe8ba0120	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	26440	M0	N0	Stage IA	T1	6th	primary	0	800.0	e405bb3f-169e-5148-9c9f-46bf2cdf1b81	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-38-7271_diagnosis	Yes	Upper lobe, lung	NA	2006	NA	NA	371	329	Recurrent Disease	3	NA	30.0	mg/m2	Intravenous	TCGA-38-7271_treatment4	Cisplatin	NA	324	mg	289ce790-2086-429d-a7cf-0e6891cf2abd	NA	yes	NA	Chemotherapy
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	26440	M0	N0	Stage IA	T1	6th	primary	0	800.0	e405bb3f-169e-5148-9c9f-46bf2cdf1b81	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-38-7271_diagnosis	Yes	Upper lobe, lung	NA	2006	NA	NA	623	574	NA	2	NA	500.0	mg/m2	Intravenous	TCGA-38-7271_treatment5	Pemetrexed Disodium	NA	1760	mg	af32bf8d-7169-4c67-9d63-3e9bf14afe24	Palliative	yes	NA	Chemotherapy
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	26440	M0	N0	Stage IA	T1	6th	primary	0	800.0	e405bb3f-169e-5148-9c9f-46bf2cdf1b81	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-38-7271_diagnosis	Yes	Upper lobe, lung	NA	2006	NA	3.0	665	633	NA	NA	14.0	NA	NA	NA	TCGA-38-7271_treatment2	NA	Distant Site	2500	cGy	b7c84094-5900-4e6b-8433-11b067444c53	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	26440	M0	N0	Stage IA	T1	6th	primary	0	800.0	e405bb3f-169e-5148-9c9f-46bf2cdf1b81	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-38-7271_diagnosis	Yes	Upper lobe, lung	NA	2006	NA	2.0	564	564	NA	NA	1.0	NA	NA	NA	TCGA-38-7271_treatment	NA	Distant Site	2000	cGy	efb9e09e-36e7-5c3f-8aa2-563d548af2c5	Palliative	yes	NA	Radiation, Cyberknife
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	26440	M0	N0	Stage IA	T1	6th	primary	0	800.0	e405bb3f-169e-5148-9c9f-46bf2cdf1b81	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-38-7271_diagnosis	Yes	Upper lobe, lung	NA	2006	NA	NA	574	574	NA	1	NA	NA	NA	Intravenous	TCGA-38-7271_treatment6	Carboplatin	NA	798	mg	f05b738a-ba39-42d5-8052-ecee03f335c7	Palliative	yes	NA	Chemotherapy
TCGA-LUAD	8214a0d1-5e2d-4a7a-acb1-e5580755db83	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-7271	72	false	United States	-26440	800	3081168f-d6ae-54cd-b182-db7c052b4c04	not hispanic or latino	female	white	TCGA-38-7271_demographic	Dead	26440	M0	N0	Stage IA	T1	6th	primary	0	800.0	e405bb3f-169e-5148-9c9f-46bf2cdf1b81	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-38-7271_diagnosis	Yes	Upper lobe, lung	NA	2006	NA	1.0	379	329	Recurrent Disease	NA	23.0	NA	NA	NA	TCGA-38-7271_treatment3	NA	Locoregional Site	7000	cGy	f1881945-4d7e-40b8-a8c8-9c3f37f9678a	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	82476d2d-e403-4f6b-8dd6-cc84e3329478	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6595	74	false	United States	-27197	189	9936423d-72b7-5358-a38d-a4c21bc938f0	not hispanic or latino	female	white	TCGA-50-6595_demographic	Dead	27197	M0	N2	Stage IIIA	T2	6th	primary	0	189.0	915defd8-0947-5db1-8222-0ea77d808b37	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-6595_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	161	123	NA	NA	27.0	NA	NA	NA	TCGA-50-6595_treatment	NA	Primary Tumor Field	54	Gy	52c92075-612d-56dc-ae77-83f16fbd89a4	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	82476d2d-e403-4f6b-8dd6-cc84e3329478	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6595	74	false	United States	-27197	189	9936423d-72b7-5358-a38d-a4c21bc938f0	not hispanic or latino	female	white	TCGA-50-6595_demographic	Dead	27197	M0	N2	Stage IIIA	T2	6th	primary	0	189.0	915defd8-0947-5db1-8222-0ea77d808b37	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-6595_diagnosis	No	Upper lobe, lung	NA	2009	No	NA	162	123	NA	NA	NA	NA	NA	NA	TCGA-50-6595_treatment2	Carboplatin	NA	NA	NA	fe19f7ba-0d7d-4c69-910b-65491f4b093b	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	82476d2d-e403-4f6b-8dd6-cc84e3329478	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6595	74	false	United States	-27197	189	9936423d-72b7-5358-a38d-a4c21bc938f0	not hispanic or latino	female	white	TCGA-50-6595_demographic	Dead	27379	NA	NA	NA	NA	NA	metastasis	182	NA	f970746e-a6b6-461b-92f0-f564dc301019	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-6595_diagnosis2	NA	Not Reported	TCGA-50-6595_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-6595_treatment3	NA	NA	NA	NA	001f5e18-735b-4f50-a377-7dcf00c209c3	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	82476d2d-e403-4f6b-8dd6-cc84e3329478	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6595	74	false	United States	-27197	189	9936423d-72b7-5358-a38d-a4c21bc938f0	not hispanic or latino	female	white	TCGA-50-6595_demographic	Dead	27379	NA	NA	NA	NA	NA	metastasis	182	NA	f970746e-a6b6-461b-92f0-f564dc301019	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-6595_diagnosis2	NA	Not Reported	TCGA-50-6595_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6595_treatment5	NA	Locoregional Site	NA	NA	0a19202b-2610-4cc0-b6b5-de31445a7482	NA	no	NA	Surgery, NOS
TCGA-LUAD	82476d2d-e403-4f6b-8dd6-cc84e3329478	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6595	74	false	United States	-27197	189	9936423d-72b7-5358-a38d-a4c21bc938f0	not hispanic or latino	female	white	TCGA-50-6595_demographic	Dead	27379	NA	NA	NA	NA	NA	metastasis	182	NA	f970746e-a6b6-461b-92f0-f564dc301019	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-6595_diagnosis2	NA	Not Reported	TCGA-50-6595_diagnosis	NA	NA	NA	NA	187	NA	NA	NA	NA	NA	NA	TCGA-50-6595_treatment6	NA	Distant Site	NA	NA	a53b6e27-0ff1-4668-94c8-1a14cbc852dc	NA	yes	NA	Surgery, NOS
TCGA-LUAD	82476d2d-e403-4f6b-8dd6-cc84e3329478	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6595	74	false	United States	-27197	189	9936423d-72b7-5358-a38d-a4c21bc938f0	not hispanic or latino	female	white	TCGA-50-6595_demographic	Dead	27379	NA	NA	NA	NA	NA	metastasis	182	NA	f970746e-a6b6-461b-92f0-f564dc301019	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-6595_diagnosis2	NA	Not Reported	TCGA-50-6595_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-6595_treatment4	NA	NA	NA	NA	e6fd196d-0031-4245-ace5-c5b37a5adad9	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	83a6ed20-b3cf-48b9-8ed3-a080cd4951fa	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6968	61	false	United States	-22344	1293	9442080e-3081-52da-92ca-116b2fefd353	not hispanic or latino	male	white	TCGA-55-6968_demographic	Dead	22344	M1	N0	Stage IV	T1	6th	primary	0	1293.0	b5d8e411-22f8-503f-a151-394ceb3ebdf0	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6968_diagnosis	No	Lower lobe, lung	NA	2004	No	NA	NA	13	NA	NA	NA	NA	NA	NA	TCGA-55-6968_treatment2	NA	NA	NA	NA	0c327503-c63e-4ddd-ae0b-c4c1a0c26b5e	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	83a6ed20-b3cf-48b9-8ed3-a080cd4951fa	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6968	61	false	United States	-22344	1293	9442080e-3081-52da-92ca-116b2fefd353	not hispanic or latino	male	white	TCGA-55-6968_demographic	Dead	22344	M1	N0	Stage IV	T1	6th	primary	0	1293.0	b5d8e411-22f8-503f-a151-394ceb3ebdf0	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6968_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	57	13	NA	NA	NA	NA	NA	NA	TCGA-55-6968_treatment	NA	Distant Site	NA	NA	c27577e8-1407-5f87-891b-d15be42c8486	NA	yes	Stable Disease	Radiation, External Beam
TCGA-LUAD	83e38dbd-edab-47f2-b19f-6ea38fc6bece	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-8120	58	false	United States	-21188	NA	7f993051-5040-5315-9d4a-9f8bec908e84	not hispanic or latino	male	black or african american	TCGA-44-8120_demographic	Alive	21188	M0	N0	Stage IB	T2a	7th	primary	0	260.0	bd28099c-519b-5069-93d1-31d654f47482	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-8120_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-8120_treatment2	NA	NA	NA	NA	71879de6-80f6-4083-865e-d6fd232a8ecc	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	83e38dbd-edab-47f2-b19f-6ea38fc6bece	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-8120	58	false	United States	-21188	NA	7f993051-5040-5315-9d4a-9f8bec908e84	not hispanic or latino	male	black or african american	TCGA-44-8120_demographic	Alive	21188	M0	N0	Stage IB	T2a	7th	primary	0	260.0	bd28099c-519b-5069-93d1-31d654f47482	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-8120_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-8120_treatment	NA	NA	NA	NA	ee994c84-8dd8-5420-a753-2a20eb2d10b3	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	84c3ba70-afa7-4b69-be69-7ec8d6022c56	Informed Consent	427	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-8025	72	false	United States	-26634	NA	91e8b562-83a3-5bae-b082-ffae59f3525b	not hispanic or latino	female	black or african american	TCGA-99-8025_demographic	Alive	26634	M0	N2	Stage IIIA	T3	7th	primary	0	1060.0	91e14e03-b16e-5462-ba79-e92bc27ae9c6	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-99-8025_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	286	213	NA	NA	NA	NA	NA	NA	TCGA-99-8025_treatment	Gemcitabine Hydrochloride	NA	NA	NA	0956c709-c7be-589e-bbf3-5bd413fa72b3	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	84c3ba70-afa7-4b69-be69-7ec8d6022c56	Informed Consent	427	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-8025	72	false	United States	-26634	NA	91e8b562-83a3-5bae-b082-ffae59f3525b	not hispanic or latino	female	black or african american	TCGA-99-8025_demographic	Alive	26634	M0	N2	Stage IIIA	T3	7th	primary	0	1060.0	91e14e03-b16e-5462-ba79-e92bc27ae9c6	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-99-8025_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-99-8025_treatment2	NA	NA	NA	NA	db79f9a4-7a08-4a60-9b1d-f832cc8f5fd9	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8504fd86-a70a-4cba-9ec8-25c9e60ca549	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6594	79	false	United States	-28924	370	485c4dff-5e4c-5886-ac31-ae68ff15c192	not hispanic or latino	female	black or african american	TCGA-50-6594_demographic	Dead	29209	NA	NA	NA	NA	NA	metastasis	285	NA	124201af-b1fc-4072-8620-e86b6b3d7c3b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-6594_diagnosis2	NA	Not Reported	TCGA-50-6594_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6594_treatment5	NA	Distant Site	NA	NA	051f2d9c-623a-4bff-9e38-bf3f979bddaa	NA	no	NA	Surgery, NOS
TCGA-LUAD	8504fd86-a70a-4cba-9ec8-25c9e60ca549	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6594	79	false	United States	-28924	370	485c4dff-5e4c-5886-ac31-ae68ff15c192	not hispanic or latino	female	black or african american	TCGA-50-6594_demographic	Dead	29209	NA	NA	NA	NA	NA	metastasis	285	NA	124201af-b1fc-4072-8620-e86b6b3d7c3b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-6594_diagnosis2	NA	Not Reported	TCGA-50-6594_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-6594_treatment3	NA	NA	NA	NA	2da2a88e-9617-4c50-a9f2-b939864a35ad	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8504fd86-a70a-4cba-9ec8-25c9e60ca549	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6594	79	false	United States	-28924	370	485c4dff-5e4c-5886-ac31-ae68ff15c192	not hispanic or latino	female	black or african american	TCGA-50-6594_demographic	Dead	29209	NA	NA	NA	NA	NA	metastasis	285	NA	124201af-b1fc-4072-8620-e86b6b3d7c3b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-6594_diagnosis2	NA	Not Reported	TCGA-50-6594_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-6594_treatment4	NA	NA	NA	NA	8f86f933-ac7a-4513-a090-f3ee7c3090f8	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	8504fd86-a70a-4cba-9ec8-25c9e60ca549	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6594	79	false	United States	-28924	370	485c4dff-5e4c-5886-ac31-ae68ff15c192	not hispanic or latino	female	black or african american	TCGA-50-6594_demographic	Dead	28924	M0	N2	Stage IIIA	T3	6th	primary	0	370.0	73a7bae1-6039-50c6-a14d-8163d20dbc78	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-6594_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6594_treatment2	NA	NA	NA	NA	37c1e8f0-3267-44f2-9db4-c9ab9550165a	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8504fd86-a70a-4cba-9ec8-25c9e60ca549	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6594	79	false	United States	-28924	370	485c4dff-5e4c-5886-ac31-ae68ff15c192	not hispanic or latino	female	black or african american	TCGA-50-6594_demographic	Dead	28924	M0	N2	Stage IIIA	T3	6th	primary	0	370.0	73a7bae1-6039-50c6-a14d-8163d20dbc78	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-6594_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	318	317	NA	NA	1.0	NA	NA	NA	TCGA-50-6594_treatment	NA	Distant Site	24	Gy	c19305b3-951a-57b7-b365-3cb647a777cb	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	851867cb-9ad0-4fdf-ac75-9bb0427ad440	Informed Consent	13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A479	73	false	United States	-27024	NA	f1797926-fb45-506d-b23b-3343c56f72ec	not hispanic or latino	female	black or african american	TCGA-44-A479_demographic	Alive	27024	MX	N0	Stage IB	T2	7th	primary	0	486.0	5a49829c-3527-52c7-8de3-b148782f84f4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-A479_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A479_treatment2	NA	NA	NA	NA	4bd538bd-d152-42bd-ab91-799288cb8a60	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	851867cb-9ad0-4fdf-ac75-9bb0427ad440	Informed Consent	13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A479	73	false	United States	-27024	NA	f1797926-fb45-506d-b23b-3343c56f72ec	not hispanic or latino	female	black or african american	TCGA-44-A479_demographic	Alive	27024	MX	N0	Stage IB	T2	7th	primary	0	486.0	5a49829c-3527-52c7-8de3-b148782f84f4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-A479_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A479_treatment	NA	NA	NA	NA	b5a7895c-5134-5911-9b31-188732a5e1aa	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	851867cb-9ad0-4fdf-ac75-9bb0427ad440	Informed Consent	13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A479	73	false	United States	-27024	NA	f1797926-fb45-506d-b23b-3343c56f72ec	not hispanic or latino	female	black or african american	TCGA-44-A479_demographic	Alive	27461	NA	NA	NA	NA	NA	Subsequent Primary	437	NA	91fff07c-05b1-4232-a1a8-59815dd47f3a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-A479_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-44-A479_treatment3	NA	NA	NA	NA	2208bc76-2724-4d40-8b2b-8ac18917d629	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	851867cb-9ad0-4fdf-ac75-9bb0427ad440	Informed Consent	13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A479	73	false	United States	-27024	NA	f1797926-fb45-506d-b23b-3343c56f72ec	not hispanic or latino	female	black or african american	TCGA-44-A479_demographic	Alive	27461	NA	NA	NA	NA	NA	Subsequent Primary	437	NA	91fff07c-05b1-4232-a1a8-59815dd47f3a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-A479_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	437	NA	NA	NA	NA	NA	NA	TCGA-44-A479_treatment5	NA	Locoregional Site	NA	NA	49a20711-c8e3-46f5-b68a-469c01ecbb7f	NA	yes	NA	Surgery, NOS
TCGA-LUAD	851867cb-9ad0-4fdf-ac75-9bb0427ad440	Informed Consent	13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A479	73	false	United States	-27024	NA	f1797926-fb45-506d-b23b-3343c56f72ec	not hispanic or latino	female	black or african american	TCGA-44-A479_demographic	Alive	27461	NA	NA	NA	NA	NA	Subsequent Primary	437	NA	91fff07c-05b1-4232-a1a8-59815dd47f3a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-A479_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-44-A479_treatment4	NA	NA	NA	NA	b35894e9-b4b7-4a69-adfb-837fc08daeb5	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	851867cb-9ad0-4fdf-ac75-9bb0427ad440	Informed Consent	13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A479	73	false	United States	-27024	NA	f1797926-fb45-506d-b23b-3343c56f72ec	not hispanic or latino	female	black or african american	TCGA-44-A479_demographic	Alive	27461	NA	NA	NA	NA	NA	Subsequent Primary	437	NA	91fff07c-05b1-4232-a1a8-59815dd47f3a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-A479_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A479_treatment6	NA	Distant Site	NA	NA	f0b36626-5656-42fd-9f25-42b22e628dc3	NA	no	NA	Surgery, NOS
TCGA-LUAD	8609edfc-119d-4d63-9188-c86aabd5ca52	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8076	42	false	Russia	-15605	NA	9cb726d6-99f8-50e7-ad25-d443d90fcd38	not hispanic or latino	male	white	TCGA-86-8076_demographic	Alive	15605	M0	N0	Stage IA	T1	7th	primary	0	993.0	0623766e-992a-5e6e-9712-aaf67c235428	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8076_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	193	40	NA	NA	NA	NA	NA	NA	TCGA-86-8076_treatment	Etoposide	NA	NA	NA	551978e9-773a-567d-b578-98859b3c1ed9	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	8609edfc-119d-4d63-9188-c86aabd5ca52	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8076	42	false	Russia	-15605	NA	9cb726d6-99f8-50e7-ad25-d443d90fcd38	not hispanic or latino	male	white	TCGA-86-8076_demographic	Alive	15605	M0	N0	Stage IA	T1	7th	primary	0	993.0	0623766e-992a-5e6e-9712-aaf67c235428	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8076_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8076_treatment3	NA	NA	NA	NA	902b151c-618f-4a5b-9781-14b9d256fb7d	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	8609edfc-119d-4d63-9188-c86aabd5ca52	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8076	42	false	Russia	-15605	NA	9cb726d6-99f8-50e7-ad25-d443d90fcd38	not hispanic or latino	male	white	TCGA-86-8076_demographic	Alive	15605	M0	N0	Stage IA	T1	7th	primary	0	993.0	0623766e-992a-5e6e-9712-aaf67c235428	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8076_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	193	40	NA	NA	NA	NA	NA	NA	TCGA-86-8076_treatment2	Cisplatin	NA	NA	NA	a4a98db1-854e-46e8-80dd-d71fcfd8b6d9	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	86dac334-f30e-438e-810a-8e45f69dbb7e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TF	58	false	United States	-21387	336	bbfe7da8-460d-5645-95a6-4aa847f35f10	not hispanic or latino	female	white	TCGA-MP-A4TF_demographic	Dead	21387	M0	N0	Stage IIA	T2b	7th	primary	0	336.0	4b03a6c5-0fbb-5cc3-9a61-7c72ac5910d1	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-MP-A4TF_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	133	48	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TF_treatment2	Cisplatin	NA	NA	NA	2d81b23a-4e70-4d19-937f-cd7856951a39	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	86dac334-f30e-438e-810a-8e45f69dbb7e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TF	58	false	United States	-21387	336	bbfe7da8-460d-5645-95a6-4aa847f35f10	not hispanic or latino	female	white	TCGA-MP-A4TF_demographic	Dead	21387	M0	N0	Stage IIA	T2b	7th	primary	0	336.0	4b03a6c5-0fbb-5cc3-9a61-7c72ac5910d1	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-MP-A4TF_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	151	48	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TF_treatment	Vinorelbine Tartrate	NA	NA	NA	e0d3d53f-3cdf-5baf-b3a5-66111b4d7321	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	86dac334-f30e-438e-810a-8e45f69dbb7e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TF	58	false	United States	-21387	336	bbfe7da8-460d-5645-95a6-4aa847f35f10	not hispanic or latino	female	white	TCGA-MP-A4TF_demographic	Dead	21387	M0	N0	Stage IIA	T2b	7th	primary	0	336.0	4b03a6c5-0fbb-5cc3-9a61-7c72ac5910d1	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-MP-A4TF_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TF_treatment3	NA	NA	NA	NA	eda2b09e-5340-4471-bc5f-61e53a40fb8f	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	86dac334-f30e-438e-810a-8e45f69dbb7e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TF	58	false	United States	-21387	336	bbfe7da8-460d-5645-95a6-4aa847f35f10	not hispanic or latino	female	white	TCGA-MP-A4TF_demographic	Dead	21582	NA	NA	NA	NA	NA	metastasis	195	NA	e923f617-fdd3-4e4d-a15d-6f3840b528d5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TF_diagnosis2	NA	Not Reported	TCGA-MP-A4TF_diagnosis	NA	NA	NA	NA	202	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TF_treatment6	NA	Distant Site	NA	NA	1d7e56d6-d165-45fa-94ed-6c752c180517	NA	yes	NA	Surgery, NOS
TCGA-LUAD	86dac334-f30e-438e-810a-8e45f69dbb7e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TF	58	false	United States	-21387	336	bbfe7da8-460d-5645-95a6-4aa847f35f10	not hispanic or latino	female	white	TCGA-MP-A4TF_demographic	Dead	21582	NA	NA	NA	NA	NA	metastasis	195	NA	e923f617-fdd3-4e4d-a15d-6f3840b528d5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TF_diagnosis2	NA	Not Reported	TCGA-MP-A4TF_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TF_treatment4	NA	NA	NA	NA	58dde524-9b3a-49da-b3c3-ebd28f92f643	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	86dac334-f30e-438e-810a-8e45f69dbb7e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TF	58	false	United States	-21387	336	bbfe7da8-460d-5645-95a6-4aa847f35f10	not hispanic or latino	female	white	TCGA-MP-A4TF_demographic	Dead	21582	NA	NA	NA	NA	NA	metastasis	195	NA	e923f617-fdd3-4e4d-a15d-6f3840b528d5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TF_diagnosis2	NA	Not Reported	TCGA-MP-A4TF_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TF_treatment5	NA	NA	NA	NA	cace3114-547d-4e6a-9192-8fb100e582a1	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	86faf16c-56fd-4b7b-a6b2-b4c83bec93e1	Informed Consent	-55	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7161	69	false	Australia	-25294	291	602066ca-85df-5c4a-a832-d7dd2aff25be	not reported	female	white	TCGA-78-7161_demographic	Dead	25294	M0	N0	Stage IIB	T3	7th	primary	0	291.0	04bafd62-334b-5f2b-a476-d404e8e4295f	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7161_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	132	40	NA	4	NA	40.0	mg	Intravenous	TCGA-78-7161_treatment2	Vinorelbine	NA	450	mg	77d82fab-8938-4ca0-a7c8-5dacbeb1ea59	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	86faf16c-56fd-4b7b-a6b2-b4c83bec93e1	Informed Consent	-55	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7161	69	false	Australia	-25294	291	602066ca-85df-5c4a-a832-d7dd2aff25be	not reported	female	white	TCGA-78-7161_demographic	Dead	25294	M0	N0	Stage IIB	T3	7th	primary	0	291.0	04bafd62-334b-5f2b-a476-d404e8e4295f	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7161_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	132	40	NA	4	NA	80.0	mg	Intravenous	TCGA-78-7161_treatment	Cisplatin	NA	600	mg	a94f9c3c-f790-5824-9061-cbc1a0d3d6c7	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	86faf16c-56fd-4b7b-a6b2-b4c83bec93e1	Informed Consent	-55	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7161	69	false	Australia	-25294	291	602066ca-85df-5c4a-a832-d7dd2aff25be	not reported	female	white	TCGA-78-7161_demographic	Dead	25294	M0	N0	Stage IIB	T3	7th	primary	0	291.0	04bafd62-334b-5f2b-a476-d404e8e4295f	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-78-7161_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7161_treatment3	NA	NA	NA	NA	dc254fdc-a096-489c-b64d-62a19c2f0515	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	86faf16c-56fd-4b7b-a6b2-b4c83bec93e1	Informed Consent	-55	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7161	69	false	Australia	-25294	291	602066ca-85df-5c4a-a832-d7dd2aff25be	not reported	female	white	TCGA-78-7161_demographic	Dead	25456	NA	NA	NA	NA	NA	recurrence	162	NA	325c4b56-9e14-435d-90cd-3fd8dec879e4	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-78-7161_diagnosis3	NA	Not Reported	TCGA-78-7161_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-78-7161_treatment8	NA	NA	NA	NA	3097649a-db4c-4cfc-8750-15dacc1f9680	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	86faf16c-56fd-4b7b-a6b2-b4c83bec93e1	Informed Consent	-55	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7161	69	false	Australia	-25294	291	602066ca-85df-5c4a-a832-d7dd2aff25be	not reported	female	white	TCGA-78-7161_demographic	Dead	25456	NA	NA	NA	NA	NA	recurrence	162	NA	325c4b56-9e14-435d-90cd-3fd8dec879e4	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-78-7161_diagnosis3	NA	Not Reported	TCGA-78-7161_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-78-7161_treatment9	NA	NA	NA	NA	6dbd54ee-7bfc-4d47-bca9-feea45cc65de	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	86faf16c-56fd-4b7b-a6b2-b4c83bec93e1	Informed Consent	-55	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7161	69	false	Australia	-25294	291	602066ca-85df-5c4a-a832-d7dd2aff25be	not reported	female	white	TCGA-78-7161_demographic	Dead	25456	NA	NA	NA	NA	NA	recurrence	162	NA	325c4b56-9e14-435d-90cd-3fd8dec879e4	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-78-7161_diagnosis3	NA	Not Reported	TCGA-78-7161_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7161_treatment10	NA	Locoregional Site	NA	NA	bed4f80e-0453-47d0-984f-cf85d261127a	NA	no	NA	Surgery, NOS
TCGA-LUAD	86faf16c-56fd-4b7b-a6b2-b4c83bec93e1	Informed Consent	-55	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7161	69	false	Australia	-25294	291	602066ca-85df-5c4a-a832-d7dd2aff25be	not reported	female	white	TCGA-78-7161_demographic	Dead	25456	NA	NA	NA	NA	NA	not reported	162	NA	e86d5f9f-6c7f-471a-912f-9e2ca338ae25	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7161_diagnosis2	NA	Not Reported	TCGA-78-7161_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7161_treatment6	NA	Locoregional Site	NA	NA	1d40ad84-126c-41ac-9817-2e5fbf5bbf02	NA	no	NA	Surgery, NOS
TCGA-LUAD	86faf16c-56fd-4b7b-a6b2-b4c83bec93e1	Informed Consent	-55	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7161	69	false	Australia	-25294	291	602066ca-85df-5c4a-a832-d7dd2aff25be	not reported	female	white	TCGA-78-7161_demographic	Dead	25456	NA	NA	NA	NA	NA	not reported	162	NA	e86d5f9f-6c7f-471a-912f-9e2ca338ae25	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7161_diagnosis2	NA	Not Reported	TCGA-78-7161_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7161_treatment5	NA	NA	NA	NA	a1f080c8-1830-4303-8c46-4dd1c43c8799	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	86faf16c-56fd-4b7b-a6b2-b4c83bec93e1	Informed Consent	-55	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7161	69	false	Australia	-25294	291	602066ca-85df-5c4a-a832-d7dd2aff25be	not reported	female	white	TCGA-78-7161_demographic	Dead	25456	NA	NA	NA	NA	NA	not reported	162	NA	e86d5f9f-6c7f-471a-912f-9e2ca338ae25	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7161_diagnosis2	NA	Not Reported	TCGA-78-7161_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7161_treatment4	NA	NA	NA	NA	e5ddda94-6702-45fb-b837-228e7766455c	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	86faf16c-56fd-4b7b-a6b2-b4c83bec93e1	Informed Consent	-55	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7161	69	false	Australia	-25294	291	602066ca-85df-5c4a-a832-d7dd2aff25be	not reported	female	white	TCGA-78-7161_demographic	Dead	25456	NA	NA	NA	NA	NA	not reported	162	NA	e86d5f9f-6c7f-471a-912f-9e2ca338ae25	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7161_diagnosis2	NA	Not Reported	TCGA-78-7161_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7161_treatment7	NA	Distant Site	NA	NA	f3f991e3-41af-4b3b-8972-9ee852dcb656	NA	no	NA	Surgery, NOS
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	16098	NA	NA	NA	NA	NA	not reported	680	NA	3be03f40-a5d2-42d5-94cd-24c21385d5a1	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4632_diagnosis2	NA	Not Reported	TCGA-38-4632_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4632_treatment8	NA	NA	NA	NA	6d14dc69-9588-4c96-bfaa-3823ec5e4425	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	16098	NA	NA	NA	NA	NA	not reported	680	NA	3be03f40-a5d2-42d5-94cd-24c21385d5a1	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4632_diagnosis2	NA	Not Reported	TCGA-38-4632_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4632_treatment7	NA	NA	NA	NA	88e44da5-d87d-4b59-affc-8315f0989083	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	16098	NA	NA	NA	NA	NA	not reported	680	NA	3be03f40-a5d2-42d5-94cd-24c21385d5a1	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4632_diagnosis2	NA	Not Reported	TCGA-38-4632_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4632_treatment9	NA	Locoregional Site	NA	NA	c4e3468d-1d10-4c63-bbf4-f28309651e04	NA	no	NA	Surgery, NOS
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	16098	NA	NA	NA	NA	NA	not reported	680	NA	3be03f40-a5d2-42d5-94cd-24c21385d5a1	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4632_diagnosis2	NA	Not Reported	TCGA-38-4632_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4632_treatment10	NA	Distant Site	NA	NA	c7d5e3f3-7fc0-4172-bc98-cd0642a25699	NA	no	NA	Surgery, NOS
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	16343	NA	NA	NA	NA	NA	not reported	925	NA	8b4b2a8d-e141-46c1-a6e1-a0b84c4f6a18	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4632_diagnosis3	NA	Not Reported	TCGA-38-4632_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4632_treatment11	NA	NA	NA	NA	103937db-88eb-4e52-9bd0-3f292160927c	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	16343	NA	NA	NA	NA	NA	not reported	925	NA	8b4b2a8d-e141-46c1-a6e1-a0b84c4f6a18	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4632_diagnosis3	NA	Not Reported	TCGA-38-4632_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4632_treatment12	NA	NA	NA	NA	44d921a6-6b85-4b87-8130-aeafb6724561	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	16343	NA	NA	NA	NA	NA	not reported	925	NA	8b4b2a8d-e141-46c1-a6e1-a0b84c4f6a18	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4632_diagnosis3	NA	Not Reported	TCGA-38-4632_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4632_treatment14	NA	Distant Site	NA	NA	63b1129f-425f-4eea-b038-7d28d98e5732	NA	no	NA	Surgery, NOS
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	16343	NA	NA	NA	NA	NA	not reported	925	NA	8b4b2a8d-e141-46c1-a6e1-a0b84c4f6a18	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4632_diagnosis3	NA	Not Reported	TCGA-38-4632_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4632_treatment13	NA	Locoregional Site	NA	NA	e3df717a-9b7c-4cbe-8863-ead469c6d472	NA	no	NA	Surgery, NOS
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	15418	M1	N1	Stage IV	T2	5th	primary	0	1357.0	c6be4b88-44e7-595a-817c-5839df811846	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4632_diagnosis	No	Upper lobe, lung	NA	1998	NA	NA	802	679	Recurrent Disease	6	NA	NA	NA	Intravenous	TCGA-38-4632_treatment3	Gemcitabine	NA	NA	NA	1528b2bd-22dd-4c08-879f-350165d26c13	NA	yes	NA	Chemotherapy
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	15418	M1	N1	Stage IV	T2	5th	primary	0	1357.0	c6be4b88-44e7-595a-817c-5839df811846	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4632_diagnosis	No	Upper lobe, lung	NA	1998	NA	NA	70	35	NA	NA	22.0	NA	NA	NA	TCGA-38-4632_treatment2	NA	Distant Site	5800	cGy	8c3c2b97-7324-4dc4-994c-58aaabfe0cdb	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	15418	M1	N1	Stage IV	T2	5th	primary	0	1357.0	c6be4b88-44e7-595a-817c-5839df811846	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4632_diagnosis	No	Upper lobe, lung	NA	1998	NA	3.0	955	955	NA	NA	10.0	NA	NA	NA	TCGA-38-4632_treatment	NA	Distant Site	2500	cGy	9595e0c9-0c6c-5b07-8fc8-86fa80011f90	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	15418	M1	N1	Stage IV	T2	5th	primary	0	1357.0	c6be4b88-44e7-595a-817c-5839df811846	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4632_diagnosis	No	Upper lobe, lung	NA	1998	NA	NA	1169	1136	NA	2	NA	NA	NA	Intravenous	TCGA-38-4632_treatment4	Carboplatin	NA	NA	NA	965153e1-eff6-4907-8e97-e88f742e94a5	Palliative	yes	NA	Chemotherapy
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	15418	M1	N1	Stage IV	T2	5th	primary	0	1357.0	c6be4b88-44e7-595a-817c-5839df811846	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4632_diagnosis	No	Upper lobe, lung	NA	1998	NA	NA	802	679	Recurrent Disease	6	NA	NA	NA	Intravenous	TCGA-38-4632_treatment5	Paclitaxel	NA	NA	NA	dede2233-e9d4-40e4-bf18-6d9c3f6c5b18	NA	yes	NA	Chemotherapy
TCGA-LUAD	875333ab-9048-462d-aaa2-693ad127e3cc	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4632	42	false	United States	-15418	1357	b981e477-aae4-5e51-8ac7-51686ea43a89	not hispanic or latino	male	black or african american	TCGA-38-4632_demographic	Dead	15418	M1	N1	Stage IV	T2	5th	primary	0	1357.0	c6be4b88-44e7-595a-817c-5839df811846	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-38-4632_diagnosis	No	Upper lobe, lung	NA	1998	NA	NA	1169	1127	NA	2	NA	NA	NA	Intravenous	TCGA-38-4632_treatment6	Irinotecan Hydrochloride	NA	NA	NA	e06d9172-9b95-48a3-94c7-f7d18e369def	Palliative	yes	NA	Chemotherapy
TCGA-LUAD	87eeaf49-3c02-402f-9ae4-3627391e7749	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z028	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	87f1b3df-4bc7-4336-b658-f30ac1c5c796	Informed Consent	-2	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-95-8039	72	false	United States	-26317	NA	7f2c75ad-d372-586c-a39b-33b16eec7fc4	not hispanic or latino	male	white	TCGA-95-8039_demographic	Alive	26317	MX	N0	Stage IA	T1	7th	primary	0	830.0	1467b199-8f4f-5122-befa-73ad3823eff2	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	RX	Lung, NOS	NA	TCGA-95-8039_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-8039_treatment2	NA	NA	NA	NA	64ee5a23-852e-4f26-a8b8-3154ccb9d055	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	87f1b3df-4bc7-4336-b658-f30ac1c5c796	Informed Consent	-2	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-95-8039	72	false	United States	-26317	NA	7f2c75ad-d372-586c-a39b-33b16eec7fc4	not hispanic or latino	male	white	TCGA-95-8039_demographic	Alive	26317	MX	N0	Stage IA	T1	7th	primary	0	830.0	1467b199-8f4f-5122-befa-73ad3823eff2	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	RX	Lung, NOS	NA	TCGA-95-8039_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-8039_treatment	NA	NA	NA	NA	fe1cea89-c9fc-5012-8d44-7340ae8a31b1	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	87f1b3df-4bc7-4336-b658-f30ac1c5c796	Informed Consent	-2	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-95-8039	72	false	United States	-26317	NA	7f2c75ad-d372-586c-a39b-33b16eec7fc4	not hispanic or latino	male	white	TCGA-95-8039_demographic	Alive	26545	NA	NA	NA	NA	NA	recurrence	228	NA	cbda7681-ac73-44f5-a121-1c5b6830c741	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-95-8039_diagnosis2	NA	Not Reported	TCGA-95-8039_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-95-8039_treatment4	NA	NA	NA	NA	47d8b715-33a0-44da-a649-dedb381a86ad	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	87f1b3df-4bc7-4336-b658-f30ac1c5c796	Informed Consent	-2	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-95-8039	72	false	United States	-26317	NA	7f2c75ad-d372-586c-a39b-33b16eec7fc4	not hispanic or latino	male	white	TCGA-95-8039_demographic	Alive	26545	NA	NA	NA	NA	NA	recurrence	228	NA	cbda7681-ac73-44f5-a121-1c5b6830c741	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-95-8039_diagnosis2	NA	Not Reported	TCGA-95-8039_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-8039_treatment5	NA	Locoregional Site	NA	NA	6830481e-614b-48bd-8fa9-eb96325b3771	NA	no	NA	Surgery, NOS
TCGA-LUAD	87f1b3df-4bc7-4336-b658-f30ac1c5c796	Informed Consent	-2	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-95-8039	72	false	United States	-26317	NA	7f2c75ad-d372-586c-a39b-33b16eec7fc4	not hispanic or latino	male	white	TCGA-95-8039_demographic	Alive	26545	NA	NA	NA	NA	NA	recurrence	228	NA	cbda7681-ac73-44f5-a121-1c5b6830c741	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-95-8039_diagnosis2	NA	Not Reported	TCGA-95-8039_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-95-8039_treatment3	NA	NA	NA	NA	eccdc1a5-1035-4710-bd11-37dc5ed162a8	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8869000d-09d7-465a-ac32-54d1935c43e7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8075	66	false	Russia	-24402	694	dedbb4dd-64f3-514c-aaeb-677c28c5546a	not hispanic or latino	female	white	TCGA-86-8075_demographic	Dead	24402	M0	N0	Stage IB	T2	7th	primary	0	694.0	2883b33f-f1da-52ae-8622-822395d2105d	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8075_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	364	201	NA	NA	NA	NA	NA	NA	TCGA-86-8075_treatment	Etoposide	NA	NA	NA	3977b0b1-c768-5b37-b2eb-90142d8ba9b8	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	8869000d-09d7-465a-ac32-54d1935c43e7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8075	66	false	Russia	-24402	694	dedbb4dd-64f3-514c-aaeb-677c28c5546a	not hispanic or latino	female	white	TCGA-86-8075_demographic	Dead	24402	M0	N0	Stage IB	T2	7th	primary	0	694.0	2883b33f-f1da-52ae-8622-822395d2105d	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8075_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	NA	388	NA	NA	NA	NA	NA	NA	TCGA-86-8075_treatment3	Gefitinib	NA	NA	NA	66300f4d-8698-4a16-8d92-0f1e339742fc	NA	yes	Treatment Ongoing	Targeted Molecular Therapy
TCGA-LUAD	8869000d-09d7-465a-ac32-54d1935c43e7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8075	66	false	Russia	-24402	694	dedbb4dd-64f3-514c-aaeb-677c28c5546a	not hispanic or latino	female	white	TCGA-86-8075_demographic	Dead	24402	M0	N0	Stage IB	T2	7th	primary	0	694.0	2883b33f-f1da-52ae-8622-822395d2105d	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8075_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8075_treatment4	NA	NA	NA	NA	bd14c282-e0c3-4ad1-afd6-c08afbfe55de	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	8869000d-09d7-465a-ac32-54d1935c43e7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8075	66	false	Russia	-24402	694	dedbb4dd-64f3-514c-aaeb-677c28c5546a	not hispanic or latino	female	white	TCGA-86-8075_demographic	Dead	24402	M0	N0	Stage IB	T2	7th	primary	0	694.0	2883b33f-f1da-52ae-8622-822395d2105d	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8075_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	364	201	NA	NA	NA	NA	NA	NA	TCGA-86-8075_treatment2	Cisplatin	NA	NA	NA	d25c8428-7714-4d95-88e8-eb5cb6b8146a	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	8869000d-09d7-465a-ac32-54d1935c43e7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8075	66	false	Russia	-24402	694	dedbb4dd-64f3-514c-aaeb-677c28c5546a	not hispanic or latino	female	white	TCGA-86-8075_demographic	Dead	24601	NA	NA	NA	NA	NA	recurrence	199	NA	2d12b04d-04f5-4692-9926-7688c8407e26	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-8075_diagnosis2	NA	Not Reported	TCGA-86-8075_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-86-8075_treatment5	NA	NA	NA	NA	cc5f2e68-5630-4238-958c-bc2cd5f914b1	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8869000d-09d7-465a-ac32-54d1935c43e7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8075	66	false	Russia	-24402	694	dedbb4dd-64f3-514c-aaeb-677c28c5546a	not hispanic or latino	female	white	TCGA-86-8075_demographic	Dead	24601	NA	NA	NA	NA	NA	recurrence	199	NA	2d12b04d-04f5-4692-9926-7688c8407e26	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-8075_diagnosis2	NA	Not Reported	TCGA-86-8075_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8075_treatment8	NA	Distant Site	NA	NA	cd912d06-1ee1-47bd-b026-1bdf702180f4	NA	no	NA	Surgery, NOS
TCGA-LUAD	8869000d-09d7-465a-ac32-54d1935c43e7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8075	66	false	Russia	-24402	694	dedbb4dd-64f3-514c-aaeb-677c28c5546a	not hispanic or latino	female	white	TCGA-86-8075_demographic	Dead	24601	NA	NA	NA	NA	NA	recurrence	199	NA	2d12b04d-04f5-4692-9926-7688c8407e26	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-8075_diagnosis2	NA	Not Reported	TCGA-86-8075_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-86-8075_treatment6	NA	NA	NA	NA	d69ad652-a399-4518-9adf-94d07c9631d9	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8869000d-09d7-465a-ac32-54d1935c43e7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8075	66	false	Russia	-24402	694	dedbb4dd-64f3-514c-aaeb-677c28c5546a	not hispanic or latino	female	white	TCGA-86-8075_demographic	Dead	24601	NA	NA	NA	NA	NA	recurrence	199	NA	2d12b04d-04f5-4692-9926-7688c8407e26	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-8075_diagnosis2	NA	Not Reported	TCGA-86-8075_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8075_treatment7	NA	Locoregional Site	NA	NA	dbc0fa78-a3cb-4314-b87a-d483ad7e3b5e	NA	no	NA	Surgery, NOS
TCGA-LUAD	889aec8e-14ba-48d9-8fe1-f2416e82b333	Informed Consent	86	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6147	67	false	United States	-24631	NA	2c74e074-e9dc-5e2b-8284-7de2efa903f0	not hispanic or latino	female	white	TCGA-44-6147_demographic	Alive	24631	M0	NX	Stage IA	T1b	7th	primary	0	845.0	37538544-ef28-5c73-99ab-43472e510485	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-6147_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6147_treatment2	NA	NA	NA	NA	340bc4cb-cb9a-4956-8577-71dc0c660bff	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	889aec8e-14ba-48d9-8fe1-f2416e82b333	Informed Consent	86	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6147	67	false	United States	-24631	NA	2c74e074-e9dc-5e2b-8284-7de2efa903f0	not hispanic or latino	female	white	TCGA-44-6147_demographic	Alive	24631	M0	NX	Stage IA	T1b	7th	primary	0	845.0	37538544-ef28-5c73-99ab-43472e510485	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-6147_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6147_treatment	NA	NA	NA	NA	6b97a9d8-e3c3-5622-a452-dfefc7cad61c	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	889aec8e-14ba-48d9-8fe1-f2416e82b333	Informed Consent	86	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6147	67	false	United States	-24631	NA	2c74e074-e9dc-5e2b-8284-7de2efa903f0	not hispanic or latino	female	white	TCGA-44-6147_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	c1781f2d-a4ac-44a8-b57a-397a3266ddf8	false	NA	NA	NA	Right	8130/3	Papillary transitional cell carcinoma	NA	NA	NA	Not Reported	NA	TCGA-44-6147_diagnosis2	NA	Kidney, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6147_treatment4	NA	NA	NA	NA	b9dd8c06-bf79-491f-99f8-fd3ba95bb5d7	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	889aec8e-14ba-48d9-8fe1-f2416e82b333	Informed Consent	86	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6147	67	false	United States	-24631	NA	2c74e074-e9dc-5e2b-8284-7de2efa903f0	not hispanic or latino	female	white	TCGA-44-6147_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	c1781f2d-a4ac-44a8-b57a-397a3266ddf8	false	NA	NA	NA	Right	8130/3	Papillary transitional cell carcinoma	NA	NA	NA	Not Reported	NA	TCGA-44-6147_diagnosis2	NA	Kidney, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6147_treatment3	NA	NA	NA	NA	f68ac295-4764-4083-ae7c-a079a8df5c04	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	889aec8e-14ba-48d9-8fe1-f2416e82b333	Informed Consent	86	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6147	67	false	United States	-24631	NA	2c74e074-e9dc-5e2b-8284-7de2efa903f0	not hispanic or latino	female	white	TCGA-44-6147_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ecae7f97-eade-43db-bad1-f1529b31364e	false	NA	NA	NA	NA	8240/3	Carcinoid tumor, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-6147_diagnosis3	NA	Intestinal tract, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6147_treatment6	NA	NA	NA	NA	16a5ccc5-0a8e-4d4a-9354-3b74895c94e5	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	889aec8e-14ba-48d9-8fe1-f2416e82b333	Informed Consent	86	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6147	67	false	United States	-24631	NA	2c74e074-e9dc-5e2b-8284-7de2efa903f0	not hispanic or latino	female	white	TCGA-44-6147_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ecae7f97-eade-43db-bad1-f1529b31364e	false	NA	NA	NA	NA	8240/3	Carcinoid tumor, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-6147_diagnosis3	NA	Intestinal tract, NOS	NA	NA	NA	NA	NA	-770	NA	NA	NA	NA	NA	NA	TCGA-44-6147_treatment5	Octreotide Acetate	NA	NA	NA	eaa38709-8dcf-418a-966c-573a41ed1531	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8981f0c9-7155-4c96-bf77-7d40fe404323	Informed Consent	7	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7760	73	false	United States	-26777	NA	985590df-66c0-5b89-a958-b38f6efacd90	not hispanic or latino	male	white	TCGA-69-7760_demographic	Alive	26777	M0	N0	Stage IIB	T3	7th	primary	0	202.0	36a19602-d337-521c-909c-0afd7cdfd06d	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7760_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7760_treatment3	NA	NA	NA	NA	0d546f11-15ea-4fad-a323-dc4fd7bdab36	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8981f0c9-7155-4c96-bf77-7d40fe404323	Informed Consent	7	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7760	73	false	United States	-26777	NA	985590df-66c0-5b89-a958-b38f6efacd90	not hispanic or latino	male	white	TCGA-69-7760_demographic	Alive	26777	M0	N0	Stage IIB	T3	7th	primary	0	202.0	36a19602-d337-521c-909c-0afd7cdfd06d	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7760_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	110	47	NA	4	NA	588.6	mg	Intravenous	TCGA-69-7760_treatment	Carboplatin	NA	NA	NA	2b2fe94a-513c-556a-830f-247b86b99c8c	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	8981f0c9-7155-4c96-bf77-7d40fe404323	Informed Consent	7	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7760	73	false	United States	-26777	NA	985590df-66c0-5b89-a958-b38f6efacd90	not hispanic or latino	male	white	TCGA-69-7760_demographic	Alive	26777	M0	N0	Stage IIB	T3	7th	primary	0	202.0	36a19602-d337-521c-909c-0afd7cdfd06d	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7760_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	110	47	NA	4	NA	905.0	mg	Intravenous	TCGA-69-7760_treatment2	Pemetrexed Disodium	NA	NA	NA	dcc309a8-6f87-431e-ad65-712b0d82e81e	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	8994c8c4-9ea0-46cb-b4a5-0055d7da5bfa	Informed Consent	0	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-44-6148	60	false	United States	-22138	NA	21331063-9e38-5918-81e2-e3412c68dc3a	not hispanic or latino	male	white	TCGA-44-6148_demographic	Alive	22138	M0	N0	Stage IA	T1b	7th	primary	0	704.0	9c0d92a8-b75f-53b8-a5f2-57cd7a8bb8b5	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	no	No	RX	Lung, NOS	NA	TCGA-44-6148_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6148_treatment2	NA	NA	NA	NA	497c1502-5f28-447e-ae31-8a4adc32428b	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8994c8c4-9ea0-46cb-b4a5-0055d7da5bfa	Informed Consent	0	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-44-6148	60	false	United States	-22138	NA	21331063-9e38-5918-81e2-e3412c68dc3a	not hispanic or latino	male	white	TCGA-44-6148_demographic	Alive	22138	M0	N0	Stage IA	T1b	7th	primary	0	704.0	9c0d92a8-b75f-53b8-a5f2-57cd7a8bb8b5	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	no	No	RX	Lung, NOS	NA	TCGA-44-6148_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6148_treatment	NA	NA	NA	NA	72e54820-f603-53ff-9c89-f98c00e023ea	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8a16ddb3-4861-4128-bed9-0b1f94fe8cf7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1677	77	false	United States	-28482	628	1f7b27b5-d506-5b71-ad36-59f18c9c9afb	not hispanic or latino	female	white	TCGA-64-1677_demographic	Dead	28842	NA	NA	NA	NA	NA	not reported	360	NA	1f07c69c-ea3b-4792-96cc-a7dbac10e4d5	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-1677_diagnosis2	NA	Not Reported	TCGA-64-1677_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-64-1677_treatment8	NA	NA	NA	NA	07d32a40-c077-4d4e-92c8-b2358945c9b5	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	8a16ddb3-4861-4128-bed9-0b1f94fe8cf7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1677	77	false	United States	-28482	628	1f7b27b5-d506-5b71-ad36-59f18c9c9afb	not hispanic or latino	female	white	TCGA-64-1677_demographic	Dead	28842	NA	NA	NA	NA	NA	not reported	360	NA	1f07c69c-ea3b-4792-96cc-a7dbac10e4d5	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-1677_diagnosis2	NA	Not Reported	TCGA-64-1677_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-1677_treatment9	NA	Locoregional Site	NA	NA	137e355b-8f6f-43d4-a875-9f944ee93805	NA	no	NA	Surgery, NOS
TCGA-LUAD	8a16ddb3-4861-4128-bed9-0b1f94fe8cf7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1677	77	false	United States	-28482	628	1f7b27b5-d506-5b71-ad36-59f18c9c9afb	not hispanic or latino	female	white	TCGA-64-1677_demographic	Dead	28842	NA	NA	NA	NA	NA	not reported	360	NA	1f07c69c-ea3b-4792-96cc-a7dbac10e4d5	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-1677_diagnosis2	NA	Not Reported	TCGA-64-1677_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-64-1677_treatment7	NA	NA	NA	NA	288482a4-7501-4ada-a1a8-c80a9750920b	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8a16ddb3-4861-4128-bed9-0b1f94fe8cf7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1677	77	false	United States	-28482	628	1f7b27b5-d506-5b71-ad36-59f18c9c9afb	not hispanic or latino	female	white	TCGA-64-1677_demographic	Dead	28842	NA	NA	NA	NA	NA	not reported	360	NA	1f07c69c-ea3b-4792-96cc-a7dbac10e4d5	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-1677_diagnosis2	NA	Not Reported	TCGA-64-1677_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-1677_treatment10	NA	Distant Site	NA	NA	ae037ab3-e76e-49a6-9b8c-e135fc262a68	NA	no	NA	Surgery, NOS
TCGA-LUAD	8a16ddb3-4861-4128-bed9-0b1f94fe8cf7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1677	77	false	United States	-28482	628	1f7b27b5-d506-5b71-ad36-59f18c9c9afb	not hispanic or latino	female	white	TCGA-64-1677_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	2b2f2f70-3093-4f48-a4f3-bf7ce21d524d	false	NA	NA	NA	NA	8050/3	Papillary carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-64-1677_diagnosis3	NA	Thyroid gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-1677_treatment5	NA	NA	NA	NA	b9fb73fe-0de2-4d8c-9fb3-4941dfb32f2e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8a16ddb3-4861-4128-bed9-0b1f94fe8cf7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1677	77	false	United States	-28482	628	1f7b27b5-d506-5b71-ad36-59f18c9c9afb	not hispanic or latino	female	white	TCGA-64-1677_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	2b2f2f70-3093-4f48-a4f3-bf7ce21d524d	false	NA	NA	NA	NA	8050/3	Papillary carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-64-1677_diagnosis3	NA	Thyroid gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-1677_treatment6	NA	Locoregional Site	NA	NA	e8ce46ac-84eb-4a6e-b0ba-4cd80dece55b	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	8a16ddb3-4861-4128-bed9-0b1f94fe8cf7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1677	77	false	United States	-28482	628	1f7b27b5-d506-5b71-ad36-59f18c9c9afb	not hispanic or latino	female	white	TCGA-64-1677_demographic	Dead	28482	M0	N2	Stage IIIA	T2	NA	primary	0	628.0	988eae39-1a05-52fd-b4ef-10bc1185956a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-64-1677_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	121	51	NA	4	NA	1600.0	mg	Intravenous	TCGA-64-1677_treatment2	Gemcitabine	NA	NA	NA	2349449c-df4c-48c0-824d-fa8182ebeaf6	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	8a16ddb3-4861-4128-bed9-0b1f94fe8cf7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1677	77	false	United States	-28482	628	1f7b27b5-d506-5b71-ad36-59f18c9c9afb	not hispanic or latino	female	white	TCGA-64-1677_demographic	Dead	28482	M0	N2	Stage IIIA	T2	NA	primary	0	628.0	988eae39-1a05-52fd-b4ef-10bc1185956a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-64-1677_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	121	51	NA	4	NA	425.0	mg	Intravenous	TCGA-64-1677_treatment4	Carboplatin	NA	NA	NA	6176bafb-07fc-4053-8ad9-4fefe7718ef4	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	8a16ddb3-4861-4128-bed9-0b1f94fe8cf7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1677	77	false	United States	-28482	628	1f7b27b5-d506-5b71-ad36-59f18c9c9afb	not hispanic or latino	female	white	TCGA-64-1677_demographic	Dead	28482	M0	N2	Stage IIIA	T2	NA	primary	0	628.0	988eae39-1a05-52fd-b4ef-10bc1185956a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-64-1677_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	Recurrent Disease	2	NA	NA	NA	NA	TCGA-64-1677_treatment3	NA	NA	NA	NA	6650c4bb-f0a7-48e1-95d2-32aa0f21ffab	NA	yes	NA	Chemotherapy
TCGA-LUAD	8a16ddb3-4861-4128-bed9-0b1f94fe8cf7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1677	77	false	United States	-28482	628	1f7b27b5-d506-5b71-ad36-59f18c9c9afb	not hispanic or latino	female	white	TCGA-64-1677_demographic	Dead	28482	M0	N2	Stage IIIA	T2	NA	primary	0	628.0	988eae39-1a05-52fd-b4ef-10bc1185956a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-64-1677_diagnosis	No	Upper lobe, lung	NA	2005	NA	2.0	448	417	Recurrent Disease	NA	31.0	NA	NA	NA	TCGA-64-1677_treatment	NA	Regional Site	NA	NA	859bcc01-5803-5c99-957c-d851b1717b96	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	8ab8c4ba-311e-41d0-85ea-a0245aca1bdd	Informed Consent	-15	Cystic, Mucinous and Serous Neoplasms	Diagnosis	Yes	Bronchus and lung	TCGA-NJ-A55O	56	false	United States	-20628	NA	2e73ef5b-16bc-5d96-8e41-401d09a4302e	not hispanic or latino	female	white	TCGA-NJ-A55O_demographic	Alive	20628	M0	N1	Stage IIA	T1b	7th	primary	0	13.0	e1496a85-ffa2-5afc-bfee-8a6a3fb437fb	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	NA	TCGA-NJ-A55O_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A55O_treatment	NA	NA	NA	NA	454a69fc-b68f-5332-941c-88efdfb9782b	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8ab8c4ba-311e-41d0-85ea-a0245aca1bdd	Informed Consent	-15	Cystic, Mucinous and Serous Neoplasms	Diagnosis	Yes	Bronchus and lung	TCGA-NJ-A55O	56	false	United States	-20628	NA	2e73ef5b-16bc-5d96-8e41-401d09a4302e	not hispanic or latino	female	white	TCGA-NJ-A55O_demographic	Alive	20628	M0	N1	Stage IIA	T1b	7th	primary	0	13.0	e1496a85-ffa2-5afc-bfee-8a6a3fb437fb	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	NA	TCGA-NJ-A55O_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A55O_treatment2	NA	NA	NA	NA	649cd455-6657-47d8-b45b-e93a7378f37e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8b119d1c-6d21-4bbd-8a00-12da7b97d6c4	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5420	67	false	Germany	-24472	NA	9650f432-c6cf-578f-ac8b-ced9be3e1b4d	not reported	male	not reported	TCGA-05-5420_demographic	Alive	NA	M1	NA	NA	NA	NA	Prior primary	NA	NA	01525134-1218-44f6-9be9-e8b56252c64a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-5420_diagnosis3	NA	Unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-5420_treatment3	NA	NA	NA	NA	15d74a53-39eb-45e2-a5e1-6aad84f30d58	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8b119d1c-6d21-4bbd-8a00-12da7b97d6c4	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5420	67	false	Germany	-24472	NA	9650f432-c6cf-578f-ac8b-ced9be3e1b4d	not reported	male	not reported	TCGA-05-5420_demographic	Alive	NA	M1	NA	NA	NA	NA	Prior primary	NA	NA	01525134-1218-44f6-9be9-e8b56252c64a	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-5420_diagnosis3	NA	Unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-5420_treatment4	NA	NA	NA	NA	41b2864f-11a7-4b94-959b-b77107eb274c	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	8b119d1c-6d21-4bbd-8a00-12da7b97d6c4	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5420	67	false	Germany	-24472	NA	9650f432-c6cf-578f-ac8b-ced9be3e1b4d	not reported	male	not reported	TCGA-05-5420_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	65fd6cd7-dec5-4e1b-9389-693fca6dc823	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-5420_diagnosis4	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-5420_treatment6	NA	NA	NA	NA	1eca062e-68dd-4acd-a0ee-8aae7cbe7f44	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8b119d1c-6d21-4bbd-8a00-12da7b97d6c4	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5420	67	false	Germany	-24472	NA	9650f432-c6cf-578f-ac8b-ced9be3e1b4d	not reported	male	not reported	TCGA-05-5420_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	65fd6cd7-dec5-4e1b-9389-693fca6dc823	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-5420_diagnosis4	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-5420_treatment5	Unknown	NA	NA	NA	f8e4449c-dc0c-4a0b-ac99-72bc0e4554fb	NA	yes	NA	Hormone Therapy
TCGA-LUAD	8b119d1c-6d21-4bbd-8a00-12da7b97d6c4	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5420	67	false	Germany	-24472	NA	9650f432-c6cf-578f-ac8b-ced9be3e1b4d	not reported	male	not reported	TCGA-05-5420_demographic	Alive	24472	M0	N2	Stage IIIA	T2	6th	primary	0	457.0	a3a7cc14-b5eb-5b97-a1d3-bf5824e04e00	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-05-5420_diagnosis	No	Lung, NOS	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-5420_treatment	NA	NA	NA	NA	3a46379f-cfb5-5b33-9127-f0a8f4b270df	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8b119d1c-6d21-4bbd-8a00-12da7b97d6c4	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5420	67	false	Germany	-24472	NA	9650f432-c6cf-578f-ac8b-ced9be3e1b4d	not reported	male	not reported	TCGA-05-5420_demographic	Alive	24472	M0	N2	Stage IIIA	T2	6th	primary	0	457.0	a3a7cc14-b5eb-5b97-a1d3-bf5824e04e00	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-05-5420_diagnosis	No	Lung, NOS	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-5420_treatment2	NA	NA	NA	NA	40b06bb6-25e4-4e9b-93ef-3a454c41af23	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	8b119d1c-6d21-4bbd-8a00-12da7b97d6c4	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5420	67	false	Germany	-24472	NA	9650f432-c6cf-578f-ac8b-ced9be3e1b4d	not reported	male	not reported	TCGA-05-5420_demographic	Alive	24717	NA	NA	NA	NA	NA	not reported	245	NA	a3fe8ae2-4989-48ef-896d-ae7b24d8b27e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-5420_diagnosis2	NA	Not Reported	TCGA-05-5420_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-5420_treatment8	NA	NA	NA	NA	2f39544f-49e2-486e-a0b6-3a2bd203e1ff	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	8b119d1c-6d21-4bbd-8a00-12da7b97d6c4	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5420	67	false	Germany	-24472	NA	9650f432-c6cf-578f-ac8b-ced9be3e1b4d	not reported	male	not reported	TCGA-05-5420_demographic	Alive	24717	NA	NA	NA	NA	NA	not reported	245	NA	a3fe8ae2-4989-48ef-896d-ae7b24d8b27e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-5420_diagnosis2	NA	Not Reported	TCGA-05-5420_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-5420_treatment7	NA	NA	NA	NA	44e078cd-f450-4475-82bd-a4c5ca902b0d	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8b3a111a-aa46-41b9-bbec-28f4290da939	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z026	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	8c695c24-e7f9-449a-9258-a1bc8a33bf9a	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-97-8174	67	false	United States	-24725	164	f7892669-bf13-5e6f-a179-721bc8848238	not hispanic or latino	male	white	TCGA-97-8174_demographic	Dead	24725	M0	N0	Stage IIA	T2b	7th	primary	0	164.0	3016cbaa-0b61-519d-9318-8a7f2826c04b	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-97-8174_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	102	53	NA	NA	NA	NA	NA	NA	TCGA-97-8174_treatment	Vinorelbine	NA	NA	NA	158a0ead-f55f-51dd-b230-18f473663689	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	8c695c24-e7f9-449a-9258-a1bc8a33bf9a	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-97-8174	67	false	United States	-24725	164	f7892669-bf13-5e6f-a179-721bc8848238	not hispanic or latino	male	white	TCGA-97-8174_demographic	Dead	24725	M0	N0	Stage IIA	T2b	7th	primary	0	164.0	3016cbaa-0b61-519d-9318-8a7f2826c04b	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-97-8174_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	102	53	NA	NA	NA	NA	NA	NA	TCGA-97-8174_treatment2	Cisplatin	NA	NA	NA	44e950fa-6728-444c-b4f7-b69c2f41ac39	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	8c695c24-e7f9-449a-9258-a1bc8a33bf9a	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-97-8174	67	false	United States	-24725	164	f7892669-bf13-5e6f-a179-721bc8848238	not hispanic or latino	male	white	TCGA-97-8174_demographic	Dead	24725	M0	N0	Stage IIA	T2b	7th	primary	0	164.0	3016cbaa-0b61-519d-9318-8a7f2826c04b	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-97-8174_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8174_treatment3	NA	NA	NA	NA	bb726f1f-1a86-4bab-823b-bc9296294cb2	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8cc6bcec-65df-46a9-a88c-09762a132857	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4SY	61	false	United States	-22448	1501	79b4a31f-648d-59ed-8214-89ce055a3802	not hispanic or latino	male	white	TCGA-MP-A4SY_demographic	Dead	22937	NA	NA	NA	NA	NA	recurrence	489	NA	6263e985-1847-47c0-9bbf-b496dccc904f	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4SY_diagnosis2	NA	Not Reported	TCGA-MP-A4SY_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4SY_treatment4	NA	NA	NA	NA	0c41fddb-f85f-41b6-b8bf-7ae214c47f07	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8cc6bcec-65df-46a9-a88c-09762a132857	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4SY	61	false	United States	-22448	1501	79b4a31f-648d-59ed-8214-89ce055a3802	not hispanic or latino	male	white	TCGA-MP-A4SY_demographic	Dead	22937	NA	NA	NA	NA	NA	recurrence	489	NA	6263e985-1847-47c0-9bbf-b496dccc904f	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4SY_diagnosis2	NA	Not Reported	TCGA-MP-A4SY_diagnosis	NA	NA	NA	NA	489	NA	NA	NA	NA	NA	NA	TCGA-MP-A4SY_treatment5	NA	Locoregional Site	NA	NA	9ae328e7-69ee-4f30-8e45-d621b263fb47	NA	yes	NA	Surgery, NOS
TCGA-LUAD	8cc6bcec-65df-46a9-a88c-09762a132857	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4SY	61	false	United States	-22448	1501	79b4a31f-648d-59ed-8214-89ce055a3802	not hispanic or latino	male	white	TCGA-MP-A4SY_demographic	Dead	22937	NA	NA	NA	NA	NA	recurrence	489	NA	6263e985-1847-47c0-9bbf-b496dccc904f	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4SY_diagnosis2	NA	Not Reported	TCGA-MP-A4SY_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4SY_treatment3	NA	NA	NA	NA	f49eac19-8a2d-4dda-bbaa-a69f025bc41c	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8cc6bcec-65df-46a9-a88c-09762a132857	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4SY	61	false	United States	-22448	1501	79b4a31f-648d-59ed-8214-89ce055a3802	not hispanic or latino	male	white	TCGA-MP-A4SY_demographic	Dead	22448	M0	N1	Stage IIB	T2	5th	primary	0	1501.0	f708410f-a230-5916-b1e9-2e6dc9e141d4	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-MP-A4SY_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4SY_treatment2	NA	NA	NA	NA	6363957e-2bc9-4997-9cab-7c381738801f	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8cc6bcec-65df-46a9-a88c-09762a132857	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4SY	61	false	United States	-22448	1501	79b4a31f-648d-59ed-8214-89ce055a3802	not hispanic or latino	male	white	TCGA-MP-A4SY_demographic	Dead	22448	M0	N1	Stage IIB	T2	5th	primary	0	1501.0	f708410f-a230-5916-b1e9-2e6dc9e141d4	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-MP-A4SY_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4SY_treatment	NA	NA	NA	NA	b3d39d6e-899c-5511-9e0a-70c2fcd914c1	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8d0736fe-261c-445c-bfd2-a3ea3ceaf367	Informed Consent	390	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6971	59	false	United States	-21734	NA	db2f841d-3976-50d8-9810-89a5b928dda5	not reported	female	white	TCGA-55-6971_demographic	Alive	21734	MX	N0	Stage IB	T2	7th	primary	0	1400.0	5953c141-2cf8-5965-8457-5d74db8e5720	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-6971_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6971_treatment	NA	NA	NA	NA	a9796ae0-b459-57ee-a8b4-9e9075ff7d0b	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8d0736fe-261c-445c-bfd2-a3ea3ceaf367	Informed Consent	390	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6971	59	false	United States	-21734	NA	db2f841d-3976-50d8-9810-89a5b928dda5	not reported	female	white	TCGA-55-6971_demographic	Alive	21734	MX	N0	Stage IB	T2	7th	primary	0	1400.0	5953c141-2cf8-5965-8457-5d74db8e5720	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-6971_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6971_treatment2	NA	NA	NA	NA	be4ddccd-e40c-48c7-8e61-625d94d23ceb	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8d535aa6-6d59-4965-b5ed-17217d8f5930	Informed Consent	106	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8621	75	false	United States	-27485	NA	41bcd369-366b-52ec-950b-0a60e5277c2e	not hispanic or latino	female	white	TCGA-55-8621_demographic	Alive	26993	NA	NA	NA	NA	NA	Prior primary	-492	NA	d339f26e-4ec1-4c0f-9120-3e1016f8c48a	false	NA	NA	NA	Left	8310/3	Clear cell carcinoma	NA	NA	NA	Not Reported	NA	TCGA-55-8621_diagnosis2	NA	Kidney, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8621_treatment4	NA	NA	NA	NA	cdcced74-29a2-4cba-b620-bca8145968c8	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8d535aa6-6d59-4965-b5ed-17217d8f5930	Informed Consent	106	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8621	75	false	United States	-27485	NA	41bcd369-366b-52ec-950b-0a60e5277c2e	not hispanic or latino	female	white	TCGA-55-8621_demographic	Alive	26993	NA	NA	NA	NA	NA	Prior primary	-492	NA	d339f26e-4ec1-4c0f-9120-3e1016f8c48a	false	NA	NA	NA	Left	8310/3	Clear cell carcinoma	NA	NA	NA	Not Reported	NA	TCGA-55-8621_diagnosis2	NA	Kidney, NOS	NA	NA	NA	NA	NA	-492	NA	NA	NA	NA	NA	NA	TCGA-55-8621_treatment5	NA	NA	NA	NA	f58e1cf9-2d62-4f1e-9d10-d536c52601a3	NA	yes	NA	Surgery, NOS
TCGA-LUAD	8d535aa6-6d59-4965-b5ed-17217d8f5930	Informed Consent	106	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8621	75	false	United States	-27485	NA	41bcd369-366b-52ec-950b-0a60e5277c2e	not hispanic or latino	female	white	TCGA-55-8621_demographic	Alive	26993	NA	NA	NA	NA	NA	Prior primary	-492	NA	d339f26e-4ec1-4c0f-9120-3e1016f8c48a	false	NA	NA	NA	Left	8310/3	Clear cell carcinoma	NA	NA	NA	Not Reported	NA	TCGA-55-8621_diagnosis2	NA	Kidney, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8621_treatment3	NA	NA	NA	NA	fed32717-8f01-46af-8b70-637ab915989d	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8d535aa6-6d59-4965-b5ed-17217d8f5930	Informed Consent	106	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8621	75	false	United States	-27485	NA	41bcd369-366b-52ec-950b-0a60e5277c2e	not hispanic or latino	female	white	TCGA-55-8621_demographic	Alive	27485	MX	N0	Stage IA	T1a	7th	primary	0	515.0	d4f85871-d994-55fa-a294-4819ae155f28	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-8621_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8621_treatment2	NA	NA	NA	NA	3eb93b61-602d-4de7-b184-038899301ab4	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8d535aa6-6d59-4965-b5ed-17217d8f5930	Informed Consent	106	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8621	75	false	United States	-27485	NA	41bcd369-366b-52ec-950b-0a60e5277c2e	not hispanic or latino	female	white	TCGA-55-8621_demographic	Alive	27485	MX	N0	Stage IA	T1a	7th	primary	0	515.0	d4f85871-d994-55fa-a294-4819ae155f28	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-8621_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8621_treatment	NA	NA	NA	NA	f81fc704-8f7e-5df9-b7e1-3c1c4a7ebcc4	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8e2aca86-7cba-4631-9f25-4d14219dbc6d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A456	78	false	Vietnam	-28533	NA	98a54dc4-9e8c-5ac1-9e2b-0ecada9b4ba8	not hispanic or latino	female	asian	TCGA-86-A456_demographic	Alive	28533	M0	N0	Stage IA	T1a	7th	primary	0	896.0	3f1aafd6-287b-52a7-aa43-506139486340	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-A456_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-A456_treatment2	NA	NA	NA	NA	353a5a0c-89f8-4b38-a20c-a7cc502dc255	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	8e2aca86-7cba-4631-9f25-4d14219dbc6d	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A456	78	false	Vietnam	-28533	NA	98a54dc4-9e8c-5ac1-9e2b-0ecada9b4ba8	not hispanic or latino	female	asian	TCGA-86-A456_demographic	Alive	28533	M0	N0	Stage IA	T1a	7th	primary	0	896.0	3f1aafd6-287b-52a7-aa43-506139486340	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-A456_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-A456_treatment	NA	NA	NA	NA	a1331b0c-44d1-5d6e-adf0-3b2ac6041d8d	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8e41153b-9faf-45c3-8397-8a428ef5c0d5	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7573	72	false	United States	-26302	NA	3812cffc-5a93-5c75-9987-4ec312ad2468	not hispanic or latino	female	white	TCGA-55-7573_demographic	Alive	26302	MX	N0	Stage IA	T1b	7th	primary	0	487.0	321b5d8a-3d2b-55a0-9ba1-e24c624188c4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	Central Lung	TCGA-55-7573_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7573_treatment	NA	NA	NA	NA	5ca42e42-0910-5eb5-9724-1c4124269417	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8e41153b-9faf-45c3-8397-8a428ef5c0d5	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7573	72	false	United States	-26302	NA	3812cffc-5a93-5c75-9987-4ec312ad2468	not hispanic or latino	female	white	TCGA-55-7573_demographic	Alive	26302	MX	N0	Stage IA	T1b	7th	primary	0	487.0	321b5d8a-3d2b-55a0-9ba1-e24c624188c4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	Central Lung	TCGA-55-7573_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7573_treatment2	NA	NA	NA	NA	eb8ee463-ce68-4a7b-a88b-58c3dd553331	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8e41153b-9faf-45c3-8397-8a428ef5c0d5	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7573	72	false	United States	-26302	NA	3812cffc-5a93-5c75-9987-4ec312ad2468	not hispanic or latino	female	white	TCGA-55-7573_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	fc645d87-2107-4c27-a4ec-c512a9deed6a	false	NA	NA	NA	Left	8312/3	Renal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-7573_diagnosis2	NA	Kidney, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7573_treatment4	NA	NA	NA	NA	0bc1dc18-df4a-4697-b847-ed172d29dd11	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8e41153b-9faf-45c3-8397-8a428ef5c0d5	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7573	72	false	United States	-26302	NA	3812cffc-5a93-5c75-9987-4ec312ad2468	not hispanic or latino	female	white	TCGA-55-7573_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	fc645d87-2107-4c27-a4ec-c512a9deed6a	false	NA	NA	NA	Left	8312/3	Renal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-7573_diagnosis2	NA	Kidney, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7573_treatment3	NA	NA	NA	NA	8df8b8b9-8f0f-4956-91f2-c12e09419e0c	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8f04660a-2efb-4947-9eab-375066b9eb33	Informed Consent	1515	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A5C7	76	false	United States	-28015	NA	b45d5702-8d38-574e-bc70-bf4686bf7d27	not hispanic or latino	female	white	TCGA-MP-A5C7_demographic	Alive	28015	M0	N0	Stage IB	T2	6th	primary	0	2248.0	d09656e9-03cd-58e6-b9d2-2afbe24d04e3	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-MP-A5C7_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A5C7_treatment2	NA	NA	NA	NA	047171d8-9383-4c66-bfbc-35847a30cee8	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8f04660a-2efb-4947-9eab-375066b9eb33	Informed Consent	1515	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A5C7	76	false	United States	-28015	NA	b45d5702-8d38-574e-bc70-bf4686bf7d27	not hispanic or latino	female	white	TCGA-MP-A5C7_demographic	Alive	28015	M0	N0	Stage IB	T2	6th	primary	0	2248.0	d09656e9-03cd-58e6-b9d2-2afbe24d04e3	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-MP-A5C7_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A5C7_treatment	NA	NA	NA	NA	fde29055-9bf2-5d2f-b9ac-0149367d510b	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8f52cccd-5709-4753-9670-31a573ee27ab	Consent by Death	NA	Cystic, Mucinous and Serous Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TJ	62	false	United States	-22875	339	9360994a-f205-5107-bb6a-18b4511a7eb8	Unknown	female	Unknown	TCGA-MP-A4TJ_demographic	Dead	22875	M0	N0	Stage IA	T1	6th	primary	0	339.0	9efa862a-24ec-5378-b0ee-e1ceb195b4b6	true	NA	NA	C34.1	Right	8490/3	Signet ring cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-MP-A4TJ_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TJ_treatment2	NA	NA	NA	NA	4caa08b8-ba03-4e56-af1d-17b5a67325e4	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8f52cccd-5709-4753-9670-31a573ee27ab	Consent by Death	NA	Cystic, Mucinous and Serous Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TJ	62	false	United States	-22875	339	9360994a-f205-5107-bb6a-18b4511a7eb8	Unknown	female	Unknown	TCGA-MP-A4TJ_demographic	Dead	22875	M0	N0	Stage IA	T1	6th	primary	0	339.0	9efa862a-24ec-5378-b0ee-e1ceb195b4b6	true	NA	NA	C34.1	Right	8490/3	Signet ring cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-MP-A4TJ_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TJ_treatment	NA	NA	NA	NA	e2e13267-ed3f-547d-8b6d-9d3202bd81c4	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8fdbd88f-19ae-4ab8-bcd7-6bfa1bbde742	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-5778	60	false	United States	-21927	NA	a14935a1-37e8-5b99-b730-1b1faa66f1fe	not hispanic or latino	male	white	TCGA-64-5778_demographic	Alive	21927	M0	N0	Stage IB	T2	6th	primary	0	1305.0	0ac00a93-c50e-5079-bc67-9445ef67da6f	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5778_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	NA	1174	NA	NA	NA	NA	NA	NA	TCGA-64-5778_treatment2	Erlotinib Hydrochloride	NA	NA	NA	12aea7fb-d2a7-4a19-8453-99030321c51b	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	8fdbd88f-19ae-4ab8-bcd7-6bfa1bbde742	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-5778	60	false	United States	-21927	NA	a14935a1-37e8-5b99-b730-1b1faa66f1fe	not hispanic or latino	male	white	TCGA-64-5778_demographic	Alive	21927	M0	N0	Stage IB	T2	6th	primary	0	1305.0	0ac00a93-c50e-5079-bc67-9445ef67da6f	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5778_diagnosis	No	Upper lobe, lung	NA	2008	NA	1.0	1022	994	Recurrent Disease	NA	20.0	NA	NA	NA	TCGA-64-5778_treatment	NA	Distant Site	NA	NA	4e0d80ae-2156-5c7c-8a67-b9d9ae44ed5f	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	8fdbd88f-19ae-4ab8-bcd7-6bfa1bbde742	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-5778	60	false	United States	-21927	NA	a14935a1-37e8-5b99-b730-1b1faa66f1fe	not hispanic or latino	male	white	TCGA-64-5778_demographic	Alive	23095	NA	NA	NA	NA	NA	not reported	1168	NA	75fe3bbb-ff31-473b-9b3a-4bf4466f8b0e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-5778_diagnosis3	NA	Not Reported	TCGA-64-5778_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-5778_treatment9	NA	Distant Site	NA	NA	083dff4e-0c6f-4ea9-8a55-990f03d41e81	NA	no	NA	Surgery, NOS
TCGA-LUAD	8fdbd88f-19ae-4ab8-bcd7-6bfa1bbde742	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-5778	60	false	United States	-21927	NA	a14935a1-37e8-5b99-b730-1b1faa66f1fe	not hispanic or latino	male	white	TCGA-64-5778_demographic	Alive	23095	NA	NA	NA	NA	NA	not reported	1168	NA	75fe3bbb-ff31-473b-9b3a-4bf4466f8b0e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-5778_diagnosis3	NA	Not Reported	TCGA-64-5778_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-64-5778_treatment7	NA	NA	NA	NA	22177526-230d-4c6d-b476-dc99d237d782	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	8fdbd88f-19ae-4ab8-bcd7-6bfa1bbde742	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-5778	60	false	United States	-21927	NA	a14935a1-37e8-5b99-b730-1b1faa66f1fe	not hispanic or latino	male	white	TCGA-64-5778_demographic	Alive	23095	NA	NA	NA	NA	NA	not reported	1168	NA	75fe3bbb-ff31-473b-9b3a-4bf4466f8b0e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-5778_diagnosis3	NA	Not Reported	TCGA-64-5778_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-64-5778_treatment6	NA	NA	NA	NA	71bb8cf2-9900-48a9-84bc-9908b317f9d5	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	8fdbd88f-19ae-4ab8-bcd7-6bfa1bbde742	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-5778	60	false	United States	-21927	NA	a14935a1-37e8-5b99-b730-1b1faa66f1fe	not hispanic or latino	male	white	TCGA-64-5778_demographic	Alive	23095	NA	NA	NA	NA	NA	not reported	1168	NA	75fe3bbb-ff31-473b-9b3a-4bf4466f8b0e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-5778_diagnosis3	NA	Not Reported	TCGA-64-5778_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-5778_treatment8	NA	Locoregional Site	NA	NA	f8696e8d-d9ee-4fd2-a7e6-7362ecc1a7f7	NA	no	NA	Surgery, NOS
TCGA-LUAD	8fdbd88f-19ae-4ab8-bcd7-6bfa1bbde742	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-5778	60	false	United States	-21927	NA	a14935a1-37e8-5b99-b730-1b1faa66f1fe	not hispanic or latino	male	white	TCGA-64-5778_demographic	Alive	22889	NA	NA	NA	NA	NA	metastasis	962	NA	c311227a-3dda-474e-a8f1-bed54a10bfb8	false	NA	NA	NA	NA	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	Yes	NA	Not Reported	NA	TCGA-64-5778_diagnosis2	NA	Not Reported	TCGA-64-5778_diagnosis	NA	NA	NA	NA	975	NA	NA	NA	NA	NA	NA	TCGA-64-5778_treatment5	NA	Distant Site	NA	NA	1395c29c-4624-402b-9d48-985220e88557	NA	yes	NA	Surgery, NOS
TCGA-LUAD	8fdbd88f-19ae-4ab8-bcd7-6bfa1bbde742	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-5778	60	false	United States	-21927	NA	a14935a1-37e8-5b99-b730-1b1faa66f1fe	not hispanic or latino	male	white	TCGA-64-5778_demographic	Alive	22889	NA	NA	NA	NA	NA	metastasis	962	NA	c311227a-3dda-474e-a8f1-bed54a10bfb8	false	NA	NA	NA	NA	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	Yes	NA	Not Reported	NA	TCGA-64-5778_diagnosis2	NA	Not Reported	TCGA-64-5778_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-64-5778_treatment4	NA	NA	NA	NA	844ef4c4-0d84-4c83-9f60-78aea9b37456	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	8fdbd88f-19ae-4ab8-bcd7-6bfa1bbde742	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-64-5778	60	false	United States	-21927	NA	a14935a1-37e8-5b99-b730-1b1faa66f1fe	not hispanic or latino	male	white	TCGA-64-5778_demographic	Alive	22889	NA	NA	NA	NA	NA	metastasis	962	NA	c311227a-3dda-474e-a8f1-bed54a10bfb8	false	NA	NA	NA	NA	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	Yes	NA	Not Reported	NA	TCGA-64-5778_diagnosis2	NA	Not Reported	TCGA-64-5778_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-64-5778_treatment3	NA	NA	NA	NA	e4494752-b41b-47b9-bc82-fcdb8de6b721	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	923b37e4-fcf7-46a0-8cb2-9139711fec7b	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7726	72	false	United States	-26451	NA	c8b925cb-2614-56b0-a5d7-ae838ffbc3c0	not hispanic or latino	female	white	TCGA-55-7726_demographic	Alive	26451	MX	N0	Stage IA	T1b	7th	primary	0	652.0	6faa9287-f15a-5428-81dc-d3c862e9604a	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-7726_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7726_treatment2	NA	NA	NA	NA	a5c57260-85ad-43a3-a7aa-c5f27e040110	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	923b37e4-fcf7-46a0-8cb2-9139711fec7b	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7726	72	false	United States	-26451	NA	c8b925cb-2614-56b0-a5d7-ae838ffbc3c0	not hispanic or latino	female	white	TCGA-55-7726_demographic	Alive	26451	MX	N0	Stage IA	T1b	7th	primary	0	652.0	6faa9287-f15a-5428-81dc-d3c862e9604a	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-7726_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7726_treatment	NA	NA	NA	NA	d4236d30-d907-5e1e-86d9-1d2b07b6d940	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	923b37e4-fcf7-46a0-8cb2-9139711fec7b	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7726	72	false	United States	-26451	NA	c8b925cb-2614-56b0-a5d7-ae838ffbc3c0	not hispanic or latino	female	white	TCGA-55-7726_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ac6a2652-cc72-47ad-a8e4-22eb8436c8ad	false	NA	NA	NA	Left	8410/3	Sebaceous adenocarcinoma	NA	NA	NA	Not Reported	NA	TCGA-55-7726_diagnosis2	NA	Eyelid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7726_treatment3	NA	NA	NA	NA	b12059b1-a566-4fc2-abce-40f4cb798ac4	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	923b37e4-fcf7-46a0-8cb2-9139711fec7b	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7726	72	false	United States	-26451	NA	c8b925cb-2614-56b0-a5d7-ae838ffbc3c0	not hispanic or latino	female	white	TCGA-55-7726_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ac6a2652-cc72-47ad-a8e4-22eb8436c8ad	false	NA	NA	NA	Left	8410/3	Sebaceous adenocarcinoma	NA	NA	NA	Not Reported	NA	TCGA-55-7726_diagnosis2	NA	Eyelid	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7726_treatment4	NA	NA	NA	NA	d6ec36fa-0772-4c48-bbf3-af6b7903e0df	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9240d5fc-de23-4436-8099-da9bd3054860	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8397	70	false	Germany	-25728	NA	956526bb-8ed8-5711-90ae-be0a6a6b3f56	not hispanic or latino	female	white	TCGA-62-8397_demographic	Alive	25728	M0	N0	Stage IIB	T3	6th	primary	0	1289.0	f13a871d-abf3-524e-9550-e5001beb7cbb	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-8397_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8397_treatment	NA	NA	NA	NA	058d6d30-ffbe-54d9-8315-3eb4e67003fe	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9240d5fc-de23-4436-8099-da9bd3054860	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-8397	70	false	Germany	-25728	NA	956526bb-8ed8-5711-90ae-be0a6a6b3f56	not hispanic or latino	female	white	TCGA-62-8397_demographic	Alive	25728	M0	N0	Stage IIB	T3	6th	primary	0	1289.0	f13a871d-abf3-524e-9550-e5001beb7cbb	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-8397_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-8397_treatment2	NA	NA	NA	NA	321e43e1-e3d0-40ea-a17d-4bd62f2ed43e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	927fc5e0-2c14-4c20-a49b-f10d8a1175c3	Informed Consent	56	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A8F4	64	false	United States	-23617	NA	c4de4cce-360f-5a80-bf5e-332bc6a1f20f	not hispanic or latino	female	black or african american	TCGA-L9-A8F4_demographic	Alive	23617	MX	N0	Stage IB	T2a	7th	primary	0	476.0	b4308ca4-d6dd-51d1-a3ee-913e0b54b9be	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-L9-A8F4_diagnosis	No	Upper lobe, lung	NA	2013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A8F4_treatment2	NA	NA	NA	NA	282bfdaf-21c1-4546-9518-0bf91701092c	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	927fc5e0-2c14-4c20-a49b-f10d8a1175c3	Informed Consent	56	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A8F4	64	false	United States	-23617	NA	c4de4cce-360f-5a80-bf5e-332bc6a1f20f	not hispanic or latino	female	black or african american	TCGA-L9-A8F4_demographic	Alive	23617	MX	N0	Stage IB	T2a	7th	primary	0	476.0	b4308ca4-d6dd-51d1-a3ee-913e0b54b9be	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-L9-A8F4_diagnosis	No	Upper lobe, lung	NA	2013	NA	NA	NA	64	NA	NA	NA	NA	NA	NA	TCGA-L9-A8F4_treatment	NA	Primary Tumor Field	82	Gy	bff0908b-8871-54a9-884e-100872747443	NA	yes	Treatment Ongoing	Radiation, Internal
TCGA-LUAD	93766482-2f20-4c8f-bbd8-bdd203c37d5a	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-5126	NA	false	Canada	NA	NA	a65ae387-93e7-5788-ac03-7ae0c78afc76	not reported	female	not reported	TCGA-75-5126_demographic	Alive	NA	M0	N2	Stage IIIA	T3	NA	primary	NA	NA	389482d1-7400-5b4b-8497-5855d1bde98a	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R2	Lung, NOS	Peripheral Lung	TCGA-75-5126_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5126_treatment2	NA	NA	NA	NA	9e53babd-e254-493e-9803-491c8cd37f05	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	93766482-2f20-4c8f-bbd8-bdd203c37d5a	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-5126	NA	false	Canada	NA	NA	a65ae387-93e7-5788-ac03-7ae0c78afc76	not reported	female	not reported	TCGA-75-5126_demographic	Alive	NA	M0	N2	Stage IIIA	T3	NA	primary	NA	NA	389482d1-7400-5b4b-8497-5855d1bde98a	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R2	Lung, NOS	Peripheral Lung	TCGA-75-5126_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5126_treatment	NA	NA	NA	NA	f6433158-f812-5e4b-b3a4-88a51b23eccc	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	93766482-2f20-4c8f-bbd8-bdd203c37d5a	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-5126	NA	false	Canada	NA	NA	a65ae387-93e7-5788-ac03-7ae0c78afc76	not reported	female	not reported	TCGA-75-5126_demographic	Alive	NA	NA	NA	NA	NA	NA	not reported	NA	NA	4b809a51-ca75-4426-afcb-38fd2529723f	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-5126_diagnosis2	NA	Not Reported	TCGA-75-5126_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5126_treatment5	NA	Locoregional Site	NA	NA	254a9c8b-f33a-41e3-848c-84bbbf20ce83	NA	no	NA	Surgery, NOS
TCGA-LUAD	93766482-2f20-4c8f-bbd8-bdd203c37d5a	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-5126	NA	false	Canada	NA	NA	a65ae387-93e7-5788-ac03-7ae0c78afc76	not reported	female	not reported	TCGA-75-5126_demographic	Alive	NA	NA	NA	NA	NA	NA	not reported	NA	NA	4b809a51-ca75-4426-afcb-38fd2529723f	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-5126_diagnosis2	NA	Not Reported	TCGA-75-5126_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-75-5126_treatment3	NA	NA	NA	NA	2e3a33ff-f9f4-4e4f-9f3e-9842460f4635	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	93766482-2f20-4c8f-bbd8-bdd203c37d5a	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-5126	NA	false	Canada	NA	NA	a65ae387-93e7-5788-ac03-7ae0c78afc76	not reported	female	not reported	TCGA-75-5126_demographic	Alive	NA	NA	NA	NA	NA	NA	not reported	NA	NA	4b809a51-ca75-4426-afcb-38fd2529723f	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-5126_diagnosis2	NA	Not Reported	TCGA-75-5126_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-75-5126_treatment4	NA	NA	NA	NA	778a3cc2-55b0-4e59-ab66-a71d88d2590f	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	93b62fc5-a0d3-4d32-bf27-cd7c9d43cd5f	Informed Consent	-30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2664	66	false	United States	-24468	NA	c02e904c-3886-5633-8d51-5e4c95e06e31	not hispanic or latino	female	black or african american	TCGA-44-2664_demographic	Alive	25281	NA	NA	NA	NA	NA	metastasis	813	NA	28a3099f-6b5c-4d7d-b126-2f62d1479ff4	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-2664_diagnosis2	NA	Not Reported	TCGA-44-2664_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-44-2664_treatment3	NA	NA	NA	NA	1fd0928c-95ed-432a-b658-587b9ee58a18	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	93b62fc5-a0d3-4d32-bf27-cd7c9d43cd5f	Informed Consent	-30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2664	66	false	United States	-24468	NA	c02e904c-3886-5633-8d51-5e4c95e06e31	not hispanic or latino	female	black or african american	TCGA-44-2664_demographic	Alive	25281	NA	NA	NA	NA	NA	metastasis	813	NA	28a3099f-6b5c-4d7d-b126-2f62d1479ff4	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-2664_diagnosis2	NA	Not Reported	TCGA-44-2664_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2664_treatment5	NA	Distant Site	NA	NA	6088cce3-b921-4178-8be1-ca482029f979	NA	no	NA	Surgery, NOS
TCGA-LUAD	93b62fc5-a0d3-4d32-bf27-cd7c9d43cd5f	Informed Consent	-30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2664	66	false	United States	-24468	NA	c02e904c-3886-5633-8d51-5e4c95e06e31	not hispanic or latino	female	black or african american	TCGA-44-2664_demographic	Alive	25281	NA	NA	NA	NA	NA	metastasis	813	NA	28a3099f-6b5c-4d7d-b126-2f62d1479ff4	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-2664_diagnosis2	NA	Not Reported	TCGA-44-2664_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-44-2664_treatment4	NA	NA	NA	NA	c83b830a-21ff-45db-a1cc-d72f7c48c2ea	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	93b62fc5-a0d3-4d32-bf27-cd7c9d43cd5f	Informed Consent	-30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2664	66	false	United States	-24468	NA	c02e904c-3886-5633-8d51-5e4c95e06e31	not hispanic or latino	female	black or african american	TCGA-44-2664_demographic	Alive	25300	NA	NA	NA	NA	NA	recurrence	832	NA	4a237f78-f1d8-4568-b829-60222e893f42	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-2664_diagnosis3	NA	Not Reported	TCGA-44-2664_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-2664_treatment6	NA	NA	NA	NA	00249c0b-093f-44a0-b6d5-39f0f07c52c2	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	93b62fc5-a0d3-4d32-bf27-cd7c9d43cd5f	Informed Consent	-30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2664	66	false	United States	-24468	NA	c02e904c-3886-5633-8d51-5e4c95e06e31	not hispanic or latino	female	black or african american	TCGA-44-2664_demographic	Alive	25300	NA	NA	NA	NA	NA	recurrence	832	NA	4a237f78-f1d8-4568-b829-60222e893f42	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-2664_diagnosis3	NA	Not Reported	TCGA-44-2664_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2664_treatment8	NA	Locoregional Site	NA	NA	2bddd349-308b-4619-bb88-fb600f205155	NA	no	NA	Surgery, NOS
TCGA-LUAD	93b62fc5-a0d3-4d32-bf27-cd7c9d43cd5f	Informed Consent	-30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2664	66	false	United States	-24468	NA	c02e904c-3886-5633-8d51-5e4c95e06e31	not hispanic or latino	female	black or african american	TCGA-44-2664_demographic	Alive	25300	NA	NA	NA	NA	NA	recurrence	832	NA	4a237f78-f1d8-4568-b829-60222e893f42	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-2664_diagnosis3	NA	Not Reported	TCGA-44-2664_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-2664_treatment7	NA	NA	NA	NA	9d549ade-b77c-416d-92d9-aa4dcc5e34c9	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	93b62fc5-a0d3-4d32-bf27-cd7c9d43cd5f	Informed Consent	-30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2664	66	false	United States	-24468	NA	c02e904c-3886-5633-8d51-5e4c95e06e31	not hispanic or latino	female	black or african american	TCGA-44-2664_demographic	Alive	24468	M0	N0	Stage IA	T1	6th	primary	0	1251.0	a9fa7a54-5051-560f-bb8d-a4185e39a960	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2664_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2664_treatment2	NA	NA	NA	NA	201d21fb-fa3c-4ca1-a6fa-5d9e73107ba2	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	93b62fc5-a0d3-4d32-bf27-cd7c9d43cd5f	Informed Consent	-30	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2664	66	false	United States	-24468	NA	c02e904c-3886-5633-8d51-5e4c95e06e31	not hispanic or latino	female	black or african american	TCGA-44-2664_demographic	Alive	24468	M0	N0	Stage IA	T1	6th	primary	0	1251.0	a9fa7a54-5051-560f-bb8d-a4185e39a960	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2664_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2664_treatment	NA	NA	NA	NA	747d10bd-8bf4-5e1c-8415-0f1d554c23cb	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	94ee639e-3cb4-4943-b5f1-a89eb902153c	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z041	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	9536e32d-2707-48d2-a36d-08c521665bb9	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-91-6828	70	false	United States	-25870	NA	d56d84ed-3e9c-5d14-8842-4fb95f6fb195	not hispanic or latino	male	white	TCGA-91-6828_demographic	Alive	25870	M0	N0	Stage IA	T1a	7th	primary	0	323.0	1cb57e0f-04dc-55a0-b7a7-efded807ef84	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-91-6828_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6828_treatment	NA	NA	NA	NA	3f0e3e63-e208-58a6-9ac7-0a0079a7969c	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9536e32d-2707-48d2-a36d-08c521665bb9	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-91-6828	70	false	United States	-25870	NA	d56d84ed-3e9c-5d14-8842-4fb95f6fb195	not hispanic or latino	male	white	TCGA-91-6828_demographic	Alive	25870	M0	N0	Stage IA	T1a	7th	primary	0	323.0	1cb57e0f-04dc-55a0-b7a7-efded807ef84	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-91-6828_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6828_treatment2	NA	NA	NA	NA	e5bde363-68a2-47fe-888e-c311576e0184	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	953a908d-0993-42f6-853b-512611d19a2c	Informed Consent	28	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6849	75	false	United States	-27676	NA	db6afa58-28d7-5846-9e18-b51c40bfbafb	not hispanic or latino	female	black or african american	TCGA-91-6849_demographic	Alive	27676	MX	N2	Stage IIIA	T2	6th	primary	0	35.0	bb90e2aa-9ce7-5bdb-9dc3-5580d0a59687	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6849_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6849_treatment	NA	NA	NA	NA	60722af1-072d-589a-846c-cb835e320982	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	953a908d-0993-42f6-853b-512611d19a2c	Informed Consent	28	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6849	75	false	United States	-27676	NA	db6afa58-28d7-5846-9e18-b51c40bfbafb	not hispanic or latino	female	black or african american	TCGA-91-6849_demographic	Alive	27676	MX	N2	Stage IIIA	T2	6th	primary	0	35.0	bb90e2aa-9ce7-5bdb-9dc3-5580d0a59687	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6849_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6849_treatment2	NA	NA	NA	NA	91dc3cee-d07d-4f89-8bdc-0870fd3d19d7	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	9582b436-145b-4f84-8f7f-8b39b8254cc1	Informed Consent	37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-8033	74	false	United States	-27342	656	be35b84c-8c75-5fd5-ad4d-6e7d55ae36c4	not hispanic or latino	female	white	TCGA-99-8033_demographic	Dead	27342	M1	NX	Stage IV	TX	7th	primary	0	656.0	0fe120c3-7b42-5c53-ad08-bf9e7a1ca154	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-99-8033_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	NA	78	NA	NA	NA	NA	NA	NA	TCGA-99-8033_treatment	Carboplatin	NA	NA	NA	0b3f7824-c5a1-55ef-a07d-d453cbf09fa1	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	9582b436-145b-4f84-8f7f-8b39b8254cc1	Informed Consent	37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-8033	74	false	United States	-27342	656	be35b84c-8c75-5fd5-ad4d-6e7d55ae36c4	not hispanic or latino	female	white	TCGA-99-8033_demographic	Dead	27342	M1	NX	Stage IV	TX	7th	primary	0	656.0	0fe120c3-7b42-5c53-ad08-bf9e7a1ca154	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-99-8033_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-99-8033_treatment4	NA	NA	NA	NA	1b079708-a7fe-435e-acbc-2b16ff2d327b	Adjuvant	yes	Progressive Disease	Radiation Therapy, NOS
TCGA-LUAD	9582b436-145b-4f84-8f7f-8b39b8254cc1	Informed Consent	37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-8033	74	false	United States	-27342	656	be35b84c-8c75-5fd5-ad4d-6e7d55ae36c4	not hispanic or latino	female	white	TCGA-99-8033_demographic	Dead	27342	M1	NX	Stage IV	TX	7th	primary	0	656.0	0fe120c3-7b42-5c53-ad08-bf9e7a1ca154	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-99-8033_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	NA	107	NA	NA	NA	NA	NA	NA	TCGA-99-8033_treatment3	Paclitaxel	NA	NA	NA	8368c5be-137e-4280-9d9e-a9b8895d4701	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	9582b436-145b-4f84-8f7f-8b39b8254cc1	Informed Consent	37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-8033	74	false	United States	-27342	656	be35b84c-8c75-5fd5-ad4d-6e7d55ae36c4	not hispanic or latino	female	white	TCGA-99-8033_demographic	Dead	27342	M1	NX	Stage IV	TX	7th	primary	0	656.0	0fe120c3-7b42-5c53-ad08-bf9e7a1ca154	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-99-8033_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	78	78	NA	NA	NA	NA	NA	NA	TCGA-99-8033_treatment2	Pemetrexed Disodium	NA	NA	NA	a119dfa9-ff04-4557-aa2c-efcb7a8300fa	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	95fa64b0-91e1-4427-b81a-53c47a053563	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8205	76	false	United States	-28063	NA	d92b2e0f-691e-57c5-9247-c66e7992903a	not hispanic or latino	female	white	TCGA-55-8205_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	3dd95863-b1b0-4126-8ad3-bf2aa4c4abe3	false	NA	NA	NA	Unknown	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8205_diagnosis3	NA	Skin of other and unspecified parts of face	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8205_treatment7	NA	Not Reported	NA	NA	140ff418-6e37-4eaf-abd7-42b3391e8dac	NA	yes	NA	Surgery, NOS
TCGA-LUAD	95fa64b0-91e1-4427-b81a-53c47a053563	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8205	76	false	United States	-28063	NA	d92b2e0f-691e-57c5-9247-c66e7992903a	not hispanic or latino	female	white	TCGA-55-8205_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	3dd95863-b1b0-4126-8ad3-bf2aa4c4abe3	false	NA	NA	NA	Unknown	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8205_diagnosis3	NA	Skin of other and unspecified parts of face	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8205_treatment5	NA	NA	NA	NA	2823831f-6a81-42e9-8b83-0f3c6dcc38ad	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	95fa64b0-91e1-4427-b81a-53c47a053563	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8205	76	false	United States	-28063	NA	d92b2e0f-691e-57c5-9247-c66e7992903a	not hispanic or latino	female	white	TCGA-55-8205_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	3dd95863-b1b0-4126-8ad3-bf2aa4c4abe3	false	NA	NA	NA	Unknown	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8205_diagnosis3	NA	Skin of other and unspecified parts of face	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8205_treatment6	NA	NA	NA	NA	852096f3-df92-43c6-a025-1e6abed8d86c	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	95fa64b0-91e1-4427-b81a-53c47a053563	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8205	76	false	United States	-28063	NA	d92b2e0f-691e-57c5-9247-c66e7992903a	not hispanic or latino	female	white	TCGA-55-8205_demographic	Alive	28063	M0	N0	Stage IIA	T2b	7th	primary	0	599.0	94d3d4e8-69cf-5ae9-9679-91f2c8efc36f	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-55-8205_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	154	93	NA	NA	NA	NA	NA	NA	TCGA-55-8205_treatment2	Carboplatin	NA	NA	NA	78fa3740-2ad1-4334-8613-c917ca3c62e8	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	95fa64b0-91e1-4427-b81a-53c47a053563	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8205	76	false	United States	-28063	NA	d92b2e0f-691e-57c5-9247-c66e7992903a	not hispanic or latino	female	white	TCGA-55-8205_demographic	Alive	28063	M0	N0	Stage IIA	T2b	7th	primary	0	599.0	94d3d4e8-69cf-5ae9-9679-91f2c8efc36f	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-55-8205_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	154	93	NA	NA	NA	NA	NA	NA	TCGA-55-8205_treatment3	Pemetrexed Disodium	NA	NA	NA	9bcb0056-ea2e-4ada-8514-2af3f679f9fc	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	95fa64b0-91e1-4427-b81a-53c47a053563	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8205	76	false	United States	-28063	NA	d92b2e0f-691e-57c5-9247-c66e7992903a	not hispanic or latino	female	white	TCGA-55-8205_demographic	Alive	28063	M0	N0	Stage IIA	T2b	7th	primary	0	599.0	94d3d4e8-69cf-5ae9-9679-91f2c8efc36f	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-55-8205_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	525	508	NA	NA	14.0	NA	NA	NA	TCGA-55-8205_treatment	NA	Distant Site	3500	cGy	ab91cc8c-9f28-5d8b-bebc-802df93e8f40	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	95fa64b0-91e1-4427-b81a-53c47a053563	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8205	76	false	United States	-28063	NA	d92b2e0f-691e-57c5-9247-c66e7992903a	not hispanic or latino	female	white	TCGA-55-8205_demographic	Alive	28063	M0	N0	Stage IIA	T2b	7th	primary	0	599.0	94d3d4e8-69cf-5ae9-9679-91f2c8efc36f	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-55-8205_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	NA	488	NA	NA	NA	NA	NA	NA	TCGA-55-8205_treatment4	Erlotinib Hydrochloride	NA	NA	NA	f707d458-f8a3-4a2d-85dc-8f84c580339e	NA	yes	Treatment Ongoing	Targeted Molecular Therapy
TCGA-LUAD	95fa64b0-91e1-4427-b81a-53c47a053563	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8205	76	false	United States	-28063	NA	d92b2e0f-691e-57c5-9247-c66e7992903a	not hispanic or latino	female	white	TCGA-55-8205_demographic	Alive	28558	NA	NA	NA	NA	NA	metastasis	495	NA	d3626362-23d5-40a3-b66b-01a66c96b3bf	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8205_diagnosis2	NA	Not Reported	TCGA-55-8205_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8205_treatment10	NA	Distant Site	NA	NA	68696554-426b-4ecb-89df-369167c4d3b7	NA	no	NA	Surgery, NOS
TCGA-LUAD	95fa64b0-91e1-4427-b81a-53c47a053563	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8205	76	false	United States	-28063	NA	d92b2e0f-691e-57c5-9247-c66e7992903a	not hispanic or latino	female	white	TCGA-55-8205_demographic	Alive	28558	NA	NA	NA	NA	NA	metastasis	495	NA	d3626362-23d5-40a3-b66b-01a66c96b3bf	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8205_diagnosis2	NA	Not Reported	TCGA-55-8205_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8205_treatment8	NA	NA	NA	NA	99c176a0-4503-4888-a8b1-5a3d0f3a9ba3	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	95fa64b0-91e1-4427-b81a-53c47a053563	Informed Consent	33	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8205	76	false	United States	-28063	NA	d92b2e0f-691e-57c5-9247-c66e7992903a	not hispanic or latino	female	white	TCGA-55-8205_demographic	Alive	28558	NA	NA	NA	NA	NA	metastasis	495	NA	d3626362-23d5-40a3-b66b-01a66c96b3bf	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8205_diagnosis2	NA	Not Reported	TCGA-55-8205_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8205_treatment9	NA	NA	NA	NA	b52b0a86-deaa-4f02-b7b1-6e2b05908b85	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	962fd4e7-9199-43d9-abce-e3dfa46da62c	Informed Consent	73	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8510	55	false	United States	-20410	NA	bed91d27-b7ea-5f09-a253-0d02a5794671	not hispanic or latino	female	white	TCGA-55-8510_demographic	Alive	20410	MX	N0	Stage IB	T2a	7th	primary	0	539.0	a9117477-ee48-564f-b57d-141e83666a38	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8510_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8510_treatment	NA	NA	NA	NA	70038b40-d1e5-5dba-a15b-10b4ad72d961	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	962fd4e7-9199-43d9-abce-e3dfa46da62c	Informed Consent	73	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8510	55	false	United States	-20410	NA	bed91d27-b7ea-5f09-a253-0d02a5794671	not hispanic or latino	female	white	TCGA-55-8510_demographic	Alive	20410	MX	N0	Stage IB	T2a	7th	primary	0	539.0	a9117477-ee48-564f-b57d-141e83666a38	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8510_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8510_treatment2	NA	NA	NA	NA	becd574e-37c9-41af-b5ec-adcd4b1a0009	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	967d6548-5a84-4b7e-bc3f-2e522859fce6	Informed Consent	-7	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47B	79	false	United States	-28869	NA	b1ea66c5-f1ca-54a8-b0b9-619b6412921c	not hispanic or latino	male	white	TCGA-44-A47B_demographic	Alive	28869	M0	N0	Stage IB	T2a	7th	primary	0	287.0	344eb84b-0d71-512d-b309-ac19d77878c9	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-A47B_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47B_treatment2	NA	NA	NA	NA	55e76ca2-f405-41ba-a07e-b6d4ed891be3	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	967d6548-5a84-4b7e-bc3f-2e522859fce6	Informed Consent	-7	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47B	79	false	United States	-28869	NA	b1ea66c5-f1ca-54a8-b0b9-619b6412921c	not hispanic or latino	male	white	TCGA-44-A47B_demographic	Alive	28869	M0	N0	Stage IB	T2a	7th	primary	0	287.0	344eb84b-0d71-512d-b309-ac19d77878c9	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-A47B_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47B_treatment	NA	NA	NA	NA	de962ed8-b321-54d1-ba0d-dd5d0f39bad4	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	96d93e23-bb0d-46a8-9685-5ed0d6b83059	Informed Consent	251	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-7458	74	false	United States	-27359	NA	3e57d4a0-391e-5f2c-a647-5b52b5566708	not hispanic or latino	female	white	TCGA-99-7458_demographic	Alive	27359	M0	N0	Stage IIIA	T4	7th	primary	0	747.0	d1b1fc20-9d74-5d7c-afff-e741a00a805d	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-99-7458_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-99-7458_treatment2	NA	NA	NA	NA	1fb81f92-144f-4a3a-9d51-4c4d7be3f5c8	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	96d93e23-bb0d-46a8-9685-5ed0d6b83059	Informed Consent	251	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-7458	74	false	United States	-27359	NA	3e57d4a0-391e-5f2c-a647-5b52b5566708	not hispanic or latino	female	white	TCGA-99-7458_demographic	Alive	27359	M0	N0	Stage IIIA	T4	7th	primary	0	747.0	d1b1fc20-9d74-5d7c-afff-e741a00a805d	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-99-7458_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	323	53	NA	NA	NA	150.0	mg/day	Oral	TCGA-99-7458_treatment	Erlotinib Hydrochloride	NA	NA	NA	e101ed70-d725-5284-a7e1-fc672b11501e	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	96dfa373-4597-49a5-942e-d9b4dc5d28fc	Informed Consent	-23	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AAQV	63	false	United States	-23370	677	5460ee3e-20c5-5060-b9ec-6ae211500fa1	not hispanic or latino	female	black or african american	TCGA-49-AAQV_demographic	Dead	23879	NA	NA	NA	NA	NA	metastasis	509	NA	db9f8aa3-e4f7-430b-b770-42a761deeca3	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-49-AAQV_diagnosis2	NA	Not Reported	TCGA-49-AAQV_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-49-AAQV_treatment3	NA	NA	NA	NA	2e90ee6a-da09-4870-91ee-d8f3f8109f3b	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	96dfa373-4597-49a5-942e-d9b4dc5d28fc	Informed Consent	-23	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AAQV	63	false	United States	-23370	677	5460ee3e-20c5-5060-b9ec-6ae211500fa1	not hispanic or latino	female	black or african american	TCGA-49-AAQV_demographic	Dead	23879	NA	NA	NA	NA	NA	metastasis	509	NA	db9f8aa3-e4f7-430b-b770-42a761deeca3	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-49-AAQV_diagnosis2	NA	Not Reported	TCGA-49-AAQV_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-49-AAQV_treatment4	NA	NA	NA	NA	41cab78d-600e-4645-9159-4c5ff58a4f26	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	96dfa373-4597-49a5-942e-d9b4dc5d28fc	Informed Consent	-23	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AAQV	63	false	United States	-23370	677	5460ee3e-20c5-5060-b9ec-6ae211500fa1	not hispanic or latino	female	black or african american	TCGA-49-AAQV_demographic	Dead	23879	NA	NA	NA	NA	NA	metastasis	509	NA	db9f8aa3-e4f7-430b-b770-42a761deeca3	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-49-AAQV_diagnosis2	NA	Not Reported	TCGA-49-AAQV_diagnosis	NA	NA	NA	NA	536	NA	NA	NA	NA	NA	NA	TCGA-49-AAQV_treatment5	NA	Distant Site	NA	NA	9e3cbda8-be42-4a5e-8aed-d8948affe602	NA	yes	NA	Surgery, NOS
TCGA-LUAD	96dfa373-4597-49a5-942e-d9b4dc5d28fc	Informed Consent	-23	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AAQV	63	false	United States	-23370	677	5460ee3e-20c5-5060-b9ec-6ae211500fa1	not hispanic or latino	female	black or african american	TCGA-49-AAQV_demographic	Dead	23370	MX	N1	Stage II	T1	7th	primary	0	677.0	e3a15fd6-410b-5b00-9075-65667538c5e5	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-49-AAQV_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAQV_treatment	NA	NA	NA	NA	72d2c166-0b54-54c1-8dea-6ca3b95c9efe	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	96dfa373-4597-49a5-942e-d9b4dc5d28fc	Informed Consent	-23	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AAQV	63	false	United States	-23370	677	5460ee3e-20c5-5060-b9ec-6ae211500fa1	not hispanic or latino	female	black or african american	TCGA-49-AAQV_demographic	Dead	23370	MX	N1	Stage II	T1	7th	primary	0	677.0	e3a15fd6-410b-5b00-9075-65667538c5e5	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-49-AAQV_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAQV_treatment2	NA	NA	NA	NA	87e09225-e560-4eb8-87e2-552606e62afe	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9759bf3a-74ff-433f-99bb-f9406f222ed2	Informed Consent	224	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-8028	50	false	United States	-18542	NA	1febe41d-2c57-5f8f-a1f5-3876977fabe3	not hispanic or latino	female	black or african american	TCGA-99-8028_demographic	Alive	18542	M0	N0	Stage IA	T1a	7th	primary	0	1118.0	1b1903f3-c763-55c7-a932-70281a80279a	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-99-8028_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-99-8028_treatment	NA	NA	NA	NA	94d96f66-4a50-592e-8b04-38074c06604b	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9759bf3a-74ff-433f-99bb-f9406f222ed2	Informed Consent	224	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-8028	50	false	United States	-18542	NA	1febe41d-2c57-5f8f-a1f5-3876977fabe3	not hispanic or latino	female	black or african american	TCGA-99-8028_demographic	Alive	18542	M0	N0	Stage IA	T1a	7th	primary	0	1118.0	1b1903f3-c763-55c7-a932-70281a80279a	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-99-8028_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-99-8028_treatment2	NA	NA	NA	NA	fecdd412-fbc5-4b28-81c2-b6af4956d217	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	97831d28-ab41-4c18-bfc2-c4c6bc757d13	Informed Consent	24	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6847	62	false	United States	-22862	NA	ccb0e01c-e419-5236-8f9a-dbdf47551869	not hispanic or latino	female	white	TCGA-91-6847_demographic	Alive	23634	NA	NA	NA	NA	NA	metastasis	772	NA	cf7d3f41-29f7-43c6-9fd2-a4aa91fd1a8e	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-91-6847_diagnosis2	NA	Not Reported	TCGA-91-6847_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6847_treatment6	NA	Distant Site	NA	NA	1e3143b9-6945-46b6-a086-6ab263b514bc	NA	no	NA	Surgery, NOS
TCGA-LUAD	97831d28-ab41-4c18-bfc2-c4c6bc757d13	Informed Consent	24	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6847	62	false	United States	-22862	NA	ccb0e01c-e419-5236-8f9a-dbdf47551869	not hispanic or latino	female	white	TCGA-91-6847_demographic	Alive	23634	NA	NA	NA	NA	NA	metastasis	772	NA	cf7d3f41-29f7-43c6-9fd2-a4aa91fd1a8e	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-91-6847_diagnosis2	NA	Not Reported	TCGA-91-6847_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-91-6847_treatment4	NA	NA	NA	NA	2bf93193-a163-419e-ae5a-9127809ee1e9	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	97831d28-ab41-4c18-bfc2-c4c6bc757d13	Informed Consent	24	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6847	62	false	United States	-22862	NA	ccb0e01c-e419-5236-8f9a-dbdf47551869	not hispanic or latino	female	white	TCGA-91-6847_demographic	Alive	23634	NA	NA	NA	NA	NA	metastasis	772	NA	cf7d3f41-29f7-43c6-9fd2-a4aa91fd1a8e	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-91-6847_diagnosis2	NA	Not Reported	TCGA-91-6847_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-91-6847_treatment5	NA	NA	NA	NA	b922c420-9007-4e72-a909-416c3a302050	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	97831d28-ab41-4c18-bfc2-c4c6bc757d13	Informed Consent	24	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6847	62	false	United States	-22862	NA	ccb0e01c-e419-5236-8f9a-dbdf47551869	not hispanic or latino	female	white	TCGA-91-6847_demographic	Alive	22862	MX	N0	Stage IB	T2	5th	primary	0	842.0	daa938a2-150b-582d-8c41-d03c0ca539d5	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6847_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6847_treatment3	NA	NA	NA	NA	3ee9b989-025a-45a3-840d-0505a6175ecc	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	97831d28-ab41-4c18-bfc2-c4c6bc757d13	Informed Consent	24	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6847	62	false	United States	-22862	NA	ccb0e01c-e419-5236-8f9a-dbdf47551869	not hispanic or latino	female	white	TCGA-91-6847_demographic	Alive	22862	MX	N0	Stage IB	T2	5th	primary	0	842.0	daa938a2-150b-582d-8c41-d03c0ca539d5	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6847_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	781	772	NA	NA	NA	NA	NA	NA	TCGA-91-6847_treatment	NA	Distant Site	40	Gy	68e7225b-9e48-5c9d-ac66-abc7effd2e42	NA	yes	Stable Disease	Radiation, External Beam
TCGA-LUAD	97831d28-ab41-4c18-bfc2-c4c6bc757d13	Informed Consent	24	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6847	62	false	United States	-22862	NA	ccb0e01c-e419-5236-8f9a-dbdf47551869	not hispanic or latino	female	white	TCGA-91-6847_demographic	Alive	22862	MX	N0	Stage IB	T2	5th	primary	0	842.0	daa938a2-150b-582d-8c41-d03c0ca539d5	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6847_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	842	842	NA	NA	1.0	NA	NA	NA	TCGA-91-6847_treatment2	NA	Distant Site	15	Gy	8fab983e-40f2-487f-9d0d-2d889ef1c3d1	NA	yes	Unknown	Radiation, External Beam
TCGA-LUAD	98ee294a-46ed-4572-bdd4-a932c3498a25	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TA	75	false	United States	-27513	950	ae5be67c-f7a5-5862-9927-700c93386839	not hispanic or latino	female	white	TCGA-MP-A4TA_demographic	Dead	26570	NA	NA	NA	NA	NA	Prior primary	-943	NA	7c568729-b0a8-4836-95a2-fd544eb6c00b	false	NA	NA	NA	NA	8130/3	Papillary transitional cell carcinoma	NA	NA	NA	Not Reported	NA	TCGA-MP-A4TA_diagnosis3	NA	Bladder, NOS	NA	NA	NA	NA	NA	-943	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TA_treatment5	NA	Not Reported	NA	NA	1cc4bae1-b506-406d-962c-84817057fd9d	NA	yes	NA	Surgery, NOS
TCGA-LUAD	98ee294a-46ed-4572-bdd4-a932c3498a25	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TA	75	false	United States	-27513	950	ae5be67c-f7a5-5862-9927-700c93386839	not hispanic or latino	female	white	TCGA-MP-A4TA_demographic	Dead	26570	NA	NA	NA	NA	NA	Prior primary	-943	NA	7c568729-b0a8-4836-95a2-fd544eb6c00b	false	NA	NA	NA	NA	8130/3	Papillary transitional cell carcinoma	NA	NA	NA	Not Reported	NA	TCGA-MP-A4TA_diagnosis3	NA	Bladder, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TA_treatment4	NA	NA	NA	NA	23cc9511-6221-4026-a393-f28138d4bff3	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	98ee294a-46ed-4572-bdd4-a932c3498a25	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TA	75	false	United States	-27513	950	ae5be67c-f7a5-5862-9927-700c93386839	not hispanic or latino	female	white	TCGA-MP-A4TA_demographic	Dead	26570	NA	NA	NA	NA	NA	Prior primary	-943	NA	7c568729-b0a8-4836-95a2-fd544eb6c00b	false	NA	NA	NA	NA	8130/3	Papillary transitional cell carcinoma	NA	NA	NA	Not Reported	NA	TCGA-MP-A4TA_diagnosis3	NA	Bladder, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TA_treatment3	NA	NA	NA	NA	4d989af2-083a-4a63-81c7-6f81e8449fa8	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	98ee294a-46ed-4572-bdd4-a932c3498a25	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TA	75	false	United States	-27513	950	ae5be67c-f7a5-5862-9927-700c93386839	not hispanic or latino	female	white	TCGA-MP-A4TA_demographic	Dead	28238	NA	NA	NA	NA	NA	metastasis	725	NA	c8e3c034-a067-4832-b181-7ad6146b4795	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TA_diagnosis2	NA	Not Reported	TCGA-MP-A4TA_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TA_treatment6	NA	NA	NA	NA	4fa3ad6d-9c40-4cb6-ae08-cf973598c285	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	98ee294a-46ed-4572-bdd4-a932c3498a25	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TA	75	false	United States	-27513	950	ae5be67c-f7a5-5862-9927-700c93386839	not hispanic or latino	female	white	TCGA-MP-A4TA_demographic	Dead	28238	NA	NA	NA	NA	NA	metastasis	725	NA	c8e3c034-a067-4832-b181-7ad6146b4795	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TA_diagnosis2	NA	Not Reported	TCGA-MP-A4TA_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TA_treatment8	NA	Distant Site	NA	NA	dc05339f-1259-4839-8a1e-3fd8bac92b37	NA	no	NA	Surgery, NOS
TCGA-LUAD	98ee294a-46ed-4572-bdd4-a932c3498a25	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TA	75	false	United States	-27513	950	ae5be67c-f7a5-5862-9927-700c93386839	not hispanic or latino	female	white	TCGA-MP-A4TA_demographic	Dead	28238	NA	NA	NA	NA	NA	metastasis	725	NA	c8e3c034-a067-4832-b181-7ad6146b4795	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TA_diagnosis2	NA	Not Reported	TCGA-MP-A4TA_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TA_treatment7	NA	NA	NA	NA	dffa2bce-e82d-4960-b22d-72794d611a0d	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	98ee294a-46ed-4572-bdd4-a932c3498a25	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TA	75	false	United States	-27513	950	ae5be67c-f7a5-5862-9927-700c93386839	not hispanic or latino	female	white	TCGA-MP-A4TA_demographic	Dead	27513	M0	N0	Stage IA	T1	6th	primary	0	950.0	e2b38802-3ebf-5b1b-9c3f-bc50432dca2b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-MP-A4TA_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TA_treatment2	NA	NA	NA	NA	398102a0-44d3-475a-b268-49a37addb7f3	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	98ee294a-46ed-4572-bdd4-a932c3498a25	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TA	75	false	United States	-27513	950	ae5be67c-f7a5-5862-9927-700c93386839	not hispanic or latino	female	white	TCGA-MP-A4TA_demographic	Dead	27513	M0	N0	Stage IA	T1	6th	primary	0	950.0	e2b38802-3ebf-5b1b-9c3f-bc50432dca2b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-MP-A4TA_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TA_treatment	NA	NA	NA	NA	4a84e47c-7dbb-5e6d-8a8f-de7a14544792	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	98ef41fa-3015-445a-bbdc-984361c911f7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AARN	56	false	United States	-20605	1135	4d4f3e23-3121-5391-9887-db0dd6dd1406	not hispanic or latino	female	black or african american	TCGA-49-AARN_demographic	Dead	20575	NA	NA	NA	NA	NA	Synchronous primary	-30	NA	0bac7b16-3c53-43c5-8a1a-539eb04dba65	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-49-AARN_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARN_treatment4	NA	NA	NA	NA	620d31ed-f698-4d91-8078-2c71432764f4	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	98ef41fa-3015-445a-bbdc-984361c911f7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AARN	56	false	United States	-20605	1135	4d4f3e23-3121-5391-9887-db0dd6dd1406	not hispanic or latino	female	black or african american	TCGA-49-AARN_demographic	Dead	20575	NA	NA	NA	NA	NA	Synchronous primary	-30	NA	0bac7b16-3c53-43c5-8a1a-539eb04dba65	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-49-AARN_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARN_treatment5	NA	NA	NA	NA	c5f22617-14cb-4888-b4fa-96fcfe633a63	NA	no	NA	Surgery, NOS
TCGA-LUAD	98ef41fa-3015-445a-bbdc-984361c911f7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AARN	56	false	United States	-20605	1135	4d4f3e23-3121-5391-9887-db0dd6dd1406	not hispanic or latino	female	black or african american	TCGA-49-AARN_demographic	Dead	20575	NA	NA	NA	NA	NA	Synchronous primary	-30	NA	0bac7b16-3c53-43c5-8a1a-539eb04dba65	false	NA	NA	NA	Right	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-49-AARN_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARN_treatment3	NA	NA	NA	NA	da7640f4-3d4c-49ec-ba52-5ace779bd92a	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	98ef41fa-3015-445a-bbdc-984361c911f7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AARN	56	false	United States	-20605	1135	4d4f3e23-3121-5391-9887-db0dd6dd1406	not hispanic or latino	female	black or african american	TCGA-49-AARN_demographic	Dead	20605	MX	N0	Stage IA	T1	5th	primary	0	1135.0	608ccff3-aee3-563f-9d3f-569c7a666af6	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AARN_diagnosis	Yes	Lower lobe, lung	NA	2000	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARN_treatment	NA	NA	NA	NA	06eab369-5013-53ce-a807-01f85931f8a1	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	98ef41fa-3015-445a-bbdc-984361c911f7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AARN	56	false	United States	-20605	1135	4d4f3e23-3121-5391-9887-db0dd6dd1406	not hispanic or latino	female	black or african american	TCGA-49-AARN_demographic	Dead	20605	MX	N0	Stage IA	T1	5th	primary	0	1135.0	608ccff3-aee3-563f-9d3f-569c7a666af6	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AARN_diagnosis	Yes	Lower lobe, lung	NA	2000	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARN_treatment2	NA	NA	NA	NA	bfe766b1-305c-47b8-b904-92892dd0f768	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9944f46f-9fa8-4e2c-a806-776bec7f8803	Informed Consent	-32	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5049	70	false	United States	-25577	NA	6d3ec257-9033-52c7-9c4c-de8cdf922cf0	not hispanic or latino	male	white	TCGA-50-5049_demographic	Alive	28121	NA	NA	NA	NA	NA	recurrence	2544	NA	16d4ddf9-bdbe-4ca6-ad28-51604067cd35	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5049_diagnosis3	NA	Not Reported	TCGA-50-5049_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5049_treatment8	NA	NA	NA	NA	32654b4a-7750-40b4-aa0e-deb5644394be	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9944f46f-9fa8-4e2c-a806-776bec7f8803	Informed Consent	-32	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5049	70	false	United States	-25577	NA	6d3ec257-9033-52c7-9c4c-de8cdf922cf0	not hispanic or latino	male	white	TCGA-50-5049_demographic	Alive	28121	NA	NA	NA	NA	NA	recurrence	2544	NA	16d4ddf9-bdbe-4ca6-ad28-51604067cd35	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5049_diagnosis3	NA	Not Reported	TCGA-50-5049_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5049_treatment10	NA	Locoregional Site	NA	NA	63425386-99b7-4c89-878f-f5d1b84d0ae4	NA	no	NA	Surgery, NOS
TCGA-LUAD	9944f46f-9fa8-4e2c-a806-776bec7f8803	Informed Consent	-32	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5049	70	false	United States	-25577	NA	6d3ec257-9033-52c7-9c4c-de8cdf922cf0	not hispanic or latino	male	white	TCGA-50-5049_demographic	Alive	28121	NA	NA	NA	NA	NA	recurrence	2544	NA	16d4ddf9-bdbe-4ca6-ad28-51604067cd35	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5049_diagnosis3	NA	Not Reported	TCGA-50-5049_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5049_treatment9	NA	NA	NA	NA	cf608d3f-2188-4965-a87a-2fa1da456ee1	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	9944f46f-9fa8-4e2c-a806-776bec7f8803	Informed Consent	-32	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5049	70	false	United States	-25577	NA	6d3ec257-9033-52c7-9c4c-de8cdf922cf0	not hispanic or latino	male	white	TCGA-50-5049_demographic	Alive	25577	M0	N0	Stage IA	T2	6th	primary	0	3094.0	58ee1e34-4b16-5409-8d47-463355c72cac	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5049_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	1572	1572	NA	NA	4.0	NA	NA	NA	TCGA-50-5049_treatment2	NA	Locoregional Site	12	Gy	6e22c96f-9d3c-488a-bc61-f66a6294e81c	NA	yes	Partial Response	Radiation, External Beam
TCGA-LUAD	9944f46f-9fa8-4e2c-a806-776bec7f8803	Informed Consent	-32	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5049	70	false	United States	-25577	NA	6d3ec257-9033-52c7-9c4c-de8cdf922cf0	not hispanic or latino	male	white	TCGA-50-5049_demographic	Alive	25577	M0	N0	Stage IA	T2	6th	primary	0	3094.0	58ee1e34-4b16-5409-8d47-463355c72cac	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5049_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	2544	2544	NA	NA	NA	NA	NA	NA	TCGA-50-5049_treatment3	NA	Locoregional Site	NA	NA	8eefef0d-e9e7-49f1-bfe5-cfe30d81e0c0	NA	yes	Unknown	Radiation, External Beam
TCGA-LUAD	9944f46f-9fa8-4e2c-a806-776bec7f8803	Informed Consent	-32	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5049	70	false	United States	-25577	NA	6d3ec257-9033-52c7-9c4c-de8cdf922cf0	not hispanic or latino	male	white	TCGA-50-5049_demographic	Alive	25577	M0	N0	Stage IA	T2	6th	primary	0	3094.0	58ee1e34-4b16-5409-8d47-463355c72cac	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5049_diagnosis	No	Upper lobe, lung	NA	2006	NA	1.0	0	0	NA	NA	NA	NA	NA	NA	TCGA-50-5049_treatment	NA	Primary Tumor Field	NA	NA	ce2503d6-20b0-528f-a4b1-412fd81a6d40	Adjuvant	yes	NA	Radiation, Implants
TCGA-LUAD	9944f46f-9fa8-4e2c-a806-776bec7f8803	Informed Consent	-32	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5049	70	false	United States	-25577	NA	6d3ec257-9033-52c7-9c4c-de8cdf922cf0	not hispanic or latino	male	white	TCGA-50-5049_demographic	Alive	25577	M0	N0	Stage IA	T2	6th	primary	0	3094.0	58ee1e34-4b16-5409-8d47-463355c72cac	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5049_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5049_treatment4	NA	NA	NA	NA	d6730c7d-b1bd-48a2-aa7f-f855b982e73d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9944f46f-9fa8-4e2c-a806-776bec7f8803	Informed Consent	-32	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5049	70	false	United States	-25577	NA	6d3ec257-9033-52c7-9c4c-de8cdf922cf0	not hispanic or latino	male	white	TCGA-50-5049_demographic	Alive	27145	NA	NA	NA	NA	NA	recurrence	1568	NA	9f905077-851e-4ce3-aa9c-8b68c51fc683	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5049_diagnosis2	NA	Not Reported	TCGA-50-5049_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5049_treatment5	NA	NA	NA	NA	3c73506a-16d7-474f-b948-e0237b9bdfb4	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9944f46f-9fa8-4e2c-a806-776bec7f8803	Informed Consent	-32	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5049	70	false	United States	-25577	NA	6d3ec257-9033-52c7-9c4c-de8cdf922cf0	not hispanic or latino	male	white	TCGA-50-5049_demographic	Alive	27145	NA	NA	NA	NA	NA	recurrence	1568	NA	9f905077-851e-4ce3-aa9c-8b68c51fc683	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5049_diagnosis2	NA	Not Reported	TCGA-50-5049_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5049_treatment7	NA	Distant Site	NA	NA	e1bcf288-b811-46d4-83bd-6a0727340d86	NA	no	NA	Surgery, NOS
TCGA-LUAD	9944f46f-9fa8-4e2c-a806-776bec7f8803	Informed Consent	-32	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5049	70	false	United States	-25577	NA	6d3ec257-9033-52c7-9c4c-de8cdf922cf0	not hispanic or latino	male	white	TCGA-50-5049_demographic	Alive	27145	NA	NA	NA	NA	NA	recurrence	1568	NA	9f905077-851e-4ce3-aa9c-8b68c51fc683	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5049_diagnosis2	NA	Not Reported	TCGA-50-5049_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5049_treatment6	NA	NA	NA	NA	fd289647-596e-4389-b8c8-93a850b59326	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	996a0070-e9bf-4601-8ef7-60212108258d	Informed Consent	87	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-5899	58	false	United States	NA	NA	3e120a70-0fd7-53df-979b-4d0c4b4d1439	not hispanic or latino	male	white	TCGA-55-5899_demographic	Alive	NA	M0	N1	NA	T1a	7th	primary	0	930.0	e71b7a45-0278-59d4-bdb8-deef718376fd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-5899_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	208	146	NA	NA	NA	NA	NA	NA	TCGA-55-5899_treatment2	Paclitaxel	NA	NA	NA	084181a4-82bb-4083-86b8-878940fa6e84	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	996a0070-e9bf-4601-8ef7-60212108258d	Informed Consent	87	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-5899	58	false	United States	NA	NA	3e120a70-0fd7-53df-979b-4d0c4b4d1439	not hispanic or latino	male	white	TCGA-55-5899_demographic	Alive	NA	M0	N1	NA	T1a	7th	primary	0	930.0	e71b7a45-0278-59d4-bdb8-deef718376fd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-5899_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-5899_treatment3	NA	NA	NA	NA	6adde397-4058-4fbb-a1e9-5e8c221c80cb	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	996a0070-e9bf-4601-8ef7-60212108258d	Informed Consent	87	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-5899	58	false	United States	NA	NA	3e120a70-0fd7-53df-979b-4d0c4b4d1439	not hispanic or latino	male	white	TCGA-55-5899_demographic	Alive	NA	M0	N1	NA	T1a	7th	primary	0	930.0	e71b7a45-0278-59d4-bdb8-deef718376fd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-5899_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	208	146	NA	NA	NA	NA	NA	NA	TCGA-55-5899_treatment	Carboplatin	NA	NA	NA	80175096-365e-5428-a669-2469d3863b2d	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	99c35245-e1c8-4805-b7a5-f703bb506030	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TC	77	false	United States	-28471	74	a16c2726-59d5-57b4-8576-921a2b7d4e80	not hispanic or latino	male	white	TCGA-MP-A4TC_demographic	Dead	25720	NA	NA	NA	NA	NA	Prior primary	-2751	NA	815e2f37-a9ac-4feb-b0da-9ee334550000	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MP-A4TC_diagnosis2	NA	Skin of other and unspecified parts of face	NA	NA	NA	NA	NA	-2753	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TC_treatment6	NA	Skin	NA	NA	75a12505-4eae-4e14-ab2d-ed244979e8af	NA	yes	NA	Surgery, NOS
TCGA-LUAD	99c35245-e1c8-4805-b7a5-f703bb506030	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TC	77	false	United States	-28471	74	a16c2726-59d5-57b4-8576-921a2b7d4e80	not hispanic or latino	male	white	TCGA-MP-A4TC_demographic	Dead	25720	NA	NA	NA	NA	NA	Prior primary	-2751	NA	815e2f37-a9ac-4feb-b0da-9ee334550000	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MP-A4TC_diagnosis2	NA	Skin of other and unspecified parts of face	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TC_treatment5	NA	NA	NA	NA	ab4436f5-afeb-429e-bd82-2dc5cb58de63	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	99c35245-e1c8-4805-b7a5-f703bb506030	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TC	77	false	United States	-28471	74	a16c2726-59d5-57b4-8576-921a2b7d4e80	not hispanic or latino	male	white	TCGA-MP-A4TC_demographic	Dead	25720	NA	NA	NA	NA	NA	Prior primary	-2751	NA	815e2f37-a9ac-4feb-b0da-9ee334550000	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-MP-A4TC_diagnosis2	NA	Skin of other and unspecified parts of face	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TC_treatment4	NA	NA	NA	NA	de2a139f-c2d1-469e-bb67-aad49e5d3838	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	99c35245-e1c8-4805-b7a5-f703bb506030	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TC	77	false	United States	-28471	74	a16c2726-59d5-57b4-8576-921a2b7d4e80	not hispanic or latino	male	white	TCGA-MP-A4TC_demographic	Dead	28471	M0	N2	Stage IIIA	T1	6th	primary	0	74.0	8720849f-1233-5597-82b1-0805342c26a5	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-MP-A4TC_diagnosis	No	Middle lobe, lung	NA	2008	No	NA	25	25	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TC_treatment2	Vinorelbine Tartrate	NA	NA	NA	3a44a8ba-af80-462a-8584-388ea6735c2b	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	99c35245-e1c8-4805-b7a5-f703bb506030	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TC	77	false	United States	-28471	74	a16c2726-59d5-57b4-8576-921a2b7d4e80	not hispanic or latino	male	white	TCGA-MP-A4TC_demographic	Dead	28471	M0	N2	Stage IIIA	T1	6th	primary	0	74.0	8720849f-1233-5597-82b1-0805342c26a5	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-MP-A4TC_diagnosis	No	Middle lobe, lung	NA	2008	No	NA	25	25	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TC_treatment	Cisplatin	NA	NA	NA	c0d35c20-6478-580d-b85d-38b5deaab59b	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	99c35245-e1c8-4805-b7a5-f703bb506030	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TC	77	false	United States	-28471	74	a16c2726-59d5-57b4-8576-921a2b7d4e80	not hispanic or latino	male	white	TCGA-MP-A4TC_demographic	Dead	28471	M0	N2	Stage IIIA	T1	6th	primary	0	74.0	8720849f-1233-5597-82b1-0805342c26a5	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-MP-A4TC_diagnosis	No	Middle lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TC_treatment3	NA	NA	NA	NA	dcf6b541-427d-4837-8f3a-81b7d34b1f2e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9a2a226e-9605-4214-9320-469305e664e6	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARQ	41	false	United States	-15065	NA	e1323da5-97f3-5d8c-a4d7-c73783ebb4d3	not hispanic or latino	female	black or african american	TCGA-49-AARQ_demographic	Alive	15065	MX	N0	Stage I	T2	4th	primary	0	6732.0	17e5f0f7-d965-57f2-b849-cd5f2f6284e3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AARQ_diagnosis	No	Upper lobe, lung	NA	1996	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARQ_treatment2	NA	NA	NA	NA	37dfd52b-7bee-4c99-adf1-12e93477b3ef	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9a2a226e-9605-4214-9320-469305e664e6	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARQ	41	false	United States	-15065	NA	e1323da5-97f3-5d8c-a4d7-c73783ebb4d3	not hispanic or latino	female	black or african american	TCGA-49-AARQ_demographic	Alive	15065	MX	N0	Stage I	T2	4th	primary	0	6732.0	17e5f0f7-d965-57f2-b849-cd5f2f6284e3	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AARQ_diagnosis	No	Upper lobe, lung	NA	1996	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARQ_treatment	NA	NA	NA	NA	5c01c1c8-76ec-5621-9977-bd028067b815	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9a50e7e4-831d-489f-87d2-979e987561cc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4384	66	false	Germany	-24411	NA	362996f3-6cee-5bc6-af4a-1037c6ed8a4b	not reported	male	not reported	TCGA-05-4384_demographic	Alive	24594	NA	NA	NA	NA	NA	metastasis	183	NA	0ba08030-9f9d-4c31-8018-8acd7b022d01	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-05-4384_diagnosis2	NA	Not Reported	TCGA-05-4384_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-05-4384_treatment10	NA	NA	NA	NA	1342992c-1979-4396-8e3b-43bb6ae8e348	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9a50e7e4-831d-489f-87d2-979e987561cc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4384	66	false	Germany	-24411	NA	362996f3-6cee-5bc6-af4a-1037c6ed8a4b	not reported	male	not reported	TCGA-05-4384_demographic	Alive	24594	NA	NA	NA	NA	NA	metastasis	183	NA	0ba08030-9f9d-4c31-8018-8acd7b022d01	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-05-4384_diagnosis2	NA	Not Reported	TCGA-05-4384_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-05-4384_treatment11	NA	NA	NA	NA	a7f80411-6214-4d63-b7a3-d29d87d547b6	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	9a50e7e4-831d-489f-87d2-979e987561cc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4384	66	false	Germany	-24411	NA	362996f3-6cee-5bc6-af4a-1037c6ed8a4b	not reported	male	not reported	TCGA-05-4384_demographic	Alive	24411	M0	N2	Stage IIIA	T2	6th	primary	0	426.0	13607a4a-be8f-5e01-abe5-4fd8a498e4d2	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	RX	Lung, NOS	NA	TCGA-05-4384_diagnosis	No	Lower lobe, lung	NA	2009	No	NA	426	245	NA	NA	NA	NA	NA	NA	TCGA-05-4384_treatment5	Zoledronic Acid	NA	NA	NA	5af9386e-a4bc-4d82-b520-206d80770258	NA	yes	Progressive Disease	Ancillary Treatment
TCGA-LUAD	9a50e7e4-831d-489f-87d2-979e987561cc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4384	66	false	Germany	-24411	NA	362996f3-6cee-5bc6-af4a-1037c6ed8a4b	not reported	male	not reported	TCGA-05-4384_demographic	Alive	24411	M0	N2	Stage IIIA	T2	6th	primary	0	426.0	13607a4a-be8f-5e01-abe5-4fd8a498e4d2	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	RX	Lung, NOS	NA	TCGA-05-4384_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	214	183	NA	NA	NA	NA	NA	NA	TCGA-05-4384_treatment	NA	Distant Site	NA	NA	8d570fe3-a9e3-59d7-906c-8ca720860a68	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	9a50e7e4-831d-489f-87d2-979e987561cc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4384	66	false	Germany	-24411	NA	362996f3-6cee-5bc6-af4a-1037c6ed8a4b	not reported	male	not reported	TCGA-05-4384_demographic	Alive	24411	M0	N2	Stage IIIA	T2	6th	primary	0	426.0	13607a4a-be8f-5e01-abe5-4fd8a498e4d2	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	RX	Lung, NOS	NA	TCGA-05-4384_diagnosis	No	Lower lobe, lung	NA	2009	No	NA	426	395	NA	NA	NA	NA	NA	NA	TCGA-05-4384_treatment4	Cisplatin	NA	NA	NA	ac73068c-45e0-438b-8a1b-edc24fd9777c	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	9a50e7e4-831d-489f-87d2-979e987561cc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4384	66	false	Germany	-24411	NA	362996f3-6cee-5bc6-af4a-1037c6ed8a4b	not reported	male	not reported	TCGA-05-4384_demographic	Alive	24411	M0	N2	Stage IIIA	T2	6th	primary	0	426.0	13607a4a-be8f-5e01-abe5-4fd8a498e4d2	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	RX	Lung, NOS	NA	TCGA-05-4384_diagnosis	No	Lower lobe, lung	NA	2009	No	NA	153	61	NA	NA	NA	NA	NA	NA	TCGA-05-4384_treatment2	Cisplatin	NA	NA	NA	b99d459c-da21-4d73-af99-d496ab741380	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	9a50e7e4-831d-489f-87d2-979e987561cc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4384	66	false	Germany	-24411	NA	362996f3-6cee-5bc6-af4a-1037c6ed8a4b	not reported	male	not reported	TCGA-05-4384_demographic	Alive	24411	M0	N2	Stage IIIA	T2	6th	primary	0	426.0	13607a4a-be8f-5e01-abe5-4fd8a498e4d2	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	RX	Lung, NOS	NA	TCGA-05-4384_diagnosis	No	Lower lobe, lung	NA	2009	No	NA	153	61	NA	NA	NA	NA	NA	NA	TCGA-05-4384_treatment3	Vinorelbine	NA	NA	NA	dbca4b96-0ab2-40f5-8866-d09b57939cbf	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	9a50e7e4-831d-489f-87d2-979e987561cc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4384	66	false	Germany	-24411	NA	362996f3-6cee-5bc6-af4a-1037c6ed8a4b	not reported	male	not reported	TCGA-05-4384_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	1ded7052-89b4-466e-835b-776d260cdc74	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4384_diagnosis4	NA	Bladder, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4384_treatment9	NA	NA	NA	NA	4258528f-cfa0-46c9-b87a-0e2f523b035e	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9a50e7e4-831d-489f-87d2-979e987561cc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4384	66	false	Germany	-24411	NA	362996f3-6cee-5bc6-af4a-1037c6ed8a4b	not reported	male	not reported	TCGA-05-4384_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	1ded7052-89b4-466e-835b-776d260cdc74	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4384_diagnosis4	NA	Bladder, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4384_treatment8	NA	NA	NA	NA	fd55e87b-1c89-4e44-9f6e-3f91aae7f20e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9a50e7e4-831d-489f-87d2-979e987561cc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4384	66	false	Germany	-24411	NA	362996f3-6cee-5bc6-af4a-1037c6ed8a4b	not reported	male	not reported	TCGA-05-4384_demographic	Alive	NA	M0	N0	NA	T1	NA	Prior primary	NA	NA	87e59756-6371-4db9-832a-3c1d6ea7d171	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4384_diagnosis3	NA	Rectum, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4384_treatment6	NA	NA	NA	NA	1b9e7e8c-33db-4acc-9e10-9f8ef4c6fb30	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9a50e7e4-831d-489f-87d2-979e987561cc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4384	66	false	Germany	-24411	NA	362996f3-6cee-5bc6-af4a-1037c6ed8a4b	not reported	male	not reported	TCGA-05-4384_demographic	Alive	NA	M0	N0	NA	T1	NA	Prior primary	NA	NA	87e59756-6371-4db9-832a-3c1d6ea7d171	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4384_diagnosis3	NA	Rectum, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4384_treatment7	NA	NA	NA	NA	a7041dad-9c1b-4d12-8c6e-153bcc05c602	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9a63f744-4ed4-4b4d-aac6-f9bda66aa563	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6205	NA	false	Canada	NA	NA	1a0e7c77-190b-53d2-b433-78571bc4437d	not reported	female	not reported	TCGA-75-6205_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	6d0548e2-6f12-41a6-baa7-f0019462d42c	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-6205_diagnosis2	NA	Not Reported	TCGA-75-6205_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-75-6205_treatment4	NA	NA	NA	NA	03da9b61-cdb5-4031-8399-f1df08830b46	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9a63f744-4ed4-4b4d-aac6-f9bda66aa563	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6205	NA	false	Canada	NA	NA	1a0e7c77-190b-53d2-b433-78571bc4437d	not reported	female	not reported	TCGA-75-6205_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	6d0548e2-6f12-41a6-baa7-f0019462d42c	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-6205_diagnosis2	NA	Not Reported	TCGA-75-6205_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-75-6205_treatment3	NA	NA	NA	NA	2f9d4e90-c519-406d-8cdd-7966d121f5e3	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9a63f744-4ed4-4b4d-aac6-f9bda66aa563	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6205	NA	false	Canada	NA	NA	1a0e7c77-190b-53d2-b433-78571bc4437d	not reported	female	not reported	TCGA-75-6205_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	6d0548e2-6f12-41a6-baa7-f0019462d42c	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-6205_diagnosis2	NA	Not Reported	TCGA-75-6205_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6205_treatment5	NA	Locoregional Site	NA	NA	9b0f04a8-06b0-476f-8f57-87a81b8d5b38	NA	no	NA	Surgery, NOS
TCGA-LUAD	9a63f744-4ed4-4b4d-aac6-f9bda66aa563	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6205	NA	false	Canada	NA	NA	1a0e7c77-190b-53d2-b433-78571bc4437d	not reported	female	not reported	TCGA-75-6205_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	NA	NA	6d0548e2-6f12-41a6-baa7-f0019462d42c	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-75-6205_diagnosis2	NA	Not Reported	TCGA-75-6205_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6205_treatment6	NA	Distant Site	NA	NA	bed8bfd1-168d-4a1c-a9b4-c44b43caeee0	NA	no	NA	Surgery, NOS
TCGA-LUAD	9a63f744-4ed4-4b4d-aac6-f9bda66aa563	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6205	NA	false	Canada	NA	NA	1a0e7c77-190b-53d2-b433-78571bc4437d	not reported	female	not reported	TCGA-75-6205_demographic	Dead	NA	M0	N0	Stage IB	T2a	7th	primary	NA	NA	71c494e1-994e-5f94-ad20-1b9ba0db1e4d	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6205_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6205_treatment	NA	NA	NA	NA	34a30b65-3d61-58ff-8f7d-720c7b17b389	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9a63f744-4ed4-4b4d-aac6-f9bda66aa563	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6205	NA	false	Canada	NA	NA	1a0e7c77-190b-53d2-b433-78571bc4437d	not reported	female	not reported	TCGA-75-6205_demographic	Dead	NA	M0	N0	Stage IB	T2a	7th	primary	NA	NA	71c494e1-994e-5f94-ad20-1b9ba0db1e4d	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6205_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6205_treatment2	NA	NA	NA	NA	85ec7152-fb29-4bb4-bc12-a5b391ccfd5e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9a9bd705-1ef1-4a6c-bb1e-bdd346dc01c0	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8203	69	false	United States	-25477	NA	00490453-093a-529e-9313-5ac90ec23bd2	not hispanic or latino	female	white	TCGA-55-8203_demographic	Alive	25477	M0	N0	Stage IA	T1b	7th	primary	0	547.0	075648f3-341b-59ac-b98b-53ecd4f029c5	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-8203_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8203_treatment2	NA	NA	NA	NA	0fa2dffc-dac3-431f-a4e8-98957472536d	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	9a9bd705-1ef1-4a6c-bb1e-bdd346dc01c0	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8203	69	false	United States	-25477	NA	00490453-093a-529e-9313-5ac90ec23bd2	not hispanic or latino	female	white	TCGA-55-8203_demographic	Alive	25477	M0	N0	Stage IA	T1b	7th	primary	0	547.0	075648f3-341b-59ac-b98b-53ecd4f029c5	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-8203_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8203_treatment	NA	NA	NA	NA	c39ee862-ac22-5ea0-84f4-003413d1d249	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9a9bd705-1ef1-4a6c-bb1e-bdd346dc01c0	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8203	69	false	United States	-25477	NA	00490453-093a-529e-9313-5ac90ec23bd2	not hispanic or latino	female	white	TCGA-55-8203_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	955730a8-48d6-44ff-8d39-1de6e9beba7a	false	NA	NA	NA	NA	9823/3	Chronic lymphocytic leukemia	NA	NA	NA	Not Reported	NA	TCGA-55-8203_diagnosis3	NA	Blood	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8203_treatment5	NA	NA	NA	NA	1dba748e-0c00-40c8-8cdd-c61ca2c2fc85	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9a9bd705-1ef1-4a6c-bb1e-bdd346dc01c0	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8203	69	false	United States	-25477	NA	00490453-093a-529e-9313-5ac90ec23bd2	not hispanic or latino	female	white	TCGA-55-8203_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	955730a8-48d6-44ff-8d39-1de6e9beba7a	false	NA	NA	NA	NA	9823/3	Chronic lymphocytic leukemia	NA	NA	NA	Not Reported	NA	TCGA-55-8203_diagnosis3	NA	Blood	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8203_treatment6	NA	NA	NA	NA	9519c0c2-8770-4164-b331-2862854bc644	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9a9bd705-1ef1-4a6c-bb1e-bdd346dc01c0	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8203	69	false	United States	-25477	NA	00490453-093a-529e-9313-5ac90ec23bd2	not hispanic or latino	female	white	TCGA-55-8203_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	fd02e255-9a34-4b0c-bdb3-19062053c4e3	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8203_diagnosis2	NA	Skin, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8203_treatment3	NA	NA	NA	NA	0680642b-184a-4250-9e61-a3bfd6e531af	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9a9bd705-1ef1-4a6c-bb1e-bdd346dc01c0	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8203	69	false	United States	-25477	NA	00490453-093a-529e-9313-5ac90ec23bd2	not hispanic or latino	female	white	TCGA-55-8203_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	fd02e255-9a34-4b0c-bdb3-19062053c4e3	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8203_diagnosis2	NA	Skin, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8203_treatment4	NA	NA	NA	NA	158ae956-e918-4b2a-9faf-002ae9780ee9	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9b132e4f-7e35-4cc5-8711-43ad62b906d0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6591	63	false	United States	-23067	119	361e371d-4f99-5f0e-847b-510892eac584	not hispanic or latino	female	white	TCGA-50-6591_demographic	Dead	23067	M1	N0	Stage IV	T2	6th	primary	0	119.0	ae16aec0-6593-53a2-bb38-99f9c462588a	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-6591_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6591_treatment2	NA	NA	NA	NA	60da9588-1401-4b2e-b15f-29ea57f86a98	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9b132e4f-7e35-4cc5-8711-43ad62b906d0	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6591	63	false	United States	-23067	119	361e371d-4f99-5f0e-847b-510892eac584	not hispanic or latino	female	white	TCGA-50-6591_demographic	Dead	23067	M1	N0	Stage IV	T2	6th	primary	0	119.0	ae16aec0-6593-53a2-bb38-99f9c462588a	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-6591_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6591_treatment	NA	NA	NA	NA	6dea8889-5094-59d5-9fe1-4a5b2403719f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9b38eded-3f46-4aaa-9991-68008d97bdbe	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7670	47	false	United States	-17392	NA	78f5b5b4-1057-53e3-9cfd-d2924e887e08	hispanic or latino	female	white	TCGA-44-7670_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	258d1b44-915b-450a-825d-24b08645ce53	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-7670_diagnosis2	NA	Vulva, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7670_treatment4	NA	NA	NA	NA	962c6715-538a-4904-9743-5c1841d8ad94	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9b38eded-3f46-4aaa-9991-68008d97bdbe	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7670	47	false	United States	-17392	NA	78f5b5b4-1057-53e3-9cfd-d2924e887e08	hispanic or latino	female	white	TCGA-44-7670_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	258d1b44-915b-450a-825d-24b08645ce53	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-7670_diagnosis2	NA	Vulva, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7670_treatment5	NA	NA	NA	NA	a428d636-5a8a-4b69-b52a-fb25d71fce80	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9b38eded-3f46-4aaa-9991-68008d97bdbe	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7670	47	false	United States	-17392	NA	78f5b5b4-1057-53e3-9cfd-d2924e887e08	hispanic or latino	female	white	TCGA-44-7670_demographic	Alive	17392	M0	N1	Stage IIA	T1b	7th	primary	0	882.0	bd72aa09-8c33-5744-a8d3-b86f8a73ce16	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-7670_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7670_treatment3	NA	NA	NA	NA	36b44b70-34b6-42be-9bf4-4c92b6da4d1a	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9b38eded-3f46-4aaa-9991-68008d97bdbe	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7670	47	false	United States	-17392	NA	78f5b5b4-1057-53e3-9cfd-d2924e887e08	hispanic or latino	female	white	TCGA-44-7670_demographic	Alive	17392	M0	N1	Stage IIA	T1b	7th	primary	0	882.0	bd72aa09-8c33-5744-a8d3-b86f8a73ce16	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-7670_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	165	88	NA	4	NA	NA	NA	Intravenous	TCGA-44-7670_treatment2	Cisplatin	NA	419	mg	87e95eae-004d-4e75-b9a8-fe9b527efa1d	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	9b38eded-3f46-4aaa-9991-68008d97bdbe	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7670	47	false	United States	-17392	NA	78f5b5b4-1057-53e3-9cfd-d2924e887e08	hispanic or latino	female	white	TCGA-44-7670_demographic	Alive	17392	M0	N1	Stage IIA	T1b	7th	primary	0	882.0	bd72aa09-8c33-5744-a8d3-b86f8a73ce16	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-7670_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	165	88	NA	4	NA	NA	NA	Intravenous	TCGA-44-7670_treatment	Docetaxel	NA	420	mg	e4ae2638-fced-5bbe-8dcd-1bf1d01f904c	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	9b4eeecb-6aff-435b-a244-ec362af92b7f	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5425	68	false	Germany	-25020	NA	a5a0448d-6255-558d-a34a-3bdd0f6912d0	not reported	male	not reported	TCGA-05-5425_demographic	Alive	25506	NA	NA	NA	NA	NA	not reported	486	NA	f12ff20b-3927-4ec7-b72c-97c0ae98f948	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-5425_diagnosis2	NA	Not Reported	TCGA-05-5425_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-5425_treatment7	NA	NA	NA	NA	a2d9bd70-5d50-4eb4-9bc6-ea338970a124	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	9b4eeecb-6aff-435b-a244-ec362af92b7f	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5425	68	false	Germany	-25020	NA	a5a0448d-6255-558d-a34a-3bdd0f6912d0	not reported	male	not reported	TCGA-05-5425_demographic	Alive	25506	NA	NA	NA	NA	NA	not reported	486	NA	f12ff20b-3927-4ec7-b72c-97c0ae98f948	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-5425_diagnosis2	NA	Not Reported	TCGA-05-5425_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-5425_treatment6	NA	NA	NA	NA	c194c140-ea42-4aa0-9ecb-abf73c3508c4	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9b4eeecb-6aff-435b-a244-ec362af92b7f	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5425	68	false	Germany	-25020	NA	a5a0448d-6255-558d-a34a-3bdd0f6912d0	not reported	male	not reported	TCGA-05-5425_demographic	Alive	25020	M0	N1	Stage IIB	T2b	7th	primary	0	882.0	f6215c8a-cc36-5e6a-8bea-1e7ec89c3093	true	NA	NA	C34.9	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-5425_diagnosis	No	Lung, NOS	NA	2009	No	NA	NA	792	NA	NA	NA	NA	NA	NA	TCGA-05-5425_treatment5	Erlotinib	NA	NA	NA	4793e798-e4d7-4ce1-b54c-dac2fd0f2c10	NA	yes	Treatment Ongoing	Immunotherapy (Including Vaccines)
TCGA-LUAD	9b4eeecb-6aff-435b-a244-ec362af92b7f	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5425	68	false	Germany	-25020	NA	a5a0448d-6255-558d-a34a-3bdd0f6912d0	not reported	male	not reported	TCGA-05-5425_demographic	Alive	25020	M0	N1	Stage IIB	T2b	7th	primary	0	882.0	f6215c8a-cc36-5e6a-8bea-1e7ec89c3093	true	NA	NA	C34.9	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-5425_diagnosis	No	Lung, NOS	NA	2009	NA	NA	547	516	NA	NA	NA	NA	NA	NA	TCGA-05-5425_treatment	NA	Distant Site	40	Gy	76c74da2-1a3d-5b2c-9f91-80db92937722	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	9b4eeecb-6aff-435b-a244-ec362af92b7f	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5425	68	false	Germany	-25020	NA	a5a0448d-6255-558d-a34a-3bdd0f6912d0	not reported	male	not reported	TCGA-05-5425_demographic	Alive	25020	M0	N1	Stage IIB	T2b	7th	primary	0	882.0	f6215c8a-cc36-5e6a-8bea-1e7ec89c3093	true	NA	NA	C34.9	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-5425_diagnosis	No	Lung, NOS	NA	2009	No	NA	761	700	NA	NA	NA	NA	NA	NA	TCGA-05-5425_treatment3	Carboplatin	NA	NA	NA	8c4abdb7-e23e-4f7a-959a-2796c40fc64f	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	9b4eeecb-6aff-435b-a244-ec362af92b7f	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5425	68	false	Germany	-25020	NA	a5a0448d-6255-558d-a34a-3bdd0f6912d0	not reported	male	not reported	TCGA-05-5425_demographic	Alive	25020	M0	N1	Stage IIB	T2b	7th	primary	0	882.0	f6215c8a-cc36-5e6a-8bea-1e7ec89c3093	true	NA	NA	C34.9	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-5425_diagnosis	No	Lung, NOS	NA	2009	No	NA	669	608	NA	NA	NA	NA	NA	NA	TCGA-05-5425_treatment4	Gefitinib	NA	NA	NA	bc2115f6-59a2-46b4-93f1-7185b1601bc0	NA	yes	Progressive Disease	Immunotherapy (Including Vaccines)
TCGA-LUAD	9b4eeecb-6aff-435b-a244-ec362af92b7f	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-5425	68	false	Germany	-25020	NA	a5a0448d-6255-558d-a34a-3bdd0f6912d0	not reported	male	not reported	TCGA-05-5425_demographic	Alive	25020	M0	N1	Stage IIB	T2b	7th	primary	0	882.0	f6215c8a-cc36-5e6a-8bea-1e7ec89c3093	true	NA	NA	C34.9	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-5425_diagnosis	No	Lung, NOS	NA	2009	No	NA	761	700	NA	NA	NA	NA	NA	NA	TCGA-05-5425_treatment2	Paclitaxel	NA	NA	NA	f1b5e6c0-8f6a-4277-ac3d-2449b4170d9c	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	9b714a42-62e8-4b33-947e-6c4850725afd	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z015	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	9b93a7c5-f9b4-4461-8078-0201a725c9cf	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARR	68	false	United States	-24942	NA	c7b3e86f-ecab-5184-99e4-830222c900cd	not hispanic or latino	male	black or african american	TCGA-49-AARR_demographic	Alive	24942	MX	N0	Stage IA	T1	5th	primary	0	4992.0	11f75402-3cc9-5475-a20f-2d0215596fa5	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AARR_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARR_treatment	NA	NA	NA	NA	278abdfc-9094-5732-a42e-d8615f7a7f3c	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9b93a7c5-f9b4-4461-8078-0201a725c9cf	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARR	68	false	United States	-24942	NA	c7b3e86f-ecab-5184-99e4-830222c900cd	not hispanic or latino	male	black or african american	TCGA-49-AARR_demographic	Alive	24942	MX	N0	Stage IA	T1	5th	primary	0	4992.0	11f75402-3cc9-5475-a20f-2d0215596fa5	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AARR_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARR_treatment2	NA	NA	NA	NA	e3568dcd-91e9-4394-ba88-7408b5fe2f09	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9b93a7c5-f9b4-4461-8078-0201a725c9cf	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARR	68	false	United States	-24942	NA	c7b3e86f-ecab-5184-99e4-830222c900cd	not hispanic or latino	male	black or african american	TCGA-49-AARR_demographic	Alive	29754	NA	NA	NA	NA	NA	recurrence	4812	NA	1c856351-a7b3-441b-9979-c52f582ef0ff	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARR_diagnosis3	NA	Not Reported	TCGA-49-AARR_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-AARR_treatment5	NA	NA	NA	NA	4612a664-5934-4a86-b276-48b8a166a681	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9b93a7c5-f9b4-4461-8078-0201a725c9cf	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARR	68	false	United States	-24942	NA	c7b3e86f-ecab-5184-99e4-830222c900cd	not hispanic or latino	male	black or african american	TCGA-49-AARR_demographic	Alive	29754	NA	NA	NA	NA	NA	recurrence	4812	NA	1c856351-a7b3-441b-9979-c52f582ef0ff	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARR_diagnosis3	NA	Not Reported	TCGA-49-AARR_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARR_treatment7	NA	Locoregional Site	NA	NA	cc0c8742-be83-4abd-9749-2b39fbba58f5	NA	no	NA	Surgery, NOS
TCGA-LUAD	9b93a7c5-f9b4-4461-8078-0201a725c9cf	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARR	68	false	United States	-24942	NA	c7b3e86f-ecab-5184-99e4-830222c900cd	not hispanic or latino	male	black or african american	TCGA-49-AARR_demographic	Alive	29754	NA	NA	NA	NA	NA	recurrence	4812	NA	1c856351-a7b3-441b-9979-c52f582ef0ff	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARR_diagnosis3	NA	Not Reported	TCGA-49-AARR_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-AARR_treatment6	NA	NA	NA	NA	f6d69f28-e608-4e49-99ae-7dfc499e4f9e	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9b93a7c5-f9b4-4461-8078-0201a725c9cf	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARR	68	false	United States	-24942	NA	c7b3e86f-ecab-5184-99e4-830222c900cd	not hispanic or latino	male	black or african american	TCGA-49-AARR_demographic	Alive	26041	NA	NA	NA	NA	NA	Subsequent Primary	1099	NA	874e0f33-2311-4897-bca0-e01c41f4dd61	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-AARR_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-49-AARR_treatment3	NA	NA	NA	NA	460c106d-3b81-40b8-b924-021fcf60d064	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9b93a7c5-f9b4-4461-8078-0201a725c9cf	Consent Waiver	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-AARR	68	false	United States	-24942	NA	c7b3e86f-ecab-5184-99e4-830222c900cd	not hispanic or latino	male	black or african american	TCGA-49-AARR_demographic	Alive	26041	NA	NA	NA	NA	NA	Subsequent Primary	1099	NA	874e0f33-2311-4897-bca0-e01c41f4dd61	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-AARR_diagnosis2	NA	Not Reported	NA	NA	NA	NA	NA	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-49-AARR_treatment4	NA	NA	NA	NA	b5d6565e-08f5-4412-8754-6fa0659eea40	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9c7875ad-ab71-4d48-b2e3-e4c7a46393e9	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-6745	82	false	United States	-30133	NA	96208e4a-c1c5-5e28-b8e5-c6e6e4e096c8	not reported	male	white	TCGA-49-6745_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	cdb12257-235c-4a7f-95d5-613572cffaa4	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-49-6745_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6745_treatment3	NA	NA	NA	NA	41419df1-7e61-45da-ad2d-8a4aa3e346b5	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9c7875ad-ab71-4d48-b2e3-e4c7a46393e9	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-6745	82	false	United States	-30133	NA	96208e4a-c1c5-5e28-b8e5-c6e6e4e096c8	not reported	male	white	TCGA-49-6745_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	cdb12257-235c-4a7f-95d5-613572cffaa4	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-49-6745_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6745_treatment4	NA	NA	NA	NA	7ec62bf6-5946-48d1-898d-e4b5872c6fc0	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9c7875ad-ab71-4d48-b2e3-e4c7a46393e9	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-6745	82	false	United States	-30133	NA	96208e4a-c1c5-5e28-b8e5-c6e6e4e096c8	not reported	male	white	TCGA-49-6745_demographic	Alive	30133	M0	N2	Stage IIIA	T2a	7th	primary	0	522.0	f17af2ab-6e23-55d4-946b-99873bc2e707	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-49-6745_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6745_treatment2	NA	NA	NA	NA	a019198b-d2c2-43ab-bb88-41cd5f66342f	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9c7875ad-ab71-4d48-b2e3-e4c7a46393e9	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-6745	82	false	United States	-30133	NA	96208e4a-c1c5-5e28-b8e5-c6e6e4e096c8	not reported	male	white	TCGA-49-6745_demographic	Alive	30133	M0	N2	Stage IIIA	T2a	7th	primary	0	522.0	f17af2ab-6e23-55d4-946b-99873bc2e707	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-49-6745_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	156	64	NA	NA	NA	NA	NA	Intravenous	TCGA-49-6745_treatment	NA	NA	NA	NA	fffc5502-3fa8-57a9-9d18-26e6277a2623	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	9c894668-88f5-4308-a1c0-6b8acc6aaaec	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7711	70	false	Russia	-25719	1046	0e0a923a-2a4b-5137-a828-fc6a76aa57a5	hispanic or latino	male	white	TCGA-86-7711_demographic	Dead	25719	M0	N1	Stage IIA	T2a	7th	primary	0	1046.0	8f242954-9ef0-5f2a-8cd7-b860ddc00374	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7711_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	181	37	NA	NA	NA	NA	NA	NA	TCGA-86-7711_treatment2	Etoposide	NA	NA	NA	2df45c4f-b330-4515-8102-7e5d4e8ce168	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	9c894668-88f5-4308-a1c0-6b8acc6aaaec	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7711	70	false	Russia	-25719	1046	0e0a923a-2a4b-5137-a828-fc6a76aa57a5	hispanic or latino	male	white	TCGA-86-7711_demographic	Dead	25719	M0	N1	Stage IIA	T2a	7th	primary	0	1046.0	8f242954-9ef0-5f2a-8cd7-b860ddc00374	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7711_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-7711_treatment3	NA	NA	NA	NA	b39c41c0-abf5-4668-9487-962d79296b09	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9c894668-88f5-4308-a1c0-6b8acc6aaaec	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7711	70	false	Russia	-25719	1046	0e0a923a-2a4b-5137-a828-fc6a76aa57a5	hispanic or latino	male	white	TCGA-86-7711_demographic	Dead	25719	M0	N1	Stage IIA	T2a	7th	primary	0	1046.0	8f242954-9ef0-5f2a-8cd7-b860ddc00374	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7711_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	181	37	NA	NA	NA	NA	NA	NA	TCGA-86-7711_treatment	Cisplatin	NA	NA	NA	ec25ee36-412b-549a-a36d-91dd9620a6ad	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	9ca1a26c-82e0-48b3-b3bb-2ed57086eeb1	Informed Consent	-11	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8552	55	false	United States	-20331	NA	21f29b38-cc78-57ac-9504-0c9fb40326c3	not hispanic or latino	female	white	TCGA-97-8552_demographic	Alive	20331	MX	N0	Stage I	T1a	7th	primary	0	626.0	3015dff7-2c80-59ea-ae7a-34a4a0a75dd8	true	NA	NA	C34.3	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	NA	TCGA-97-8552_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8552_treatment2	NA	NA	NA	NA	02bf8787-d596-4210-aa95-01b98fc51071	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9ca1a26c-82e0-48b3-b3bb-2ed57086eeb1	Informed Consent	-11	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8552	55	false	United States	-20331	NA	21f29b38-cc78-57ac-9504-0c9fb40326c3	not hispanic or latino	female	white	TCGA-97-8552_demographic	Alive	20331	MX	N0	Stage I	T1a	7th	primary	0	626.0	3015dff7-2c80-59ea-ae7a-34a4a0a75dd8	true	NA	NA	C34.3	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	NA	TCGA-97-8552_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8552_treatment	NA	NA	NA	NA	ec9677b2-277e-56c5-8801-d0ed594b367f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9cfc1519-33e7-4145-a4ad-78b5c449853a	Informed Consent	13	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-8459	68	false	United States	-24859	NA	e5662c53-d81b-541b-95cd-4b7f44e25a10	not hispanic or latino	male	white	TCGA-50-8459_demographic	Alive	24859	M0	N0	Stage IIB	T3	7th	primary	0	1119.0	e91e1381-690d-5eba-803c-d88ced6fc695	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	NA	TCGA-50-8459_diagnosis	No	Lower lobe, lung	NA	2012	Yes	NA	147	76	NA	NA	NA	NA	NA	NA	TCGA-50-8459_treatment3	Bevacizumab	NA	NA	NA	eae1a3be-3d14-4de5-a934-58c48080793b	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	9cfc1519-33e7-4145-a4ad-78b5c449853a	Informed Consent	13	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-8459	68	false	United States	-24859	NA	e5662c53-d81b-541b-95cd-4b7f44e25a10	not hispanic or latino	male	white	TCGA-50-8459_demographic	Alive	24859	M0	N0	Stage IIB	T3	7th	primary	0	1119.0	e91e1381-690d-5eba-803c-d88ced6fc695	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	NA	TCGA-50-8459_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-8459_treatment4	NA	NA	NA	NA	eefac945-3ae9-49ba-8e10-f107671f964c	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9cfc1519-33e7-4145-a4ad-78b5c449853a	Informed Consent	13	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-8459	68	false	United States	-24859	NA	e5662c53-d81b-541b-95cd-4b7f44e25a10	not hispanic or latino	male	white	TCGA-50-8459_demographic	Alive	24859	M0	N0	Stage IIB	T3	7th	primary	0	1119.0	e91e1381-690d-5eba-803c-d88ced6fc695	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	NA	TCGA-50-8459_diagnosis	No	Lower lobe, lung	NA	2012	Yes	NA	147	76	NA	NA	NA	NA	NA	NA	TCGA-50-8459_treatment2	Cisplatin	NA	NA	NA	eff612c9-a0d1-4c87-9d83-860383fd0783	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	9cfc1519-33e7-4145-a4ad-78b5c449853a	Informed Consent	13	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-8459	68	false	United States	-24859	NA	e5662c53-d81b-541b-95cd-4b7f44e25a10	not hispanic or latino	male	white	TCGA-50-8459_demographic	Alive	24859	M0	N0	Stage IIB	T3	7th	primary	0	1119.0	e91e1381-690d-5eba-803c-d88ced6fc695	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	NA	TCGA-50-8459_diagnosis	No	Lower lobe, lung	NA	2012	Yes	NA	147	76	NA	NA	NA	NA	NA	NA	TCGA-50-8459_treatment	Pemetrexed Disodium	NA	NA	NA	f2f2d2f9-b1ab-5e07-a4b1-fd95aeeff22d	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	9cfc1519-33e7-4145-a4ad-78b5c449853a	Informed Consent	13	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-8459	68	false	United States	-24859	NA	e5662c53-d81b-541b-95cd-4b7f44e25a10	not hispanic or latino	male	white	TCGA-50-8459_demographic	Alive	25291	NA	NA	NA	NA	NA	recurrence	432	NA	ebb2eeab-3590-482d-83ce-562101a12bdb	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-50-8459_diagnosis2	NA	Not Reported	TCGA-50-8459_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-8459_treatment6	NA	NA	NA	NA	33938d7d-e6e8-4ca4-a7d3-d417f855a36b	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9cfc1519-33e7-4145-a4ad-78b5c449853a	Informed Consent	13	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-8459	68	false	United States	-24859	NA	e5662c53-d81b-541b-95cd-4b7f44e25a10	not hispanic or latino	male	white	TCGA-50-8459_demographic	Alive	25291	NA	NA	NA	NA	NA	recurrence	432	NA	ebb2eeab-3590-482d-83ce-562101a12bdb	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-50-8459_diagnosis2	NA	Not Reported	TCGA-50-8459_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-8459_treatment5	NA	NA	NA	NA	766c8e9f-a65e-4656-ab06-56b1b8518419	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9cfc1519-33e7-4145-a4ad-78b5c449853a	Informed Consent	13	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-8459	68	false	United States	-24859	NA	e5662c53-d81b-541b-95cd-4b7f44e25a10	not hispanic or latino	male	white	TCGA-50-8459_demographic	Alive	25291	NA	NA	NA	NA	NA	recurrence	432	NA	ebb2eeab-3590-482d-83ce-562101a12bdb	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-50-8459_diagnosis2	NA	Not Reported	TCGA-50-8459_diagnosis	NA	NA	NA	NA	432	NA	NA	NA	NA	NA	NA	TCGA-50-8459_treatment7	NA	Locoregional Site	NA	NA	9da14e08-3ddb-4e43-bcbb-3cc3fb3969f1	NA	yes	NA	Surgery, NOS
TCGA-LUAD	9dda72ec-1698-44e2-b35c-11e9a2704380	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-93-A4JN	71	false	United States	-26273	NA	f09de39b-9c00-54a8-b0d8-0bcf55de224b	not hispanic or latino	male	white	TCGA-93-A4JN_demographic	Alive	26273	M1a	N0	Stage IV	T2a	7th	primary	0	718.0	14180627-fdc7-5e23-906e-ad09b9c9414a	true	NA	NA	C34.1	Left	8550/3	Acinar cell carcinoma	no	No	RX	Lung, NOS	NA	TCGA-93-A4JN_diagnosis	No	Upper lobe, lung	NA	2012	Yes	NA	399	340	NA	NA	NA	NA	NA	NA	TCGA-93-A4JN_treatment	Belinostat	NA	NA	NA	0de92c1f-7bcd-5359-ba1d-2e5c0af6c7a9	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	9dda72ec-1698-44e2-b35c-11e9a2704380	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-93-A4JN	71	false	United States	-26273	NA	f09de39b-9c00-54a8-b0d8-0bcf55de224b	not hispanic or latino	male	white	TCGA-93-A4JN_demographic	Alive	26273	M1a	N0	Stage IV	T2a	7th	primary	0	718.0	14180627-fdc7-5e23-906e-ad09b9c9414a	true	NA	NA	C34.1	Left	8550/3	Acinar cell carcinoma	no	No	RX	Lung, NOS	NA	TCGA-93-A4JN_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-A4JN_treatment3	NA	NA	NA	NA	bd5cda3d-9b0a-4abb-b753-905f88812b54	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9dda72ec-1698-44e2-b35c-11e9a2704380	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-93-A4JN	71	false	United States	-26273	NA	f09de39b-9c00-54a8-b0d8-0bcf55de224b	not hispanic or latino	male	white	TCGA-93-A4JN_demographic	Alive	26273	M1a	N0	Stage IV	T2a	7th	primary	0	718.0	14180627-fdc7-5e23-906e-ad09b9c9414a	true	NA	NA	C34.1	Left	8550/3	Acinar cell carcinoma	no	No	RX	Lung, NOS	NA	TCGA-93-A4JN_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	697	410	NA	NA	NA	NA	NA	NA	TCGA-93-A4JN_treatment2	Carboplatin	NA	NA	NA	d9651ebb-39ab-437d-88c1-95a8eba7e9b7	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	9e22a3af-7f28-4757-8684-ed64a2a27ad1	Informed Consent	-2	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-95-A4VP	66	false	United States	-24130	NA	521c9a5f-9555-5183-8f92-914fdc4c331e	not reported	female	white	TCGA-95-A4VP_demographic	Alive	24346	NA	NA	NA	NA	NA	metastasis	216	NA	23098c44-9d76-402f-b13a-bc546120abe8	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-95-A4VP_diagnosis2	NA	Not Reported	TCGA-95-A4VP_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-95-A4VP_treatment5	NA	NA	NA	NA	a86821e7-b2d7-4c4c-afb4-5578a2ec7a15	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	9e22a3af-7f28-4757-8684-ed64a2a27ad1	Informed Consent	-2	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-95-A4VP	66	false	United States	-24130	NA	521c9a5f-9555-5183-8f92-914fdc4c331e	not reported	female	white	TCGA-95-A4VP_demographic	Alive	24346	NA	NA	NA	NA	NA	metastasis	216	NA	23098c44-9d76-402f-b13a-bc546120abe8	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-95-A4VP_diagnosis2	NA	Not Reported	TCGA-95-A4VP_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VP_treatment6	NA	Distant Site	NA	NA	addf72b6-5605-4cb5-8525-5fe9c580eb43	NA	no	NA	Surgery, NOS
TCGA-LUAD	9e22a3af-7f28-4757-8684-ed64a2a27ad1	Informed Consent	-2	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-95-A4VP	66	false	United States	-24130	NA	521c9a5f-9555-5183-8f92-914fdc4c331e	not reported	female	white	TCGA-95-A4VP_demographic	Alive	24346	NA	NA	NA	NA	NA	metastasis	216	NA	23098c44-9d76-402f-b13a-bc546120abe8	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-95-A4VP_diagnosis2	NA	Not Reported	TCGA-95-A4VP_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-95-A4VP_treatment4	NA	NA	NA	NA	fa5aada3-cc1a-4ef3-bd2d-4d4ad9136c04	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9e22a3af-7f28-4757-8684-ed64a2a27ad1	Informed Consent	-2	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-95-A4VP	66	false	United States	-24130	NA	521c9a5f-9555-5183-8f92-914fdc4c331e	not reported	female	white	TCGA-95-A4VP_demographic	Alive	24130	M0	N2	Stage IIIA	T2b	7th	primary	0	605.0	6894b70f-da36-5723-afd5-a31eb7c674d8	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-95-A4VP_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	126	63	NA	NA	NA	NA	NA	NA	TCGA-95-A4VP_treatment2	Paclitaxel	NA	NA	NA	0cff08d8-14ec-47e5-a87b-0b65f6c88414	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	9e22a3af-7f28-4757-8684-ed64a2a27ad1	Informed Consent	-2	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-95-A4VP	66	false	United States	-24130	NA	521c9a5f-9555-5183-8f92-914fdc4c331e	not reported	female	white	TCGA-95-A4VP_demographic	Alive	24130	M0	N2	Stage IIIA	T2b	7th	primary	0	605.0	6894b70f-da36-5723-afd5-a31eb7c674d8	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-95-A4VP_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	126	63	NA	NA	NA	NA	NA	NA	TCGA-95-A4VP_treatment	Carboplatin	NA	NA	NA	2fb1175b-f615-57cd-a7ef-976ea4c3d00f	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	9e22a3af-7f28-4757-8684-ed64a2a27ad1	Informed Consent	-2	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-95-A4VP	66	false	United States	-24130	NA	521c9a5f-9555-5183-8f92-914fdc4c331e	not reported	female	white	TCGA-95-A4VP_demographic	Alive	24130	M0	N2	Stage IIIA	T2b	7th	primary	0	605.0	6894b70f-da36-5723-afd5-a31eb7c674d8	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-95-A4VP_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VP_treatment3	NA	NA	NA	NA	f361b411-4912-43f3-8cea-10f10004f25d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9e640ff7-996e-427b-b56c-519a1e23baab	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4P7	63	false	Russia	-23330	NA	1104f41e-44ae-515a-8661-e1a30230999c	not hispanic or latino	female	white	TCGA-86-A4P7_demographic	Alive	23330	M0	N0	Stage IB	T2a	7th	primary	0	415.0	4429bbd4-2ee7-512e-8a5c-232e37c9e569	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-A4P7_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-A4P7_treatment	NA	NA	NA	NA	22944d8f-b850-5046-964a-bd450f0b4567	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9e640ff7-996e-427b-b56c-519a1e23baab	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4P7	63	false	Russia	-23330	NA	1104f41e-44ae-515a-8661-e1a30230999c	not hispanic or latino	female	white	TCGA-86-A4P7_demographic	Alive	23330	M0	N0	Stage IB	T2a	7th	primary	0	415.0	4429bbd4-2ee7-512e-8a5c-232e37c9e569	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-A4P7_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-A4P7_treatment2	NA	NA	NA	NA	a91f694f-364b-475e-b769-2f11945a76e3	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	9ee20c0d-a1c3-47f3-abda-131b3f190f52	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5045	57	false	United States	-20961	2174	fa01b4df-a7ed-5231-92fe-8e5a43420978	not hispanic or latino	female	black or african american	TCGA-50-5045_demographic	Dead	20961	M0	N1	NA	T2	6th	primary	0	2174.0	194327a8-2c67-50d3-a613-46db5f917d5f	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5045_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	NA	63	NA	NA	NA	NA	NA	NA	TCGA-50-5045_treatment	NA	Primary Tumor Field	NA	NA	d9f36840-bd60-52bb-b9e1-9f8e3862ed44	Adjuvant	yes	NA	Brachytherapy, Low Dose
TCGA-LUAD	9ee20c0d-a1c3-47f3-abda-131b3f190f52	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5045	57	false	United States	-20961	2174	fa01b4df-a7ed-5231-92fe-8e5a43420978	not hispanic or latino	female	black or african american	TCGA-50-5045_demographic	Dead	22394	NA	NA	NA	NA	NA	recurrence	1433	NA	8a5bb051-5aa7-4074-b164-3a99e2e90cb7	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5045_diagnosis2	NA	Not Reported	TCGA-50-5045_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5045_treatment3	NA	NA	NA	NA	bba85ef4-e586-4f24-9cb8-a8cd96cec0c1	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	9ee20c0d-a1c3-47f3-abda-131b3f190f52	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5045	57	false	United States	-20961	2174	fa01b4df-a7ed-5231-92fe-8e5a43420978	not hispanic or latino	female	black or african american	TCGA-50-5045_demographic	Dead	22394	NA	NA	NA	NA	NA	recurrence	1433	NA	8a5bb051-5aa7-4074-b164-3a99e2e90cb7	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5045_diagnosis2	NA	Not Reported	TCGA-50-5045_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5045_treatment2	NA	NA	NA	NA	bea5770a-2e48-4580-a120-d740a4fd35d3	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9ee20c0d-a1c3-47f3-abda-131b3f190f52	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5045	57	false	United States	-20961	2174	fa01b4df-a7ed-5231-92fe-8e5a43420978	not hispanic or latino	female	black or african american	TCGA-50-5045_demographic	Dead	22394	NA	NA	NA	NA	NA	recurrence	1433	NA	8a5bb051-5aa7-4074-b164-3a99e2e90cb7	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5045_diagnosis2	NA	Not Reported	TCGA-50-5045_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5045_treatment4	NA	Locoregional Site	NA	NA	f0808c01-9978-44ea-895c-10a9324c2f2c	NA	no	NA	Surgery, NOS
TCGA-LUAD	9f4f2ff3-3c02-4281-a398-b0d0955e58eb	Informed Consent	-5	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-8453	77	false	United States	-28413	NA	4f662a08-c1f2-5723-a751-996de381cb05	not hispanic or latino	male	white	TCGA-69-8453_demographic	Alive	28413	MX	N0	Stage IIB	T3	7th	primary	0	813.0	0aa59438-6843-5585-ae48-0a9ed4165c27	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-8453_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	157	45	NA	NA	NA	NA	NA	NA	TCGA-69-8453_treatment5	Paclitaxel	NA	NA	NA	1dd03c40-f4e6-47c1-844e-c12621ec0aa4	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	9f4f2ff3-3c02-4281-a398-b0d0955e58eb	Informed Consent	-5	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-8453	77	false	United States	-28413	NA	4f662a08-c1f2-5723-a751-996de381cb05	not hispanic or latino	male	white	TCGA-69-8453_demographic	Alive	28413	MX	N0	Stage IIB	T3	7th	primary	0	813.0	0aa59438-6843-5585-ae48-0a9ed4165c27	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-8453_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	417	413	NA	NA	5.0	NA	NA	NA	TCGA-69-8453_treatment	NA	Locoregional Site	5000	cGy	3b0fdb16-8514-593d-932a-9aa80f3ea317	NA	yes	Unknown	Radiation, External Beam
TCGA-LUAD	9f4f2ff3-3c02-4281-a398-b0d0955e58eb	Informed Consent	-5	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-8453	77	false	United States	-28413	NA	4f662a08-c1f2-5723-a751-996de381cb05	not hispanic or latino	male	white	TCGA-69-8453_demographic	Alive	28413	MX	N0	Stage IIB	T3	7th	primary	0	813.0	0aa59438-6843-5585-ae48-0a9ed4165c27	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-8453_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	157	45	NA	NA	NA	NA	NA	NA	TCGA-69-8453_treatment2	Carboplatin	NA	NA	NA	7c9db0f4-86e5-4d6e-b8c5-f21bc0c735c9	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	9f4f2ff3-3c02-4281-a398-b0d0955e58eb	Informed Consent	-5	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-8453	77	false	United States	-28413	NA	4f662a08-c1f2-5723-a751-996de381cb05	not hispanic or latino	male	white	TCGA-69-8453_demographic	Alive	28413	MX	N0	Stage IIB	T3	7th	primary	0	813.0	0aa59438-6843-5585-ae48-0a9ed4165c27	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-8453_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	571	505	NA	NA	NA	NA	NA	NA	TCGA-69-8453_treatment4	Pemetrexed Disodium	NA	NA	NA	8f2e165a-392c-456c-bd0a-e3a230caeedd	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	9f4f2ff3-3c02-4281-a398-b0d0955e58eb	Informed Consent	-5	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-8453	77	false	United States	-28413	NA	4f662a08-c1f2-5723-a751-996de381cb05	not hispanic or latino	male	white	TCGA-69-8453_demographic	Alive	28413	MX	N0	Stage IIB	T3	7th	primary	0	813.0	0aa59438-6843-5585-ae48-0a9ed4165c27	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-8453_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	571	505	NA	NA	NA	NA	NA	NA	TCGA-69-8453_treatment3	Carboplatin	NA	NA	NA	edcc98fd-bded-41e3-a2e9-fe3f3193d187	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	9f4f2ff3-3c02-4281-a398-b0d0955e58eb	Informed Consent	-5	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-8453	77	false	United States	-28413	NA	4f662a08-c1f2-5723-a751-996de381cb05	not hispanic or latino	male	white	TCGA-69-8453_demographic	Alive	28757	NA	NA	NA	NA	NA	recurrence	344	NA	df304b52-f0d0-4705-9ebb-d3851cd0a7ec	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-69-8453_diagnosis2	NA	Not Reported	TCGA-69-8453_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-69-8453_treatment6	NA	NA	NA	NA	57ab5227-b4a3-4935-ae5c-772bd2f65c10	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9f4f2ff3-3c02-4281-a398-b0d0955e58eb	Informed Consent	-5	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-8453	77	false	United States	-28413	NA	4f662a08-c1f2-5723-a751-996de381cb05	not hispanic or latino	male	white	TCGA-69-8453_demographic	Alive	28757	NA	NA	NA	NA	NA	recurrence	344	NA	df304b52-f0d0-4705-9ebb-d3851cd0a7ec	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-69-8453_diagnosis2	NA	Not Reported	TCGA-69-8453_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-8453_treatment8	NA	Locoregional Site	NA	NA	65c7650c-89e9-4dad-99be-87674acf1d0a	NA	no	NA	Surgery, NOS
TCGA-LUAD	9f4f2ff3-3c02-4281-a398-b0d0955e58eb	Informed Consent	-5	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-8453	77	false	United States	-28413	NA	4f662a08-c1f2-5723-a751-996de381cb05	not hispanic or latino	male	white	TCGA-69-8453_demographic	Alive	28757	NA	NA	NA	NA	NA	recurrence	344	NA	df304b52-f0d0-4705-9ebb-d3851cd0a7ec	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-69-8453_diagnosis2	NA	Not Reported	TCGA-69-8453_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-69-8453_treatment7	NA	NA	NA	NA	79590695-42c1-45bc-ae6e-5cef3d3022fb	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	9f81c602-8afa-4588-b0b6-6e5a1a128d5a	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4396	76	false	Germany	-28094	303	dcb3644b-5ea1-5c2f-abd4-a6ff5df99bd3	not reported	male	not reported	TCGA-05-4396_demographic	Dead	28094	M0	N1	Stage IIIB	T4	5th	primary	0	303.0	d0e11de6-e9ff-590c-b8c5-92caa5042412	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4396_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	9f81c602-8afa-4588-b0b6-6e5a1a128d5a	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4396	76	false	Germany	-28094	303	dcb3644b-5ea1-5c2f-abd4-a6ff5df99bd3	not reported	male	not reported	TCGA-05-4396_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d9339115-8c1c-4056-86eb-36855a63d705	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4396_diagnosis2	NA	Bladder, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4396_treatment2	NA	NA	NA	NA	35fc4161-155b-43ba-915e-bff930151ebb	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9f81c602-8afa-4588-b0b6-6e5a1a128d5a	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4396	76	false	Germany	-28094	303	dcb3644b-5ea1-5c2f-abd4-a6ff5df99bd3	not reported	male	not reported	TCGA-05-4396_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d9339115-8c1c-4056-86eb-36855a63d705	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4396_diagnosis2	NA	Bladder, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4396_treatment	NA	NA	NA	NA	90f63f49-fa2e-49c8-ac69-81f02a62bfa7	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9fcdccae-676e-4071-93c3-23d2d3ab0c00	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7725	68	false	United States	-24848	NA	e8696ba2-8645-5c4d-885b-fa4d7d24a610	not hispanic or latino	female	white	TCGA-55-7725_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	19b76b32-6f8d-443c-ac0f-d55f096a834e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-7725_diagnosis3	NA	Head, face or neck, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7725_treatment5	NA	NA	NA	NA	c4f18cc8-6797-4ab8-ae4e-cf213e25335c	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9fcdccae-676e-4071-93c3-23d2d3ab0c00	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7725	68	false	United States	-24848	NA	e8696ba2-8645-5c4d-885b-fa4d7d24a610	not hispanic or latino	female	white	TCGA-55-7725_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	19b76b32-6f8d-443c-ac0f-d55f096a834e	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-7725_diagnosis3	NA	Head, face or neck, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7725_treatment6	NA	NA	NA	NA	c76bdf38-3234-43bc-babc-4576e81b42f0	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9fcdccae-676e-4071-93c3-23d2d3ab0c00	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7725	68	false	United States	-24848	NA	e8696ba2-8645-5c4d-885b-fa4d7d24a610	not hispanic or latino	female	white	TCGA-55-7725_demographic	Alive	24848	MX	N0	Stage IA	T1a	7th	primary	0	442.0	940f183d-1be7-5dd9-b897-ca7ef4219e29	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-55-7725_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7725_treatment	NA	NA	NA	NA	41380f4e-5c34-53b7-b73f-707cf977c7e0	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	9fcdccae-676e-4071-93c3-23d2d3ab0c00	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7725	68	false	United States	-24848	NA	e8696ba2-8645-5c4d-885b-fa4d7d24a610	not hispanic or latino	female	white	TCGA-55-7725_demographic	Alive	24848	MX	N0	Stage IA	T1a	7th	primary	0	442.0	940f183d-1be7-5dd9-b897-ca7ef4219e29	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-55-7725_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7725_treatment2	NA	NA	NA	NA	6561bdce-2346-4673-bc03-f79b249ee228	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	9fcdccae-676e-4071-93c3-23d2d3ab0c00	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7725	68	false	United States	-24848	NA	e8696ba2-8645-5c4d-885b-fa4d7d24a610	not hispanic or latino	female	white	TCGA-55-7725_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	cb29b78e-5cdf-4fd7-85a7-92d25daeff9a	false	NA	NA	NA	Bilateral	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-7725_diagnosis2	NA	Pharynx, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7725_treatment4	NA	Locoregional Site	NA	NA	4cff4fff-6006-4bc5-901b-a5b0851bb4bb	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	9fcdccae-676e-4071-93c3-23d2d3ab0c00	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7725	68	false	United States	-24848	NA	e8696ba2-8645-5c4d-885b-fa4d7d24a610	not hispanic or latino	female	white	TCGA-55-7725_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	cb29b78e-5cdf-4fd7-85a7-92d25daeff9a	false	NA	NA	NA	Bilateral	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-55-7725_diagnosis2	NA	Pharynx, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7725_treatment3	NA	NA	NA	NA	b1e7c9ac-51d1-4837-b64f-30b17d587a3f	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a046888c-f153-4f35-a1b6-23dd1691a91a	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6975	61	false	United States	NA	118	c71eef1d-ab92-502f-b861-87ddb9977730	not hispanic or latino	male	white	TCGA-55-6975_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	0	118.0	0834d418-acca-52cf-97e5-c9d63375848a	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-55-6975_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6975_treatment2	NA	NA	NA	NA	69bfcb13-2000-4938-a4e1-f1845f9bb6c3	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a046888c-f153-4f35-a1b6-23dd1691a91a	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6975	61	false	United States	NA	118	c71eef1d-ab92-502f-b861-87ddb9977730	not hispanic or latino	male	white	TCGA-55-6975_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	0	118.0	0834d418-acca-52cf-97e5-c9d63375848a	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-55-6975_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6975_treatment	NA	NA	NA	NA	bc3886fe-83dd-5822-b14c-ecfb2f95ad4b	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc	Informed Consent	-31	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7150	59	false	Australia	-21891	666	a363d78d-a441-55e1-9798-34217afee837	not reported	male	white	TCGA-78-7150_demographic	Dead	21891	M0	N1	Stage IIB	T2	6th	primary	0	666.0	9d225683-87bc-57aa-82a2-54bcd2cdd26f	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-78-7150_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	642	607	Recurrent Disease	2	NA	140.0	mg/m2	Intravenous	TCGA-78-7150_treatment3	Paclitaxel	NA	700	mg/m2	4ff33b49-88f5-4868-85b1-bd847eac21be	NA	yes	NA	Chemotherapy
TCGA-LUAD	a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc	Informed Consent	-31	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7150	59	false	Australia	-21891	666	a363d78d-a441-55e1-9798-34217afee837	not reported	male	white	TCGA-78-7150_demographic	Dead	21891	M0	N1	Stage IIB	T2	6th	primary	0	666.0	9d225683-87bc-57aa-82a2-54bcd2cdd26f	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-78-7150_diagnosis	No	Lower lobe, lung	NA	2002	NA	1.0	189	185	NA	NA	5.0	NA	NA	NA	TCGA-78-7150_treatment2	NA	Distant Site	2000	cGy	91be1882-b7a9-483b-aabb-aafe964e595e	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc	Informed Consent	-31	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7150	59	false	Australia	-21891	666	a363d78d-a441-55e1-9798-34217afee837	not reported	male	white	TCGA-78-7150_demographic	Dead	21891	M0	N1	Stage IIB	T2	6th	primary	0	666.0	9d225683-87bc-57aa-82a2-54bcd2cdd26f	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-78-7150_diagnosis	No	Lower lobe, lung	NA	2002	NA	2.0	546	531	Recurrent Disease	NA	10.0	NA	NA	NA	TCGA-78-7150_treatment	NA	Distant Site	2500	cGy	96d11e56-bfb9-560e-9f9c-3273609a5d52	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc	Informed Consent	-31	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7150	59	false	Australia	-21891	666	a363d78d-a441-55e1-9798-34217afee837	not reported	male	white	TCGA-78-7150_demographic	Dead	21891	M0	N1	Stage IIB	T2	6th	primary	0	666.0	9d225683-87bc-57aa-82a2-54bcd2cdd26f	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-78-7150_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	397	285	NA	5	NA	1800.0	mg	Intravenous	TCGA-78-7150_treatment5	Gemcitabine	NA	14180	mg/m2	ca5ed246-fb14-404b-b6bf-a06ed71bd0f9	Palliative	yes	NA	Chemotherapy
TCGA-LUAD	a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc	Informed Consent	-31	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7150	59	false	Australia	-21891	666	a363d78d-a441-55e1-9798-34217afee837	not reported	male	white	TCGA-78-7150_demographic	Dead	21891	M0	N1	Stage IIB	T2	6th	primary	0	666.0	9d225683-87bc-57aa-82a2-54bcd2cdd26f	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-78-7150_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	397	285	NA	5	NA	615.0	AUC	Intravenous	TCGA-78-7150_treatment4	Carboplatin	NA	2475	mg	e0795432-86fd-4134-a8c1-379b70e29d4b	Palliative	yes	NA	Chemotherapy
TCGA-LUAD	a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc	Informed Consent	-31	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7150	59	false	Australia	-21891	666	a363d78d-a441-55e1-9798-34217afee837	not reported	male	white	TCGA-78-7150_demographic	Dead	22030	NA	NA	NA	NA	NA	not reported	139	NA	cc3e3946-cfb7-4588-80d6-1d5f8bc7c339	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7150_diagnosis2	NA	Not Reported	TCGA-78-7150_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7150_treatment7	NA	NA	NA	NA	10a64805-81ca-4dad-898b-834a11e4ec85	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc	Informed Consent	-31	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7150	59	false	Australia	-21891	666	a363d78d-a441-55e1-9798-34217afee837	not reported	male	white	TCGA-78-7150_demographic	Dead	22030	NA	NA	NA	NA	NA	not reported	139	NA	cc3e3946-cfb7-4588-80d6-1d5f8bc7c339	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7150_diagnosis2	NA	Not Reported	TCGA-78-7150_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7150_treatment8	NA	Locoregional Site	NA	NA	19b6724a-c364-4396-a034-3d51a1bb1f68	NA	no	NA	Surgery, NOS
TCGA-LUAD	a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc	Informed Consent	-31	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7150	59	false	Australia	-21891	666	a363d78d-a441-55e1-9798-34217afee837	not reported	male	white	TCGA-78-7150_demographic	Dead	22030	NA	NA	NA	NA	NA	not reported	139	NA	cc3e3946-cfb7-4588-80d6-1d5f8bc7c339	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7150_diagnosis2	NA	Not Reported	TCGA-78-7150_diagnosis	NA	NA	NA	NA	164	NA	NA	NA	NA	NA	NA	TCGA-78-7150_treatment9	NA	Distant Site	NA	NA	48ef04ec-e46c-415c-9c1e-9f34af5c0e9b	NA	yes	NA	Surgery, NOS
TCGA-LUAD	a0e57b39-960e-4e46-8aa0-d0ee2fd9a7cc	Informed Consent	-31	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7150	59	false	Australia	-21891	666	a363d78d-a441-55e1-9798-34217afee837	not reported	male	white	TCGA-78-7150_demographic	Dead	22030	NA	NA	NA	NA	NA	not reported	139	NA	cc3e3946-cfb7-4588-80d6-1d5f8bc7c339	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7150_diagnosis2	NA	Not Reported	TCGA-78-7150_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7150_treatment6	NA	NA	NA	NA	aa55399d-60e5-43cd-bcb4-8ba0279a7a29	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a16d7bf7-07b7-4320-969c-fc68dd564a92	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z033	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	a19d84a1-b316-44d3-90b1-0d14b0fd7a14	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	a1e65587-24c1-4b41-92a7-4e1f15fffd78	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4512	69	false	United States	-25502	905	d1cc924a-2e5f-52bf-a115-f50f44daa25a	not hispanic or latino	female	white	TCGA-49-4512_demographic	Dead	25502	MX	N2	Stage IIIA	T2	6th	primary	0	905.0	9eeeef23-15d3-52c7-aca3-22b77161dfb9	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-49-4512_diagnosis	No	Middle lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4512_treatment2	NA	NA	NA	NA	acf7aadd-3332-4e87-9cbf-c201e43b7fb3	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a1e65587-24c1-4b41-92a7-4e1f15fffd78	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4512	69	false	United States	-25502	905	d1cc924a-2e5f-52bf-a115-f50f44daa25a	not hispanic or latino	female	white	TCGA-49-4512_demographic	Dead	25502	MX	N2	Stage IIIA	T2	6th	primary	0	905.0	9eeeef23-15d3-52c7-aca3-22b77161dfb9	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-49-4512_diagnosis	No	Middle lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	Intravenous	TCGA-49-4512_treatment	NA	NA	NA	NA	c00ef007-7ebf-5cd5-b0aa-eac96b15fbd8	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a214a959-3b21-4f25-a615-383cda7afdff	Informed Consent	46	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8206	56	false	United States	-20690	NA	10a7cce6-455d-5e85-81b8-85641200ee45	not hispanic or latino	male	white	TCGA-55-8206_demographic	Alive	20690	M0	N0	Stage IA	T1b	7th	primary	0	888.0	b61a384a-746b-5d3c-a15d-bf95e4c2a325	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8206_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8206_treatment	NA	NA	NA	NA	ab77a92a-27b0-5d68-bde2-d0ec44f5db07	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a214a959-3b21-4f25-a615-383cda7afdff	Informed Consent	46	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8206	56	false	United States	-20690	NA	10a7cce6-455d-5e85-81b8-85641200ee45	not hispanic or latino	male	white	TCGA-55-8206_demographic	Alive	20690	M0	N0	Stage IA	T1b	7th	primary	0	888.0	b61a384a-746b-5d3c-a15d-bf95e4c2a325	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8206_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8206_treatment2	NA	NA	NA	NA	f8ccdcc7-0781-46fb-befb-675de85ef456	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a244a99a-d7cc-4fb1-bc76-b66886481621	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4417	51	false	Germany	-18780	NA	fba23ccd-913c-521e-ac07-21ec0bba8986	not reported	female	not reported	TCGA-05-4417_demographic	Alive	18780	M0	N0	Stage IB	T2	6th	primary	0	455.0	099e9c44-b300-506a-9d3f-c74ffb489618	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4417_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4417_treatment	NA	NA	NA	NA	8f85bea6-209d-59fa-9c4e-63a2ca390c7c	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a244a99a-d7cc-4fb1-bc76-b66886481621	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4417	51	false	Germany	-18780	NA	fba23ccd-913c-521e-ac07-21ec0bba8986	not reported	female	not reported	TCGA-05-4417_demographic	Alive	18780	M0	N0	Stage IB	T2	6th	primary	0	455.0	099e9c44-b300-506a-9d3f-c74ffb489618	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4417_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4417_treatment2	NA	NA	NA	NA	dcf3103a-0747-476d-bd4c-ed6fe0ca69ae	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a250a369-e536-4a18-b7af-2911133d7bdc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A491	81	false	United States	-29593	NA	acd08ad5-1412-5dd6-8638-776492880a43	not hispanic or latino	female	white	TCGA-55-A491_demographic	Alive	29487	NA	NA	NA	NA	NA	Prior primary	-106	NA	0f31a6a7-d126-4ad9-a435-1145a0901cde	false	NA	NA	NA	Right	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-A491_diagnosis2	NA	Upper limb, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A491_treatment4	NA	NA	NA	NA	426b9ca8-2525-46ec-8699-1efcb637ae7f	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a250a369-e536-4a18-b7af-2911133d7bdc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A491	81	false	United States	-29593	NA	acd08ad5-1412-5dd6-8638-776492880a43	not hispanic or latino	female	white	TCGA-55-A491_demographic	Alive	29487	NA	NA	NA	NA	NA	Prior primary	-106	NA	0f31a6a7-d126-4ad9-a435-1145a0901cde	false	NA	NA	NA	Right	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-A491_diagnosis2	NA	Upper limb, NOS	NA	NA	NA	NA	NA	-95	NA	NA	NA	NA	NA	NA	TCGA-55-A491_treatment5	NA	NA	NA	NA	a7904e56-e07a-461b-a871-6bb38bd76cdc	NA	yes	NA	Surgery, NOS
TCGA-LUAD	a250a369-e536-4a18-b7af-2911133d7bdc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A491	81	false	United States	-29593	NA	acd08ad5-1412-5dd6-8638-776492880a43	not hispanic or latino	female	white	TCGA-55-A491_demographic	Alive	29487	NA	NA	NA	NA	NA	Prior primary	-106	NA	0f31a6a7-d126-4ad9-a435-1145a0901cde	false	NA	NA	NA	Right	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-A491_diagnosis2	NA	Upper limb, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A491_treatment3	NA	NA	NA	NA	e4a332b8-2ff6-442e-a298-9561d81191d0	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a250a369-e536-4a18-b7af-2911133d7bdc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A491	81	false	United States	-29593	NA	acd08ad5-1412-5dd6-8638-776492880a43	not hispanic or latino	female	white	TCGA-55-A491_demographic	Alive	29593	MX	N0	Stage IA	T1b	7th	primary	0	626.0	460e18c6-3f0c-57c7-a6b7-d7069be055d2	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-A491_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A491_treatment2	NA	NA	NA	NA	7b8f5023-df2c-40cc-9a52-c3be05304f5e	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	a250a369-e536-4a18-b7af-2911133d7bdc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A491	81	false	United States	-29593	NA	acd08ad5-1412-5dd6-8638-776492880a43	not hispanic or latino	female	white	TCGA-55-A491_demographic	Alive	29593	MX	N0	Stage IA	T1b	7th	primary	0	626.0	460e18c6-3f0c-57c7-a6b7-d7069be055d2	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-A491_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A491_treatment	NA	NA	NA	NA	f5ed0bb8-6db7-5dad-88e6-be1fbab3cd25	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a391d49f-a822-460b-981c-6fbe1868ee38	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-6743	81	false	United States	-29807	NA	a6caf557-7d30-5540-8233-fd19be5a1259	not reported	female	white	TCGA-49-6743_demographic	Alive	29807	MX	N2	Stage IIIA	T1	7th	primary	0	1621.0	0d9967b8-03c2-5e4e-a9be-676806fbaf13	true	NA	NA	C34.1	Right	8310/3	Clear cell adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-49-6743_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	140	48	NA	4	NA	NA	NA	Intravenous	TCGA-49-6743_treatment2	Bevacizumab	NA	NA	NA	8c1bc3f8-9050-4de9-8d71-671471d1570f	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a391d49f-a822-460b-981c-6fbe1868ee38	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-6743	81	false	United States	-29807	NA	a6caf557-7d30-5540-8233-fd19be5a1259	not reported	female	white	TCGA-49-6743_demographic	Alive	29807	MX	N2	Stage IIIA	T1	7th	primary	0	1621.0	0d9967b8-03c2-5e4e-a9be-676806fbaf13	true	NA	NA	C34.1	Right	8310/3	Clear cell adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-49-6743_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	140	48	NA	4	NA	NA	NA	Intravenous	TCGA-49-6743_treatment3	Pemetrexed	NA	NA	NA	a953ee7e-b62e-4550-a23b-ff5d08698841	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a391d49f-a822-460b-981c-6fbe1868ee38	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-6743	81	false	United States	-29807	NA	a6caf557-7d30-5540-8233-fd19be5a1259	not reported	female	white	TCGA-49-6743_demographic	Alive	29807	MX	N2	Stage IIIA	T1	7th	primary	0	1621.0	0d9967b8-03c2-5e4e-a9be-676806fbaf13	true	NA	NA	C34.1	Right	8310/3	Clear cell adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-49-6743_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	140	18	NA	4	NA	NA	NA	Intravenous	TCGA-49-6743_treatment	Cisplatin	NA	NA	NA	b794ff3c-7448-5df3-bc13-60bba519fe30	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a391d49f-a822-460b-981c-6fbe1868ee38	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-6743	81	false	United States	-29807	NA	a6caf557-7d30-5540-8233-fd19be5a1259	not reported	female	white	TCGA-49-6743_demographic	Alive	29807	MX	N2	Stage IIIA	T1	7th	primary	0	1621.0	0d9967b8-03c2-5e4e-a9be-676806fbaf13	true	NA	NA	C34.1	Right	8310/3	Clear cell adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-49-6743_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-6743_treatment4	NA	NA	NA	NA	e13992ff-8fa5-4e92-b523-18c457b8bd2b	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a3de401d-91fe-49a2-bb07-81c1a06506e6	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4389	70	false	Germany	-25660	NA	e427c240-7c5a-5083-8a17-ce54219a8b11	not reported	male	not reported	TCGA-05-4389_demographic	Alive	25660	M0	N0	Stage IA	T1	5th	primary	0	1369.0	0d1ac83d-d6c8-5d30-b654-207cbaad6c7b	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4389_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4389_treatment2	NA	NA	NA	NA	5f2a8f05-f001-4f24-aa73-0bdcc8c0d1d3	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a3de401d-91fe-49a2-bb07-81c1a06506e6	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4389	70	false	Germany	-25660	NA	e427c240-7c5a-5083-8a17-ce54219a8b11	not reported	male	not reported	TCGA-05-4389_demographic	Alive	25660	M0	N0	Stage IA	T1	5th	primary	0	1369.0	0d1ac83d-d6c8-5d30-b654-207cbaad6c7b	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4389_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4389_treatment	NA	NA	NA	NA	f524ac40-ebff-57db-ac28-952be70ac14f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24209	M1	N0	Stage IV	T2	7th	primary	0	947.0	027193af-bc2e-52fe-8dff-5c224645e1cd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7701_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	207	27	NA	NA	NA	NA	NA	NA	TCGA-86-7701_treatment3	Cisplatin	NA	NA	NA	01e84981-4308-43a9-bb09-d17a54e635cd	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24209	M1	N0	Stage IV	T2	7th	primary	0	947.0	027193af-bc2e-52fe-8dff-5c224645e1cd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7701_diagnosis	No	Upper lobe, lung	NA	2011	Yes	NA	601	454	NA	NA	NA	NA	NA	NA	TCGA-86-7701_treatment4	Tyrosine Kinase Inhibitor	NA	NA	NA	31176fd8-8407-452f-ad39-5c8aedaa27ae	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24209	M1	N0	Stage IV	T2	7th	primary	0	947.0	027193af-bc2e-52fe-8dff-5c224645e1cd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7701_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	601	454	NA	NA	NA	NA	NA	NA	TCGA-86-7701_treatment6	Zoledronic Acid	NA	NA	NA	37807a50-630f-4872-8a36-288e2388caf5	NA	yes	Stable Disease	Ancillary Treatment
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24209	M1	N0	Stage IV	T2	7th	primary	0	947.0	027193af-bc2e-52fe-8dff-5c224645e1cd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7701_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	601	454	NA	NA	NA	NA	NA	NA	TCGA-86-7701_treatment5	Docetaxel	NA	NA	NA	7cae7195-216d-4ddc-8661-eaf8eba1ce33	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24209	M1	N0	Stage IV	T2	7th	primary	0	947.0	027193af-bc2e-52fe-8dff-5c224645e1cd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7701_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	929	917	NA	NA	13.0	NA	NA	NA	TCGA-86-7701_treatment	NA	Distant Site	29	Gy	86fbeca2-c061-5618-9f45-77a635e0a894	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24209	M1	N0	Stage IV	T2	7th	primary	0	947.0	027193af-bc2e-52fe-8dff-5c224645e1cd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7701_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	NA	936	NA	NA	NA	NA	NA	NA	TCGA-86-7701_treatment9	Docetaxel	NA	NA	NA	9ae36b19-d013-4784-bd58-27e3504cfd8c	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24209	M1	N0	Stage IV	T2	7th	primary	0	947.0	027193af-bc2e-52fe-8dff-5c224645e1cd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7701_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	NA	936	NA	NA	NA	NA	NA	NA	TCGA-86-7701_treatment8	Gemcitabine	NA	NA	NA	a4e9fa57-1b04-45e3-bb3c-444e48a23a3d	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24209	M1	N0	Stage IV	T2	7th	primary	0	947.0	027193af-bc2e-52fe-8dff-5c224645e1cd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7701_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	NA	706	NA	NA	NA	NA	NA	NA	TCGA-86-7701_treatment7	Zoledronic Acid	NA	NA	NA	c893f20b-b2a1-4a2a-86f5-4ac11a210b17	NA	yes	Treatment Ongoing	Ancillary Treatment
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24209	M1	N0	Stage IV	T2	7th	primary	0	947.0	027193af-bc2e-52fe-8dff-5c224645e1cd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7701_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	207	27	NA	NA	NA	NA	NA	NA	TCGA-86-7701_treatment2	Etoposide	NA	NA	NA	f21488f5-d983-455d-9be2-e3bb87582b33	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	25109	NA	NA	NA	NA	NA	metastasis	900	NA	61a0339f-3afc-4f9d-ad3c-000f6ef77643	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-7701_diagnosis3	NA	Not Reported	TCGA-86-7701_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-86-7701_treatment13	NA	NA	NA	NA	3048c629-eeac-4774-863f-b002c88c8e9d	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	25109	NA	NA	NA	NA	NA	metastasis	900	NA	61a0339f-3afc-4f9d-ad3c-000f6ef77643	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-7701_diagnosis3	NA	Not Reported	TCGA-86-7701_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-7701_treatment15	NA	Distant Site	NA	NA	5032a72d-7fb7-4c02-aca9-7441388cb38e	NA	no	NA	Surgery, NOS
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	25109	NA	NA	NA	NA	NA	metastasis	900	NA	61a0339f-3afc-4f9d-ad3c-000f6ef77643	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-7701_diagnosis3	NA	Not Reported	TCGA-86-7701_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-86-7701_treatment14	NA	NA	NA	NA	c3f25e40-3dd8-4865-a55f-ef658c465957	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24633	NA	NA	NA	NA	NA	metastasis	424	NA	b4725b29-3840-4905-beba-12434cbf1167	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-7701_diagnosis2	NA	Not Reported	TCGA-86-7701_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-7701_treatment12	NA	Distant Site	NA	NA	d64b9902-0108-44b0-905d-1e44801d517f	NA	no	NA	Surgery, NOS
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24633	NA	NA	NA	NA	NA	metastasis	424	NA	b4725b29-3840-4905-beba-12434cbf1167	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-7701_diagnosis2	NA	Not Reported	TCGA-86-7701_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-86-7701_treatment10	NA	NA	NA	NA	f2032408-5814-427f-8715-18cb80d5876a	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a3f6bc1c-19ab-4eeb-a9ac-3d2fac850bde	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7701	66	false	Russia	-24209	NA	f50a405c-16d5-5bab-ad3d-82e8facc8852	not hispanic or latino	male	white	TCGA-86-7701_demographic	Alive	24633	NA	NA	NA	NA	NA	metastasis	424	NA	b4725b29-3840-4905-beba-12434cbf1167	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-7701_diagnosis2	NA	Not Reported	TCGA-86-7701_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-86-7701_treatment11	NA	NA	NA	NA	fba44aac-9c31-438b-b7ad-2c9a62733e52	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a3fd20b2-e001-44ab-9716-754e5ae70808	Informed Consent	21	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8513	77	false	United States	-28284	NA	d7443b04-aa3b-5738-ac7d-85dc615a03b6	not hispanic or latino	female	white	TCGA-55-8513_demographic	Alive	28601	NA	NA	NA	NA	NA	metastasis	317	NA	39c98aa4-564d-4893-8574-7b81dc8938be	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-55-8513_diagnosis2	NA	Not Reported	TCGA-55-8513_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8513_treatment5	NA	NA	NA	NA	4416a103-777e-4939-9dfc-81563896ed0e	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a3fd20b2-e001-44ab-9716-754e5ae70808	Informed Consent	21	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8513	77	false	United States	-28284	NA	d7443b04-aa3b-5738-ac7d-85dc615a03b6	not hispanic or latino	female	white	TCGA-55-8513_demographic	Alive	28601	NA	NA	NA	NA	NA	metastasis	317	NA	39c98aa4-564d-4893-8574-7b81dc8938be	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-55-8513_diagnosis2	NA	Not Reported	TCGA-55-8513_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8513_treatment6	NA	Locoregional Site	NA	NA	574ba5dd-fe50-4b41-961b-079c662ec9ad	NA	no	NA	Surgery, NOS
TCGA-LUAD	a3fd20b2-e001-44ab-9716-754e5ae70808	Informed Consent	21	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8513	77	false	United States	-28284	NA	d7443b04-aa3b-5738-ac7d-85dc615a03b6	not hispanic or latino	female	white	TCGA-55-8513_demographic	Alive	28601	NA	NA	NA	NA	NA	metastasis	317	NA	39c98aa4-564d-4893-8574-7b81dc8938be	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-55-8513_diagnosis2	NA	Not Reported	TCGA-55-8513_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-8513_treatment4	NA	NA	NA	NA	61d37979-097f-4ac6-9617-aa53ebb581fe	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a3fd20b2-e001-44ab-9716-754e5ae70808	Informed Consent	21	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8513	77	false	United States	-28284	NA	d7443b04-aa3b-5738-ac7d-85dc615a03b6	not hispanic or latino	female	white	TCGA-55-8513_demographic	Alive	28601	NA	NA	NA	NA	NA	metastasis	317	NA	39c98aa4-564d-4893-8574-7b81dc8938be	false	NA	NA	NA	NA	8480/3	Mucinous adenocarcinoma	NA	Yes	NA	Not Reported	NA	TCGA-55-8513_diagnosis2	NA	Not Reported	TCGA-55-8513_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8513_treatment7	NA	Distant Site	NA	NA	a65c67c7-c117-4692-a234-dd5d51c26533	NA	no	NA	Surgery, NOS
TCGA-LUAD	a3fd20b2-e001-44ab-9716-754e5ae70808	Informed Consent	21	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8513	77	false	United States	-28284	NA	d7443b04-aa3b-5738-ac7d-85dc615a03b6	not hispanic or latino	female	white	TCGA-55-8513_demographic	Alive	28284	MX	N0	Stage IIB	T3	7th	primary	0	791.0	9ef4f6a3-caab-5d46-b2a4-6478fd027081	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	NA	TCGA-55-8513_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	NA	561	NA	NA	NA	NA	NA	NA	TCGA-55-8513_treatment2	Pemetrexed Disodium	NA	NA	NA	6b0706fb-be6c-49a2-9f5d-5865aa9ccbdb	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	a3fd20b2-e001-44ab-9716-754e5ae70808	Informed Consent	21	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8513	77	false	United States	-28284	NA	d7443b04-aa3b-5738-ac7d-85dc615a03b6	not hispanic or latino	female	white	TCGA-55-8513_demographic	Alive	28284	MX	N0	Stage IIB	T3	7th	primary	0	791.0	9ef4f6a3-caab-5d46-b2a4-6478fd027081	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	NA	TCGA-55-8513_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	460	352	NA	NA	NA	NA	NA	NA	TCGA-55-8513_treatment	Erlotinib Hydrochloride	NA	NA	NA	a3fd4efd-8731-57f5-8d0f-500daa0771c9	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	a3fd20b2-e001-44ab-9716-754e5ae70808	Informed Consent	21	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8513	77	false	United States	-28284	NA	d7443b04-aa3b-5738-ac7d-85dc615a03b6	not hispanic or latino	female	white	TCGA-55-8513_demographic	Alive	28284	MX	N0	Stage IIB	T3	7th	primary	0	791.0	9ef4f6a3-caab-5d46-b2a4-6478fd027081	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	NA	TCGA-55-8513_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8513_treatment3	NA	NA	NA	NA	c22e1e69-e8e0-4743-9367-ccac244dadf6	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a41c46da-7ed4-4192-bd16-b3cbb94a5133	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1592	65	false	United States	NA	701	7101300d-a371-5aa8-bbe5-cb2ca27d1375	not hispanic or latino	male	white	TCGA-55-1592_demographic	Dead	NA	NA	NA	Stage IA	NA	5th	Prior primary	NA	NA	46f162c1-d4f8-4215-b400-ead7737d25c6	false	NA	NA	NA	Right	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-1592_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-1592_treatment4	NA	NA	NA	NA	746a71a6-37e8-4d08-972c-386234cd2988	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a41c46da-7ed4-4192-bd16-b3cbb94a5133	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1592	65	false	United States	NA	701	7101300d-a371-5aa8-bbe5-cb2ca27d1375	not hispanic or latino	male	white	TCGA-55-1592_demographic	Dead	NA	NA	NA	Stage IA	NA	5th	Prior primary	NA	NA	46f162c1-d4f8-4215-b400-ead7737d25c6	false	NA	NA	NA	Right	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-1592_diagnosis3	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-1592_treatment3	NA	NA	NA	NA	cf439a59-bbfd-424c-b7ec-86c1e2c598da	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a41c46da-7ed4-4192-bd16-b3cbb94a5133	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1592	65	false	United States	NA	701	7101300d-a371-5aa8-bbe5-cb2ca27d1375	not hispanic or latino	male	white	TCGA-55-1592_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	452	NA	8ea07c26-76ca-48fe-8406-2f3d49c83c77	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-1592_diagnosis2	NA	Not Reported	TCGA-55-1592_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-1592_treatment8	NA	Distant Site	NA	NA	3d771b8e-9692-4706-9acf-bd1b56c23d2d	NA	no	NA	Surgery, NOS
TCGA-LUAD	a41c46da-7ed4-4192-bd16-b3cbb94a5133	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1592	65	false	United States	NA	701	7101300d-a371-5aa8-bbe5-cb2ca27d1375	not hispanic or latino	male	white	TCGA-55-1592_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	452	NA	8ea07c26-76ca-48fe-8406-2f3d49c83c77	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-1592_diagnosis2	NA	Not Reported	TCGA-55-1592_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-1592_treatment7	NA	Locoregional Site	NA	NA	9ba7dedc-ceb1-4ea0-a9f2-49b25a19a268	NA	no	NA	Surgery, NOS
TCGA-LUAD	a41c46da-7ed4-4192-bd16-b3cbb94a5133	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1592	65	false	United States	NA	701	7101300d-a371-5aa8-bbe5-cb2ca27d1375	not hispanic or latino	male	white	TCGA-55-1592_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	452	NA	8ea07c26-76ca-48fe-8406-2f3d49c83c77	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-1592_diagnosis2	NA	Not Reported	TCGA-55-1592_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-55-1592_treatment5	NA	NA	NA	NA	bffc8d1c-72ee-4967-903d-6110199566c9	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a41c46da-7ed4-4192-bd16-b3cbb94a5133	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1592	65	false	United States	NA	701	7101300d-a371-5aa8-bbe5-cb2ca27d1375	not hispanic or latino	male	white	TCGA-55-1592_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	452	NA	8ea07c26-76ca-48fe-8406-2f3d49c83c77	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-1592_diagnosis2	NA	Not Reported	TCGA-55-1592_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-55-1592_treatment6	NA	NA	NA	NA	df514296-0124-4175-ade1-ddb1841237d5	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a41c46da-7ed4-4192-bd16-b3cbb94a5133	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1592	65	false	United States	NA	701	7101300d-a371-5aa8-bbe5-cb2ca27d1375	not hispanic or latino	male	white	TCGA-55-1592_demographic	Dead	NA	M0	N0	Stage IA	T2	NA	primary	0	701.0	9258dedd-f0a4-5100-89b6-ce496a7d9b93	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-1592_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-1592_treatment2	NA	NA	NA	NA	8a75f1da-b675-48f5-868a-a0e4c440090c	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a41c46da-7ed4-4192-bd16-b3cbb94a5133	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1592	65	false	United States	NA	701	7101300d-a371-5aa8-bbe5-cb2ca27d1375	not hispanic or latino	male	white	TCGA-55-1592_demographic	Dead	NA	M0	N0	Stage IA	T2	NA	primary	0	701.0	9258dedd-f0a4-5100-89b6-ce496a7d9b93	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-1592_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-1592_treatment	NA	NA	NA	NA	dd6d7f05-ab61-5cfb-8168-d4444559a676	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a52e99d6-a61a-439d-b0b1-ca7a0eabcb04	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7948	42	false	United States	-15363	NA	0a36d497-ad2d-5bac-8235-6729e1e1b789	not hispanic or latino	female	white	TCGA-95-7948_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	28c82945-1731-4b60-af2f-48133e2f61ce	false	NA	NA	NA	NA	9650/3	Hodgkin lymphoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-7948_diagnosis2	NA	Spleen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7948_treatment4	NA	Locoregional Site	NA	NA	3dca1f3e-80ca-42e5-a37a-f296c2dd1767	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	a52e99d6-a61a-439d-b0b1-ca7a0eabcb04	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7948	42	false	United States	-15363	NA	0a36d497-ad2d-5bac-8235-6729e1e1b789	not hispanic or latino	female	white	TCGA-95-7948_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	28c82945-1731-4b60-af2f-48133e2f61ce	false	NA	NA	NA	NA	9650/3	Hodgkin lymphoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-7948_diagnosis2	NA	Spleen	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7948_treatment3	NA	NA	NA	NA	c753b89d-50c1-4ec9-b342-1661700a4c13	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a52e99d6-a61a-439d-b0b1-ca7a0eabcb04	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7948	42	false	United States	-15363	NA	0a36d497-ad2d-5bac-8235-6729e1e1b789	not hispanic or latino	female	white	TCGA-95-7948_demographic	Alive	NA	MX	N0	Stage I	T1b	7th	Synchronous primary	NA	NA	6db67949-bcb0-4cdd-93a2-ce68fe5d4a46	false	NA	NA	NA	Left	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-7948_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7948_treatment7	NA	NA	NA	NA	557b2447-70e0-4ec1-a257-0a28d705224b	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a52e99d6-a61a-439d-b0b1-ca7a0eabcb04	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7948	42	false	United States	-15363	NA	0a36d497-ad2d-5bac-8235-6729e1e1b789	not hispanic or latino	female	white	TCGA-95-7948_demographic	Alive	NA	MX	N0	Stage I	T1b	7th	Synchronous primary	NA	NA	6db67949-bcb0-4cdd-93a2-ce68fe5d4a46	false	NA	NA	NA	Left	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-7948_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	49	NA	NA	NA	NA	NA	NA	TCGA-95-7948_treatment5	Cisplatin	Body, total	NA	NA	7784153b-eaff-4f16-a938-153ad2d403ce	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a52e99d6-a61a-439d-b0b1-ca7a0eabcb04	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7948	42	false	United States	-15363	NA	0a36d497-ad2d-5bac-8235-6729e1e1b789	not hispanic or latino	female	white	TCGA-95-7948_demographic	Alive	NA	MX	N0	Stage I	T1b	7th	Synchronous primary	NA	NA	6db67949-bcb0-4cdd-93a2-ce68fe5d4a46	false	NA	NA	NA	Left	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-7948_diagnosis3	NA	Breast, NOS	NA	NA	NA	NA	NA	49	NA	NA	NA	NA	NA	NA	TCGA-95-7948_treatment6	Docetaxel	Body, total	NA	NA	8162f9b3-0538-4cd5-8021-6192a6ba947e	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a52e99d6-a61a-439d-b0b1-ca7a0eabcb04	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7948	42	false	United States	-15363	NA	0a36d497-ad2d-5bac-8235-6729e1e1b789	not hispanic or latino	female	white	TCGA-95-7948_demographic	Alive	15363	M0	N0	Stage IB	T2a	7th	primary	0	476.0	7f7755a8-2822-5a19-811e-71aa6d7885a0	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-95-7948_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7948_treatment2	NA	NA	NA	NA	5df4d3e9-3b8f-4478-a3d2-293a3b99d659	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a52e99d6-a61a-439d-b0b1-ca7a0eabcb04	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7948	42	false	United States	-15363	NA	0a36d497-ad2d-5bac-8235-6729e1e1b789	not hispanic or latino	female	white	TCGA-95-7948_demographic	Alive	15363	M0	N0	Stage IB	T2a	7th	primary	0	476.0	7f7755a8-2822-5a19-811e-71aa6d7885a0	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-95-7948_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7948_treatment	NA	NA	NA	NA	7c94929d-ea58-538a-b224-e1f9c8d2c2aa	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a534b96b-1665-444a-9308-e610f2f0e510	Informed Consent	-20	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7660	72	false	United States	-26594	NA	4de4119b-7cf6-5fb7-a677-9c8a71377635	not hispanic or latino	male	white	TCGA-44-7660_demographic	Alive	26594	MX	N0	Stage IB	T2	7th	primary	0	592.0	a53f2846-a4e2-5760-9aee-6516914ee907	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7660_diagnosis	No	Upper lobe, lung	NA	2011	Yes	NA	141	78	NA	NA	NA	NA	NA	NA	TCGA-44-7660_treatment	Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A	NA	NA	NA	30f0ed9a-7ac5-5929-86f7-a1657d333111	NA	yes	Progressive Disease	Immunotherapy (Including Vaccines)
TCGA-LUAD	a534b96b-1665-444a-9308-e610f2f0e510	Informed Consent	-20	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7660	72	false	United States	-26594	NA	4de4119b-7cf6-5fb7-a677-9c8a71377635	not hispanic or latino	male	white	TCGA-44-7660_demographic	Alive	26594	MX	N0	Stage IB	T2	7th	primary	0	592.0	a53f2846-a4e2-5760-9aee-6516914ee907	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7660_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7660_treatment2	NA	NA	NA	NA	af56ed67-99cd-46d3-8392-fbcbdb54dee6	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a534b96b-1665-444a-9308-e610f2f0e510	Informed Consent	-20	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7660	72	false	United States	-26594	NA	4de4119b-7cf6-5fb7-a677-9c8a71377635	not hispanic or latino	male	white	TCGA-44-7660_demographic	Alive	26847	NA	NA	NA	NA	NA	recurrence	253	NA	dc654209-6515-40b3-98d8-6c1b0151c7fc	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-7660_diagnosis2	NA	Not Reported	TCGA-44-7660_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-7660_treatment3	NA	NA	NA	NA	71df3b0c-4cae-4f96-b453-8f46931ce871	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a534b96b-1665-444a-9308-e610f2f0e510	Informed Consent	-20	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7660	72	false	United States	-26594	NA	4de4119b-7cf6-5fb7-a677-9c8a71377635	not hispanic or latino	male	white	TCGA-44-7660_demographic	Alive	26847	NA	NA	NA	NA	NA	recurrence	253	NA	dc654209-6515-40b3-98d8-6c1b0151c7fc	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-7660_diagnosis2	NA	Not Reported	TCGA-44-7660_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7660_treatment5	NA	Locoregional Site	NA	NA	880ffa2d-9807-4427-8297-33316f3b22f2	NA	no	NA	Surgery, NOS
TCGA-LUAD	a534b96b-1665-444a-9308-e610f2f0e510	Informed Consent	-20	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7660	72	false	United States	-26594	NA	4de4119b-7cf6-5fb7-a677-9c8a71377635	not hispanic or latino	male	white	TCGA-44-7660_demographic	Alive	26847	NA	NA	NA	NA	NA	recurrence	253	NA	dc654209-6515-40b3-98d8-6c1b0151c7fc	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-7660_diagnosis2	NA	Not Reported	TCGA-44-7660_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-7660_treatment4	NA	NA	NA	NA	8d239570-543d-4e02-b223-13903220b8f8	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a56d2b48-375d-4193-91a9-f589c39523fb	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z021	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	a5bd7d50-9c14-49e6-89cf-6bf440c42309	Informed Consent	36	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-7979	71	false	United States	-26180	NA	708eacd3-4558-55a9-8fcd-836b599e9d63	not hispanic or latino	female	white	TCGA-69-7979_demographic	Alive	26180	MX	N0	Stage IB	T2a	7th	primary	0	408.0	fac52320-451f-5e0b-95dc-e907f83f8f14	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-69-7979_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7979_treatment2	NA	NA	NA	NA	72812e78-03e6-40fd-8361-2b89055c5f4e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a5bd7d50-9c14-49e6-89cf-6bf440c42309	Informed Consent	36	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-7979	71	false	United States	-26180	NA	708eacd3-4558-55a9-8fcd-836b599e9d63	not hispanic or latino	female	white	TCGA-69-7979_demographic	Alive	26180	MX	N0	Stage IB	T2a	7th	primary	0	408.0	fac52320-451f-5e0b-95dc-e907f83f8f14	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-69-7979_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7979_treatment	NA	NA	NA	NA	e716d73a-d935-5777-8d76-13641a38ecda	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a5d0c704-2888-4cff-805e-4bbe4636117c	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z019	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	a5f2576a-d628-47de-a5df-76a4f3105dcc	Informed Consent	75	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A743	56	false	United States	-20780	NA	1eb0166e-724b-5750-a648-c8b6c5cafb51	not hispanic or latino	male	black or african american	TCGA-L9-A743_demographic	Alive	20711	MX	NX	Stage IIA	T1c	7th	Prior primary	-69	NA	7a410aac-62dd-48e1-b975-cef072c58a28	false	NA	NA	NA	Unknown	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-L9-A743_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A743_treatment4	NA	NA	NA	NA	a59dc356-02ad-43c4-80e8-87ad3afe7880	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a5f2576a-d628-47de-a5df-76a4f3105dcc	Informed Consent	75	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A743	56	false	United States	-20780	NA	1eb0166e-724b-5750-a648-c8b6c5cafb51	not hispanic or latino	male	black or african american	TCGA-L9-A743_demographic	Alive	20711	MX	NX	Stage IIA	T1c	7th	Prior primary	-69	NA	7a410aac-62dd-48e1-b975-cef072c58a28	false	NA	NA	NA	Unknown	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-L9-A743_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A743_treatment6	NA	NA	NA	NA	af034d92-0c45-4ebd-b2ca-d2991d7c512f	NA	no	NA	Surgery, NOS
TCGA-LUAD	a5f2576a-d628-47de-a5df-76a4f3105dcc	Informed Consent	75	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A743	56	false	United States	-20780	NA	1eb0166e-724b-5750-a648-c8b6c5cafb51	not hispanic or latino	male	black or african american	TCGA-L9-A743_demographic	Alive	20711	MX	NX	Stage IIA	T1c	7th	Prior primary	-69	NA	7a410aac-62dd-48e1-b975-cef072c58a28	false	NA	NA	NA	Unknown	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-L9-A743_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	-2	NA	NA	NA	NA	NA	NA	TCGA-L9-A743_treatment5	NA	Locoregional Site	NA	NA	d778ad88-f4d1-4106-b5ed-76fc7652e3af	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	a5f2576a-d628-47de-a5df-76a4f3105dcc	Informed Consent	75	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A743	56	false	United States	-20780	NA	1eb0166e-724b-5750-a648-c8b6c5cafb51	not hispanic or latino	male	black or african american	TCGA-L9-A743_demographic	Alive	20780	M0	N1	Stage IIA	T2a	7th	primary	0	664.0	843692cb-f0c0-565b-bc54-c465572c95bc	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-L9-A743_diagnosis	No	Upper lobe, lung	NA	2013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A743_treatment3	NA	NA	NA	NA	0f03b7f9-8143-4eba-911a-7105ce9fec82	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a5f2576a-d628-47de-a5df-76a4f3105dcc	Informed Consent	75	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A743	56	false	United States	-20780	NA	1eb0166e-724b-5750-a648-c8b6c5cafb51	not hispanic or latino	male	black or african american	TCGA-L9-A743_demographic	Alive	20780	M0	N1	Stage IIA	T2a	7th	primary	0	664.0	843692cb-f0c0-565b-bc54-c465572c95bc	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-L9-A743_diagnosis	No	Upper lobe, lung	NA	2013	No	NA	193	120	NA	NA	NA	NA	NA	NA	TCGA-L9-A743_treatment2	Cisplatin	NA	NA	NA	20855f43-7714-42cc-b753-99478eca7b5b	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	a5f2576a-d628-47de-a5df-76a4f3105dcc	Informed Consent	75	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A743	56	false	United States	-20780	NA	1eb0166e-724b-5750-a648-c8b6c5cafb51	not hispanic or latino	male	black or african american	TCGA-L9-A743_demographic	Alive	20780	M0	N1	Stage IIA	T2a	7th	primary	0	664.0	843692cb-f0c0-565b-bc54-c465572c95bc	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-L9-A743_diagnosis	No	Upper lobe, lung	NA	2013	No	NA	193	120	NA	NA	NA	NA	NA	NA	TCGA-L9-A743_treatment	Docetaxel	NA	NA	NA	a61ca7f4-bde0-5778-8ce2-85cb32f7ef79	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	a65700c2-e58c-4fd4-aeb1-5686b8f4d212	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5815	74	false	United States	-27280	NA	7a9f776e-1051-5a55-8d88-d289bf5df801	not hispanic or latino	male	white	TCGA-64-5815_demographic	Alive	27280	M0	N1	Stage IIB	T2	6th	primary	0	866.0	49192421-117f-54c1-970c-9f218f594dc5	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5815_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	103	93	NA	3	NA	NA	NA	Intravenous	TCGA-64-5815_treatment2	Gemcitabine Hydrochloride	NA	NA	NA	15e55d37-cf90-4336-b76c-ead4cfafe954	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a65700c2-e58c-4fd4-aeb1-5686b8f4d212	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5815	74	false	United States	-27280	NA	7a9f776e-1051-5a55-8d88-d289bf5df801	not hispanic or latino	male	white	TCGA-64-5815_demographic	Alive	27280	M0	N1	Stage IIB	T2	6th	primary	0	866.0	49192421-117f-54c1-970c-9f218f594dc5	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5815_diagnosis	No	Upper lobe, lung	NA	2009	No	NA	132	83	NA	NA	NA	NA	NA	NA	TCGA-64-5815_treatment6	Carboplatin	NA	NA	NA	2f5f6d63-ee08-4638-8d9f-3a6d0b8a11d6	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	a65700c2-e58c-4fd4-aeb1-5686b8f4d212	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5815	74	false	United States	-27280	NA	7a9f776e-1051-5a55-8d88-d289bf5df801	not hispanic or latino	male	white	TCGA-64-5815_demographic	Alive	27280	M0	N1	Stage IIB	T2	6th	primary	0	866.0	49192421-117f-54c1-970c-9f218f594dc5	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5815_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-5815_treatment9	NA	NA	NA	NA	5edf44e4-c925-498f-8997-5fb5fd9c2c1d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a65700c2-e58c-4fd4-aeb1-5686b8f4d212	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5815	74	false	United States	-27280	NA	7a9f776e-1051-5a55-8d88-d289bf5df801	not hispanic or latino	male	white	TCGA-64-5815_demographic	Alive	27280	M0	N1	Stage IIB	T2	6th	primary	0	866.0	49192421-117f-54c1-970c-9f218f594dc5	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5815_diagnosis	No	Upper lobe, lung	NA	2009	No	NA	195	146	NA	NA	NA	NA	NA	NA	TCGA-64-5815_treatment8	Pemetrexed Disodium	NA	NA	NA	63014e35-6ef2-4b4e-b0fa-0e5c2f591f29	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	a65700c2-e58c-4fd4-aeb1-5686b8f4d212	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5815	74	false	United States	-27280	NA	7a9f776e-1051-5a55-8d88-d289bf5df801	not hispanic or latino	male	white	TCGA-64-5815_demographic	Alive	27280	M0	N1	Stage IIB	T2	6th	primary	0	866.0	49192421-117f-54c1-970c-9f218f594dc5	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5815_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	188	146	NA	3	NA	NA	NA	Intravenous	TCGA-64-5815_treatment3	Pemetrexed Disodium	NA	NA	NA	82eba9a2-7402-4cff-8d34-f398a8ed9ff6	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a65700c2-e58c-4fd4-aeb1-5686b8f4d212	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5815	74	false	United States	-27280	NA	7a9f776e-1051-5a55-8d88-d289bf5df801	not hispanic or latino	male	white	TCGA-64-5815_demographic	Alive	27280	M0	N1	Stage IIB	T2	6th	primary	0	866.0	49192421-117f-54c1-970c-9f218f594dc5	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5815_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	188	146	NA	3	NA	NA	NA	Intravenous	TCGA-64-5815_treatment4	Carboplatin	NA	NA	NA	9e635580-b5da-4f6d-bb10-554ad40b0494	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a65700c2-e58c-4fd4-aeb1-5686b8f4d212	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5815	74	false	United States	-27280	NA	7a9f776e-1051-5a55-8d88-d289bf5df801	not hispanic or latino	male	white	TCGA-64-5815_demographic	Alive	27280	M0	N1	Stage IIB	T2	6th	primary	0	866.0	49192421-117f-54c1-970c-9f218f594dc5	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5815_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	103	93	NA	3	NA	NA	NA	Intravenous	TCGA-64-5815_treatment	Carboplatin	NA	NA	NA	a440ba92-d523-5778-8380-bcb646f99cba	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a65700c2-e58c-4fd4-aeb1-5686b8f4d212	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5815	74	false	United States	-27280	NA	7a9f776e-1051-5a55-8d88-d289bf5df801	not hispanic or latino	male	white	TCGA-64-5815_demographic	Alive	27280	M0	N1	Stage IIB	T2	6th	primary	0	866.0	49192421-117f-54c1-970c-9f218f594dc5	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5815_diagnosis	No	Upper lobe, lung	NA	2009	No	NA	195	146	NA	NA	NA	NA	NA	NA	TCGA-64-5815_treatment7	Carboplatin	NA	NA	NA	a50f0cc2-f5dc-4cc0-8506-a51a816d1d98	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	a65700c2-e58c-4fd4-aeb1-5686b8f4d212	Informed Consent	38	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5815	74	false	United States	-27280	NA	7a9f776e-1051-5a55-8d88-d289bf5df801	not hispanic or latino	male	white	TCGA-64-5815_demographic	Alive	27280	M0	N1	Stage IIB	T2	6th	primary	0	866.0	49192421-117f-54c1-970c-9f218f594dc5	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5815_diagnosis	No	Upper lobe, lung	NA	2009	No	NA	132	83	NA	NA	NA	NA	NA	NA	TCGA-64-5815_treatment5	Gemcitabine	NA	NA	NA	b01b7a57-0f29-44c0-b6f7-e7bebdd9a5f6	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	a7911bdc-13f1-434a-bfa3-f8ba55d15846	Informed Consent	95	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7574	64	false	United States	-23703	995	639d7216-cbca-5f59-8de3-7fd48916a108	not hispanic or latino	female	white	TCGA-55-7574_demographic	Dead	23703	M0	N0	Stage IB	T2a	7th	primary	0	995.0	1cb1cd21-aeba-5c95-bd56-709b5d468257	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-7574_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	487	487	NA	NA	NA	NA	NA	NA	TCGA-55-7574_treatment2	NA	Distant Site	NA	NA	2892818d-1b3c-4cbf-8a04-7a6e1ba99a66	NA	yes	Stable Disease	Radiation, External Beam
TCGA-LUAD	a7911bdc-13f1-434a-bfa3-f8ba55d15846	Informed Consent	95	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7574	64	false	United States	-23703	995	639d7216-cbca-5f59-8de3-7fd48916a108	not hispanic or latino	female	white	TCGA-55-7574_demographic	Dead	23703	M0	N0	Stage IB	T2a	7th	primary	0	995.0	1cb1cd21-aeba-5c95-bd56-709b5d468257	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-7574_diagnosis	No	Upper lobe, lung	NA	2011	NA	1.0	162	123	NA	NA	NA	NA	NA	NA	TCGA-55-7574_treatment	NA	Primary Tumor Field	3800	cGy	41960028-2a09-518c-b8ff-8b76191f4db4	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	a7911bdc-13f1-434a-bfa3-f8ba55d15846	Informed Consent	95	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7574	64	false	United States	-23703	995	639d7216-cbca-5f59-8de3-7fd48916a108	not hispanic or latino	female	white	TCGA-55-7574_demographic	Dead	23703	M0	N0	Stage IB	T2a	7th	primary	0	995.0	1cb1cd21-aeba-5c95-bd56-709b5d468257	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-7574_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	184	130	NA	5	NA	160.0	mg	Intravenous	TCGA-55-7574_treatment3	Carboplatin	NA	NA	NA	8e8f3cc2-6d16-4821-8753-7d0b3c6838dc	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a7911bdc-13f1-434a-bfa3-f8ba55d15846	Informed Consent	95	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7574	64	false	United States	-23703	995	639d7216-cbca-5f59-8de3-7fd48916a108	not hispanic or latino	female	white	TCGA-55-7574_demographic	Dead	23703	M0	N0	Stage IB	T2a	7th	primary	0	995.0	1cb1cd21-aeba-5c95-bd56-709b5d468257	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-7574_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	631	478	NA	NA	NA	NA	NA	NA	TCGA-55-7574_treatment6	Bevacizumab	NA	NA	NA	ab01e5d0-d139-4711-b335-00bb8736a8b3	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	a7911bdc-13f1-434a-bfa3-f8ba55d15846	Informed Consent	95	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7574	64	false	United States	-23703	995	639d7216-cbca-5f59-8de3-7fd48916a108	not hispanic or latino	female	white	TCGA-55-7574_demographic	Dead	23703	M0	N0	Stage IB	T2a	7th	primary	0	995.0	1cb1cd21-aeba-5c95-bd56-709b5d468257	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-7574_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	184	130	NA	5	NA	30.0	mg	Intravenous	TCGA-55-7574_treatment4	Docetaxel	NA	NA	NA	ae722db6-1efe-4531-bad7-439aaf815d43	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a7911bdc-13f1-434a-bfa3-f8ba55d15846	Informed Consent	95	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7574	64	false	United States	-23703	995	639d7216-cbca-5f59-8de3-7fd48916a108	not hispanic or latino	female	white	TCGA-55-7574_demographic	Dead	23703	M0	N0	Stage IB	T2a	7th	primary	0	995.0	1cb1cd21-aeba-5c95-bd56-709b5d468257	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-7574_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	631	478	NA	NA	NA	NA	NA	NA	TCGA-55-7574_treatment5	Topotecan	NA	NA	NA	d4211da3-6559-4b15-9752-6f47f45b1ff0	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	a7911bdc-13f1-434a-bfa3-f8ba55d15846	Informed Consent	95	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7574	64	false	United States	-23703	995	639d7216-cbca-5f59-8de3-7fd48916a108	not hispanic or latino	female	white	TCGA-55-7574_demographic	Dead	24181	NA	NA	NA	NA	NA	metastasis	478	NA	bb39d97c-75d6-47a7-9715-9670bd617da3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7574_diagnosis2	NA	Not Reported	TCGA-55-7574_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7574_treatment8	NA	NA	NA	NA	075df9ce-46d4-44f9-8e4d-9712c75613ea	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	a7911bdc-13f1-434a-bfa3-f8ba55d15846	Informed Consent	95	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7574	64	false	United States	-23703	995	639d7216-cbca-5f59-8de3-7fd48916a108	not hispanic or latino	female	white	TCGA-55-7574_demographic	Dead	24181	NA	NA	NA	NA	NA	metastasis	478	NA	bb39d97c-75d6-47a7-9715-9670bd617da3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7574_diagnosis2	NA	Not Reported	TCGA-55-7574_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7574_treatment10	NA	Distant Site	NA	NA	4e32e84c-2108-4296-bcd1-91c51a06e557	NA	no	NA	Surgery, NOS
TCGA-LUAD	a7911bdc-13f1-434a-bfa3-f8ba55d15846	Informed Consent	95	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7574	64	false	United States	-23703	995	639d7216-cbca-5f59-8de3-7fd48916a108	not hispanic or latino	female	white	TCGA-55-7574_demographic	Dead	24181	NA	NA	NA	NA	NA	metastasis	478	NA	bb39d97c-75d6-47a7-9715-9670bd617da3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7574_diagnosis2	NA	Not Reported	TCGA-55-7574_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7574_treatment9	NA	Locoregional Site	NA	NA	6ea6ff37-f474-4c0c-8e82-d9a7062fad07	NA	no	NA	Surgery, NOS
TCGA-LUAD	a7911bdc-13f1-434a-bfa3-f8ba55d15846	Informed Consent	95	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7574	64	false	United States	-23703	995	639d7216-cbca-5f59-8de3-7fd48916a108	not hispanic or latino	female	white	TCGA-55-7574_demographic	Dead	24181	NA	NA	NA	NA	NA	metastasis	478	NA	bb39d97c-75d6-47a7-9715-9670bd617da3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7574_diagnosis2	NA	Not Reported	TCGA-55-7574_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7574_treatment7	NA	NA	NA	NA	d37ad8ba-8e07-4f0c-be8d-ab024e59cb28	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a815619f-dbba-469f-a1f7-dfbd51cd86c5	Informed Consent	148	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A50W	75	false	United States	-27414	442	f87c17ea-3bdb-5654-bf49-d181aae214f5	not hispanic or latino	male	black or african american	TCGA-L9-A50W_demographic	Dead	27414	MX	N1	Stage IIA	T1b	7th	primary	0	442.0	80dfcec1-956f-51c8-b80e-887886e7ddd4	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-L9-A50W_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A50W_treatment2	NA	NA	NA	NA	0f42ec1d-b17d-4640-90e7-6948a3c19478	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a815619f-dbba-469f-a1f7-dfbd51cd86c5	Informed Consent	148	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A50W	75	false	United States	-27414	442	f87c17ea-3bdb-5654-bf49-d181aae214f5	not hispanic or latino	male	black or african american	TCGA-L9-A50W_demographic	Dead	27414	MX	N1	Stage IIA	T1b	7th	primary	0	442.0	80dfcec1-956f-51c8-b80e-887886e7ddd4	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-L9-A50W_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A50W_treatment	NA	NA	NA	NA	a8a74e89-1ee2-5353-9c0f-4d72d36430ca	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a815619f-dbba-469f-a1f7-dfbd51cd86c5	Informed Consent	148	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A50W	75	false	United States	-27414	442	f87c17ea-3bdb-5654-bf49-d181aae214f5	not hispanic or latino	male	black or african american	TCGA-L9-A50W_demographic	Dead	27803	NA	NA	NA	NA	NA	metastasis	389	NA	9bc6a8ed-5bb0-4cb1-a3d3-6175e33bf69c	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-L9-A50W_diagnosis2	NA	Not Reported	TCGA-L9-A50W_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A50W_treatment5	NA	Locoregional Site	NA	NA	35482314-555b-4fce-8a62-2e7511aac0a1	NA	no	NA	Surgery, NOS
TCGA-LUAD	a815619f-dbba-469f-a1f7-dfbd51cd86c5	Informed Consent	148	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A50W	75	false	United States	-27414	442	f87c17ea-3bdb-5654-bf49-d181aae214f5	not hispanic or latino	male	black or african american	TCGA-L9-A50W_demographic	Dead	27803	NA	NA	NA	NA	NA	metastasis	389	NA	9bc6a8ed-5bb0-4cb1-a3d3-6175e33bf69c	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-L9-A50W_diagnosis2	NA	Not Reported	TCGA-L9-A50W_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-L9-A50W_treatment6	NA	Distant Site	NA	NA	5393b8d8-c096-4207-9f72-78fada819a9c	NA	no	NA	Surgery, NOS
TCGA-LUAD	a815619f-dbba-469f-a1f7-dfbd51cd86c5	Informed Consent	148	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A50W	75	false	United States	-27414	442	f87c17ea-3bdb-5654-bf49-d181aae214f5	not hispanic or latino	male	black or african american	TCGA-L9-A50W_demographic	Dead	27803	NA	NA	NA	NA	NA	metastasis	389	NA	9bc6a8ed-5bb0-4cb1-a3d3-6175e33bf69c	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-L9-A50W_diagnosis2	NA	Not Reported	TCGA-L9-A50W_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-L9-A50W_treatment4	NA	NA	NA	NA	57c24376-4f9e-48a8-968f-b831393dcfd7	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a815619f-dbba-469f-a1f7-dfbd51cd86c5	Informed Consent	148	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-L9-A50W	75	false	United States	-27414	442	f87c17ea-3bdb-5654-bf49-d181aae214f5	not hispanic or latino	male	black or african american	TCGA-L9-A50W_demographic	Dead	27803	NA	NA	NA	NA	NA	metastasis	389	NA	9bc6a8ed-5bb0-4cb1-a3d3-6175e33bf69c	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-L9-A50W_diagnosis2	NA	Not Reported	TCGA-L9-A50W_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-L9-A50W_treatment3	NA	NA	NA	NA	a97ca397-e4c3-46b5-9181-880cfaefcc1a	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a816e355-be6f-4d16-b051-b6d86ed8cded	Informed Consent	-1	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-86-8278	63	false	Russia	-23117	NA	2b060dab-2aeb-51ee-a00b-6a3aa642834e	not hispanic or latino	female	white	TCGA-86-8278_demographic	Alive	23117	M0	N1	Stage IIB	T2	7th	primary	0	944.0	1ba819cd-9f8f-5db1-a8d5-9be7804856ad	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8278_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	156	29	NA	NA	NA	NA	NA	NA	TCGA-86-8278_treatment	Etoposide	NA	NA	NA	0d1b7be3-9331-556b-a4ab-96a95e274362	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	a816e355-be6f-4d16-b051-b6d86ed8cded	Informed Consent	-1	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-86-8278	63	false	Russia	-23117	NA	2b060dab-2aeb-51ee-a00b-6a3aa642834e	not hispanic or latino	female	white	TCGA-86-8278_demographic	Alive	23117	M0	N1	Stage IIB	T2	7th	primary	0	944.0	1ba819cd-9f8f-5db1-a8d5-9be7804856ad	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8278_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	NA	178	NA	NA	NA	NA	NA	NA	TCGA-86-8278_treatment3	Gefitinib	NA	NA	NA	50076d7b-df25-4ac0-b3b8-ec4e4b991c3a	NA	yes	Treatment Ongoing	Targeted Molecular Therapy
TCGA-LUAD	a816e355-be6f-4d16-b051-b6d86ed8cded	Informed Consent	-1	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-86-8278	63	false	Russia	-23117	NA	2b060dab-2aeb-51ee-a00b-6a3aa642834e	not hispanic or latino	female	white	TCGA-86-8278_demographic	Alive	23117	M0	N1	Stage IIB	T2	7th	primary	0	944.0	1ba819cd-9f8f-5db1-a8d5-9be7804856ad	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8278_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	156	29	NA	NA	NA	NA	NA	NA	TCGA-86-8278_treatment2	Cisplatin	NA	NA	NA	741bd4b7-bee1-428d-9957-6197ffad5528	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	a816e355-be6f-4d16-b051-b6d86ed8cded	Informed Consent	-1	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-86-8278	63	false	Russia	-23117	NA	2b060dab-2aeb-51ee-a00b-6a3aa642834e	not hispanic or latino	female	white	TCGA-86-8278_demographic	Alive	23117	M0	N1	Stage IIB	T2	7th	primary	0	944.0	1ba819cd-9f8f-5db1-a8d5-9be7804856ad	true	NA	NA	C34.30	Left	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8278_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8278_treatment4	NA	NA	NA	NA	ba7c5be9-d715-4e45-9525-5c882ef7bb14	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a816e355-be6f-4d16-b051-b6d86ed8cded	Informed Consent	-1	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-86-8278	63	false	Russia	-23117	NA	2b060dab-2aeb-51ee-a00b-6a3aa642834e	not hispanic or latino	female	white	TCGA-86-8278_demographic	Alive	23146	NA	NA	NA	NA	NA	not reported	29	NA	670afadb-0c03-47d3-90f4-6b6f359e2b1f	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-86-8278_diagnosis2	NA	Not Reported	TCGA-86-8278_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8278_treatment7	NA	Locoregional Site	NA	NA	294bb6d3-e8bc-4a63-994b-77da7fd193c0	NA	no	NA	Surgery, NOS
TCGA-LUAD	a816e355-be6f-4d16-b051-b6d86ed8cded	Informed Consent	-1	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-86-8278	63	false	Russia	-23117	NA	2b060dab-2aeb-51ee-a00b-6a3aa642834e	not hispanic or latino	female	white	TCGA-86-8278_demographic	Alive	23146	NA	NA	NA	NA	NA	not reported	29	NA	670afadb-0c03-47d3-90f4-6b6f359e2b1f	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-86-8278_diagnosis2	NA	Not Reported	TCGA-86-8278_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-86-8278_treatment6	NA	NA	NA	NA	6c5da8e3-00e8-4e19-9b65-f0e98699665d	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a816e355-be6f-4d16-b051-b6d86ed8cded	Informed Consent	-1	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-86-8278	63	false	Russia	-23117	NA	2b060dab-2aeb-51ee-a00b-6a3aa642834e	not hispanic or latino	female	white	TCGA-86-8278_demographic	Alive	23146	NA	NA	NA	NA	NA	not reported	29	NA	670afadb-0c03-47d3-90f4-6b6f359e2b1f	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-86-8278_diagnosis2	NA	Not Reported	TCGA-86-8278_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-86-8278_treatment5	NA	NA	NA	NA	987547da-5278-4f43-9578-ac82cba8bc66	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a816e355-be6f-4d16-b051-b6d86ed8cded	Informed Consent	-1	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-86-8278	63	false	Russia	-23117	NA	2b060dab-2aeb-51ee-a00b-6a3aa642834e	not hispanic or latino	female	white	TCGA-86-8278_demographic	Alive	23146	NA	NA	NA	NA	NA	not reported	29	NA	670afadb-0c03-47d3-90f4-6b6f359e2b1f	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-86-8278_diagnosis2	NA	Not Reported	TCGA-86-8278_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8278_treatment8	NA	Distant Site	NA	NA	f348134f-84d2-4198-92f8-5bfcc0fd95cc	NA	no	NA	Surgery, NOS
TCGA-LUAD	a8d6694c-a213-4544-ac0b-63bce16d8f4e	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6203	NA	false	Canada	NA	NA	1e23ed80-8ec0-5c4b-8f8a-7f857b555828	not reported	female	not reported	TCGA-75-6203_demographic	Alive	NA	M0	N2	Stage IIIA	T2	6th	primary	NA	NA	5a55d698-d6cc-5fcb-905a-a726c8b7f780	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-75-6203_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6203_treatment4	NA	NA	NA	NA	8b046761-a556-47d3-bef8-2155db2f5bf4	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a8d6694c-a213-4544-ac0b-63bce16d8f4e	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6203	NA	false	Canada	NA	NA	1e23ed80-8ec0-5c4b-8f8a-7f857b555828	not reported	female	not reported	TCGA-75-6203_demographic	Alive	NA	M0	N2	Stage IIIA	T2	6th	primary	NA	NA	5a55d698-d6cc-5fcb-905a-a726c8b7f780	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-75-6203_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6203_treatment	NA	NA	NA	NA	c184a053-7f87-5e10-9573-d7270db13f7e	NA	yes	Treatment Ongoing	Pharmaceutical Therapy, NOS
TCGA-LUAD	a8d6694c-a213-4544-ac0b-63bce16d8f4e	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6203	NA	false	Canada	NA	NA	1e23ed80-8ec0-5c4b-8f8a-7f857b555828	not reported	female	not reported	TCGA-75-6203_demographic	Alive	NA	M0	N2	Stage IIIA	T2	6th	primary	NA	NA	5a55d698-d6cc-5fcb-905a-a726c8b7f780	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-75-6203_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	8	NA	NA	NA	Intravenous	TCGA-75-6203_treatment3	Vinorelbine Tartrate	NA	NA	NA	e88e0bbc-421b-4f59-86ba-a5365f2a4733	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a8d6694c-a213-4544-ac0b-63bce16d8f4e	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-6203	NA	false	Canada	NA	NA	1e23ed80-8ec0-5c4b-8f8a-7f857b555828	not reported	female	not reported	TCGA-75-6203_demographic	Alive	NA	M0	N2	Stage IIIA	T2	6th	primary	NA	NA	5a55d698-d6cc-5fcb-905a-a726c8b7f780	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-75-6203_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	4	NA	NA	NA	Intravenous	TCGA-75-6203_treatment2	Cisplatin	NA	NA	NA	ea2a4a6a-3df2-45ef-9055-b8ba106f5817	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a8de1beb-6296-44eb-bd63-c603f70faaf3	Informed Consent	41	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8614	76	false	United States	-27924	NA	fd20a73b-91c9-53d3-b303-41a73a4249d2	not hispanic or latino	male	white	TCGA-55-8614_demographic	Alive	27924	MX	N0	Stage IB	T2a	7th	primary	0	536.0	f58b92f7-b626-5622-97d4-f5f409561c57	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8614_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8614_treatment	NA	NA	NA	NA	c09c51f2-635d-531f-8451-fc7465e22ad6	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a8de1beb-6296-44eb-bd63-c603f70faaf3	Informed Consent	41	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8614	76	false	United States	-27924	NA	fd20a73b-91c9-53d3-b303-41a73a4249d2	not hispanic or latino	male	white	TCGA-55-8614_demographic	Alive	27924	MX	N0	Stage IB	T2a	7th	primary	0	536.0	f58b92f7-b626-5622-97d4-f5f409561c57	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8614_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8614_treatment2	NA	NA	NA	NA	fda772f1-6a51-45c3-82e7-da67d0df127f	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a8f3da11-890c-4fff-bfc5-d99357dc4e46	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z051	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	a905d275-9283-4fa6-bbbf-46019bd1bcb7	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-78-8655	77	false	Australia	-28379	NA	8a8f1618-6da1-595d-a44d-db016e688bda	not reported	female	not reported	TCGA-78-8655_demographic	Alive	28379	M0	N0	Stage IA	T1	6th	primary	0	2360.0	a197be4d-6a65-5365-990d-6dac6ae3a6ae	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-8655_diagnosis	No	Lower lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8655_treatment	NA	NA	NA	NA	92f7684f-9eae-50cd-9594-dfd126c9957e	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	a905d275-9283-4fa6-bbbf-46019bd1bcb7	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-78-8655	77	false	Australia	-28379	NA	8a8f1618-6da1-595d-a44d-db016e688bda	not reported	female	not reported	TCGA-78-8655_demographic	Alive	28379	M0	N0	Stage IA	T1	6th	primary	0	2360.0	a197be4d-6a65-5365-990d-6dac6ae3a6ae	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-8655_diagnosis	No	Lower lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-8655_treatment2	NA	NA	NA	NA	e321413f-14e4-444c-8549-a8dc36e9ec14	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	a9644274-13bb-4228-9b4f-14260ccc26eb	Informed Consent	218	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-97-7554	83	false	United States	-30327	NA	4dda3905-28b0-5737-b0db-32430ce22bd7	not hispanic or latino	female	white	TCGA-97-7554_demographic	Alive	30327	M0	N2	Stage IIIA	T2a	7th	primary	0	775.0	e93f1e4c-d375-5de5-bc71-e46734740284	true	NA	NA	C34.3	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-97-7554_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	111	49	NA	4	NA	817.0	mg	Intravenous	TCGA-97-7554_treatment	Pemetrexed Disodium	NA	3268	mg	b5d801c3-70ef-5a9d-a3b2-68f77eb716b9	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a9644274-13bb-4228-9b4f-14260ccc26eb	Informed Consent	218	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-97-7554	83	false	United States	-30327	NA	4dda3905-28b0-5737-b0db-32430ce22bd7	not hispanic or latino	female	white	TCGA-97-7554_demographic	Alive	30327	M0	N2	Stage IIIA	T2a	7th	primary	0	775.0	e93f1e4c-d375-5de5-bc71-e46734740284	true	NA	NA	C34.3	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-97-7554_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	111	49	NA	4	NA	350.0	mg	Intravenous	TCGA-97-7554_treatment2	Carboplatin	NA	1400	mg	c6bf1fb0-6907-48de-be9b-00c21baf4141	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	a9644274-13bb-4228-9b4f-14260ccc26eb	Informed Consent	218	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-97-7554	83	false	United States	-30327	NA	4dda3905-28b0-5737-b0db-32430ce22bd7	not hispanic or latino	female	white	TCGA-97-7554_demographic	Alive	30327	M0	N2	Stage IIIA	T2a	7th	primary	0	775.0	e93f1e4c-d375-5de5-bc71-e46734740284	true	NA	NA	C34.3	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-97-7554_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7554_treatment3	NA	NA	NA	NA	cd33b36c-b62e-4e8a-8f08-04af281c0b9b	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ab8d7f84-dd71-42c7-9471-4db967a9c89c	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6673	84	false	United States	-30689	22	14836e6f-2e41-5e76-9e44-c253f8d3840e	not reported	female	white	TCGA-50-6673_demographic	Dead	30689	M0	N0	Stage I	T1	6th	primary	0	22.0	15885ef4-0b28-5161-8c59-85fc7b53409a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-6673_diagnosis	No	Upper lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6673_treatment2	NA	NA	NA	NA	b56a7b59-6cbb-4b56-b8e7-6365bea39735	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ab8d7f84-dd71-42c7-9471-4db967a9c89c	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6673	84	false	United States	-30689	22	14836e6f-2e41-5e76-9e44-c253f8d3840e	not reported	female	white	TCGA-50-6673_demographic	Dead	30689	M0	N0	Stage I	T1	6th	primary	0	22.0	15885ef4-0b28-5161-8c59-85fc7b53409a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-6673_diagnosis	No	Upper lobe, lung	NA	2004	NA	NA	0	0	NA	NA	50.0	NA	NA	NA	TCGA-50-6673_treatment	NA	Primary Tumor Field	1	mCi	e1bf388d-8fed-57b4-ad0b-590468de6f09	NA	yes	Progressive Disease	Radiation, Internal
TCGA-LUAD	ab9e6815-4d13-44db-93e5-553eb4f5bc95	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7662	61	false	United States	-22543	NA	730c725f-2094-59c0-a896-e9e13d43bbdd	not hispanic or latino	male	white	TCGA-44-7662_demographic	Alive	22543	MX	N0	Stage IB	T2a	7th	primary	0	218.0	4f044b1f-79b0-519f-84b3-3b6c9750636b	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7662_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7662_treatment2	NA	NA	NA	NA	9797faea-3a10-4b87-a4a7-4b4ad5967288	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ab9e6815-4d13-44db-93e5-553eb4f5bc95	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7662	61	false	United States	-22543	NA	730c725f-2094-59c0-a896-e9e13d43bbdd	not hispanic or latino	male	white	TCGA-44-7662_demographic	Alive	22543	MX	N0	Stage IB	T2a	7th	primary	0	218.0	4f044b1f-79b0-519f-84b3-3b6c9750636b	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7662_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7662_treatment	NA	NA	NA	NA	e18a2258-cd6d-5321-ac98-39c75efdaaad	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	abab925c-bef3-4072-b9c4-40f808744593	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7944	71	false	United States	-26003	NA	a69fed60-cf3a-5c60-b3fd-d2ceeddec204	not hispanic or latino	male	white	TCGA-95-7944_demographic	Alive	26003	M0	N0	Stage IA	T1a	7th	primary	0	377.0	c7e25352-38b8-5bb7-978d-cb4967b13f2b	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-95-7944_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7944_treatment2	NA	NA	NA	NA	2716d36c-f2f1-4c93-882e-04e0cac32f8b	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	abab925c-bef3-4072-b9c4-40f808744593	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7944	71	false	United States	-26003	NA	a69fed60-cf3a-5c60-b3fd-d2ceeddec204	not hispanic or latino	male	white	TCGA-95-7944_demographic	Alive	26003	M0	N0	Stage IA	T1a	7th	primary	0	377.0	c7e25352-38b8-5bb7-978d-cb4967b13f2b	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-95-7944_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7944_treatment	NA	NA	NA	NA	5050135f-07be-5793-b44c-82c37b0e4b0d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	abb86d09-d4ff-41f4-ba22-185dc48347c9	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z025	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	abd6647b-d2eb-404d-8283-443e92addf55	Informed Consent	5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7995	73	false	United States	-26837	NA	2e64e46f-bb8c-54f3-a471-c855f8be925f	not hispanic or latino	female	white	TCGA-55-7995_demographic	Alive	27305	NA	NA	NA	NA	NA	recurrence	468	NA	4787944b-007a-426d-9476-c93b72bb6d73	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7995_diagnosis2	NA	Not Reported	TCGA-55-7995_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-7995_treatment4	NA	NA	NA	NA	35d0837f-2a1d-4d8f-aaa2-104ee455b4d1	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	abd6647b-d2eb-404d-8283-443e92addf55	Informed Consent	5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7995	73	false	United States	-26837	NA	2e64e46f-bb8c-54f3-a471-c855f8be925f	not hispanic or latino	female	white	TCGA-55-7995_demographic	Alive	27305	NA	NA	NA	NA	NA	recurrence	468	NA	4787944b-007a-426d-9476-c93b72bb6d73	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7995_diagnosis2	NA	Not Reported	TCGA-55-7995_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-7995_treatment5	NA	NA	NA	NA	f23c9fd8-00be-4736-85cd-fdb2bb1105ed	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	abd6647b-d2eb-404d-8283-443e92addf55	Informed Consent	5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7995	73	false	United States	-26837	NA	2e64e46f-bb8c-54f3-a471-c855f8be925f	not hispanic or latino	female	white	TCGA-55-7995_demographic	Alive	27305	NA	NA	NA	NA	NA	recurrence	468	NA	4787944b-007a-426d-9476-c93b72bb6d73	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7995_diagnosis2	NA	Not Reported	TCGA-55-7995_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7995_treatment6	NA	Locoregional Site	NA	NA	fc56e10d-f786-464c-8a15-776c224cdf00	NA	no	NA	Surgery, NOS
TCGA-LUAD	abd6647b-d2eb-404d-8283-443e92addf55	Informed Consent	5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7995	73	false	United States	-26837	NA	2e64e46f-bb8c-54f3-a471-c855f8be925f	not hispanic or latino	female	white	TCGA-55-7995_demographic	Alive	26837	M0	N0	Stage IA	T1b	7th	primary	0	889.0	6b7ca755-7559-5daa-954e-1a6bca292c21	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-7995_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	525	483	NA	NA	NA	NA	NA	NA	TCGA-55-7995_treatment2	Carboplatin	NA	NA	NA	49360911-94da-4534-bc48-1b72ac2efcb0	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	abd6647b-d2eb-404d-8283-443e92addf55	Informed Consent	5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7995	73	false	United States	-26837	NA	2e64e46f-bb8c-54f3-a471-c855f8be925f	not hispanic or latino	female	white	TCGA-55-7995_demographic	Alive	26837	M0	N0	Stage IA	T1b	7th	primary	0	889.0	6b7ca755-7559-5daa-954e-1a6bca292c21	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-7995_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	525	483	NA	NA	NA	NA	NA	NA	TCGA-55-7995_treatment	NA	Regional Site	6500	cGy	e2d53a6d-b609-5194-88e3-deb62c182ed8	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	abd6647b-d2eb-404d-8283-443e92addf55	Informed Consent	5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7995	73	false	United States	-26837	NA	2e64e46f-bb8c-54f3-a471-c855f8be925f	not hispanic or latino	female	white	TCGA-55-7995_demographic	Alive	26837	M0	N0	Stage IA	T1b	7th	primary	0	889.0	6b7ca755-7559-5daa-954e-1a6bca292c21	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-7995_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	525	483	NA	NA	NA	NA	NA	NA	TCGA-55-7995_treatment3	Paclitaxel	NA	NA	NA	ec7e5aa5-0cd4-48da-b5d3-265985259443	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	abf6eb5f-fa06-4032-8cff-c8522b0a3c9a	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z047	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	ac0d7a82-82cb-4aec-b859-e37375f3de8b	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8547	78	false	United States	-28801	NA	3102cc07-2af1-559c-af8a-62b0a97f310b	not reported	female	not reported	TCGA-97-8547_demographic	Alive	28801	MX	N2	Stage IIIA	T2a	7th	primary	0	657.0	e557ad74-40d2-5460-ada9-54fb6b8b5663	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-97-8547_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	111	47	NA	NA	NA	NA	NA	NA	TCGA-97-8547_treatment2	Carboplatin	NA	NA	NA	0cc1670b-3c92-4c3d-8db7-39c244806d50	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	ac0d7a82-82cb-4aec-b859-e37375f3de8b	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8547	78	false	United States	-28801	NA	3102cc07-2af1-559c-af8a-62b0a97f310b	not reported	female	not reported	TCGA-97-8547_demographic	Alive	28801	MX	N2	Stage IIIA	T2a	7th	primary	0	657.0	e557ad74-40d2-5460-ada9-54fb6b8b5663	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-97-8547_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8547_treatment4	NA	NA	NA	NA	17372d7b-3f3a-4486-aa21-7efa92c45f9c	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ac0d7a82-82cb-4aec-b859-e37375f3de8b	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8547	78	false	United States	-28801	NA	3102cc07-2af1-559c-af8a-62b0a97f310b	not reported	female	not reported	TCGA-97-8547_demographic	Alive	28801	MX	N2	Stage IIIA	T2a	7th	primary	0	657.0	e557ad74-40d2-5460-ada9-54fb6b8b5663	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-97-8547_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	111	47	NA	NA	NA	NA	NA	NA	TCGA-97-8547_treatment	Paclitaxel	NA	NA	NA	20517eb2-7727-56b1-b136-ee91bcf65aa0	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	ac0d7a82-82cb-4aec-b859-e37375f3de8b	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8547	78	false	United States	-28801	NA	3102cc07-2af1-559c-af8a-62b0a97f310b	not reported	female	not reported	TCGA-97-8547_demographic	Alive	28801	MX	N2	Stage IIIA	T2a	7th	primary	0	657.0	e557ad74-40d2-5460-ada9-54fb6b8b5663	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-97-8547_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	NA	124	NA	NA	NA	NA	NA	NA	TCGA-97-8547_treatment3	Erlotinib Hydrochloride	NA	NA	NA	55069de1-f053-4949-a64d-be5856c168b4	NA	yes	Treatment Ongoing	Pharmaceutical Therapy, NOS
TCGA-LUAD	ad74c0e8-8878-4efc-997d-981cd547bc5b	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7498	58	false	United States	-21527	NA	1cde668e-cd8e-59f1-b297-5983ad812be9	not hispanic or latino	female	white	TCGA-73-7498_demographic	Alive	21527	M0	N0	Stage IA	T1b	7th	primary	0	1189.0	580754c0-a6e3-59f2-acb2-100dca8ab3f0	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-7498_diagnosis	Yes	Lower lobe, lung	NA	2010	No	NA	131	47	NA	NA	NA	NA	NA	NA	TCGA-73-7498_treatment5	Cisplatin	NA	NA	NA	02a68efc-f9f8-4107-9266-1063cd6babfb	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	ad74c0e8-8878-4efc-997d-981cd547bc5b	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7498	58	false	United States	-21527	NA	1cde668e-cd8e-59f1-b297-5983ad812be9	not hispanic or latino	female	white	TCGA-73-7498_demographic	Alive	21527	M0	N0	Stage IA	T1b	7th	primary	0	1189.0	580754c0-a6e3-59f2-acb2-100dca8ab3f0	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-7498_diagnosis	Yes	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-7498_treatment6	NA	NA	NA	NA	3bda493e-dfe9-4d2f-8dee-1596812556ba	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ad74c0e8-8878-4efc-997d-981cd547bc5b	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7498	58	false	United States	-21527	NA	1cde668e-cd8e-59f1-b297-5983ad812be9	not hispanic or latino	female	white	TCGA-73-7498_demographic	Alive	21527	M0	N0	Stage IA	T1b	7th	primary	0	1189.0	580754c0-a6e3-59f2-acb2-100dca8ab3f0	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-7498_diagnosis	Yes	Lower lobe, lung	NA	2010	No	NA	110	68	NA	NA	NA	NA	NA	NA	TCGA-73-7498_treatment3	Carboplatin	NA	NA	NA	48c26703-8646-4c93-b59f-013c16386f5a	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	ad74c0e8-8878-4efc-997d-981cd547bc5b	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7498	58	false	United States	-21527	NA	1cde668e-cd8e-59f1-b297-5983ad812be9	not hispanic or latino	female	white	TCGA-73-7498_demographic	Alive	21527	M0	N0	Stage IA	T1b	7th	primary	0	1189.0	580754c0-a6e3-59f2-acb2-100dca8ab3f0	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-7498_diagnosis	Yes	Lower lobe, lung	NA	2010	No	NA	131	47	NA	NA	NA	NA	NA	NA	TCGA-73-7498_treatment4	Pemetrexed	NA	NA	NA	5f81bf0a-3fc3-4383-9d97-047b59241829	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	ad74c0e8-8878-4efc-997d-981cd547bc5b	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7498	58	false	United States	-21527	NA	1cde668e-cd8e-59f1-b297-5983ad812be9	not hispanic or latino	female	white	TCGA-73-7498_demographic	Alive	21527	M0	N0	Stage IA	T1b	7th	primary	0	1189.0	580754c0-a6e3-59f2-acb2-100dca8ab3f0	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-7498_diagnosis	Yes	Lower lobe, lung	NA	2010	No	NA	68	47	NA	NA	NA	NA	NA	NA	TCGA-73-7498_treatment2	Cisplatin	NA	NA	NA	b004fdf9-f48d-4c3e-b3a7-b8326d86fadb	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	ad74c0e8-8878-4efc-997d-981cd547bc5b	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7498	58	false	United States	-21527	NA	1cde668e-cd8e-59f1-b297-5983ad812be9	not hispanic or latino	female	white	TCGA-73-7498_demographic	Alive	21527	M0	N0	Stage IA	T1b	7th	primary	0	1189.0	580754c0-a6e3-59f2-acb2-100dca8ab3f0	true	NA	NA	C34.3	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-7498_diagnosis	Yes	Lower lobe, lung	NA	2010	No	NA	110	47	NA	NA	NA	NA	NA	NA	TCGA-73-7498_treatment	Pemetrexed	NA	NA	NA	c9436fce-beed-5051-ad23-3b54c46ba808	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	ad74c0e8-8878-4efc-997d-981cd547bc5b	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7498	58	false	United States	-21527	NA	1cde668e-cd8e-59f1-b297-5983ad812be9	not hispanic or latino	female	white	TCGA-73-7498_demographic	Alive	NA	M0	N0	Stage IA	T1a	7th	Synchronous primary	NA	NA	f8150031-2253-4e9e-9549-b02aca6d0eab	false	NA	NA	NA	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	NA	NA	Not Reported	NA	TCGA-73-7498_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-7498_treatment8	NA	NA	NA	NA	12ea4eda-df6e-4fe4-bf7b-80e5557a8dd8	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ad74c0e8-8878-4efc-997d-981cd547bc5b	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-7498	58	false	United States	-21527	NA	1cde668e-cd8e-59f1-b297-5983ad812be9	not hispanic or latino	female	white	TCGA-73-7498_demographic	Alive	NA	M0	N0	Stage IA	T1a	7th	Synchronous primary	NA	NA	f8150031-2253-4e9e-9549-b02aca6d0eab	false	NA	NA	NA	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	NA	NA	Not Reported	NA	TCGA-73-7498_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-7498_treatment7	NA	NA	NA	NA	4c3ba03d-2ca8-402d-a027-0d91a39ab7a5	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	adbaba9c-5efc-4130-82f6-8055eab13795	Informed Consent	5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A494	61	false	United States	-22540	NA	58ba9997-b0e1-5dbd-9bc8-aa025d89c003	not hispanic or latino	female	white	TCGA-55-A494_demographic	Alive	22540	MX	N0	Stage IB	T2a	7th	primary	0	481.0	45708845-c1af-5a02-ba3b-4c85cbd7be4d	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-A494_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A494_treatment2	NA	NA	NA	NA	332be1cd-642a-43ec-a767-cd0450f58c71	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	adbaba9c-5efc-4130-82f6-8055eab13795	Informed Consent	5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A494	61	false	United States	-22540	NA	58ba9997-b0e1-5dbd-9bc8-aa025d89c003	not hispanic or latino	female	white	TCGA-55-A494_demographic	Alive	22540	MX	N0	Stage IB	T2a	7th	primary	0	481.0	45708845-c1af-5a02-ba3b-4c85cbd7be4d	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-A494_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A494_treatment	NA	NA	NA	NA	ed319e15-4ed3-5fa1-9b20-914ffc66d1a6	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ae39e358-08d7-4367-ae68-82b469e791e4	Informed Consent	-37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4675	59	false	United States	-21614	922	bc0b37a1-8f87-5961-91ab-7f5c3b0b975b	not hispanic or latino	male	white	TCGA-73-4675_demographic	Dead	21614	M0	N1	Stage IIIA	T3	7th	primary	0	922.0	696a6f6f-c605-565f-86d0-b0a11a25a0c1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-73-4675_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4675_treatment8	NA	NA	NA	NA	0c589b69-6e4b-4cb6-bc99-fbdf943ec18d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ae39e358-08d7-4367-ae68-82b469e791e4	Informed Consent	-37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4675	59	false	United States	-21614	922	bc0b37a1-8f87-5961-91ab-7f5c3b0b975b	not hispanic or latino	male	white	TCGA-73-4675_demographic	Dead	21614	M0	N1	Stage IIIA	T3	7th	primary	0	922.0	696a6f6f-c605-565f-86d0-b0a11a25a0c1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-73-4675_diagnosis	No	Lower lobe, lung	NA	2010	No	NA	676	592	NA	NA	NA	NA	NA	NA	TCGA-73-4675_treatment7	Erlotinib Hydrochloride	NA	NA	NA	39ef0917-4a78-4ed0-b836-248a20681111	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	ae39e358-08d7-4367-ae68-82b469e791e4	Informed Consent	-37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4675	59	false	United States	-21614	922	bc0b37a1-8f87-5961-91ab-7f5c3b0b975b	not hispanic or latino	male	white	TCGA-73-4675_demographic	Dead	21614	M0	N1	Stage IIIA	T3	7th	primary	0	922.0	696a6f6f-c605-565f-86d0-b0a11a25a0c1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-73-4675_diagnosis	No	Lower lobe, lung	NA	2010	No	NA	482	110	NA	NA	NA	NA	NA	NA	TCGA-73-4675_treatment	Carboplatin	NA	NA	NA	3ceeba6b-f1d1-57e8-b081-0d940c6a8fb2	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	ae39e358-08d7-4367-ae68-82b469e791e4	Informed Consent	-37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4675	59	false	United States	-21614	922	bc0b37a1-8f87-5961-91ab-7f5c3b0b975b	not hispanic or latino	male	white	TCGA-73-4675_demographic	Dead	21614	M0	N1	Stage IIIA	T3	7th	primary	0	922.0	696a6f6f-c605-565f-86d0-b0a11a25a0c1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-73-4675_diagnosis	No	Lower lobe, lung	NA	2010	No	NA	483	459	NA	NA	NA	NA	NA	NA	TCGA-73-4675_treatment6	Bevacizumab	NA	NA	NA	4a6a0b33-9ace-4b04-b15d-b2fbb9eec4aa	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	ae39e358-08d7-4367-ae68-82b469e791e4	Informed Consent	-37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4675	59	false	United States	-21614	922	bc0b37a1-8f87-5961-91ab-7f5c3b0b975b	not hispanic or latino	male	white	TCGA-73-4675_demographic	Dead	21614	M0	N1	Stage IIIA	T3	7th	primary	0	922.0	696a6f6f-c605-565f-86d0-b0a11a25a0c1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-73-4675_diagnosis	No	Lower lobe, lung	NA	2010	No	NA	117	27	NA	NA	NA	NA	NA	NA	TCGA-73-4675_treatment2	Pemetrexed Disodium	NA	NA	NA	4eac7dc2-13fb-4132-ab22-e107da0dc70e	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	ae39e358-08d7-4367-ae68-82b469e791e4	Informed Consent	-37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4675	59	false	United States	-21614	922	bc0b37a1-8f87-5961-91ab-7f5c3b0b975b	not hispanic or latino	male	white	TCGA-73-4675_demographic	Dead	21614	M0	N1	Stage IIIA	T3	7th	primary	0	922.0	696a6f6f-c605-565f-86d0-b0a11a25a0c1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-73-4675_diagnosis	No	Lower lobe, lung	NA	2010	No	NA	483	459	NA	NA	NA	NA	NA	NA	TCGA-73-4675_treatment5	Docetaxel	NA	NA	NA	799ec4ba-3a07-41b4-8553-a10c3055296e	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	ae39e358-08d7-4367-ae68-82b469e791e4	Informed Consent	-37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4675	59	false	United States	-21614	922	bc0b37a1-8f87-5961-91ab-7f5c3b0b975b	not hispanic or latino	male	white	TCGA-73-4675_demographic	Dead	21614	M0	N1	Stage IIIA	T3	7th	primary	0	922.0	696a6f6f-c605-565f-86d0-b0a11a25a0c1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-73-4675_diagnosis	No	Lower lobe, lung	NA	2010	No	NA	104	27	NA	NA	NA	NA	NA	NA	TCGA-73-4675_treatment3	Cisplatin	NA	NA	NA	9ff3bbde-6a2c-479d-858a-29aa76e5f91e	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	ae39e358-08d7-4367-ae68-82b469e791e4	Informed Consent	-37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4675	59	false	United States	-21614	922	bc0b37a1-8f87-5961-91ab-7f5c3b0b975b	not hispanic or latino	male	white	TCGA-73-4675_demographic	Dead	21614	M0	N1	Stage IIIA	T3	7th	primary	0	922.0	696a6f6f-c605-565f-86d0-b0a11a25a0c1	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-73-4675_diagnosis	No	Lower lobe, lung	NA	2010	No	NA	483	459	NA	NA	NA	NA	NA	NA	TCGA-73-4675_treatment4	Carboplatin	NA	NA	NA	f7bc035c-e16f-46cc-95f6-2b955d9bb322	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	ae39e358-08d7-4367-ae68-82b469e791e4	Informed Consent	-37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4675	59	false	United States	-21614	922	bc0b37a1-8f87-5961-91ab-7f5c3b0b975b	not hispanic or latino	male	white	TCGA-73-4675_demographic	Dead	21975	NA	NA	NA	NA	NA	recurrence	361	NA	c9202e4f-4fd4-4123-b4aa-79fa6b2bb584	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-73-4675_diagnosis2	NA	Not Reported	TCGA-73-4675_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-73-4675_treatment9	NA	NA	NA	NA	087b9ce3-1058-4e2e-be14-983ccc56e833	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ae39e358-08d7-4367-ae68-82b469e791e4	Informed Consent	-37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4675	59	false	United States	-21614	922	bc0b37a1-8f87-5961-91ab-7f5c3b0b975b	not hispanic or latino	male	white	TCGA-73-4675_demographic	Dead	21975	NA	NA	NA	NA	NA	recurrence	361	NA	c9202e4f-4fd4-4123-b4aa-79fa6b2bb584	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-73-4675_diagnosis2	NA	Not Reported	TCGA-73-4675_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4675_treatment11	NA	Locoregional Site	NA	NA	7240f563-902e-44e9-884b-f5c4b29cf9cb	NA	no	NA	Surgery, NOS
TCGA-LUAD	ae39e358-08d7-4367-ae68-82b469e791e4	Informed Consent	-37	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4675	59	false	United States	-21614	922	bc0b37a1-8f87-5961-91ab-7f5c3b0b975b	not hispanic or latino	male	white	TCGA-73-4675_demographic	Dead	21975	NA	NA	NA	NA	NA	recurrence	361	NA	c9202e4f-4fd4-4123-b4aa-79fa6b2bb584	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-73-4675_diagnosis2	NA	Not Reported	TCGA-73-4675_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-73-4675_treatment10	NA	NA	NA	NA	f49f72ec-fd33-425c-b547-f6f06c855a94	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ae702159-5b6a-41dd-868c-7540f9e1131c	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7039	54	false	United States	-19981	NA	84f2d225-3dfd-5c62-a44e-dd1cf54557c4	not hispanic or latino	female	white	TCGA-95-7039_demographic	Alive	21239	NA	NA	NA	NA	NA	recurrence	1258	NA	67aea50a-0f17-4fec-9d7c-0e10dc04156d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-95-7039_diagnosis2	NA	Not Reported	TCGA-95-7039_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7039_treatment5	NA	Locoregional Site	NA	NA	1d8d960c-1160-4603-9bf4-65854a7a048e	NA	no	NA	Surgery, NOS
TCGA-LUAD	ae702159-5b6a-41dd-868c-7540f9e1131c	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7039	54	false	United States	-19981	NA	84f2d225-3dfd-5c62-a44e-dd1cf54557c4	not hispanic or latino	female	white	TCGA-95-7039_demographic	Alive	21239	NA	NA	NA	NA	NA	recurrence	1258	NA	67aea50a-0f17-4fec-9d7c-0e10dc04156d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-95-7039_diagnosis2	NA	Not Reported	TCGA-95-7039_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-95-7039_treatment4	NA	NA	NA	NA	7829b4f4-fdbe-44e0-a90c-152ddd12fe4d	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ae702159-5b6a-41dd-868c-7540f9e1131c	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7039	54	false	United States	-19981	NA	84f2d225-3dfd-5c62-a44e-dd1cf54557c4	not hispanic or latino	female	white	TCGA-95-7039_demographic	Alive	21239	NA	NA	NA	NA	NA	recurrence	1258	NA	67aea50a-0f17-4fec-9d7c-0e10dc04156d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-95-7039_diagnosis2	NA	Not Reported	TCGA-95-7039_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-95-7039_treatment3	NA	NA	NA	NA	ec978047-12f4-4a8c-ab6b-e382d4f33480	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ae702159-5b6a-41dd-868c-7540f9e1131c	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7039	54	false	United States	-19981	NA	84f2d225-3dfd-5c62-a44e-dd1cf54557c4	not hispanic or latino	female	white	TCGA-95-7039_demographic	Alive	19981	MX	N0	Stage IIB	T3	7th	primary	0	1272.0	cbaa0507-87ce-5818-a855-104907c94f31	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-95-7039_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7039_treatment	NA	NA	NA	NA	5f152ded-d5ce-5c8e-8ad2-7a62c867f8b9	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ae702159-5b6a-41dd-868c-7540f9e1131c	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7039	54	false	United States	-19981	NA	84f2d225-3dfd-5c62-a44e-dd1cf54557c4	not hispanic or latino	female	white	TCGA-95-7039_demographic	Alive	19981	MX	N0	Stage IIB	T3	7th	primary	0	1272.0	cbaa0507-87ce-5818-a855-104907c94f31	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-95-7039_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7039_treatment2	NA	NA	NA	NA	c380b479-9b6d-42d7-8324-e5ed910ddc38	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	aea68827-dc0f-484d-a00d-06deeaa4b3ce	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4433	82	false	Germany	-30194	NA	25ef4502-732f-501a-ac5b-64efe7181115	not reported	male	not reported	TCGA-05-4433_demographic	Alive	30194	M0	N0	Stage IB	T2	6th	primary	0	730.0	7eae98ef-db69-5204-8f8a-5677bbc8ab7f	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4433_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4433_treatment2	NA	NA	NA	NA	b08e5d41-a598-40c5-8482-d57fe1392a72	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	aea68827-dc0f-484d-a00d-06deeaa4b3ce	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4433	82	false	Germany	-30194	NA	25ef4502-732f-501a-ac5b-64efe7181115	not reported	male	not reported	TCGA-05-4433_demographic	Alive	30194	M0	N0	Stage IB	T2	6th	primary	0	730.0	7eae98ef-db69-5204-8f8a-5677bbc8ab7f	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4433_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4433_treatment	NA	NA	NA	NA	eded1212-28a3-56a5-a3c8-ccd528e5001c	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	aebd0313-23be-46a8-abc6-b16c531c3a8e	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	aee86a89-0377-4080-b16c-408bfbe78687	Informed Consent	22	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-7980	70	false	United States	-25583	NA	b3e82034-4df5-5532-b3d8-4ad8ee48027b	not hispanic or latino	female	white	TCGA-69-7980_demographic	Alive	25583	M0	N0	Stage I	T1b	7th	primary	0	411.0	c9a8df02-44b3-5c04-aded-98c21cb17fc0	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-69-7980_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7980_treatment2	NA	NA	NA	NA	daffa529-4171-4283-96cf-251fb70ed6a9	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	aee86a89-0377-4080-b16c-408bfbe78687	Informed Consent	22	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-69-7980	70	false	United States	-25583	NA	b3e82034-4df5-5532-b3d8-4ad8ee48027b	not hispanic or latino	female	white	TCGA-69-7980_demographic	Alive	25583	M0	N0	Stage I	T1b	7th	primary	0	411.0	c9a8df02-44b3-5c04-aded-98c21cb17fc0	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-69-7980_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7980_treatment	NA	NA	NA	NA	e7d2c346-9750-5325-a880-a5b200277a3a	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	afb91740-2668-46d7-ba01-bb26153ad1c7	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4658	80	false	United States	-29508	1600	21d19606-f883-5be3-adbb-20b41c95627b	not hispanic or latino	female	white	TCGA-73-4658_demographic	Dead	29508	M0	N0	Stage IB	T2	6th	primary	0	1600.0	6e678430-a27c-5412-b531-49b344cadb05	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-73-4658_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4658_treatment2	NA	NA	NA	NA	842f9a5d-b41c-4b39-ae3b-d7241d9c91a6	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	afb91740-2668-46d7-ba01-bb26153ad1c7	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4658	80	false	United States	-29508	1600	21d19606-f883-5be3-adbb-20b41c95627b	not hispanic or latino	female	white	TCGA-73-4658_demographic	Dead	29508	M0	N0	Stage IB	T2	6th	primary	0	1600.0	6e678430-a27c-5412-b531-49b344cadb05	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-73-4658_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4658_treatment	NA	NA	NA	NA	fb2ca36d-b0c5-58c7-80fb-56e83e5998c2	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	afb91740-2668-46d7-ba01-bb26153ad1c7	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4658	80	false	United States	-29508	1600	21d19606-f883-5be3-adbb-20b41c95627b	not hispanic or latino	female	white	TCGA-73-4658_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	eb26942f-76e0-404a-a90f-dc85be9df300	false	NA	NA	NA	Left	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-73-4658_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4658_treatment3	NA	NA	NA	NA	aa281d36-2663-4576-b8e5-85dd26b9b3f9	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	afb91740-2668-46d7-ba01-bb26153ad1c7	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-73-4658	80	false	United States	-29508	1600	21d19606-f883-5be3-adbb-20b41c95627b	not hispanic or latino	female	white	TCGA-73-4658_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	eb26942f-76e0-404a-a90f-dc85be9df300	false	NA	NA	NA	Left	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-73-4658_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4658_treatment4	NA	NA	NA	NA	dba6b037-79b6-4cf3-bfd9-c981aacdb789	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	afe83af5-af22-49c0-88b4-f1d0dfcbe238	Informed Consent	15	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8097	60	false	United States	-22260	NA	edf3676b-2fb1-53c9-8e42-cbe827f3d408	not hispanic or latino	female	white	TCGA-55-8097_demographic	Alive	22260	MX	N0	Stage IA	T1a	7th	primary	0	476.0	ffd8d6e3-cd0d-5597-846d-1e6b92c0afbd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8097_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8097_treatment	NA	NA	NA	NA	2cfdd9a7-6172-5085-9250-1bb915fb3587	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	afe83af5-af22-49c0-88b4-f1d0dfcbe238	Informed Consent	15	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8097	60	false	United States	-22260	NA	edf3676b-2fb1-53c9-8e42-cbe827f3d408	not hispanic or latino	female	white	TCGA-55-8097_demographic	Alive	22260	MX	N0	Stage IA	T1a	7th	primary	0	476.0	ffd8d6e3-cd0d-5597-846d-1e6b92c0afbd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8097_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8097_treatment2	NA	NA	NA	NA	6031e462-1b98-4bc8-b5e4-605be88e72ca	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24255	M0	N1	Stage IIB	T2	NA	primary	0	467.0	45441cf2-bc3a-58ef-b8bc-fa3694e9b2e9	true	NA	NA	C34.1	Left	8507/3	Invasive micropapillary carcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-4668_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	369	NA	5	NA	1000.0	mg/m2	Intravenous	TCGA-73-4668_treatment2	Gemcitabine	NA	NA	NA	09331341-2858-4a15-981b-da021605f93a	Palliative	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24255	M0	N1	Stage IIB	T2	NA	primary	0	467.0	45441cf2-bc3a-58ef-b8bc-fa3694e9b2e9	true	NA	NA	C34.1	Left	8507/3	Invasive micropapillary carcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-4668_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	369	NA	5	NA	5.0	AUC	Intravenous	TCGA-73-4668_treatment4	Carboplatin	NA	NA	NA	72892272-e740-43ea-82dc-8a42faf3ad51	Palliative	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24255	M0	N1	Stage IIB	T2	NA	primary	0	467.0	45441cf2-bc3a-58ef-b8bc-fa3694e9b2e9	true	NA	NA	C34.1	Left	8507/3	Invasive micropapillary carcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-4668_diagnosis	No	Upper lobe, lung	NA	2009	NA	1.0	299	299	Progressive Disease	NA	1.0	NA	NA	NA	TCGA-73-4668_treatment	NA	Distant Site	4000	cGy	9407d91c-ccac-5bd5-90c9-dbc6e80dc491	NA	yes	NA	Radiation, Stereotactic/Gamma Knife/SRS
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24255	M0	N1	Stage IIB	T2	NA	primary	0	467.0	45441cf2-bc3a-58ef-b8bc-fa3694e9b2e9	true	NA	NA	C34.1	Left	8507/3	Invasive micropapillary carcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-4668_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	110	43	NA	4	NA	500.0	mg/m2	Intravenous	TCGA-73-4668_treatment3	Pemetrexed	NA	4320	mg	a2ffa403-fa6b-406e-8586-c4d4d5ad8d9c	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24255	M0	N1	Stage IIB	T2	NA	primary	0	467.0	45441cf2-bc3a-58ef-b8bc-fa3694e9b2e9	true	NA	NA	C34.1	Left	8507/3	Invasive micropapillary carcinoma	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-73-4668_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	110	43	NA	4	NA	6.0	AUC	Intravenous	TCGA-73-4668_treatment5	Carboplatin	NA	2184	mg	fb047a73-d60f-4007-b5eb-ea82a2dc5956	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24491	NA	NA	NA	NA	NA	not reported	236	NA	6e778f3e-31c2-4876-a1ca-6ebae69f7bcb	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4668_diagnosis2	NA	Not Reported	TCGA-73-4668_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-73-4668_treatment6	NA	NA	NA	NA	22768fe6-2cea-45b7-8cc9-5f7ea49c42f7	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24491	NA	NA	NA	NA	NA	not reported	236	NA	6e778f3e-31c2-4876-a1ca-6ebae69f7bcb	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4668_diagnosis2	NA	Not Reported	TCGA-73-4668_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-73-4668_treatment7	NA	NA	NA	NA	44573a66-a2f0-41ae-9bf0-311a0491e9b5	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24491	NA	NA	NA	NA	NA	not reported	236	NA	6e778f3e-31c2-4876-a1ca-6ebae69f7bcb	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4668_diagnosis2	NA	Not Reported	TCGA-73-4668_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4668_treatment8	NA	Locoregional Site	NA	NA	60563364-d731-4d8e-9aef-f80a67106b92	NA	no	NA	Surgery, NOS
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24491	NA	NA	NA	NA	NA	not reported	236	NA	6e778f3e-31c2-4876-a1ca-6ebae69f7bcb	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4668_diagnosis2	NA	Not Reported	TCGA-73-4668_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4668_treatment9	NA	Distant Site	NA	NA	e5cd356a-b93a-481d-b326-5b62c52ea49f	NA	no	NA	Surgery, NOS
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24537	NA	NA	NA	NA	NA	not reported	282	NA	986aaacd-e701-4548-92da-1ca58a523933	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4668_diagnosis3	NA	Not Reported	TCGA-73-4668_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4668_treatment13	NA	Distant Site	NA	NA	0058eb87-eba1-48a3-86a6-f54ec0ab19ed	NA	no	NA	Surgery, NOS
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24537	NA	NA	NA	NA	NA	not reported	282	NA	986aaacd-e701-4548-92da-1ca58a523933	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4668_diagnosis3	NA	Not Reported	TCGA-73-4668_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-73-4668_treatment10	NA	NA	NA	NA	1caa10a3-6b0f-4dfb-a745-5bad3eca2ae2	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24537	NA	NA	NA	NA	NA	not reported	282	NA	986aaacd-e701-4548-92da-1ca58a523933	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4668_diagnosis3	NA	Not Reported	TCGA-73-4668_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-73-4668_treatment11	NA	NA	NA	NA	57cd880c-6962-472c-84c3-be2c3dad13fb	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	b2285924-9813-4f46-bb8f-91a0efd8a9b6	Informed Consent	-29	Ductal and Lobular Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-73-4668	66	false	United States	-24255	NA	d4f125be-32d0-5ef4-a88f-b6e526d7717b	not hispanic or latino	female	american indian or alaska native	TCGA-73-4668_demographic	Alive	24537	NA	NA	NA	NA	NA	not reported	282	NA	986aaacd-e701-4548-92da-1ca58a523933	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4668_diagnosis3	NA	Not Reported	TCGA-73-4668_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4668_treatment12	NA	Locoregional Site	NA	NA	b4c71f71-146f-4389-b1ad-b6ba804c10ff	NA	no	NA	Surgery, NOS
TCGA-LUAD	b256e065-c681-4f82-8b68-a8ef7c413791	Informed Consent	60	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8207	73	false	United States	-26897	NA	cce22ab5-ea77-5b92-b9b1-338f17426768	not hispanic or latino	male	white	TCGA-55-8207_demographic	Alive	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	4f511f2e-1838-4be2-85b4-6963260666f8	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8207_diagnosis2	NA	Colon, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8207_treatment4	NA	NA	NA	NA	467ea763-bb1a-42de-93e2-e9874c0e8b14	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	b256e065-c681-4f82-8b68-a8ef7c413791	Informed Consent	60	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8207	73	false	United States	-26897	NA	cce22ab5-ea77-5b92-b9b1-338f17426768	not hispanic or latino	male	white	TCGA-55-8207_demographic	Alive	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	4f511f2e-1838-4be2-85b4-6963260666f8	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8207_diagnosis2	NA	Colon, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8207_treatment3	NA	NA	NA	NA	a23980fe-d46c-4f40-beac-e25a9aed13f1	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b256e065-c681-4f82-8b68-a8ef7c413791	Informed Consent	60	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8207	73	false	United States	-26897	NA	cce22ab5-ea77-5b92-b9b1-338f17426768	not hispanic or latino	male	white	TCGA-55-8207_demographic	Alive	26897	MX	N0	Stage IB	T2a	7th	primary	0	977.0	d9e8c54a-f954-5e23-801b-b855af373290	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-55-8207_diagnosis	Yes	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8207_treatment	NA	NA	NA	NA	cb8846ea-b8e4-5eb4-90d8-fb28021dc91e	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b256e065-c681-4f82-8b68-a8ef7c413791	Informed Consent	60	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8207	73	false	United States	-26897	NA	cce22ab5-ea77-5b92-b9b1-338f17426768	not hispanic or latino	male	white	TCGA-55-8207_demographic	Alive	26897	MX	N0	Stage IB	T2a	7th	primary	0	977.0	d9e8c54a-f954-5e23-801b-b855af373290	true	NA	NA	C34.3	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-55-8207_diagnosis	Yes	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8207_treatment2	NA	NA	NA	NA	de409b1d-a595-4f2a-ab69-4956add8f272	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	b266cbf5-80de-4473-b16f-08c502d365ca	Informed Consent	-6	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-7941	72	false	United States	-26298	NA	c6e7b870-61cd-5a6b-acfd-26007fc39813	not hispanic or latino	female	white	TCGA-97-7941_demographic	Alive	26298	MX	N0	Stage IA	T1b	7th	primary	0	484.0	61f4318d-3f77-59fd-9629-016a899026c0	true	NA	NA	C34.1	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-7941_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7941_treatment	NA	NA	NA	NA	0db0e2d8-8f90-5d6f-ba94-b9ac2a61f722	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b266cbf5-80de-4473-b16f-08c502d365ca	Informed Consent	-6	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-7941	72	false	United States	-26298	NA	c6e7b870-61cd-5a6b-acfd-26007fc39813	not hispanic or latino	female	white	TCGA-97-7941_demographic	Alive	26298	MX	N0	Stage IA	T1b	7th	primary	0	484.0	61f4318d-3f77-59fd-9629-016a899026c0	true	NA	NA	C34.1	Left	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-97-7941_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7941_treatment2	NA	NA	NA	NA	2d992fc5-f2ad-43ad-8672-e493afa74182	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	b2bc53d6-ef78-4ae9-a6b5-1c7cad9a43eb	Informed Consent	197	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7910	50	false	United States	-18289	NA	8a99b94d-ae94-5aaa-890b-fa394cd0b028	not hispanic or latino	female	black or african american	TCGA-55-7910_demographic	Alive	18289	M0	N0	Stage IIA	T2b	7th	primary	0	1040.0	529d8e32-bb4e-5146-b61d-8f9b118e1fea	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-7910_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	1040	NA	NA	NA	NA	NA	NA	TCGA-55-7910_treatment	NA	Unknown	NA	NA	57ff687c-c2d6-507c-9436-4b1a529f704d	NA	yes	Treatment Ongoing	Radiation, External Beam
TCGA-LUAD	b2bc53d6-ef78-4ae9-a6b5-1c7cad9a43eb	Informed Consent	197	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7910	50	false	United States	-18289	NA	8a99b94d-ae94-5aaa-890b-fa394cd0b028	not hispanic or latino	female	black or african american	TCGA-55-7910_demographic	Alive	18289	M0	N0	Stage IIA	T2b	7th	primary	0	1040.0	529d8e32-bb4e-5146-b61d-8f9b118e1fea	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-7910_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	NA	253	NA	NA	NA	NA	NA	NA	TCGA-55-7910_treatment2	Cisplatin	NA	NA	NA	e8da969d-925d-41b9-8891-881fe6df73e1	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	b2bc53d6-ef78-4ae9-a6b5-1c7cad9a43eb	Informed Consent	197	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7910	50	false	United States	-18289	NA	8a99b94d-ae94-5aaa-890b-fa394cd0b028	not hispanic or latino	female	black or african american	TCGA-55-7910_demographic	Alive	19307	NA	NA	NA	NA	NA	not reported	1018	NA	cb5293d6-a55e-43eb-ac74-3858bf919aba	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-7910_diagnosis2	NA	Not Reported	TCGA-55-7910_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-55-7910_treatment3	NA	NA	NA	NA	0a9c4a35-a1e7-483d-867a-c26805cf1b37	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b2bc53d6-ef78-4ae9-a6b5-1c7cad9a43eb	Informed Consent	197	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7910	50	false	United States	-18289	NA	8a99b94d-ae94-5aaa-890b-fa394cd0b028	not hispanic or latino	female	black or african american	TCGA-55-7910_demographic	Alive	19307	NA	NA	NA	NA	NA	not reported	1018	NA	cb5293d6-a55e-43eb-ac74-3858bf919aba	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-7910_diagnosis2	NA	Not Reported	TCGA-55-7910_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7910_treatment6	NA	Distant Site	NA	NA	183b2ead-9979-4688-8c03-3018ce08ceca	NA	unknown	NA	Surgery, NOS
TCGA-LUAD	b2bc53d6-ef78-4ae9-a6b5-1c7cad9a43eb	Informed Consent	197	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7910	50	false	United States	-18289	NA	8a99b94d-ae94-5aaa-890b-fa394cd0b028	not hispanic or latino	female	black or african american	TCGA-55-7910_demographic	Alive	19307	NA	NA	NA	NA	NA	not reported	1018	NA	cb5293d6-a55e-43eb-ac74-3858bf919aba	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-7910_diagnosis2	NA	Not Reported	TCGA-55-7910_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-55-7910_treatment4	NA	NA	NA	NA	35a29683-5191-4258-a4cc-63d448682e14	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	b2bc53d6-ef78-4ae9-a6b5-1c7cad9a43eb	Informed Consent	197	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7910	50	false	United States	-18289	NA	8a99b94d-ae94-5aaa-890b-fa394cd0b028	not hispanic or latino	female	black or african american	TCGA-55-7910_demographic	Alive	19307	NA	NA	NA	NA	NA	not reported	1018	NA	cb5293d6-a55e-43eb-ac74-3858bf919aba	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-7910_diagnosis2	NA	Not Reported	TCGA-55-7910_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7910_treatment5	NA	Locoregional Site	NA	NA	b689671c-5634-49bf-b135-6aaff209bee2	NA	unknown	NA	Surgery, NOS
TCGA-LUAD	b2c6939b-d8ec-4a07-8ea6-06c4553ee446	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	b36b7567-30d3-4d0c-84c4-b203986e0fdb	Informed Consent	44	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8301	58	false	United States	-21535	NA	076e36b0-4792-5937-84b4-49064cec809d	not hispanic or latino	male	white	TCGA-55-8301_demographic	Alive	21773	NA	NA	NA	NA	NA	recurrence	238	NA	4bc4aa2b-fc4d-43bb-a2d9-d27b82aab102	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8301_diagnosis2	NA	Not Reported	TCGA-55-8301_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-8301_treatment4	NA	NA	NA	NA	0ff30d9a-fa3e-4d2d-bc5b-ac3b5f1708e7	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b36b7567-30d3-4d0c-84c4-b203986e0fdb	Informed Consent	44	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8301	58	false	United States	-21535	NA	076e36b0-4792-5937-84b4-49064cec809d	not hispanic or latino	male	white	TCGA-55-8301_demographic	Alive	21773	NA	NA	NA	NA	NA	recurrence	238	NA	4bc4aa2b-fc4d-43bb-a2d9-d27b82aab102	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8301_diagnosis2	NA	Not Reported	TCGA-55-8301_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8301_treatment7	NA	Distant Site	NA	NA	492452e7-3586-4e1f-8f80-4acc54b9916e	NA	no	NA	Surgery, NOS
TCGA-LUAD	b36b7567-30d3-4d0c-84c4-b203986e0fdb	Informed Consent	44	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8301	58	false	United States	-21535	NA	076e36b0-4792-5937-84b4-49064cec809d	not hispanic or latino	male	white	TCGA-55-8301_demographic	Alive	21773	NA	NA	NA	NA	NA	recurrence	238	NA	4bc4aa2b-fc4d-43bb-a2d9-d27b82aab102	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8301_diagnosis2	NA	Not Reported	TCGA-55-8301_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8301_treatment6	NA	Locoregional Site	NA	NA	72c0cab4-ac8e-401c-8519-f5dfc8ad78b9	NA	no	NA	Surgery, NOS
TCGA-LUAD	b36b7567-30d3-4d0c-84c4-b203986e0fdb	Informed Consent	44	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8301	58	false	United States	-21535	NA	076e36b0-4792-5937-84b4-49064cec809d	not hispanic or latino	male	white	TCGA-55-8301_demographic	Alive	21773	NA	NA	NA	NA	NA	recurrence	238	NA	4bc4aa2b-fc4d-43bb-a2d9-d27b82aab102	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-8301_diagnosis2	NA	Not Reported	TCGA-55-8301_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-8301_treatment5	NA	NA	NA	NA	ab489e74-1083-4cd3-b07f-858a4422139d	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	b36b7567-30d3-4d0c-84c4-b203986e0fdb	Informed Consent	44	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8301	58	false	United States	-21535	NA	076e36b0-4792-5937-84b4-49064cec809d	not hispanic or latino	male	white	TCGA-55-8301_demographic	Alive	21535	MX	N0	Stage IB	T2a	7th	primary	0	534.0	d6366e9f-8251-5f23-a60d-041f332e6e67	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8301_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	NA	261	NA	NA	NA	NA	NA	NA	TCGA-55-8301_treatment3	Paclitaxel	NA	NA	NA	1399c1d3-cfc6-4068-8874-594956f66028	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	b36b7567-30d3-4d0c-84c4-b203986e0fdb	Informed Consent	44	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8301	58	false	United States	-21535	NA	076e36b0-4792-5937-84b4-49064cec809d	not hispanic or latino	male	white	TCGA-55-8301_demographic	Alive	21535	MX	N0	Stage IB	T2a	7th	primary	0	534.0	d6366e9f-8251-5f23-a60d-041f332e6e67	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8301_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	NA	261	NA	NA	NA	NA	NA	NA	TCGA-55-8301_treatment2	Carboplatin	NA	NA	NA	407af7b1-b5a4-4b66-9b0a-70d320098f07	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	b36b7567-30d3-4d0c-84c4-b203986e0fdb	Informed Consent	44	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8301	58	false	United States	-21535	NA	076e36b0-4792-5937-84b4-49064cec809d	not hispanic or latino	male	white	TCGA-55-8301_demographic	Alive	21535	MX	N0	Stage IB	T2a	7th	primary	0	534.0	d6366e9f-8251-5f23-a60d-041f332e6e67	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8301_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	309	257	NA	NA	30.0	NA	NA	NA	TCGA-55-8301_treatment	NA	Regional Site	6660	cGy	dbc4a15f-d1ce-5f60-b7b9-03c4cb0b0c15	NA	yes	Partial Response	Radiation, External Beam
TCGA-LUAD	b3c31fdc-26a7-4b39-8127-8006307eb1f5	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z040	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	b40d0849-f4ef-4a14-9732-9beb708cb46b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7166	84	false	Australia	-30869	258	df28f80e-e489-54f4-ac2b-7a7852a05284	not reported	male	white	TCGA-78-7166_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	981f2483-9e01-4d6f-88db-38eb06261c59	false	NA	NA	NA	Right	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-78-7166_diagnosis2	NA	External ear	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7166_treatment3	NA	NA	NA	NA	e3028099-7a9f-4cf5-a20c-b2f9530d6b41	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b40d0849-f4ef-4a14-9732-9beb708cb46b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7166	84	false	Australia	-30869	258	df28f80e-e489-54f4-ac2b-7a7852a05284	not reported	male	white	TCGA-78-7166_demographic	Dead	30869	M0	N1	Stage IIB	T2	6th	primary	0	258.0	bb420358-3559-58a3-b6cd-5ef7a337fc8c	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-78-7166_diagnosis	No	Lower lobe, lung	NA	2002	NA	1.0	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7166_treatment	NA	Regional Site	NA	NA	2439f823-2687-5fe4-9837-e58d5ad373dd	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	b40d0849-f4ef-4a14-9732-9beb708cb46b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7166	84	false	Australia	-30869	258	df28f80e-e489-54f4-ac2b-7a7852a05284	not reported	male	white	TCGA-78-7166_demographic	Dead	30869	M0	N1	Stage IIB	T2	6th	primary	0	258.0	bb420358-3559-58a3-b6cd-5ef7a337fc8c	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	Central Lung	TCGA-78-7166_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7166_treatment2	NA	NA	NA	NA	92b66ea8-0ca4-4d77-8706-786e860c503b	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b40d0849-f4ef-4a14-9732-9beb708cb46b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7166	84	false	Australia	-30869	258	df28f80e-e489-54f4-ac2b-7a7852a05284	not reported	male	white	TCGA-78-7166_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	bc4bc5d7-6d63-40b9-bb72-56bbb6c5d3a5	false	NA	NA	NA	Bilateral	8090/3	Basal cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-78-7166_diagnosis3	NA	Head, face or neck, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7166_treatment4	NA	NA	NA	NA	1136f09b-7e69-4206-ad40-548968f2631d	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b56dad1e-2fd5-47d8-9cc7-a54be9a1bae2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7152	65	false	Australia	-23782	1215	b5bc4e26-ddbb-5903-9be0-61d9cb0804cd	not reported	male	white	TCGA-78-7152_demographic	Dead	24984	NA	NA	NA	NA	NA	metastasis	1202	NA	060c4018-f2bc-4156-a214-26f5c614f8a1	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-78-7152_diagnosis3	NA	Not Reported	TCGA-78-7152_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-78-7152_treatment6	NA	NA	NA	NA	88468c01-837c-4781-9d1c-12cda90697f5	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b56dad1e-2fd5-47d8-9cc7-a54be9a1bae2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7152	65	false	Australia	-23782	1215	b5bc4e26-ddbb-5903-9be0-61d9cb0804cd	not reported	male	white	TCGA-78-7152_demographic	Dead	24984	NA	NA	NA	NA	NA	metastasis	1202	NA	060c4018-f2bc-4156-a214-26f5c614f8a1	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-78-7152_diagnosis3	NA	Not Reported	TCGA-78-7152_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-78-7152_treatment7	NA	NA	NA	NA	a07e8461-32be-4458-ae81-3ef1456ee5c3	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	b56dad1e-2fd5-47d8-9cc7-a54be9a1bae2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7152	65	false	Australia	-23782	1215	b5bc4e26-ddbb-5903-9be0-61d9cb0804cd	not reported	male	white	TCGA-78-7152_demographic	Dead	24984	NA	NA	NA	NA	NA	metastasis	1202	NA	060c4018-f2bc-4156-a214-26f5c614f8a1	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-78-7152_diagnosis3	NA	Not Reported	TCGA-78-7152_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7152_treatment8	NA	Distant Site	NA	NA	e1025aad-215a-498a-a4c0-dd44f525132e	NA	no	NA	Surgery, NOS
TCGA-LUAD	b56dad1e-2fd5-47d8-9cc7-a54be9a1bae2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7152	65	false	Australia	-23782	1215	b5bc4e26-ddbb-5903-9be0-61d9cb0804cd	not reported	male	white	TCGA-78-7152_demographic	Dead	23782	M0	N0	Stage IB	T2	6th	primary	0	1215.0	09c59a9b-6a67-5ed4-a04d-ae22311df0ca	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7152_diagnosis	No	Upper lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7152_treatment2	NA	NA	NA	NA	25b5b96d-6ebb-4a48-9d43-169a607041e1	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b56dad1e-2fd5-47d8-9cc7-a54be9a1bae2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7152	65	false	Australia	-23782	1215	b5bc4e26-ddbb-5903-9be0-61d9cb0804cd	not reported	male	white	TCGA-78-7152_demographic	Dead	23782	M0	N0	Stage IB	T2	6th	primary	0	1215.0	09c59a9b-6a67-5ed4-a04d-ae22311df0ca	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7152_diagnosis	No	Upper lobe, lung	NA	2003	NA	1.0	NA	1154	NA	NA	NA	NA	NA	NA	TCGA-78-7152_treatment	NA	Distant Site	NA	NA	6c1fc184-cd22-5e8b-af5f-e0a960de804b	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	b56dad1e-2fd5-47d8-9cc7-a54be9a1bae2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7152	65	false	Australia	-23782	1215	b5bc4e26-ddbb-5903-9be0-61d9cb0804cd	not reported	male	white	TCGA-78-7152_demographic	Dead	24984	NA	NA	NA	NA	NA	not reported	1202	NA	a31331eb-e8a2-4b5d-8fb2-25d1a9a12053	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7152_diagnosis2	NA	Not Reported	TCGA-78-7152_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7152_treatment4	NA	Locoregional Site	NA	NA	3e77bef1-04e6-485d-8c1b-e143fb64386b	NA	no	NA	Surgery, NOS
TCGA-LUAD	b56dad1e-2fd5-47d8-9cc7-a54be9a1bae2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7152	65	false	Australia	-23782	1215	b5bc4e26-ddbb-5903-9be0-61d9cb0804cd	not reported	male	white	TCGA-78-7152_demographic	Dead	24984	NA	NA	NA	NA	NA	not reported	1202	NA	a31331eb-e8a2-4b5d-8fb2-25d1a9a12053	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7152_diagnosis2	NA	Not Reported	TCGA-78-7152_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7152_treatment5	NA	Distant Site	NA	NA	5a39f2b2-7ce0-4991-87b9-8b14e81b3c1a	NA	no	NA	Surgery, NOS
TCGA-LUAD	b56dad1e-2fd5-47d8-9cc7-a54be9a1bae2	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7152	65	false	Australia	-23782	1215	b5bc4e26-ddbb-5903-9be0-61d9cb0804cd	not reported	male	white	TCGA-78-7152_demographic	Dead	24984	NA	NA	NA	NA	NA	not reported	1202	NA	a31331eb-e8a2-4b5d-8fb2-25d1a9a12053	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7152_diagnosis2	NA	Not Reported	TCGA-78-7152_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7152_treatment3	NA	NA	NA	NA	8ac046dc-8e88-45c8-8fd6-705c47c7f920	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	b5cdf68a-9903-4f82-9017-ab88d2b73d4f	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z018	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	b61abdfd-b7a0-4e1a-b570-d1eaecad3a9e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4506	68	false	United States	-25132	999	316a7066-abc8-5cc2-8948-a0e1f6d93859	not hispanic or latino	female	white	TCGA-49-4506_demographic	Dead	25132	M0	N1	Stage IIB	T2	4th	primary	0	999.0	1c996f83-32e5-54a7-8779-7130ccf1e531	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-49-4506_diagnosis	No	Upper lobe, lung	NA	1997	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4506_treatment2	NA	NA	NA	NA	6d4d7eeb-25fc-4b54-9301-ed42418df0ea	Adjuvant	yes	Complete Response	Radiation Therapy, NOS
TCGA-LUAD	b61abdfd-b7a0-4e1a-b570-d1eaecad3a9e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4506	68	false	United States	-25132	999	316a7066-abc8-5cc2-8948-a0e1f6d93859	not hispanic or latino	female	white	TCGA-49-4506_demographic	Dead	25132	M0	N1	Stage IIB	T2	4th	primary	0	999.0	1c996f83-32e5-54a7-8779-7130ccf1e531	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	Peripheral Lung	TCGA-49-4506_diagnosis	No	Upper lobe, lung	NA	1997	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4506_treatment	NA	NA	NA	NA	b68bd919-605e-58c8-8dec-d73ecb2fcb8a	Adjuvant	yes	Complete Response	Pharmaceutical Therapy, NOS
TCGA-LUAD	b61abdfd-b7a0-4e1a-b570-d1eaecad3a9e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4506	68	false	United States	-25132	999	316a7066-abc8-5cc2-8948-a0e1f6d93859	not hispanic or latino	female	white	TCGA-49-4506_demographic	Dead	25824	NA	NA	NA	NA	NA	recurrence	692	NA	e0a3414b-bcf4-4e08-8389-74aebce77821	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4506_diagnosis2	NA	Not Reported	TCGA-49-4506_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-4506_treatment4	NA	NA	NA	NA	4cd6dbde-e466-4e39-9f4c-0dbf273965ac	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	b61abdfd-b7a0-4e1a-b570-d1eaecad3a9e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4506	68	false	United States	-25132	999	316a7066-abc8-5cc2-8948-a0e1f6d93859	not hispanic or latino	female	white	TCGA-49-4506_demographic	Dead	25824	NA	NA	NA	NA	NA	recurrence	692	NA	e0a3414b-bcf4-4e08-8389-74aebce77821	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4506_diagnosis2	NA	Not Reported	TCGA-49-4506_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-4506_treatment3	NA	NA	NA	NA	614530c0-4764-4fec-906a-f5a21a7f8777	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b61abdfd-b7a0-4e1a-b570-d1eaecad3a9e	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4506	68	false	United States	-25132	999	316a7066-abc8-5cc2-8948-a0e1f6d93859	not hispanic or latino	female	white	TCGA-49-4506_demographic	Dead	25824	NA	NA	NA	NA	NA	recurrence	692	NA	e0a3414b-bcf4-4e08-8389-74aebce77821	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4506_diagnosis2	NA	Not Reported	TCGA-49-4506_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4506_treatment5	NA	Locoregional Site	NA	NA	8e54aece-9a44-4746-aa42-80c4c6ef90c6	NA	no	NA	Surgery, NOS
TCGA-LUAD	b8475929-2d9d-4909-bd62-59684a140bd7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4390	58	false	Germany	-21430	NA	40b1cd07-8d93-542f-ac05-447a08812dfb	not reported	female	not reported	TCGA-05-4390_demographic	Alive	21430	M0	N0	Stage IB	T2	5th	primary	0	1126.0	66b76eb8-c791-57aa-b3b4-2bc70c5eb323	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4390_diagnosis	No	Upper lobe, lung	NA	2005	No	NA	92	61	NA	NA	NA	NA	NA	NA	TCGA-05-4390_treatment	Cisplatin	NA	NA	NA	0e0dcb24-732c-59c5-a958-f2789737abc4	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	b8475929-2d9d-4909-bd62-59684a140bd7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4390	58	false	Germany	-21430	NA	40b1cd07-8d93-542f-ac05-447a08812dfb	not reported	female	not reported	TCGA-05-4390_demographic	Alive	21430	M0	N0	Stage IB	T2	5th	primary	0	1126.0	66b76eb8-c791-57aa-b3b4-2bc70c5eb323	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4390_diagnosis	No	Upper lobe, lung	NA	2005	No	NA	92	61	NA	NA	NA	NA	NA	NA	TCGA-05-4390_treatment2	Vinorelbine	NA	NA	NA	7c6f793f-1775-43aa-8d17-8705564a136e	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	b8475929-2d9d-4909-bd62-59684a140bd7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4390	58	false	Germany	-21430	NA	40b1cd07-8d93-542f-ac05-447a08812dfb	not reported	female	not reported	TCGA-05-4390_demographic	Alive	21430	M0	N0	Stage IB	T2	5th	primary	0	1126.0	66b76eb8-c791-57aa-b3b4-2bc70c5eb323	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4390_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4390_treatment3	NA	NA	NA	NA	ffe6d8e6-41d9-49ae-83f8-c28a2e6cc387	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	b8475929-2d9d-4909-bd62-59684a140bd7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4390	58	false	Germany	-21430	NA	40b1cd07-8d93-542f-ac05-447a08812dfb	not reported	female	not reported	TCGA-05-4390_demographic	Alive	21825	NA	NA	NA	NA	NA	not reported	395	NA	81bc433f-28eb-46c9-95ab-e537b51d32a0	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-4390_diagnosis2	NA	Not Reported	TCGA-05-4390_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-4390_treatment5	NA	NA	NA	NA	c51b7527-3f7d-4cae-9fef-77833153744a	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	b8475929-2d9d-4909-bd62-59684a140bd7	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4390	58	false	Germany	-21430	NA	40b1cd07-8d93-542f-ac05-447a08812dfb	not reported	female	not reported	TCGA-05-4390_demographic	Alive	21825	NA	NA	NA	NA	NA	not reported	395	NA	81bc433f-28eb-46c9-95ab-e537b51d32a0	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-4390_diagnosis2	NA	Not Reported	TCGA-05-4390_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-4390_treatment4	NA	NA	NA	NA	f0364bbf-05a4-42e8-9365-a570acd9c387	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b86b1616-20a2-4300-8daa-03dcc9938215	Informed Consent	131	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7659	70	false	United States	-25730	NA	d50bf0b3-c820-500e-8218-b307f2ba1d86	not hispanic or latino	male	white	TCGA-44-7659_demographic	Alive	25730	MX	N0	Stage IA	T1b	7th	primary	0	691.0	e3ca48ad-6dd1-5e75-a16b-fc6b7a21e357	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7659_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7659_treatment2	NA	NA	NA	NA	9e30fc07-23e8-45c9-8488-ce2bbfbea37b	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	b86b1616-20a2-4300-8daa-03dcc9938215	Informed Consent	131	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7659	70	false	United States	-25730	NA	d50bf0b3-c820-500e-8218-b307f2ba1d86	not hispanic or latino	male	white	TCGA-44-7659_demographic	Alive	25730	MX	N0	Stage IA	T1b	7th	primary	0	691.0	e3ca48ad-6dd1-5e75-a16b-fc6b7a21e357	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-7659_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7659_treatment	NA	NA	NA	NA	f92d90ce-f7f6-5f54-bf51-c5ee6863c568	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b87a5d92-4c09-48fe-bb08-b3c89a7c892e	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4514	79	false	United States	-28908	NA	d1b0d9dd-84fd-518a-9f58-5ef6d87f1be2	not reported	female	white	TCGA-49-4514_demographic	Alive	28908	M0	N0	Stage IA	T1	6th	primary	0	1700.0	df42ea3b-8252-5d4f-af13-0f7559df99bf	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4514_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4514_treatment2	NA	NA	NA	NA	04f08888-fb94-4940-aef1-059f10e4f8c9	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	b87a5d92-4c09-48fe-bb08-b3c89a7c892e	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4514	79	false	United States	-28908	NA	d1b0d9dd-84fd-518a-9f58-5ef6d87f1be2	not reported	female	white	TCGA-49-4514_demographic	Alive	28908	M0	N0	Stage IA	T1	6th	primary	0	1700.0	df42ea3b-8252-5d4f-af13-0f7559df99bf	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4514_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4514_treatment	NA	NA	NA	NA	0d2601b6-d104-5d19-b02f-838a4dbc78be	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b89de053-d253-447f-952e-9a2edcf6bca5	Informed Consent	48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A490	78	false	United States	-28728	99	b39f73e0-fafd-55d3-bdac-64f66ccfa90d	not hispanic or latino	male	white	TCGA-55-A490_demographic	Dead	28728	MX	N0	Stage IIA	T2b	7th	primary	0	99.0	353c4378-17ec-5040-8a72-f0ba4fc2251e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-A490_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	89	89	NA	NA	NA	NA	NA	NA	TCGA-55-A490_treatment	Carboplatin	NA	NA	NA	5e7dd790-4bf3-5285-94a3-28b1369a1fe8	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	b89de053-d253-447f-952e-9a2edcf6bca5	Informed Consent	48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A490	78	false	United States	-28728	99	b39f73e0-fafd-55d3-bdac-64f66ccfa90d	not hispanic or latino	male	white	TCGA-55-A490_demographic	Dead	28728	MX	N0	Stage IIA	T2b	7th	primary	0	99.0	353c4378-17ec-5040-8a72-f0ba4fc2251e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-A490_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A490_treatment3	NA	NA	NA	NA	a321150f-9d7b-4911-b035-8ab4cf715de1	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	b89de053-d253-447f-952e-9a2edcf6bca5	Informed Consent	48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-A490	78	false	United States	-28728	99	b39f73e0-fafd-55d3-bdac-64f66ccfa90d	not hispanic or latino	male	white	TCGA-55-A490_demographic	Dead	28728	MX	N0	Stage IIA	T2b	7th	primary	0	99.0	353c4378-17ec-5040-8a72-f0ba4fc2251e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-A490_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	89	89	NA	NA	NA	NA	NA	NA	TCGA-55-A490_treatment2	Pemetrexed Disodium	NA	NA	NA	fadab3eb-84ec-42f5-8755-b7409358b8ed	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	b8b5ed35-b299-4c1e-9226-5ca055dc7a43	Informed Consent	-5	Acinar Cell Neoplasms	Diagnosis	Yes	Bronchus and lung	TCGA-NJ-A55A	76	false	United States	-28022	NA	913c5d19-34a6-5cb8-bc36-6bad07f17dce	not hispanic or latino	female	white	TCGA-NJ-A55A_demographic	Alive	28022	M0	N0	Stage IB	T2	6th	primary	0	15.0	2e76ac6f-52b7-5da2-b564-180446cfe90c	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-NJ-A55A_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A55A_treatment	NA	NA	NA	NA	0936c9d5-b96e-50ec-8c92-4cf68592d8a8	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	b8b5ed35-b299-4c1e-9226-5ca055dc7a43	Informed Consent	-5	Acinar Cell Neoplasms	Diagnosis	Yes	Bronchus and lung	TCGA-NJ-A55A	76	false	United States	-28022	NA	913c5d19-34a6-5cb8-bc36-6bad07f17dce	not hispanic or latino	female	white	TCGA-NJ-A55A_demographic	Alive	28022	M0	N0	Stage IB	T2	6th	primary	0	15.0	2e76ac6f-52b7-5da2-b564-180446cfe90c	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	NA	Lung, NOS	NA	TCGA-NJ-A55A_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-NJ-A55A_treatment2	NA	NA	NA	NA	a70e3c77-07be-4b35-ba96-e95cb70f41f3	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ba49117e-dab6-4e7d-bc44-f11dcafa1318	Informed Consent	34	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-55-7727	70	false	United States	-25929	NA	0ae20e22-9a87-59dd-9292-5e3e877f7e5c	not hispanic or latino	male	white	TCGA-55-7727_demographic	Alive	25929	MX	N2	Stage IIIA	T1a	7th	primary	0	119.0	3a536d91-2298-5bd4-ae01-0691e839e782	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7727_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7727_treatment2	NA	NA	NA	NA	65833044-52a5-47c5-918d-0fafd4362bb1	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ba49117e-dab6-4e7d-bc44-f11dcafa1318	Informed Consent	34	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-55-7727	70	false	United States	-25929	NA	0ae20e22-9a87-59dd-9292-5e3e877f7e5c	not hispanic or latino	male	white	TCGA-55-7727_demographic	Alive	25929	MX	N2	Stage IIIA	T1a	7th	primary	0	119.0	3a536d91-2298-5bd4-ae01-0691e839e782	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7727_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7727_treatment	NA	NA	NA	NA	bddecec6-1d96-5dd5-9ea6-8823edd0ac4d	Adjuvant	yes	Complete Response	Pharmaceutical Therapy, NOS
TCGA-LUAD	bab335f9-b241-41a7-b107-79b9676b37b8	Informed Consent	15	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8508	60	false	United States	-22159	NA	c15fcef9-c8fd-512e-bb13-2995f1d4d7f2	not hispanic or latino	female	black or african american	TCGA-55-8508_demographic	Alive	22159	MX	N1	Stage IIA	T2a	7th	primary	0	617.0	01d3a6b0-a59d-5e74-ac52-04bd2fd747fe	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-55-8508_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8508_treatment3	NA	NA	NA	NA	0f9052a5-575f-4225-bc10-a5872793242d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bab335f9-b241-41a7-b107-79b9676b37b8	Informed Consent	15	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8508	60	false	United States	-22159	NA	c15fcef9-c8fd-512e-bb13-2995f1d4d7f2	not hispanic or latino	female	black or african american	TCGA-55-8508_demographic	Alive	22159	MX	N1	Stage IIA	T2a	7th	primary	0	617.0	01d3a6b0-a59d-5e74-ac52-04bd2fd747fe	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-55-8508_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	120	57	NA	NA	NA	NA	NA	NA	TCGA-55-8508_treatment2	Pemetrexed	NA	NA	NA	3ae94caf-abf3-41ba-b0a7-e12935b9e734	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	bab335f9-b241-41a7-b107-79b9676b37b8	Informed Consent	15	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-8508	60	false	United States	-22159	NA	c15fcef9-c8fd-512e-bb13-2995f1d4d7f2	not hispanic or latino	female	black or african american	TCGA-55-8508_demographic	Alive	22159	MX	N1	Stage IIA	T2a	7th	primary	0	617.0	01d3a6b0-a59d-5e74-ac52-04bd2fd747fe	true	NA	NA	C34.1	Right	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-55-8508_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	120	57	NA	NA	NA	NA	NA	NA	TCGA-55-8508_treatment	Cisplatin	NA	NA	NA	56fcdbf2-7280-5b68-a26f-8f909a272675	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	bab43415-d413-40be-a4c0-2c40a52afe6a	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-2668	51	false	United States	-18856	761	8c08c48a-dee8-5400-9e26-9c968a47702f	not hispanic or latino	male	white	TCGA-44-2668_demographic	Dead	18856	M0	N0	Stage IB	T2	6th	primary	0	761.0	62552a9f-3f39-5833-b1c6-6466e93a530e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2668_diagnosis	No	Upper lobe, lung	NA	2009	NA	2.0	587	587	NA	NA	1.0	NA	NA	NA	TCGA-44-2668_treatment2	NA	Distant Site	1800	cGy	3928832f-4244-4843-9df9-d90b4c8d0737	Palliative	yes	NA	Radiation, Cyberknife
TCGA-LUAD	bab43415-d413-40be-a4c0-2c40a52afe6a	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-2668	51	false	United States	-18856	761	8c08c48a-dee8-5400-9e26-9c968a47702f	not hispanic or latino	male	white	TCGA-44-2668_demographic	Dead	18856	M0	N0	Stage IB	T2	6th	primary	0	761.0	62552a9f-3f39-5833-b1c6-6466e93a530e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2668_diagnosis	No	Upper lobe, lung	NA	2009	NA	1.0	488	468	NA	NA	14.0	NA	NA	NA	TCGA-44-2668_treatment3	NA	Distant Site	3500	cGy	74a24b06-a647-4055-8623-52b481ac71fd	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	bab43415-d413-40be-a4c0-2c40a52afe6a	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-2668	51	false	United States	-18856	761	8c08c48a-dee8-5400-9e26-9c968a47702f	not hispanic or latino	male	white	TCGA-44-2668_demographic	Dead	18856	M0	N0	Stage IB	T2	6th	primary	0	761.0	62552a9f-3f39-5833-b1c6-6466e93a530e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2668_diagnosis	No	Upper lobe, lung	NA	2009	NA	2.0	587	586	NA	NA	2.0	NA	NA	NA	TCGA-44-2668_treatment	NA	Distant Site	1800	cGy	db7c40c8-d870-5c7c-bf9c-478abde6f2f7	Palliative	yes	NA	Radiation, Cyberknife
TCGA-LUAD	bab43415-d413-40be-a4c0-2c40a52afe6a	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-2668	51	false	United States	-18856	761	8c08c48a-dee8-5400-9e26-9c968a47702f	not hispanic or latino	male	white	TCGA-44-2668_demographic	Dead	18856	M0	N0	Stage IB	T2	6th	primary	0	761.0	62552a9f-3f39-5833-b1c6-6466e93a530e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2668_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2668_treatment5	NA	NA	NA	NA	de0ee7bf-a3db-4a19-9e46-3cfca2c00255	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bab43415-d413-40be-a4c0-2c40a52afe6a	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-2668	51	false	United States	-18856	761	8c08c48a-dee8-5400-9e26-9c968a47702f	not hispanic or latino	male	white	TCGA-44-2668_demographic	Dead	18856	M0	N0	Stage IB	T2	6th	primary	0	761.0	62552a9f-3f39-5833-b1c6-6466e93a530e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2668_diagnosis	No	Upper lobe, lung	NA	2009	NA	2.0	589	586	NA	NA	3.0	NA	NA	NA	TCGA-44-2668_treatment4	NA	Distant Site	2100	cGy	e01b48c6-6d64-4af3-a7d8-7affbc76a1d8	Palliative	yes	NA	Radiation, Cyberknife
TCGA-LUAD	bab43415-d413-40be-a4c0-2c40a52afe6a	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-2668	51	false	United States	-18856	761	8c08c48a-dee8-5400-9e26-9c968a47702f	not hispanic or latino	male	white	TCGA-44-2668_demographic	Dead	19289	NA	NA	NA	NA	NA	not reported	433	NA	d9b7ea0a-37ac-4a33-9c36-4ae24f1e3e95	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2668_diagnosis2	NA	Not Reported	TCGA-44-2668_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2668_treatment8	NA	Distant Site	NA	NA	19ecc45b-2825-4756-88ae-a746ec7efddb	NA	no	NA	Surgery, NOS
TCGA-LUAD	bab43415-d413-40be-a4c0-2c40a52afe6a	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-2668	51	false	United States	-18856	761	8c08c48a-dee8-5400-9e26-9c968a47702f	not hispanic or latino	male	white	TCGA-44-2668_demographic	Dead	19289	NA	NA	NA	NA	NA	not reported	433	NA	d9b7ea0a-37ac-4a33-9c36-4ae24f1e3e95	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2668_diagnosis2	NA	Not Reported	TCGA-44-2668_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-2668_treatment6	NA	NA	NA	NA	844451e4-ea26-43b4-b1b3-132dc5732451	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	bab43415-d413-40be-a4c0-2c40a52afe6a	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-2668	51	false	United States	-18856	761	8c08c48a-dee8-5400-9e26-9c968a47702f	not hispanic or latino	male	white	TCGA-44-2668_demographic	Dead	19289	NA	NA	NA	NA	NA	not reported	433	NA	d9b7ea0a-37ac-4a33-9c36-4ae24f1e3e95	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2668_diagnosis2	NA	Not Reported	TCGA-44-2668_diagnosis	NA	NA	NA	NA	453	NA	NA	NA	NA	NA	NA	TCGA-44-2668_treatment7	NA	Locoregional Site	NA	NA	c1e61a2b-b26d-4b6e-a122-40b5fe3ce7d5	NA	yes	NA	Surgery, NOS
TCGA-LUAD	bbe88801-34f3-46d2-bbfd-b46c3901ed71	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-8067	77	false	United States	-28453	NA	4b850d67-395b-5818-8139-c23b36156fe0	not hispanic or latino	male	asian	TCGA-93-8067_demographic	Alive	28453	MX	N0	Stage IB	T2a	7th	primary	0	186.0	cebd6b0a-119a-5847-b2ac-897bde972c23	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	RX	Lung, NOS	Peripheral Lung	TCGA-93-8067_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-8067_treatment	NA	NA	NA	NA	dffafdee-5785-5876-8947-4a6f7f27d4bd	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bbe88801-34f3-46d2-bbfd-b46c3901ed71	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-8067	77	false	United States	-28453	NA	4b850d67-395b-5818-8139-c23b36156fe0	not hispanic or latino	male	asian	TCGA-93-8067_demographic	Alive	28453	MX	N0	Stage IB	T2a	7th	primary	0	186.0	cebd6b0a-119a-5847-b2ac-897bde972c23	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	yes	No	RX	Lung, NOS	Peripheral Lung	TCGA-93-8067_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-8067_treatment2	NA	NA	NA	NA	e959d0b2-4b7a-43db-b95d-89fc25cccf4d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bbe88801-34f3-46d2-bbfd-b46c3901ed71	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-8067	77	false	United States	-28453	NA	4b850d67-395b-5818-8139-c23b36156fe0	not hispanic or latino	male	asian	TCGA-93-8067_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d19f8370-78c1-4b53-8854-b2202ea57520	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-93-8067_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-8067_treatment4	NA	Locoregional Site	NA	NA	b724abbd-ece4-41db-9e2a-9273c4bb557e	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	bbe88801-34f3-46d2-bbfd-b46c3901ed71	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-8067	77	false	United States	-28453	NA	4b850d67-395b-5818-8139-c23b36156fe0	not hispanic or latino	male	asian	TCGA-93-8067_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	d19f8370-78c1-4b53-8854-b2202ea57520	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-93-8067_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-8067_treatment3	NA	NA	NA	NA	b92424fd-9b3a-4e65-aea5-9af78d0a69e1	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bc4c4079-b449-485d-84e4-a40496e563e8	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8673	61	false	Ukraine	-22571	NA	cb44581c-64b4-5a13-bc65-400d75088e83	not hispanic or latino	male	white	TCGA-86-8673_demographic	Alive	22571	M0	N0	Stage IB	T2	7th	primary	0	862.0	501bcf19-55bf-5360-a66a-fe147f7533af	true	NA	NA	C34.1	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-86-8673_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8673_treatment	NA	NA	NA	NA	54ea1070-36b5-5411-becb-3268565b4e07	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bc4c4079-b449-485d-84e4-a40496e563e8	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8673	61	false	Ukraine	-22571	NA	cb44581c-64b4-5a13-bc65-400d75088e83	not hispanic or latino	male	white	TCGA-86-8673_demographic	Alive	22571	M0	N0	Stage IB	T2	7th	primary	0	862.0	501bcf19-55bf-5360-a66a-fe147f7533af	true	NA	NA	C34.1	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-86-8673_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8673_treatment2	NA	NA	NA	NA	da2d690d-8fb3-4484-9ee3-a8f49a91548a	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	bc4c4079-b449-485d-84e4-a40496e563e8	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8673	61	false	Ukraine	-22571	NA	cb44581c-64b4-5a13-bc65-400d75088e83	not hispanic or latino	male	white	TCGA-86-8673_demographic	Alive	23207	NA	NA	NA	NA	NA	recurrence	636	NA	5c57833e-01d7-431b-9df6-69056f1ae432	false	NA	NA	NA	NA	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	Yes	NA	Not Reported	NA	TCGA-86-8673_diagnosis2	NA	Not Reported	TCGA-86-8673_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-86-8673_treatment4	NA	NA	NA	NA	7acffb74-4beb-439f-bcf8-1fa38cb1f4be	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bc4c4079-b449-485d-84e4-a40496e563e8	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8673	61	false	Ukraine	-22571	NA	cb44581c-64b4-5a13-bc65-400d75088e83	not hispanic or latino	male	white	TCGA-86-8673_demographic	Alive	23207	NA	NA	NA	NA	NA	recurrence	636	NA	5c57833e-01d7-431b-9df6-69056f1ae432	false	NA	NA	NA	NA	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	Yes	NA	Not Reported	NA	TCGA-86-8673_diagnosis2	NA	Not Reported	TCGA-86-8673_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-86-8673_treatment3	NA	NA	NA	NA	8a50068d-9b59-48e7-badb-87914c92506d	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bc4c4079-b449-485d-84e4-a40496e563e8	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8673	61	false	Ukraine	-22571	NA	cb44581c-64b4-5a13-bc65-400d75088e83	not hispanic or latino	male	white	TCGA-86-8673_demographic	Alive	23207	NA	NA	NA	NA	NA	recurrence	636	NA	5c57833e-01d7-431b-9df6-69056f1ae432	false	NA	NA	NA	NA	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	NA	Yes	NA	Not Reported	NA	TCGA-86-8673_diagnosis2	NA	Not Reported	TCGA-86-8673_diagnosis	NA	NA	NA	NA	639	NA	NA	NA	NA	NA	NA	TCGA-86-8673_treatment5	NA	Locoregional Site	NA	NA	8c3771ff-4f7d-4923-964b-7a5467480c26	NA	yes	NA	Surgery, NOS
TCGA-LUAD	bcf2e591-9dae-440f-bd03-5f27c57db741	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7765	56	false	United States	-20625	NA	ffb07643-9e89-5410-974b-d3f404bef3b9	not hispanic or latino	male	black or african american	TCGA-69-7765_demographic	Alive	20625	MX	N0	NA	T4	7th	primary	0	165.0	dda7c0d9-9b82-57ab-abf9-f89745ea1f0b	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7765_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7765_treatment3	NA	NA	NA	NA	37ef55cb-1931-48fe-bd78-abf7051c4a38	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bcf2e591-9dae-440f-bd03-5f27c57db741	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7765	56	false	United States	-20625	NA	ffb07643-9e89-5410-974b-d3f404bef3b9	not hispanic or latino	male	black or african american	TCGA-69-7765_demographic	Alive	20625	MX	N0	NA	T4	7th	primary	0	165.0	dda7c0d9-9b82-57ab-abf9-f89745ea1f0b	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7765_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	93	NA	4	NA	6.0	AUC	Intravenous	TCGA-69-7765_treatment	Carboplatin	NA	NA	NA	944a62e9-22b5-5b83-bee7-d381472026e2	Adjuvant	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	bcf2e591-9dae-440f-bd03-5f27c57db741	Informed Consent	29	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7765	56	false	United States	-20625	NA	ffb07643-9e89-5410-974b-d3f404bef3b9	not hispanic or latino	male	black or african american	TCGA-69-7765_demographic	Alive	20625	MX	N0	NA	T4	7th	primary	0	165.0	dda7c0d9-9b82-57ab-abf9-f89745ea1f0b	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7765_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	93	NA	4	NA	500.0	mg/m2	Intravenous	TCGA-69-7765_treatment2	Pemetrexed	NA	NA	NA	f6fe71ef-3e44-429a-97f0-8458ef2207a6	Adjuvant	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	bd4e9a9f-17f3-4d33-92fc-fcc45dd0e7b4	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4487	72	false	United States	-26583	855	53f0ab49-87ae-5805-96cc-ea82fd72eecc	not hispanic or latino	female	white	TCGA-49-4487_demographic	Dead	26583	M0	N0	Stage IA	T1	3rd	primary	0	855.0	0a96b278-90d2-5228-9e7d-3e5154da0ca6	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4487_diagnosis	No	Upper lobe, lung	NA	1992	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4487_treatment2	NA	NA	NA	NA	2d045936-845e-4aec-a51a-1a1520d453b2	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bd4e9a9f-17f3-4d33-92fc-fcc45dd0e7b4	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4487	72	false	United States	-26583	855	53f0ab49-87ae-5805-96cc-ea82fd72eecc	not hispanic or latino	female	white	TCGA-49-4487_demographic	Dead	26583	M0	N0	Stage IA	T1	3rd	primary	0	855.0	0a96b278-90d2-5228-9e7d-3e5154da0ca6	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4487_diagnosis	No	Upper lobe, lung	NA	1992	NA	2.0	741	725	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-4487_treatment	NA	Distant Site	3600	cGy	5706126d-a5ae-52a2-ae28-38f4c3fb9b6e	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	bd4e9a9f-17f3-4d33-92fc-fcc45dd0e7b4	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4487	72	false	United States	-26583	855	53f0ab49-87ae-5805-96cc-ea82fd72eecc	not hispanic or latino	female	white	TCGA-49-4487_demographic	Dead	27280	NA	NA	NA	NA	NA	not reported	697	NA	9142b89f-4d1a-4ff9-bc36-1b7cb19778f9	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4487_diagnosis2	NA	Not Reported	TCGA-49-4487_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-49-4487_treatment4	NA	NA	NA	NA	49986345-9e7f-4d7a-b89c-d44feec7413a	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	bd4e9a9f-17f3-4d33-92fc-fcc45dd0e7b4	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4487	72	false	United States	-26583	855	53f0ab49-87ae-5805-96cc-ea82fd72eecc	not hispanic or latino	female	white	TCGA-49-4487_demographic	Dead	27280	NA	NA	NA	NA	NA	not reported	697	NA	9142b89f-4d1a-4ff9-bc36-1b7cb19778f9	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4487_diagnosis2	NA	Not Reported	TCGA-49-4487_diagnosis	NA	NA	NA	NA	712	NA	NA	NA	NA	NA	NA	TCGA-49-4487_treatment6	NA	Distant Site	NA	NA	58c74a9e-7452-4a33-ae7e-729a32b781af	NA	yes	NA	Surgery, NOS
TCGA-LUAD	bd4e9a9f-17f3-4d33-92fc-fcc45dd0e7b4	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4487	72	false	United States	-26583	855	53f0ab49-87ae-5805-96cc-ea82fd72eecc	not hispanic or latino	female	white	TCGA-49-4487_demographic	Dead	27280	NA	NA	NA	NA	NA	not reported	697	NA	9142b89f-4d1a-4ff9-bc36-1b7cb19778f9	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4487_diagnosis2	NA	Not Reported	TCGA-49-4487_diagnosis	NA	NA	NA	NA	697	NA	NA	NA	NA	NA	NA	TCGA-49-4487_treatment5	NA	Locoregional Site	NA	NA	59da29c4-3d7f-4510-a06e-f56bdb5402e6	NA	yes	NA	Surgery, NOS
TCGA-LUAD	bd4e9a9f-17f3-4d33-92fc-fcc45dd0e7b4	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4487	72	false	United States	-26583	855	53f0ab49-87ae-5805-96cc-ea82fd72eecc	not hispanic or latino	female	white	TCGA-49-4487_demographic	Dead	27280	NA	NA	NA	NA	NA	not reported	697	NA	9142b89f-4d1a-4ff9-bc36-1b7cb19778f9	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4487_diagnosis2	NA	Not Reported	TCGA-49-4487_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-49-4487_treatment3	NA	NA	NA	NA	8671c18e-657a-4dbc-8fc9-58af2a581638	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bd693ad9-6ce9-469a-a3f9-c2779c32d6bc	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z046	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	bebd0025-74e2-451b-93b3-86f82df43573	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TE	56	false	United States	-20627	896	13d16998-fbeb-561c-8750-71479e7b4e04	not hispanic or latino	male	white	TCGA-MP-A4TE_demographic	Dead	20853	NA	NA	NA	NA	NA	recurrence	226	NA	1996672e-87d6-46ca-935f-10a0cb2cc07b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TE_diagnosis2	NA	Not Reported	TCGA-MP-A4TE_diagnosis	NA	NA	NA	NA	226	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TE_treatment5	NA	Locoregional Site	NA	NA	97849c99-13f1-41c2-8b10-b8a581fd1f34	NA	yes	NA	Surgery, NOS
TCGA-LUAD	bebd0025-74e2-451b-93b3-86f82df43573	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TE	56	false	United States	-20627	896	13d16998-fbeb-561c-8750-71479e7b4e04	not hispanic or latino	male	white	TCGA-MP-A4TE_demographic	Dead	20853	NA	NA	NA	NA	NA	recurrence	226	NA	1996672e-87d6-46ca-935f-10a0cb2cc07b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TE_diagnosis2	NA	Not Reported	TCGA-MP-A4TE_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TE_treatment3	NA	NA	NA	NA	ae87ba2b-5200-4a2c-9226-98a9e6bd39fa	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bebd0025-74e2-451b-93b3-86f82df43573	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TE	56	false	United States	-20627	896	13d16998-fbeb-561c-8750-71479e7b4e04	not hispanic or latino	male	white	TCGA-MP-A4TE_demographic	Dead	20853	NA	NA	NA	NA	NA	recurrence	226	NA	1996672e-87d6-46ca-935f-10a0cb2cc07b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TE_diagnosis2	NA	Not Reported	TCGA-MP-A4TE_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TE_treatment4	NA	NA	NA	NA	ec32a55b-ff94-465a-b233-3d6475be8e76	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bebd0025-74e2-451b-93b3-86f82df43573	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TE	56	false	United States	-20627	896	13d16998-fbeb-561c-8750-71479e7b4e04	not hispanic or latino	male	white	TCGA-MP-A4TE_demographic	Dead	21038	NA	NA	NA	NA	NA	recurrence	411	NA	2a0e0eea-b052-45ed-8ba9-c7661a99e1b3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TE_diagnosis3	NA	Not Reported	TCGA-MP-A4TE_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TE_treatment8	NA	Locoregional Site	NA	NA	198431ec-765d-482a-91c3-9fbb020305a5	NA	no	NA	Surgery, NOS
TCGA-LUAD	bebd0025-74e2-451b-93b3-86f82df43573	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TE	56	false	United States	-20627	896	13d16998-fbeb-561c-8750-71479e7b4e04	not hispanic or latino	male	white	TCGA-MP-A4TE_demographic	Dead	21038	NA	NA	NA	NA	NA	recurrence	411	NA	2a0e0eea-b052-45ed-8ba9-c7661a99e1b3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TE_diagnosis3	NA	Not Reported	TCGA-MP-A4TE_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TE_treatment6	NA	NA	NA	NA	22f274d6-da71-4de9-a95b-a491ce6b94f1	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bebd0025-74e2-451b-93b3-86f82df43573	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TE	56	false	United States	-20627	896	13d16998-fbeb-561c-8750-71479e7b4e04	not hispanic or latino	male	white	TCGA-MP-A4TE_demographic	Dead	21038	NA	NA	NA	NA	NA	recurrence	411	NA	2a0e0eea-b052-45ed-8ba9-c7661a99e1b3	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TE_diagnosis3	NA	Not Reported	TCGA-MP-A4TE_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TE_treatment7	NA	NA	NA	NA	5f09fe23-87c7-4067-8a04-9800bd7212fe	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bebd0025-74e2-451b-93b3-86f82df43573	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TE	56	false	United States	-20627	896	13d16998-fbeb-561c-8750-71479e7b4e04	not hispanic or latino	male	white	TCGA-MP-A4TE_demographic	Dead	21472	NA	NA	NA	NA	NA	metastasis	845	NA	2cff90ab-220a-4950-b80d-bd25e98372da	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TE_diagnosis4	NA	Not Reported	TCGA-MP-A4TE_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TE_treatment10	NA	NA	NA	NA	7aeb0350-cc93-427b-819f-90e1272c9e8d	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	bebd0025-74e2-451b-93b3-86f82df43573	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TE	56	false	United States	-20627	896	13d16998-fbeb-561c-8750-71479e7b4e04	not hispanic or latino	male	white	TCGA-MP-A4TE_demographic	Dead	21472	NA	NA	NA	NA	NA	metastasis	845	NA	2cff90ab-220a-4950-b80d-bd25e98372da	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TE_diagnosis4	NA	Not Reported	TCGA-MP-A4TE_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TE_treatment11	NA	Distant Site	NA	NA	7e140fcf-51fa-47f7-a2f9-e5aa36e86703	NA	no	NA	Surgery, NOS
TCGA-LUAD	bebd0025-74e2-451b-93b3-86f82df43573	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TE	56	false	United States	-20627	896	13d16998-fbeb-561c-8750-71479e7b4e04	not hispanic or latino	male	white	TCGA-MP-A4TE_demographic	Dead	21472	NA	NA	NA	NA	NA	metastasis	845	NA	2cff90ab-220a-4950-b80d-bd25e98372da	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TE_diagnosis4	NA	Not Reported	TCGA-MP-A4TE_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TE_treatment9	NA	NA	NA	NA	84ce001c-3b56-4eaa-a82d-549aafa2785d	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bebd0025-74e2-451b-93b3-86f82df43573	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TE	56	false	United States	-20627	896	13d16998-fbeb-561c-8750-71479e7b4e04	not hispanic or latino	male	white	TCGA-MP-A4TE_demographic	Dead	20627	MX	N0	Stage IIA	T2b	7th	primary	0	896.0	324176a1-4ead-58fc-b41f-501e6f12e5c6	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-MP-A4TE_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TE_treatment	NA	NA	NA	NA	104fa549-ee18-5bfa-9a91-2e2ad9165383	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bebd0025-74e2-451b-93b3-86f82df43573	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TE	56	false	United States	-20627	896	13d16998-fbeb-561c-8750-71479e7b4e04	not hispanic or latino	male	white	TCGA-MP-A4TE_demographic	Dead	20627	MX	N0	Stage IIA	T2b	7th	primary	0	896.0	324176a1-4ead-58fc-b41f-501e6f12e5c6	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	RX	Lung, NOS	Peripheral Lung	TCGA-MP-A4TE_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TE_treatment2	NA	NA	NA	NA	2f8f6828-a63d-4397-abd0-a632ce7d87ca	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bf15f7ad-9d92-473b-91d1-f24aa373ab97	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2659	65	false	United States	-23808	NA	3f2db12e-7bf1-5cd1-8110-0cb855a69766	not hispanic or latino	female	white	TCGA-44-2659_demographic	Alive	23808	M0	N1	Stage IIB	T1	6th	primary	0	1367.0	056b4bf9-1989-5543-a0b8-3eeaaa772c63	true	NA	NA	C34.3	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2659_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	101	39	NA	4	NA	160.0	mg	Intravenous	TCGA-44-2659_treatment2	Cisplatin	NA	640	mg	66c46963-6803-4b76-976f-c9de75001f92	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	bf15f7ad-9d92-473b-91d1-f24aa373ab97	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2659	65	false	United States	-23808	NA	3f2db12e-7bf1-5cd1-8110-0cb855a69766	not hispanic or latino	female	white	TCGA-44-2659_demographic	Alive	23808	M0	N1	Stage IIB	T1	6th	primary	0	1367.0	056b4bf9-1989-5543-a0b8-3eeaaa772c63	true	NA	NA	C34.3	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2659_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	101	39	NA	4	NA	1100.0	mg	Intravenous	TCGA-44-2659_treatment	Pemetrexed Disodium	NA	4400	mg	a198be22-f499-5d45-ad97-bc8a365bc150	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	bf15f7ad-9d92-473b-91d1-f24aa373ab97	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2659	65	false	United States	-23808	NA	3f2db12e-7bf1-5cd1-8110-0cb855a69766	not hispanic or latino	female	white	TCGA-44-2659_demographic	Alive	23808	M0	N1	Stage IIB	T1	6th	primary	0	1367.0	056b4bf9-1989-5543-a0b8-3eeaaa772c63	true	NA	NA	C34.3	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2659_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2659_treatment3	NA	NA	NA	NA	da1a3dd2-f1cf-4712-8200-abcc0bff1a34	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bf15f7ad-9d92-473b-91d1-f24aa373ab97	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2659	65	false	United States	-23808	NA	3f2db12e-7bf1-5cd1-8110-0cb855a69766	not hispanic or latino	female	white	TCGA-44-2659_demographic	Alive	24954	NA	NA	NA	NA	NA	recurrence	1146	NA	6d6cdd78-5a7d-402a-9043-9f4b611c22e0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-2659_diagnosis2	NA	Not Reported	TCGA-44-2659_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-2659_treatment5	NA	NA	NA	NA	41602a16-5bdf-43e5-9dff-71c7a635df83	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bf15f7ad-9d92-473b-91d1-f24aa373ab97	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2659	65	false	United States	-23808	NA	3f2db12e-7bf1-5cd1-8110-0cb855a69766	not hispanic or latino	female	white	TCGA-44-2659_demographic	Alive	24954	NA	NA	NA	NA	NA	recurrence	1146	NA	6d6cdd78-5a7d-402a-9043-9f4b611c22e0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-2659_diagnosis2	NA	Not Reported	TCGA-44-2659_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2659_treatment6	NA	Locoregional Site	NA	NA	a36007bd-454f-4a0e-9238-de02b2239a03	NA	no	NA	Surgery, NOS
TCGA-LUAD	bf15f7ad-9d92-473b-91d1-f24aa373ab97	Informed Consent	-48	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2659	65	false	United States	-23808	NA	3f2db12e-7bf1-5cd1-8110-0cb855a69766	not hispanic or latino	female	white	TCGA-44-2659_demographic	Alive	24954	NA	NA	NA	NA	NA	recurrence	1146	NA	6d6cdd78-5a7d-402a-9043-9f4b611c22e0	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-2659_diagnosis2	NA	Not Reported	TCGA-44-2659_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-2659_treatment4	NA	NA	NA	NA	d3a8c25a-b7ba-4d01-910e-5b8305cd2944	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bf34664d-423d-4257-99d4-797f7d366455	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A4SU	67	false	United States	-24820	409	f852f5de-7d56-58e9-a9b4-80bcbdca119f	not hispanic or latino	female	white	TCGA-44-A4SU_demographic	Dead	24820	MX	N0	Stage IA	T1a	7th	primary	0	409.0	1d2191be-0843-5557-9129-0998079df0bf	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-A4SU_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A4SU_treatment2	NA	NA	NA	NA	3442e5e3-d956-4417-ad55-24f4316c1a32	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bf34664d-423d-4257-99d4-797f7d366455	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A4SU	67	false	United States	-24820	409	f852f5de-7d56-58e9-a9b4-80bcbdca119f	not hispanic or latino	female	white	TCGA-44-A4SU_demographic	Dead	24820	MX	N0	Stage IA	T1a	7th	primary	0	409.0	1d2191be-0843-5557-9129-0998079df0bf	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-A4SU_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A4SU_treatment	NA	NA	NA	NA	65e40332-32a1-5f9c-8695-6a8360b98830	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bf34664d-423d-4257-99d4-797f7d366455	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A4SU	67	false	United States	-24820	409	f852f5de-7d56-58e9-a9b4-80bcbdca119f	not hispanic or latino	female	white	TCGA-44-A4SU_demographic	Dead	25080	NA	NA	NA	NA	NA	recurrence	260	NA	4fe2432e-db86-4c20-a584-6aecd5d7d0aa	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-A4SU_diagnosis2	NA	Not Reported	TCGA-44-A4SU_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-A4SU_treatment3	NA	NA	NA	NA	0bdffbde-72ef-403a-bfd6-312c129feba8	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bf34664d-423d-4257-99d4-797f7d366455	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A4SU	67	false	United States	-24820	409	f852f5de-7d56-58e9-a9b4-80bcbdca119f	not hispanic or latino	female	white	TCGA-44-A4SU_demographic	Dead	25080	NA	NA	NA	NA	NA	recurrence	260	NA	4fe2432e-db86-4c20-a584-6aecd5d7d0aa	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-A4SU_diagnosis2	NA	Not Reported	TCGA-44-A4SU_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A4SU_treatment5	NA	Locoregional Site	NA	NA	54f404cb-4821-4c4b-9b72-dfe600290992	NA	no	NA	Surgery, NOS
TCGA-LUAD	bf34664d-423d-4257-99d4-797f7d366455	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A4SU	67	false	United States	-24820	409	f852f5de-7d56-58e9-a9b4-80bcbdca119f	not hispanic or latino	female	white	TCGA-44-A4SU_demographic	Dead	25080	NA	NA	NA	NA	NA	recurrence	260	NA	4fe2432e-db86-4c20-a584-6aecd5d7d0aa	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-A4SU_diagnosis2	NA	Not Reported	TCGA-44-A4SU_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-A4SU_treatment4	NA	NA	NA	NA	65b1f5b4-0f04-4f51-b36e-6616265052a9	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bf755bc2-b7aa-4c3c-8b3c-58b089b5cab6	Informed Consent	16	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7907	77	false	United States	-28201	343	096e3d58-b967-51a9-9c78-d6cc36dbc10e	not hispanic or latino	male	white	TCGA-55-7907_demographic	Dead	28495	NA	NA	NA	NA	NA	metastasis	294	NA	582d47f2-03a9-4636-afdd-8c79e11aedf5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7907_diagnosis2	NA	Not Reported	TCGA-55-7907_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7907_treatment3	NA	NA	NA	NA	09c5ad58-7b25-4ec7-bd4b-a8beb9f57d22	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	bf755bc2-b7aa-4c3c-8b3c-58b089b5cab6	Informed Consent	16	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7907	77	false	United States	-28201	343	096e3d58-b967-51a9-9c78-d6cc36dbc10e	not hispanic or latino	male	white	TCGA-55-7907_demographic	Dead	28495	NA	NA	NA	NA	NA	metastasis	294	NA	582d47f2-03a9-4636-afdd-8c79e11aedf5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7907_diagnosis2	NA	Not Reported	TCGA-55-7907_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7907_treatment4	NA	NA	NA	NA	397b8e68-d378-4432-b79a-1cd567e4d01d	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bf755bc2-b7aa-4c3c-8b3c-58b089b5cab6	Informed Consent	16	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7907	77	false	United States	-28201	343	096e3d58-b967-51a9-9c78-d6cc36dbc10e	not hispanic or latino	male	white	TCGA-55-7907_demographic	Dead	28495	NA	NA	NA	NA	NA	metastasis	294	NA	582d47f2-03a9-4636-afdd-8c79e11aedf5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7907_diagnosis2	NA	Not Reported	TCGA-55-7907_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7907_treatment5	NA	Distant Site	NA	NA	7fce0b2e-8d8f-429a-93ae-6767be0dc6a1	NA	no	NA	Surgery, NOS
TCGA-LUAD	bf755bc2-b7aa-4c3c-8b3c-58b089b5cab6	Informed Consent	16	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7907	77	false	United States	-28201	343	096e3d58-b967-51a9-9c78-d6cc36dbc10e	not hispanic or latino	male	white	TCGA-55-7907_demographic	Dead	28201	MX	N1	Stage IIA	T2a	7th	primary	0	343.0	6db0e61f-6df2-5b6c-ac6d-19618c35b230	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7907_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7907_treatment2	NA	NA	NA	NA	25fad6af-4bdf-4044-87f9-0f3a2ed38f13	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	bf755bc2-b7aa-4c3c-8b3c-58b089b5cab6	Informed Consent	16	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7907	77	false	United States	-28201	343	096e3d58-b967-51a9-9c78-d6cc36dbc10e	not hispanic or latino	male	white	TCGA-55-7907_demographic	Dead	28201	MX	N1	Stage IIA	T2a	7th	primary	0	343.0	6db0e61f-6df2-5b6c-ac6d-19618c35b230	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7907_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7907_treatment	NA	NA	NA	NA	dc7cacc5-3f4d-5e60-878e-eb66180fd4bf	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c05b1a5c-2f6d-448a-94c8-58cce3d34b37	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	c0c879f7-c332-4d31-9f7e-a3bf361b36ee	Informed Consent	-10	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M1	52	false	United States	-19272	NA	d87fdc36-3ed2-594c-83b7-15eec4733761	not hispanic or latino	female	white	TCGA-97-A4M1_demographic	Alive	19272	M0	N0	Stage IA	T1a	7th	primary	0	601.0	98303964-0d1b-548f-97ab-491600988907	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-A4M1_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M1_treatment	NA	NA	NA	NA	27736246-e359-5ca7-a7cf-d51bd5a9d4da	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c0c879f7-c332-4d31-9f7e-a3bf361b36ee	Informed Consent	-10	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M1	52	false	United States	-19272	NA	d87fdc36-3ed2-594c-83b7-15eec4733761	not hispanic or latino	female	white	TCGA-97-A4M1_demographic	Alive	19272	M0	N0	Stage IA	T1a	7th	primary	0	601.0	98303964-0d1b-548f-97ab-491600988907	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-A4M1_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M1_treatment2	NA	NA	NA	NA	adca3af3-b1d0-4e0c-8f79-ac57b49bacfd	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c0e263eb-1a83-4dc8-8abe-3dd2a59bae1b	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8672	59	false	Ukraine	-21682	19	394426f6-6045-5537-9fe6-f367ba490442	not hispanic or latino	male	white	TCGA-86-8672_demographic	Dead	21682	M0	N0	Stage IIB	T3	7th	primary	0	19.0	68eee202-0ad0-59fa-adb9-484b9e72a4ce	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-86-8672_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8672_treatment	NA	NA	NA	NA	562b57a6-7abe-5bcd-b53a-58744333d720	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c0e263eb-1a83-4dc8-8abe-3dd2a59bae1b	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8672	59	false	Ukraine	-21682	19	394426f6-6045-5537-9fe6-f367ba490442	not hispanic or latino	male	white	TCGA-86-8672_demographic	Dead	21682	M0	N0	Stage IIB	T3	7th	primary	0	19.0	68eee202-0ad0-59fa-adb9-484b9e72a4ce	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-86-8672_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8672_treatment2	NA	NA	NA	NA	be0a11e0-9877-4751-8c64-d9b9696b129f	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	c0fdb152-25d2-404b-bec7-a43ece381f5b	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-7771	62	false	United States	-22926	NA	b333acb0-0721-5323-86db-c311aabde567	not hispanic or latino	male	white	TCGA-91-7771_demographic	Alive	22926	MX	N0	Stage IIB	T3	7th	primary	0	492.0	17726be7-a6ce-59f1-8775-4f2e15af3e01	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-7771_diagnosis	Yes	Upper lobe, lung	NA	2011	NA	NA	156	77	NA	NA	NA	NA	NA	NA	TCGA-91-7771_treatment2	Pemetrexed	NA	NA	NA	456bb099-f3a6-40ed-9f1d-11c1cf7ef8fe	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	c0fdb152-25d2-404b-bec7-a43ece381f5b	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-7771	62	false	United States	-22926	NA	b333acb0-0721-5323-86db-c311aabde567	not hispanic or latino	male	white	TCGA-91-7771_demographic	Alive	22926	MX	N0	Stage IIB	T3	7th	primary	0	492.0	17726be7-a6ce-59f1-8775-4f2e15af3e01	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-7771_diagnosis	Yes	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-7771_treatment3	NA	NA	NA	NA	cdec67c8-6628-40bc-bcd4-2cd92ec60e8e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c0fdb152-25d2-404b-bec7-a43ece381f5b	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-7771	62	false	United States	-22926	NA	b333acb0-0721-5323-86db-c311aabde567	not hispanic or latino	male	white	TCGA-91-7771_demographic	Alive	22926	MX	N0	Stage IIB	T3	7th	primary	0	492.0	17726be7-a6ce-59f1-8775-4f2e15af3e01	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-7771_diagnosis	Yes	Upper lobe, lung	NA	2011	NA	NA	156	77	NA	NA	NA	NA	NA	NA	TCGA-91-7771_treatment	Cisplatin	NA	NA	NA	ed8a62fd-c9e3-53b6-b6eb-a22e3e586fbc	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	c0fdb152-25d2-404b-bec7-a43ece381f5b	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-7771	62	false	United States	-22926	NA	b333acb0-0721-5323-86db-c311aabde567	not hispanic or latino	male	white	TCGA-91-7771_demographic	Alive	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	a5ec1339-075e-437e-8be1-a928be77c2e7	false	NA	NA	NA	NA	8580/1	Thymoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-91-7771_diagnosis2	NA	Thymus	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-7771_treatment4	NA	NA	NA	NA	03ed0306-b4b6-4191-bbb6-b3fa1eb14793	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c0fdb152-25d2-404b-bec7-a43ece381f5b	Informed Consent	31	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-91-7771	62	false	United States	-22926	NA	b333acb0-0721-5323-86db-c311aabde567	not hispanic or latino	male	white	TCGA-91-7771_demographic	Alive	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	a5ec1339-075e-437e-8be1-a928be77c2e7	false	NA	NA	NA	NA	8580/1	Thymoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-91-7771_diagnosis2	NA	Thymus	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-7771_treatment5	NA	NA	NA	NA	ff88e730-4271-4092-9205-ccf031b7e44c	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c1a01e8c-1f7e-4e24-bfad-90b73f88e992	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7160	61	false	Australia	-22385	697	e156e6fb-c5de-5a71-b91b-b3318c34a2e4	not reported	male	white	TCGA-78-7160_demographic	Dead	22385	M1	N2	Stage IV	T4	6th	primary	0	697.0	03b90fd8-9e17-5a88-b6ee-9d3f65137692	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-78-7160_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7160_treatment2	NA	NA	NA	NA	ee4e1e78-242a-4185-91c1-ea86e53968d6	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c1a01e8c-1f7e-4e24-bfad-90b73f88e992	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7160	61	false	Australia	-22385	697	e156e6fb-c5de-5a71-b91b-b3318c34a2e4	not reported	male	white	TCGA-78-7160_demographic	Dead	22385	M1	N2	Stage IV	T4	6th	primary	0	697.0	03b90fd8-9e17-5a88-b6ee-9d3f65137692	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-78-7160_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	Intravenous	TCGA-78-7160_treatment	NA	NA	NA	NA	f5a52f2f-fb22-53ce-af7d-b7d3183de8b9	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	c2a1de2e-6451-4c95-8ce6-263f2b7e6eff	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6776	60	false	United States	-22150	NA	99b8e07b-4d7c-5505-bac1-7907edaf329e	not reported	female	white	TCGA-44-6776_demographic	Alive	22150	MX	N0	Stage IA	T1	6th	primary	0	2616.0	81b2458e-450a-5466-83d4-483aad174803	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-6776_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6776_treatment2	NA	NA	NA	NA	37e6272d-9301-49ce-8e86-556e077cb6b3	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c2a1de2e-6451-4c95-8ce6-263f2b7e6eff	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6776	60	false	United States	-22150	NA	99b8e07b-4d7c-5505-bac1-7907edaf329e	not reported	female	white	TCGA-44-6776_demographic	Alive	22150	MX	N0	Stage IA	T1	6th	primary	0	2616.0	81b2458e-450a-5466-83d4-483aad174803	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-6776_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6776_treatment	NA	NA	NA	NA	f8afd24b-4d45-5365-98b6-290f01cdd8cb	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c2a1de2e-6451-4c95-8ce6-263f2b7e6eff	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6776	60	false	United States	-22150	NA	99b8e07b-4d7c-5505-bac1-7907edaf329e	not reported	female	white	TCGA-44-6776_demographic	Alive	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	f9ec9e0d-540a-494d-a2d4-1bab06dc07ea	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-6776_diagnosis2	NA	Unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6776_treatment3	NA	NA	NA	NA	12e91af1-f920-44f8-b90c-cb11a86fda37	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c2a1de2e-6451-4c95-8ce6-263f2b7e6eff	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-6776	60	false	United States	-22150	NA	99b8e07b-4d7c-5505-bac1-7907edaf329e	not reported	female	white	TCGA-44-6776_demographic	Alive	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	f9ec9e0d-540a-494d-a2d4-1bab06dc07ea	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-6776_diagnosis2	NA	Unknown	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6776_treatment4	NA	NA	NA	NA	3fb5fc77-0670-4c18-ba12-14fca6027c77	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c353f949-5f66-4a2c-b8f0-17be8bf19e0a	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7153	65	false	Australia	-23922	NA	c7b2da5d-c823-5941-8aae-07ab5face609	not reported	female	white	TCGA-78-7153_demographic	Alive	23922	M0	N0	Stage IB	T2	6th	primary	0	3635.0	7f45ece4-7dbf-5a39-8467-1fa8e96bd043	true	NA	NA	C34.8	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7153_diagnosis	No	Overlapping lesion of lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7153_treatment2	NA	NA	NA	NA	c664803d-3f59-4dcf-abf2-971a9fa2e340	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c353f949-5f66-4a2c-b8f0-17be8bf19e0a	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-78-7153	65	false	Australia	-23922	NA	c7b2da5d-c823-5941-8aae-07ab5face609	not reported	female	white	TCGA-78-7153_demographic	Alive	23922	M0	N0	Stage IB	T2	6th	primary	0	3635.0	7f45ece4-7dbf-5a39-8467-1fa8e96bd043	true	NA	NA	C34.8	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7153_diagnosis	No	Overlapping lesion of lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7153_treatment	NA	NA	NA	NA	d390a7b7-f0b8-5be3-b3af-58eedaf2f422	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c390b6ad-14c8-49ea-9b38-798c9fad5b62	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	c43c8eea-7014-4abe-b805-397a9062d3e0	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z031	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	c497f8c7-2fb5-44d9-bc7c-69cfd0b51b54	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46R	54	false	Germany	-20063	1725	9d325399-028b-5f8d-9c39-f91d3a970b97	not hispanic or latino	female	white	TCGA-62-A46R_demographic	Dead	20063	M0	N0	Stage IB	T2	6th	primary	0	1725.0	cb8542b7-3f87-5c7e-95c4-5e05377e080d	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A46R_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46R_treatment	NA	NA	NA	NA	65dca1d3-347d-5ad3-b658-d3e1b40344ac	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c497f8c7-2fb5-44d9-bc7c-69cfd0b51b54	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46R	54	false	Germany	-20063	1725	9d325399-028b-5f8d-9c39-f91d3a970b97	not hispanic or latino	female	white	TCGA-62-A46R_demographic	Dead	20063	M0	N0	Stage IB	T2	6th	primary	0	1725.0	cb8542b7-3f87-5c7e-95c4-5e05377e080d	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A46R_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46R_treatment2	NA	NA	NA	NA	8f85573e-3f2e-4c2b-a01d-4a3c2b8719cd	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c4c1469d-752f-42b6-8686-714ad4a8ac97	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-6206	NA	false	Canada	NA	NA	4fd50b11-330a-5ecb-9abe-6b12aaac3fb3	not reported	male	not reported	TCGA-75-6206_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	2590.0	dc9d9e80-e87c-5900-94a7-eb2967966f58	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6206_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6206_treatment	NA	NA	NA	NA	a6434e00-31f5-55fc-80af-3a12bb178c37	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c4c1469d-752f-42b6-8686-714ad4a8ac97	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-6206	NA	false	Canada	NA	NA	4fd50b11-330a-5ecb-9abe-6b12aaac3fb3	not reported	male	not reported	TCGA-75-6206_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	2590.0	dc9d9e80-e87c-5900-94a7-eb2967966f58	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-6206_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-6206_treatment2	NA	NA	NA	NA	ff69622e-eb3a-48e1-86c8-e140dcd05e89	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c4cfa3cc-e305-42dd-be57-97efbb891659	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8671	72	false	Russia	-26448	NA	de4ee0f3-fd4b-57ec-8cb9-199ed3109a07	not hispanic or latino	female	white	TCGA-86-8671_demographic	Alive	26448	M0	N1	Stage IIB	T2b	7th	primary	0	839.0	f0d10c1b-6df7-5e1e-92bd-c07305dd2e26	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8671_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8671_treatment3	NA	NA	NA	NA	0685c953-e1e2-448a-9555-eadd99eac1cf	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	c4cfa3cc-e305-42dd-be57-97efbb891659	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8671	72	false	Russia	-26448	NA	de4ee0f3-fd4b-57ec-8cb9-199ed3109a07	not hispanic or latino	female	white	TCGA-86-8671_demographic	Alive	26448	M0	N1	Stage IIB	T2b	7th	primary	0	839.0	f0d10c1b-6df7-5e1e-92bd-c07305dd2e26	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8671_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	104	18	NA	NA	NA	NA	NA	NA	TCGA-86-8671_treatment2	Etoposide	NA	NA	NA	c0538beb-5f3a-4267-87fd-5e553966e31f	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	c4cfa3cc-e305-42dd-be57-97efbb891659	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8671	72	false	Russia	-26448	NA	de4ee0f3-fd4b-57ec-8cb9-199ed3109a07	not hispanic or latino	female	white	TCGA-86-8671_demographic	Alive	26448	M0	N1	Stage IIB	T2b	7th	primary	0	839.0	f0d10c1b-6df7-5e1e-92bd-c07305dd2e26	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8671_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	104	18	NA	NA	NA	NA	NA	NA	TCGA-86-8671_treatment	Cisplatin	NA	NA	NA	d72624b4-6a7e-567f-87ee-3eb71e969cbe	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	c4d1e105-28b7-48df-abef-fbe09782fdb2	Informed Consent	12	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6972	72	false	United States	-26625	1632	149e50ed-49b8-5519-83f6-fe4997b18f2a	not hispanic or latino	male	white	TCGA-55-6972_demographic	Dead	26625	M0	N0	Stage IB	T2	6th	primary	0	1632.0	01a23057-05f3-53fd-8858-f52c5258411e	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-6972_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6972_treatment2	NA	NA	NA	NA	05802a07-0fc1-4dfa-8092-f041e251ed3d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c4d1e105-28b7-48df-abef-fbe09782fdb2	Informed Consent	12	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6972	72	false	United States	-26625	1632	149e50ed-49b8-5519-83f6-fe4997b18f2a	not hispanic or latino	male	white	TCGA-55-6972_demographic	Dead	26625	M0	N0	Stage IB	T2	6th	primary	0	1632.0	01a23057-05f3-53fd-8858-f52c5258411e	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-6972_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6972_treatment	NA	NA	NA	NA	fb14af2b-bbe8-5bf7-a294-be0e44dc9b81	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c583fdd1-8cd2-4c15-a23e-0644261f65da	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1681	61	false	United States	-22525	1167	6291f336-0676-5c03-ab39-1461f73c1a4c	not hispanic or latino	female	white	TCGA-64-1681_demographic	Dead	22525	M0	N0	Stage IA	T1	6th	primary	0	1167.0	6a9b3344-d488-56e4-835c-7458c92ade4b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-64-1681_diagnosis	No	Lung, NOS	NA	2008	NA	NA	NA	481	Recurrent Disease	NA	NA	150.0	mg	Oral	TCGA-64-1681_treatment2	Erlotinib Hydrochloride	NA	NA	NA	288d8e53-a82e-4747-9fe3-6ee2caf2dbd4	NA	yes	NA	Chemotherapy
TCGA-LUAD	c583fdd1-8cd2-4c15-a23e-0644261f65da	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1681	61	false	United States	-22525	1167	6291f336-0676-5c03-ab39-1461f73c1a4c	not hispanic or latino	female	white	TCGA-64-1681_demographic	Dead	22525	M0	N0	Stage IA	T1	6th	primary	0	1167.0	6a9b3344-d488-56e4-835c-7458c92ade4b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-64-1681_diagnosis	No	Lung, NOS	NA	2008	NA	1.0	NA	711	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-64-1681_treatment	NA	Distant Site	3000	cGy	3314582d-e4a8-51aa-9a9a-4d35720773a1	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	c583fdd1-8cd2-4c15-a23e-0644261f65da	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1681	61	false	United States	-22525	1167	6291f336-0676-5c03-ab39-1461f73c1a4c	not hispanic or latino	female	white	TCGA-64-1681_demographic	Dead	22964	NA	NA	NA	NA	NA	not reported	439	NA	b2a18d17-d0ba-45c4-ad14-3ccd34eb2b24	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-1681_diagnosis2	NA	Not Reported	TCGA-64-1681_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-64-1681_treatment3	NA	NA	NA	NA	43c09342-44c2-4951-8ab3-9aaa2590a73a	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c583fdd1-8cd2-4c15-a23e-0644261f65da	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1681	61	false	United States	-22525	1167	6291f336-0676-5c03-ab39-1461f73c1a4c	not hispanic or latino	female	white	TCGA-64-1681_demographic	Dead	22964	NA	NA	NA	NA	NA	not reported	439	NA	b2a18d17-d0ba-45c4-ad14-3ccd34eb2b24	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-1681_diagnosis2	NA	Not Reported	TCGA-64-1681_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-64-1681_treatment4	NA	NA	NA	NA	846dbbe3-4c1b-4d07-8c53-c632e526957e	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	c583fdd1-8cd2-4c15-a23e-0644261f65da	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1681	61	false	United States	-22525	1167	6291f336-0676-5c03-ab39-1461f73c1a4c	not hispanic or latino	female	white	TCGA-64-1681_demographic	Dead	22964	NA	NA	NA	NA	NA	not reported	439	NA	b2a18d17-d0ba-45c4-ad14-3ccd34eb2b24	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-1681_diagnosis2	NA	Not Reported	TCGA-64-1681_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-1681_treatment5	NA	Locoregional Site	NA	NA	e98184c4-c1cb-4798-af43-50c856404103	NA	no	NA	Surgery, NOS
TCGA-LUAD	c650b1ff-8a4c-4ee9-b7c1-268c28c83827	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7043	63	false	United States	-23165	503	5bf9ddab-e5a6-5e06-9c5b-746b029471de	not hispanic or latino	female	white	TCGA-95-7043_demographic	Dead	NA	NA	NX	NA	T1a	NA	Synchronous primary	NA	NA	49a60728-c55a-4ed2-803b-1051f1fd9fb6	false	NA	NA	NA	Right	8255/3	Adenocarcinoma with mixed subtypes	NA	NA	NA	Not Reported	NA	TCGA-95-7043_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7043_treatment4	NA	NA	NA	NA	8cb37b7f-eaeb-470d-a32a-1467421416a6	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c650b1ff-8a4c-4ee9-b7c1-268c28c83827	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7043	63	false	United States	-23165	503	5bf9ddab-e5a6-5e06-9c5b-746b029471de	not hispanic or latino	female	white	TCGA-95-7043_demographic	Dead	NA	NA	NX	NA	T1a	NA	Synchronous primary	NA	NA	49a60728-c55a-4ed2-803b-1051f1fd9fb6	false	NA	NA	NA	Right	8255/3	Adenocarcinoma with mixed subtypes	NA	NA	NA	Not Reported	NA	TCGA-95-7043_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7043_treatment3	NA	NA	NA	NA	acc3dc2b-5e64-4633-9e57-56fd91e27630	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c650b1ff-8a4c-4ee9-b7c1-268c28c83827	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7043	63	false	United States	-23165	503	5bf9ddab-e5a6-5e06-9c5b-746b029471de	not hispanic or latino	female	white	TCGA-95-7043_demographic	Dead	23165	MX	N0	Stage IA	T1a	7th	primary	0	503.0	e9bccdce-1518-5c2c-860f-b585bf00cfb6	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-95-7043_diagnosis	Yes	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7043_treatment	NA	NA	NA	NA	03f4e5cd-fb0a-576e-9a3b-1633643ebaac	Adjuvant	yes	Complete Response	Pharmaceutical Therapy, NOS
TCGA-LUAD	c650b1ff-8a4c-4ee9-b7c1-268c28c83827	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7043	63	false	United States	-23165	503	5bf9ddab-e5a6-5e06-9c5b-746b029471de	not hispanic or latino	female	white	TCGA-95-7043_demographic	Dead	23165	MX	N0	Stage IA	T1a	7th	primary	0	503.0	e9bccdce-1518-5c2c-860f-b585bf00cfb6	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-95-7043_diagnosis	Yes	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7043_treatment2	NA	NA	NA	NA	5ff2e435-ebab-45ea-ad13-0def533e3b5a	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	c6b680e3-d96e-4fc7-8053-77454b7a14fa	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M7	74	false	United States	-27062	NA	e4098a4a-49b2-571f-8b83-3efcbbb7d324	not hispanic or latino	male	white	TCGA-97-A4M7_demographic	Alive	27062	NA	NA	NA	NA	NA	Synchronous primary	0	NA	a6f47847-a453-462a-bf51-48f2f61cabde	false	NA	NA	NA	Right	8255/3	Adenocarcinoma with mixed subtypes	NA	NA	NA	Not Reported	NA	TCGA-97-A4M7_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA	NA	TCGA-97-A4M7_treatment5	NA	NA	NA	NA	27b1a059-2552-4488-bc59-62ab969ee351	NA	yes	NA	Surgery, NOS
TCGA-LUAD	c6b680e3-d96e-4fc7-8053-77454b7a14fa	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M7	74	false	United States	-27062	NA	e4098a4a-49b2-571f-8b83-3efcbbb7d324	not hispanic or latino	male	white	TCGA-97-A4M7_demographic	Alive	27062	NA	NA	NA	NA	NA	Synchronous primary	0	NA	a6f47847-a453-462a-bf51-48f2f61cabde	false	NA	NA	NA	Right	8255/3	Adenocarcinoma with mixed subtypes	NA	NA	NA	Not Reported	NA	TCGA-97-A4M7_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M7_treatment4	NA	NA	NA	NA	b628d32e-f5d1-4fbe-ac54-77b4c43e286a	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c6b680e3-d96e-4fc7-8053-77454b7a14fa	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M7	74	false	United States	-27062	NA	e4098a4a-49b2-571f-8b83-3efcbbb7d324	not hispanic or latino	male	white	TCGA-97-A4M7_demographic	Alive	27062	NA	NA	NA	NA	NA	Synchronous primary	0	NA	a6f47847-a453-462a-bf51-48f2f61cabde	false	NA	NA	NA	Right	8255/3	Adenocarcinoma with mixed subtypes	NA	NA	NA	Not Reported	NA	TCGA-97-A4M7_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M7_treatment3	NA	NA	NA	NA	c5c2ddb2-73fa-4219-ac0e-a7601d70281d	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c6b680e3-d96e-4fc7-8053-77454b7a14fa	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M7	74	false	United States	-27062	NA	e4098a4a-49b2-571f-8b83-3efcbbb7d324	not hispanic or latino	male	white	TCGA-97-A4M7_demographic	Alive	27062	M0	N0	Stage IA	T1b	7th	primary	0	629.0	a848d4db-cdba-54b8-b28c-eb74683cbcf0	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-97-A4M7_diagnosis	Yes	Middle lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M7_treatment	NA	NA	NA	NA	03ae8af5-be7e-5108-92b9-f4cc148eecf5	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c6b680e3-d96e-4fc7-8053-77454b7a14fa	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M7	74	false	United States	-27062	NA	e4098a4a-49b2-571f-8b83-3efcbbb7d324	not hispanic or latino	male	white	TCGA-97-A4M7_demographic	Alive	27062	M0	N0	Stage IA	T1b	7th	primary	0	629.0	a848d4db-cdba-54b8-b28c-eb74683cbcf0	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-97-A4M7_diagnosis	Yes	Middle lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M7_treatment2	NA	NA	NA	NA	cbb5a73c-6a7c-4fd3-b632-c501dda2ad7d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c6d78e27-e510-4f57-abae-19efa6105a8d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4494	77	false	United States	-28387	1081	e6fc1afb-a2e9-55e1-851b-d56448cc27ce	not hispanic or latino	male	white	TCGA-49-4494_demographic	Dead	28387	M0	N2	Stage IIIA	T3	4th	primary	0	1081.0	72a22beb-7021-5b36-b654-3cb89d97a71f	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4494_diagnosis	No	Upper lobe, lung	NA	1995	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4494_treatment	NA	NA	NA	NA	884cbbc6-82aa-5dcc-9344-a2ac3a6e522c	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c6d78e27-e510-4f57-abae-19efa6105a8d	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4494	77	false	United States	-28387	1081	e6fc1afb-a2e9-55e1-851b-d56448cc27ce	not hispanic or latino	male	white	TCGA-49-4494_demographic	Dead	28387	M0	N2	Stage IIIA	T3	4th	primary	0	1081.0	72a22beb-7021-5b36-b654-3cb89d97a71f	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4494_diagnosis	No	Upper lobe, lung	NA	1995	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4494_treatment2	NA	NA	NA	NA	d16c9ad3-6a7b-4522-b37e-fb52e77a02ed	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	c8544fb3-b26e-4672-bb81-a271db724b04	Informed Consent	-21	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5775	71	false	United States	-26058	62	5c165dad-73d5-5297-96d9-30fa0bffa53a	not hispanic or latino	male	white	TCGA-64-5775_demographic	Dead	26058	M0	N0	Stage IIIA	T4	NA	primary	0	62.0	0cb61081-598d-5a15-b89e-5cfd7b0123c9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Yes	R0	Lung, NOS	NA	TCGA-64-5775_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-5775_treatment3	NA	NA	NA	NA	2556bc43-78e9-4fc5-b2ff-3150f284afe8	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c8544fb3-b26e-4672-bb81-a271db724b04	Informed Consent	-21	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5775	71	false	United States	-26058	62	5c165dad-73d5-5297-96d9-30fa0bffa53a	not hispanic or latino	male	white	TCGA-64-5775_demographic	Dead	26058	M0	N0	Stage IIIA	T4	NA	primary	0	62.0	0cb61081-598d-5a15-b89e-5cfd7b0123c9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Yes	R0	Lung, NOS	NA	TCGA-64-5775_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	34	0	Not Reported	5	NA	80.0	mg/m2	Intravenous	TCGA-64-5775_treatment2	Paclitaxel	NA	NA	NA	65f0aba7-8739-401a-aae3-e898413806ba	Neoadjuvant	yes	NA	Chemotherapy
TCGA-LUAD	c8544fb3-b26e-4672-bb81-a271db724b04	Informed Consent	-21	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5775	71	false	United States	-26058	62	5c165dad-73d5-5297-96d9-30fa0bffa53a	not hispanic or latino	male	white	TCGA-64-5775_demographic	Dead	26058	M0	N0	Stage IIIA	T4	NA	primary	0	62.0	0cb61081-598d-5a15-b89e-5cfd7b0123c9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	Yes	R0	Lung, NOS	NA	TCGA-64-5775_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	28	0	Not Reported	2	NA	5.0	AUC	Intravenous	TCGA-64-5775_treatment	Carboplatin	NA	NA	NA	7454b085-ff3c-5fae-8ef9-b5a82540054f	Neoadjuvant	yes	NA	Chemotherapy
TCGA-LUAD	c95957a7-1a1a-4c8d-bb61-7c99b500f224	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5946	62	false	United States	-22852	NA	b3cc11b6-5267-5158-92fa-3903195e41e6	not reported	male	white	TCGA-50-5946_demographic	Alive	23073	NA	NA	NA	NA	NA	metastasis	221	NA	6666fc21-437c-42d0-8496-4cd0d8e5329b	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5946_diagnosis2	NA	Not Reported	TCGA-50-5946_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5946_treatment3	NA	NA	NA	NA	1b927f99-4ad9-4a3b-a1ba-0b49d7095764	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c95957a7-1a1a-4c8d-bb61-7c99b500f224	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5946	62	false	United States	-22852	NA	b3cc11b6-5267-5158-92fa-3903195e41e6	not reported	male	white	TCGA-50-5946_demographic	Alive	23073	NA	NA	NA	NA	NA	metastasis	221	NA	6666fc21-437c-42d0-8496-4cd0d8e5329b	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5946_diagnosis2	NA	Not Reported	TCGA-50-5946_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5946_treatment4	NA	NA	NA	NA	52ee89b0-d94d-4307-a2ad-3456034f2809	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	c95957a7-1a1a-4c8d-bb61-7c99b500f224	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5946	62	false	United States	-22852	NA	b3cc11b6-5267-5158-92fa-3903195e41e6	not reported	male	white	TCGA-50-5946_demographic	Alive	23073	NA	NA	NA	NA	NA	metastasis	221	NA	6666fc21-437c-42d0-8496-4cd0d8e5329b	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5946_diagnosis2	NA	Not Reported	TCGA-50-5946_diagnosis	NA	NA	NA	NA	221	NA	NA	NA	NA	NA	NA	TCGA-50-5946_treatment6	NA	Distant Site	NA	NA	d6b3075b-4f19-43c6-883f-e892abe82d6e	NA	yes	NA	Surgery, NOS
TCGA-LUAD	c95957a7-1a1a-4c8d-bb61-7c99b500f224	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5946	62	false	United States	-22852	NA	b3cc11b6-5267-5158-92fa-3903195e41e6	not reported	male	white	TCGA-50-5946_demographic	Alive	23073	NA	NA	NA	NA	NA	metastasis	221	NA	6666fc21-437c-42d0-8496-4cd0d8e5329b	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5946_diagnosis2	NA	Not Reported	TCGA-50-5946_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5946_treatment5	NA	Locoregional Site	NA	NA	edad2012-e8de-47fa-b89b-e458b8d165cf	NA	no	NA	Surgery, NOS
TCGA-LUAD	c95957a7-1a1a-4c8d-bb61-7c99b500f224	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5946	62	false	United States	-22852	NA	b3cc11b6-5267-5158-92fa-3903195e41e6	not reported	male	white	TCGA-50-5946_demographic	Alive	23663	NA	NA	NA	NA	NA	metastasis	811	NA	bacc0bfd-764c-45e5-992a-60e4d9db3c28	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5946_diagnosis3	NA	Not Reported	TCGA-50-5946_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5946_treatment7	NA	NA	NA	NA	4a30a096-2fab-4449-931a-784260f1df85	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c95957a7-1a1a-4c8d-bb61-7c99b500f224	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5946	62	false	United States	-22852	NA	b3cc11b6-5267-5158-92fa-3903195e41e6	not reported	male	white	TCGA-50-5946_demographic	Alive	23663	NA	NA	NA	NA	NA	metastasis	811	NA	bacc0bfd-764c-45e5-992a-60e4d9db3c28	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5946_diagnosis3	NA	Not Reported	TCGA-50-5946_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5946_treatment9	NA	Distant Site	NA	NA	8ca4ab1d-cc21-42e8-b0a1-d552367fef53	NA	no	NA	Surgery, NOS
TCGA-LUAD	c95957a7-1a1a-4c8d-bb61-7c99b500f224	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5946	62	false	United States	-22852	NA	b3cc11b6-5267-5158-92fa-3903195e41e6	not reported	male	white	TCGA-50-5946_demographic	Alive	23663	NA	NA	NA	NA	NA	metastasis	811	NA	bacc0bfd-764c-45e5-992a-60e4d9db3c28	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5946_diagnosis3	NA	Not Reported	TCGA-50-5946_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5946_treatment8	NA	NA	NA	NA	eade9d65-0b13-4140-b4f5-f15bedb9fa26	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c95957a7-1a1a-4c8d-bb61-7c99b500f224	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5946	62	false	United States	-22852	NA	b3cc11b6-5267-5158-92fa-3903195e41e6	not reported	male	white	TCGA-50-5946_demographic	Alive	22852	MX	N0	Stage IA	T1	NA	primary	0	1617.0	fd90fd05-50b3-5816-8d56-b0f0c7b37c59	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-50-5946_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5946_treatment	NA	NA	NA	NA	2d8c4486-8912-551f-b95d-d27728ac75b4	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c95957a7-1a1a-4c8d-bb61-7c99b500f224	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5946	62	false	United States	-22852	NA	b3cc11b6-5267-5158-92fa-3903195e41e6	not reported	male	white	TCGA-50-5946_demographic	Alive	22852	MX	N0	Stage IA	T1	NA	primary	0	1617.0	fd90fd05-50b3-5816-8d56-b0f0c7b37c59	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-50-5946_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5946_treatment2	NA	NA	NA	NA	5051286e-7fae-4717-a8eb-1e842d90d2ff	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	c9c533ee-e154-4a56-bce9-b5af37574b2f	Informed Consent	62	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7913	61	false	United States	-22326	561	19b8093e-b421-54c1-b9ed-f6d050138df0	not hispanic or latino	female	black or african american	TCGA-55-7913_demographic	Dead	22806	NA	NA	NA	NA	NA	metastasis	480	NA	26d744c6-1519-46b8-995f-031c92802ea2	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7913_diagnosis2	NA	Not Reported	TCGA-55-7913_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7913_treatment4	NA	NA	NA	NA	a4b3b6bc-9a40-48be-aa29-baceaf1311bd	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	c9c533ee-e154-4a56-bce9-b5af37574b2f	Informed Consent	62	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7913	61	false	United States	-22326	561	19b8093e-b421-54c1-b9ed-f6d050138df0	not hispanic or latino	female	black or african american	TCGA-55-7913_demographic	Dead	22806	NA	NA	NA	NA	NA	metastasis	480	NA	26d744c6-1519-46b8-995f-031c92802ea2	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7913_diagnosis2	NA	Not Reported	TCGA-55-7913_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7913_treatment3	NA	NA	NA	NA	c26d1eb0-763d-4d62-98c1-f0d2cec10121	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c9c533ee-e154-4a56-bce9-b5af37574b2f	Informed Consent	62	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7913	61	false	United States	-22326	561	19b8093e-b421-54c1-b9ed-f6d050138df0	not hispanic or latino	female	black or african american	TCGA-55-7913_demographic	Dead	22806	NA	NA	NA	NA	NA	metastasis	480	NA	26d744c6-1519-46b8-995f-031c92802ea2	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7913_diagnosis2	NA	Not Reported	TCGA-55-7913_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7913_treatment5	NA	Distant Site	NA	NA	dcd58e07-c320-49ae-89d0-6d6f9cb14178	NA	no	NA	Surgery, NOS
TCGA-LUAD	c9c533ee-e154-4a56-bce9-b5af37574b2f	Informed Consent	62	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7913	61	false	United States	-22326	561	19b8093e-b421-54c1-b9ed-f6d050138df0	not hispanic or latino	female	black or african american	TCGA-55-7913_demographic	Dead	22326	MX	N0	Stage IA	T1b	7th	primary	0	561.0	fc139c55-5494-5202-bcd4-2a0e94cd0d71	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-55-7913_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7913_treatment	NA	NA	NA	NA	ca8a45b6-3565-5938-b6a7-9870b7b33bcb	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	c9c533ee-e154-4a56-bce9-b5af37574b2f	Informed Consent	62	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7913	61	false	United States	-22326	561	19b8093e-b421-54c1-b9ed-f6d050138df0	not hispanic or latino	female	black or african american	TCGA-55-7913_demographic	Dead	22326	MX	N0	Stage IA	T1b	7th	primary	0	561.0	fc139c55-5494-5202-bcd4-2a0e94cd0d71	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-55-7913_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7913_treatment2	NA	NA	NA	NA	e8619b96-e115-4bfd-90b5-2512e41ce80e	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	cbbea9f1-396a-4bf3-b67c-2cac3394dceb	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-6779	50	false	United States	-18469	500	ac5430ab-508e-5901-8f55-a2e11f6f91a0	not reported	female	white	TCGA-44-6779_demographic	Dead	18701	NA	NA	NA	NA	NA	not reported	232	NA	0ffd2bf1-447c-4c66-a9a9-ffd3696dac60	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-6779_diagnosis2	NA	Not Reported	TCGA-44-6779_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-6779_treatment6	NA	NA	NA	NA	2dd532ee-cbe2-48c8-9067-918327362303	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cbbea9f1-396a-4bf3-b67c-2cac3394dceb	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-6779	50	false	United States	-18469	500	ac5430ab-508e-5901-8f55-a2e11f6f91a0	not reported	female	white	TCGA-44-6779_demographic	Dead	18701	NA	NA	NA	NA	NA	not reported	232	NA	0ffd2bf1-447c-4c66-a9a9-ffd3696dac60	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-6779_diagnosis2	NA	Not Reported	TCGA-44-6779_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6779_treatment8	NA	Locoregional Site	NA	NA	7c0bc3aa-587f-4412-a002-e77a205ef94e	NA	no	NA	Surgery, NOS
TCGA-LUAD	cbbea9f1-396a-4bf3-b67c-2cac3394dceb	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-6779	50	false	United States	-18469	500	ac5430ab-508e-5901-8f55-a2e11f6f91a0	not reported	female	white	TCGA-44-6779_demographic	Dead	18701	NA	NA	NA	NA	NA	not reported	232	NA	0ffd2bf1-447c-4c66-a9a9-ffd3696dac60	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-6779_diagnosis2	NA	Not Reported	TCGA-44-6779_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-6779_treatment7	NA	NA	NA	NA	d5baab48-a030-4fe8-8918-53376f588bab	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cbbea9f1-396a-4bf3-b67c-2cac3394dceb	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-6779	50	false	United States	-18469	500	ac5430ab-508e-5901-8f55-a2e11f6f91a0	not reported	female	white	TCGA-44-6779_demographic	Dead	18469	MX	N1	Stage IIB	T2	6th	primary	0	500.0	150dea56-8a22-5dd1-bc74-49a4db018b72	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6779_diagnosis	No	Lung, NOS	NA	2008	NA	NA	141	77	NA	4	NA	340.0	mg	Intravenous	TCGA-44-6779_treatment	Paclitaxel	NA	1360	mg	16141d63-8779-5928-846c-57550ce96982	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	cbbea9f1-396a-4bf3-b67c-2cac3394dceb	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-6779	50	false	United States	-18469	500	ac5430ab-508e-5901-8f55-a2e11f6f91a0	not reported	female	white	TCGA-44-6779_demographic	Dead	18469	MX	N1	Stage IIB	T2	6th	primary	0	500.0	150dea56-8a22-5dd1-bc74-49a4db018b72	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6779_diagnosis	No	Lung, NOS	NA	2008	NA	NA	435	391	Progressive Disease	5	NA	1600.0	mg	Intravenous	TCGA-44-6779_treatment2	Gemcitabine	NA	8000	mg	175778a0-7448-46a9-bfe0-b7722f7f0178	NA	yes	NA	Chemotherapy
TCGA-LUAD	cbbea9f1-396a-4bf3-b67c-2cac3394dceb	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-6779	50	false	United States	-18469	500	ac5430ab-508e-5901-8f55-a2e11f6f91a0	not reported	female	white	TCGA-44-6779_demographic	Dead	18469	MX	N1	Stage IIB	T2	6th	primary	0	500.0	150dea56-8a22-5dd1-bc74-49a4db018b72	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6779_diagnosis	No	Lung, NOS	NA	2008	NA	NA	141	77	NA	4	NA	650.0	mg	Intravenous	TCGA-44-6779_treatment3	Carboplatin	NA	2600	mg	28c822af-6879-4ffa-bcab-077592bb617e	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	cbbea9f1-396a-4bf3-b67c-2cac3394dceb	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-6779	50	false	United States	-18469	500	ac5430ab-508e-5901-8f55-a2e11f6f91a0	not reported	female	white	TCGA-44-6779_demographic	Dead	18469	MX	N1	Stage IIB	T2	6th	primary	0	500.0	150dea56-8a22-5dd1-bc74-49a4db018b72	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6779_diagnosis	No	Lung, NOS	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-6779_treatment5	NA	NA	NA	NA	dd6afc56-c3cc-473e-875e-ee866e6c8c53	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cbbea9f1-396a-4bf3-b67c-2cac3394dceb	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-6779	50	false	United States	-18469	500	ac5430ab-508e-5901-8f55-a2e11f6f91a0	not reported	female	white	TCGA-44-6779_demographic	Dead	18469	MX	N1	Stage IIB	T2	6th	primary	0	500.0	150dea56-8a22-5dd1-bc74-49a4db018b72	true	NA	NA	C34.1	NA	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-6779_diagnosis	No	Lung, NOS	NA	2008	NA	NA	303	257	Recurrent Disease	3	NA	130.0	mg	Intravenous	TCGA-44-6779_treatment4	Docetaxel	NA	390	mg	e07c90e5-f0b3-4037-aff7-8d55d595bbf0	NA	yes	NA	Chemotherapy
TCGA-LUAD	cbf1f718-6bb7-4daf-b9d6-fb294281decb	Informed Consent	-10	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8172	75	false	United States	-27416	NA	f03b1c7f-f19d-5d71-8606-eb4cf4825389	not hispanic or latino	female	white	TCGA-97-8172_demographic	Alive	27416	M0	N0	Stage IB	T2a	7th	primary	0	545.0	1230238f-f315-5b9c-9d6a-f46a92ed34a8	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	yes	No	NA	Lung, NOS	NA	TCGA-97-8172_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8172_treatment	NA	NA	NA	NA	28699788-42fe-5db3-868c-5ab11ffdcb66	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cbf1f718-6bb7-4daf-b9d6-fb294281decb	Informed Consent	-10	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8172	75	false	United States	-27416	NA	f03b1c7f-f19d-5d71-8606-eb4cf4825389	not hispanic or latino	female	white	TCGA-97-8172_demographic	Alive	27416	M0	N0	Stage IB	T2a	7th	primary	0	545.0	1230238f-f315-5b9c-9d6a-f46a92ed34a8	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	yes	No	NA	Lung, NOS	NA	TCGA-97-8172_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8172_treatment2	NA	NA	NA	NA	eeddb548-c328-478a-882b-780564af8db1	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cbf1f718-6bb7-4daf-b9d6-fb294281decb	Informed Consent	-10	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8172	75	false	United States	-27416	NA	f03b1c7f-f19d-5d71-8606-eb4cf4825389	not hispanic or latino	female	white	TCGA-97-8172_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ffd58476-0f30-48b2-8cd8-43cd300c7493	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-97-8172_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8172_treatment4	NA	NA	NA	NA	1286b9d4-96ed-4357-be58-3a1b4dbf5b68	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cbf1f718-6bb7-4daf-b9d6-fb294281decb	Informed Consent	-10	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-8172	75	false	United States	-27416	NA	f03b1c7f-f19d-5d71-8606-eb4cf4825389	not hispanic or latino	female	white	TCGA-97-8172_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ffd58476-0f30-48b2-8cd8-43cd300c7493	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-97-8172_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-8172_treatment3	NA	NA	NA	NA	4a5ad460-3e84-436d-9653-0503becdae56	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cbfef004-b437-4d51-9d88-a2db50aa6481	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7661	69	false	United States	-25483	557	bc703056-2351-508c-9da6-42d3e4ce1cdf	not hispanic or latino	female	white	TCGA-44-7661_demographic	Dead	25818	NA	NA	NA	NA	NA	recurrence	335	NA	73ca63eb-8ec3-4dac-807a-655096a0505c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-7661_diagnosis3	NA	Not Reported	TCGA-44-7661_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-7661_treatment9	NA	NA	NA	NA	5213825d-d56e-47b4-8594-2ed01d44e05e	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	cbfef004-b437-4d51-9d88-a2db50aa6481	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7661	69	false	United States	-25483	557	bc703056-2351-508c-9da6-42d3e4ce1cdf	not hispanic or latino	female	white	TCGA-44-7661_demographic	Dead	25818	NA	NA	NA	NA	NA	recurrence	335	NA	73ca63eb-8ec3-4dac-807a-655096a0505c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-7661_diagnosis3	NA	Not Reported	TCGA-44-7661_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7661_treatment11	NA	Distant Site	NA	NA	ba559e88-7f2d-4df3-a7a4-fd42a298ee3a	NA	no	NA	Surgery, NOS
TCGA-LUAD	cbfef004-b437-4d51-9d88-a2db50aa6481	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7661	69	false	United States	-25483	557	bc703056-2351-508c-9da6-42d3e4ce1cdf	not hispanic or latino	female	white	TCGA-44-7661_demographic	Dead	25818	NA	NA	NA	NA	NA	recurrence	335	NA	73ca63eb-8ec3-4dac-807a-655096a0505c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-7661_diagnosis3	NA	Not Reported	TCGA-44-7661_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-7661_treatment8	NA	NA	NA	NA	e5128e06-65ca-421e-9619-a1d82b831899	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cbfef004-b437-4d51-9d88-a2db50aa6481	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7661	69	false	United States	-25483	557	bc703056-2351-508c-9da6-42d3e4ce1cdf	not hispanic or latino	female	white	TCGA-44-7661_demographic	Dead	25818	NA	NA	NA	NA	NA	recurrence	335	NA	73ca63eb-8ec3-4dac-807a-655096a0505c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-7661_diagnosis3	NA	Not Reported	TCGA-44-7661_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7661_treatment10	NA	Locoregional Site	NA	NA	fb32592e-54a2-42bb-a5ee-ec379a79f4b1	NA	no	NA	Surgery, NOS
TCGA-LUAD	cbfef004-b437-4d51-9d88-a2db50aa6481	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7661	69	false	United States	-25483	557	bc703056-2351-508c-9da6-42d3e4ce1cdf	not hispanic or latino	female	white	TCGA-44-7661_demographic	Dead	25818	NA	NA	NA	NA	NA	recurrence	335	NA	aa85fb12-5fb1-4a40-8153-0ded058897a5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-7661_diagnosis2	NA	Not Reported	TCGA-44-7661_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-7661_treatment5	NA	NA	NA	NA	89142ba8-6f38-4b7d-a41f-38af83eef58c	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cbfef004-b437-4d51-9d88-a2db50aa6481	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7661	69	false	United States	-25483	557	bc703056-2351-508c-9da6-42d3e4ce1cdf	not hispanic or latino	female	white	TCGA-44-7661_demographic	Dead	25818	NA	NA	NA	NA	NA	recurrence	335	NA	aa85fb12-5fb1-4a40-8153-0ded058897a5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-7661_diagnosis2	NA	Not Reported	TCGA-44-7661_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-7661_treatment6	NA	NA	NA	NA	adffb146-90a0-422d-a7d5-ce5f6dee796d	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	cbfef004-b437-4d51-9d88-a2db50aa6481	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7661	69	false	United States	-25483	557	bc703056-2351-508c-9da6-42d3e4ce1cdf	not hispanic or latino	female	white	TCGA-44-7661_demographic	Dead	25818	NA	NA	NA	NA	NA	recurrence	335	NA	aa85fb12-5fb1-4a40-8153-0ded058897a5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-44-7661_diagnosis2	NA	Not Reported	TCGA-44-7661_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7661_treatment7	NA	Locoregional Site	NA	NA	f6d5be07-979e-40ac-bd75-4ccc8e2ab88f	NA	no	NA	Surgery, NOS
TCGA-LUAD	cbfef004-b437-4d51-9d88-a2db50aa6481	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7661	69	false	United States	-25483	557	bc703056-2351-508c-9da6-42d3e4ce1cdf	not hispanic or latino	female	white	TCGA-44-7661_demographic	Dead	NA	M0	N0	Stage I	T1a	7th	Synchronous primary	NA	NA	aaf3615b-c5cf-425d-831f-2b34f8415845	false	NA	NA	NA	NA	8380/3	Endometrioid adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-7661_diagnosis4	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7661_treatment3	NA	NA	NA	NA	a6d4db7f-7d08-4f23-b600-20998d59523e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cbfef004-b437-4d51-9d88-a2db50aa6481	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7661	69	false	United States	-25483	557	bc703056-2351-508c-9da6-42d3e4ce1cdf	not hispanic or latino	female	white	TCGA-44-7661_demographic	Dead	NA	M0	N0	Stage I	T1a	7th	Synchronous primary	NA	NA	aaf3615b-c5cf-425d-831f-2b34f8415845	false	NA	NA	NA	NA	8380/3	Endometrioid adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-7661_diagnosis4	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7661_treatment4	NA	NA	NA	NA	cfb50dae-1582-48f9-97cb-74ef071c162f	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cbfef004-b437-4d51-9d88-a2db50aa6481	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7661	69	false	United States	-25483	557	bc703056-2351-508c-9da6-42d3e4ce1cdf	not hispanic or latino	female	white	TCGA-44-7661_demographic	Dead	25483	M0	N0	Stage IB	T2a	7th	primary	0	557.0	e101de53-dfa9-5905-bd7a-54fe4e51ec2e	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-44-7661_diagnosis	Yes	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7661_treatment	NA	NA	NA	NA	5e66d924-1b32-5a10-86e9-b59f866131ba	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cbfef004-b437-4d51-9d88-a2db50aa6481	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7661	69	false	United States	-25483	557	bc703056-2351-508c-9da6-42d3e4ce1cdf	not hispanic or latino	female	white	TCGA-44-7661_demographic	Dead	25483	M0	N0	Stage IB	T2a	7th	primary	0	557.0	e101de53-dfa9-5905-bd7a-54fe4e51ec2e	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-44-7661_diagnosis	Yes	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7661_treatment2	NA	NA	NA	NA	c0ca1032-138a-4fd7-a3d4-7ec14675384a	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	28988	M0	N1	Stage IIA	T1	6th	primary	0	1830.0	38c706ff-7826-5e95-bf08-984c3bb89d10	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-5055_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5055_treatment7	NA	NA	NA	NA	16d9377a-48f1-4ed7-a557-375646af916b	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	28988	M0	N1	Stage IIA	T1	6th	primary	0	1830.0	38c706ff-7826-5e95-bf08-984c3bb89d10	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-5055_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	1522	1284	NA	NA	NA	NA	NA	NA	TCGA-50-5055_treatment4	Pemetrexed Disodium	NA	NA	NA	296842b0-5e1d-4c49-9c55-1637de5b2ba8	NA	yes	Progressive Disease	Pharmaceutical Therapy, NOS
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	28988	M0	N1	Stage IIA	T1	6th	primary	0	1830.0	38c706ff-7826-5e95-bf08-984c3bb89d10	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-5055_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	153	31	NA	NA	NA	NA	NA	NA	TCGA-50-5055_treatment	Unknown	NA	NA	NA	90cb3911-4a99-5ab1-9379-f69126afec7e	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	28988	M0	N1	Stage IIA	T1	6th	primary	0	1830.0	38c706ff-7826-5e95-bf08-984c3bb89d10	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-5055_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	1284	1135	NA	NA	NA	NA	NA	NA	TCGA-50-5055_treatment3	Paclitaxel	NA	NA	NA	a5a65582-47a5-42fe-9f09-2db0c691d3e9	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	28988	M0	N1	Stage IIA	T1	6th	primary	0	1830.0	38c706ff-7826-5e95-bf08-984c3bb89d10	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-5055_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	1284	1135	NA	NA	NA	NA	NA	NA	TCGA-50-5055_treatment2	Carboplatin	NA	NA	NA	ab49446e-d866-4568-a042-41a310878586	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	28988	M0	N1	Stage IIA	T1	6th	primary	0	1830.0	38c706ff-7826-5e95-bf08-984c3bb89d10	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-5055_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	1649	1522	NA	NA	NA	NA	NA	NA	TCGA-50-5055_treatment5	Erlotinib Hydrochloride	NA	NA	NA	b15ca394-39d7-496e-98b7-afe81dc51539	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	28988	M0	N1	Stage IIA	T1	6th	primary	0	1830.0	38c706ff-7826-5e95-bf08-984c3bb89d10	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-5055_diagnosis	No	Lower lobe, lung	NA	2008	No	NA	NA	1649	NA	NA	NA	NA	NA	NA	TCGA-50-5055_treatment6	Docetaxel	NA	NA	NA	e09de412-31fc-49d7-85cb-c3c40369c904	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	29759	NA	NA	NA	NA	NA	recurrence	771	NA	6c80e52a-f825-49e5-98f6-d2a12da3e65d	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5055_diagnosis2	NA	Not Reported	TCGA-50-5055_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5055_treatment8	NA	NA	NA	NA	56502141-2d31-4225-970b-2fed9ca9aff4	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	29759	NA	NA	NA	NA	NA	recurrence	771	NA	6c80e52a-f825-49e5-98f6-d2a12da3e65d	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5055_diagnosis2	NA	Not Reported	TCGA-50-5055_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5055_treatment9	NA	NA	NA	NA	7331dc4d-a09f-413f-9f07-dc7269bf1f70	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	29759	NA	NA	NA	NA	NA	recurrence	771	NA	6c80e52a-f825-49e5-98f6-d2a12da3e65d	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5055_diagnosis2	NA	Not Reported	TCGA-50-5055_diagnosis	NA	NA	NA	NA	792	NA	NA	NA	NA	NA	NA	TCGA-50-5055_treatment10	NA	Locoregional Site	NA	NA	9aa53399-4da6-4c9d-96e9-ed90e3e26e13	NA	yes	NA	Surgery, NOS
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	29759	NA	NA	NA	NA	NA	recurrence	771	NA	6c80e52a-f825-49e5-98f6-d2a12da3e65d	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5055_diagnosis2	NA	Not Reported	TCGA-50-5055_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5055_treatment11	NA	Distant Site	NA	NA	e3c303da-70a3-4b32-a334-69976d861713	NA	no	NA	Surgery, NOS
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	29759	NA	NA	NA	NA	NA	metastasis	771	NA	c339d99b-da86-4356-96f2-52b92e709862	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5055_diagnosis3	NA	Not Reported	TCGA-50-5055_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5055_treatment12	NA	NA	NA	NA	352f9131-0c72-45b3-9f4a-32bd90628e0b	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	29759	NA	NA	NA	NA	NA	metastasis	771	NA	c339d99b-da86-4356-96f2-52b92e709862	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5055_diagnosis3	NA	Not Reported	TCGA-50-5055_diagnosis	NA	NA	NA	NA	792	NA	NA	NA	NA	NA	NA	TCGA-50-5055_treatment14	NA	Locoregional Site	NA	NA	8d211fa2-3553-471b-90d1-f40b603bad24	NA	yes	NA	Surgery, NOS
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	29759	NA	NA	NA	NA	NA	metastasis	771	NA	c339d99b-da86-4356-96f2-52b92e709862	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5055_diagnosis3	NA	Not Reported	TCGA-50-5055_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5055_treatment15	NA	Distant Site	NA	NA	a127ad54-9b1e-4ca3-adee-57679260d121	NA	no	NA	Surgery, NOS
TCGA-LUAD	cc3d9750-7ce0-489f-86d4-8017b7ebed29	Informed Consent	-19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5055	79	false	United States	-28988	1830	eef115d0-6802-57a1-a63a-f094df964c6e	not hispanic or latino	female	white	TCGA-50-5055_demographic	Dead	29759	NA	NA	NA	NA	NA	metastasis	771	NA	c339d99b-da86-4356-96f2-52b92e709862	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-5055_diagnosis3	NA	Not Reported	TCGA-50-5055_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5055_treatment13	NA	NA	NA	NA	e26365a7-412c-4ffe-afe9-04eb282b36c5	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	cc4bd56a-25c5-4c48-b583-ac3aeb778ca6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4628	65	false	United States	-24057	1492	68676fa7-4bfb-54b8-a507-62d90b393239	not hispanic or latino	female	white	TCGA-38-4628_demographic	Dead	25140	NA	NA	NA	NA	NA	not reported	1083	NA	0d1ee451-3c60-497e-beec-8a0f5a30b92b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4628_diagnosis2	NA	Not Reported	TCGA-38-4628_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4628_treatment4	NA	NA	NA	NA	3c102c41-0c21-4160-8696-b4bd3e31e0d9	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cc4bd56a-25c5-4c48-b583-ac3aeb778ca6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4628	65	false	United States	-24057	1492	68676fa7-4bfb-54b8-a507-62d90b393239	not hispanic or latino	female	white	TCGA-38-4628_demographic	Dead	25140	NA	NA	NA	NA	NA	not reported	1083	NA	0d1ee451-3c60-497e-beec-8a0f5a30b92b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4628_diagnosis2	NA	Not Reported	TCGA-38-4628_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4628_treatment6	NA	Locoregional Site	NA	NA	4f54eacd-1cd9-4858-b619-e1bdadc9dfae	NA	no	NA	Surgery, NOS
TCGA-LUAD	cc4bd56a-25c5-4c48-b583-ac3aeb778ca6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4628	65	false	United States	-24057	1492	68676fa7-4bfb-54b8-a507-62d90b393239	not hispanic or latino	female	white	TCGA-38-4628_demographic	Dead	25140	NA	NA	NA	NA	NA	not reported	1083	NA	0d1ee451-3c60-497e-beec-8a0f5a30b92b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4628_diagnosis2	NA	Not Reported	TCGA-38-4628_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4628_treatment5	NA	NA	NA	NA	5cc9d762-cdee-431e-8ab6-86a88ad63406	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cc4bd56a-25c5-4c48-b583-ac3aeb778ca6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4628	65	false	United States	-24057	1492	68676fa7-4bfb-54b8-a507-62d90b393239	not hispanic or latino	female	white	TCGA-38-4628_demographic	Dead	25140	NA	NA	NA	NA	NA	not reported	1083	NA	0d1ee451-3c60-497e-beec-8a0f5a30b92b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4628_diagnosis2	NA	Not Reported	TCGA-38-4628_diagnosis	NA	NA	NA	NA	1118	NA	NA	NA	NA	NA	NA	TCGA-38-4628_treatment7	NA	Distant Site	NA	NA	9804fc8e-c6e5-4682-b782-c5faa1193691	NA	yes	NA	Surgery, NOS
TCGA-LUAD	cc4bd56a-25c5-4c48-b583-ac3aeb778ca6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4628	65	false	United States	-24057	1492	68676fa7-4bfb-54b8-a507-62d90b393239	not hispanic or latino	female	white	TCGA-38-4628_demographic	Dead	24057	M0	N1	Stage IIB	T2	5th	primary	0	1492.0	f4b0df2c-5c72-5720-97ec-f4a06f3b065e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-38-4628_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	1238	1147	Recurrent Disease	4	NA	NA	NA	Intravenous	TCGA-38-4628_treatment	Carboplatin	NA	NA	NA	31080afd-07b5-50d2-b0f2-e329a4b25de7	NA	yes	NA	Chemotherapy
TCGA-LUAD	cc4bd56a-25c5-4c48-b583-ac3aeb778ca6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4628	65	false	United States	-24057	1492	68676fa7-4bfb-54b8-a507-62d90b393239	not hispanic or latino	female	white	TCGA-38-4628_demographic	Dead	24057	M0	N1	Stage IIB	T2	5th	primary	0	1492.0	f4b0df2c-5c72-5720-97ec-f4a06f3b065e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-38-4628_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	1238	1147	Recurrent Disease	4	NA	NA	NA	Intravenous	TCGA-38-4628_treatment2	Paclitaxel	NA	NA	NA	c8621d90-5953-44d6-9f97-285ac0a11950	NA	yes	NA	Chemotherapy
TCGA-LUAD	cc4bd56a-25c5-4c48-b583-ac3aeb778ca6	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4628	65	false	United States	-24057	1492	68676fa7-4bfb-54b8-a507-62d90b393239	not hispanic or latino	female	white	TCGA-38-4628_demographic	Dead	24057	M0	N1	Stage IIB	T2	5th	primary	0	1492.0	f4b0df2c-5c72-5720-97ec-f4a06f3b065e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-38-4628_diagnosis	No	Upper lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4628_treatment3	NA	NA	NA	NA	d85e4433-1abf-4c78-b824-ace7891a1677	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cc68632c-b1e3-491b-b562-9468e2d1c101	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7713	70	false	Russia	-25791	NA	df8fe597-d4c0-535d-9f98-b2d8efca4e7d	not hispanic or latino	male	white	TCGA-86-7713_demographic	Alive	25791	M0	N0	Stage IIA	T2b	7th	primary	0	1157.0	9a00eba3-4b62-5160-9187-ace5051627f8	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7713_diagnosis	No	Middle lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-7713_treatment3	NA	NA	NA	NA	931aadd3-76c1-419d-a406-ede5e9ec2781	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cc68632c-b1e3-491b-b562-9468e2d1c101	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7713	70	false	Russia	-25791	NA	df8fe597-d4c0-535d-9f98-b2d8efca4e7d	not hispanic or latino	male	white	TCGA-86-7713_demographic	Alive	25791	M0	N0	Stage IIA	T2b	7th	primary	0	1157.0	9a00eba3-4b62-5160-9187-ace5051627f8	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7713_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	182	29	NA	NA	NA	NA	NA	NA	TCGA-86-7713_treatment2	Cisplatin	NA	NA	NA	c4df6481-e49c-4471-8c2e-8ae69a235017	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	cc68632c-b1e3-491b-b562-9468e2d1c101	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-7713	70	false	Russia	-25791	NA	df8fe597-d4c0-535d-9f98-b2d8efca4e7d	not hispanic or latino	male	white	TCGA-86-7713_demographic	Alive	25791	M0	N0	Stage IIA	T2b	7th	primary	0	1157.0	9a00eba3-4b62-5160-9187-ace5051627f8	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-7713_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	182	29	NA	NA	NA	NA	NA	NA	TCGA-86-7713_treatment	Etoposide	NA	NA	NA	f956e021-689a-5713-acad-7c64b4ee7561	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2662	65	false	United States	-24014	NA	74437697-a86d-50cf-a76e-f7ee7b48113b	not hispanic or latino	male	white	TCGA-44-2662_demographic	Alive	24259	NA	NA	NA	NA	NA	not reported	245	NA	34f36df5-51f7-4f9b-892b-eea34b898ff3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2662_diagnosis2	NA	Not Reported	TCGA-44-2662_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-2662_treatment9	NA	NA	NA	NA	2b75760d-34d7-4936-8f84-915a99ee5afb	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2662	65	false	United States	-24014	NA	74437697-a86d-50cf-a76e-f7ee7b48113b	not hispanic or latino	male	white	TCGA-44-2662_demographic	Alive	24259	NA	NA	NA	NA	NA	not reported	245	NA	34f36df5-51f7-4f9b-892b-eea34b898ff3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2662_diagnosis2	NA	Not Reported	TCGA-44-2662_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2662_treatment11	NA	Distant Site	NA	NA	430fdc34-8f1f-449f-a1d9-799f6f47d4cd	NA	no	NA	Surgery, NOS
TCGA-LUAD	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2662	65	false	United States	-24014	NA	74437697-a86d-50cf-a76e-f7ee7b48113b	not hispanic or latino	male	white	TCGA-44-2662_demographic	Alive	24259	NA	NA	NA	NA	NA	not reported	245	NA	34f36df5-51f7-4f9b-892b-eea34b898ff3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2662_diagnosis2	NA	Not Reported	TCGA-44-2662_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2662_treatment10	NA	Locoregional Site	NA	NA	454a7421-0918-44af-bff4-a35a7dd2cfd1	NA	no	NA	Surgery, NOS
TCGA-LUAD	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2662	65	false	United States	-24014	NA	74437697-a86d-50cf-a76e-f7ee7b48113b	not hispanic or latino	male	white	TCGA-44-2662_demographic	Alive	24259	NA	NA	NA	NA	NA	not reported	245	NA	34f36df5-51f7-4f9b-892b-eea34b898ff3	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-44-2662_diagnosis2	NA	Not Reported	TCGA-44-2662_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-44-2662_treatment8	NA	NA	NA	NA	a186be3a-e251-4a13-a997-72ff5125ade1	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2662	65	false	United States	-24014	NA	74437697-a86d-50cf-a76e-f7ee7b48113b	not hispanic or latino	male	white	TCGA-44-2662_demographic	Alive	19522	NA	NA	NA	NA	NA	Prior primary	-4492	NA	36ab0f79-3ee6-4755-b4b8-da96a63f8a75	false	NA	NA	NA	Left	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-2662_diagnosis3	NA	Thorax, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2662_treatment6	NA	NA	NA	NA	200410dc-22e0-473f-aa8a-5c1adc7ffd3d	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2662	65	false	United States	-24014	NA	74437697-a86d-50cf-a76e-f7ee7b48113b	not hispanic or latino	male	white	TCGA-44-2662_demographic	Alive	19522	NA	NA	NA	NA	NA	Prior primary	-4492	NA	36ab0f79-3ee6-4755-b4b8-da96a63f8a75	false	NA	NA	NA	Left	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-2662_diagnosis3	NA	Thorax, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2662_treatment5	NA	NA	NA	NA	607cd464-ab76-4538-a88c-67b7309f933b	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2662	65	false	United States	-24014	NA	74437697-a86d-50cf-a76e-f7ee7b48113b	not hispanic or latino	male	white	TCGA-44-2662_demographic	Alive	19522	NA	NA	NA	NA	NA	Prior primary	-4492	NA	36ab0f79-3ee6-4755-b4b8-da96a63f8a75	false	NA	NA	NA	Left	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-2662_diagnosis3	NA	Thorax, NOS	NA	NA	NA	NA	NA	-4492	NA	NA	NA	NA	NA	NA	TCGA-44-2662_treatment7	NA	Skin	NA	NA	f97f8c33-2553-4fa0-b122-e26b2fbabf2e	NA	yes	NA	Surgery, NOS
TCGA-LUAD	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2662	65	false	United States	-24014	NA	74437697-a86d-50cf-a76e-f7ee7b48113b	not hispanic or latino	male	white	TCGA-44-2662_demographic	Alive	24014	M0	N0	Stage IB	T2	6th	primary	0	1280.0	5d03f15b-da09-5567-baac-d198f7478421	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-44-2662_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	162	76	NA	5	NA	0.5	mL	Intramuscular	TCGA-44-2662_treatment2	Clinical Trial	NA	3	mL	444b3ea6-9022-45a3-a63c-6217f725e7d5	Adjuvant	yes	NA	Immunotherapy (Including Vaccines)
TCGA-LUAD	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2662	65	false	United States	-24014	NA	74437697-a86d-50cf-a76e-f7ee7b48113b	not hispanic or latino	male	white	TCGA-44-2662_demographic	Alive	24014	M0	N0	Stage IB	T2	6th	primary	0	1280.0	5d03f15b-da09-5567-baac-d198f7478421	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-44-2662_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	362	277	Progressive Disease	8	NA	935.0	mg	Intravenous	TCGA-44-2662_treatment4	Carboplatin	NA	3817	mg	470a92c3-e220-4ceb-b12d-563bbc14f8a6	NA	yes	NA	Chemotherapy
TCGA-LUAD	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2662	65	false	United States	-24014	NA	74437697-a86d-50cf-a76e-f7ee7b48113b	not hispanic or latino	male	white	TCGA-44-2662_demographic	Alive	24014	M0	N0	Stage IB	T2	6th	primary	0	1280.0	5d03f15b-da09-5567-baac-d198f7478421	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-44-2662_diagnosis	No	Upper lobe, lung	NA	2009	NA	1.0	316	277	Progressive Disease	NA	30.0	NA	NA	NA	TCGA-44-2662_treatment	NA	Locoregional Site	6000	cGy	73219191-118c-5c17-a830-0f30474cecef	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	ccda26c1-a6d6-4317-8cf8-8a87e15ce12e	Informed Consent	-22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2662	65	false	United States	-24014	NA	74437697-a86d-50cf-a76e-f7ee7b48113b	not hispanic or latino	male	white	TCGA-44-2662_demographic	Alive	24014	M0	N0	Stage IB	T2	6th	primary	0	1280.0	5d03f15b-da09-5567-baac-d198f7478421	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-44-2662_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	362	277	Progressive Disease	8	NA	480.0	mg	Intravenous	TCGA-44-2662_treatment3	Paclitaxel	NA	1608	mg	778a2cec-bd23-4f11-ae1f-f7c934c4e258	NA	yes	NA	Chemotherapy
TCGA-LUAD	ccecce70-dd54-4c5b-bf9f-ca87d290cb00	Informed Consent	10	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6216	57	false	United States	-20967	NA	aa915b28-aa8b-54d1-8301-8c6feb0d83fe	not hispanic or latino	female	white	TCGA-67-6216_demographic	Alive	20967	M0	N0	Stage IA	T1a	7th	primary	0	141.0	60da3209-a447-5b7b-b8af-c4b69f61a6ca	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-6216_diagnosis	No	Middle lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-67-6216_treatment2	NA	NA	NA	NA	16f5456d-293b-4a84-9d98-60d0937aa3fc	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ccecce70-dd54-4c5b-bf9f-ca87d290cb00	Informed Consent	10	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6216	57	false	United States	-20967	NA	aa915b28-aa8b-54d1-8301-8c6feb0d83fe	not hispanic or latino	female	white	TCGA-67-6216_demographic	Alive	20967	M0	N0	Stage IA	T1a	7th	primary	0	141.0	60da3209-a447-5b7b-b8af-c4b69f61a6ca	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-6216_diagnosis	No	Middle lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-67-6216_treatment	NA	NA	NA	NA	9755068a-5107-5cd1-be67-d614005408ba	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ccfdad76-cc45-447f-bed8-ede8f6a8844d	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7283	76	false	United States	-27946	NA	9beaebfc-c95e-5746-87ad-8442ee7e977b	not hispanic or latino	female	white	TCGA-55-7283_demographic	Alive	27946	MX	N2	Stage IIIA	T3	7th	primary	0	609.0	67451eed-b29f-5da0-9cf8-e89c614b9b21	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	Central Lung	TCGA-55-7283_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	386	83	NA	NA	NA	NA	NA	NA	TCGA-55-7283_treatment	Carboplatin	NA	NA	NA	4bdbbe96-11a8-5c1b-8e1e-2ed87c2f6382	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	ccfdad76-cc45-447f-bed8-ede8f6a8844d	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7283	76	false	United States	-27946	NA	9beaebfc-c95e-5746-87ad-8442ee7e977b	not hispanic or latino	female	white	TCGA-55-7283_demographic	Alive	27946	MX	N2	Stage IIIA	T3	7th	primary	0	609.0	67451eed-b29f-5da0-9cf8-e89c614b9b21	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	Central Lung	TCGA-55-7283_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7283_treatment3	NA	NA	NA	NA	a2480c7e-22e5-4357-a789-bef34c6bf6a9	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ccfdad76-cc45-447f-bed8-ede8f6a8844d	Informed Consent	35	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7283	76	false	United States	-27946	NA	9beaebfc-c95e-5746-87ad-8442ee7e977b	not hispanic or latino	female	white	TCGA-55-7283_demographic	Alive	27946	MX	N2	Stage IIIA	T3	7th	primary	0	609.0	67451eed-b29f-5da0-9cf8-e89c614b9b21	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	NA	Lung, NOS	Central Lung	TCGA-55-7283_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	386	83	NA	NA	NA	NA	NA	NA	TCGA-55-7283_treatment2	Pemetrexed Disodium	NA	NA	NA	a48000fb-8a5b-463f-93d7-ebb8dee0e111	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24253	M0	N2	Stage IIIA	T2	6th	primary	0	711.0	28287ed6-5c08-570e-a9d1-2e41547ad187	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4659_diagnosis	No	Lung, NOS	NA	2006	NA	NA	581	539	Progressive Disease	2	NA	NA	NA	Intravenous	TCGA-73-4659_treatment10	Gemcitabine	NA	NA	NA	25be8c44-90ae-4cc5-a805-56a882a16d58	NA	yes	NA	Chemotherapy
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24253	M0	N2	Stage IIIA	T2	6th	primary	0	711.0	28287ed6-5c08-570e-a9d1-2e41547ad187	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4659_diagnosis	No	Lung, NOS	NA	2006	NA	NA	581	546	Progressive Disease	2	NA	NA	NA	Intravenous	TCGA-73-4659_treatment9	Cisplatin	NA	300	mg	5643ed1e-0d54-4a7e-938e-e31fbf3e5074	NA	yes	NA	Chemotherapy
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24253	M0	N2	Stage IIIA	T2	6th	primary	0	711.0	28287ed6-5c08-570e-a9d1-2e41547ad187	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4659_diagnosis	No	Lung, NOS	NA	2006	NA	2.0	529	516	NA	NA	10.0	NA	NA	NA	TCGA-73-4659_treatment2	NA	Regional Site	3000	cGy	99a16f13-625e-4df8-9ef5-35b2e828c655	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24253	M0	N2	Stage IIIA	T2	6th	primary	0	711.0	28287ed6-5c08-570e-a9d1-2e41547ad187	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4659_diagnosis	No	Lung, NOS	NA	2006	NA	NA	609	602	Progressive Disease	2	NA	NA	NA	Intravenous	TCGA-73-4659_treatment3	Paclitaxel	NA	200	mg	9b723b86-5564-4660-bad7-d4107c7752e1	NA	yes	NA	Chemotherapy
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24253	M0	N2	Stage IIIA	T2	6th	primary	0	711.0	28287ed6-5c08-570e-a9d1-2e41547ad187	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4659_diagnosis	No	Lung, NOS	NA	2006	NA	NA	406	312	Progressive Disease	5	NA	150.0	mg	Oral	TCGA-73-4659_treatment7	Erlotinib	NA	9000	mg	9e5da961-9c09-47da-b35d-2e3ff95d70e1	NA	yes	NA	Targeted Molecular Therapy
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24253	M0	N2	Stage IIIA	T2	6th	primary	0	711.0	28287ed6-5c08-570e-a9d1-2e41547ad187	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4659_diagnosis	No	Lung, NOS	NA	2006	NA	NA	298	257	Progressive Disease	3	NA	500.0	mg/m2	Intravenous	TCGA-73-4659_treatment5	Pemetrexed Disodium	NA	3000	mg	b42f4f96-a2f8-4646-b0b3-c9757fef5683	NA	yes	NA	Chemotherapy
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24253	M0	N2	Stage IIIA	T2	6th	primary	0	711.0	28287ed6-5c08-570e-a9d1-2e41547ad187	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4659_diagnosis	No	Lung, NOS	NA	2006	NA	1.0	337	337	Progressive Disease	NA	1.0	NA	NA	NA	TCGA-73-4659_treatment	NA	Distant Site	2200	cGy	c18830d1-ed85-5248-a842-a7e7550bd2b2	NA	yes	NA	Radiation, Stereotactic/Gamma Knife/SRS
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24253	M0	N2	Stage IIIA	T2	6th	primary	0	711.0	28287ed6-5c08-570e-a9d1-2e41547ad187	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4659_diagnosis	No	Lung, NOS	NA	2006	NA	NA	452	410	Progressive Disease	2	NA	NA	NA	Intravenous	TCGA-73-4659_treatment6	Vinorelbine	NA	300	mg	c2c7771c-3e24-49b8-b721-e5c1b04cb829	NA	yes	NA	Chemotherapy
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24253	M0	N2	Stage IIIA	T2	6th	primary	0	711.0	28287ed6-5c08-570e-a9d1-2e41547ad187	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4659_diagnosis	No	Lung, NOS	NA	2006	NA	NA	494	473	Progressive Disease	4	NA	NA	NA	Intravenous	TCGA-73-4659_treatment8	Docetaxel	NA	150	mg	deb5acf8-0cdd-49a4-922d-a2177971b4bd	NA	yes	NA	Chemotherapy
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24253	M0	N2	Stage IIIA	T2	6th	primary	0	711.0	28287ed6-5c08-570e-a9d1-2e41547ad187	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-73-4659_diagnosis	No	Lung, NOS	NA	2006	NA	NA	657	624	Not Reported	3	NA	720.0	mg	Oral	TCGA-73-4659_treatment4	Aurora Kinase/VEGFR2 Inhibitor CYC116	NA	15120	mg	fd94b1a9-d30c-4666-af0f-e72dc2986880	Not Reported	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24288	NA	NA	NA	NA	NA	not reported	35	NA	400f1aea-39f4-434c-933d-994b0194ccd5	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4659_diagnosis2	NA	Not Reported	TCGA-73-4659_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-73-4659_treatment11	NA	NA	NA	NA	13654918-73f6-4dc1-ae81-0784527bb9f1	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24288	NA	NA	NA	NA	NA	not reported	35	NA	400f1aea-39f4-434c-933d-994b0194ccd5	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4659_diagnosis2	NA	Not Reported	TCGA-73-4659_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4659_treatment13	NA	Locoregional Site	NA	NA	9741b885-2a17-4ecb-98f1-76366b284f17	NA	no	NA	Surgery, NOS
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24288	NA	NA	NA	NA	NA	not reported	35	NA	400f1aea-39f4-434c-933d-994b0194ccd5	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-73-4659_diagnosis2	NA	Not Reported	TCGA-73-4659_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-73-4659_treatment12	NA	NA	NA	NA	fea64ec4-08d5-4469-b31c-9b7391f522a5	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24569	NA	NA	NA	NA	NA	metastasis	316	NA	536d4d35-a014-498b-be8c-00fae3586780	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-73-4659_diagnosis4	NA	Not Reported	TCGA-73-4659_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-73-4659_treatment18	NA	NA	NA	NA	1faa3d7e-54cd-44e6-80a7-87ed00f48e08	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24569	NA	NA	NA	NA	NA	metastasis	316	NA	536d4d35-a014-498b-be8c-00fae3586780	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-73-4659_diagnosis4	NA	Not Reported	TCGA-73-4659_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4659_treatment19	NA	Distant Site	NA	NA	3ba8a70b-b372-444e-b5fa-96f6517083ce	NA	no	NA	Surgery, NOS
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24569	NA	NA	NA	NA	NA	metastasis	316	NA	536d4d35-a014-498b-be8c-00fae3586780	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-73-4659_diagnosis4	NA	Not Reported	TCGA-73-4659_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-73-4659_treatment17	NA	NA	NA	NA	d93911c0-8a63-40ea-8958-0c97b6440e06	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24300	NA	NA	NA	NA	NA	recurrence	47	NA	75081e24-de38-415f-baef-e6ca07d2f09b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-73-4659_diagnosis3	NA	Not Reported	TCGA-73-4659_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-73-4659_treatment16	NA	Locoregional Site	NA	NA	09611bb2-0d9c-4cd0-9cd1-158cf21a5d44	NA	no	NA	Surgery, NOS
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24300	NA	NA	NA	NA	NA	recurrence	47	NA	75081e24-de38-415f-baef-e6ca07d2f09b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-73-4659_diagnosis3	NA	Not Reported	TCGA-73-4659_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-73-4659_treatment15	NA	NA	NA	NA	42258705-6328-43cc-982b-76f6d9de8193	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cd0dc947-b708-464e-beb7-954c9d4583e7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-73-4659	66	false	United States	-24253	711	ec90791b-e6c0-5e62-8dc4-7b721ae1e5db	not hispanic or latino	male	white	TCGA-73-4659_demographic	Dead	24300	NA	NA	NA	NA	NA	recurrence	47	NA	75081e24-de38-415f-baef-e6ca07d2f09b	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-73-4659_diagnosis3	NA	Not Reported	TCGA-73-4659_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-73-4659_treatment14	NA	NA	NA	NA	5593ecf3-7881-4143-bcb0-47cf10739b8b	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cd902d08-215e-4bd0-88e4-4fd01ab43cbf	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8073	58	false	Russia	-21214	NA	a7f73687-5e40-53d9-a2d9-6512eb86f33d	not hispanic or latino	male	white	TCGA-86-8073_demographic	Alive	21214	M0	N0	Stage IB	T2a	7th	primary	0	740.0	ee363bf4-fd32-5882-a41f-d23c04cb4b92	true	NA	NA	C34.1	Left	8250/3	Bronchiolo-alveolar adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8073_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8073_treatment	NA	NA	NA	NA	ac5ff6dd-43f8-5fcf-a08e-14e6a0975f7b	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cd902d08-215e-4bd0-88e4-4fd01ab43cbf	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8073	58	false	Russia	-21214	NA	a7f73687-5e40-53d9-a2d9-6512eb86f33d	not hispanic or latino	male	white	TCGA-86-8073_demographic	Alive	21214	M0	N0	Stage IB	T2a	7th	primary	0	740.0	ee363bf4-fd32-5882-a41f-d23c04cb4b92	true	NA	NA	C34.1	Left	8250/3	Bronchiolo-alveolar adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8073_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8073_treatment2	NA	NA	NA	NA	dccbc750-1aec-425c-b518-5f1f45e3f882	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	cd9e70e4-8622-4a07-8646-63f8275c1737	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AARE	51	false	United States	-18893	1229	383e2b8e-b3c9-59d7-85a8-445d698fdf34	not hispanic or latino	female	black or african american	TCGA-49-AARE_demographic	Dead	19281	NA	NA	NA	NA	NA	recurrence	388	NA	06af331e-89f7-4df8-82da-d0946bbc6e90	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARE_diagnosis2	NA	Not Reported	TCGA-49-AARE_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-AARE_treatment3	NA	NA	NA	NA	326f1858-a4b3-4936-b975-686c0dd4a369	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cd9e70e4-8622-4a07-8646-63f8275c1737	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AARE	51	false	United States	-18893	1229	383e2b8e-b3c9-59d7-85a8-445d698fdf34	not hispanic or latino	female	black or african american	TCGA-49-AARE_demographic	Dead	19281	NA	NA	NA	NA	NA	recurrence	388	NA	06af331e-89f7-4df8-82da-d0946bbc6e90	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARE_diagnosis2	NA	Not Reported	TCGA-49-AARE_diagnosis	NA	NA	NA	NA	392	NA	NA	NA	NA	NA	NA	TCGA-49-AARE_treatment5	NA	Locoregional Site	NA	NA	9590d7c9-a81e-44d1-bcc2-b15c0f14d36e	NA	yes	NA	Surgery, NOS
TCGA-LUAD	cd9e70e4-8622-4a07-8646-63f8275c1737	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AARE	51	false	United States	-18893	1229	383e2b8e-b3c9-59d7-85a8-445d698fdf34	not hispanic or latino	female	black or african american	TCGA-49-AARE_demographic	Dead	19281	NA	NA	NA	NA	NA	recurrence	388	NA	06af331e-89f7-4df8-82da-d0946bbc6e90	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-AARE_diagnosis2	NA	Not Reported	TCGA-49-AARE_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-AARE_treatment4	NA	NA	NA	NA	993af981-591f-48c2-9d8d-c37cb324bea6	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	cd9e70e4-8622-4a07-8646-63f8275c1737	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AARE	51	false	United States	-18893	1229	383e2b8e-b3c9-59d7-85a8-445d698fdf34	not hispanic or latino	female	black or african american	TCGA-49-AARE_demographic	Dead	18893	MX	N0	Stage IA	T1	5th	primary	0	1229.0	52a07365-bfff-5715-81a2-6bf6143108eb	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AARE_diagnosis	No	Upper lobe, lung	NA	1999	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARE_treatment2	NA	NA	NA	NA	aed3831b-5285-4925-9266-4b18da171dd0	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	cd9e70e4-8622-4a07-8646-63f8275c1737	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-AARE	51	false	United States	-18893	1229	383e2b8e-b3c9-59d7-85a8-445d698fdf34	not hispanic or latino	female	black or african american	TCGA-49-AARE_demographic	Dead	18893	MX	N0	Stage IA	T1	5th	primary	0	1229.0	52a07365-bfff-5715-81a2-6bf6143108eb	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-AARE_diagnosis	No	Upper lobe, lung	NA	1999	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AARE_treatment	NA	NA	NA	NA	cfe01cdb-deb3-53b3-b309-94d90c05be4d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ce15f31f-2bad-4485-96fa-495bfa262e66	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4403	76	false	Germany	-27881	NA	3b781506-d343-5c71-925a-64b713c2c120	not reported	male	not reported	TCGA-05-4403_demographic	Alive	27881	M0	N0	Stage IB	T2	5th	primary	0	578.0	6bb4d500-47b2-5686-b276-9fc67e4c9ce0	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4403_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	ceead734-1ce0-4385-b65a-a9c853b7308e	Informed Consent	-10	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MN-A4N4	57	false	United States	-20888	NA	17131553-dff0-5b14-b75a-7a68fdbf575b	not hispanic or latino	male	white	TCGA-MN-A4N4_demographic	Alive	20888	M0	N0	Stage IA	T1b	7th	primary	0	1175.0	4c6182ff-c45f-51fd-bf09-15c2a93a3fc9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MN-A4N4_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MN-A4N4_treatment2	NA	NA	NA	NA	6e4428a6-b373-45d5-835d-54a722c50f2f	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ceead734-1ce0-4385-b65a-a9c853b7308e	Informed Consent	-10	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MN-A4N4	57	false	United States	-20888	NA	17131553-dff0-5b14-b75a-7a68fdbf575b	not hispanic or latino	male	white	TCGA-MN-A4N4_demographic	Alive	20888	M0	N0	Stage IA	T1b	7th	primary	0	1175.0	4c6182ff-c45f-51fd-bf09-15c2a93a3fc9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MN-A4N4_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MN-A4N4_treatment	NA	NA	NA	NA	6f92d14e-698d-57fe-a59a-f4d5ef42c01d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	cf411fc0-0cce-42d2-ae79-24de1a105c05	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z023	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	d020e685-0435-4b0a-b03f-45853e1c6eed	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z032	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	d12b6930-9ae4-4fe7-ad69-d183135c91ab	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8091	74	false	United States	-27385	NA	db06d45d-91f0-5f44-9489-9c1d8004d2f7	not hispanic or latino	male	white	TCGA-55-8091_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	55a731f0-a590-4425-88ce-2f9c8cce5d94	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8091_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8091_treatment3	NA	NA	NA	NA	7445c77b-38d8-4e53-b1da-fe60fedde0a3	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d12b6930-9ae4-4fe7-ad69-d183135c91ab	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8091	74	false	United States	-27385	NA	db06d45d-91f0-5f44-9489-9c1d8004d2f7	not hispanic or latino	male	white	TCGA-55-8091_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	55a731f0-a590-4425-88ce-2f9c8cce5d94	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-8091_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8091_treatment4	NA	NA	NA	NA	e78efc4d-3020-40d9-84c5-83cb6a3adf6a	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d12b6930-9ae4-4fe7-ad69-d183135c91ab	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8091	74	false	United States	-27385	NA	db06d45d-91f0-5f44-9489-9c1d8004d2f7	not hispanic or latino	male	white	TCGA-55-8091_demographic	Alive	27385	MX	N0	Stage IB	T2	7th	primary	0	600.0	bce965b0-d099-5a8b-927c-d90c7364d02a	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-8091_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8091_treatment	NA	NA	NA	NA	45b239f3-38d7-5053-b7f4-bab7c1f75ac6	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d12b6930-9ae4-4fe7-ad69-d183135c91ab	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8091	74	false	United States	-27385	NA	db06d45d-91f0-5f44-9489-9c1d8004d2f7	not hispanic or latino	male	white	TCGA-55-8091_demographic	Alive	27385	MX	N0	Stage IB	T2	7th	primary	0	600.0	bce965b0-d099-5a8b-927c-d90c7364d02a	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-55-8091_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8091_treatment2	NA	NA	NA	NA	db745377-b2cd-4eb7-bf7b-51b40df12732	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	d15b7b29-c5c5-41d8-b83b-7cc12fe92820	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4415	57	false	Germany	-20880	91	1dd704b0-9fd5-50f2-a3be-f9655f0e9e32	not reported	male	not reported	TCGA-05-4415_demographic	Dead	20940	NA	NA	NA	NA	NA	not reported	60	NA	94274f06-18d4-4491-8927-781ab74d02d7	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-4415_diagnosis2	NA	Not Reported	TCGA-05-4415_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-4415_treatment3	NA	NA	NA	NA	a23eb0d9-5a08-488a-9a4c-fd2c7ccdbb3f	NA	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d15b7b29-c5c5-41d8-b83b-7cc12fe92820	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4415	57	false	Germany	-20880	91	1dd704b0-9fd5-50f2-a3be-f9655f0e9e32	not reported	male	not reported	TCGA-05-4415_demographic	Dead	20940	NA	NA	NA	NA	NA	not reported	60	NA	94274f06-18d4-4491-8927-781ab74d02d7	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-05-4415_diagnosis2	NA	Not Reported	TCGA-05-4415_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-05-4415_treatment4	NA	NA	NA	NA	f27febb3-c5fb-4826-bf23-1ebe37a91355	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	d15b7b29-c5c5-41d8-b83b-7cc12fe92820	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4415	57	false	Germany	-20880	91	1dd704b0-9fd5-50f2-a3be-f9655f0e9e32	not reported	male	not reported	TCGA-05-4415_demographic	Dead	20880	M0	N2	Stage IIIB	T4	6th	primary	0	91.0	b4072c25-08c6-5917-9698-ba8de9fda8b8	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4415_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4415_treatment	NA	NA	NA	NA	29e50887-0b98-5886-a68c-11c7648527b7	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d15b7b29-c5c5-41d8-b83b-7cc12fe92820	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4415	57	false	Germany	-20880	91	1dd704b0-9fd5-50f2-a3be-f9655f0e9e32	not reported	male	not reported	TCGA-05-4415_demographic	Dead	20880	M0	N2	Stage IIIB	T4	6th	primary	0	91.0	b4072c25-08c6-5917-9698-ba8de9fda8b8	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4415_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4415_treatment2	NA	NA	NA	NA	59b73f93-2758-4b43-b639-d527e54c9e52	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d2824e6d-3784-45c2-9b0f-52b17356b5da	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-5147	NA	false	Canada	NA	NA	bcf9767d-3646-54cb-a8a5-8ccddcb4f64c	not reported	female	not reported	TCGA-75-5147_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	1333.0	e2cd2d18-8b7c-5895-b6bc-a7b3d1177f51	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-5147_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5147_treatment2	NA	NA	NA	NA	0668f454-1893-42a3-a716-6f8feeef1e8a	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d2824e6d-3784-45c2-9b0f-52b17356b5da	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-75-5147	NA	false	Canada	NA	NA	bcf9767d-3646-54cb-a8a5-8ccddcb4f64c	not reported	female	not reported	TCGA-75-5147_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	1333.0	e2cd2d18-8b7c-5895-b6bc-a7b3d1177f51	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-5147_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-5147_treatment	NA	NA	NA	NA	08737307-5bcc-5a3c-8928-a1ce87f512b3	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d288b69f-1e79-4429-8646-9994b7c54f8f	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7154	72	false	Australia	-26481	593	4a829f8d-02f5-5e92-888e-f045ba603d8b	not reported	male	white	TCGA-78-7154_demographic	Dead	26481	M0	N2	Stage IIIA	T3	6th	primary	0	593.0	73bb4e25-c5e0-5512-b492-2b639a7b93d0	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7154_diagnosis	No	Upper lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	d28e465c-e553-4c53-8bb7-3d8199b9a8a5	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4410	62	false	Germany	-22888	NA	883ee3ec-ddd4-5897-a878-695d42a63b5b	not reported	male	not reported	TCGA-05-4410_demographic	Alive	22888	M0	N0	Stage IB	T2	6th	primary	0	0.0	1e1381da-1b32-564e-bf6b-c3609c213f83	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	yes	No	RX	Lung, NOS	NA	TCGA-05-4410_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	d28e465c-e553-4c53-8bb7-3d8199b9a8a5	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4410	62	false	Germany	-22888	NA	883ee3ec-ddd4-5897-a878-695d42a63b5b	not reported	male	not reported	TCGA-05-4410_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	3defd627-764f-43df-9a97-8b61c6d56faa	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4410_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4410_treatment	NA	NA	NA	NA	4140338e-0816-4508-ba65-ae6c7dec2f48	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d28e465c-e553-4c53-8bb7-3d8199b9a8a5	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4410	62	false	Germany	-22888	NA	883ee3ec-ddd4-5897-a878-695d42a63b5b	not reported	male	not reported	TCGA-05-4410_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	3defd627-764f-43df-9a97-8b61c6d56faa	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4410_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4410_treatment2	NA	NA	NA	NA	e2b63946-6683-4b4f-a654-5458f0eaed2b	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d2c1e896-6886-4122-bb48-5fbcd3f641f4	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4418	69	false	Germany	-25417	274	6c38e4a5-bbb0-5672-8541-ea208a915ac6	not reported	male	not reported	TCGA-05-4418_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	0cb7dcc0-6db0-4f38-8bcf-fca5d9a15767	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4418_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4418_treatment2	NA	NA	NA	NA	2eb3d357-8b28-465b-aad4-37c9e79225f5	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d2c1e896-6886-4122-bb48-5fbcd3f641f4	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4418	69	false	Germany	-25417	274	6c38e4a5-bbb0-5672-8541-ea208a915ac6	not reported	male	not reported	TCGA-05-4418_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	0cb7dcc0-6db0-4f38-8bcf-fca5d9a15767	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4418_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4418_treatment	NA	NA	NA	NA	4b4d67c4-10df-48b3-8b99-09f47b2b2689	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d2c1e896-6886-4122-bb48-5fbcd3f641f4	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4418	69	false	Germany	-25417	274	6c38e4a5-bbb0-5672-8541-ea208a915ac6	not reported	male	not reported	TCGA-05-4418_demographic	Dead	25417	M0	N2	Stage IIIA	T3	6th	primary	0	274.0	8b9860c6-68e4-5efe-af6b-3e78d5bd83c2	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-05-4418_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	d31aeefc-b59b-42e9-9919-750b17a70a3d	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1595	74	false	United States	NA	NA	f18d4042-1df7-5c94-aa22-be24c3f23236	not hispanic or latino	female	asian	TCGA-55-1595_demographic	Alive	NA	M0	N0	NA	T1c	4th	Prior primary	NA	NA	de91c8bb-a83b-4b60-bcb8-eb484bd786b2	false	NA	NA	NA	Right	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-1595_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	-2717	NA	NA	NA	NA	NA	NA	TCGA-55-1595_treatment4	NA	Locoregional Site	NA	NA	d0961f2a-8a77-4b2a-a461-a6f4a5a8d494	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	d31aeefc-b59b-42e9-9919-750b17a70a3d	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1595	74	false	United States	NA	NA	f18d4042-1df7-5c94-aa22-be24c3f23236	not hispanic or latino	female	asian	TCGA-55-1595_demographic	Alive	NA	M0	N0	NA	T1c	4th	Prior primary	NA	NA	de91c8bb-a83b-4b60-bcb8-eb484bd786b2	false	NA	NA	NA	Right	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-55-1595_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-1595_treatment3	NA	NA	NA	NA	e28d5a32-3527-4d9d-bca8-93a03304165f	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d31aeefc-b59b-42e9-9919-750b17a70a3d	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1595	74	false	United States	NA	NA	f18d4042-1df7-5c94-aa22-be24c3f23236	not hispanic or latino	female	asian	TCGA-55-1595_demographic	Alive	NA	M0	N0	Stage IA	T1	6th	primary	0	1479.0	ed623db2-1a20-599e-b07d-209e3dbe14da	true	NA	NA	C34.3	Left	8310/3	Clear cell adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-55-1595_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-1595_treatment2	NA	NA	NA	NA	3159825f-8991-4633-8673-dfa21f0a9540	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d31aeefc-b59b-42e9-9919-750b17a70a3d	Informed Consent	4	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-1595	74	false	United States	NA	NA	f18d4042-1df7-5c94-aa22-be24c3f23236	not hispanic or latino	female	asian	TCGA-55-1595_demographic	Alive	NA	M0	N0	Stage IA	T1	6th	primary	0	1479.0	ed623db2-1a20-599e-b07d-209e3dbe14da	true	NA	NA	C34.3	Left	8310/3	Clear cell adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-55-1595_diagnosis	No	Lower lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-1595_treatment	NA	NA	NA	NA	9fb0ee03-8ce6-55ff-a65c-cdb5734feb45	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d344dae0-adf4-4697-b703-7690c13d8331	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VK	74	false	United States	-27040	NA	b0dbea01-94e9-5d48-beb3-092ba893ab4f	not hispanic or latino	female	white	TCGA-95-A4VK_demographic	Alive	27040	M0	N2	Stage IIIA	T2b	7th	primary	0	651.0	5468024a-6d83-5849-b59d-52a167eabf4a	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	RX	Lung, NOS	NA	TCGA-95-A4VK_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	121	76	NA	NA	NA	NA	NA	NA	TCGA-95-A4VK_treatment3	Pemetrexed Disodium	NA	NA	NA	226d9bc4-1709-4e3c-8e17-2bb33506c15f	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	d344dae0-adf4-4697-b703-7690c13d8331	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VK	74	false	United States	-27040	NA	b0dbea01-94e9-5d48-beb3-092ba893ab4f	not hispanic or latino	female	white	TCGA-95-A4VK_demographic	Alive	27040	M0	N2	Stage IIIA	T2b	7th	primary	0	651.0	5468024a-6d83-5849-b59d-52a167eabf4a	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	RX	Lung, NOS	NA	TCGA-95-A4VK_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	202	202	NA	NA	28.0	NA	NA	NA	TCGA-95-A4VK_treatment	NA	Regional Site	50	Gy	9f2e311b-10c1-5ebe-b1d4-7d232077d909	NA	yes	Stable Disease	Radiation, External Beam
TCGA-LUAD	d344dae0-adf4-4697-b703-7690c13d8331	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VK	74	false	United States	-27040	NA	b0dbea01-94e9-5d48-beb3-092ba893ab4f	not hispanic or latino	female	white	TCGA-95-A4VK_demographic	Alive	27040	M0	N2	Stage IIIA	T2b	7th	primary	0	651.0	5468024a-6d83-5849-b59d-52a167eabf4a	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	RX	Lung, NOS	NA	TCGA-95-A4VK_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	121	76	NA	NA	NA	NA	NA	NA	TCGA-95-A4VK_treatment2	Cisplatin	NA	NA	NA	ef2b3163-5e1d-4f79-a99a-edbaa12ca17e	NA	yes	Stable Disease	Chemotherapy
TCGA-LUAD	d344dae0-adf4-4697-b703-7690c13d8331	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VK	74	false	United States	-27040	NA	b0dbea01-94e9-5d48-beb3-092ba893ab4f	not hispanic or latino	female	white	TCGA-95-A4VK_demographic	Alive	24818	NA	NA	NA	NA	NA	Prior primary	-2222	NA	7a933ec3-655a-4ffe-a1ee-448b32b4ab0b	false	NA	NA	NA	Right	8720/3	Melanoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-A4VK_diagnosis3	NA	Thorax, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VK_treatment4	NA	NA	NA	NA	27067f36-d188-4c4e-afeb-4324bcd5c8e4	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d344dae0-adf4-4697-b703-7690c13d8331	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VK	74	false	United States	-27040	NA	b0dbea01-94e9-5d48-beb3-092ba893ab4f	not hispanic or latino	female	white	TCGA-95-A4VK_demographic	Alive	24818	NA	NA	NA	NA	NA	Prior primary	-2222	NA	7a933ec3-655a-4ffe-a1ee-448b32b4ab0b	false	NA	NA	NA	Right	8720/3	Melanoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-A4VK_diagnosis3	NA	Thorax, NOS	NA	NA	NA	NA	NA	-2233	NA	NA	NA	NA	NA	NA	TCGA-95-A4VK_treatment6	NA	Not Reported	NA	NA	3ce45068-d42d-48f8-99d7-e47031d8fe4d	NA	yes	NA	Surgery, NOS
TCGA-LUAD	d344dae0-adf4-4697-b703-7690c13d8331	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VK	74	false	United States	-27040	NA	b0dbea01-94e9-5d48-beb3-092ba893ab4f	not hispanic or latino	female	white	TCGA-95-A4VK_demographic	Alive	24818	NA	NA	NA	NA	NA	Prior primary	-2222	NA	7a933ec3-655a-4ffe-a1ee-448b32b4ab0b	false	NA	NA	NA	Right	8720/3	Melanoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-A4VK_diagnosis3	NA	Thorax, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VK_treatment5	NA	NA	NA	NA	8a5edf6a-379b-4e74-95e0-72cdae2da117	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d344dae0-adf4-4697-b703-7690c13d8331	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VK	74	false	United States	-27040	NA	b0dbea01-94e9-5d48-beb3-092ba893ab4f	not hispanic or latino	female	white	TCGA-95-A4VK_demographic	Alive	27536	NA	NA	NA	NA	NA	metastasis	496	NA	a39f131e-0a01-471a-a8d6-b6ee81b6d9e9	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-95-A4VK_diagnosis2	NA	Not Reported	TCGA-95-A4VK_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-95-A4VK_treatment7	NA	NA	NA	NA	7060524e-dbd5-48b0-97bf-e0975f2e32f6	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d344dae0-adf4-4697-b703-7690c13d8331	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VK	74	false	United States	-27040	NA	b0dbea01-94e9-5d48-beb3-092ba893ab4f	not hispanic or latino	female	white	TCGA-95-A4VK_demographic	Alive	27536	NA	NA	NA	NA	NA	metastasis	496	NA	a39f131e-0a01-471a-a8d6-b6ee81b6d9e9	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-95-A4VK_diagnosis2	NA	Not Reported	TCGA-95-A4VK_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-A4VK_treatment9	NA	Distant Site	NA	NA	911711d4-3c1c-44c0-83cc-b498f43cd2dc	NA	no	NA	Surgery, NOS
TCGA-LUAD	d344dae0-adf4-4697-b703-7690c13d8331	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-A4VK	74	false	United States	-27040	NA	b0dbea01-94e9-5d48-beb3-092ba893ab4f	not hispanic or latino	female	white	TCGA-95-A4VK_demographic	Alive	27536	NA	NA	NA	NA	NA	metastasis	496	NA	a39f131e-0a01-471a-a8d6-b6ee81b6d9e9	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-95-A4VK_diagnosis2	NA	Not Reported	TCGA-95-A4VK_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-95-A4VK_treatment8	NA	NA	NA	NA	c61a7a93-bda6-4bab-8fab-090b7cf12b48	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	d3e23815-7f9d-48aa-9aef-3a1dd9d464d7	Informed Consent	-7	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-AA5R	70	false	United States	-25778	NA	b261abbd-3943-5f92-bbe5-934885493fbb	not hispanic or latino	female	black or african american	TCGA-99-AA5R_demographic	Alive	25778	M0	N0	Stage IA	T1a	7th	primary	0	658.0	83a7e788-05c9-5fe2-881e-15037124d503	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-99-AA5R_diagnosis	No	Lower lobe, lung	NA	2013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-99-AA5R_treatment2	NA	NA	NA	NA	4067a253-2417-458c-97ee-f672c6c88960	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d3e23815-7f9d-48aa-9aef-3a1dd9d464d7	Informed Consent	-7	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-99-AA5R	70	false	United States	-25778	NA	b261abbd-3943-5f92-bbe5-934885493fbb	not hispanic or latino	female	black or african american	TCGA-99-AA5R_demographic	Alive	25778	M0	N0	Stage IA	T1a	7th	primary	0	658.0	83a7e788-05c9-5fe2-881e-15037124d503	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-99-AA5R_diagnosis	No	Lower lobe, lung	NA	2013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-99-AA5R_treatment	NA	NA	NA	NA	fd85cf15-5999-5069-916e-1cb4f1b327d3	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d3ff328c-2488-47bd-8663-366b6812c7b5	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7626	76	false	United States	-28024	929	8e490bf9-3da9-5197-9f19-2969563327d9	not hispanic or latino	female	white	TCGA-53-7626_demographic	Dead	28024	M0	N1	Stage IIA	T1	6th	primary	0	929.0	7066be41-d6dc-5385-8c11-332c13c3fc99	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7626_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-53-7626_treatment3	NA	NA	NA	NA	4776b5c5-670f-4665-8f9c-3209beefd322	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d3ff328c-2488-47bd-8663-366b6812c7b5	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7626	76	false	United States	-28024	929	8e490bf9-3da9-5197-9f19-2969563327d9	not hispanic or latino	female	white	TCGA-53-7626_demographic	Dead	28024	M0	N1	Stage IIA	T1	6th	primary	0	929.0	7066be41-d6dc-5385-8c11-332c13c3fc99	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7626_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-53-7626_treatment	Cisplatin	NA	NA	NA	c776ddb8-4cff-53ce-aee3-1d289768e087	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	d3ff328c-2488-47bd-8663-366b6812c7b5	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7626	76	false	United States	-28024	929	8e490bf9-3da9-5197-9f19-2969563327d9	not hispanic or latino	female	white	TCGA-53-7626_demographic	Dead	28024	M0	N1	Stage IIA	T1	6th	primary	0	929.0	7066be41-d6dc-5385-8c11-332c13c3fc99	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-53-7626_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-53-7626_treatment2	Docetaxel	NA	NA	NA	fdb65e6b-3492-43b8-96eb-729111effb9a	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	d3ff328c-2488-47bd-8663-366b6812c7b5	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7626	76	false	United States	-28024	929	8e490bf9-3da9-5197-9f19-2969563327d9	not hispanic or latino	female	white	TCGA-53-7626_demographic	Dead	28889	NA	NA	NA	NA	NA	recurrence	865	NA	8978d0b9-e775-44a5-abe3-96f5d1f1e958	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-53-7626_diagnosis2	NA	Not Reported	TCGA-53-7626_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-53-7626_treatment4	NA	NA	NA	NA	039d476a-b35a-4f98-a435-c84a25ab1c28	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d3ff328c-2488-47bd-8663-366b6812c7b5	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7626	76	false	United States	-28024	929	8e490bf9-3da9-5197-9f19-2969563327d9	not hispanic or latino	female	white	TCGA-53-7626_demographic	Dead	28889	NA	NA	NA	NA	NA	recurrence	865	NA	8978d0b9-e775-44a5-abe3-96f5d1f1e958	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-53-7626_diagnosis2	NA	Not Reported	TCGA-53-7626_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-53-7626_treatment6	NA	Locoregional Site	NA	NA	21cc5b2b-dbc3-4b89-a7bc-ea640e06b625	NA	no	NA	Surgery, NOS
TCGA-LUAD	d3ff328c-2488-47bd-8663-366b6812c7b5	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-53-7626	76	false	United States	-28024	929	8e490bf9-3da9-5197-9f19-2969563327d9	not hispanic or latino	female	white	TCGA-53-7626_demographic	Dead	28889	NA	NA	NA	NA	NA	recurrence	865	NA	8978d0b9-e775-44a5-abe3-96f5d1f1e958	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-53-7626_diagnosis2	NA	Not Reported	TCGA-53-7626_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-53-7626_treatment5	NA	NA	NA	NA	93734af3-b890-4675-8bed-cd4280e72ae4	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d45aee46-838e-44af-8422-46710b3240a8	Informed Consent	16	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-8457	63	false	United States	-23055	NA	c4a49121-f73f-5ce6-99a2-974398b12a77	not hispanic or latino	female	black or african american	TCGA-50-8457_demographic	Alive	23055	M0	N0	Stage IA	T1a	7th	primary	0	1125.0	9635969b-01a5-5cbb-9116-aec2e98aca48	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-50-8457_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-8457_treatment	NA	NA	NA	NA	2b0c7146-6961-5f32-97d0-c3f0a1a3389a	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d45aee46-838e-44af-8422-46710b3240a8	Informed Consent	16	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-8457	63	false	United States	-23055	NA	c4a49121-f73f-5ce6-99a2-974398b12a77	not hispanic or latino	female	black or african american	TCGA-50-8457_demographic	Alive	23055	M0	N0	Stage IA	T1a	7th	primary	0	1125.0	9635969b-01a5-5cbb-9116-aec2e98aca48	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-50-8457_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-8457_treatment2	NA	NA	NA	NA	f057adb4-231f-4bba-aac9-15c15ea2471a	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d5326429-9805-47f9-97b0-fbda658e3f01	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-91-6840	59	false	United States	-21854	NA	397af860-3b05-5070-9e20-96a1b2a3e28e	not hispanic or latino	female	white	TCGA-91-6840_demographic	Alive	21854	M0	N0	Stage IA	T1b	7th	primary	0	372.0	911bc8bc-c4ad-5c68-997e-26ed70ee82c0	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-91-6840_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6840_treatment	NA	NA	NA	NA	b817df2c-6ada-586b-b1df-2168cd95c047	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d5326429-9805-47f9-97b0-fbda658e3f01	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-91-6840	59	false	United States	-21854	NA	397af860-3b05-5070-9e20-96a1b2a3e28e	not hispanic or latino	female	white	TCGA-91-6840_demographic	Alive	21854	M0	N0	Stage IA	T1b	7th	primary	0	372.0	911bc8bc-c4ad-5c68-997e-26ed70ee82c0	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-91-6840_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6840_treatment2	NA	NA	NA	NA	bfb4b533-f4d0-4828-8d43-fd6ba0b3a2d9	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d63c028b-b6d3-49ce-b63e-261eed3b86df	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8507	53	false	United States	-19390	NA	a21c451b-ca0b-51c1-939b-f04430053dc8	not hispanic or latino	male	white	TCGA-55-8507_demographic	Alive	19390	MX	N0	Stage IA	T1a	7th	primary	0	418.0	b44793eb-baab-56bd-96be-5b5aa67b4ccd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-8507_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8507_treatment2	NA	NA	NA	NA	9651ae25-e18f-42f2-bd9d-2ed91767b144	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d63c028b-b6d3-49ce-b63e-261eed3b86df	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8507	53	false	United States	-19390	NA	a21c451b-ca0b-51c1-939b-f04430053dc8	not hispanic or latino	male	white	TCGA-55-8507_demographic	Alive	19390	MX	N0	Stage IA	T1a	7th	primary	0	418.0	b44793eb-baab-56bd-96be-5b5aa67b4ccd	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-55-8507_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8507_treatment	NA	NA	NA	NA	a17e53af-2c1b-538e-ba83-ebeef515e013	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d6a08727-affd-4a59-837b-ea71741d7f09	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z049	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	d6e274a0-6425-437b-bc07-1225be7808d5	Informed Consent	43	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-6969	52	false	United States	-19270	NA	f7dc54c8-3cee-53a9-8b9f-98e2569e58c3	not reported	male	white	TCGA-55-6969_demographic	Alive	19270	M0	N0	Stage IB	T2	6th	primary	0	1239.0	68a2b5c0-0f8a-51bc-8f7a-0c7a07913cf9	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6969_diagnosis	No	Upper lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	d717fa33-3c91-4ced-89c6-79ff5542f04c	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4627	64	false	United States	-23510	1147	c60247f4-f119-521c-910d-fd7ae80de4eb	not hispanic or latino	female	white	TCGA-38-4627_demographic	Dead	23510	M0	N1	Stage IIA	T1b	NA	primary	0	1147.0	45e29d84-0d87-549d-ae66-5c2172ee5ff6	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-38-4627_diagnosis	No	Upper lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4627_treatment	NA	NA	NA	NA	088ba3e7-34ac-5370-9604-563d2a369659	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d717fa33-3c91-4ced-89c6-79ff5542f04c	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4627	64	false	United States	-23510	1147	c60247f4-f119-521c-910d-fd7ae80de4eb	not hispanic or latino	female	white	TCGA-38-4627_demographic	Dead	23510	M0	N1	Stage IIA	T1b	NA	primary	0	1147.0	45e29d84-0d87-549d-ae66-5c2172ee5ff6	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-38-4627_diagnosis	No	Upper lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4627_treatment2	NA	NA	NA	NA	1bf5a277-d206-4d2f-a6a5-d8e64aefecf8	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d721bfe0-90e3-415e-b9f3-1a270efa5fbb	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4488	74	false	United States	-27332	869	eb7aab18-27de-5ff3-99bb-bfcbb362c2c8	not hispanic or latino	female	white	TCGA-49-4488_demographic	Dead	27332	MX	N0	Stage IA	T1	3rd	primary	0	869.0	2918144e-6399-565d-ae42-7fa9bee71fc2	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4488_diagnosis	No	Lower lobe, lung	NA	1992	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4488_treatment2	NA	NA	NA	NA	52c60cbf-5ccf-4050-8b74-a9fc11bf160a	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d721bfe0-90e3-415e-b9f3-1a270efa5fbb	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4488	74	false	United States	-27332	869	eb7aab18-27de-5ff3-99bb-bfcbb362c2c8	not hispanic or latino	female	white	TCGA-49-4488_demographic	Dead	27332	MX	N0	Stage IA	T1	3rd	primary	0	869.0	2918144e-6399-565d-ae42-7fa9bee71fc2	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4488_diagnosis	No	Lower lobe, lung	NA	1992	NA	2.0	717	703	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-49-4488_treatment	NA	Distant Site	3000	cGy	9ee9af52-f81c-5858-a682-23db68828230	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	d721bfe0-90e3-415e-b9f3-1a270efa5fbb	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4488	74	false	United States	-27332	869	eb7aab18-27de-5ff3-99bb-bfcbb362c2c8	not hispanic or latino	female	white	TCGA-49-4488_demographic	Dead	27966	NA	NA	NA	NA	NA	not reported	634	NA	54d47c3d-a150-4dac-8bda-35eb61807993	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4488_diagnosis2	NA	Not Reported	TCGA-49-4488_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-49-4488_treatment3	NA	NA	NA	NA	b492aee3-2e5e-4d97-b14f-636a23804edb	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d721bfe0-90e3-415e-b9f3-1a270efa5fbb	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-49-4488	74	false	United States	-27332	869	eb7aab18-27de-5ff3-99bb-bfcbb362c2c8	not hispanic or latino	female	white	TCGA-49-4488_demographic	Dead	27966	NA	NA	NA	NA	NA	not reported	634	NA	54d47c3d-a150-4dac-8bda-35eb61807993	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-49-4488_diagnosis2	NA	Not Reported	TCGA-49-4488_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-49-4488_treatment4	NA	NA	NA	NA	e728fcb6-9844-49c8-86ca-b80654215df5	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	d7ae8efb-aa4d-4807-9772-55b0a28ccd5c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46O	65	false	Germany	-24050	1454	9b58c7ed-99e7-53c2-98c3-9059f8a1afdd	not hispanic or latino	female	white	TCGA-62-A46O_demographic	Dead	24993	NA	NA	NA	NA	NA	recurrence	943	NA	280acd21-af8f-499b-bc86-fd60455b7c6d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46O_diagnosis2	NA	Not Reported	TCGA-62-A46O_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46O_treatment6	NA	Distant Site	NA	NA	7e38efc2-d191-4a08-a5b0-1751e312268f	NA	no	NA	Surgery, NOS
TCGA-LUAD	d7ae8efb-aa4d-4807-9772-55b0a28ccd5c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46O	65	false	Germany	-24050	1454	9b58c7ed-99e7-53c2-98c3-9059f8a1afdd	not hispanic or latino	female	white	TCGA-62-A46O_demographic	Dead	24993	NA	NA	NA	NA	NA	recurrence	943	NA	280acd21-af8f-499b-bc86-fd60455b7c6d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46O_diagnosis2	NA	Not Reported	TCGA-62-A46O_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-A46O_treatment4	NA	NA	NA	NA	96bdcd61-a005-4f88-a062-00d55af8c565	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d7ae8efb-aa4d-4807-9772-55b0a28ccd5c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46O	65	false	Germany	-24050	1454	9b58c7ed-99e7-53c2-98c3-9059f8a1afdd	not hispanic or latino	female	white	TCGA-62-A46O_demographic	Dead	24993	NA	NA	NA	NA	NA	recurrence	943	NA	280acd21-af8f-499b-bc86-fd60455b7c6d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46O_diagnosis2	NA	Not Reported	TCGA-62-A46O_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46O_treatment5	NA	Locoregional Site	NA	NA	9dc1ae6c-58c6-4423-b265-dc2d9d8a4624	NA	no	NA	Surgery, NOS
TCGA-LUAD	d7ae8efb-aa4d-4807-9772-55b0a28ccd5c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46O	65	false	Germany	-24050	1454	9b58c7ed-99e7-53c2-98c3-9059f8a1afdd	not hispanic or latino	female	white	TCGA-62-A46O_demographic	Dead	24993	NA	NA	NA	NA	NA	recurrence	943	NA	280acd21-af8f-499b-bc86-fd60455b7c6d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46O_diagnosis2	NA	Not Reported	TCGA-62-A46O_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-A46O_treatment3	NA	NA	NA	NA	cf52808f-e357-4063-9d91-fcbab23dd7dd	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d7ae8efb-aa4d-4807-9772-55b0a28ccd5c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46O	65	false	Germany	-24050	1454	9b58c7ed-99e7-53c2-98c3-9059f8a1afdd	not hispanic or latino	female	white	TCGA-62-A46O_demographic	Dead	24993	NA	NA	NA	NA	NA	metastasis	943	NA	712cae90-b324-4519-b315-cd977a5fbebe	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46O_diagnosis3	NA	Not Reported	TCGA-62-A46O_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-A46O_treatment8	NA	NA	NA	NA	529c8c16-3423-4366-9b01-3c95310bcfb8	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d7ae8efb-aa4d-4807-9772-55b0a28ccd5c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46O	65	false	Germany	-24050	1454	9b58c7ed-99e7-53c2-98c3-9059f8a1afdd	not hispanic or latino	female	white	TCGA-62-A46O_demographic	Dead	24993	NA	NA	NA	NA	NA	metastasis	943	NA	712cae90-b324-4519-b315-cd977a5fbebe	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46O_diagnosis3	NA	Not Reported	TCGA-62-A46O_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46O_treatment10	NA	Distant Site	NA	NA	9d89f10c-5b42-4dd7-a252-fc1f7bff4bf3	NA	no	NA	Surgery, NOS
TCGA-LUAD	d7ae8efb-aa4d-4807-9772-55b0a28ccd5c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46O	65	false	Germany	-24050	1454	9b58c7ed-99e7-53c2-98c3-9059f8a1afdd	not hispanic or latino	female	white	TCGA-62-A46O_demographic	Dead	24993	NA	NA	NA	NA	NA	metastasis	943	NA	712cae90-b324-4519-b315-cd977a5fbebe	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46O_diagnosis3	NA	Not Reported	TCGA-62-A46O_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-A46O_treatment7	NA	NA	NA	NA	9da9c2e0-c970-4e4a-ada2-02464eeea982	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d7ae8efb-aa4d-4807-9772-55b0a28ccd5c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46O	65	false	Germany	-24050	1454	9b58c7ed-99e7-53c2-98c3-9059f8a1afdd	not hispanic or latino	female	white	TCGA-62-A46O_demographic	Dead	24993	NA	NA	NA	NA	NA	metastasis	943	NA	712cae90-b324-4519-b315-cd977a5fbebe	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46O_diagnosis3	NA	Not Reported	TCGA-62-A46O_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46O_treatment9	NA	Locoregional Site	NA	NA	c799281b-fcb0-427e-bc55-7a98b9ef8134	NA	no	NA	Surgery, NOS
TCGA-LUAD	d7ae8efb-aa4d-4807-9772-55b0a28ccd5c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46O	65	false	Germany	-24050	1454	9b58c7ed-99e7-53c2-98c3-9059f8a1afdd	not hispanic or latino	female	white	TCGA-62-A46O_demographic	Dead	24050	M0	N0	Stage IB	T2	6th	primary	0	1454.0	a2b7d3c3-8a8b-5d91-8440-6a28daf136b2	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A46O_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46O_treatment2	NA	NA	NA	NA	2ec53860-0d98-4583-9c2a-1f3a1ba3fadb	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d7ae8efb-aa4d-4807-9772-55b0a28ccd5c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46O	65	false	Germany	-24050	1454	9b58c7ed-99e7-53c2-98c3-9059f8a1afdd	not hispanic or latino	female	white	TCGA-62-A46O_demographic	Dead	24050	M0	N0	Stage IB	T2	6th	primary	0	1454.0	a2b7d3c3-8a8b-5d91-8440-6a28daf136b2	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A46O_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46O_treatment	NA	NA	NA	NA	abf39466-2cae-58b1-b4eb-7e484b740474	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d8faa3a7-6b3f-4e69-8c88-184e41055bd7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8280	54	false	Russia	-19977	NA	66e2a36e-ddae-5ef2-bf01-c142ae2b6958	not hispanic or latino	female	white	TCGA-86-8280_demographic	Alive	19977	M0	N0	Stage IIA	T2b	7th	primary	0	701.0	c0af29b0-e813-5566-b9e0-1ba811bea22c	true	NA	NA	C34.3	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8280_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	129	16	NA	NA	NA	NA	NA	NA	TCGA-86-8280_treatment2	Etoposide	NA	NA	NA	bf3e4a29-2cdc-4e20-9a90-0b9257d3dff5	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	d8faa3a7-6b3f-4e69-8c88-184e41055bd7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8280	54	false	Russia	-19977	NA	66e2a36e-ddae-5ef2-bf01-c142ae2b6958	not hispanic or latino	female	white	TCGA-86-8280_demographic	Alive	19977	M0	N0	Stage IIA	T2b	7th	primary	0	701.0	c0af29b0-e813-5566-b9e0-1ba811bea22c	true	NA	NA	C34.3	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8280_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8280_treatment3	NA	NA	NA	NA	e3e37310-d3fa-4e03-99c6-556682993ede	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	d8faa3a7-6b3f-4e69-8c88-184e41055bd7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8280	54	false	Russia	-19977	NA	66e2a36e-ddae-5ef2-bf01-c142ae2b6958	not hispanic or latino	female	white	TCGA-86-8280_demographic	Alive	19977	M0	N0	Stage IIA	T2b	7th	primary	0	701.0	c0af29b0-e813-5566-b9e0-1ba811bea22c	true	NA	NA	C34.3	Left	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8280_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	129	16	NA	NA	NA	NA	NA	NA	TCGA-86-8280_treatment	Cisplatin	NA	NA	NA	fddac721-867c-5861-b5e5-1adf3354a654	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	d94fe32f-bedd-4f4c-9feb-fcb60d40f4bb	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4434	67	false	Germany	-24472	457	03a1f867-574e-5c83-9421-ea3a8a9801e8	not reported	female	not reported	TCGA-05-4434_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	0b2e6d8a-d04d-4ebd-aa21-41046439d053	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4434_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4434_treatment	NA	NA	NA	NA	61fa1deb-4f1f-4f68-b9af-a26711ab4dfb	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	d94fe32f-bedd-4f4c-9feb-fcb60d40f4bb	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4434	67	false	Germany	-24472	457	03a1f867-574e-5c83-9421-ea3a8a9801e8	not reported	female	not reported	TCGA-05-4434_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	0b2e6d8a-d04d-4ebd-aa21-41046439d053	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4434_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4434_treatment2	NA	NA	NA	NA	cfa2bb6f-b575-44c1-9978-34b2bbc3f367	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	d94fe32f-bedd-4f4c-9feb-fcb60d40f4bb	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4434	67	false	Germany	-24472	457	03a1f867-574e-5c83-9421-ea3a8a9801e8	not reported	female	not reported	TCGA-05-4434_demographic	Dead	24472	M1	N1	Stage IV	T4	6th	primary	0	457.0	1bb95593-a778-5bed-8790-a70bf19ecbb2	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R2	Lung, NOS	NA	TCGA-05-4434_diagnosis	No	Lower lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	da345947-498b-4272-a231-a987ed4fe151	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47G	73	false	United States	-26800	NA	26bf0097-c014-5c3d-9d41-311a1f56232d	not hispanic or latino	female	white	TCGA-44-A47G_demographic	Alive	26800	M0	N0	Stage IA	T1	7th	primary	0	351.0	bfd6bbb5-2c1a-513a-8d64-41edd87db64b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-A47G_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47G_treatment	NA	NA	NA	NA	40c5cc72-9272-598a-8752-afeaf2595e89	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	da345947-498b-4272-a231-a987ed4fe151	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47G	73	false	United States	-26800	NA	26bf0097-c014-5c3d-9d41-311a1f56232d	not hispanic or latino	female	white	TCGA-44-A47G_demographic	Alive	26800	M0	N0	Stage IA	T1	7th	primary	0	351.0	bfd6bbb5-2c1a-513a-8d64-41edd87db64b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-A47G_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47G_treatment2	NA	NA	NA	NA	ae546dec-2ce7-47c6-afc2-1203bf368786	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	daf0e08e-1738-43f8-874a-b37d79cbe3a7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7536	69	false	Australia	-25558	244	d2717fde-35c3-5174-aded-e6ac1b84acaf	not reported	male	white	TCGA-78-7536_demographic	Dead	25789	NA	NA	NA	NA	NA	not reported	231	NA	307e22ad-4b53-41ad-b00f-bc90ea64a44b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7536_diagnosis2	NA	Not Reported	TCGA-78-7536_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7536_treatment3	NA	NA	NA	NA	164acace-b27a-4d23-bffb-2f7c99b351b1	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	daf0e08e-1738-43f8-874a-b37d79cbe3a7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7536	69	false	Australia	-25558	244	d2717fde-35c3-5174-aded-e6ac1b84acaf	not reported	male	white	TCGA-78-7536_demographic	Dead	25789	NA	NA	NA	NA	NA	not reported	231	NA	307e22ad-4b53-41ad-b00f-bc90ea64a44b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7536_diagnosis2	NA	Not Reported	TCGA-78-7536_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7536_treatment5	NA	Locoregional Site	NA	NA	406bde65-c6c7-4e43-aca5-650487b70c12	NA	no	NA	Surgery, NOS
TCGA-LUAD	daf0e08e-1738-43f8-874a-b37d79cbe3a7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7536	69	false	Australia	-25558	244	d2717fde-35c3-5174-aded-e6ac1b84acaf	not reported	male	white	TCGA-78-7536_demographic	Dead	25789	NA	NA	NA	NA	NA	not reported	231	NA	307e22ad-4b53-41ad-b00f-bc90ea64a44b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7536_diagnosis2	NA	Not Reported	TCGA-78-7536_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7536_treatment4	NA	NA	NA	NA	79906d16-7b2c-4448-80e6-368415a5d3b7	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	daf0e08e-1738-43f8-874a-b37d79cbe3a7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7536	69	false	Australia	-25558	244	d2717fde-35c3-5174-aded-e6ac1b84acaf	not reported	male	white	TCGA-78-7536_demographic	Dead	25789	NA	NA	NA	NA	NA	not reported	231	NA	307e22ad-4b53-41ad-b00f-bc90ea64a44b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7536_diagnosis2	NA	Not Reported	TCGA-78-7536_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7536_treatment6	NA	Distant Site	NA	NA	87dc4634-ff63-4621-859b-7678d1d7aaf7	NA	no	NA	Surgery, NOS
TCGA-LUAD	daf0e08e-1738-43f8-874a-b37d79cbe3a7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7536	69	false	Australia	-25558	244	d2717fde-35c3-5174-aded-e6ac1b84acaf	not reported	male	white	TCGA-78-7536_demographic	Dead	25558	M0	N2	Stage IIIA	T2	6th	primary	0	244.0	f09aa542-c593-5fcd-b79a-f2cc1edc56e4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-78-7536_diagnosis	No	Upper lobe, lung	NA	2001	NA	1.0	90	55	NA	NA	25.0	NA	NA	NA	TCGA-78-7536_treatment	NA	Regional Site	5000	cGy	a87373c5-4c30-533a-ade7-45148364319b	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	daf0e08e-1738-43f8-874a-b37d79cbe3a7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7536	69	false	Australia	-25558	244	d2717fde-35c3-5174-aded-e6ac1b84acaf	not reported	male	white	TCGA-78-7536_demographic	Dead	25558	M0	N2	Stage IIIA	T2	6th	primary	0	244.0	f09aa542-c593-5fcd-b79a-f2cc1edc56e4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-78-7536_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7536_treatment2	NA	NA	NA	NA	b847834b-17f7-4be8-b4f8-8c38920da35a	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	db0b9e63-4272-4f29-bf0e-1ec0fe79a9d7	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6831	66	false	United States	-24436	NA	00b3ab06-a364-580d-a544-231219b640a2	not hispanic or latino	male	white	TCGA-91-6831_demographic	Alive	24436	MX	N0	Stage IB	T2	5th	primary	0	310.0	e4204556-0e97-5250-a786-29b00b4e7743	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6831_diagnosis	No	Middle lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6831_treatment	NA	NA	NA	NA	6c20e2d7-89a4-5966-843c-d9b715ec64a1	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	db0b9e63-4272-4f29-bf0e-1ec0fe79a9d7	Informed Consent	39	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-6831	66	false	United States	-24436	NA	00b3ab06-a364-580d-a544-231219b640a2	not hispanic or latino	male	white	TCGA-91-6831_demographic	Alive	24436	MX	N0	Stage IB	T2	5th	primary	0	310.0	e4204556-0e97-5250-a786-29b00b4e7743	true	NA	NA	C34.2	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-6831_diagnosis	No	Middle lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-6831_treatment2	NA	NA	NA	NA	a7055ec4-831c-4222-a789-1c1fe64a85c5	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	db769d5c-a794-448d-9130-38a82d051c95	Informed Consent	22	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-7728	64	false	United States	-23505	NA	052dbde9-b730-5001-bb67-c2e944bc9b52	not hispanic or latino	female	white	TCGA-55-7728_demographic	Alive	23505	MX	N0	Stage IB	T2a	7th	primary	0	704.0	7ba0f252-dbd0-5834-9ad7-ad6ef471abe0	true	NA	NA	C34.1	Left	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	NA	TCGA-55-7728_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7728_treatment	NA	NA	NA	NA	13cfec82-3da3-57b2-844a-31b74ae3f432	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	db769d5c-a794-448d-9130-38a82d051c95	Informed Consent	22	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-55-7728	64	false	United States	-23505	NA	052dbde9-b730-5001-bb67-c2e944bc9b52	not hispanic or latino	female	white	TCGA-55-7728_demographic	Alive	23505	MX	N0	Stage IB	T2a	7th	primary	0	704.0	7ba0f252-dbd0-5834-9ad7-ad6ef471abe0	true	NA	NA	C34.1	Left	8480/3	Mucinous adenocarcinoma	no	No	R0	Lung, NOS	NA	TCGA-55-7728_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7728_treatment2	NA	NA	NA	NA	48168f74-f3e6-4860-8179-e41e22a86ba4	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	dbd5b0de-94c9-45dd-afb3-6820a7ecaca2	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6215	52	false	United States	-19310	NA	9d1b24ef-476f-5f71-bee8-c8002d90c841	not hispanic or latino	female	white	TCGA-67-6215_demographic	Alive	19310	M0	N0	Stage IB	T2a	7th	primary	0	174.0	4e2a33e5-452e-584d-b7d9-c001fea8c22f	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-6215_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	148	85	NA	4	NA	135.0	mg	Intravenous	TCGA-67-6215_treatment	Cisplatin	NA	NA	NA	5f99d7fe-a648-5b39-8dd3-549373fea6fc	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	dbd5b0de-94c9-45dd-afb3-6820a7ecaca2	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6215	52	false	United States	-19310	NA	9d1b24ef-476f-5f71-bee8-c8002d90c841	not hispanic or latino	female	white	TCGA-67-6215_demographic	Alive	19310	M0	N0	Stage IB	T2a	7th	primary	0	174.0	4e2a33e5-452e-584d-b7d9-c001fea8c22f	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-6215_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-67-6215_treatment3	NA	NA	NA	NA	861c8629-c6ec-4bb4-aa58-44a16a15cf0e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	dbd5b0de-94c9-45dd-afb3-6820a7ecaca2	Informed Consent	14	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-6215	52	false	United States	-19310	NA	9d1b24ef-476f-5f71-bee8-c8002d90c841	not hispanic or latino	female	white	TCGA-67-6215_demographic	Alive	19310	M0	N0	Stage IB	T2a	7th	primary	0	174.0	4e2a33e5-452e-584d-b7d9-c001fea8c22f	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-6215_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	148	85	NA	4	NA	900.0	mg	Intravenous	TCGA-67-6215_treatment2	Pemetrexed Disodium	NA	NA	NA	aa698371-308d-46c7-b873-84d27392bdc8	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	dc9eaaa0-0bfd-46d0-994f-310826879da4	Informed Consent	20	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7973	42	false	United States	-15355	NA	918b7134-c5db-564b-b48b-6507a9881865	not hispanic or latino	female	white	TCGA-69-7973_demographic	Alive	15355	M0	N0	Stage IB	T2a	7th	primary	0	230.0	660a76a9-007e-5620-ae63-e38b8eda90b4	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Central Lung	TCGA-69-7973_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	63	63	NA	NA	NA	NA	NA	NA	TCGA-69-7973_treatment2	Docetaxel	NA	NA	NA	0e65d9cd-d5a5-42ec-be94-7f3d55cd084f	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	dc9eaaa0-0bfd-46d0-994f-310826879da4	Informed Consent	20	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7973	42	false	United States	-15355	NA	918b7134-c5db-564b-b48b-6507a9881865	not hispanic or latino	female	white	TCGA-69-7973_demographic	Alive	15355	M0	N0	Stage IB	T2a	7th	primary	0	230.0	660a76a9-007e-5620-ae63-e38b8eda90b4	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Central Lung	TCGA-69-7973_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	132	91	NA	NA	NA	NA	NA	NA	TCGA-69-7973_treatment3	Cisplatin	NA	NA	NA	59ad67cd-0fb9-4483-8bc5-5f2d595af584	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	dc9eaaa0-0bfd-46d0-994f-310826879da4	Informed Consent	20	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7973	42	false	United States	-15355	NA	918b7134-c5db-564b-b48b-6507a9881865	not hispanic or latino	female	white	TCGA-69-7973_demographic	Alive	15355	M0	N0	Stage IB	T2a	7th	primary	0	230.0	660a76a9-007e-5620-ae63-e38b8eda90b4	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Central Lung	TCGA-69-7973_diagnosis	No	Middle lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7973_treatment5	NA	NA	NA	NA	75cff769-7eed-4453-bd04-b998f441d369	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	dc9eaaa0-0bfd-46d0-994f-310826879da4	Informed Consent	20	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7973	42	false	United States	-15355	NA	918b7134-c5db-564b-b48b-6507a9881865	not hispanic or latino	female	white	TCGA-69-7973_demographic	Alive	15355	M0	N0	Stage IB	T2a	7th	primary	0	230.0	660a76a9-007e-5620-ae63-e38b8eda90b4	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Central Lung	TCGA-69-7973_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	132	91	NA	NA	NA	NA	NA	NA	TCGA-69-7973_treatment4	Pemetrexed	NA	NA	NA	b993c96e-cddd-42bc-9335-51dc2033647d	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	dc9eaaa0-0bfd-46d0-994f-310826879da4	Informed Consent	20	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-69-7973	42	false	United States	-15355	NA	918b7134-c5db-564b-b48b-6507a9881865	not hispanic or latino	female	white	TCGA-69-7973_demographic	Alive	15355	M0	N0	Stage IB	T2a	7th	primary	0	230.0	660a76a9-007e-5620-ae63-e38b8eda90b4	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Central Lung	TCGA-69-7973_diagnosis	No	Middle lobe, lung	NA	2011	No	NA	63	63	NA	NA	NA	NA	NA	NA	TCGA-69-7973_treatment	Cisplatin	NA	NA	NA	d3bb060d-e476-52ae-bb18-687459daa9fc	NA	yes	Unknown	Chemotherapy
TCGA-LUAD	dcd066ba-5894-453e-b1da-82092858c3db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-86-6562	52	false	Russia	-19301	376	2c2b77ca-a909-52ae-a465-3f6b5c466abe	not hispanic or latino	male	white	TCGA-86-6562_demographic	Dead	19301	M0	N1	Stage IIA	T2a	7th	primary	0	376.0	78196193-10e2-5e04-8d7b-742fb00295c4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-86-6562_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	253	27	NA	4	NA	6.0	mg/day	Intravenous	TCGA-86-6562_treatment	Vinblastine	NA	120	mg	a462b6ab-7ddc-58fc-ac26-847299bf5283	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	dcd066ba-5894-453e-b1da-82092858c3db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-86-6562	52	false	Russia	-19301	376	2c2b77ca-a909-52ae-a465-3f6b5c466abe	not hispanic or latino	male	white	TCGA-86-6562_demographic	Dead	19301	M0	N1	Stage IIA	T2a	7th	primary	0	376.0	78196193-10e2-5e04-8d7b-742fb00295c4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-86-6562_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-6562_treatment3	NA	NA	NA	NA	e6dac379-3ac7-4c4c-ac5e-60b76619753b	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	dcd066ba-5894-453e-b1da-82092858c3db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-86-6562	52	false	Russia	-19301	376	2c2b77ca-a909-52ae-a465-3f6b5c466abe	not hispanic or latino	male	white	TCGA-86-6562_demographic	Dead	19301	M0	N1	Stage IIA	T2a	7th	primary	0	376.0	78196193-10e2-5e04-8d7b-742fb00295c4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-86-6562_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	253	27	NA	4	NA	150.0	mg/day	Intravenous	TCGA-86-6562_treatment2	Cisplatin	NA	600	mg	f88fefb1-3301-4fff-b874-32900662624d	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	dcd066ba-5894-453e-b1da-82092858c3db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-86-6562	52	false	Russia	-19301	376	2c2b77ca-a909-52ae-a465-3f6b5c466abe	not hispanic or latino	male	white	TCGA-86-6562_demographic	Dead	19575	NA	NA	NA	NA	NA	not reported	274	NA	9fec6a1a-d07e-46aa-9f12-1d63c88ab9c6	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-86-6562_diagnosis2	NA	Not Reported	TCGA-86-6562_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-86-6562_treatment5	NA	NA	NA	NA	77896106-8a23-4e63-b87f-5248fee8ec61	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	dcd066ba-5894-453e-b1da-82092858c3db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-86-6562	52	false	Russia	-19301	376	2c2b77ca-a909-52ae-a465-3f6b5c466abe	not hispanic or latino	male	white	TCGA-86-6562_demographic	Dead	19575	NA	NA	NA	NA	NA	not reported	274	NA	9fec6a1a-d07e-46aa-9f12-1d63c88ab9c6	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-86-6562_diagnosis2	NA	Not Reported	TCGA-86-6562_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-6562_treatment6	NA	Locoregional Site	NA	NA	8dc7abb9-5cad-404a-9f6e-02c63104646d	NA	no	NA	Surgery, NOS
TCGA-LUAD	dcd066ba-5894-453e-b1da-82092858c3db	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-86-6562	52	false	Russia	-19301	376	2c2b77ca-a909-52ae-a465-3f6b5c466abe	not hispanic or latino	male	white	TCGA-86-6562_demographic	Dead	19575	NA	NA	NA	NA	NA	not reported	274	NA	9fec6a1a-d07e-46aa-9f12-1d63c88ab9c6	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-86-6562_diagnosis2	NA	Not Reported	TCGA-86-6562_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-86-6562_treatment4	NA	NA	NA	NA	b5d58af0-95f8-4299-b184-680043f56c16	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	dcf8e752-e95c-4087-a0f5-c041787c8569	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	dd46c83e-6551-485b-b935-f3beed891244	Informed Consent	54	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7815	76	false	United States	-28119	NA	259a5c2e-4d0c-545b-8ca9-14eab931050c	not reported	male	not reported	TCGA-55-7815_demographic	Alive	28711	NA	NA	NA	NA	NA	metastasis	592	NA	18a9d9a0-2d3b-4206-a12b-d505285e7c40	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7815_diagnosis3	NA	Not Reported	TCGA-55-7815_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7815_treatment9	NA	Locoregional Site	NA	NA	30d21cac-780c-492a-9983-4e43bdccdc94	NA	no	NA	Surgery, NOS
TCGA-LUAD	dd46c83e-6551-485b-b935-f3beed891244	Informed Consent	54	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7815	76	false	United States	-28119	NA	259a5c2e-4d0c-545b-8ca9-14eab931050c	not reported	male	not reported	TCGA-55-7815_demographic	Alive	28711	NA	NA	NA	NA	NA	metastasis	592	NA	18a9d9a0-2d3b-4206-a12b-d505285e7c40	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7815_diagnosis3	NA	Not Reported	TCGA-55-7815_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7815_treatment8	NA	NA	NA	NA	3798486b-82e4-4b56-8e7c-a191932cedeb	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	dd46c83e-6551-485b-b935-f3beed891244	Informed Consent	54	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7815	76	false	United States	-28119	NA	259a5c2e-4d0c-545b-8ca9-14eab931050c	not reported	male	not reported	TCGA-55-7815_demographic	Alive	28711	NA	NA	NA	NA	NA	metastasis	592	NA	18a9d9a0-2d3b-4206-a12b-d505285e7c40	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7815_diagnosis3	NA	Not Reported	TCGA-55-7815_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-55-7815_treatment7	NA	NA	NA	NA	3e4f7e87-c1c7-4565-b97a-75a9346314c6	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	dd46c83e-6551-485b-b935-f3beed891244	Informed Consent	54	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7815	76	false	United States	-28119	NA	259a5c2e-4d0c-545b-8ca9-14eab931050c	not reported	male	not reported	TCGA-55-7815_demographic	Alive	28711	NA	NA	NA	NA	NA	metastasis	592	NA	18a9d9a0-2d3b-4206-a12b-d505285e7c40	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7815_diagnosis3	NA	Not Reported	TCGA-55-7815_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7815_treatment10	NA	Distant Site	NA	NA	eb2dd103-2ae9-4814-a685-f27728b364c5	NA	no	NA	Surgery, NOS
TCGA-LUAD	dd46c83e-6551-485b-b935-f3beed891244	Informed Consent	54	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7815	76	false	United States	-28119	NA	259a5c2e-4d0c-545b-8ca9-14eab931050c	not reported	male	not reported	TCGA-55-7815_demographic	Alive	28119	MX	N0	Stage IB	T2a	7th	primary	0	773.0	22ff963c-dcab-5136-ba27-f9a1583a10ed	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7815_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	616	616	NA	NA	NA	NA	NA	NA	TCGA-55-7815_treatment	NA	Distant Site	NA	NA	119a6066-241b-52d7-b479-cefe78b8c996	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	dd46c83e-6551-485b-b935-f3beed891244	Informed Consent	54	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7815	76	false	United States	-28119	NA	259a5c2e-4d0c-545b-8ca9-14eab931050c	not reported	male	not reported	TCGA-55-7815_demographic	Alive	28119	MX	N0	Stage IB	T2a	7th	primary	0	773.0	22ff963c-dcab-5136-ba27-f9a1583a10ed	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7815_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	NA	706	NA	NA	NA	NA	NA	NA	TCGA-55-7815_treatment3	Unknown	NA	NA	NA	36e31805-5673-4c3e-a01a-7d0501ffba35	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	dd46c83e-6551-485b-b935-f3beed891244	Informed Consent	54	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7815	76	false	United States	-28119	NA	259a5c2e-4d0c-545b-8ca9-14eab931050c	not reported	male	not reported	TCGA-55-7815_demographic	Alive	28119	MX	N0	Stage IB	T2a	7th	primary	0	773.0	22ff963c-dcab-5136-ba27-f9a1583a10ed	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7815_diagnosis	No	Lower lobe, lung	NA	2011	No	NA	585	493	NA	NA	NA	NA	NA	NA	TCGA-55-7815_treatment2	Unknown	NA	NA	NA	c3c479db-078a-430e-8ed8-6f2be338a19d	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	dd46c83e-6551-485b-b935-f3beed891244	Informed Consent	54	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7815	76	false	United States	-28119	NA	259a5c2e-4d0c-545b-8ca9-14eab931050c	not reported	male	not reported	TCGA-55-7815_demographic	Alive	28585	NA	NA	NA	NA	NA	recurrence	466	NA	cd743aa7-27d3-49a2-b890-6934be10e85c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7815_diagnosis2	NA	Not Reported	TCGA-55-7815_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-7815_treatment4	NA	NA	NA	NA	0a15e2f9-d23f-46d0-b0d4-5320176dc27f	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	dd46c83e-6551-485b-b935-f3beed891244	Informed Consent	54	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7815	76	false	United States	-28119	NA	259a5c2e-4d0c-545b-8ca9-14eab931050c	not reported	male	not reported	TCGA-55-7815_demographic	Alive	28585	NA	NA	NA	NA	NA	recurrence	466	NA	cd743aa7-27d3-49a2-b890-6934be10e85c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7815_diagnosis2	NA	Not Reported	TCGA-55-7815_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7815_treatment6	NA	Locoregional Site	NA	NA	52eb0c50-2ee1-4d91-9eb5-ebdf1d30d0b6	NA	no	NA	Surgery, NOS
TCGA-LUAD	dd46c83e-6551-485b-b935-f3beed891244	Informed Consent	54	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7815	76	false	United States	-28119	NA	259a5c2e-4d0c-545b-8ca9-14eab931050c	not reported	male	not reported	TCGA-55-7815_demographic	Alive	28585	NA	NA	NA	NA	NA	recurrence	466	NA	cd743aa7-27d3-49a2-b890-6934be10e85c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-55-7815_diagnosis2	NA	Not Reported	TCGA-55-7815_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-55-7815_treatment5	NA	NA	NA	NA	d293627e-c736-4bf5-b6a0-616df19e1c71	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	dd63d0fd-e24b-40a5-88c5-7d3d4106631e	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M0	60	false	United States	-22206	NA	06734217-29ca-59f3-91a0-7419fcf87b60	not hispanic or latino	female	white	TCGA-97-A4M0_demographic	Alive	22206	M0	N0	Stage IB	T2a	7th	primary	0	652.0	52b12b5e-e43d-5770-84d7-e68a82b36c51	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-A4M0_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M0_treatment	NA	NA	NA	NA	1f607364-f4d8-5987-9034-8b20618ddc9d	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	dd63d0fd-e24b-40a5-88c5-7d3d4106631e	Informed Consent	-4	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4M0	60	false	United States	-22206	NA	06734217-29ca-59f3-91a0-7419fcf87b60	not hispanic or latino	female	white	TCGA-97-A4M0_demographic	Alive	22206	M0	N0	Stage IB	T2a	7th	primary	0	652.0	52b12b5e-e43d-5770-84d7-e68a82b36c51	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-A4M0_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4M0_treatment2	NA	NA	NA	NA	281fc25e-7910-4b84-abbd-f16c33b653a2	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ddeacccf-0953-4952-8a4e-c2617f2e7bcc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-5645	61	false	United States	-22471	NA	99944f55-267f-5d61-b860-194e1cca2cbb	not hispanic or latino	female	black or african american	TCGA-44-5645_demographic	Alive	22471	NA	NX	Stage IA	T1	7th	primary	0	852.0	bc350e21-463f-5381-acc1-ea667fc13cdb	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-5645_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-5645_treatment	NA	NA	NA	NA	0a75ec6a-6f2d-504a-aa74-6423da973fc2	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ddeacccf-0953-4952-8a4e-c2617f2e7bcc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-5645	61	false	United States	-22471	NA	99944f55-267f-5d61-b860-194e1cca2cbb	not hispanic or latino	female	black or african american	TCGA-44-5645_demographic	Alive	22471	NA	NX	Stage IA	T1	7th	primary	0	852.0	bc350e21-463f-5381-acc1-ea667fc13cdb	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-5645_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-5645_treatment2	NA	NA	NA	NA	d9aea9e1-d9cb-4e2d-a428-3f1ae6c19aa1	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	df576520-a6b6-4c9b-8d06-3f59cc5342fd	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-7030	NA	false	Canada	NA	NA	e23ee442-f97f-5880-bd41-b2d49305443a	not reported	male	not reported	TCGA-75-7030_demographic	Alive	NA	M0	N0	Stage IIB	T3	6th	primary	NA	NA	3d095c27-4f5e-5f47-94aa-5d775edc7385	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-7030_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	4	NA	92.0	mg/day	Intravenous	TCGA-75-7030_treatment	Cisplatin	NA	736	mg	76c908bf-98d2-5168-b8e5-146c4095971d	Adjuvant	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	df576520-a6b6-4c9b-8d06-3f59cc5342fd	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-7030	NA	false	Canada	NA	NA	e23ee442-f97f-5880-bd41-b2d49305443a	not reported	male	not reported	TCGA-75-7030_demographic	Alive	NA	M0	N0	Stage IIB	T3	6th	primary	NA	NA	3d095c27-4f5e-5f47-94aa-5d775edc7385	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-7030_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	4	NA	46.0	mg/day	Intravenous	TCGA-75-7030_treatment2	Vinorelbine Tartrate	NA	552	mg	f73083f1-24c2-424a-9547-fd5060305986	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	df576520-a6b6-4c9b-8d06-3f59cc5342fd	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-75-7030	NA	false	Canada	NA	NA	e23ee442-f97f-5880-bd41-b2d49305443a	not reported	male	not reported	TCGA-75-7030_demographic	Alive	NA	M0	N0	Stage IIB	T3	6th	primary	NA	NA	3d095c27-4f5e-5f47-94aa-5d775edc7385	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-75-7030_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-75-7030_treatment3	NA	NA	NA	NA	fb05d018-05ab-4c38-807d-d63ef0f0eab2	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e00a60d7-4253-443d-a187-680ad0931349	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46S	73	false	Germany	-26825	1653	e0c9bfdf-cc04-5086-8704-c1e257c170a4	not hispanic or latino	male	white	TCGA-62-A46S_demographic	Dead	26825	M0	N0	Stage IB	T2	6th	primary	0	1653.0	0f2a0d69-4f53-5177-96cb-5432be0c6266	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A46S_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46S_treatment3	NA	NA	NA	NA	35627b95-2bf7-4624-9367-6c119f301e12	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e00a60d7-4253-443d-a187-680ad0931349	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46S	73	false	Germany	-26825	1653	e0c9bfdf-cc04-5086-8704-c1e257c170a4	not hispanic or latino	male	white	TCGA-62-A46S_demographic	Dead	26825	M0	N0	Stage IB	T2	6th	primary	0	1653.0	0f2a0d69-4f53-5177-96cb-5432be0c6266	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A46S_diagnosis	No	Upper lobe, lung	NA	2007	Yes	NA	198	78	NA	NA	NA	NA	NA	NA	TCGA-62-A46S_treatment	Erlotinib Hydrochloride	NA	NA	NA	52136391-5d03-5c83-a14a-943b344ab7a5	NA	yes	Unknown	Targeted Molecular Therapy
TCGA-LUAD	e00a60d7-4253-443d-a187-680ad0931349	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46S	73	false	Germany	-26825	1653	e0c9bfdf-cc04-5086-8704-c1e257c170a4	not hispanic or latino	male	white	TCGA-62-A46S_demographic	Dead	26825	M0	N0	Stage IB	T2	6th	primary	0	1653.0	0f2a0d69-4f53-5177-96cb-5432be0c6266	true	NA	NA	C34.1	Left	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A46S_diagnosis	No	Upper lobe, lung	NA	2007	Yes	NA	198	78	NA	NA	NA	NA	NA	NA	TCGA-62-A46S_treatment2	Clinical Trial	NA	NA	NA	79d66b2e-9d8b-458b-b6b6-e41f45083564	NA	yes	Unknown	Targeted Molecular Therapy
TCGA-LUAD	e00a60d7-4253-443d-a187-680ad0931349	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46S	73	false	Germany	-26825	1653	e0c9bfdf-cc04-5086-8704-c1e257c170a4	not hispanic or latino	male	white	TCGA-62-A46S_demographic	Dead	27352	NA	NA	NA	NA	NA	recurrence	527	NA	cfd4ed9d-1671-4610-a85a-4a4bd3fddde0	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46S_diagnosis2	NA	Not Reported	TCGA-62-A46S_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-A46S_treatment5	NA	NA	NA	NA	0db79df7-a15f-4f4d-800d-c10a1712e296	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e00a60d7-4253-443d-a187-680ad0931349	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46S	73	false	Germany	-26825	1653	e0c9bfdf-cc04-5086-8704-c1e257c170a4	not hispanic or latino	male	white	TCGA-62-A46S_demographic	Dead	27352	NA	NA	NA	NA	NA	recurrence	527	NA	cfd4ed9d-1671-4610-a85a-4a4bd3fddde0	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46S_diagnosis2	NA	Not Reported	TCGA-62-A46S_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-A46S_treatment4	NA	NA	NA	NA	1cd84ed9-1ef3-4987-93f8-88d17317407f	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e00a60d7-4253-443d-a187-680ad0931349	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46S	73	false	Germany	-26825	1653	e0c9bfdf-cc04-5086-8704-c1e257c170a4	not hispanic or latino	male	white	TCGA-62-A46S_demographic	Dead	27352	NA	NA	NA	NA	NA	recurrence	527	NA	cfd4ed9d-1671-4610-a85a-4a4bd3fddde0	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46S_diagnosis2	NA	Not Reported	TCGA-62-A46S_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46S_treatment7	NA	Distant Site	NA	NA	262c0293-bc4b-472d-aa0d-092b7ba11d32	NA	no	NA	Surgery, NOS
TCGA-LUAD	e00a60d7-4253-443d-a187-680ad0931349	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46S	73	false	Germany	-26825	1653	e0c9bfdf-cc04-5086-8704-c1e257c170a4	not hispanic or latino	male	white	TCGA-62-A46S_demographic	Dead	27352	NA	NA	NA	NA	NA	recurrence	527	NA	cfd4ed9d-1671-4610-a85a-4a4bd3fddde0	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46S_diagnosis2	NA	Not Reported	TCGA-62-A46S_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46S_treatment6	NA	Locoregional Site	NA	NA	ddd106e7-2721-410b-8535-6483b325f5fd	NA	no	NA	Surgery, NOS
TCGA-LUAD	e00a60d7-4253-443d-a187-680ad0931349	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46S	73	false	Germany	-26825	1653	e0c9bfdf-cc04-5086-8704-c1e257c170a4	not hispanic or latino	male	white	TCGA-62-A46S_demographic	Dead	27352	NA	NA	NA	NA	NA	metastasis	527	NA	d7de18d8-bc77-4276-b8e0-92d6b9435d78	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46S_diagnosis3	NA	Not Reported	TCGA-62-A46S_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-A46S_treatment8	NA	NA	NA	NA	41212e25-dcf4-4c21-8033-b0750d65d0e2	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e00a60d7-4253-443d-a187-680ad0931349	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46S	73	false	Germany	-26825	1653	e0c9bfdf-cc04-5086-8704-c1e257c170a4	not hispanic or latino	male	white	TCGA-62-A46S_demographic	Dead	27352	NA	NA	NA	NA	NA	metastasis	527	NA	d7de18d8-bc77-4276-b8e0-92d6b9435d78	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46S_diagnosis3	NA	Not Reported	TCGA-62-A46S_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46S_treatment10	NA	Locoregional Site	NA	NA	4d914b67-c7bf-4339-b7cc-7497e93ea2af	NA	no	NA	Surgery, NOS
TCGA-LUAD	e00a60d7-4253-443d-a187-680ad0931349	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46S	73	false	Germany	-26825	1653	e0c9bfdf-cc04-5086-8704-c1e257c170a4	not hispanic or latino	male	white	TCGA-62-A46S_demographic	Dead	27352	NA	NA	NA	NA	NA	metastasis	527	NA	d7de18d8-bc77-4276-b8e0-92d6b9435d78	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46S_diagnosis3	NA	Not Reported	TCGA-62-A46S_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46S_treatment11	NA	Distant Site	NA	NA	50e34bb7-1bc8-405c-b8c7-32d0eb37198f	NA	no	NA	Surgery, NOS
TCGA-LUAD	e00a60d7-4253-443d-a187-680ad0931349	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-62-A46S	73	false	Germany	-26825	1653	e0c9bfdf-cc04-5086-8704-c1e257c170a4	not hispanic or latino	male	white	TCGA-62-A46S_demographic	Dead	27352	NA	NA	NA	NA	NA	metastasis	527	NA	d7de18d8-bc77-4276-b8e0-92d6b9435d78	false	NA	NA	NA	NA	8260/3	Papillary adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A46S_diagnosis3	NA	Not Reported	TCGA-62-A46S_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-62-A46S_treatment9	NA	NA	NA	NA	ae1fbd17-a560-479b-95dc-a53594ac7e95	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e01e4fb3-236a-4d16-9073-555876b688e9	Informed Consent	-17	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4JF	56	false	Romania	-20491	737	0d966974-c3f3-55fb-be18-9003201d902e	not hispanic or latino	male	white	TCGA-86-A4JF_demographic	Dead	20927	NA	NA	NA	NA	NA	metastasis	436	NA	e5734a39-965c-41e8-904e-d1f5205a2ff4	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-A4JF_diagnosis2	NA	Not Reported	TCGA-86-A4JF_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-86-A4JF_treatment5	NA	NA	NA	NA	27f335fa-2aac-49bf-9503-b457538dcd37	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	e01e4fb3-236a-4d16-9073-555876b688e9	Informed Consent	-17	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4JF	56	false	Romania	-20491	737	0d966974-c3f3-55fb-be18-9003201d902e	not hispanic or latino	male	white	TCGA-86-A4JF_demographic	Dead	20927	NA	NA	NA	NA	NA	metastasis	436	NA	e5734a39-965c-41e8-904e-d1f5205a2ff4	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-A4JF_diagnosis2	NA	Not Reported	TCGA-86-A4JF_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-86-A4JF_treatment4	NA	NA	NA	NA	78ead908-98d8-43a5-b5ec-c410b72bee26	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e01e4fb3-236a-4d16-9073-555876b688e9	Informed Consent	-17	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4JF	56	false	Romania	-20491	737	0d966974-c3f3-55fb-be18-9003201d902e	not hispanic or latino	male	white	TCGA-86-A4JF_demographic	Dead	20927	NA	NA	NA	NA	NA	metastasis	436	NA	e5734a39-965c-41e8-904e-d1f5205a2ff4	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-86-A4JF_diagnosis2	NA	Not Reported	TCGA-86-A4JF_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-A4JF_treatment6	NA	Distant Site	NA	NA	cdeefd14-b791-4209-8ba9-71c101f24547	NA	no	NA	Surgery, NOS
TCGA-LUAD	e01e4fb3-236a-4d16-9073-555876b688e9	Informed Consent	-17	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4JF	56	false	Romania	-20491	737	0d966974-c3f3-55fb-be18-9003201d902e	not hispanic or latino	male	white	TCGA-86-A4JF_demographic	Dead	20491	M0	N0	Stage IIB	T3	7th	primary	0	737.0	fc754412-d232-5a96-bbe1-411fac2d6c6b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-86-A4JF_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	171	31	NA	NA	NA	NA	NA	NA	TCGA-86-A4JF_treatment	NA	NA	NA	NA	35cd8e73-75b4-5da1-b1ed-149baa134eee	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	e01e4fb3-236a-4d16-9073-555876b688e9	Informed Consent	-17	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4JF	56	false	Romania	-20491	737	0d966974-c3f3-55fb-be18-9003201d902e	not hispanic or latino	male	white	TCGA-86-A4JF_demographic	Dead	20491	M0	N0	Stage IIB	T3	7th	primary	0	737.0	fc754412-d232-5a96-bbe1-411fac2d6c6b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-86-A4JF_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	536	444	NA	NA	NA	NA	NA	NA	TCGA-86-A4JF_treatment2	NA	NA	NA	NA	41346388-05b4-4880-8f4a-129dd1d6742d	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	e01e4fb3-236a-4d16-9073-555876b688e9	Informed Consent	-17	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-A4JF	56	false	Romania	-20491	737	0d966974-c3f3-55fb-be18-9003201d902e	not hispanic or latino	male	white	TCGA-86-A4JF_demographic	Dead	20491	M0	N0	Stage IIB	T3	7th	primary	0	737.0	fc754412-d232-5a96-bbe1-411fac2d6c6b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-86-A4JF_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-A4JF_treatment3	NA	NA	NA	NA	ae0e4a13-5021-44e2-9ff1-d73657b46e92	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	e0a19099-5d25-40df-ad73-6260df3a1b32	Informed Consent	62	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-5715	69	false	Germany	-25383	NA	d1425085-fc5f-5ccb-9849-cce52bab92a6	not reported	female	not reported	TCGA-05-5715_demographic	Alive	25383	M0	N0	Stage IB	T2a	7th	primary	0	62.0	aa5bc36b-d390-5df9-8e50-66931ff72d04	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-5715_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	e0acafdd-06d0-48a6-bd68-577ef666a419	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7947	67	false	United States	-24752	NA	d3d64a9e-1b32-51a3-a30e-529027d399a4	not hispanic or latino	male	white	TCGA-95-7947_demographic	Alive	24752	M0	N0	Stage IA	T1a	7th	primary	0	477.0	8f9d1140-b278-57db-bda1-a79e0a0d2685	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-95-7947_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7947_treatment2	NA	NA	NA	NA	0d13b8b4-5e76-4149-a821-b153b0085156	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e0acafdd-06d0-48a6-bd68-577ef666a419	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7947	67	false	United States	-24752	NA	d3d64a9e-1b32-51a3-a30e-529027d399a4	not hispanic or latino	male	white	TCGA-95-7947_demographic	Alive	24752	M0	N0	Stage IA	T1a	7th	primary	0	477.0	8f9d1140-b278-57db-bda1-a79e0a0d2685	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-95-7947_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7947_treatment	NA	NA	NA	NA	6af0e427-51fd-5247-9106-88bc886e1a24	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e0acafdd-06d0-48a6-bd68-577ef666a419	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7947	67	false	United States	-24752	NA	d3d64a9e-1b32-51a3-a30e-529027d399a4	not hispanic or latino	male	white	TCGA-95-7947_demographic	Alive	NA	MX	NX	Stage III	T3	6th	Prior primary	NA	NA	94ab5713-02cd-428f-841d-36fc884cf20e	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-7947_diagnosis2	NA	Larynx, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7947_treatment3	NA	NA	NA	NA	4444a490-7639-4d83-b039-78f7fd21a600	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e0acafdd-06d0-48a6-bd68-577ef666a419	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-95-7947	67	false	United States	-24752	NA	d3d64a9e-1b32-51a3-a30e-529027d399a4	not hispanic or latino	male	white	TCGA-95-7947_demographic	Alive	NA	MX	NX	Stage III	T3	6th	Prior primary	NA	NA	94ab5713-02cd-428f-841d-36fc884cf20e	false	NA	NA	NA	NA	8070/3	Squamous cell carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-95-7947_diagnosis2	NA	Larynx, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-95-7947_treatment4	NA	NA	NA	NA	e6172c4b-9ea2-48be-afb1-51e0a990f335	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e10568fe-0436-43f2-9f0f-48f9903868c4	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6593	49	false	United States	-18152	336	0f8475f0-34f5-5bcb-8fa3-5dfdfa3a8344	not hispanic or latino	female	white	TCGA-50-6593_demographic	Dead	18152	M0	N2	Stage IIIA	T1	6th	primary	0	336.0	46e52e8f-8283-5091-b268-a0fe40a13e7a	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-6593_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	210	173	NA	NA	27.0	NA	NA	NA	TCGA-50-6593_treatment	NA	Primary Tumor Field	5400	cGy	5a736a2b-6a0e-5a4d-b22e-9367d72374f2	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	e10568fe-0436-43f2-9f0f-48f9903868c4	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6593	49	false	United States	-18152	336	0f8475f0-34f5-5bcb-8fa3-5dfdfa3a8344	not hispanic or latino	female	white	TCGA-50-6593_demographic	Dead	18152	M0	N2	Stage IIIA	T1	6th	primary	0	336.0	46e52e8f-8283-5091-b268-a0fe40a13e7a	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-50-6593_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6593_treatment2	NA	NA	NA	NA	ab17930a-e04b-4a13-8c26-a7d9429ceba8	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e10568fe-0436-43f2-9f0f-48f9903868c4	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6593	49	false	United States	-18152	336	0f8475f0-34f5-5bcb-8fa3-5dfdfa3a8344	not hispanic or latino	female	white	TCGA-50-6593_demographic	Dead	18418	NA	NA	NA	NA	NA	metastasis	266	NA	a8e2ea0f-cddb-48d3-b753-90a207954ad8	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-6593_diagnosis2	NA	Not Reported	TCGA-50-6593_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-6593_treatment5	NA	Distant Site	NA	NA	2abe4fd3-1122-44c9-9d80-95c1f5a346ff	NA	no	NA	Surgery, NOS
TCGA-LUAD	e10568fe-0436-43f2-9f0f-48f9903868c4	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6593	49	false	United States	-18152	336	0f8475f0-34f5-5bcb-8fa3-5dfdfa3a8344	not hispanic or latino	female	white	TCGA-50-6593_demographic	Dead	18418	NA	NA	NA	NA	NA	metastasis	266	NA	a8e2ea0f-cddb-48d3-b753-90a207954ad8	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-6593_diagnosis2	NA	Not Reported	TCGA-50-6593_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-6593_treatment4	NA	NA	NA	NA	f406f721-30f0-47e5-8039-3f30d2769101	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e10568fe-0436-43f2-9f0f-48f9903868c4	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-6593	49	false	United States	-18152	336	0f8475f0-34f5-5bcb-8fa3-5dfdfa3a8344	not hispanic or latino	female	white	TCGA-50-6593_demographic	Dead	18418	NA	NA	NA	NA	NA	metastasis	266	NA	a8e2ea0f-cddb-48d3-b753-90a207954ad8	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-50-6593_diagnosis2	NA	Not Reported	TCGA-50-6593_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-6593_treatment3	NA	NA	NA	NA	fdffc632-51b8-4ebd-a512-7e4b702eee1c	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e16ca88f-488b-40f0-9169-e5a62482a2ff	Informed Consent	-44	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-2666	43	false	United States	-15970	97	ff677bbc-29e7-5824-8389-a2fa0ec0d9b3	hispanic or latino	male	white	TCGA-44-2666_demographic	Dead	15970	M0	N0	Stage IB	T2	6th	primary	0	97.0	81aac5d5-517e-5772-acf7-c28f5b2dff46	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2666_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2666_treatment2	NA	NA	NA	NA	18ad30c0-7b3b-462b-a382-73a011a0d2b7	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e16ca88f-488b-40f0-9169-e5a62482a2ff	Informed Consent	-44	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-44-2666	43	false	United States	-15970	97	ff677bbc-29e7-5824-8389-a2fa0ec0d9b3	hispanic or latino	male	white	TCGA-44-2666_demographic	Dead	15970	M0	N0	Stage IB	T2	6th	primary	0	97.0	81aac5d5-517e-5772-acf7-c28f5b2dff46	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2666_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2666_treatment	NA	NA	NA	NA	bed1c650-8067-5a63-858f-15a740f8febb	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e1c55bac-bb41-4964-add5-ecd6ba04b58d	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5051	42	false	United States	-15585	478	d9211ca6-8432-5cdf-aad9-72a141f5e1a7	not hispanic or latino	female	white	TCGA-50-5051_demographic	Dead	15585	M0	N2	Stage IIIA	T2	6th	primary	0	478.0	a42c1a52-f54b-59a7-a1e6-8a7e3a9f8031	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-5051_diagnosis	No	Upper lobe, lung	NA	2007	NA	1.0	124	71	NA	NA	33.0	NA	NA	NA	TCGA-50-5051_treatment	NA	Primary Tumor Field	5490	cGy	14ae7fc5-9417-5f99-a074-10c0aa479d97	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	e1c55bac-bb41-4964-add5-ecd6ba04b58d	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5051	42	false	United States	-15585	478	d9211ca6-8432-5cdf-aad9-72a141f5e1a7	not hispanic or latino	female	white	TCGA-50-5051_demographic	Dead	15585	M0	N2	Stage IIIA	T2	6th	primary	0	478.0	a42c1a52-f54b-59a7-a1e6-8a7e3a9f8031	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-5051_diagnosis	No	Upper lobe, lung	NA	2007	No	NA	123	62	NA	NA	NA	NA	NA	NA	TCGA-50-5051_treatment3	Paclitaxel	NA	NA	NA	26067887-4065-4ff5-bd56-35b25ae8578c	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	e1c55bac-bb41-4964-add5-ecd6ba04b58d	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5051	42	false	United States	-15585	478	d9211ca6-8432-5cdf-aad9-72a141f5e1a7	not hispanic or latino	female	white	TCGA-50-5051_demographic	Dead	15585	M0	N2	Stage IIIA	T2	6th	primary	0	478.0	a42c1a52-f54b-59a7-a1e6-8a7e3a9f8031	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-50-5051_diagnosis	No	Upper lobe, lung	NA	2007	No	NA	123	62	NA	NA	NA	NA	NA	NA	TCGA-50-5051_treatment2	Carboplatin	NA	NA	NA	2f7c89da-8671-44fe-bdf1-8c8ff5023aed	NA	yes	Partial Response	Chemotherapy
TCGA-LUAD	e1c55bac-bb41-4964-add5-ecd6ba04b58d	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5051	42	false	United States	-15585	478	d9211ca6-8432-5cdf-aad9-72a141f5e1a7	not hispanic or latino	female	white	TCGA-50-5051_demographic	Dead	15769	NA	NA	NA	NA	NA	metastasis	184	NA	fe7a4664-c27b-43ff-bc2b-caa6e1e00c79	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5051_diagnosis2	NA	Not Reported	TCGA-50-5051_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5051_treatment7	NA	Distant Site	NA	NA	1a5cf1ef-c77c-4959-84db-06ba0b22800a	NA	no	NA	Surgery, NOS
TCGA-LUAD	e1c55bac-bb41-4964-add5-ecd6ba04b58d	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5051	42	false	United States	-15585	478	d9211ca6-8432-5cdf-aad9-72a141f5e1a7	not hispanic or latino	female	white	TCGA-50-5051_demographic	Dead	15769	NA	NA	NA	NA	NA	metastasis	184	NA	fe7a4664-c27b-43ff-bc2b-caa6e1e00c79	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5051_diagnosis2	NA	Not Reported	TCGA-50-5051_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5051_treatment6	NA	Locoregional Site	NA	NA	727d2f29-1ac5-4788-9f43-dcf12899f3ae	NA	no	NA	Surgery, NOS
TCGA-LUAD	e1c55bac-bb41-4964-add5-ecd6ba04b58d	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5051	42	false	United States	-15585	478	d9211ca6-8432-5cdf-aad9-72a141f5e1a7	not hispanic or latino	female	white	TCGA-50-5051_demographic	Dead	15769	NA	NA	NA	NA	NA	metastasis	184	NA	fe7a4664-c27b-43ff-bc2b-caa6e1e00c79	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5051_diagnosis2	NA	Not Reported	TCGA-50-5051_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5051_treatment4	NA	NA	NA	NA	d71b0a5e-8f0a-4398-9a63-1c731d6c863e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e1c55bac-bb41-4964-add5-ecd6ba04b58d	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5051	42	false	United States	-15585	478	d9211ca6-8432-5cdf-aad9-72a141f5e1a7	not hispanic or latino	female	white	TCGA-50-5051_demographic	Dead	15769	NA	NA	NA	NA	NA	metastasis	184	NA	fe7a4664-c27b-43ff-bc2b-caa6e1e00c79	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5051_diagnosis2	NA	Not Reported	TCGA-50-5051_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5051_treatment5	NA	NA	NA	NA	d854c66b-8db4-4e4a-a895-4d243421e96e	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e21e2af3-dc71-41fa-94ba-7a7929f47d90	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-A4AG	66	false	United States	-24224	NA	e16de832-4947-57da-8593-6a34e281d780	not hispanic or latino	female	white	TCGA-J2-A4AG_demographic	Alive	24224	MX	N0	Stage IA	T1b	7th	primary	0	988.0	ae0ea1d2-617a-5261-8643-84879758a648	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-J2-A4AG_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-A4AG_treatment2	NA	NA	NA	NA	67974082-b9af-40e4-ab43-fda764f662ac	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e21e2af3-dc71-41fa-94ba-7a7929f47d90	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-A4AG	66	false	United States	-24224	NA	e16de832-4947-57da-8593-6a34e281d780	not hispanic or latino	female	white	TCGA-J2-A4AG_demographic	Alive	24224	MX	N0	Stage IA	T1b	7th	primary	0	988.0	ae0ea1d2-617a-5261-8643-84879758a648	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-J2-A4AG_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-A4AG_treatment	NA	NA	NA	NA	add6bccd-7f76-56ce-8174-c88473ac756e	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e254aaeb-012c-4d92-8a03-cce1f6a2bcd6	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8087	59	false	United States	-21655	NA	f1a5d7f9-cf9e-5bca-9dcf-b49d87aa4199	not hispanic or latino	female	white	TCGA-55-8087_demographic	Alive	21655	MX	N0	Stage IB	T2a	7th	primary	0	462.0	c14ad3bb-b7d3-5007-b4ca-4f54f7de4981	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8087_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8087_treatment	NA	NA	NA	NA	9f173b35-d252-5e47-b505-47141b944ced	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e254aaeb-012c-4d92-8a03-cce1f6a2bcd6	Informed Consent	21	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8087	59	false	United States	-21655	NA	f1a5d7f9-cf9e-5bca-9dcf-b49d87aa4199	not hispanic or latino	female	white	TCGA-55-8087_demographic	Alive	21655	MX	N0	Stage IB	T2a	7th	primary	0	462.0	c14ad3bb-b7d3-5007-b4ca-4f54f7de4981	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8087_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8087_treatment2	NA	NA	NA	NA	e3ce4e0b-b2ce-444d-b228-c8cf13baa190	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	e2b0d873-4942-4483-9a88-d5c6338d0382	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4LX	81	false	United States	-29915	NA	58a999f3-f9e3-5b96-8030-059ab1b7c9a1	not hispanic or latino	male	white	TCGA-97-A4LX_demographic	Alive	29915	M0	N0	Stage IB	T2a	7th	primary	0	614.0	6d7700ef-d3a8-59ac-9a58-cd96f8929486	true	NA	NA	C34.1	NA	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-A4LX_diagnosis	Yes	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4LX_treatment	NA	NA	NA	NA	4c10aa67-887b-5e14-a976-7d7025ad7ded	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e2b0d873-4942-4483-9a88-d5c6338d0382	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4LX	81	false	United States	-29915	NA	58a999f3-f9e3-5b96-8030-059ab1b7c9a1	not hispanic or latino	male	white	TCGA-97-A4LX_demographic	Alive	29915	M0	N0	Stage IB	T2a	7th	primary	0	614.0	6d7700ef-d3a8-59ac-9a58-cd96f8929486	true	NA	NA	C34.1	NA	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-97-A4LX_diagnosis	Yes	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4LX_treatment2	NA	NA	NA	NA	d3c149a0-129b-4042-bbd0-b4caf0587bf6	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e2b0d873-4942-4483-9a88-d5c6338d0382	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4LX	81	false	United States	-29915	NA	58a999f3-f9e3-5b96-8030-059ab1b7c9a1	not hispanic or latino	male	white	TCGA-97-A4LX_demographic	Alive	29915	NA	NA	NA	NA	NA	Synchronous primary	0	NA	cc293ae2-b098-485d-ae9e-29331fd96e27	false	NA	NA	NA	Left	8255/3	Adenocarcinoma with mixed subtypes	NA	NA	NA	Not Reported	NA	TCGA-97-A4LX_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4LX_treatment4	NA	NA	NA	NA	6762ccf1-c56f-4d5b-ae6a-c5f1fb939a28	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e2b0d873-4942-4483-9a88-d5c6338d0382	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4LX	81	false	United States	-29915	NA	58a999f3-f9e3-5b96-8030-059ab1b7c9a1	not hispanic or latino	male	white	TCGA-97-A4LX_demographic	Alive	29915	NA	NA	NA	NA	NA	Synchronous primary	0	NA	cc293ae2-b098-485d-ae9e-29331fd96e27	false	NA	NA	NA	Left	8255/3	Adenocarcinoma with mixed subtypes	NA	NA	NA	Not Reported	NA	TCGA-97-A4LX_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-A4LX_treatment3	NA	NA	NA	NA	a7d72a4e-233c-4e39-a47f-2d7f8abe0651	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e2b0d873-4942-4483-9a88-d5c6338d0382	Informed Consent	-27	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-A4LX	81	false	United States	-29915	NA	58a999f3-f9e3-5b96-8030-059ab1b7c9a1	not hispanic or latino	male	white	TCGA-97-A4LX_demographic	Alive	29915	NA	NA	NA	NA	NA	Synchronous primary	0	NA	cc293ae2-b098-485d-ae9e-29331fd96e27	false	NA	NA	NA	Left	8255/3	Adenocarcinoma with mixed subtypes	NA	NA	NA	Not Reported	NA	TCGA-97-A4LX_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	0	NA	NA	NA	NA	NA	NA	TCGA-97-A4LX_treatment5	NA	NA	NA	NA	ad3bea08-a35a-40fa-9498-858f0b10429f	NA	yes	NA	Surgery, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	27120	NA	NA	NA	NA	NA	metastasis	1110	NA	1ecd3931-3af7-4d79-b5e0-920099042d2f	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T2_diagnosis4	NA	Not Reported	TCGA-MP-A4T2_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment10	NA	NA	NA	NA	2d814456-8619-481d-b0c6-76187f620610	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	27120	NA	NA	NA	NA	NA	metastasis	1110	NA	1ecd3931-3af7-4d79-b5e0-920099042d2f	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T2_diagnosis4	NA	Not Reported	TCGA-MP-A4T2_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment13	NA	Distant Site	NA	NA	7b714c03-2648-4b9a-95db-54cac8e41db2	NA	no	NA	Surgery, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	27120	NA	NA	NA	NA	NA	metastasis	1110	NA	1ecd3931-3af7-4d79-b5e0-920099042d2f	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T2_diagnosis4	NA	Not Reported	TCGA-MP-A4T2_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment12	NA	Locoregional Site	NA	NA	7e3d3ded-6a45-491b-9117-b2bfb7cb4c27	NA	no	NA	Surgery, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	27120	NA	NA	NA	NA	NA	metastasis	1110	NA	1ecd3931-3af7-4d79-b5e0-920099042d2f	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T2_diagnosis4	NA	Not Reported	TCGA-MP-A4T2_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment11	NA	NA	NA	NA	bd95d415-be8e-4928-ab73-dd8850f23c05	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	27120	NA	NA	NA	NA	NA	recurrence	1110	NA	4416e357-004e-482c-98fc-c55a8aaa459d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T2_diagnosis3	NA	Not Reported	TCGA-MP-A4T2_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment6	NA	NA	NA	NA	7f7be8c8-6127-4aa9-8617-ff6aaee1d666	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	27120	NA	NA	NA	NA	NA	recurrence	1110	NA	4416e357-004e-482c-98fc-c55a8aaa459d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T2_diagnosis3	NA	Not Reported	TCGA-MP-A4T2_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment8	NA	Locoregional Site	NA	NA	c60ee429-966d-402b-9f06-4c99c93e927b	NA	no	NA	Surgery, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	27120	NA	NA	NA	NA	NA	recurrence	1110	NA	4416e357-004e-482c-98fc-c55a8aaa459d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T2_diagnosis3	NA	Not Reported	TCGA-MP-A4T2_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment9	NA	Distant Site	NA	NA	cf283cbf-0f79-4626-b8e8-80ecfa66ba87	NA	no	NA	Surgery, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	27120	NA	NA	NA	NA	NA	recurrence	1110	NA	4416e357-004e-482c-98fc-c55a8aaa459d	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T2_diagnosis3	NA	Not Reported	TCGA-MP-A4T2_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment7	NA	NA	NA	NA	d8f9c0cf-2d16-40ba-8f8d-d5424bb42736	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	26585	NA	NA	NA	NA	NA	metastasis	575	NA	5ef8be60-f2ac-4d50-9a07-0de8d5df21d6	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T2_diagnosis2	NA	Not Reported	TCGA-MP-A4T2_diagnosis	NA	NA	NA	NA	575	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment5	NA	Distant Site	NA	NA	56267a25-1ece-4f9f-93d2-748ea06d0f1b	NA	yes	NA	Surgery, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	26585	NA	NA	NA	NA	NA	metastasis	575	NA	5ef8be60-f2ac-4d50-9a07-0de8d5df21d6	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T2_diagnosis2	NA	Not Reported	TCGA-MP-A4T2_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment4	NA	NA	NA	NA	84ebd933-4c96-41a5-acc7-cc9f88038282	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	26585	NA	NA	NA	NA	NA	metastasis	575	NA	5ef8be60-f2ac-4d50-9a07-0de8d5df21d6	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4T2_diagnosis2	NA	Not Reported	TCGA-MP-A4T2_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment3	NA	NA	NA	NA	a1f93a24-2aa4-4fc5-8df9-7547c353669e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	26010	M0	N0	Stage IA	T1	6th	primary	0	1136.0	6d5474f0-cd3c-5fb7-94da-70f4348d06c4	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4T2_diagnosis	No	Lower lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment	NA	NA	NA	NA	51d9cea4-9b83-590c-b8e1-96de6f2914ca	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e379cf55-68ef-4fbc-af3e-0a5040c27f0f	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4T2	71	false	United States	-26010	1136	8470b8dc-9635-5680-bc54-f9ca53efef45	not hispanic or latino	male	white	TCGA-MP-A4T2_demographic	Dead	26010	M0	N0	Stage IA	T1	6th	primary	0	1136.0	6d5474f0-cd3c-5fb7-94da-70f4348d06c4	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4T2_diagnosis	No	Lower lobe, lung	NA	2003	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4T2_treatment2	NA	NA	NA	NA	96d5928f-c1ba-47b3-9b78-46b9072774bb	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e43a2b72-35c6-4466-9007-ce96caf77ea8	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-A493	54	false	United States	-20027	NA	6888b498-fd7f-564f-8623-85227461663b	not hispanic or latino	female	white	TCGA-55-A493_demographic	Alive	20027	M0	N0	Stage IB	T2a	7th	primary	0	28.0	d55da43b-bd56-5b14-8def-437e784b39eb	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-A493_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A493_treatment2	NA	NA	NA	NA	2b00b548-e913-4113-baf0-85a40dc1b6d7	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	e43a2b72-35c6-4466-9007-ce96caf77ea8	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-A493	54	false	United States	-20027	NA	6888b498-fd7f-564f-8623-85227461663b	not hispanic or latino	female	white	TCGA-55-A493_demographic	Alive	20027	M0	N0	Stage IB	T2a	7th	primary	0	28.0	d55da43b-bd56-5b14-8def-437e784b39eb	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-A493_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-A493_treatment	NA	NA	NA	NA	b5e1eb0b-d4c6-5ef6-b17e-f33634b73fd3	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e44e279b-103e-436e-8988-1139b000bdfd	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z022	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	e499069b-a16a-49e9-941a-e3e9ea62af25	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A472	70	false	Germany	-25893	NA	99d3b54f-ae1d-5328-8a05-17f44c1b9370	not hispanic or latino	male	white	TCGA-62-A472_demographic	Alive	26183	NA	NA	NA	NA	NA	recurrence	290	NA	53f39f9f-6ecb-4dcb-9586-357f2fbe91c5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A472_diagnosis2	NA	Not Reported	TCGA-62-A472_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A472_treatment5	NA	Locoregional Site	NA	NA	4611ceca-ef44-4ec8-9a34-d6f98ea31a2d	NA	no	NA	Surgery, NOS
TCGA-LUAD	e499069b-a16a-49e9-941a-e3e9ea62af25	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A472	70	false	Germany	-25893	NA	99d3b54f-ae1d-5328-8a05-17f44c1b9370	not hispanic or latino	male	white	TCGA-62-A472_demographic	Alive	26183	NA	NA	NA	NA	NA	recurrence	290	NA	53f39f9f-6ecb-4dcb-9586-357f2fbe91c5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A472_diagnosis2	NA	Not Reported	TCGA-62-A472_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-A472_treatment4	NA	NA	NA	NA	54e31c2b-314e-433d-9850-389c26b70467	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	e499069b-a16a-49e9-941a-e3e9ea62af25	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A472	70	false	Germany	-25893	NA	99d3b54f-ae1d-5328-8a05-17f44c1b9370	not hispanic or latino	male	white	TCGA-62-A472_demographic	Alive	26183	NA	NA	NA	NA	NA	recurrence	290	NA	53f39f9f-6ecb-4dcb-9586-357f2fbe91c5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-62-A472_diagnosis2	NA	Not Reported	TCGA-62-A472_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-A472_treatment3	NA	NA	NA	NA	71823676-db13-40e2-97c2-e029c379c700	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e499069b-a16a-49e9-941a-e3e9ea62af25	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A472	70	false	Germany	-25893	NA	99d3b54f-ae1d-5328-8a05-17f44c1b9370	not hispanic or latino	male	white	TCGA-62-A472_demographic	Alive	25893	M0	N0	Stage IIB	T3	7th	primary	0	910.0	8dd42d9b-6cfe-5f3b-bc8b-4a20d946230e	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A472_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A472_treatment	NA	NA	NA	NA	2a144b2d-2dc2-5ac0-958e-748f8b725002	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e499069b-a16a-49e9-941a-e3e9ea62af25	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A472	70	false	Germany	-25893	NA	99d3b54f-ae1d-5328-8a05-17f44c1b9370	not hispanic or latino	male	white	TCGA-62-A472_demographic	Alive	25893	M0	N0	Stage IIB	T3	7th	primary	0	910.0	8dd42d9b-6cfe-5f3b-bc8b-4a20d946230e	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A472_diagnosis	No	Lower lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A472_treatment2	NA	NA	NA	NA	ce2fafd3-a861-4e29-949f-591c1faf9021	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e51f717f-72e8-400e-9f35-fc5dc32fdf71	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-80-5611	NA	false	Canada	NA	NA	6d28d6eb-cb85-5339-9cc6-bd0cac428fbb	not reported	male	not reported	TCGA-80-5611_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	57d3b62a-588a-46cb-b052-1187eddb718b	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-80-5611_diagnosis2	NA	Head, face or neck, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-80-5611_treatment3	NA	NA	NA	NA	29450f8b-957d-4be4-88ff-eb70ee2e72e0	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	e51f717f-72e8-400e-9f35-fc5dc32fdf71	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-80-5611	NA	false	Canada	NA	NA	6d28d6eb-cb85-5339-9cc6-bd0cac428fbb	not reported	male	not reported	TCGA-80-5611_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	2595.0	60eaee92-7f6d-54ec-8538-1ca752e4b8e7	true	NA	NA	C34.1	Left	8230/3	Solid carcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-80-5611_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-80-5611_treatment	NA	NA	NA	NA	55e3783a-b822-5c9d-ae3e-f44ee47150a7	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e51f717f-72e8-400e-9f35-fc5dc32fdf71	Informed Consent	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-80-5611	NA	false	Canada	NA	NA	6d28d6eb-cb85-5339-9cc6-bd0cac428fbb	not reported	male	not reported	TCGA-80-5611_demographic	Alive	NA	M0	N0	Stage IB	T2	6th	primary	NA	2595.0	60eaee92-7f6d-54ec-8538-1ca752e4b8e7	true	NA	NA	C34.1	Left	8230/3	Solid carcinoma, NOS	yes	No	R0	Lung, NOS	Peripheral Lung	TCGA-80-5611_diagnosis	No	Upper lobe, lung	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-80-5611_treatment2	NA	NA	NA	NA	ac7a3e38-d0fb-4d00-8a55-0a63a8c061ed	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e5cb0c86-8fe2-4cfc-b32b-e8ec3839ffc4	Informed Consent	89	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-55-6985	58	false	United States	-21381	NA	8a352ce7-36ec-59e9-99c8-c813247c272d	not reported	female	white	TCGA-55-6985_demographic	Alive	21381	MX	N0	Stage IB	T2	6th	primary	0	1233.0	e52b1fe0-2352-5bdb-a324-efccc000bfec	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-6985_diagnosis	No	Upper lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6985_treatment	NA	NA	NA	NA	97d1b31a-e358-59ce-bc40-91533a99464f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e5cb0c86-8fe2-4cfc-b32b-e8ec3839ffc4	Informed Consent	89	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-55-6985	58	false	United States	-21381	NA	8a352ce7-36ec-59e9-99c8-c813247c272d	not reported	female	white	TCGA-55-6985_demographic	Alive	21381	MX	N0	Stage IB	T2	6th	primary	0	1233.0	e52b1fe0-2352-5bdb-a324-efccc000bfec	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-6985_diagnosis	No	Upper lobe, lung	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6985_treatment2	NA	NA	NA	NA	cc2d64fb-aaa6-410b-9008-8766473eec2d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e5f956dd-f49f-435c-83c3-5b1b0a2050ed	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-A4AE	77	false	United States	-28163	NA	053ffdab-4e45-55e0-ac86-c656502314de	not hispanic or latino	female	white	TCGA-J2-A4AE_demographic	Alive	28163	MX	N0	Stage IA	T1a	7th	primary	0	1079.0	85897235-21d3-5fba-8505-5aac154087b0	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-J2-A4AE_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-A4AE_treatment	NA	NA	NA	NA	9ede9d23-07e5-579e-9f39-0d4d9647eabb	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e5f956dd-f49f-435c-83c3-5b1b0a2050ed	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-J2-A4AE	77	false	United States	-28163	NA	053ffdab-4e45-55e0-ac86-c656502314de	not hispanic or latino	female	white	TCGA-J2-A4AE_demographic	Alive	28163	MX	N0	Stage IA	T1a	7th	primary	0	1079.0	85897235-21d3-5fba-8505-5aac154087b0	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-J2-A4AE_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-J2-A4AE_treatment2	NA	NA	NA	NA	bf18b3b4-2ed1-44d5-a8f2-5b2ef82420f2	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e60a8f8a-0fe6-40e5-9f30-bcff48ac73f4	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-62-A470	84	false	Germany	-30689	1194	29055b33-2111-5a2a-8985-ce831bd06f4b	not hispanic or latino	male	white	TCGA-62-A470_demographic	Dead	31228	NA	NA	NA	NA	NA	recurrence	539	NA	61437afe-450a-4ac4-8f9a-b182fe016f9e	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-62-A470_diagnosis2	NA	Not Reported	TCGA-62-A470_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-A470_treatment3	NA	NA	NA	NA	4200f80a-fe4e-45d4-9bcd-8a9696d1318a	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e60a8f8a-0fe6-40e5-9f30-bcff48ac73f4	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-62-A470	84	false	Germany	-30689	1194	29055b33-2111-5a2a-8985-ce831bd06f4b	not hispanic or latino	male	white	TCGA-62-A470_demographic	Dead	31228	NA	NA	NA	NA	NA	recurrence	539	NA	61437afe-450a-4ac4-8f9a-b182fe016f9e	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-62-A470_diagnosis2	NA	Not Reported	TCGA-62-A470_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A470_treatment5	NA	Locoregional Site	NA	NA	5eff094b-7c3f-4fdb-bf8b-97d92d3f5361	NA	no	NA	Surgery, NOS
TCGA-LUAD	e60a8f8a-0fe6-40e5-9f30-bcff48ac73f4	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-62-A470	84	false	Germany	-30689	1194	29055b33-2111-5a2a-8985-ce831bd06f4b	not hispanic or latino	male	white	TCGA-62-A470_demographic	Dead	31228	NA	NA	NA	NA	NA	recurrence	539	NA	61437afe-450a-4ac4-8f9a-b182fe016f9e	false	NA	NA	NA	NA	8550/3	Acinar cell carcinoma	NA	Yes	NA	Not Reported	NA	TCGA-62-A470_diagnosis2	NA	Not Reported	TCGA-62-A470_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-62-A470_treatment4	NA	NA	NA	NA	abc88b39-4e78-4752-b875-29d77052ac1f	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	e60a8f8a-0fe6-40e5-9f30-bcff48ac73f4	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-62-A470	84	false	Germany	-30689	1194	29055b33-2111-5a2a-8985-ce831bd06f4b	not hispanic or latino	male	white	TCGA-62-A470_demographic	Dead	30689	M0	N0	Stage IB	T2	6th	primary	0	1194.0	7ed45c21-23fc-5fad-8729-cdee5dce09bd	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A470_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A470_treatment2	NA	NA	NA	NA	7de81e56-c4fc-45c5-bdec-dc37f35fe5a8	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e60a8f8a-0fe6-40e5-9f30-bcff48ac73f4	Informed Consent	0	Acinar Cell Neoplasms	Diagnosis	NA	Bronchus and lung	TCGA-62-A470	84	false	Germany	-30689	1194	29055b33-2111-5a2a-8985-ce831bd06f4b	not hispanic or latino	male	white	TCGA-62-A470_demographic	Dead	30689	M0	N0	Stage IB	T2	6th	primary	0	1194.0	7ed45c21-23fc-5fad-8729-cdee5dce09bd	true	NA	NA	C34.1	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	Central Lung	TCGA-62-A470_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A470_treatment	NA	NA	NA	NA	f11aefb9-76d6-5179-a7b7-ef9be6b2b38f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e64f76e4-f748-4d9e-ba71-53e2818a7920	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7542	56	false	Australia	-20763	321	c0ae101c-b643-5333-86bf-6c2484db38ac	not reported	male	white	TCGA-78-7542_demographic	Dead	20763	M0	N0	Stage IB	T2	6th	primary	0	321.0	d1d15f1e-57d9-5b74-b37a-32228cf63cf4	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-78-7542_diagnosis	No	Upper lobe, lung	NA	1993	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	e68219b0-a9c2-49df-8f0d-db5ea97fd2dc	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6543	60	false	United States	NA	NA	77ae36e6-e891-5c98-a5b8-74001c71a397	not reported	female	white	TCGA-55-6543_demographic	Alive	NA	MX	N0	Stage IA	T1b	7th	primary	0	435.0	f53fcad4-b6d4-5777-8a75-4e97ed95c785	true	NA	NA	C34.1	Right	8253/3	Bronchio-alveolar carcinoma, mucinous	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-55-6543_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6543_treatment2	NA	NA	NA	NA	43c4fcc9-00a1-40e7-9602-1087c20cecc8	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e68219b0-a9c2-49df-8f0d-db5ea97fd2dc	Informed Consent	2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6543	60	false	United States	NA	NA	77ae36e6-e891-5c98-a5b8-74001c71a397	not reported	female	white	TCGA-55-6543_demographic	Alive	NA	MX	N0	Stage IA	T1b	7th	primary	0	435.0	f53fcad4-b6d4-5777-8a75-4e97ed95c785	true	NA	NA	C34.1	Right	8253/3	Bronchio-alveolar carcinoma, mucinous	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-55-6543_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6543_treatment	NA	NA	NA	NA	8888f418-b6ed-5552-ba3e-789e96ce3263	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e6e75590-9520-4b1c-8a28-4a1d2b2218fc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7938	76	false	United States	-27980	18	309574ea-6ca0-5d39-919d-ec6d0915800a	not hispanic or latino	female	white	TCGA-97-7938_demographic	Dead	27980	MX	N0	Stage IA	T1a	7th	primary	0	18.0	85fd52fd-2ab4-5759-a2ff-15ddbfd10452	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-97-7938_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7938_treatment	NA	NA	NA	NA	1f753a51-d415-5d2d-9631-689711eba0a8	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e6e75590-9520-4b1c-8a28-4a1d2b2218fc	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-7938	76	false	United States	-27980	18	309574ea-6ca0-5d39-919d-ec6d0915800a	not hispanic or latino	female	white	TCGA-97-7938_demographic	Dead	27980	MX	N0	Stage IA	T1a	7th	primary	0	18.0	85fd52fd-2ab4-5759-a2ff-15ddbfd10452	true	NA	NA	C34.1	Right	8252/3	Bronchiolo-alveolar carcinoma, non-mucinous	no	No	R0	Lung, NOS	NA	TCGA-97-7938_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7938_treatment2	NA	NA	NA	NA	c378fe14-aa1e-481e-8c72-05260a56e143	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e737f650-b72d-44e7-b750-558a56716803	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4432	66	false	Germany	-24350	NA	c393b056-ba8c-586c-8b10-e9a0d4a0471d	not reported	male	not reported	TCGA-05-4432_demographic	Alive	24350	M0	N1	Stage IIB	T2	6th	primary	0	761.0	0556644d-ff91-5c64-8d38-3918e4cb3136	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4432_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	61	31	NA	NA	NA	NA	NA	NA	TCGA-05-4432_treatment	Cisplatin	NA	NA	NA	3adce2a5-7607-5796-8077-ae5d59d70474	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	e737f650-b72d-44e7-b750-558a56716803	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4432	66	false	Germany	-24350	NA	c393b056-ba8c-586c-8b10-e9a0d4a0471d	not reported	male	not reported	TCGA-05-4432_demographic	Alive	24350	M0	N1	Stage IIB	T2	6th	primary	0	761.0	0556644d-ff91-5c64-8d38-3918e4cb3136	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4432_diagnosis	No	Upper lobe, lung	NA	2008	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4432_treatment3	NA	NA	NA	NA	789fb956-acdc-4308-be9f-53bcf4f93bbb	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e737f650-b72d-44e7-b750-558a56716803	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4432	66	false	Germany	-24350	NA	c393b056-ba8c-586c-8b10-e9a0d4a0471d	not reported	male	not reported	TCGA-05-4432_demographic	Alive	24350	M0	N1	Stage IIB	T2	6th	primary	0	761.0	0556644d-ff91-5c64-8d38-3918e4cb3136	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	NA	TCGA-05-4432_diagnosis	No	Upper lobe, lung	NA	2008	No	NA	61	31	NA	NA	NA	NA	NA	NA	TCGA-05-4432_treatment2	Vinorelbine	NA	NA	NA	f772517b-3172-49e3-82a8-0402b7580ca5	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	e739b4f7-ae46-45c6-9013-9571cbadaf99	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-7348	75	false	United States	-27456	NA	648d4c36-a337-5d09-a2d2-0de44d4daf12	not hispanic or latino	female	white	TCGA-93-7348_demographic	Alive	27456	MX	N0	Stage IA	T1a	7th	primary	0	531.0	c033f3c4-2fb9-5349-8ab4-a9ed0b8863cb	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-93-7348_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-7348_treatment	NA	NA	NA	NA	571db393-c06a-5446-bc5b-c8ec28492ac5	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e739b4f7-ae46-45c6-9013-9571cbadaf99	Informed Consent	-13	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-7348	75	false	United States	-27456	NA	648d4c36-a337-5d09-a2d2-0de44d4daf12	not hispanic or latino	female	white	TCGA-93-7348_demographic	Alive	27456	MX	N0	Stage IA	T1a	7th	primary	0	531.0	c033f3c4-2fb9-5349-8ab4-a9ed0b8863cb	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-93-7348_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-7348_treatment2	NA	NA	NA	NA	c843e489-6fb5-479d-92cd-e6a776a3dfdb	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e7d30bc2-42e8-49c5-a5b3-9f58411b007a	Informed Consent	174	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7147	67	false	Australia	-24809	586	dc9c3d23-aa95-51b5-9d95-9cdbbaf6cb15	not reported	female	white	TCGA-78-7147_demographic	Dead	24809	M0	N1	Stage IIB	T2	6th	primary	0	586.0	174884bb-00c0-5a0a-a5a1-6f4671b240e7	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7147_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7147_treatment2	NA	NA	NA	NA	b700d72d-c616-4743-a758-ee4cb2f90bf4	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e7d30bc2-42e8-49c5-a5b3-9f58411b007a	Informed Consent	174	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7147	67	false	Australia	-24809	586	dc9c3d23-aa95-51b5-9d95-9cdbbaf6cb15	not reported	female	white	TCGA-78-7147_demographic	Dead	24809	M0	N1	Stage IIB	T2	6th	primary	0	586.0	174884bb-00c0-5a0a-a5a1-6f4671b240e7	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7147_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7147_treatment	NA	NA	NA	NA	ea82cb10-176e-5502-951f-1c57af29ea89	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e7d30bc2-42e8-49c5-a5b3-9f58411b007a	Informed Consent	174	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7147	67	false	Australia	-24809	586	dc9c3d23-aa95-51b5-9d95-9cdbbaf6cb15	not reported	female	white	TCGA-78-7147_demographic	Dead	25387	NA	NA	NA	NA	NA	not reported	578	NA	3d15f993-2476-4999-992f-79cd40be3138	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7147_diagnosis2	NA	Not Reported	TCGA-78-7147_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7147_treatment3	NA	NA	NA	NA	478eecc0-efc0-4dd2-ba6d-9e4ee383588c	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e7d30bc2-42e8-49c5-a5b3-9f58411b007a	Informed Consent	174	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7147	67	false	Australia	-24809	586	dc9c3d23-aa95-51b5-9d95-9cdbbaf6cb15	not reported	female	white	TCGA-78-7147_demographic	Dead	25387	NA	NA	NA	NA	NA	not reported	578	NA	3d15f993-2476-4999-992f-79cd40be3138	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7147_diagnosis2	NA	Not Reported	TCGA-78-7147_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7147_treatment4	NA	NA	NA	NA	a0b58e67-7eeb-45f8-bcc0-14681d7dd604	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e7d30bc2-42e8-49c5-a5b3-9f58411b007a	Informed Consent	174	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7147	67	false	Australia	-24809	586	dc9c3d23-aa95-51b5-9d95-9cdbbaf6cb15	not reported	female	white	TCGA-78-7147_demographic	Dead	25387	NA	NA	NA	NA	NA	not reported	578	NA	3d15f993-2476-4999-992f-79cd40be3138	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7147_diagnosis2	NA	Not Reported	TCGA-78-7147_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7147_treatment6	NA	Distant Site	NA	NA	d050f32e-50e7-4ca8-9c63-369e4aa0efdf	NA	no	NA	Surgery, NOS
TCGA-LUAD	e7d30bc2-42e8-49c5-a5b3-9f58411b007a	Informed Consent	174	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7147	67	false	Australia	-24809	586	dc9c3d23-aa95-51b5-9d95-9cdbbaf6cb15	not reported	female	white	TCGA-78-7147_demographic	Dead	25387	NA	NA	NA	NA	NA	not reported	578	NA	3d15f993-2476-4999-992f-79cd40be3138	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7147_diagnosis2	NA	Not Reported	TCGA-78-7147_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7147_treatment5	NA	Locoregional Site	NA	NA	dee31d56-09e0-4c4a-ac38-51414efcbd72	NA	no	NA	Surgery, NOS
TCGA-LUAD	e8060c45-451d-4779-9584-f284db47e63e	Informed Consent	181	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7148	71	false	Australia	-25990	626	ac28c474-ce5e-55e5-bb17-35ed03872bf1	not reported	male	white	TCGA-78-7148_demographic	Dead	25990	M0	N1	Stage IIB	T2	6th	primary	0	626.0	1bbb99a8-be22-5116-b539-2c95dae3dfcb	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7148_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7148_treatment	NA	NA	NA	NA	69c6bdf8-9bc7-5f5e-b91b-880c0976b621	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	e8060c45-451d-4779-9584-f284db47e63e	Informed Consent	181	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7148	71	false	Australia	-25990	626	ac28c474-ce5e-55e5-bb17-35ed03872bf1	not reported	male	white	TCGA-78-7148_demographic	Dead	25990	M0	N1	Stage IIB	T2	6th	primary	0	626.0	1bbb99a8-be22-5116-b539-2c95dae3dfcb	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7148_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7148_treatment2	NA	NA	NA	NA	e331f962-c115-4e77-ac47-91febb65fb77	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	e8060c45-451d-4779-9584-f284db47e63e	Informed Consent	181	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7148	71	false	Australia	-25990	626	ac28c474-ce5e-55e5-bb17-35ed03872bf1	not reported	male	white	TCGA-78-7148_demographic	Dead	26172	NA	NA	NA	NA	NA	not reported	182	NA	accff4c4-c791-437b-94f6-471094af58d6	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7148_diagnosis2	NA	Not Reported	TCGA-78-7148_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7148_treatment3	NA	Locoregional Site	NA	NA	1b7dbe03-c8be-4375-a3d6-b3478fd956b9	NA	no	NA	Surgery, NOS
TCGA-LUAD	e8060c45-451d-4779-9584-f284db47e63e	Informed Consent	181	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7148	71	false	Australia	-25990	626	ac28c474-ce5e-55e5-bb17-35ed03872bf1	not reported	male	white	TCGA-78-7148_demographic	Dead	26172	NA	NA	NA	NA	NA	not reported	182	NA	accff4c4-c791-437b-94f6-471094af58d6	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7148_diagnosis2	NA	Not Reported	TCGA-78-7148_diagnosis	NA	NA	NA	NA	182	NA	NA	NA	NA	NA	NA	TCGA-78-7148_treatment4	NA	Distant Site	NA	NA	d4cc2a95-acb7-46de-bcf9-18f02195db0f	NA	yes	NA	Surgery, NOS
TCGA-LUAD	e8b7a103-644f-4865-92f8-80b053bd5e17	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-35-3615	57	false	Russia	-21076	NA	ed17db80-fac6-5df6-9563-74e1cb27cf92	not hispanic or latino	male	white	TCGA-35-3615_demographic	Alive	21076	M0	N0	Stage IB	T2	NA	primary	0	14.0	30de0928-a4d8-51e5-93af-fc4261fb3f97	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-35-3615_diagnosis	No	Upper lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	e998a607-ac73-4849-afaa-57eee49cf051	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z000	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	ea0b9461-0d4d-4ade-a255-1b03dd85e30e	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-A4BC	59	false	United States	-21565	NA	7a3adc9b-b085-5204-bbb8-eb243eefa43f	not hispanic or latino	male	white	TCGA-91-A4BC_demographic	Alive	21565	MX	N0	Stage IIA	T2b	7th	primary	0	44.0	2e06f6e2-099d-57a2-88dc-2fced81217b9	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-A4BC_diagnosis	Yes	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-A4BC_treatment2	NA	NA	NA	NA	697d972f-de4e-4a86-9cd5-b64b2f3b3229	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	ea0b9461-0d4d-4ade-a255-1b03dd85e30e	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-A4BC	59	false	United States	-21565	NA	7a3adc9b-b085-5204-bbb8-eb243eefa43f	not hispanic or latino	male	white	TCGA-91-A4BC_demographic	Alive	21565	MX	N0	Stage IIA	T2b	7th	primary	0	44.0	2e06f6e2-099d-57a2-88dc-2fced81217b9	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-91-A4BC_diagnosis	Yes	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-A4BC_treatment	NA	NA	NA	NA	734fd43a-c5d7-5ebc-8476-e509a97e08d2	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ea0b9461-0d4d-4ade-a255-1b03dd85e30e	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-A4BC	59	false	United States	-21565	NA	7a3adc9b-b085-5204-bbb8-eb243eefa43f	not hispanic or latino	male	white	TCGA-91-A4BC_demographic	Alive	21573	MX	N0	Stage IIA	T2b	7th	Synchronous primary	8	NA	3e4e72e5-ffdc-45e5-88e3-da5ef3808ede	false	NA	NA	NA	Right	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-91-A4BC_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-A4BC_treatment4	NA	NA	NA	NA	5bfa6c7c-a2e5-4264-82d1-633465de4625	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ea0b9461-0d4d-4ade-a255-1b03dd85e30e	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-A4BC	59	false	United States	-21565	NA	7a3adc9b-b085-5204-bbb8-eb243eefa43f	not hispanic or latino	male	white	TCGA-91-A4BC_demographic	Alive	21573	MX	N0	Stage IIA	T2b	7th	Synchronous primary	8	NA	3e4e72e5-ffdc-45e5-88e3-da5ef3808ede	false	NA	NA	NA	Right	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-91-A4BC_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-91-A4BC_treatment3	NA	NA	NA	NA	62f51f6e-9a59-4e60-ac9b-7b44fe9fc4f2	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ea0b9461-0d4d-4ade-a255-1b03dd85e30e	Informed Consent	8	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-91-A4BC	59	false	United States	-21565	NA	7a3adc9b-b085-5204-bbb8-eb243eefa43f	not hispanic or latino	male	white	TCGA-91-A4BC_demographic	Alive	21573	MX	N0	Stage IIA	T2b	7th	Synchronous primary	8	NA	3e4e72e5-ffdc-45e5-88e3-da5ef3808ede	false	NA	NA	NA	Right	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-91-A4BC_diagnosis2	NA	Lung, NOS	NA	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	NA	TCGA-91-A4BC_treatment5	NA	Lung	NA	NA	c74912ec-2cc6-4e2d-adad-30fb6e883dea	NA	yes	NA	Surgery, NOS
TCGA-LUAD	ebb33753-9d38-4368-9033-3e55f129d00d	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7671	64	false	United States	-23538	NA	1bb33216-7547-53ce-95a8-c7e16704eb29	not hispanic or latino	male	black or african american	TCGA-44-7671_demographic	Alive	23538	M0	N0	Stage IB	T2a	7th	primary	0	889.0	4379f787-a241-5f23-86a9-6c960b6b78be	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-44-7671_diagnosis	No	Middle lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7671_treatment	NA	NA	NA	NA	0d88ab6c-813a-5b16-9e30-15414a382292	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ebb33753-9d38-4368-9033-3e55f129d00d	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7671	64	false	United States	-23538	NA	1bb33216-7547-53ce-95a8-c7e16704eb29	not hispanic or latino	male	black or african american	TCGA-44-7671_demographic	Alive	23538	M0	N0	Stage IB	T2a	7th	primary	0	889.0	4379f787-a241-5f23-86a9-6c960b6b78be	true	NA	NA	C34.2	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	NA	Lung, NOS	NA	TCGA-44-7671_diagnosis	No	Middle lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7671_treatment2	NA	NA	NA	NA	d4aaee0d-1f64-4e09-be16-d45ff66323a9	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ebb33753-9d38-4368-9033-3e55f129d00d	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7671	64	false	United States	-23538	NA	1bb33216-7547-53ce-95a8-c7e16704eb29	not hispanic or latino	male	black or african american	TCGA-44-7671_demographic	Alive	24421	NA	NA	NA	NA	NA	recurrence	883	NA	af694538-2913-48d5-acd1-9dc999324182	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-44-7671_diagnosis2	NA	Not Reported	TCGA-44-7671_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-7671_treatment6	NA	NA	NA	NA	564ad5e7-54bc-4d66-9935-76477faf8448	NA	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	ebb33753-9d38-4368-9033-3e55f129d00d	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7671	64	false	United States	-23538	NA	1bb33216-7547-53ce-95a8-c7e16704eb29	not hispanic or latino	male	black or african american	TCGA-44-7671_demographic	Alive	24421	NA	NA	NA	NA	NA	recurrence	883	NA	af694538-2913-48d5-acd1-9dc999324182	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-44-7671_diagnosis2	NA	Not Reported	TCGA-44-7671_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-44-7671_treatment5	NA	NA	NA	NA	cdcbb757-150f-49c8-a914-1ab0a9e75e33	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ebb33753-9d38-4368-9033-3e55f129d00d	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7671	64	false	United States	-23538	NA	1bb33216-7547-53ce-95a8-c7e16704eb29	not hispanic or latino	male	black or african american	TCGA-44-7671_demographic	Alive	24421	NA	NA	NA	NA	NA	recurrence	883	NA	af694538-2913-48d5-acd1-9dc999324182	false	NA	NA	NA	NA	8255/3	Adenocarcinoma with mixed subtypes	NA	Yes	NA	Not Reported	NA	TCGA-44-7671_diagnosis2	NA	Not Reported	TCGA-44-7671_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7671_treatment7	NA	Locoregional Site	NA	NA	d8200937-a53a-40d6-9473-621c48b93224	NA	no	NA	Surgery, NOS
TCGA-LUAD	ebb33753-9d38-4368-9033-3e55f129d00d	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7671	64	false	United States	-23538	NA	1bb33216-7547-53ce-95a8-c7e16704eb29	not hispanic or latino	male	black or african american	TCGA-44-7671_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ca8c757f-f213-487e-b8e3-3d64cbbd7ec6	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-7671_diagnosis3	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7671_treatment4	NA	NA	NA	NA	1f61aaab-45fe-404d-8a5d-0095951d4e6d	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ebb33753-9d38-4368-9033-3e55f129d00d	Informed Consent	42	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-7671	64	false	United States	-23538	NA	1bb33216-7547-53ce-95a8-c7e16704eb29	not hispanic or latino	male	black or african american	TCGA-44-7671_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	ca8c757f-f213-487e-b8e3-3d64cbbd7ec6	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-44-7671_diagnosis3	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-7671_treatment3	NA	NA	NA	NA	7c4bcf6f-fd41-4156-83e0-d2ce40759941	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ebcba7f2-ce13-4bae-97cd-91a6b1dcd465	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5932	75	false	United States	-27454	1235	7d799fb3-4baf-5194-825a-ce1d4614f75c	not hispanic or latino	male	white	TCGA-50-5932_demographic	Dead	NA	M0	N0	Stage IA	T1a	4th	Prior primary	NA	NA	02f19afb-63f1-4b18-8d54-993b8cf9b643	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-50-5932_diagnosis3	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5932_treatment3	NA	NA	NA	NA	5c7ebfe2-d78e-4df5-924a-87e90612f317	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ebcba7f2-ce13-4bae-97cd-91a6b1dcd465	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5932	75	false	United States	-27454	1235	7d799fb3-4baf-5194-825a-ce1d4614f75c	not hispanic or latino	male	white	TCGA-50-5932_demographic	Dead	NA	M0	N0	Stage IA	T1a	4th	Prior primary	NA	NA	02f19afb-63f1-4b18-8d54-993b8cf9b643	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-50-5932_diagnosis3	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5932_treatment4	NA	NA	NA	NA	f9c08c57-b58f-4b5d-89e1-0152cefec369	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ebcba7f2-ce13-4bae-97cd-91a6b1dcd465	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5932	75	false	United States	-27454	1235	7d799fb3-4baf-5194-825a-ce1d4614f75c	not hispanic or latino	male	white	TCGA-50-5932_demographic	Dead	28544	NA	NA	NA	NA	NA	recurrence	1090	NA	2bba52df-48ce-42e5-a703-c8b7bdc30909	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5932_diagnosis2	NA	Not Reported	TCGA-50-5932_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5932_treatment7	NA	Locoregional Site	NA	NA	095382e5-e374-41d2-96d1-c58c3e2273d6	NA	no	NA	Surgery, NOS
TCGA-LUAD	ebcba7f2-ce13-4bae-97cd-91a6b1dcd465	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5932	75	false	United States	-27454	1235	7d799fb3-4baf-5194-825a-ce1d4614f75c	not hispanic or latino	male	white	TCGA-50-5932_demographic	Dead	28544	NA	NA	NA	NA	NA	recurrence	1090	NA	2bba52df-48ce-42e5-a703-c8b7bdc30909	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5932_diagnosis2	NA	Not Reported	TCGA-50-5932_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5932_treatment8	NA	Distant Site	NA	NA	39effa8d-d03f-4f83-8999-ed16f120b8b6	NA	no	NA	Surgery, NOS
TCGA-LUAD	ebcba7f2-ce13-4bae-97cd-91a6b1dcd465	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5932	75	false	United States	-27454	1235	7d799fb3-4baf-5194-825a-ce1d4614f75c	not hispanic or latino	male	white	TCGA-50-5932_demographic	Dead	28544	NA	NA	NA	NA	NA	recurrence	1090	NA	2bba52df-48ce-42e5-a703-c8b7bdc30909	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5932_diagnosis2	NA	Not Reported	TCGA-50-5932_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5932_treatment6	NA	NA	NA	NA	6e84b942-fad9-496b-8756-e16308ed1e3d	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ebcba7f2-ce13-4bae-97cd-91a6b1dcd465	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5932	75	false	United States	-27454	1235	7d799fb3-4baf-5194-825a-ce1d4614f75c	not hispanic or latino	male	white	TCGA-50-5932_demographic	Dead	28544	NA	NA	NA	NA	NA	recurrence	1090	NA	2bba52df-48ce-42e5-a703-c8b7bdc30909	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5932_diagnosis2	NA	Not Reported	TCGA-50-5932_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-50-5932_treatment5	NA	NA	NA	NA	e8753fe8-4b5a-4023-89f7-124e926d1c70	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ebcba7f2-ce13-4bae-97cd-91a6b1dcd465	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5932	75	false	United States	-27454	1235	7d799fb3-4baf-5194-825a-ce1d4614f75c	not hispanic or latino	male	white	TCGA-50-5932_demographic	Dead	27454	M0	N1	Stage IIB	T2	5th	primary	0	1235.0	c97501f7-0fa5-5768-8a06-fa8750bd4d4b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	Central Lung	TCGA-50-5932_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5932_treatment	NA	NA	NA	NA	d102c72b-e143-5606-80e7-2771c0fde9e9	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ebcba7f2-ce13-4bae-97cd-91a6b1dcd465	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5932	75	false	United States	-27454	1235	7d799fb3-4baf-5194-825a-ce1d4614f75c	not hispanic or latino	male	white	TCGA-50-5932_demographic	Dead	27454	M0	N1	Stage IIB	T2	5th	primary	0	1235.0	c97501f7-0fa5-5768-8a06-fa8750bd4d4b	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	Central Lung	TCGA-50-5932_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5932_treatment2	NA	NA	NA	NA	d8c3e5a9-e31e-4b25-aed8-e1eed3187593	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	edd05f61-35f8-4133-a579-f9f32dff3bb8	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	edf80622-aea2-4b50-bb69-691d6708aa83	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-6178	70	false	United States	-25593	NA	5bd80b7c-54e2-5f82-a6ef-51fbc3222f77	not hispanic or latino	female	white	TCGA-38-6178_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	01cfc6c5-d0c2-49cd-8c78-761ec4f73df1	false	Stage IC	1995	NA	Left	8620/3	Granulosa cell tumor, malignant	NA	NA	NA	Not Reported	NA	TCGA-38-6178_diagnosis2	NA	Ovary	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-6178_treatment5	NA	NA	NA	NA	419939c0-a90c-4ced-b3b2-d95bc11ea265	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	edf80622-aea2-4b50-bb69-691d6708aa83	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-6178	70	false	United States	-25593	NA	5bd80b7c-54e2-5f82-a6ef-51fbc3222f77	not hispanic or latino	female	white	TCGA-38-6178_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	01cfc6c5-d0c2-49cd-8c78-761ec4f73df1	false	Stage IC	1995	NA	Left	8620/3	Granulosa cell tumor, malignant	NA	NA	NA	Not Reported	NA	TCGA-38-6178_diagnosis2	NA	Ovary	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-6178_treatment4	NA	NA	NA	NA	fd595ad4-861c-46f9-a05d-1039e97de0d4	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	edf80622-aea2-4b50-bb69-691d6708aa83	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-6178	70	false	United States	-25593	NA	5bd80b7c-54e2-5f82-a6ef-51fbc3222f77	not hispanic or latino	female	white	TCGA-38-6178_demographic	Alive	25593	NA	N2	Stage IIIA	T2b	NA	primary	0	448.0	d9f9c2dc-8a6d-5397-a9ad-dbc88ce9e3b4	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R1	Lung, NOS	Central Lung	TCGA-38-6178_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-6178_treatment3	NA	NA	NA	NA	51334e29-3184-4abf-95c7-b2c733eff1f4	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	edf80622-aea2-4b50-bb69-691d6708aa83	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-6178	70	false	United States	-25593	NA	5bd80b7c-54e2-5f82-a6ef-51fbc3222f77	not hispanic or latino	female	white	TCGA-38-6178_demographic	Alive	25593	NA	N2	Stage IIIA	T2b	NA	primary	0	448.0	d9f9c2dc-8a6d-5397-a9ad-dbc88ce9e3b4	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R1	Lung, NOS	Central Lung	TCGA-38-6178_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	98	57	NA	3	NA	6.0	AUC	Intravenous	TCGA-38-6178_treatment	Carboplatin	NA	NA	NA	7303a39b-ac3a-5ca2-a96c-c88bfec26a9e	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	edf80622-aea2-4b50-bb69-691d6708aa83	Informed Consent	-6	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-6178	70	false	United States	-25593	NA	5bd80b7c-54e2-5f82-a6ef-51fbc3222f77	not hispanic or latino	female	white	TCGA-38-6178_demographic	Alive	25593	NA	N2	Stage IIIA	T2b	NA	primary	0	448.0	d9f9c2dc-8a6d-5397-a9ad-dbc88ce9e3b4	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R1	Lung, NOS	Central Lung	TCGA-38-6178_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	98	57	NA	3	NA	175.0	mg/m2	Intravenous	TCGA-38-6178_treatment2	Paclitaxel	NA	NA	NA	b47ac769-8f96-4451-b40a-0650b4389614	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	eeab558b-8d1e-4843-861d-dbfb06061758	Informed Consent	47	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-67-3770	70	false	United States	-25658	NA	42e35199-18d8-5ad7-8565-7654fbe4f4d5	not hispanic or latino	female	white	TCGA-67-3770_demographic	Alive	25658	M0	N0	Stage IA	T1	NA	primary	0	610.0	f355dc76-e602-5007-8151-8ba0ae1c1929	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-67-3770_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	ef03654a-dcf1-41ff-a67e-4f3fbf9ba807	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-7347	76	false	United States	-27949	NA	89732cc9-7d2e-5ca2-a288-e9b306c26743	not hispanic or latino	female	white	TCGA-93-7347_demographic	Alive	27949	MX	N0	Stage IA	T1a	7th	primary	0	683.0	553029e5-6e87-586f-934e-b403497ad364	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-93-7347_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-7347_treatment	NA	NA	NA	NA	27a55348-2b2e-50cf-b821-63038ec22e02	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ef03654a-dcf1-41ff-a67e-4f3fbf9ba807	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-93-7347	76	false	United States	-27949	NA	89732cc9-7d2e-5ca2-a288-e9b306c26743	not hispanic or latino	female	white	TCGA-93-7347_demographic	Alive	27949	MX	N0	Stage IA	T1a	7th	primary	0	683.0	553029e5-6e87-586f-934e-b403497ad364	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Central Lung	TCGA-93-7347_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-93-7347_treatment2	NA	NA	NA	NA	c417b89a-079a-4137-b893-fe122ddff958	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ef42ae4c-a108-468e-beed-437cf3cf2962	Consent by Death	NA	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-5936	58	false	United States	-21238	257	9deb2db7-e097-5355-acc6-9702cd119c4c	not hispanic or latino	male	white	TCGA-50-5936_demographic	Dead	21388	NA	NA	NA	NA	NA	not reported	150	NA	026667d3-4876-4449-97e8-e40fd3d61029	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-50-5936_diagnosis2	NA	Not Reported	TCGA-50-5936_diagnosis	NA	NA	NA	NA	177	NA	NA	NA	NA	NA	NA	TCGA-50-5936_treatment5	NA	Locoregional Site	NA	NA	019639b3-bfdf-4bc3-a20b-154ec6451fc8	NA	yes	NA	Surgery, NOS
TCGA-LUAD	ef42ae4c-a108-468e-beed-437cf3cf2962	Consent by Death	NA	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-5936	58	false	United States	-21238	257	9deb2db7-e097-5355-acc6-9702cd119c4c	not hispanic or latino	male	white	TCGA-50-5936_demographic	Dead	21388	NA	NA	NA	NA	NA	not reported	150	NA	026667d3-4876-4449-97e8-e40fd3d61029	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-50-5936_diagnosis2	NA	Not Reported	TCGA-50-5936_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5936_treatment6	NA	Distant Site	NA	NA	391b07c4-e9f8-41e7-9196-afc2837e5faa	NA	no	NA	Surgery, NOS
TCGA-LUAD	ef42ae4c-a108-468e-beed-437cf3cf2962	Consent by Death	NA	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-5936	58	false	United States	-21238	257	9deb2db7-e097-5355-acc6-9702cd119c4c	not hispanic or latino	male	white	TCGA-50-5936_demographic	Dead	21388	NA	NA	NA	NA	NA	not reported	150	NA	026667d3-4876-4449-97e8-e40fd3d61029	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-50-5936_diagnosis2	NA	Not Reported	TCGA-50-5936_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-50-5936_treatment3	NA	NA	NA	NA	5094b0e5-1ba5-4285-aa3d-e82ad17ca4ea	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ef42ae4c-a108-468e-beed-437cf3cf2962	Consent by Death	NA	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-5936	58	false	United States	-21238	257	9deb2db7-e097-5355-acc6-9702cd119c4c	not hispanic or latino	male	white	TCGA-50-5936_demographic	Dead	21388	NA	NA	NA	NA	NA	not reported	150	NA	026667d3-4876-4449-97e8-e40fd3d61029	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-50-5936_diagnosis2	NA	Not Reported	TCGA-50-5936_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-50-5936_treatment4	NA	NA	NA	NA	5e658328-6ad1-4276-b2f2-1c51c542ab2b	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ef42ae4c-a108-468e-beed-437cf3cf2962	Consent by Death	NA	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-5936	58	false	United States	-21238	257	9deb2db7-e097-5355-acc6-9702cd119c4c	not hispanic or latino	male	white	TCGA-50-5936_demographic	Dead	21238	M0	N2	Stage IIIA	T2	6th	primary	0	257.0	1a752045-0992-509a-9685-bb3450df28b1	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	NA	TCGA-50-5936_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5936_treatment2	NA	NA	NA	NA	1b4ea5cd-4b0f-4d8f-a42a-f5098af4105e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ef42ae4c-a108-468e-beed-437cf3cf2962	Consent by Death	NA	Cystic, Mucinous and Serous Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-50-5936	58	false	United States	-21238	257	9deb2db7-e097-5355-acc6-9702cd119c4c	not hispanic or latino	male	white	TCGA-50-5936_demographic	Dead	21238	M0	N2	Stage IIIA	T2	6th	primary	0	257.0	1a752045-0992-509a-9685-bb3450df28b1	true	NA	NA	C34.30	Right	8480/3	Mucinous adenocarcinoma	no	No	NA	Lung, NOS	NA	TCGA-50-5936_diagnosis	No	Lower lobe, lung	NA	2007	No	NA	257	188	NA	NA	NA	NA	NA	NA	TCGA-50-5936_treatment	Paclitaxel	NA	NA	NA	ccae18c8-ee8f-5579-91d2-ba16efcae692	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	f063ddbb-1668-40df-9ec2-b0a23ca2c389	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6984	71	false	United States	NA	760	017afb43-8abd-53ab-b0e1-fea2eae33666	not hispanic or latino	female	white	TCGA-55-6984_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	0	760.0	24c96d7a-fcf3-540e-9697-ae1bac0e1742	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6984_diagnosis	No	Lower lobe, lung	NA	2006	No	NA	NA	65	NA	NA	NA	NA	NA	NA	TCGA-55-6984_treatment	Unknown	NA	NA	NA	09c143ed-f825-5b52-bac5-1da9427da058	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	f063ddbb-1668-40df-9ec2-b0a23ca2c389	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6984	71	false	United States	NA	760	017afb43-8abd-53ab-b0e1-fea2eae33666	not hispanic or latino	female	white	TCGA-55-6984_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	0	760.0	24c96d7a-fcf3-540e-9697-ae1bac0e1742	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6984_diagnosis	No	Lower lobe, lung	NA	2006	No	NA	747	724	NA	NA	NA	NA	NA	NA	TCGA-55-6984_treatment2	Unknown	NA	NA	NA	27e6df5f-341f-4c25-9ba8-0ac446508836	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	f063ddbb-1668-40df-9ec2-b0a23ca2c389	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6984	71	false	United States	NA	760	017afb43-8abd-53ab-b0e1-fea2eae33666	not hispanic or latino	female	white	TCGA-55-6984_demographic	Dead	NA	M0	N1	Stage IIB	T2	6th	primary	0	760.0	24c96d7a-fcf3-540e-9697-ae1bac0e1742	true	NA	NA	C34.3	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-55-6984_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6984_treatment3	NA	NA	NA	NA	58f795e4-2852-4f91-8981-55136ca6b5fb	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f063ddbb-1668-40df-9ec2-b0a23ca2c389	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6984	71	false	United States	NA	760	017afb43-8abd-53ab-b0e1-fea2eae33666	not hispanic or latino	female	white	TCGA-55-6984_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	724	NA	4631a93f-98c8-4a3c-a58e-ee9623c148d2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-6984_diagnosis2	NA	Not Reported	TCGA-55-6984_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-55-6984_treatment4	NA	NA	NA	NA	5ed8b12f-28be-48ff-90df-79a8b6a92d57	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f063ddbb-1668-40df-9ec2-b0a23ca2c389	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6984	71	false	United States	NA	760	017afb43-8abd-53ab-b0e1-fea2eae33666	not hispanic or latino	female	white	TCGA-55-6984_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	724	NA	4631a93f-98c8-4a3c-a58e-ee9623c148d2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-6984_diagnosis2	NA	Not Reported	TCGA-55-6984_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6984_treatment6	NA	Locoregional Site	NA	NA	711cf48c-3ad3-447a-99ba-edd4c1eeee67	NA	no	NA	Surgery, NOS
TCGA-LUAD	f063ddbb-1668-40df-9ec2-b0a23ca2c389	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6984	71	false	United States	NA	760	017afb43-8abd-53ab-b0e1-fea2eae33666	not hispanic or latino	female	white	TCGA-55-6984_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	724	NA	4631a93f-98c8-4a3c-a58e-ee9623c148d2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-6984_diagnosis2	NA	Not Reported	TCGA-55-6984_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-55-6984_treatment5	NA	NA	NA	NA	92755c66-f223-41c1-9a7d-3dd76101785f	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f063ddbb-1668-40df-9ec2-b0a23ca2c389	Informed Consent	1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6984	71	false	United States	NA	760	017afb43-8abd-53ab-b0e1-fea2eae33666	not hispanic or latino	female	white	TCGA-55-6984_demographic	Dead	NA	NA	NA	NA	NA	NA	not reported	724	NA	4631a93f-98c8-4a3c-a58e-ee9623c148d2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-55-6984_diagnosis2	NA	Not Reported	TCGA-55-6984_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6984_treatment7	NA	Distant Site	NA	NA	beb1fd26-3e2c-4553-b567-c812900e42e5	NA	no	NA	Surgery, NOS
TCGA-LUAD	f0c94f68-bfd9-45cb-b4fd-8bb1ae4e9a2b	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-8254	85	false	United States	-31134	NA	08ee3cca-2fae-5418-826f-a123494629ea	not hispanic or latino	male	white	TCGA-69-8254_demographic	Alive	31134	NA	NA	NA	T2b	7th	primary	0	409.0	7d0e5844-707d-5b4b-a143-9002c242a21c	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-69-8254_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-8254_treatment2	NA	NA	NA	NA	1f3d17fc-2ca9-408f-b93f-29d02083b547	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f0c94f68-bfd9-45cb-b4fd-8bb1ae4e9a2b	Informed Consent	-3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-8254	85	false	United States	-31134	NA	08ee3cca-2fae-5418-826f-a123494629ea	not hispanic or latino	male	white	TCGA-69-8254_demographic	Alive	31134	NA	NA	NA	T2b	7th	primary	0	409.0	7d0e5844-707d-5b4b-a143-9002c242a21c	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	NA	TCGA-69-8254_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-8254_treatment	NA	NA	NA	NA	c4a76412-ccf5-53f3-9bd8-d68d8555dece	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f17d3463-af6c-42c2-a8e9-fae45f69286f	Informed Consent	24	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6712	71	false	United States	NA	171	ee6088c3-5197-5379-a8db-4a5362bd01eb	not reported	male	white	TCGA-55-6712_demographic	Dead	NA	MX	N1	Stage IIA	T2a	7th	primary	0	171.0	0d259420-2ae5-502e-8f4f-7e40fa61d571	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-6712_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-6712_treatment3	NA	NA	NA	NA	0208056a-0e9d-49fb-893a-20e904d44c86	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f17d3463-af6c-42c2-a8e9-fae45f69286f	Informed Consent	24	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6712	71	false	United States	NA	171	ee6088c3-5197-5379-a8db-4a5362bd01eb	not reported	male	white	TCGA-55-6712_demographic	Dead	NA	MX	N1	Stage IIA	T2a	7th	primary	0	171.0	0d259420-2ae5-502e-8f4f-7e40fa61d571	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-6712_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	164	55	NA	NA	NA	NA	NA	NA	TCGA-55-6712_treatment2	Paclitaxel	NA	NA	NA	790832ea-1440-4b6d-9b4c-7e6ef994d285	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	f17d3463-af6c-42c2-a8e9-fae45f69286f	Informed Consent	24	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-6712	71	false	United States	NA	171	ee6088c3-5197-5379-a8db-4a5362bd01eb	not reported	male	white	TCGA-55-6712_demographic	Dead	NA	MX	N1	Stage IIA	T2a	7th	primary	0	171.0	0d259420-2ae5-502e-8f4f-7e40fa61d571	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R1	Lung, NOS	NA	TCGA-55-6712_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	164	55	NA	NA	NA	NA	NA	NA	TCGA-55-6712_treatment	Carboplatin	NA	NA	NA	c3d3741e-6734-52ce-936e-b9cb6f176b28	NA	yes	Progressive Disease	Chemotherapy
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	28413	NA	NA	NA	NA	NA	not reported	746	NA	3ac37519-b101-4f71-adbd-c677dd9aec18	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4630_diagnosis3	NA	Not Reported	TCGA-38-4630_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4630_treatment12	NA	NA	NA	NA	19150aec-ebac-43ad-b701-9c916bf306ad	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	28413	NA	NA	NA	NA	NA	not reported	746	NA	3ac37519-b101-4f71-adbd-c677dd9aec18	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4630_diagnosis3	NA	Not Reported	TCGA-38-4630_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4630_treatment13	NA	Locoregional Site	NA	NA	3ca18cb2-0ded-4530-9c5f-6f2b3566d49e	NA	no	NA	Surgery, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	28413	NA	NA	NA	NA	NA	not reported	746	NA	3ac37519-b101-4f71-adbd-c677dd9aec18	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4630_diagnosis3	NA	Not Reported	TCGA-38-4630_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4630_treatment11	NA	NA	NA	NA	a36dd259-ca86-4155-af06-72f2598fc532	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	67a62057-4083-47d6-8303-51b000e5fbbb	false	NA	NA	NA	NA	8441/3	Serous cystadenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-38-4630_diagnosis5	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4630_treatment5	NA	NA	NA	NA	3caf6f14-6b7b-4759-a0f2-af1a490c81e7	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	67a62057-4083-47d6-8303-51b000e5fbbb	false	NA	NA	NA	NA	8441/3	Serous cystadenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-38-4630_diagnosis5	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4630_treatment6	NA	Body, total	NA	NA	92850077-e207-4830-a18c-d3d7e307630a	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	28191	NA	NA	NA	NA	NA	not reported	524	NA	871d4a29-2f78-4c96-b981-8cd17f6f1376	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4630_diagnosis2	NA	Not Reported	TCGA-38-4630_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4630_treatment10	NA	Distant Site	NA	NA	47c77aad-345c-41c0-8f04-f5a6d97f2fe5	NA	no	NA	Surgery, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	28191	NA	NA	NA	NA	NA	not reported	524	NA	871d4a29-2f78-4c96-b981-8cd17f6f1376	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4630_diagnosis2	NA	Not Reported	TCGA-38-4630_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4630_treatment8	NA	NA	NA	NA	7b9f7ee7-8939-452d-b6ce-da466f6845c6	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	28191	NA	NA	NA	NA	NA	not reported	524	NA	871d4a29-2f78-4c96-b981-8cd17f6f1376	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4630_diagnosis2	NA	Not Reported	TCGA-38-4630_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4630_treatment9	NA	Locoregional Site	NA	NA	87ff2960-a554-43fc-8445-fb21d0a5a89e	NA	no	NA	Surgery, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	28191	NA	NA	NA	NA	NA	not reported	524	NA	871d4a29-2f78-4c96-b981-8cd17f6f1376	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4630_diagnosis2	NA	Not Reported	TCGA-38-4630_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4630_treatment7	NA	NA	NA	NA	e7243eb2-5004-4cb1-a26f-ac19122a409e	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	27667	M0	N0	Stage IB	T2	6th	primary	0	1073.0	8b58b4ed-0c9d-5b60-8407-85dec7202749	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	yes	No	R1	Lung, NOS	Peripheral Lung	TCGA-38-4630_diagnosis	No	Upper lobe, lung	NA	2000	NA	3.0	869	848	NA	NA	15.0	NA	NA	NA	TCGA-38-4630_treatment3	NA	Distant Site	3000	cGy	05b7d973-9a9a-4a9b-8bc9-f366c8896370	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	27667	M0	N0	Stage IB	T2	6th	primary	0	1073.0	8b58b4ed-0c9d-5b60-8407-85dec7202749	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	yes	No	R1	Lung, NOS	Peripheral Lung	TCGA-38-4630_diagnosis	No	Upper lobe, lung	NA	2000	NA	1.0	573	554	NA	NA	14.0	NA	NA	NA	TCGA-38-4630_treatment2	NA	Locoregional Site	3500	cGy	132cd514-490d-43ad-bd14-f3eeb77873f0	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	27667	M0	N0	Stage IB	T2	6th	primary	0	1073.0	8b58b4ed-0c9d-5b60-8407-85dec7202749	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	yes	No	R1	Lung, NOS	Peripheral Lung	TCGA-38-4630_diagnosis	No	Upper lobe, lung	NA	2000	NA	2.0	772	754	NA	NA	10.0	NA	NA	NA	TCGA-38-4630_treatment	NA	Distant Site	2250	cGy	61c3420c-ab0a-5bbf-8fa3-9e309ed581f8	Palliative	yes	NA	Radiation, External Beam
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	27667	M0	N0	Stage IB	T2	6th	primary	0	1073.0	8b58b4ed-0c9d-5b60-8407-85dec7202749	true	NA	NA	C34.1	Right	8260/3	Papillary adenocarcinoma, NOS	yes	No	R1	Lung, NOS	Peripheral Lung	TCGA-38-4630_diagnosis	No	Upper lobe, lung	NA	2000	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4630_treatment4	NA	NA	NA	NA	c13fa2bb-820b-421c-8379-c4b0ab0951f9	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	28503	NA	NA	NA	NA	NA	not reported	836	NA	966ab615-f6c4-48d2-894b-11ea1aaa7eb2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4630_diagnosis4	NA	Not Reported	TCGA-38-4630_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4630_treatment16	NA	Locoregional Site	NA	NA	2137b2c7-b036-468e-b56f-e4ca35b45812	NA	no	NA	Surgery, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	28503	NA	NA	NA	NA	NA	not reported	836	NA	966ab615-f6c4-48d2-894b-11ea1aaa7eb2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4630_diagnosis4	NA	Not Reported	TCGA-38-4630_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-38-4630_treatment17	NA	Distant Site	NA	NA	61e65e18-a3a7-439b-95cd-b81d06fbf983	NA	no	NA	Surgery, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	28503	NA	NA	NA	NA	NA	not reported	836	NA	966ab615-f6c4-48d2-894b-11ea1aaa7eb2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4630_diagnosis4	NA	Not Reported	TCGA-38-4630_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4630_treatment14	NA	NA	NA	NA	7d2156b4-a331-4b77-b5bb-795b75d51017	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f1985735-a188-4567-a88a-530f9b80291b	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-38-4630	75	false	United States	-27667	1073	73045831-df4b-5fb6-bf2f-a35e07715e5a	not hispanic or latino	female	white	TCGA-38-4630_demographic	Dead	28503	NA	NA	NA	NA	NA	not reported	836	NA	966ab615-f6c4-48d2-894b-11ea1aaa7eb2	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-38-4630_diagnosis4	NA	Not Reported	TCGA-38-4630_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-38-4630_treatment15	NA	NA	NA	NA	80170709-84c5-44d7-b3fd-7dd677453382	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	f1f80dd2-891d-46dd-a3e0-f007628cb515	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-4B-A93V	52	false	United States	-19035	300	86fc362c-4b84-596e-9eda-e66af29d7c7d	not hispanic or latino	female	black or african american	TCGA-4B-A93V_demographic	Dead	19035	M0	N0	Stage IA	T1b	7th	primary	0	300.0	9f9b0d4c-2ebf-5993-a54c-8d6fb404c956	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-4B-A93V_diagnosis	No	Lower lobe, lung	NA	2013	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-4B-A93V_treatment2	NA	NA	NA	NA	19b2f556-3ab9-4b5a-9d5f-f7fcb73b043a	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f1f80dd2-891d-46dd-a3e0-f007628cb515	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-4B-A93V	52	false	United States	-19035	300	86fc362c-4b84-596e-9eda-e66af29d7c7d	not hispanic or latino	female	black or african american	TCGA-4B-A93V_demographic	Dead	19035	M0	N0	Stage IA	T1b	7th	primary	0	300.0	9f9b0d4c-2ebf-5993-a54c-8d6fb404c956	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-4B-A93V_diagnosis	No	Lower lobe, lung	NA	2013	NA	NA	267	252	NA	NA	10.0	NA	NA	NA	TCGA-4B-A93V_treatment	NA	Distant Site	2500	cGy	40d17e46-0608-5744-a6a8-bef73adefb23	NA	yes	Progressive Disease	Radiation, External Beam
TCGA-LUAD	f1f80dd2-891d-46dd-a3e0-f007628cb515	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-4B-A93V	52	false	United States	-19035	300	86fc362c-4b84-596e-9eda-e66af29d7c7d	not hispanic or latino	female	black or african american	TCGA-4B-A93V_demographic	Dead	19286	NA	NA	NA	NA	NA	metastasis	251	NA	fb80a9ea-f87d-48d6-ac00-3286d9a3f10c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-4B-A93V_diagnosis2	NA	Not Reported	TCGA-4B-A93V_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-4B-A93V_treatment5	NA	Locoregional Site	NA	NA	1645db4b-f17a-4822-860d-7a9be00aa17b	NA	no	NA	Surgery, NOS
TCGA-LUAD	f1f80dd2-891d-46dd-a3e0-f007628cb515	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-4B-A93V	52	false	United States	-19035	300	86fc362c-4b84-596e-9eda-e66af29d7c7d	not hispanic or latino	female	black or african american	TCGA-4B-A93V_demographic	Dead	19286	NA	NA	NA	NA	NA	metastasis	251	NA	fb80a9ea-f87d-48d6-ac00-3286d9a3f10c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-4B-A93V_diagnosis2	NA	Not Reported	TCGA-4B-A93V_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-4B-A93V_treatment6	NA	Distant Site	NA	NA	454e335d-7500-4a6e-95c3-ec9498625f84	NA	no	NA	Surgery, NOS
TCGA-LUAD	f1f80dd2-891d-46dd-a3e0-f007628cb515	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-4B-A93V	52	false	United States	-19035	300	86fc362c-4b84-596e-9eda-e66af29d7c7d	not hispanic or latino	female	black or african american	TCGA-4B-A93V_demographic	Dead	19286	NA	NA	NA	NA	NA	metastasis	251	NA	fb80a9ea-f87d-48d6-ac00-3286d9a3f10c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-4B-A93V_diagnosis2	NA	Not Reported	TCGA-4B-A93V_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-4B-A93V_treatment4	NA	NA	NA	NA	b8eff60c-53a3-404d-a1b4-3b42f97e619e	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	f1f80dd2-891d-46dd-a3e0-f007628cb515	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	Yes	Bronchus and lung	TCGA-4B-A93V	52	false	United States	-19035	300	86fc362c-4b84-596e-9eda-e66af29d7c7d	not hispanic or latino	female	black or african american	TCGA-4B-A93V_demographic	Dead	19286	NA	NA	NA	NA	NA	metastasis	251	NA	fb80a9ea-f87d-48d6-ac00-3286d9a3f10c	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-4B-A93V_diagnosis2	NA	Not Reported	TCGA-4B-A93V_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-4B-A93V_treatment3	NA	NA	NA	NA	c8968498-4461-4b23-bdb0-fe494e0d1d69	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f29b5aef-d53e-457d-b140-b0b5fd1960bc	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z062	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	f2d8b332-2f03-46e5-a9d5-f163972e5fa7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8668	61	false	Russia	-22383	NA	e279a0dc-071e-580b-bd34-adbc3dd176ab	not hispanic or latino	female	white	TCGA-86-8668_demographic	Alive	22383	M0	N0	Stage IA	T1b	7th	primary	0	423.0	a5cc9bfc-5508-59de-8fbb-6191acc51a2b	true	NA	NA	C34.3	Left	8253/3	Bronchio-alveolar carcinoma, mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8668_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8668_treatment2	NA	NA	NA	NA	5357cae2-1713-43f7-96f1-f66edc1f4ef0	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	f2d8b332-2f03-46e5-a9d5-f163972e5fa7	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-86-8668	61	false	Russia	-22383	NA	e279a0dc-071e-580b-bd34-adbc3dd176ab	not hispanic or latino	female	white	TCGA-86-8668_demographic	Alive	22383	M0	N0	Stage IA	T1b	7th	primary	0	423.0	a5cc9bfc-5508-59de-8fbb-6191acc51a2b	true	NA	NA	C34.3	Left	8253/3	Bronchio-alveolar carcinoma, mucinous	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-86-8668_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-86-8668_treatment	NA	NA	NA	NA	c87617d4-422f-53f1-8ba0-5520a150c606	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f327dea0-2d30-482f-809c-76a148a749b7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TI	72	false	United States	-26565	429	48b071ad-ce05-5630-b41a-1634cf0c2f94	not hispanic or latino	male	white	TCGA-MP-A4TI_demographic	Dead	26565	M0	N1	Stage IIA	T2a	7th	primary	0	429.0	79f3488a-9448-573b-977f-bb7a769487ea	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4TI_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TI_treatment2	NA	NA	NA	NA	24a2c599-5d65-4188-ae22-0e009df53caf	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	f327dea0-2d30-482f-809c-76a148a749b7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TI	72	false	United States	-26565	429	48b071ad-ce05-5630-b41a-1634cf0c2f94	not hispanic or latino	male	white	TCGA-MP-A4TI_demographic	Dead	26565	M0	N1	Stage IIA	T2a	7th	primary	0	429.0	79f3488a-9448-573b-977f-bb7a769487ea	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4TI_diagnosis	No	Lower lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TI_treatment	NA	NA	NA	NA	ed985a92-43bd-5441-9cbe-13f33f9686ca	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f327dea0-2d30-482f-809c-76a148a749b7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TI	72	false	United States	-26565	429	48b071ad-ce05-5630-b41a-1634cf0c2f94	not hispanic or latino	male	white	TCGA-MP-A4TI_demographic	Dead	26649	NA	NA	NA	NA	NA	metastasis	84	NA	b2e9881d-3e29-4a98-a6eb-4c7dca5a6932	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TI_diagnosis3	NA	Not Reported	TCGA-MP-A4TI_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TI_treatment10	NA	Distant Site	NA	NA	20b7732f-fef5-4944-bb5d-8765692f989b	NA	unknown	NA	Surgery, NOS
TCGA-LUAD	f327dea0-2d30-482f-809c-76a148a749b7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TI	72	false	United States	-26565	429	48b071ad-ce05-5630-b41a-1634cf0c2f94	not hispanic or latino	male	white	TCGA-MP-A4TI_demographic	Dead	26649	NA	NA	NA	NA	NA	metastasis	84	NA	b2e9881d-3e29-4a98-a6eb-4c7dca5a6932	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TI_diagnosis3	NA	Not Reported	TCGA-MP-A4TI_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TI_treatment8	NA	NA	NA	NA	4d2823e3-9702-4567-93c7-af43cb31d977	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	f327dea0-2d30-482f-809c-76a148a749b7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TI	72	false	United States	-26565	429	48b071ad-ce05-5630-b41a-1634cf0c2f94	not hispanic or latino	male	white	TCGA-MP-A4TI_demographic	Dead	26649	NA	NA	NA	NA	NA	metastasis	84	NA	b2e9881d-3e29-4a98-a6eb-4c7dca5a6932	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TI_diagnosis3	NA	Not Reported	TCGA-MP-A4TI_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TI_treatment9	NA	Locoregional Site	NA	NA	bd15c6c4-8ef0-4776-8f84-7d87789fd935	NA	unknown	NA	Surgery, NOS
TCGA-LUAD	f327dea0-2d30-482f-809c-76a148a749b7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TI	72	false	United States	-26565	429	48b071ad-ce05-5630-b41a-1634cf0c2f94	not hispanic or latino	male	white	TCGA-MP-A4TI_demographic	Dead	26649	NA	NA	NA	NA	NA	metastasis	84	NA	b2e9881d-3e29-4a98-a6eb-4c7dca5a6932	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TI_diagnosis3	NA	Not Reported	TCGA-MP-A4TI_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TI_treatment7	NA	NA	NA	NA	d468c4f2-705f-437f-8031-87c1afcd934f	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f327dea0-2d30-482f-809c-76a148a749b7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TI	72	false	United States	-26565	429	48b071ad-ce05-5630-b41a-1634cf0c2f94	not hispanic or latino	male	white	TCGA-MP-A4TI_demographic	Dead	26649	NA	NA	NA	NA	NA	recurrence	84	NA	eef313a4-e0b3-4f2e-b5cb-0931be93ebdc	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TI_diagnosis2	NA	Not Reported	TCGA-MP-A4TI_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TI_treatment6	NA	Distant Site	NA	NA	06944068-f537-4054-8d95-4d42faf8518a	NA	unknown	NA	Surgery, NOS
TCGA-LUAD	f327dea0-2d30-482f-809c-76a148a749b7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TI	72	false	United States	-26565	429	48b071ad-ce05-5630-b41a-1634cf0c2f94	not hispanic or latino	male	white	TCGA-MP-A4TI_demographic	Dead	26649	NA	NA	NA	NA	NA	recurrence	84	NA	eef313a4-e0b3-4f2e-b5cb-0931be93ebdc	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TI_diagnosis2	NA	Not Reported	TCGA-MP-A4TI_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TI_treatment5	NA	Locoregional Site	NA	NA	1aa19e41-2709-4706-862d-afcd0ced0e49	NA	unknown	NA	Surgery, NOS
TCGA-LUAD	f327dea0-2d30-482f-809c-76a148a749b7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TI	72	false	United States	-26565	429	48b071ad-ce05-5630-b41a-1634cf0c2f94	not hispanic or latino	male	white	TCGA-MP-A4TI_demographic	Dead	26649	NA	NA	NA	NA	NA	recurrence	84	NA	eef313a4-e0b3-4f2e-b5cb-0931be93ebdc	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TI_diagnosis2	NA	Not Reported	TCGA-MP-A4TI_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TI_treatment4	NA	NA	NA	NA	87aa0cb4-7050-4ca9-8f1e-9430bc8be0e7	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	f327dea0-2d30-482f-809c-76a148a749b7	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-MP-A4TI	72	false	United States	-26565	429	48b071ad-ce05-5630-b41a-1634cf0c2f94	not hispanic or latino	male	white	TCGA-MP-A4TI_demographic	Dead	26649	NA	NA	NA	NA	NA	recurrence	84	NA	eef313a4-e0b3-4f2e-b5cb-0931be93ebdc	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TI_diagnosis2	NA	Not Reported	TCGA-MP-A4TI_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TI_treatment3	NA	NA	NA	NA	daec4350-5a01-48d1-9199-5a47984bd056	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f3501466-cf32-4866-b5fb-e94dd32341bc	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2661	69	false	United States	-25313	NA	58e2c036-94cc-5ebf-a3e3-1e0e28182c8d	not hispanic or latino	female	white	TCGA-44-2661_demographic	Alive	25313	M0	N0	Stage IA	T1	6th	primary	0	1159.0	62584f05-9d54-5926-8d4e-2e3787dd6508	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-44-2661_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2661_treatment	NA	NA	NA	NA	8a366bb6-3f9b-546c-989a-7049e7c5317e	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f3501466-cf32-4866-b5fb-e94dd32341bc	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2661	69	false	United States	-25313	NA	58e2c036-94cc-5ebf-a3e3-1e0e28182c8d	not hispanic or latino	female	white	TCGA-44-2661_demographic	Alive	25313	M0	N0	Stage IA	T1	6th	primary	0	1159.0	62584f05-9d54-5926-8d4e-2e3787dd6508	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	R0	Lung, NOS	NA	TCGA-44-2661_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2661_treatment2	NA	NA	NA	NA	d0d2f353-e9e1-4988-8b4b-e2388e8db190	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f3501466-cf32-4866-b5fb-e94dd32341bc	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2661	69	false	United States	-25313	NA	58e2c036-94cc-5ebf-a3e3-1e0e28182c8d	not hispanic or latino	female	white	TCGA-44-2661_demographic	Alive	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	e93e09c7-a410-4ca2-baa7-4d21c1794eaf	false	NA	NA	NA	Right	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-2661_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2661_treatment4	NA	NA	NA	NA	07eef560-97c2-4090-8545-f7ff05d2f5c2	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f3501466-cf32-4866-b5fb-e94dd32341bc	Informed Consent	-2	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2661	69	false	United States	-25313	NA	58e2c036-94cc-5ebf-a3e3-1e0e28182c8d	not hispanic or latino	female	white	TCGA-44-2661_demographic	Alive	NA	NA	NA	NA	NA	NA	Synchronous primary	NA	NA	e93e09c7-a410-4ca2-baa7-4d21c1794eaf	false	NA	NA	NA	Right	8500/3	Infiltrating duct carcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-2661_diagnosis2	NA	Breast, NOS	NA	NA	NA	NA	NA	-24	NA	NA	NA	NA	NA	NA	TCGA-44-2661_treatment3	Letrozole	Body, total	NA	NA	112b5700-cc70-4a20-be4f-262a3b3cde1c	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f3f024c2-52f1-400e-946c-398f5b72e6dc	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5941	55	false	United States	-20350	NA	e8267781-5e4a-52d9-9061-5e3cca625629	not reported	female	white	TCGA-50-5941_demographic	Alive	20350	M0	N2	Stage IIIA	T2a	7th	primary	0	1474.0	4482ef51-004f-5ed7-a775-1c7c6aedc198	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5941_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5941_treatment2	Docetaxel	NA	NA	NA	2d156a3d-0cbc-44ad-953e-704d7ce88285	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	f3f024c2-52f1-400e-946c-398f5b72e6dc	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5941	55	false	United States	-20350	NA	e8267781-5e4a-52d9-9061-5e3cca625629	not reported	female	white	TCGA-50-5941_demographic	Alive	20350	M0	N2	Stage IIIA	T2a	7th	primary	0	1474.0	4482ef51-004f-5ed7-a775-1c7c6aedc198	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5941_diagnosis	No	Upper lobe, lung	NA	2010	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5941_treatment3	NA	NA	NA	NA	44cfc728-f7c7-4b80-a3f6-f120d62eab52	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f3f024c2-52f1-400e-946c-398f5b72e6dc	Informed Consent	-9	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5941	55	false	United States	-20350	NA	e8267781-5e4a-52d9-9061-5e3cca625629	not reported	female	white	TCGA-50-5941_demographic	Alive	20350	M0	N2	Stage IIIA	T2a	7th	primary	0	1474.0	4482ef51-004f-5ed7-a775-1c7c6aedc198	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5941_diagnosis	No	Upper lobe, lung	NA	2010	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5941_treatment	Cisplatin	NA	NA	NA	6737fb9a-0997-54e0-a5a4-bf91f6f0211b	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	f40301ba-831e-4afd-9ce8-5f3c1a05ff7e	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2657	74	false	United States	-27298	NA	f9ecfdd0-5d6f-5f0a-a990-b7d5167143b5	not hispanic or latino	female	white	TCGA-44-2657_demographic	Alive	27298	M0	NX	Stage IB	T2	6th	primary	0	1351.0	7982fa01-64e5-508d-9bc7-fa962a4d4b47	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2657_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2657_treatment	NA	NA	NA	NA	93d097b5-0fb6-59f1-98dd-b719b1b69091	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f40301ba-831e-4afd-9ce8-5f3c1a05ff7e	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2657	74	false	United States	-27298	NA	f9ecfdd0-5d6f-5f0a-a990-b7d5167143b5	not hispanic or latino	female	white	TCGA-44-2657_demographic	Alive	27298	M0	NX	Stage IB	T2	6th	primary	0	1351.0	7982fa01-64e5-508d-9bc7-fa962a4d4b47	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2657_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2657_treatment2	NA	NA	NA	NA	de8ac759-fc5e-4936-9465-5a1d718f0278	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f4350d9c-3f40-4829-bbc4-8acb2f3ff512	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8175	55	false	United States	-20206	NA	f7d173f0-a63f-5ce1-b3f2-ab2673ef96c0	not hispanic or latino	female	white	TCGA-97-8175_demographic	Alive	20206	M0	N0	Stage IB	T2a	7th	primary	0	551.0	40d8542e-cef4-5868-904d-57fb3be69d83	true	NA	NA	C34.1	Left	8230/3	Solid carcinoma, NOS	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-97-8175_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	NA	472	NA	NA	NA	NA	NA	NA	TCGA-97-8175_treatment3	Cisplatin	NA	NA	NA	09e66b11-43b2-4921-9274-3a4a55787190	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	f4350d9c-3f40-4829-bbc4-8acb2f3ff512	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8175	55	false	United States	-20206	NA	f7d173f0-a63f-5ce1-b3f2-ab2673ef96c0	not hispanic or latino	female	white	TCGA-97-8175_demographic	Alive	20206	M0	N0	Stage IB	T2a	7th	primary	0	551.0	40d8542e-cef4-5868-904d-57fb3be69d83	true	NA	NA	C34.1	Left	8230/3	Solid carcinoma, NOS	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-97-8175_diagnosis	No	Upper lobe, lung	NA	2011	No	NA	NA	472	NA	NA	NA	NA	NA	NA	TCGA-97-8175_treatment2	Pemetrexed Disodium	NA	NA	NA	bc6154ca-927b-4acb-bcfc-9b3ea404a98f	NA	yes	Treatment Ongoing	Chemotherapy
TCGA-LUAD	f4350d9c-3f40-4829-bbc4-8acb2f3ff512	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8175	55	false	United States	-20206	NA	f7d173f0-a63f-5ce1-b3f2-ab2673ef96c0	not hispanic or latino	female	white	TCGA-97-8175_demographic	Alive	20206	M0	N0	Stage IB	T2a	7th	primary	0	551.0	40d8542e-cef4-5868-904d-57fb3be69d83	true	NA	NA	C34.1	Left	8230/3	Solid carcinoma, NOS	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-97-8175_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	441	427	NA	NA	5.0	NA	NA	NA	TCGA-97-8175_treatment	NA	Locoregional Site	5000	cGy	e3ad7cf6-ac2d-549e-9b9a-903f01ea0a8b	NA	yes	Complete Response	Radiation, External Beam
TCGA-LUAD	f4350d9c-3f40-4829-bbc4-8acb2f3ff512	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8175	55	false	United States	-20206	NA	f7d173f0-a63f-5ce1-b3f2-ab2673ef96c0	not hispanic or latino	female	white	TCGA-97-8175_demographic	Alive	20500	NA	NA	NA	NA	NA	recurrence	294	NA	8533a0d9-4c11-4712-9d7d-a10ab664d1da	false	NA	NA	NA	NA	8230/3	Solid carcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-97-8175_diagnosis2	NA	Not Reported	TCGA-97-8175_diagnosis	NA	NA	NA	NA	294	NA	NA	NA	NA	NA	NA	TCGA-97-8175_treatment6	NA	Locoregional Site	NA	NA	700ea5ce-be0e-4fba-9f7c-32d10f7c3802	NA	yes	NA	Surgery, NOS
TCGA-LUAD	f4350d9c-3f40-4829-bbc4-8acb2f3ff512	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8175	55	false	United States	-20206	NA	f7d173f0-a63f-5ce1-b3f2-ab2673ef96c0	not hispanic or latino	female	white	TCGA-97-8175_demographic	Alive	20500	NA	NA	NA	NA	NA	recurrence	294	NA	8533a0d9-4c11-4712-9d7d-a10ab664d1da	false	NA	NA	NA	NA	8230/3	Solid carcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-97-8175_diagnosis2	NA	Not Reported	TCGA-97-8175_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-97-8175_treatment5	NA	NA	NA	NA	9d22825a-1a20-4079-ab9c-d7e09bfd5f25	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	f4350d9c-3f40-4829-bbc4-8acb2f3ff512	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-97-8175	55	false	United States	-20206	NA	f7d173f0-a63f-5ce1-b3f2-ab2673ef96c0	not hispanic or latino	female	white	TCGA-97-8175_demographic	Alive	20500	NA	NA	NA	NA	NA	recurrence	294	NA	8533a0d9-4c11-4712-9d7d-a10ab664d1da	false	NA	NA	NA	NA	8230/3	Solid carcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-97-8175_diagnosis2	NA	Not Reported	TCGA-97-8175_diagnosis	NA	NA	NA	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-97-8175_treatment4	NA	NA	NA	NA	d5e6d518-1aa1-4f55-9718-5da7b36c0e4b	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f462cfef-f60a-4d3e-b92d-b8d8f50b6bb3	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-7978	59	false	United States	-21785	NA	da6af0bc-83ee-598b-9ac7-fcd8b4c93d93	not hispanic or latino	male	white	TCGA-69-7978_demographic	Alive	21785	MX	N1	Stage IIB	T2b	7th	primary	0	134.0	7daeda03-2ce3-5131-bbbe-863943db20a5	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7978_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7978_treatment	NA	NA	NA	NA	3ac06809-bac3-50bb-81a6-5cf6c0e177d8	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f462cfef-f60a-4d3e-b92d-b8d8f50b6bb3	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-69-7978	59	false	United States	-21785	NA	da6af0bc-83ee-598b-9ac7-fcd8b4c93d93	not hispanic or latino	male	white	TCGA-69-7978_demographic	Alive	21785	MX	N1	Stage IIB	T2b	7th	primary	0	134.0	7daeda03-2ce3-5131-bbbe-863943db20a5	true	NA	NA	C34.1	Right	8255/3	Adenocarcinoma with mixed subtypes	no	No	NA	Lung, NOS	Peripheral Lung	TCGA-69-7978_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-69-7978_treatment2	NA	NA	NA	NA	4d81f2bb-d20a-42f1-b8f0-00c6f39a2087	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f4b83449-7d0e-49f3-be53-81cf0d485ed8	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z061	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	f587c9ab-2949-4410-80d6-a050865d48aa	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4405	74	false	Germany	-27241	NA	d17b7af8-fdc6-5ce5-9b71-020a46e4376d	not reported	female	not reported	TCGA-05-4405_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	9b5980b7-92d9-4d48-9b9f-3a17ef311df1	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4405_diagnosis2	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4405_treatment4	NA	NA	NA	NA	a706e3c7-4c7d-4644-8039-08a6670254bc	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f587c9ab-2949-4410-80d6-a050865d48aa	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4405	74	false	Germany	-27241	NA	d17b7af8-fdc6-5ce5-9b71-020a46e4376d	not reported	female	not reported	TCGA-05-4405_demographic	Alive	NA	NA	NA	NA	NA	NA	Prior primary	NA	NA	9b5980b7-92d9-4d48-9b9f-3a17ef311df1	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	NA	NA	Not Reported	NA	TCGA-05-4405_diagnosis2	NA	Uterus, NOS	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4405_treatment3	NA	NA	NA	NA	df6f4dab-91d1-4aad-a9c3-93d92a0276eb	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f587c9ab-2949-4410-80d6-a050865d48aa	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4405	74	false	Germany	-27241	NA	d17b7af8-fdc6-5ce5-9b71-020a46e4376d	not reported	female	not reported	TCGA-05-4405_demographic	Alive	27241	M0	N0	Stage IB	T2	5th	primary	0	610.0	f6413e40-b355-565d-842f-15db3edcf214	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-05-4405_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4405_treatment	NA	NA	NA	NA	96d0160b-105b-5bbe-bc99-a3d866ae6bd3	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f587c9ab-2949-4410-80d6-a050865d48aa	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-05-4405	74	false	Germany	-27241	NA	d17b7af8-fdc6-5ce5-9b71-020a46e4376d	not reported	female	not reported	TCGA-05-4405_demographic	Alive	27241	M0	N0	Stage IB	T2	5th	primary	0	610.0	f6413e40-b355-565d-842f-15db3edcf214	true	NA	NA	C34.3	Right	8255/3	Adenocarcinoma with mixed subtypes	yes	No	R0	Lung, NOS	NA	TCGA-05-4405_diagnosis	No	Lower lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-05-4405_treatment2	NA	NA	NA	NA	ec727714-86ce-4406-9dcd-3c97c1e897a1	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f59e5a76-f803-470b-910c-a897a149d939	Informed Consent	23	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8505	62	false	United States	-22676	NA	c22fbbfb-36d5-5276-b42f-4b37e38bbdbd	not hispanic or latino	male	white	TCGA-55-8505_demographic	Alive	22676	MX	N2	Stage IIIA	T1a	7th	primary	0	440.0	09a609af-35ee-5587-8c44-80f8ae83e937	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8505_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	159	96	NA	NA	NA	NA	NA	NA	TCGA-55-8505_treatment2	Pemetrexed Disodium	NA	NA	NA	57265237-3b9f-4b45-9938-80f7fa3b8eb4	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	f59e5a76-f803-470b-910c-a897a149d939	Informed Consent	23	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8505	62	false	United States	-22676	NA	c22fbbfb-36d5-5276-b42f-4b37e38bbdbd	not hispanic or latino	male	white	TCGA-55-8505_demographic	Alive	22676	MX	N2	Stage IIIA	T1a	7th	primary	0	440.0	09a609af-35ee-5587-8c44-80f8ae83e937	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8505_diagnosis	No	Lower lobe, lung	NA	2012	No	NA	159	96	NA	NA	NA	NA	NA	NA	TCGA-55-8505_treatment	Cisplatin	NA	NA	NA	681d3e30-fd3f-512c-8fe8-2313b248495d	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	f59e5a76-f803-470b-910c-a897a149d939	Informed Consent	23	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-8505	62	false	United States	-22676	NA	c22fbbfb-36d5-5276-b42f-4b37e38bbdbd	not hispanic or latino	male	white	TCGA-55-8505_demographic	Alive	22676	MX	N2	Stage IIIA	T1a	7th	primary	0	440.0	09a609af-35ee-5587-8c44-80f8ae83e937	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8505_diagnosis	No	Lower lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8505_treatment3	NA	NA	NA	NA	abc82ecf-6485-4732-97bf-0b12c1414b9a	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	f61d599a-43bd-4743-9568-678317e75955	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47F	74	false	United States	-27122	NA	e6040ce5-3774-56a3-bd6a-52b3f5731cf4	not hispanic or latino	male	white	TCGA-44-A47F_demographic	Alive	27122	M0	N1	Stage IIB	T2b	7th	primary	0	337.0	81353cb1-9267-5fc1-8c24-31b50272ce35	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-A47F_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47F_treatment3	NA	NA	NA	NA	193587e2-e20f-4d04-aaf9-90cd08d8887e	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f61d599a-43bd-4743-9568-678317e75955	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47F	74	false	United States	-27122	NA	e6040ce5-3774-56a3-bd6a-52b3f5731cf4	not hispanic or latino	male	white	TCGA-44-A47F_demographic	Alive	27122	M0	N1	Stage IIB	T2b	7th	primary	0	337.0	81353cb1-9267-5fc1-8c24-31b50272ce35	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-A47F_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	185	122	NA	NA	NA	NA	NA	NA	TCGA-44-A47F_treatment2	Cisplatin	NA	NA	NA	48fffc62-ad51-42ef-bceb-460d38bd2957	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	f61d599a-43bd-4743-9568-678317e75955	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47F	74	false	United States	-27122	NA	e6040ce5-3774-56a3-bd6a-52b3f5731cf4	not hispanic or latino	male	white	TCGA-44-A47F_demographic	Alive	27122	M0	N1	Stage IIB	T2b	7th	primary	0	337.0	81353cb1-9267-5fc1-8c24-31b50272ce35	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	yes	No	NA	Lung, NOS	NA	TCGA-44-A47F_diagnosis	No	Upper lobe, lung	NA	2012	No	NA	185	122	NA	NA	NA	NA	NA	NA	TCGA-44-A47F_treatment	Pemetrexed Disodium	NA	NA	NA	5aa70321-8537-5494-917e-6f6967d5e172	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	f61d599a-43bd-4743-9568-678317e75955	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47F	74	false	United States	-27122	NA	e6040ce5-3774-56a3-bd6a-52b3f5731cf4	not hispanic or latino	male	white	TCGA-44-A47F_demographic	Alive	25200	NA	NA	NA	NA	NA	Prior primary	-1922	NA	bf5c382a-498a-4930-929b-7ab9bad2da9a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-A47F_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	-1817	NA	NA	NA	NA	NA	NA	TCGA-44-A47F_treatment5	NA	Locoregional Site	NA	NA	51437310-a052-41b6-aef3-f6c30cadef37	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	f61d599a-43bd-4743-9568-678317e75955	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47F	74	false	United States	-27122	NA	e6040ce5-3774-56a3-bd6a-52b3f5731cf4	not hispanic or latino	male	white	TCGA-44-A47F_demographic	Alive	25200	NA	NA	NA	NA	NA	Prior primary	-1922	NA	bf5c382a-498a-4930-929b-7ab9bad2da9a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-A47F_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47F_treatment4	NA	NA	NA	NA	aeb7b640-ab48-4f3e-9fb6-298ae426c0e3	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f61d599a-43bd-4743-9568-678317e75955	Informed Consent	18	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A47F	74	false	United States	-27122	NA	e6040ce5-3774-56a3-bd6a-52b3f5731cf4	not hispanic or latino	male	white	TCGA-44-A47F_demographic	Alive	25200	NA	NA	NA	NA	NA	Prior primary	-1922	NA	bf5c382a-498a-4930-929b-7ab9bad2da9a	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	NA	NA	Not Reported	NA	TCGA-44-A47F_diagnosis2	NA	Prostate gland	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A47F_treatment6	NA	NA	NA	NA	b19a9305-213f-4f67-b334-67ed746bd05a	NA	no	NA	Surgery, NOS
TCGA-LUAD	f77b6930-a1ce-446e-a15d-c018cbbecfee	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4510	51	false	United States	-18762	896	0bf011e3-73bf-5590-a100-2fbb453a18b5	not hispanic or latino	female	black or african american	TCGA-49-4510_demographic	Dead	18762	M0	N1	Stage IIB	T2	5th	primary	0	896.0	4a94eb8d-939a-567e-9051-15519961fc73	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4510_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4510_treatment2	NA	NA	NA	NA	15caebf8-a3cd-4839-8262-786a7cb57144	Adjuvant	yes	Stable Disease	Radiation Therapy, NOS
TCGA-LUAD	f77b6930-a1ce-446e-a15d-c018cbbecfee	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4510	51	false	United States	-18762	896	0bf011e3-73bf-5590-a100-2fbb453a18b5	not hispanic or latino	female	black or african american	TCGA-49-4510_demographic	Dead	18762	M0	N1	Stage IIB	T2	5th	primary	0	896.0	4a94eb8d-939a-567e-9051-15519961fc73	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-49-4510_diagnosis	No	Upper lobe, lung	NA	2001	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4510_treatment	NA	NA	NA	NA	f16b9072-3bdc-5ec4-9cb5-017e8f1d7cac	Adjuvant	yes	Stable Disease	Pharmaceutical Therapy, NOS
TCGA-LUAD	f77b6930-a1ce-446e-a15d-c018cbbecfee	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4510	51	false	United States	-18762	896	0bf011e3-73bf-5590-a100-2fbb453a18b5	not hispanic or latino	female	black or african american	TCGA-49-4510_demographic	Dead	19264	NA	NA	NA	NA	NA	metastasis	502	NA	d1374b4d-b27f-42a0-bde5-729123339adf	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4510_diagnosis2	NA	Not Reported	TCGA-49-4510_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4510_treatment6	NA	Distant Site	NA	NA	856fa8ce-639e-4f11-b539-af5568de6e9e	NA	no	NA	Surgery, NOS
TCGA-LUAD	f77b6930-a1ce-446e-a15d-c018cbbecfee	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4510	51	false	United States	-18762	896	0bf011e3-73bf-5590-a100-2fbb453a18b5	not hispanic or latino	female	black or african american	TCGA-49-4510_demographic	Dead	19264	NA	NA	NA	NA	NA	metastasis	502	NA	d1374b4d-b27f-42a0-bde5-729123339adf	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4510_diagnosis2	NA	Not Reported	TCGA-49-4510_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-49-4510_treatment4	NA	NA	NA	NA	c31d7d0d-d3f4-45ec-886d-94e16e408dea	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f77b6930-a1ce-446e-a15d-c018cbbecfee	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4510	51	false	United States	-18762	896	0bf011e3-73bf-5590-a100-2fbb453a18b5	not hispanic or latino	female	black or african american	TCGA-49-4510_demographic	Dead	19264	NA	NA	NA	NA	NA	metastasis	502	NA	d1374b4d-b27f-42a0-bde5-729123339adf	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4510_diagnosis2	NA	Not Reported	TCGA-49-4510_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-49-4510_treatment3	NA	NA	NA	NA	e85d18aa-3c84-4e95-8e1d-76fef1332b84	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f77b6930-a1ce-446e-a15d-c018cbbecfee	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-49-4510	51	false	United States	-18762	896	0bf011e3-73bf-5590-a100-2fbb453a18b5	not hispanic or latino	female	black or african american	TCGA-49-4510_demographic	Dead	19264	NA	NA	NA	NA	NA	metastasis	502	NA	d1374b4d-b27f-42a0-bde5-729123339adf	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-49-4510_diagnosis2	NA	Not Reported	TCGA-49-4510_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-4510_treatment5	NA	Locoregional Site	NA	NA	fa37b1a5-7122-44a0-ad97-77091ee068f9	NA	no	NA	Surgery, NOS
TCGA-LUAD	f77cf4d3-9829-4fd3-95a1-b29aed9e94b8	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1678	70	false	United States	-25931	NA	be0e76a7-31b2-51e9-b9bb-20d5a93cc106	not hispanic or latino	female	white	TCGA-64-1678_demographic	Alive	25931	M0	N0	NA	T2b	6th	primary	0	1189.0	46265c2f-93dc-5a82-bfe5-2019e1421c4e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-64-1678_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	132	69	NA	4	NA	6.0	AUC	Intravenous	TCGA-64-1678_treatment	Carboplatin	NA	NA	NA	5e7b32e3-d153-528b-9400-e27c40e95ea0	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	f77cf4d3-9829-4fd3-95a1-b29aed9e94b8	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1678	70	false	United States	-25931	NA	be0e76a7-31b2-51e9-b9bb-20d5a93cc106	not hispanic or latino	female	white	TCGA-64-1678_demographic	Alive	25931	M0	N0	NA	T2b	6th	primary	0	1189.0	46265c2f-93dc-5a82-bfe5-2019e1421c4e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-64-1678_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-1678_treatment3	NA	NA	NA	NA	def92e76-bb06-4fe7-b339-be41460de426	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f77cf4d3-9829-4fd3-95a1-b29aed9e94b8	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1678	70	false	United States	-25931	NA	be0e76a7-31b2-51e9-b9bb-20d5a93cc106	not hispanic or latino	female	white	TCGA-64-1678_demographic	Alive	25931	M0	N0	NA	T2b	6th	primary	0	1189.0	46265c2f-93dc-5a82-bfe5-2019e1421c4e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-64-1678_diagnosis	No	Upper lobe, lung	NA	2006	NA	NA	132	69	NA	4	NA	200.0	mg/m2	Intravenous	TCGA-64-1678_treatment2	Paclitaxel	NA	NA	NA	e9693d33-4f66-4a0b-9707-5d3aa0c4f4c9	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	f7f9f522-de88-4f9c-8ba4-7be3726faaf8	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TK	56	false	United States	-20581	582	abceadc1-f5b1-5644-a5ba-2d0049f1a642	Unknown	female	Unknown	TCGA-MP-A4TK_demographic	Dead	21126	NA	NA	NA	NA	NA	metastasis	545	NA	60b7cae2-24a0-43fc-88f4-79317bbbf1b6	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TK_diagnosis3	NA	Not Reported	TCGA-MP-A4TK_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TK_treatment7	NA	NA	NA	NA	43decc05-f00d-4820-9049-d6cb70f604b6	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	f7f9f522-de88-4f9c-8ba4-7be3726faaf8	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TK	56	false	United States	-20581	582	abceadc1-f5b1-5644-a5ba-2d0049f1a642	Unknown	female	Unknown	TCGA-MP-A4TK_demographic	Dead	21126	NA	NA	NA	NA	NA	metastasis	545	NA	60b7cae2-24a0-43fc-88f4-79317bbbf1b6	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TK_diagnosis3	NA	Not Reported	TCGA-MP-A4TK_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TK_treatment6	NA	NA	NA	NA	bb2414e6-8ef1-45aa-9f52-c84ff3072044	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f7f9f522-de88-4f9c-8ba4-7be3726faaf8	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TK	56	false	United States	-20581	582	abceadc1-f5b1-5644-a5ba-2d0049f1a642	Unknown	female	Unknown	TCGA-MP-A4TK_demographic	Dead	21126	NA	NA	NA	NA	NA	metastasis	545	NA	60b7cae2-24a0-43fc-88f4-79317bbbf1b6	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TK_diagnosis3	NA	Not Reported	TCGA-MP-A4TK_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TK_treatment8	NA	Distant Site	NA	NA	dd1825cb-12c0-4691-9e2f-bab77151132a	NA	no	NA	Surgery, NOS
TCGA-LUAD	f7f9f522-de88-4f9c-8ba4-7be3726faaf8	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TK	56	false	United States	-20581	582	abceadc1-f5b1-5644-a5ba-2d0049f1a642	Unknown	female	Unknown	TCGA-MP-A4TK_demographic	Dead	20581	MX	N1	Stage IIB	T2	5th	primary	0	582.0	c105fe5e-b554-5e09-a872-fedc9220a72c	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4TK_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TK_treatment	NA	NA	NA	NA	26ca25ad-09c7-5b35-81b6-fe73567b1c2f	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f7f9f522-de88-4f9c-8ba4-7be3726faaf8	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TK	56	false	United States	-20581	582	abceadc1-f5b1-5644-a5ba-2d0049f1a642	Unknown	female	Unknown	TCGA-MP-A4TK_demographic	Dead	20581	MX	N1	Stage IIB	T2	5th	primary	0	582.0	c105fe5e-b554-5e09-a872-fedc9220a72c	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-MP-A4TK_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TK_treatment2	NA	NA	NA	NA	67c18ae0-638c-4edf-a75d-79f7cf2e1431	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f7f9f522-de88-4f9c-8ba4-7be3726faaf8	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TK	56	false	United States	-20581	582	abceadc1-f5b1-5644-a5ba-2d0049f1a642	Unknown	female	Unknown	TCGA-MP-A4TK_demographic	Dead	20978	NA	NA	NA	NA	NA	metastasis	397	NA	e9d5620b-925c-4a36-aa2f-4c2fbcb693db	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TK_diagnosis2	NA	Not Reported	TCGA-MP-A4TK_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-MP-A4TK_treatment5	NA	Distant Site	NA	NA	1a9f9f1d-d182-4145-878e-2bed71a16b7b	NA	no	NA	Surgery, NOS
TCGA-LUAD	f7f9f522-de88-4f9c-8ba4-7be3726faaf8	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TK	56	false	United States	-20581	582	abceadc1-f5b1-5644-a5ba-2d0049f1a642	Unknown	female	Unknown	TCGA-MP-A4TK_demographic	Dead	20978	NA	NA	NA	NA	NA	metastasis	397	NA	e9d5620b-925c-4a36-aa2f-4c2fbcb693db	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TK_diagnosis2	NA	Not Reported	TCGA-MP-A4TK_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TK_treatment3	NA	NA	NA	NA	63a60601-6233-412b-a888-ec75ae43c862	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f7f9f522-de88-4f9c-8ba4-7be3726faaf8	Consent by Death	NA	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-MP-A4TK	56	false	United States	-20581	582	abceadc1-f5b1-5644-a5ba-2d0049f1a642	Unknown	female	Unknown	TCGA-MP-A4TK_demographic	Dead	20978	NA	NA	NA	NA	NA	metastasis	397	NA	e9d5620b-925c-4a36-aa2f-4c2fbcb693db	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-MP-A4TK_diagnosis2	NA	Not Reported	TCGA-MP-A4TK_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-MP-A4TK_treatment4	NA	NA	NA	NA	722cdec1-ffbe-42b6-b1b0-91166f0cc39d	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	f809e21d-5f2e-4f3b-a1aa-d6b8d463552a	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A46V	78	false	Germany	-28495	NA	190035d4-ff6e-5ae3-adbc-1acbcec973c7	not hispanic or latino	female	white	TCGA-62-A46V_demographic	Alive	28495	M0	N0	Stage IB	T2	6th	primary	0	2199.0	f73727a4-b2ed-5928-94fd-ccd64dd2bf49	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A46V_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46V_treatment2	NA	NA	NA	NA	c11dad27-6f7b-473c-a213-b6ee5ec7f95d	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f809e21d-5f2e-4f3b-a1aa-d6b8d463552a	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-62-A46V	78	false	Germany	-28495	NA	190035d4-ff6e-5ae3-adbc-1acbcec973c7	not hispanic or latino	female	white	TCGA-62-A46V_demographic	Alive	28495	M0	N0	Stage IB	T2	6th	primary	0	2199.0	f73727a4-b2ed-5928-94fd-ccd64dd2bf49	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-62-A46V_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-62-A46V_treatment	NA	NA	NA	NA	fc1049c4-502e-5b5d-a27b-6b543183fe64	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f809e7d9-a75e-41c9-ac2c-5bec6ffcb4a2	Consent Waiver	NA	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-AAR2	64	false	United States	-23479	NA	b810b864-c5f3-529c-b3bf-59e92f6ba023	not hispanic or latino	male	black or african american	TCGA-49-AAR2_demographic	Alive	23479	MX	N0	Stage IB	T2	6th	primary	0	2224.0	66de4fbb-78b4-55fd-a035-1c3fea6bfb6f	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-49-AAR2_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-49-AAR2_treatment2	NA	NA	NA	NA	1a862246-a2d0-40a2-9a49-cbe7d5eb89c9	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f809e7d9-a75e-41c9-ac2c-5bec6ffcb4a2	Consent Waiver	NA	Acinar Cell Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-49-AAR2	64	false	United States	-23479	NA	b810b864-c5f3-529c-b3bf-59e92f6ba023	not hispanic or latino	male	black or african american	TCGA-49-AAR2_demographic	Alive	23479	MX	N0	Stage IB	T2	6th	primary	0	2224.0	66de4fbb-78b4-55fd-a035-1c3fea6bfb6f	true	NA	NA	C34.3	Right	8550/3	Acinar cell carcinoma	no	No	R0	Lung, NOS	NA	TCGA-49-AAR2_diagnosis	No	Lower lobe, lung	NA	2009	No	NA	123	85	NA	NA	NA	NA	NA	NA	TCGA-49-AAR2_treatment	Paclitaxel	NA	NA	NA	5d193352-bcb2-548b-bf98-84493cf5580f	NA	yes	Complete Response	Chemotherapy
TCGA-LUAD	f86e1da7-bad6-4eb8-ae4c-fa9421308d47	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z043	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	f934ed41-090e-4313-bbc5-d1a4a9ed9ad7	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A4SS	73	false	United States	-26991	NA	042f7aba-5d22-54cb-bc08-8fdf0405c456	not hispanic or latino	male	white	TCGA-44-A4SS_demographic	Alive	26991	M0	N0	Stage IA	T1b	7th	primary	0	415.0	a2d576ba-85a3-5eea-9c6d-c712a0e7ce34	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-A4SS_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A4SS_treatment2	NA	NA	NA	NA	045963f5-5291-4720-b086-4c2ae9fc7783	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	f934ed41-090e-4313-bbc5-d1a4a9ed9ad7	Informed Consent	-5	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-A4SS	73	false	United States	-26991	NA	042f7aba-5d22-54cb-bc08-8fdf0405c456	not hispanic or latino	male	white	TCGA-44-A4SS_demographic	Alive	26991	M0	N0	Stage IA	T1b	7th	primary	0	415.0	a2d576ba-85a3-5eea-9c6d-c712a0e7ce34	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-44-A4SS_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-A4SS_treatment	NA	NA	NA	NA	28d0ee5c-ab35-5a44-9d66-cdc674c0fcfe	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	f98ecd8a-b878-4f53-b911-20cd8e17281c	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-05-4250	79	false	Germany	-29068	121	5f0a2b7e-0263-5480-a6f7-2c1f434693ed	not reported	female	not reported	TCGA-05-4250_demographic	Dead	29068	M0	N1	Stage IIIA	T3	6th	primary	0	121.0	e3e1b5bf-7f8d-52dc-9a43-fcd54b78cb3d	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R2	Lung, NOS	NA	TCGA-05-4250_diagnosis	No	Lower lobe, lung	NA	2007	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	fa0c7392-d485-41ac-bf7e-244a528209ae	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5044	72	false	United States	-26567	624	f475320d-a242-5d5f-b95d-523ad3e60bc6	not hispanic or latino	female	white	TCGA-50-5044_demographic	Dead	26567	M0	N1	Stage IIIB	T4	5th	primary	0	624.0	3aacaa75-46a2-581e-becf-6f1cfaf83750	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5044_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5044_treatment2	NA	NA	NA	NA	0bf6d011-fe43-4da6-a1bd-cb38a2093f6e	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fa0c7392-d485-41ac-bf7e-244a528209ae	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5044	72	false	United States	-26567	624	f475320d-a242-5d5f-b95d-523ad3e60bc6	not hispanic or latino	female	white	TCGA-50-5044_demographic	Dead	26567	M0	N1	Stage IIIB	T4	5th	primary	0	624.0	3aacaa75-46a2-581e-becf-6f1cfaf83750	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	NA	Lung, NOS	NA	TCGA-50-5044_diagnosis	No	Lower lobe, lung	NA	2002	NA	NA	500	491	NA	NA	7.0	NA	NA	NA	TCGA-50-5044_treatment	NA	Primary Tumor Field	NA	NA	78f1ed4e-f332-5622-b098-25ccd8a77cf5	NA	yes	Unknown	Radiation, External Beam
TCGA-LUAD	fa0c7392-d485-41ac-bf7e-244a528209ae	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5044	72	false	United States	-26567	624	f475320d-a242-5d5f-b95d-523ad3e60bc6	not hispanic or latino	female	white	TCGA-50-5044_demographic	Dead	27050	NA	NA	NA	NA	NA	metastasis	483	NA	c46515b8-822e-4eea-9846-ea80d7572ec5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5044_diagnosis2	NA	Not Reported	TCGA-50-5044_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5044_treatment4	NA	NA	NA	NA	0e178cdc-e7ff-4901-af2f-4735cfca13c7	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	fa0c7392-d485-41ac-bf7e-244a528209ae	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5044	72	false	United States	-26567	624	f475320d-a242-5d5f-b95d-523ad3e60bc6	not hispanic or latino	female	white	TCGA-50-5044_demographic	Dead	27050	NA	NA	NA	NA	NA	metastasis	483	NA	c46515b8-822e-4eea-9846-ea80d7572ec5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5044_diagnosis2	NA	Not Reported	TCGA-50-5044_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-50-5044_treatment3	NA	NA	NA	NA	2f58be6f-a513-472f-9a7c-52267936e8cc	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fa0c7392-d485-41ac-bf7e-244a528209ae	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5044	72	false	United States	-26567	624	f475320d-a242-5d5f-b95d-523ad3e60bc6	not hispanic or latino	female	white	TCGA-50-5044_demographic	Dead	27050	NA	NA	NA	NA	NA	metastasis	483	NA	c46515b8-822e-4eea-9846-ea80d7572ec5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5044_diagnosis2	NA	Not Reported	TCGA-50-5044_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5044_treatment6	NA	Distant Site	NA	NA	7cf366f8-650b-44d8-b659-176134d47932	NA	no	NA	Surgery, NOS
TCGA-LUAD	fa0c7392-d485-41ac-bf7e-244a528209ae	Informed Consent	3	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-50-5044	72	false	United States	-26567	624	f475320d-a242-5d5f-b95d-523ad3e60bc6	not hispanic or latino	female	white	TCGA-50-5044_demographic	Dead	27050	NA	NA	NA	NA	NA	metastasis	483	NA	c46515b8-822e-4eea-9846-ea80d7572ec5	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-50-5044_diagnosis2	NA	Not Reported	TCGA-50-5044_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-50-5044_treatment5	NA	Locoregional Site	NA	NA	a5934aa9-ad90-4bc4-8d00-40a122cd5454	NA	no	NA	Surgery, NOS
TCGA-LUAD	fae64c9d-5204-4dc6-a561-bf59506aabcc	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z029	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	fb6b289c-aaf9-4d8e-b6e0-5d35bce1b6e1	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1676	58	false	United States	-21428	NA	20897392-1ab3-52f9-a737-1a2490ffd388	not hispanic or latino	male	white	TCGA-64-1676_demographic	Alive	21428	M0	N0	Stage IA	T1a	NA	primary	0	1728.0	5c419873-433f-5191-b238-0a5b09e6cd28	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-64-1676_diagnosis	No	Lower lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-1676_treatment	NA	NA	NA	NA	5b8bebdc-1baf-5f00-888f-7c1c87c4c039	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fb6b289c-aaf9-4d8e-b6e0-5d35bce1b6e1	Informed Consent	0	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-1676	58	false	United States	-21428	NA	20897392-1ab3-52f9-a737-1a2490ffd388	not hispanic or latino	male	white	TCGA-64-1676_demographic	Alive	21428	M0	N0	Stage IA	T1a	NA	primary	0	1728.0	5c419873-433f-5191-b238-0a5b09e6cd28	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-64-1676_diagnosis	No	Lower lobe, lung	NA	2005	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-1676_treatment2	NA	NA	NA	NA	8405c41f-a867-4bb2-8bf1-35f4a8775b05	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	fb79c491-7b01-42ae-8369-8364e442e31b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2665	55	false	United States	-20349	NA	8a2a58ad-ac93-5ca4-bde8-89ef17d6076d	not hispanic or latino	female	white	TCGA-44-2665_demographic	Alive	20349	M0	N1	Stage IIB	T2	6th	primary	0	1301.0	b39aeefd-e2c0-5482-b3be-c9d527169f7a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2665_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-2665_treatment4	NA	NA	NA	NA	252ca45a-a049-4533-9c49-94ca99044dfb	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	fb79c491-7b01-42ae-8369-8364e442e31b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2665	55	false	United States	-20349	NA	8a2a58ad-ac93-5ca4-bde8-89ef17d6076d	not hispanic or latino	female	white	TCGA-44-2665_demographic	Alive	20349	M0	N1	Stage IIB	T2	6th	primary	0	1301.0	b39aeefd-e2c0-5482-b3be-c9d527169f7a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2665_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	140	77	NA	4	NA	910.0	mg	Intravenous	TCGA-44-2665_treatment2	Pemetrexed Disodium	NA	3625	mg	8858eb4a-b4a1-4a47-be6a-c3c8c4e5cd38	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	fb79c491-7b01-42ae-8369-8364e442e31b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2665	55	false	United States	-20349	NA	8a2a58ad-ac93-5ca4-bde8-89ef17d6076d	not hispanic or latino	female	white	TCGA-44-2665_demographic	Alive	20349	M0	N1	Stage IIB	T2	6th	primary	0	1301.0	b39aeefd-e2c0-5482-b3be-c9d527169f7a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2665_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	140	77	NA	4	NA	137.0	mg	Intravenous	TCGA-44-2665_treatment3	Cisplatin	NA	545	mg	909a64f3-0b25-4fdf-acd1-b8dc04a413dd	Adjuvant	yes	NA	Chemotherapy
TCGA-LUAD	fb79c491-7b01-42ae-8369-8364e442e31b	Informed Consent	19	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-2665	55	false	United States	-20349	NA	8a2a58ad-ac93-5ca4-bde8-89ef17d6076d	not hispanic or latino	female	white	TCGA-44-2665_demographic	Alive	20349	M0	N1	Stage IIB	T2	6th	primary	0	1301.0	b39aeefd-e2c0-5482-b3be-c9d527169f7a	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-2665_diagnosis	No	Upper lobe, lung	NA	2009	NA	NA	308	77	NA	12	NA	1139.0	mg	Intravenous	TCGA-44-2665_treatment	Bevacizumab	NA	12988	mg	d01675e5-8b1f-590f-bbec-9e246dc7335a	Adjuvant	yes	NA	Targeted Molecular Therapy
TCGA-LUAD	fc79086c-af9a-4c27-b074-f7050b6f3381	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7155	68	false	Australia	-24863	1171	5e9f31d2-5857-544b-8111-f754d64d1eb0	not reported	male	white	TCGA-78-7155_demographic	Dead	25072	NA	NA	NA	NA	NA	not reported	209	NA	4f982452-6422-4058-9041-282f825005de	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7155_diagnosis2	NA	Not Reported	TCGA-78-7155_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7155_treatment5	NA	NA	NA	NA	3581694b-cc6b-491e-8434-8f3b4c52e767	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	fc79086c-af9a-4c27-b074-f7050b6f3381	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7155	68	false	Australia	-24863	1171	5e9f31d2-5857-544b-8111-f754d64d1eb0	not reported	male	white	TCGA-78-7155_demographic	Dead	25072	NA	NA	NA	NA	NA	not reported	209	NA	4f982452-6422-4058-9041-282f825005de	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7155_diagnosis2	NA	Not Reported	TCGA-78-7155_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7155_treatment7	NA	Distant Site	NA	NA	3b16b14d-2fb5-40e4-9a1d-10b8b943e732	NA	no	NA	Surgery, NOS
TCGA-LUAD	fc79086c-af9a-4c27-b074-f7050b6f3381	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7155	68	false	Australia	-24863	1171	5e9f31d2-5857-544b-8111-f754d64d1eb0	not reported	male	white	TCGA-78-7155_demographic	Dead	25072	NA	NA	NA	NA	NA	not reported	209	NA	4f982452-6422-4058-9041-282f825005de	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7155_diagnosis2	NA	Not Reported	TCGA-78-7155_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7155_treatment6	NA	Locoregional Site	NA	NA	6c5d7036-171e-4f87-be54-a0d3f8566d1f	NA	no	NA	Surgery, NOS
TCGA-LUAD	fc79086c-af9a-4c27-b074-f7050b6f3381	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7155	68	false	Australia	-24863	1171	5e9f31d2-5857-544b-8111-f754d64d1eb0	not reported	male	white	TCGA-78-7155_demographic	Dead	25072	NA	NA	NA	NA	NA	not reported	209	NA	4f982452-6422-4058-9041-282f825005de	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7155_diagnosis2	NA	Not Reported	TCGA-78-7155_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7155_treatment4	NA	NA	NA	NA	c6002426-1d32-4ecd-afac-876b06cf5bf9	NA	yes	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fc79086c-af9a-4c27-b074-f7050b6f3381	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7155	68	false	Australia	-24863	1171	5e9f31d2-5857-544b-8111-f754d64d1eb0	not reported	male	white	TCGA-78-7155_demographic	Dead	24863	M0	N0	Stage IB	T2	6th	primary	0	1171.0	8e8965dc-87d2-5cd7-a6c4-54dc3bfa9c34	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7155_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	253	253	Initial Diagnosis	2	NA	NA	NA	Intravenous	TCGA-78-7155_treatment3	Gemcitabine	NA	NA	NA	30dd8904-0db4-4522-b0af-32d4328f99c0	Not Reported	yes	NA	Chemotherapy
TCGA-LUAD	fc79086c-af9a-4c27-b074-f7050b6f3381	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7155	68	false	Australia	-24863	1171	5e9f31d2-5857-544b-8111-f754d64d1eb0	not reported	male	white	TCGA-78-7155_demographic	Dead	24863	M0	N0	Stage IB	T2	6th	primary	0	1171.0	8e8965dc-87d2-5cd7-a6c4-54dc3bfa9c34	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7155_diagnosis	No	Upper lobe, lung	NA	2005	NA	NA	NA	253	Not Reported	2	NA	NA	NA	Intravenous	TCGA-78-7155_treatment2	Carboplatin	NA	NA	NA	5026dca3-d741-4728-9fc8-5c2a9a4f8c57	Not Reported	yes	NA	Chemotherapy
TCGA-LUAD	fc79086c-af9a-4c27-b074-f7050b6f3381	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7155	68	false	Australia	-24863	1171	5e9f31d2-5857-544b-8111-f754d64d1eb0	not reported	male	white	TCGA-78-7155_demographic	Dead	24863	M0	N0	Stage IB	T2	6th	primary	0	1171.0	8e8965dc-87d2-5cd7-a6c4-54dc3bfa9c34	true	NA	NA	C34.1	Left	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7155_diagnosis	No	Upper lobe, lung	NA	2005	NA	1.0	314	NA	Initial Diagnosis	NA	NA	NA	NA	NA	TCGA-78-7155_treatment	NA	Primary Tumor Field	NA	NA	b3c413d1-4cf4-5ec7-a6e7-cf773852a81e	Not Reported	yes	NA	Radiation, External Beam
TCGA-LUAD	fcfe0b53-dfc1-42fa-9efc-2b2ff259297e	Informed Consent	-10	Ductal and Lobular Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-7937	65	false	United States	-23919	NA	894a84b6-6c47-52d4-8eab-12b7fbfc6d28	not hispanic or latino	male	white	TCGA-97-7937_demographic	Alive	23919	MX	N0	Stage IB	T2a	7th	primary	0	564.0	5b8f6a01-8816-5b33-b89d-19ef8b3d9720	true	NA	NA	C34.1	Left	8507/3	Invasive micropapillary carcinoma	no	No	NA	Lung, NOS	NA	TCGA-97-7937_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7937_treatment	NA	NA	NA	NA	dbb1d169-a986-56e1-a8e9-791fdf09da27	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fcfe0b53-dfc1-42fa-9efc-2b2ff259297e	Informed Consent	-10	Ductal and Lobular Neoplasms	Diagnosis	No	Bronchus and lung	TCGA-97-7937	65	false	United States	-23919	NA	894a84b6-6c47-52d4-8eab-12b7fbfc6d28	not hispanic or latino	male	white	TCGA-97-7937_demographic	Alive	23919	MX	N0	Stage IB	T2a	7th	primary	0	564.0	5b8f6a01-8816-5b33-b89d-19ef8b3d9720	true	NA	NA	C34.1	Left	8507/3	Invasive micropapillary carcinoma	no	No	NA	Lung, NOS	NA	TCGA-97-7937_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-97-7937_treatment2	NA	NA	NA	NA	f8429110-459f-4277-a613-5a61afafc808	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	fd3fc273-c035-40ea-a459-ff4806f5d592	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5774	60	false	United States	-22059	NA	c0ac2ec8-afa2-5d50-9022-723da29884d9	not hispanic or latino	male	white	TCGA-64-5774_demographic	Alive	22305	NA	NA	NA	NA	NA	not reported	246	NA	40be996e-0188-47f6-867b-d15c7f669c37	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-5774_diagnosis2	NA	Not Reported	TCGA-64-5774_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-64-5774_treatment3	NA	NA	NA	NA	29e0e8fe-5758-4fb5-a7bc-6378227d1e74	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fd3fc273-c035-40ea-a459-ff4806f5d592	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5774	60	false	United States	-22059	NA	c0ac2ec8-afa2-5d50-9022-723da29884d9	not hispanic or latino	male	white	TCGA-64-5774_demographic	Alive	22305	NA	NA	NA	NA	NA	not reported	246	NA	40be996e-0188-47f6-867b-d15c7f669c37	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-5774_diagnosis2	NA	Not Reported	TCGA-64-5774_diagnosis	NA	NA	NA	NA	277	NA	NA	NA	NA	NA	NA	TCGA-64-5774_treatment5	NA	Distant Site	NA	NA	2c1710ba-551e-4493-8951-81f7959aa2ea	NA	yes	NA	Surgery, NOS
TCGA-LUAD	fd3fc273-c035-40ea-a459-ff4806f5d592	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5774	60	false	United States	-22059	NA	c0ac2ec8-afa2-5d50-9022-723da29884d9	not hispanic or latino	male	white	TCGA-64-5774_demographic	Alive	22305	NA	NA	NA	NA	NA	not reported	246	NA	40be996e-0188-47f6-867b-d15c7f669c37	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-64-5774_diagnosis2	NA	Not Reported	TCGA-64-5774_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-64-5774_treatment4	NA	NA	NA	NA	328164d9-7ef7-45c5-ba1f-b65dd45ec6a3	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	fd3fc273-c035-40ea-a459-ff4806f5d592	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5774	60	false	United States	-22059	NA	c0ac2ec8-afa2-5d50-9022-723da29884d9	not hispanic or latino	male	white	TCGA-64-5774_demographic	Alive	22336	NA	NA	NA	NA	NA	metastasis	277	NA	73f64d38-861c-472c-a659-3315255d84c2	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-64-5774_diagnosis3	NA	Not Reported	TCGA-64-5774_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-64-5774_treatment7	NA	NA	NA	NA	bc16045c-24f9-46dd-9721-c5419e8755b0	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	fd3fc273-c035-40ea-a459-ff4806f5d592	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5774	60	false	United States	-22059	NA	c0ac2ec8-afa2-5d50-9022-723da29884d9	not hispanic or latino	male	white	TCGA-64-5774_demographic	Alive	22336	NA	NA	NA	NA	NA	metastasis	277	NA	73f64d38-861c-472c-a659-3315255d84c2	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-64-5774_diagnosis3	NA	Not Reported	TCGA-64-5774_diagnosis	NA	NA	NA	NA	NA	Progressive Disease	NA	NA	NA	NA	NA	TCGA-64-5774_treatment6	NA	NA	NA	NA	bdf9b41a-e5b5-43b0-b412-1b4dde31f402	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fd3fc273-c035-40ea-a459-ff4806f5d592	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5774	60	false	United States	-22059	NA	c0ac2ec8-afa2-5d50-9022-723da29884d9	not hispanic or latino	male	white	TCGA-64-5774_demographic	Alive	22336	NA	NA	NA	NA	NA	metastasis	277	NA	73f64d38-861c-472c-a659-3315255d84c2	false	NA	NA	NA	NA	8140/3	Adenocarcinoma, NOS	NA	Yes	NA	Not Reported	NA	TCGA-64-5774_diagnosis3	NA	Not Reported	TCGA-64-5774_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-5774_treatment8	NA	Distant Site	NA	NA	e4ce2eb9-9f00-4151-bd53-c500edcd61db	NA	yes	NA	Surgery, NOS
TCGA-LUAD	fd3fc273-c035-40ea-a459-ff4806f5d592	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5774	60	false	United States	-22059	NA	c0ac2ec8-afa2-5d50-9022-723da29884d9	not hispanic or latino	male	white	TCGA-64-5774_demographic	Alive	22059	M0	N0	Stage IB	T2	6th	primary	0	2676.0	bba06034-4ad4-582a-ac47-c54e2f4ffddf	true	NA	NA	C34.0	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5774_diagnosis	No	Main bronchus	NA	2004	NA	1.0	NA	NA	Recurrent Disease	NA	NA	NA	NA	NA	TCGA-64-5774_treatment	NA	Distant Site	NA	NA	d26918ae-f043-551d-a1c3-756e82731590	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	fd3fc273-c035-40ea-a459-ff4806f5d592	Informed Consent	-8	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-64-5774	60	false	United States	-22059	NA	c0ac2ec8-afa2-5d50-9022-723da29884d9	not hispanic or latino	male	white	TCGA-64-5774_demographic	Alive	22059	M0	N0	Stage IB	T2	6th	primary	0	2676.0	bba06034-4ad4-582a-ac47-c54e2f4ffddf	true	NA	NA	C34.0	NA	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	Central Lung	TCGA-64-5774_diagnosis	No	Main bronchus	NA	2004	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-64-5774_treatment2	NA	NA	NA	NA	e2c5e5d5-e198-41c9-a968-d847028e99d5	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fd5c44ef-ea50-4fba-9e8d-e371cf34ebdb	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7220	53	false	Australia	-19480	807	a53548be-4a55-5c59-82b9-2c8d93818dc1	not reported	female	white	TCGA-78-7220_demographic	Dead	20011	NA	NA	NA	NA	NA	not reported	531	NA	49c083e9-49ea-4fdc-b989-ec8d1a973def	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7220_diagnosis2	NA	Not Reported	TCGA-78-7220_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7220_treatment6	NA	Locoregional Site	NA	NA	1a874270-2db1-4ef1-8e4d-ea36734f3158	NA	no	NA	Surgery, NOS
TCGA-LUAD	fd5c44ef-ea50-4fba-9e8d-e371cf34ebdb	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7220	53	false	Australia	-19480	807	a53548be-4a55-5c59-82b9-2c8d93818dc1	not reported	female	white	TCGA-78-7220_demographic	Dead	20011	NA	NA	NA	NA	NA	not reported	531	NA	49c083e9-49ea-4fdc-b989-ec8d1a973def	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7220_diagnosis2	NA	Not Reported	TCGA-78-7220_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7220_treatment5	NA	NA	NA	NA	2a6b0c61-c663-4895-9c55-9774add24303	NA	yes	NA	Radiation Therapy, NOS
TCGA-LUAD	fd5c44ef-ea50-4fba-9e8d-e371cf34ebdb	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7220	53	false	Australia	-19480	807	a53548be-4a55-5c59-82b9-2c8d93818dc1	not reported	female	white	TCGA-78-7220_demographic	Dead	20011	NA	NA	NA	NA	NA	not reported	531	NA	49c083e9-49ea-4fdc-b989-ec8d1a973def	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7220_diagnosis2	NA	Not Reported	TCGA-78-7220_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7220_treatment4	NA	NA	NA	NA	6d07e813-c155-432c-bfd2-2ace0c09b8a3	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fd5c44ef-ea50-4fba-9e8d-e371cf34ebdb	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7220	53	false	Australia	-19480	807	a53548be-4a55-5c59-82b9-2c8d93818dc1	not reported	female	white	TCGA-78-7220_demographic	Dead	20011	NA	NA	NA	NA	NA	not reported	531	NA	49c083e9-49ea-4fdc-b989-ec8d1a973def	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7220_diagnosis2	NA	Not Reported	TCGA-78-7220_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7220_treatment7	NA	Distant Site	NA	NA	75980e31-12df-43c6-8f54-6d805c48c4c9	NA	no	NA	Surgery, NOS
TCGA-LUAD	fd5c44ef-ea50-4fba-9e8d-e371cf34ebdb	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7220	53	false	Australia	-19480	807	a53548be-4a55-5c59-82b9-2c8d93818dc1	not reported	female	white	TCGA-78-7220_demographic	Dead	19480	M0	N2	Stage IIIA	T2	6th	primary	0	807.0	d70c4164-ccf1-5e1a-880d-2a5e7c762fe9	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7220_diagnosis	No	Upper lobe, lung	NA	2000	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7220_treatment3	NA	NA	NA	NA	83b12d9b-5bfe-4f08-99e0-bd4cc6e21c8e	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fd5c44ef-ea50-4fba-9e8d-e371cf34ebdb	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7220	53	false	Australia	-19480	807	a53548be-4a55-5c59-82b9-2c8d93818dc1	not reported	female	white	TCGA-78-7220_demographic	Dead	19480	M0	N2	Stage IIIA	T2	6th	primary	0	807.0	d70c4164-ccf1-5e1a-880d-2a5e7c762fe9	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7220_diagnosis	No	Upper lobe, lung	NA	2000	NA	2.0	740	734	Recurrent Disease	NA	5.0	NA	NA	NA	TCGA-78-7220_treatment2	NA	Distant Site	2000	cGy	95890dda-499e-4d9d-8722-7dfac575a8f2	NA	yes	NA	Radiation, External Beam
TCGA-LUAD	fd5c44ef-ea50-4fba-9e8d-e371cf34ebdb	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7220	53	false	Australia	-19480	807	a53548be-4a55-5c59-82b9-2c8d93818dc1	not reported	female	white	TCGA-78-7220_demographic	Dead	19480	M0	N2	Stage IIIA	T2	6th	primary	0	807.0	d70c4164-ccf1-5e1a-880d-2a5e7c762fe9	true	NA	NA	C34.1	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7220_diagnosis	No	Upper lobe, lung	NA	2000	NA	1.0	96	60	NA	NA	25.0	NA	NA	NA	TCGA-78-7220_treatment	NA	Primary Tumor Field	5000	cGy	ba031555-b354-5a71-b39b-654fd56706de	Adjuvant	yes	NA	Radiation, External Beam
TCGA-LUAD	fddc4d29-1ae8-451d-a13e-8ef6492be201	NA	NA	Adenomas and Adenocarcinomas	NA	NA	Bronchus and lung	TCGA-17-Z030	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCGA-LUAD	fe3eeeb6-0db4-46d7-a020-55604d474c12	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7167	77	false	Australia	-28295	2681	2a5a18f0-6944-5f02-a018-e7d7b3b9dd12	not reported	male	white	TCGA-78-7167_demographic	Dead	29021	NA	NA	NA	NA	NA	not reported	726	NA	0f8ac1dd-c69c-4eea-9348-fd2d9b7d1400	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7167_diagnosis2	NA	Not Reported	TCGA-78-7167_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7167_treatment5	NA	Locoregional Site	NA	NA	4c6839be-c565-4967-b153-0c1304f6d2d0	NA	no	NA	Surgery, NOS
TCGA-LUAD	fe3eeeb6-0db4-46d7-a020-55604d474c12	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7167	77	false	Australia	-28295	2681	2a5a18f0-6944-5f02-a018-e7d7b3b9dd12	not reported	male	white	TCGA-78-7167_demographic	Dead	29021	NA	NA	NA	NA	NA	not reported	726	NA	0f8ac1dd-c69c-4eea-9348-fd2d9b7d1400	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7167_diagnosis2	NA	Not Reported	TCGA-78-7167_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7167_treatment4	NA	NA	NA	NA	790fe5d2-5c92-4259-bfc4-729059d48f17	NA	no	NA	Radiation Therapy, NOS
TCGA-LUAD	fe3eeeb6-0db4-46d7-a020-55604d474c12	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7167	77	false	Australia	-28295	2681	2a5a18f0-6944-5f02-a018-e7d7b3b9dd12	not reported	male	white	TCGA-78-7167_demographic	Dead	29021	NA	NA	NA	NA	NA	not reported	726	NA	0f8ac1dd-c69c-4eea-9348-fd2d9b7d1400	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7167_diagnosis2	NA	Not Reported	TCGA-78-7167_diagnosis	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7167_treatment6	NA	Distant Site	NA	NA	85a6bfaf-cc00-4284-8412-489d4c688cee	NA	no	NA	Surgery, NOS
TCGA-LUAD	fe3eeeb6-0db4-46d7-a020-55604d474c12	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7167	77	false	Australia	-28295	2681	2a5a18f0-6944-5f02-a018-e7d7b3b9dd12	not reported	male	white	TCGA-78-7167_demographic	Dead	29021	NA	NA	NA	NA	NA	not reported	726	NA	0f8ac1dd-c69c-4eea-9348-fd2d9b7d1400	false	NA	NA	NA	NA	Not Reported	Not Reported	NA	Yes	NA	Not Reported	NA	TCGA-78-7167_diagnosis2	NA	Not Reported	TCGA-78-7167_diagnosis	NA	NA	NA	NA	NA	Not Reported	NA	NA	NA	NA	NA	TCGA-78-7167_treatment3	NA	NA	NA	NA	9a8e038e-35a6-4157-8b1c-93ab0dc83372	NA	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fe3eeeb6-0db4-46d7-a020-55604d474c12	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7167	77	false	Australia	-28295	2681	2a5a18f0-6944-5f02-a018-e7d7b3b9dd12	not reported	male	white	TCGA-78-7167_demographic	Dead	28295	M1	N0	Stage IV	T2	6th	primary	0	2681.0	ae743f10-d7fa-59d1-8f88-2c704924730d	true	NA	NA	C34.9	NA	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7167_diagnosis	No	Lung, NOS	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7167_treatment2	NA	NA	NA	NA	a66cda0c-d746-451c-83ca-00db34eabbb0	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	fe3eeeb6-0db4-46d7-a020-55604d474c12	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7167	77	false	Australia	-28295	2681	2a5a18f0-6944-5f02-a018-e7d7b3b9dd12	not reported	male	white	TCGA-78-7167_demographic	Dead	28295	M1	N0	Stage IV	T2	6th	primary	0	2681.0	ae743f10-d7fa-59d1-8f88-2c704924730d	true	NA	NA	C34.9	NA	8260/3	Papillary adenocarcinoma, NOS	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7167_diagnosis	No	Lung, NOS	NA	2002	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7167_treatment	NA	NA	NA	NA	ae4fd33e-bda0-5dd4-8ed1-de71bb8513df	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fe714ac0-f874-426a-924b-a2980232b5f7	Informed Consent	48	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-8616	58	false	United States	-21225	NA	09082c79-2303-5525-86d6-f963477b4828	not hispanic or latino	female	white	TCGA-55-8616_demographic	Alive	21225	M0	N0	Stage IB	T2a	7th	primary	0	48.0	314c85df-99b5-51e1-b766-66c7087b189e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8616_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8616_treatment	NA	NA	NA	NA	11da1884-187c-5f8e-b3ac-ad884ea78c81	Adjuvant	unknown	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	fe714ac0-f874-426a-924b-a2980232b5f7	Informed Consent	48	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-55-8616	58	false	United States	-21225	NA	09082c79-2303-5525-86d6-f963477b4828	not hispanic or latino	female	white	TCGA-55-8616_demographic	Alive	21225	M0	N0	Stage IB	T2a	7th	primary	0	48.0	314c85df-99b5-51e1-b766-66c7087b189e	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-8616_diagnosis	No	Upper lobe, lung	NA	2012	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-8616_treatment2	NA	NA	NA	NA	3e73d441-1e02-49d2-8b71-608fcbd7b5f8	Adjuvant	unknown	NA	Radiation Therapy, NOS
TCGA-LUAD	ff07ea4b-4e50-410d-99d6-96a351dad7b1	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7570	60	false	United States	-22218	NA	eed6cb01-7084-5a52-802c-e7c51ab4f11c	not hispanic or latino	male	black or african american	TCGA-55-7570_demographic	Alive	22218	MX	N0	Stage IA	T1a	7th	primary	0	824.0	f026c5e8-d485-593f-af5c-38080d0ea4f9	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7570_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7570_treatment	NA	NA	NA	NA	1128205d-e79b-5ab5-a125-ca4470795ca8	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ff07ea4b-4e50-410d-99d6-96a351dad7b1	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-55-7570	60	false	United States	-22218	NA	eed6cb01-7084-5a52-802c-e7c51ab4f11c	not hispanic or latino	male	black or african american	TCGA-55-7570_demographic	Alive	22218	MX	N0	Stage IA	T1a	7th	primary	0	824.0	f026c5e8-d485-593f-af5c-38080d0ea4f9	true	NA	NA	C34.1	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-55-7570_diagnosis	No	Upper lobe, lung	NA	2011	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-55-7570_treatment2	NA	NA	NA	NA	de646035-4930-49cb-845c-8a56771da942	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ff9def3d-17e5-4ef6-b74e-933f11ed6f00	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7146	71	false	Australia	-26272	173	30a2647f-cbb9-53a8-8a5d-6b05682caabc	not reported	female	white	TCGA-78-7146_demographic	Dead	26272	M0	N2	Stage IIIA	T2	6th	primary	0	173.0	8f95399b-ac7f-55fc-8b9c-388cdbe45b8f	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7146_diagnosis	No	Lower lobe, lung	NA	1999	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7146_treatment	NA	NA	NA	NA	1990c0f8-746f-5934-a5ac-fe7e48831901	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ff9def3d-17e5-4ef6-b74e-933f11ed6f00	Informed Consent	-1	Adenomas and Adenocarcinomas	Diagnosis	NA	Bronchus and lung	TCGA-78-7146	71	false	Australia	-26272	173	30a2647f-cbb9-53a8-8a5d-6b05682caabc	not reported	female	white	TCGA-78-7146_demographic	Dead	26272	M0	N2	Stage IIIA	T2	6th	primary	0	173.0	8f95399b-ac7f-55fc-8b9c-388cdbe45b8f	true	NA	NA	C34.3	Left	8255/3	Adenocarcinoma with mixed subtypes	no	No	R0	Lung, NOS	Peripheral Lung	TCGA-78-7146_diagnosis	No	Lower lobe, lung	NA	1999	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-78-7146_treatment2	NA	NA	NA	NA	aa43474a-15a9-4c0a-97c5-ebf9a86eb432	Adjuvant	no	NA	Radiation Therapy, NOS
TCGA-LUAD	ffb0c0b7-165e-4439-b3e6-62431f40b7fe	Informed Consent	22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3398	77	false	United States	-28392	NA	18e7ccc6-feff-5f40-b633-98f85ee2f6c9	not hispanic or latino	female	white	TCGA-44-3398_demographic	Alive	28392	M0	N0	Stage IA	T1b	6th	primary	0	1163.0	9e7e4689-929c-5c1d-a1ed-5efcdf3edee3	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3398_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3398_treatment	NA	NA	NA	NA	618b2cab-ad73-5787-92e0-c754545feeec	Adjuvant	no	NA	Pharmaceutical Therapy, NOS
TCGA-LUAD	ffb0c0b7-165e-4439-b3e6-62431f40b7fe	Informed Consent	22	Adenomas and Adenocarcinomas	Diagnosis	No	Bronchus and lung	TCGA-44-3398	77	false	United States	-28392	NA	18e7ccc6-feff-5f40-b633-98f85ee2f6c9	not hispanic or latino	female	white	TCGA-44-3398_demographic	Alive	28392	M0	N0	Stage IA	T1b	6th	primary	0	1163.0	9e7e4689-929c-5c1d-a1ed-5efcdf3edee3	true	NA	NA	C34.3	Right	8140/3	Adenocarcinoma, NOS	no	No	R0	Lung, NOS	NA	TCGA-44-3398_diagnosis	No	Lower lobe, lung	NA	2009	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TCGA-44-3398_treatment2	NA	NA	NA	NA	be375682-0520-4254-9595-c4fedf9d8a2b	Adjuvant	no	NA	Radiation Therapy, NOS
